data_1ys5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ys5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 3.06 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.93 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 6.65 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 4.39 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.69 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 4.18 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 4.38 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 4.68 106.616 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.58 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.8 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.86 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 5.38 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 2.89 111.905 168.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 2.25 112.155 -161.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.407 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 4.3 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 5.68 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.83 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.78 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 1.61 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 4.19 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.97 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.65 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.99 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 2.31 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.13 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 1.07 112.735 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 4.49 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 2.07 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 2.6 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 3.39 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 1.54 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 2.71 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.36 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 4.81 110.683 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 2.71 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.31 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 5.07 113.247 172.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.31 108.726 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.95 112.638 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.88 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 5.08 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 2.89 107.072 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 4.9 112.691 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 2.59 111.028 -174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.94 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.89 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.62 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 2.98 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.58 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.91 106.721 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.9 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 4.12 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 2.14 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 2.19 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 2.02 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 2.63 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 8.07 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 6.69 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.41 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 4.6 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 7.67 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 8.02 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 10.02 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 5.94 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 3.12 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 3.66 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 2.33 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 2.02 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 2.29 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 3.06 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 7.25 107.453 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 4.47 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 3.83 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 2.63 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.24 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.98 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.85 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 1.1 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 6.35 108.629 172.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 3.13 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.83 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.18 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 3.92 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 6.18 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.37 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.76 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 5.73 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 2.83 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 5.19 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.41 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 2.51 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 2.17 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 1.05 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 2.99 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.79 110.032 158.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.41 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 3.83 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 5.24 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 3.66 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.19 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.52 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 3.0 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 3.26 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 3.27 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 2.65 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.85 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 2.77 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 2.5 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.94 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.27 105.071 179.45 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 3.07 112.325 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.64 111.315 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 5.29 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 3.45 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.75 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 4.55 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.41 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 4.69 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 4.05 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.79 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.86 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.99 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 2.36 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 6.62 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 2.43 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 2.91 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 5.76 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 8.36 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.88 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 3.03 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.15 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 3.63 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.15 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.24 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 2.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.48 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.6 113.211 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 7.39 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 1.98 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.99 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 3.91 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 2.05 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 3.09 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 4.54 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 3.17 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 2.42 109.915 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 4.44 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 3.77 107.156 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.55 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.15 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.94 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.82 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 3.18 106.571 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.66 104.568 157.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 7.45 104.986 31.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 2.63 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 5.27 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 2.75 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 2.04 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.78 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 3.18 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.82 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 2.24 109.572 -171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.76 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 3.29 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.88 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 2.53 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.81 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.01 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.45 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.66 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 6.04 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.55 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.9 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 5.65 111.671 -158.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 8.88 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 6.91 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 3.32 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 2.23 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 3.24 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 2.3 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.93 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.89 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 2.18 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 4.05 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.85 107.562 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 3.39 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.16 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 2.56 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.61 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 4.83 111.123 140.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.62 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 1.39 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 3.44 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 3.18 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 2.08 108.426 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.38 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 3.75 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 8.41 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.81 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.73 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 5.2 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 2.69 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 4.8 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.56 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 2.44 107.301 163.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 2.23 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.17 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 2.65 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 1.88 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.44 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 3.29 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 4.76 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 3.25 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 3.15 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.53 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.36 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 2.5 109.69 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 3.5 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 3.37 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 2.1 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 1.18 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 3.34 112.403 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 2.89 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 2.36 111.317 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 4.25 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 3.24 108.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.76 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 3.77 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 2.34 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 3.62 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.74 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 5.48 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7 115.112 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 5.91 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.18 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 6.46 111.365 -166.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 2.08 112.692 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 2.02 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.444 ' CE1' ' CG2' ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 3.97 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 5.7 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.08 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 3.67 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.92 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 3.94 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.36 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.95 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.12 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 2.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.91 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.86 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.97 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 2.24 105.686 169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.88 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 3.7 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 2.37 109.011 168.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.456 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 2.73 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.38 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 4.67 113.126 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.97 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 2.14 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 6.24 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.88 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.456 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.59 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.01 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.15 110.273 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 4.7 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 3.03 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.3 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 4.57 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 3.02 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 5.86 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 2.71 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.75 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.05 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 3.07 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 1.99 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.14 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 2.79 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.98 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 2.92 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.63 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.44 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 2.19 108.152 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 9.05 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 4.94 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.08 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.97 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 5.3 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 7.64 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.87 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 4.86 105.792 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 2.22 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 3.63 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 2.55 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.77 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 3.09 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 1.85 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 3.01 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 5.34 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 3.29 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 3.27 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 2.58 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.11 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.78 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.63 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 1.25 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 4.83 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 2.57 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 2.07 112.359 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 3.1 106.222 154.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 6.8 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 4.8 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.37 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 4.43 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 2.05 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 4.64 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.64 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.78 107.391 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 2.37 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 2.42 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 1.68 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 3.08 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 4.3 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.83 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 3.97 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.9 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 1.18 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 3.56 108.319 -167.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 4.46 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 3.81 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 2.1 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 1.09 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.8 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 2.1 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 1.68 109.097 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 6.09 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.31 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 3.62 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.03 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 5.09 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 3.61 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.62 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 4.02 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.8 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 6.07 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 3.24 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 2.5 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.57 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 2.16 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.74 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 2.36 109.578 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 2.0 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 4.22 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 5.79 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.62 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 3.34 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.85 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 3.95 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.33 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 2.37 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.57 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.39 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 2.56 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.43 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.28 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 4.36 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 2.28 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.85 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 3.36 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.78 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 2.18 104.217 159.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.51 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 5.13 114.0 -171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 2.21 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 2.31 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.92 110.591 164.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.92 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.62 112.343 -158.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.97 108.933 -171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.17 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.95 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 2.74 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.59 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 4.36 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 2.54 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 4.72 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 2.11 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.77 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.08 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 3.04 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.88 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 2.22 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 3.0 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 2.1 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 2.58 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 2.46 111.962 -165.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.26 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.92 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.59 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 5.21 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.83 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 3.02 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 6.68 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 8.36 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 7.57 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 3.33 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 2.13 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 3.89 106.063 158.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 2.28 109.667 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.16 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.88 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 1.9 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 3.25 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.92 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.62 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.53 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 2.14 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.91 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 4.34 109.839 133.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.6 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 1.28 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 3.89 112.197 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 2.63 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 1.77 107.791 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.15 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 3.5 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 6.27 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 4.29 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 3.42 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 5.49 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 2.2 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 4.82 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.17 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 2.23 105.251 166.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 1.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 2.56 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 1.84 111.291 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.07 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 3.32 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.78 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 3.53 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 3.0 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.01 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.47 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 3.71 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.84 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 3.3 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 2.32 106.618 162.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.92 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 3.24 112.707 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 2.85 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 2.13 107.667 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 5.35 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.17 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 3.46 111.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.67 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 5.52 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.79 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 4.45 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 3.88 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 4.66 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 5.43 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 2.6 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.76 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.34 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 2.08 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 7.39 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 2.7 111.147 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 2.37 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 5.37 109.47 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 7.18 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 1.2 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.68 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 1.57 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 3.35 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.98 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.76 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.53 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.99 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.18 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 1.04 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 4.67 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 1.57 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 3.32 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 3.39 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.85 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 2.44 108.302 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.61 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 3.83 112.653 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 2.03 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 2.56 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 6.44 114.062 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.88 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.64 110.656 -169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.58 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 4.04 114.08 -164.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.83 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.14 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 4.77 112.334 153.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 2.33 111.202 -166.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 4.02 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.91 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.68 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.22 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.81 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.97 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.87 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 2.84 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.83 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.92 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.11 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 2.06 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 9.1 114.409 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 5.13 112.984 -166.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.63 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.3 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 5.7 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 6.52 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 7.16 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 3.17 110.733 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 2.5 111.007 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 3.34 108.928 162.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 2.01 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.61 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 2.05 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 3.62 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.64 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 4.31 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.44 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 2.3 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 4.01 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.72 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 1.33 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 3.57 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 2.23 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 2.06 112.635 -170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.08 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 3.42 108.275 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 8.68 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 3.8 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.97 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 2.3 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 3.33 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.72 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 2.1 107.822 167.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 1.75 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.95 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 2.23 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 1.58 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 3.1 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 3.38 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 5.96 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 3.93 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 3.83 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.84 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.61 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 2.58 108.754 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.95 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 3.73 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 2.48 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.29 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.86 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 2.35 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 2.2 110.972 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.93 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.34 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.189 0 N-CA-C 112.025 -0.43 . . . . 4.16 112.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.35 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 5.05 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 3.88 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 2.71 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.97 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 5.38 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 3.18 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 2.32 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.76 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.67 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 2.19 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 7.42 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 2.29 110.242 161.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 2.1 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 4.35 108.447 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 6.39 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 1.0 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 3.57 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.24 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 3.66 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.08 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.59 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.88 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.65 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.89 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.1 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 1.3 114.957 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 6.45 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 2.07 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 2.57 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 3.68 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 2.07 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 2.37 107.188 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.14 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 4.12 112.662 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 2.34 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 2.01 113.799 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 7.23 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.08 107.16 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.9 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.72 107.569 -164.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.89 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 5.04 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.98 107.041 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 5.86 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 3.02 110.089 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 4.63 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 3.41 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 3.15 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.05 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 3.45 113.367 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.08 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 4.0 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 4.0 109.613 -163.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.98 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.89 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 2.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.99 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 2.15 109.047 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 8.56 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 4.94 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.82 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 6.52 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 7.46 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 8.66 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 7.18 112.843 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 4.72 111.229 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 2.57 111.786 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 3.81 109.737 153.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 3.39 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.99 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 2.1 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 2.26 109.409 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 3.02 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 8.51 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.44 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 3.31 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 3.32 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.68 108.563 168.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.92 111.13 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.58 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 4.31 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 2.95 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 1.89 107.659 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 4.2 109.771 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 6.11 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 3.66 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.86 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 4.12 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 2.13 112.92 171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 3.5 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.11 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 2.25 105.993 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 2.17 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.16 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 2.65 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 2.21 108.738 160.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.37 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 3.46 111.492 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 5.02 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 3.77 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.94 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.63 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.25 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 2.37 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 4.33 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 3.27 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 3.64 106.78 167.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.4 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 3.3 111.909 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 2.91 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 2.05 111.267 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 4.87 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.93 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 3.36 113.685 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.8 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 6.79 114.104 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 4.17 109.775 167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.95 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 5.04 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.45 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 4.63 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.81 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 4.76 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.53 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 3.3 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.17 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 6.18 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 2.44 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.87 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 4.44 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 6.63 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 3.16 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 1.74 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 3.62 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 1.03 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 4.06 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.67 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 2.23 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.09 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 1.08 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.81 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 2.48 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.73 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 3.75 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 2.07 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 3.15 108.934 160.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.22 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 3.55 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 2.83 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 2.86 114.884 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 5.05 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.95 107.025 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 3.37 110.661 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 6.28 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.92 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.16 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 4.33 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 3.6 110.654 -150.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 4.9 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 2.36 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.56 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.3 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 3.02 112.015 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 2.1 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.26 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 2.84 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 2.05 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 2.34 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 2.28 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' A' ' 100' ' ' LYS . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.32 109.75 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 2.06 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 7.14 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.434 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 5.24 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.51 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.05 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 6.52 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 6.81 109.431 -162.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 10.3 108.804 -160.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 3.87 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 2.47 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.96 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.58 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.81 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 3.47 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 1.97 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 3.7 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 5.38 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 3.27 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 2.09 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.43 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.91 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.64 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 1.27 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 3.66 110.59 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 2.39 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 2.19 109.603 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.67 111.498 -166.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 3.58 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 9.29 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 4.24 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.89 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 4.14 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 2.13 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 3.64 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.91 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 2.3 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 1.95 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.99 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 2.48 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.92 111.343 168.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.45 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 2.89 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 3.72 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 3.86 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 3.69 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.96 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.29 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 2.43 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 3.28 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.99 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 2.35 107.186 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.12 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.89 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 2.54 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 2.25 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.91 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.24 109.828 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 3.08 109.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.44 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 3.46 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 3.57 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 5.87 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.11 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 4.54 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 3.15 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 3.22 112.845 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.95 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 3.84 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 3.13 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 6.97 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 3.8 109.059 167.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 2.38 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 4.48 109.598 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 5.06 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.67 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 3.4 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 1.74 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 3.86 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.06 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.62 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.53 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.23 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 2.45 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 1.05 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.5 112.173 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 7.0 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 2.07 109.425 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 3.01 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 3.62 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.92 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 2.52 107.027 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.17 106.944 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 3.56 113.849 -169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.93 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 2.44 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 5.66 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 2.01 106.995 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.93 114.826 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.74 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 1.2 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 4.15 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 3.09 107.616 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.57 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 6.66 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 2.62 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 5.6 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 2.76 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 4.1 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.03 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 3.58 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 2.08 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 2.18 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.36 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 2.65 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 2.28 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 2.26 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.75 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.51 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.43 ' CG2' HG23 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 3.39 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 7.94 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 5.86 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.82 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.58 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 5.39 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 8.45 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.446 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 6.34 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 3.06 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.94 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.43 HG23 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 4.45 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 2.59 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.89 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 2.96 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 1.84 109.227 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.93 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 6.79 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 6.58 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.93 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.92 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.77 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 1.59 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 4.18 108.888 -168.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 3.3 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 1.74 110.636 -171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.12 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.446 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 3.85 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 8.35 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 3.66 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.12 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 4.56 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 2.18 113.433 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 3.44 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.96 109.864 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 1.82 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.8 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 3.4 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 1.89 110.842 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 3.5 108.043 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 3.58 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 4.13 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 5.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.36 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.93 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 2.56 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.88 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 4.13 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 2.12 107.868 168.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.93 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 2.23 107.223 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 2.21 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 2.18 111.751 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 5.64 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.44 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 116.098 1.199 . . . . 3.87 116.098 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.49 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.68 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.95 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 2.53 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 4.18 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 5.13 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 3.33 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 2.66 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.47 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 2.67 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 2.38 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 6.77 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 2.56 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 2.15 109.81 -168.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 4.6 109.083 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 5.03 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.83 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.93 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.88 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 3.73 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.94 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.86 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.36 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.86 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.96 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 1.03 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 4.63 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 2.11 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 3.22 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 3.46 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.86 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 2.17 108.753 158.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.33 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 3.37 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 2.38 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 2.41 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 5.13 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.25 110.318 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.9 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.32 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 4.17 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 4.58 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.74 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 4.78 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 3.21 111.054 -164.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 6.31 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 2.59 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.66 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 3.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.03 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 2.2 109.008 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.65 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.91 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 2.38 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 2.33 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.93 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.92 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 2.23 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 9.26 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 6.43 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 5.44 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 6.3 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 8.54 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 7.06 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 4.93 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 3.34 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 3.96 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 3.25 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 1.01 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 3.18 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 1.75 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 3.75 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 5.68 106.684 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.64 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.62 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 2.25 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 4.19 110.348 135.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.65 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 1.18 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 3.6 113.43 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.7 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 1.99 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.35 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 4.14 107.855 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 6.51 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.75 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 3.3 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.92 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 2.2 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 3.25 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 2.04 106.5 154.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 1.96 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 1.02 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 2.63 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 2.06 111.425 166.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 2.98 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.85 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 3.34 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 4.46 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.41 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.5 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.71 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 3.24 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 3.91 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 2.13 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.97 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 2.26 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 2.24 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 1.94 111.526 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.91 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.85 111.613 -170.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.198 -0.761 . . . . 3.29 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.61 112.284 -174.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.59 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 4.25 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 3.23 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 4.02 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.11 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 5.22 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 3.64 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 2.59 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.01 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 2.66 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 2.4 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 5.97 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 2.52 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 2.3 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 4.29 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.94 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.84 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.85 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 1.64 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 3.33 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.14 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 2.19 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.95 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.44 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 2.7 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.12 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.99 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HZ2' ' CD2' ' A' ' 84' ' ' HIS . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 4.41 107.352 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 1.87 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 3.04 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 3.86 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 2.39 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 2.62 105.287 152.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.38 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 3.93 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 2.14 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 2.05 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 5.39 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 2.14 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.81 112.098 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.68 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.96 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.98 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 3.1 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.66 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' CD2' ' HZ2' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 4.82 116.805 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 3.06 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.86 113.378 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 3.13 110.096 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 2.05 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 3.84 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 3.74 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.32 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 3.72 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 2.23 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.75 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 1.99 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 2.78 110.87 168.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 7.42 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 5.58 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.67 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 3.21 114.248 164.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 7.15 110.763 -171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 10.34 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 7.06 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 5.66 113.268 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 4.03 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 4.4 108.319 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 2.76 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 1.04 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 2.81 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 1.81 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 4.26 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 8.0 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.38 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.86 113.029 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 2.8 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.81 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 4.37 108.681 141.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.73 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 2.01 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 3.47 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 2.48 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 2.12 109.567 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.15 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 3.4 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 5.64 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 3.62 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.45 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 4.6 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 2.02 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 3.59 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.95 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 2.09 107.516 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 2.46 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.95 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 2.6 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 1.58 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.31 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 3.48 109.43 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.97 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 3.42 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.97 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.83 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.1 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.81 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 6.42 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 2.77 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 2.46 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.88 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 2.27 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 2.58 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 2.14 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 4.46 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.24 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 4.05 108.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.55 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 5.09 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 4.39 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 3.09 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 4.56 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.41 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 4.26 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 3.82 106.312 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 2.46 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.48 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.42 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 2.02 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 6.81 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 3.54 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.72 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 6.05 115.083 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 7.4 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 1.25 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 3.18 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 1.82 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 3.18 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.05 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.87 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.97 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.76 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 2.56 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.9 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.63 113.206 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 7.09 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.97 108.127 -167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 4.57 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 3.43 112.02 -169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.67 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 3.35 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.1 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 4.1 114.826 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 2.91 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 2.23 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 5.07 110.204 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.66 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 2.3 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.3 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 5.7 111.622 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 3.27 107.708 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' GLU . 85.7 m-70 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 5.32 107.815 158.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 3.04 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 6.23 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 3.34 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.29 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.61 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 3.78 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 2.26 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 2.6 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 2.02 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 2.54 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 2.25 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 2.83 106.636 169.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 7.48 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 6.78 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.33 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.75 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 9.29 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 9.04 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 10.27 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 5.14 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 3.35 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 3.59 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.96 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.89 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 2.06 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 2.11 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 3.51 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 8.36 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.58 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 3.57 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 2.35 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.69 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.97 109.755 166.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 1.26 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 3.84 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 3.34 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 2.23 109.144 -170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 4.15 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 5.37 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.78 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.36 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 5.21 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 3.55 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 5.58 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.07 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 2.1 107.488 167.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 2.27 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.36 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 2.9 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.81 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.17 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 3.46 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 4.88 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 4.3 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 3.12 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.3 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 2.23 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 3.05 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 4.72 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 4.84 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 2.27 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.94 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 2.02 107.61 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 2.45 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.62 109.271 167.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 4.11 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.63 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 CA-C-O 120.095 -0.281 . . . . 3.61 112.654 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.24 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 7.16 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 4.02 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 2.43 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 4.13 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.06 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 4.33 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 3.67 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 2.49 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.33 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.45 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 2.04 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 7.71 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 2.7 111.509 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 2.19 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 4.15 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 5.92 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.84 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 3.46 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 1.85 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 3.84 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.87 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.58 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.58 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 2.44 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 1.01 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 6.48 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 2.02 109.374 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 3.07 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 3.6 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 2.41 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.423 HG21 ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 2.82 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.83 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 3.96 112.711 -164.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 2.19 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' CB ' HE22 ' A' ' 77' ' ' GLN . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 2.27 112.71 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 5.52 113.159 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.418 HE22 ' CB ' ' A' ' 75' ' ' ALA . 7.9 mm-40 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.88 111.047 -172.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 2.25 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.86 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 8.03 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.419 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 4.17 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.82 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 6.96 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 2.44 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.94 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.83 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.6 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.24 111.667 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 5.01 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.34 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 3.65 109.987 -157.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.58 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 2.95 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 2.01 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.96 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.42 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.41 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 2.24 111.293 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 8.04 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 5.45 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.09 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.1 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 6.13 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 7.36 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.92 109.434 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 3.7 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 2.35 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 3.77 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 2.37 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.2 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 3.0 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 2.06 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 3.2 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 5.51 104.702 168.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 3.54 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 4.55 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 2.23 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.78 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 5.68 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.66 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.47 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 3.39 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 3.33 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 1.97 111.124 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.35 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 3.32 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 5.64 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 3.87 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.68 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 4.72 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 2.17 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 3.38 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.81 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.83 107.605 157.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 2.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 2.5 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 2.13 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.14 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 3.88 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 4.53 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 3.04 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 3.71 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.88 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.32 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 2.85 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 5.74 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 4.09 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 2.43 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 1.01 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 2.17 106.907 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.94 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 2.03 113.224 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 6.64 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.92 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.43 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 4.54 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 3.85 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 2.46 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.99 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 5.28 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 3.11 108.193 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 2.46 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.83 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.87 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 2.65 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 5.53 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 2.16 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 2.73 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 6.31 112.335 172.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 6.8 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 1.07 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 3.73 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 1.55 105.549 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 3.98 110.28 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.37 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.82 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.06 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 2.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.47 110.449 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 1.36 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 5.26 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 2.17 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 4.23 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 3.58 112.252 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 2.39 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 2.77 105.923 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.42 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 3.59 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 2.21 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 2.43 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 5.01 114.494 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.63 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.52 112.575 -137.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.41 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 1.07 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 5.57 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 3.92 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.93 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.476 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 7.04 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 3.36 110.876 -164.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 5.41 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.64 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.47 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.35 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 4.49 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 2.18 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 3.28 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.94 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.92 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.95 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.3 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 2.39 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 8.0 112.101 170.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.81 111.404 -169.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.99 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.63 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 6.76 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 7.24 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.49 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 5.16 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 3.12 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 3.65 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.92 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.9 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.8 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 1.8 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 3.08 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 6.37 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.67 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.7 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 2.48 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.91 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 4.33 109.961 131.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.69 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 1.54 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 3.95 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 3.69 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 1.83 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.06 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.91 109.889 -162.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 7.18 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 4.1 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.16 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 4.85 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 3.13 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 5.34 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.85 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 2.08 106.744 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 2.1 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.79 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 3.47 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.9 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.11 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 3.19 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 4.57 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 3.05 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 3.6 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.85 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.18 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 3.34 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.84 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 3.89 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 5.16 108.7 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 1.1 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.77 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 2.2 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 2.28 109.656 172.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 4.33 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.92 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 109.25 -1.54 . . . . 2.71 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.6 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.86 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 3.44 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.82 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 4.67 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 6.26 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 3.2 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 2.39 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.67 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 4.08 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.49 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 6.79 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 2.19 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 2.66 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 6.46 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 5.62 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 1.04 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 3.14 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 2.23 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 5.78 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.34 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 2.35 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.82 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.66 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 2.2 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 1.33 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 1.38 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 4.14 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 2.26 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.44 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 3.32 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 2.26 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 3.28 105.123 167.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.35 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 4.08 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.86 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 2.62 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 6.13 113.121 174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.12 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 2.5 110.73 171.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.57 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 1.25 109.553 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 6.47 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 4.0 110.087 -169.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 4.58 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 2.74 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 6.32 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 3.02 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.73 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.8 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 2.65 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 2.32 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.56 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 2.96 106.427 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.82 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 2.09 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 2.55 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.57 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 2.14 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 9.27 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 5.51 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.41 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.45 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 5.29 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 7.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 6.38 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 3.31 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.97 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 3.65 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 3.08 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.89 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 2.54 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 2.64 108.187 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 3.53 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 5.6 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.63 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.88 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 2.11 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 4.04 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 1.28 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 4.49 110.246 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 2.74 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.97 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 4.79 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 7.28 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 4.82 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.55 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 5.15 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.68 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 3.36 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.03 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 2.03 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 1.95 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.25 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 2.47 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 1.96 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 3.11 106.086 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 4.43 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.99 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 3.74 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.96 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.48 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.67 109.109 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.62 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 3.46 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 2.36 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 3.37 112.235 -166.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 2.76 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 2.29 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.98 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.67 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 3.69 110.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 5.88 110.936 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 3.89 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 2.36 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 4.24 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.8 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 5.58 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 3.14 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.74 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.98 110.905 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 3.47 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 2.48 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 5.58 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 2.76 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 3.22 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 4.06 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 5.27 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.96 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 4.12 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.73 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 4.41 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 3.12 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.17 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.63 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 3.28 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.92 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 1.13 112.734 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 4.53 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 2.03 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 3.17 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 3.27 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 2.35 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 2.67 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 3.49 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 2.46 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 2.05 112.749 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 6.38 111.72 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7 105.528 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.63 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 5.64 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 2.63 106.895 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.37 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 5.6 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.99 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.75 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 2.47 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.87 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.59 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 3.05 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.51 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 1.89 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.66 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 2.75 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.92 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.26 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 2.7 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.56 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.73 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.99 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 6.14 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.23 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 5.19 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 5.23 110.92 163.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 6.56 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 7.51 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.96 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 2.43 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 4.26 107.58 150.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 2.31 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 1.08 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.86 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 1.88 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 3.33 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.83 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.39 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.71 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 2.38 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.32 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.8 107.77 167.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.68 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 1.43 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 5.33 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 2.33 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 1.76 112.933 -170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.17 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 4.28 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 7.03 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 3.53 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.67 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 5.11 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.33 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 4.08 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 155' ' ' LYS . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2 107.076 -174.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 2.62 108.899 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 2.34 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.92 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 2.43 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 2.08 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.56 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 3.36 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.92 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 3.79 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 3.28 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.79 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.54 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.95 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.91 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 3.77 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 2.73 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.29 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.66 108.597 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 2.01 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.98 109.635 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 134' ' ' GLU . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.78 113.774 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 CA-C-O 119.377 -0.679 . . . . 2.56 112.346 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.82 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 5.03 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 4.4 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.62 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 5.38 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.36 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 6.67 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 3.62 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 3.03 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.83 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 4.21 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 2.72 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 6.26 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 2.63 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 2.56 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 6.12 110.027 162.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 5.46 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 1.25 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 4.06 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 1.64 104.584 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 3.27 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.16 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.78 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.38 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.99 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.99 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 1.42 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 4.09 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 2.37 108.419 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 3.03 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 3.83 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.87 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.97 106.41 163.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 5.16 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 2.8 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 2.73 114.012 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 6.49 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.54 107.785 168.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.86 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.88 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 7.42 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 2.65 109.18 -171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 4.51 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 2.87 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 4.79 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 2.08 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.78 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.12 111.039 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.95 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 2.1 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.95 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 3.49 106.433 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 2.36 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.91 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.91 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.84 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.8 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.83 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.441 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 4.4 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.65 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 4.06 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 6.88 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 7.26 108.24 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.421 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 6.1 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 3.7 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 2.33 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 3.52 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 3.07 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.94 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.77 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 1.97 109.404 168.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 2.8 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 5.69 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 3.23 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.53 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 2.12 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.85 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 4.38 110.603 135.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.67 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.24 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 5.13 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.81 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 2.0 109.113 -174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.15 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.421 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 3.09 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 6.78 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 4.99 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.39 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 4.41 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 2.05 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 4.36 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.99 108.581 -170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 2.36 107.768 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 2.27 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 3.28 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 1.69 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.11 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 3.12 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 4.55 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 3.18 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 2.92 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.38 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 2.41 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 3.24 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 4.48 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 2.39 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.94 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.88 107.91 -171.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.88 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 2.11 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.99 107.628 160.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.76 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 2.77 113.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.52 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.59 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.69 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.63 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 5.63 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.87 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 5.44 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 3.52 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 2.56 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.69 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 3.74 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 5.86 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 2.31 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 2.62 110.288 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 4.11 109.109 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 5.59 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.82 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.85 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 1.89 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 3.57 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.09 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.4 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.78 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 2.25 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 1.07 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 1.25 112.555 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.98 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 1.86 107.321 165.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 3.3 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 3.6 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 2.03 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.41 109.501 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.66 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 3.69 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 2.67 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.96 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.74 115.444 167.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.55 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.48 112.074 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 4.27 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 2.81 107.952 -169.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.89 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.493 ' CE1' ' H ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 7.5 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 2.53 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 4.82 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 2.14 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 3.62 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.94 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 1.91 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.58 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 2.79 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 2.76 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 2.27 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 2.01 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.66 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 2.39 111.394 174.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 7.72 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 5.27 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.14 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.7 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 7.36 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.9 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.571 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 6.45 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 3.14 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 2.02 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 3.94 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 3.08 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.72 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 2.42 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 2.04 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 4.18 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 6.36 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.28 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.99 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 2.16 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 4.17 108.365 170.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.75 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.12 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 3.42 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.98 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 1.82 109.419 -171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.16 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.571 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 3.25 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 5.58 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 3.71 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.33 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.93 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.87 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 4.61 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.01 108.07 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.84 109.21 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 1.84 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.8 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 3.59 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 2.57 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.14 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 3.57 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 4.55 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.76 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.83 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.78 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.28 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 3.76 108.143 -171.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 3.42 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 3.51 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 2.68 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.86 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.99 107.115 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.66 109.798 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.99 109.396 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.08 110.118 -157.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 3.28 108.099 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.11 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.73 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 3.75 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 2.37 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 3.68 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 5.42 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.83 115.001 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 5.81 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.78 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.13 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 6.47 111.604 -165.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 2.04 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 2.0 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 4.08 110.925 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 6.23 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.97 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 3.81 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 2.18 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 3.75 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.18 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.83 112.943 173.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.35 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 2.72 105.701 153.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.05 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.82 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 5.29 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.97 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.87 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 3.78 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 2.32 108.355 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.479 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 2.68 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.44 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 4.9 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 3.11 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 2.2 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 6.28 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.91 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.69 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.94 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 1.13 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 4.63 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 3.15 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.65 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 5.0 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 2.68 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 6.27 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 2.68 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.82 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 3.04 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.87 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 2.08 109.793 -169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.24 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 2.7 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 2.05 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 2.99 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.68 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 2.19 108.764 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 9.06 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 4.95 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.05 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.97 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 5.24 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 7.63 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.87 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 4.86 105.771 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 2.29 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 3.7 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.54 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.89 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 2.96 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 1.77 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 3.04 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 5.21 106.622 170.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 3.33 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 3.07 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 2.5 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.13 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 4.08 108.669 163.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.81 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 1.16 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 4.64 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.72 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 2.07 112.892 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.49 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 3.13 106.044 155.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 6.84 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 4.78 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.33 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 4.2 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 2.05 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 4.8 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.62 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.84 107.694 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 2.7 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.13 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 1.84 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 3.02 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.68 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.92 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 4.09 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.16 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.32 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 3.59 109.364 -167.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 4.05 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 3.79 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 2.24 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 1.0 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 2.23 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 3.0 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.77 109.381 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.99 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.33 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 3.65 111.679 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.56 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 5.0 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 4.28 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 3.04 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 4.79 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.06 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 6.42 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 3.38 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 2.69 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.32 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 3.18 116.775 -160.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 2.5 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 9.31 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 3.54 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 2.45 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 5.54 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 6.37 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.5 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.99 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.69 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 3.49 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.31 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.21 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.47 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.72 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 2.84 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.43 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.46 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.98 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 2.62 109.629 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 2.55 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 3.99 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 2.19 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 2.87 106.833 158.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.24 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 4.38 113.437 172.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 2.39 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 2.28 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.89 114.268 169.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.441 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.89 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.49 111.704 -172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.86 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.7 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.93 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 4.97 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.72 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 6.1 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 2.96 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 5.17 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 3.01 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 3.34 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.15 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 2.12 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.08 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 3.3 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 3.23 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 2.29 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 2.12 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.31 112.887 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.92 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 4.83 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 4.72 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 7.98 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 9.47 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 6.19 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 3.55 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 2.31 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 3.47 107.895 164.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 2.06 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 1.04 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 3.24 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 1.91 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 3.25 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 8.65 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.76 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.67 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 3.86 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.9 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 7.09 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.1 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.31 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 4.0 111.942 -171.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 2.42 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 2.75 110.184 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 4.31 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 6.94 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 4.5 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.76 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 6.38 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 2.24 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 3.63 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.61 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 2.32 107.919 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 2.66 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.2 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 2.89 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 1.74 110.513 163.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.03 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.98 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 5.72 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.82 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 4.27 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.65 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.84 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 2.89 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 3.17 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 3.6 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 2.29 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.94 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.99 107.946 -171.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 2.28 110.85 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 5.59 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.77 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 3.62 111.185 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 12.6 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 4.71 109.213 -165.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.64 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 6.13 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 5.05 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 3.85 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 4.29 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.8 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 4.19 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 3.23 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 6.66 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 2.3 108.759 158.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 2.26 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 4.12 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 6.72 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 1.01 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.76 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 1.75 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 3.3 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 2.07 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.24 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.92 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 2.03 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.06 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.68 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 4.51 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 2.1 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.85 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 3.21 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 2.01 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 2.88 109.122 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 4.2 115.943 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 2.79 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 2.02 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 5.46 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.91 106.668 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.58 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.61 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.8 106.587 161.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 6.87 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 4.52 107.702 -177.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.69 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 5.16 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 3.23 109.859 -158.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 4.87 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.63 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 2.12 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.63 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 3.72 110.921 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 1.84 109.08 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 2.64 109.134 -173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 2.64 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 2.04 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 2.36 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.09 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 2.34 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 7.9 111.976 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.96 113.642 177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.04 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 7.39 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 11.64 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 8.81 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 3.79 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 2.08 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 3.26 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 3.22 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 1.01 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.94 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 1.98 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 4.15 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 6.19 108.286 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.8 t30 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.66 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.45 109.201 177.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 2.35 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.87 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.61 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 1.23 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 3.81 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 3.63 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.78 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.3 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 4.14 108.547 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 5.54 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 3.42 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.85 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.99 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 2.15 113.241 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 3.97 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.08 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 3.0 108.42 170.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 3.37 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.4 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 3.5 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.78 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.03 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 3.14 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 4.71 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 3.67 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.92 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.93 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 1.11 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 2.18 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 4.15 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 3.5 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 2.48 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.42 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 2.0 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 2.0 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 1.95 108.835 171.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.79 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.03 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 3.7 113.483 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.54 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.69 111.812 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 3.37 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.43 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 4.63 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.51 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 7.49 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 3.47 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.68 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.77 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.49 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 9.87 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 2.98 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 2.55 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 5.96 112.524 157.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 6.87 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.58 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.92 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 1.83 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 3.31 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.12 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.97 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.38 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.4 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 2.5 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 1.07 113.671 -174.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 4.31 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 2.07 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 2.91 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 4.51 112.398 -172.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 2.79 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 2.74 111.16 173.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.47 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 3.51 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 2.41 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.89 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 6.16 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.37 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.55 110.932 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.97 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.07 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 4.52 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 2.69 107.504 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.22 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 4.27 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 2.81 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 4.51 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.85 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.06 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 3.32 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.84 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 2.12 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.28 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 3.61 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.82 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 2.34 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 2.08 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.49 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.75 103.619 166.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 8.21 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 4.13 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.07 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.14 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 6.18 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 10.16 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.86 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.65 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 2.35 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 3.14 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 2.31 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.97 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.87 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 1.96 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 3.17 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 6.29 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.81 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.83 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 2.07 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 4.07 109.438 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.71 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 1.34 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 3.99 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 2.24 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 1.95 111.96 -163.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2 113.064 -168.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 3.19 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 6.14 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 5.52 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.68 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 4.05 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.11 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 4.56 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.63 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 2.38 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 1.77 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.11 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 3.46 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 2.42 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.99 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.82 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 3.23 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.76 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 1.21 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 2.45 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 4.22 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 3.3 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 2.19 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.4 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 2.2 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 2.22 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 3.07 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 4.11 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.86 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.208 -0.757 . . . . 3.34 111.208 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.83 113.128 -175.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 5.1 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 3.69 111.17 165.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.99 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 5.65 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.03 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 4.65 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 4.17 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.6 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.85 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 4.33 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 2.91 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.92 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 2.24 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 2.02 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 5.26 116.967 -177.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 6.03 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 1.12 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 4.16 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 2.15 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 3.55 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.94 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 2.02 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.19 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.38 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 2.0 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.9 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.98 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 2.28 109.63 174.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.51 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 3.93 111.597 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 2.99 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 3.48 104.518 160.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.99 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 4.26 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.92 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 2.12 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 8.23 113.969 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.79 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.14 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.97 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 7.92 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 3.31 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.34 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 5.38 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 3.09 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 5.03 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 3.17 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.53 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.35 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.94 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.84 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 2.15 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.32 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 2.81 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 2.3 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 2.4 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 2.31 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.89 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 2.73 108.543 170.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 8.59 110.138 163.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 8.11 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.69 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 5.06 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 8.8 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 7.34 112.013 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 3.37 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 2.01 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 4.01 108.242 157.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 2.98 110.937 177.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.95 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 2.21 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 2.09 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 3.43 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 7.39 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 4.32 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 3.39 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 2.79 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.71 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.69 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.67 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 3.92 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 2.33 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 2.0 108.015 -174.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.17 111.402 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 4.06 111.2 -174.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 8.6 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 4.14 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.36 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 6.78 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.89 107.117 -164.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 3.58 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.15 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 2.17 106.545 155.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 2.27 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.71 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 3.05 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 1.9 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.05 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 3.06 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.88 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 3.22 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.91 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.65 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.19 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 3.66 106.872 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 3.34 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 3.31 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 2.5 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.17 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.89 107.57 -175.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 2.37 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.79 109.879 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 5.18 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.37 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 3.01 111.052 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.07 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.35 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 3.26 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 2.08 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 4.66 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.02 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 6.57 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 4.19 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 2.67 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.59 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 2.74 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 2.44 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 6.29 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 3.12 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.35 109.202 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 4.13 108.053 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 6.05 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.8 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 3.04 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 1.85 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 3.49 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.12 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.43 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.51 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.82 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.87 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 1.07 112.32 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 4.51 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 2.3 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 3.06 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 3.53 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.87 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 2.74 106.605 170.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.28 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 3.67 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 2.67 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 2.35 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.89 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 3.27 107.194 172.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.75 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.26 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 6.1 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 2.64 106.56 172.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.49 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 4.77 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 2.66 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 4.27 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 2.44 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.12 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.53 110.277 -172.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 3.12 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.24 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 2.16 108.465 -174.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.06 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 2.82 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 2.79 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 2.44 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.95 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.13 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 2.38 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 9.22 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 5.19 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.98 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 5.41 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 10.31 110.912 -174.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.75 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.93 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 4.87 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 2.19 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 3.67 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.98 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.95 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 2.42 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 2.08 113.656 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 3.04 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 5.64 104.711 174.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.45 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 2.02 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.461 ' H ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 8.92 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.32 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 1.33 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 3.87 109.695 -176.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 2.91 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 1.98 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.17 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 3.33 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 6.09 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 4.97 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.55 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 6.36 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 2.73 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 5.12 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 2.24 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 2.05 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.9 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 3.58 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 1.87 112.069 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.44 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 3.11 106.559 -166.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 4.18 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 3.01 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 2.75 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.58 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.3 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 2.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 3.18 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 4.78 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 2.25 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 1.0 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 2.38 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 2.15 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 2.64 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 4.36 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.33 110.752 -177.22 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 5.01 109.788 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.94 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 7.08 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 4.48 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 3.17 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 4.35 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.14 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 4.57 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 3.13 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 2.3 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.02 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.49 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 2.44 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 7.29 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 2.32 111.5 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.95 110.611 -165.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 4.57 110.031 -178.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 6.17 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.82 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 3.63 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.62 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 3.63 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.34 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.55 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.24 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.28 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 2.65 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.19 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 1.4 111.987 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.97 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 1.79 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 3.46 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 3.53 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 2.72 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.426 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 2.42 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.55 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 4.22 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 3.31 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 2.67 114.021 -162.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 5.39 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.54 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.63 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.88 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 5.12 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.81 106.647 172.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.35 104.082 153.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 6.54 107.493 37.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 3.0 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 5.4 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 3.05 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.53 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 3.52 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.94 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 2.42 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.19 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 3.03 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 3.25 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 2.27 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 2.07 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.47 110.302 -179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.13 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.91 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 5.62 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.1 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.44 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 6.64 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 7.29 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 6.54 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 3.53 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 2.13 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 3.54 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 2.31 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.91 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 2.12 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 1.83 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 2.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 7.33 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.89 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.95 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 3.7 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 5.4 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.65 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 1.39 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 3.46 109.87 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 2.67 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 2.7 107.404 -176.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 4.08 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 5.59 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 3.59 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.95 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 4.84 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 2.04 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 4.29 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 2.05 106.356 170.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 2.06 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.41 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.83 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 2.01 109.783 165.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.35 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 3.24 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 3.35 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.9 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.98 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.62 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 2.45 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 3.1 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 2.93 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 3.75 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.23 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 3.53 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 2.61 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 2.01 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 5.01 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 5.4 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 3.66 110.616 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.15 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 5.09 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 3.58 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.66 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 4.09 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.91 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 6.1 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 3.22 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 2.54 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.19 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.59 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 2.19 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.77 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 2.57 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 2.17 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 4.34 108.234 -177.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.82 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 1.36 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 3.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.78 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 3.66 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 2.13 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.42 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 2.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.32 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 4.44 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 2.16 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.79 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 3.34 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.83 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 2.3 104.621 163.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 5.13 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 2.19 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 2.28 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.94 110.169 165.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.87 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.72 111.912 -162.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.92 109.13 -172.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.89 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.64 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 4.36 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 2.62 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 4.66 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 2.32 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.8 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.08 113.534 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 3.07 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.84 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 2.15 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 3.07 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 2.15 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 2.54 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 2.31 111.179 -167.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.96 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 7.46 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 5.4 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 3.01 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 6.67 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 8.42 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 7.51 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 3.38 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 2.14 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 4.03 104.921 155.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 3.21 109.713 176.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.22 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.86 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 1.88 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 3.2 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.99 106.415 176.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.58 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.42 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 2.15 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.99 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 4.31 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.63 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 1.25 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 3.99 113.022 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 2.74 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.86 108.209 -174.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.13 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 3.51 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 6.28 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 4.37 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 3.42 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 5.61 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.43 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 4.97 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.17 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 2.38 106.153 165.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 2.14 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.07 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 2.53 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 1.86 111.024 169.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 3.25 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.7 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 3.5 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 2.87 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.39 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 3.25 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.92 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 3.53 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 2.21 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 1.03 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 3.16 112.458 173.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 2.36 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.97 107.27 178.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 5.01 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.39 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 CA-C-O 119.575 -0.57 . . . . 3.67 113.224 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' CD ' ' HD1' ' A' ' 39' ' ' HIS 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.69 114.57 -178.155 . . . . . . . . 4 4 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HD1' ' CD ' ' A' ' 38' ' ' GLU . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.53 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 4.3 111.166 176.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.47 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 5.32 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 4.3 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 6.14 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 6.02 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 4.46 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.63 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.13 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.9 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 7.57 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 3.21 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 2.54 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 3.9 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 5.71 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.82 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 4.09 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 2.31 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 4.45 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 3.36 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.09 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.47 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 3.22 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.9 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.78 113.426 -168.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.97 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 1.83 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 2.57 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 3.43 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 1.95 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 2.9 109.374 167.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.72 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 4.55 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 2.27 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 2.57 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 6.61 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.66 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 4.19 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.52 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.9 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 5.33 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 3.26 107.923 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.43 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 6.19 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 3.49 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.98 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 2.41 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.74 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.35 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 4.73 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 2.01 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 2.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.43 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 2.99 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.98 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 2.46 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.86 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.95 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.93 107.896 -178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 8.05 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 4.45 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.24 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 5.36 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 12.27 113.561 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 10.02 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 3.49 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 2.08 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 3.82 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 2.3 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.97 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 2.63 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 2.32 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 3.49 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 7.11 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 7.17 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 3.3 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.97 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.68 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 5.03 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 1.33 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 4.23 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.87 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 2.32 109.551 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 4.19 108.416 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 8.85 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 3.28 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.59 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.95 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.5 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 3.86 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 2.22 108.408 165.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 1.98 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.74 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 3.01 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 1.87 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.51 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 3.11 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 7.34 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 4.01 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 4.6 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.1 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.21 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 4.63 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 4.22 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 3.35 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 2.57 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.56 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 2.53 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 2.12 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 2.32 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 4.39 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 3.77 115.616 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.01 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.8 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 4.12 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.66 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 4.04 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.01 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 4.19 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 3.58 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 2.55 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.3 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.6 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 2.33 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 6.1 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 2.58 111.758 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 2.73 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 4.55 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 5.0 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.97 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.88 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 1.84 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 3.48 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.18 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.51 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.39 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.31 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 2.39 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 1.41 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.99 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 2.03 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 2.59 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 3.54 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.99 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 2.6 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 4.69 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 2.54 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 2.12 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 6.16 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.66 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.14 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 4.64 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 3.0 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 5.84 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 2.5 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 5.27 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 2.75 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.37 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.41 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 3.76 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.17 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 2.22 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.44 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 4.35 111.015 177.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 2.5 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.94 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 2.07 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.03 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 2.67 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 9.69 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 5.14 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.3 113.134 -176.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.15 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 5.32 109.254 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 8.04 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 8.31 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 4.18 110.579 -176.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 2.37 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 3.52 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.92 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.89 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 1.98 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 2.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 8.64 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.74 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.94 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.93 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.61 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 5.19 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.92 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 1.43 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 3.4 111.042 164.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 3.04 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 2.87 109.426 -178.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 3.43 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 6.8 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 4.99 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.03 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 4.54 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 2.09 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 4.32 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.89 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 2.2 104.563 162.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 1.9 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.94 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 3.19 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 2.03 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.93 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 3.63 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 5.44 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 4.5 108.054 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 3.74 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.66 109.156 174.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 2.33 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 3.9 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 6.2 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 2.99 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 2.6 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.96 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 2.08 108.25 -173.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 1.87 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 1.64 111.847 175.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.99 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 4.0 109.975 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.92 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.77 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 3.73 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.53 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 5.31 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.4 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 4.19 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 3.34 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 2.31 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.22 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.45 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 2.24 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.8 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 2.23 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 2.77 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 4.24 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 8.74 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.84 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 3.71 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.76 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 3.55 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.98 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 2.14 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.49 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.3 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 2.3 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.06 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 1.19 113.559 -169.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 4.83 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 2.46 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 3.43 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 3.48 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 2.23 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 2.44 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 3.63 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 2.41 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 2.13 115.032 169.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 7.36 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.72 111.602 -170.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 2.65 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.08 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 4.62 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 2.88 107.983 -174.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.38 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 5.5 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 4.13 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 5.8 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 2.23 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 2.05 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.96 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 4.3 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 2.42 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.8 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 2.82 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 2.18 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 2.39 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 2.54 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.51 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 2.36 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 10.25 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 4.98 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.52 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.65 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.78 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 7.63 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 7.81 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 4.59 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 2.47 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 3.72 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 3.16 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.92 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 2.29 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 2.35 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 3.46 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 6.67 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 4.1 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.59 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 3.65 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 6.67 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.87 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.23 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 5.73 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 3.15 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 2.06 108.004 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.06 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 3.84 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 5.25 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 3.61 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.82 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 5.05 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.94 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 3.66 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.57 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 2.24 106.77 164.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 1.97 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.9 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 2.48 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 2.34 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.18 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 5.53 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.502 ' H ' ' CG2' ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 4.82 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 4.35 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 2.79 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.99 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.92 108.263 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 2.49 107.84 174.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.97 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 3.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 2.67 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 1.06 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 2.59 107.056 178.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 2.1 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 2.01 108.838 175.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 6.3 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.17 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 3.61 108.154 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.69 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.51 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 4.16 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 2.54 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 4.77 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.511 ' CG ' ' HZ1' ' A' ' 44' ' ' LYS . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.8 109.837 -177.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HZ1' ' CG ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 5.24 110.913 -178.447 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 3.88 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.71 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.31 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 3.1 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 2.6 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 6.08 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 3.56 108.027 168.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.43 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.99 114.463 -172.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 5.46 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.94 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.81 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 1.68 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 3.78 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.97 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.75 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.58 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.56 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 2.29 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.19 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 1.23 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 4.28 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 2.07 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 4.27 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 4.02 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 2.21 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 2.4 106.284 175.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.92 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 4.4 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 2.14 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 2.17 112.779 173.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 6.02 115.087 178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 2.19 114.131 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.99 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 1.07 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 4.76 111.432 -176.6 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 5.98 107.097 177.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.34 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 5.53 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 4.22 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.92 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 2.84 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 2.07 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.13 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 3.47 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.49 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.28 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.97 107.486 167.306 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 2.77 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 2.15 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 2.42 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 2.5 108.728 171.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.7 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 4.91 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.66 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.4 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 6.19 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 7.53 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 6.56 110.896 -172.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 3.36 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 2.08 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 3.44 107.223 158.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 2.54 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.74 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 2.28 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 2.21 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 3.27 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 8.42 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.88 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 2.49 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.45 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 4.39 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.63 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 1.34 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 4.05 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 2.8 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 2.0 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.01 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 3.71 109.517 157.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 5.77 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 4.17 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.82 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 6.11 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 3.32 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.82 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.39 108.02 170.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 2.64 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.99 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 2.54 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 1.62 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.44 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 3.37 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 4.12 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 3.51 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.93 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.4 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 1.1 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 2.31 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.97 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 3.59 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 2.32 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 1.08 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.72 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 1.89 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 2.56 107.172 161.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 5.93 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.69 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 3.38 111.942 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.66 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 5.48 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.78 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 4.44 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 3.82 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.64 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 4.7 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 5.42 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 2.59 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.8 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.3 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 2.02 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 7.44 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 2.66 111.084 168.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 2.39 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 5.3 109.223 167.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 7.18 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 1.25 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.64 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 1.55 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 3.44 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.08 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.84 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.95 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.99 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.13 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 1.0 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 4.68 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 1.61 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 3.34 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 3.39 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.91 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 2.48 108.533 177.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.65 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 3.88 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.98 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 2.46 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 6.43 114.415 178.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.83 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.63 111.165 -169.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.91 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 4.11 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.82 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.91 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 4.84 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 2.33 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 4.08 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.89 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.67 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.27 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.81 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 2.09 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.01 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 2.78 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 1.91 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.82 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.9 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.16 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 2.05 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 9.15 114.378 176.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 5.07 112.989 -166.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.61 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.31 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 5.69 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 6.53 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 7.16 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 3.2 110.996 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 2.38 110.403 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 3.32 108.883 159.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 2.04 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.85 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.69 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 1.85 112.353 -160.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 3.48 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.72 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 4.08 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.44 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 2.41 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 4.99 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.9 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.29 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 3.57 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 2.33 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 2.01 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.06 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 3.4 108.35 175.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 8.61 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 3.81 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.53 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.93 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 2.24 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 3.31 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.72 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 2.14 107.81 167.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 1.8 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 2.23 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.82 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 3.47 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 3.55 104.935 168.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 5.56 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 3.63 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 3.53 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.36 107.484 170.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.63 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 2.77 108.73 179.023 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 3.3 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 3.53 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 2.4 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.49 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.97 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 2.46 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 2.22 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.91 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.32 111.988 177.335 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 106.185 -1.783 . . . . 54.41 106.185 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.83 95.56 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.214 -1.773 . . . . 49.42 106.214 155.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -159.09 118.25 2.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.426 -0.953 . . . . 46.11 108.426 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -163.63 156.02 17.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.329 -0.989 . . . . 41.03 108.329 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -173.07 153.63 2.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.745 2.418 . . . . 36.83 105.854 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.43 136.09 5.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.138 -1.06 . . . . 32.38 108.138 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.7 mt -148.93 153.15 37.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.394 -1.706 . . . . 28.63 106.394 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -168.43 166.61 12.22 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.48 -1.304 . . . . 24.8 107.48 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.41 148.65 1.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.157 1.783 . . . . 21.01 107.612 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -169.56 156.75 6.78 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.533 -1.284 . . . . 16.72 107.533 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.17 159.74 15.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.27 1.428 . . . . 16.51 108.206 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -176.18 173.61 2.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.214 1.806 . . . . 11.39 106.403 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.41 73.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.767 1.627 . . . . 7.78 111.359 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -166.62 -43.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.745 2.418 . . . . 15.45 107.093 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.11 100.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.482 -0.562 . . . . 16.42 109.482 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -41.18 138.18 1.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.447 1.499 . . . . 17.01 111.783 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t0 69.32 -53.92 0.59 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.265 2.226 . . . . 13.17 113.153 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -49.31 -36.52 21.3 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.611 -0.68 . . . . 12.0 109.943 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -34.2 -42.2 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.012 2.125 . . . . 9.9 113.837 167.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -58.93 -46.35 88.18 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.309 -0.869 . . . . 12.16 109.883 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.8 m -61.03 -52.2 65.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.023 -1.103 . . . . 10.62 108.023 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -40.98 -83.9 0.01 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.881 1.705 . . . . 7.94 114.596 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -72.11 -98.36 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.502 1.151 . . . . 9.13 112.806 -164.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 72.5 mtm -137.19 -87.89 0.28 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 119.382 -2.074 . . . . 13.54 109.133 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t 69.27 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 125.314 1.634 . . . . 14.23 110.496 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 179.21 108.5 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.045 1.338 . . . . 16.9 108.122 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -166.57 153.77 9.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.326 -1.361 . . . . 16.57 107.326 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -71.34 -63.2 1.16 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.487 -0.931 . . . . 24.86 108.487 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 52.97 -144.24 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.058 0.943 . . . . 19.19 110.586 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -153.34 -70.31 0.14 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.485 1.914 . . . . 22.55 108.59 -169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -170.61 22.03 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.477 1.111 . . . . 24.14 111.413 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.0 mt -125.25 112.3 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.951 -1.87 . . . . 15.11 105.951 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.82 174.27 26.72 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 106.815 -2.514 . . . . 11.51 106.815 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.09 -64.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.925 1.69 . . . . 8.85 112.027 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 mt 49.03 41.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.98 1.312 . . . . 11.4 111.614 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.57 -61.55 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.605 1.162 . . . . 4.11 109.978 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.52 -5.0 54.6 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 3.06 113.064 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.93 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 6.65 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 4.39 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.69 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 4.18 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 4.38 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 4.68 106.616 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.58 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.8 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.86 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 5.38 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 2.89 111.905 168.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 2.25 112.155 -161.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.407 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 4.3 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 5.68 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.83 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.78 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 1.61 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 4.19 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.97 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.65 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.99 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 2.31 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.13 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 1.07 112.735 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 4.49 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 2.07 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 2.6 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 3.39 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 1.54 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 2.71 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.36 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 4.81 110.683 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 2.71 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.31 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 5.07 113.247 172.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.31 108.726 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.95 112.638 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.88 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 5.08 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 2.89 107.072 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 4.9 112.691 -170.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 2.59 111.028 -174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.94 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.89 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.62 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 2.98 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.58 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.91 106.721 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.9 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 4.12 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 2.14 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 2.19 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 2.02 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 2.63 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 8.07 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 6.69 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.41 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 4.6 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 7.67 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 8.02 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 10.02 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 5.94 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 3.12 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 3.66 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 2.33 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 2.02 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 2.29 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 3.06 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 7.25 107.453 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 4.47 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 3.83 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 2.63 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.24 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.98 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.85 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 1.1 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 6.35 108.629 172.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 3.13 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.83 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.18 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 3.92 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 6.18 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.37 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.76 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 5.73 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 2.83 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 5.19 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.41 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 2.51 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 2.17 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 1.05 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 2.99 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.79 110.032 158.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.41 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 3.83 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 5.24 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.38 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 3.66 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.19 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.52 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 3.0 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 3.26 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 3.27 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 2.65 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.85 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 2.77 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 2.5 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 2.5 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.94 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.27 105.071 179.45 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 107.272 -1.381 . . . . 60.84 107.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.2 98.61 0.33 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.871 -1.159 . . . . 55.7 107.871 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -156.2 126.86 6.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.892 -1.151 . . . . 49.54 107.892 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.47 170.19 22.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.526 1.53 . . . . 46.28 107.295 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -166.5 178.54 6.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.026 -1.472 . . . . 39.72 107.026 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.49 38.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.57 -1.27 . . . . 34.98 107.57 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.7 tp -147.41 137.99 23.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.264 -2.125 . . . . 30.17 105.264 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.6 t -85.24 140.61 30.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.651 -0.87 . . . . 25.88 108.651 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.51 174.17 11.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.839 0.456 . . . . 21.87 110.53 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -170.73 161.58 7.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.607 -1.627 . . . . 20.31 106.607 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.3 176.66 0.23 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.613 0.765 . . . . 16.2 109.392 -169.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 p 56.59 -167.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.896 0.879 . . . . 12.09 109.945 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.33 70.57 0.41 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.793 1.637 . . . . 8.0 112.198 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -67.25 176.8 2.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.776 1.63 . . . . 14.58 111.295 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -130.6 153.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.474 -1.306 . . . . 15.28 107.474 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.0 100.08 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.822 1.649 . . . . 17.77 110.281 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 62.77 -68.84 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.84 2.056 . . . . 15.4 111.703 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -42.74 -34.61 0.95 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.467 1.907 . . . . 13.34 111.876 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -30.18 -56.21 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.702 2.001 . . . . 9.8 111.39 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -55.74 -45.43 78.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.749 0.42 . . . . 12.59 110.988 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.5 m -64.98 -58.51 5.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.917 -0.771 . . . . 10.26 108.917 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.0 36.99 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.304 0.954 . . . . 7.73 112.989 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -53.47 -40.86 65.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.287 1.435 . . . . 10.1 111.979 -170.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptp 169.97 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.502 1.921 . . . . 11.26 112.715 165.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t 68.9 -52.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.923 1.689 . . . . 14.05 114.013 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.61 -174.5 4.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.222 0.919 . . . . 14.54 110.194 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -122.21 168.54 11.89 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.225 1.41 . . . . 16.24 107.367 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 75.38 -60.92 0.49 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.49 1.916 . . . . 20.49 108.598 -167.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -118.88 158.29 25.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.006 -1.85 . . . . 20.4 106.006 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.88 171.14 18.21 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.406 -0.59 . . . . 18.9 109.406 -171.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.45 74.23 2.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.511 1.124 . . . . 15.65 110.671 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.78 155.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.238 -1.347 . . . . 13.88 113.229 168.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.2 56.97 10.87 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.829 1.204 . . . . 10.95 111.347 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -171.98 -175.05 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.937 -1.875 . . . . 8.36 105.937 -172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt 68.72 158.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.767 1.627 . . . . 8.04 110.365 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.19 -84.03 0.18 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.929 -1.107 . . . . 5.11 110.226 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.47 49.31 3.67 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 3.07 112.325 -162.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.64 111.315 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 5.29 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 3.45 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.75 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 4.55 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.41 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 4.69 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 4.05 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.79 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.86 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.99 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 2.36 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 6.62 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 2.43 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 2.91 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 5.76 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 8.36 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.88 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 3.03 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.15 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 3.63 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.15 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.24 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 2.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.48 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.6 113.211 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 7.39 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 1.98 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.99 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 3.91 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 2.05 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 3.09 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 4.54 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 3.17 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 2.42 109.915 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 4.44 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 3.77 107.156 172.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.55 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.15 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.94 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.82 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 3.18 106.571 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.66 104.568 157.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 7.45 104.986 31.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 2.63 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 5.27 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 2.75 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 2.04 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.78 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 3.18 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.82 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 2.24 109.572 -171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.76 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 3.29 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.88 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 2.53 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.81 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.01 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.45 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.66 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 6.04 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.55 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.9 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 5.65 111.671 -158.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 8.88 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 6.91 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 3.32 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 2.23 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 3.24 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 2.3 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.93 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.89 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 2.18 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 4.05 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.85 107.562 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 3.39 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.16 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 2.56 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.61 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 4.83 111.123 140.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.62 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 1.39 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 3.44 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 3.18 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 2.08 108.426 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.38 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 3.75 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 8.41 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.81 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.73 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 5.2 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 2.69 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 4.8 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.56 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 2.44 107.301 163.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 2.23 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.17 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 2.65 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 1.88 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.44 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 3.29 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 4.76 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 3.25 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 3.15 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.53 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.36 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 2.5 109.69 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 3.5 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 3.37 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 2.1 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 1.18 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 3.34 112.403 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 2.89 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 2.36 111.317 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 4.25 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.9 -0.407 . . . . 53.88 109.9 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.03 162.72 13.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.516 -1.661 . . . . 45.58 106.516 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -168.87 179.79 4.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.029 -1.471 . . . . 41.28 107.029 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.95 169.33 8.23 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 127.16 2.184 . . . . 37.57 107.281 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -165.17 170.41 14.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.456 -1.313 . . . . 33.25 107.456 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.35 162.34 33.4 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.248 -1.39 . . . . 29.72 107.248 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -157.17 146.58 20.29 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.764 -2.31 . . . . 25.42 104.764 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -159.73 170.76 20.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.947 -1.131 . . . . 22.16 107.947 172.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.86 154.57 1.53 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.953 1.701 . . . . 18.56 108.128 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -155.45 138.9 15.86 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.92 -1.141 . . . . 15.06 107.92 163.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -165.65 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.004 1.721 . . . . 13.5 108.405 -167.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 t -142.18 170.86 14.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.823 0.738 . . . . 10.64 109.934 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -173.97 48.71 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.494 1.518 . . . . 6.24 107.875 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -134.54 100.12 4.55 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.446 0.698 . . . . 12.03 111.108 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.1 mm -94.86 -54.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.781 1.233 . . . . 16.51 109.411 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.82 -104.28 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.642 -1.244 . . . . 20.72 107.642 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -45.81 -42.69 12.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.546 1.138 . . . . 18.25 110.325 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.7 -29.15 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.942 2.097 . . . . 14.23 113.999 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -49.24 -45.79 45.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.413 1.085 . . . . 10.78 110.958 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.44 -76.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.78 -0.822 . . . . 15.2 108.78 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -68.35 -49.07 62.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.634 0.605 . . . . 14.12 112.634 -166.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.14 -60.03 6.81 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.86 -0.896 . . . . 8.64 110.86 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -70.41 -41.83 72.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 118.012 -0.994 . . . . 10.81 110.993 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.8 ptt? 38.31 66.41 0.5 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.053 1.341 . . . . 12.71 111.659 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t 68.01 -65.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 126.0 1.72 . . . . 13.11 109.581 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.16 96.21 1.19 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.349 0.66 . . . . 13.48 110.925 172.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 80.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.261 1.025 . . . . 18.96 109.212 168.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -59.09 107.55 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.871 1.269 . . . . 21.03 109.959 169.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.06 -76.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.237 -1.394 . . . . 21.61 107.237 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -140.9 -169.38 2.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 103.77 -2.678 . . . . 23.98 103.77 166.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -78.41 58.24 2.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.726 1.148 . . . . 18.37 109.876 167.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.7 mm -144.09 160.25 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 106.34 -1.726 . . . . 16.24 106.34 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.06 -127.95 2.93 Favored Glycine 0 N--CA 1.449 -0.452 1 N-CA-C 103.015 -4.034 . . . . 10.37 103.015 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 76.46 -56.0 0.57 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.678 1.991 . . . . 7.91 111.825 156.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.2 mt -53.34 -67.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 126.161 1.785 . . . . 10.46 109.722 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 164.5 168.67 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.715 2.406 . . . . 5.26 106.201 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.79 -54.65 0.49 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 3.24 108.499 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.76 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 3.77 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 2.34 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 3.62 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.74 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 5.48 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7 115.112 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 5.91 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.18 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 6.46 111.365 -166.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 2.08 112.692 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 2.02 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.444 ' CE1' ' CG2' ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 3.97 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 5.7 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.08 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 3.67 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.92 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 3.94 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.36 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.95 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.12 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 2.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.91 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.86 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.97 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 2.24 105.686 169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.88 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 3.7 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 2.37 109.011 168.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.456 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 2.73 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.38 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 4.67 113.126 -173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.97 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 2.14 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 6.24 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.88 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.456 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.59 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.01 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.15 110.273 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 4.7 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 3.03 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.3 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 4.57 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 3.02 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 5.86 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 2.71 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.75 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.05 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 3.07 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 1.99 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.14 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 2.79 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.98 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 2.92 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.63 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.44 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 2.19 108.152 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 9.05 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 4.94 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.08 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.97 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 5.3 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 7.64 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.87 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 4.86 105.792 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 2.22 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 3.63 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 2.55 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.77 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 3.09 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 1.85 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 3.01 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 5.34 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 3.29 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 3.27 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 2.58 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.11 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.78 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.63 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 1.25 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 4.83 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 2.57 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 2.07 112.359 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 3.1 106.222 154.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 6.8 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 4.8 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.37 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 4.43 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 2.05 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 4.64 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.64 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.78 107.391 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 2.37 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 2.42 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 1.68 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 3.08 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 4.3 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.83 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 3.97 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.9 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 1.18 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 3.56 108.319 -167.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 4.46 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 3.81 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 2.1 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 1.09 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.8 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 2.1 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 1.68 109.097 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 6.09 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.31 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.444 -0.947 . . . . 68.26 108.444 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -172.02 -171.83 0.91 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.432 -1.692 . . . . 61.23 106.432 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -147.83 -173.64 4.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.182 -1.784 . . . . 57.06 106.182 159.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.06 164.79 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.073 1.749 . . . . 52.61 108.17 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -154.86 -170.84 3.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.577 -1.268 . . . . 47.24 107.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.9 146.05 39.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.887 1.275 . . . . 42.99 109.547 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 153.27 35.64 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.311 -0.626 . . . . 37.63 109.311 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -70.79 158.72 35.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.861 0.362 . . . . 34.78 110.097 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 166.55 22.41 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.515 -0.921 . . . . 29.55 108.515 160.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.23 174.19 10.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.055 1.342 . . . . 27.71 108.165 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -51.65 -60.69 2.87 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.64 0.776 . . . . 22.92 109.85 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m 69.2 158.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.009 1.324 . . . . 16.56 111.612 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -48.05 -56.93 6.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.843 2.057 . . . . 11.08 110.234 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.38 -179.01 5.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.5 -1.667 . . . . 14.11 106.5 165.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 149.94 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.171 -1.789 . . . . 20.5 106.171 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.6 88.32 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.975 1.31 . . . . 21.72 110.87 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.37 -62.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.495 1.918 . . . . 18.61 111.935 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.45 -41.07 1.34 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.318 1.847 . . . . 15.09 111.357 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -36.65 -56.29 0.83 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.232 1.413 . . . . 19.13 111.463 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -62.74 -43.92 97.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.493 0.717 . . . . 19.92 109.643 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.03 -44.6 94.52 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.227 0.211 . . . . 11.98 110.573 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.05 2.32 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.258 -0.737 . . . . 9.68 111.258 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -70.65 -32.3 69.55 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.874 1.67 . . . . 17.04 112.924 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.371 0.0 OUTLIER 31.71 -124.48 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.339 1.855 . . . . 15.11 115.452 -170.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t 54.08 57.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.223 0.92 . . . . 20.37 109.419 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -174.48 72.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.773 -1.566 . . . . 21.09 106.773 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.0 tttp 67.58 169.31 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.086 -1.416 . . . . 25.81 108.367 -155.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -145.58 143.7 30.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.083 -2.562 . . . . 20.36 104.083 163.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -166.71 -64.41 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.892 -0.781 . . . . 23.25 108.892 -171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -73.21 178.32 4.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.451 0.7 . . . . 21.41 110.31 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.69 64.47 1.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.01 0.924 . . . . 22.03 110.656 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -84.26 146.36 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.281 1.432 . . . . 13.75 107.827 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.13 -154.64 5.31 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.767 -0.583 . . . . 12.9 111.744 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -89.41 -37.42 14.84 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 128.724 2.81 . . . . 12.01 110.135 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mt -28.54 133.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.828 2.851 . . . . 10.0 114.137 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.35 -63.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.239 2.216 . . . . 5.17 107.095 161.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 62.12 3.76 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 3.62 110.511 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.03 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 5.09 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 3.61 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.62 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 4.02 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.8 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 6.07 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 3.24 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 2.5 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.57 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 2.16 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.74 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 2.36 109.578 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 2.0 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 4.22 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 5.79 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.62 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 3.34 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.85 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 3.95 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.33 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 2.37 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.57 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.39 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 2.56 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.43 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.28 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 4.36 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 2.28 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.85 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 3.36 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.78 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 2.18 104.217 159.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.51 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 5.13 114.0 -171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 2.21 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 2.31 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.92 110.591 164.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.92 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.62 112.343 -158.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.97 108.933 -171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.17 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.95 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 2.74 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.59 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 4.36 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 2.54 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 4.72 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 2.11 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.77 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.08 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 3.04 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.88 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 2.22 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 3.0 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 2.1 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 2.58 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 2.46 111.962 -165.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.26 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.92 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.59 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 5.21 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.83 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 3.02 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 6.68 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 8.36 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 7.57 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 3.33 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 2.13 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 3.89 106.063 158.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 2.28 109.667 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.16 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.88 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 1.9 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 3.25 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.92 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.62 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.53 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 2.14 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.91 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 4.34 109.839 133.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.6 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 1.28 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 3.89 112.197 174.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 2.63 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 1.77 107.791 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.15 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 3.5 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 6.27 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 4.29 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 3.42 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 5.49 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 2.2 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 4.82 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.17 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 2.23 105.251 166.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 1.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 2.56 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 1.84 111.291 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.07 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 3.32 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.78 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 3.53 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 3.0 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.01 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.47 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 3.71 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.84 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 3.3 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 2.32 106.618 162.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.92 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 3.24 112.707 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 2.85 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 2.13 107.667 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 5.35 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.17 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.537 -0.268 . . . . 49.63 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -147.36 56.09 1.1 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.69 -1.596 . . . . 44.68 106.69 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -163.47 143.19 8.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.079 -1.452 . . . . 41.24 107.079 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.57 156.54 13.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.61 -1.256 . . . . 36.33 107.61 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.4 p -163.01 162.71 26.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.746 -1.575 . . . . 32.7 106.746 166.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.3 53.94 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.83 0.852 . . . . 28.16 109.219 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.52 130.6 35.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.575 -0.898 . . . . 25.82 108.575 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -159.5 178.37 9.96 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.249 -1.389 . . . . 21.78 107.249 170.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.41 178.79 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.083 1.353 . . . . 18.66 109.093 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -158.09 179.53 9.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.419 1.888 . . . . 14.87 106.395 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -153.61 155.73 36.64 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.725 0.693 . . . . 15.15 110.312 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 t 158.11 -152.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 131.177 3.791 . . . . 9.7 104.166 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.21 24.05 0.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.571 1.948 . . . . 6.07 110.456 -170.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -116.65 104.28 11.22 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.185 -1.413 . . . . 11.91 107.185 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.305 40.5 pt 43.37 -136.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.522 1.929 . . . . 15.97 113.114 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 14.95 85.17 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.775 2.83 . . . . 16.5 116.19 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.99 -59.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.608 2.363 . . . . 12.61 112.063 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.1 m -48.56 -27.7 2.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.98 1.712 . . . . 10.17 112.759 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -29.57 -57.33 0.16 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.141 2.176 . . . . 11.64 111.916 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -70.26 -67.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.476 1.11 . . . . 13.29 109.121 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -71.05 -57.91 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.917 1.287 . . . . 10.47 112.718 -158.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 -52.61 10.92 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.486 1.041 . . . . 7.91 111.473 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -8.89 56.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.184 1.393 . . . . 9.53 111.819 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 55.89 77.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.88 1.672 . . . . 14.52 111.529 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.29 93.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.489 -0.93 . . . . 15.12 108.489 163.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 70.6 175.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.176 1.39 . . . . 19.08 111.274 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.57 45.07 24.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.176 0.99 . . . . 23.26 111.84 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -74.09 71.79 1.64 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.245 -0.65 . . . . 20.95 109.245 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -143.35 54.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.916 1.686 . . . . 27.33 107.926 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -141.69 -167.83 2.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.174 1.39 . . . . 22.54 108.185 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -72.0 68.36 0.68 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.915 0.886 . . . . 23.77 110.643 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -77.7 71.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.999 -1.482 . . . . 18.36 106.999 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.52 57.27 0.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.418 -2.273 . . . . 15.26 107.418 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -169.82 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.718 2.007 . . . . 12.68 107.103 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.96 139.96 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.085 0.954 . . . . 10.15 109.396 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.04 170.87 7.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.553 1.141 . . . . 4.5 110.319 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.08 2.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 3.46 111.389 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.67 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 5.52 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.79 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 4.45 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 3.88 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 4.66 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 5.43 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 2.6 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.76 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.34 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 2.08 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 7.39 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 2.7 111.147 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 2.37 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 5.37 109.47 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 7.18 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 1.2 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.68 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 1.57 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 3.35 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.98 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.76 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.53 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.99 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.18 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 1.04 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 4.67 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 1.57 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 3.32 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 3.39 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.85 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 2.44 108.302 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.61 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 3.83 112.653 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 2.03 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 2.56 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 6.44 114.062 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.88 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.64 110.656 -169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.58 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 4.04 114.08 -164.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.83 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.14 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 4.77 112.334 153.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 2.33 111.202 -166.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 4.02 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.91 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.68 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.22 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.81 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.97 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.87 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 2.84 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.83 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.92 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.11 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 2.06 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 9.1 114.409 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 5.13 112.984 -166.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.63 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.3 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 5.7 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 6.52 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 7.16 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 3.17 110.733 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 2.5 111.007 -175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 3.34 108.928 162.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 2.01 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.61 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 2.05 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 3.62 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.64 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 4.31 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.44 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 2.3 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 4.01 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.72 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 1.33 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 3.57 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 2.23 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 2.06 112.635 -170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.08 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 3.42 108.275 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 8.68 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 3.8 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.97 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 2.3 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 3.33 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.72 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 2.1 107.822 167.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 1.75 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.95 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 2.23 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 1.58 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 3.1 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 3.38 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 5.96 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 3.93 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 3.83 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.84 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.61 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 2.58 108.754 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.95 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 3.73 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 2.48 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.29 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.86 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 2.35 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 2.2 110.972 176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.93 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.34 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 106.31 -1.737 . . . . 68.13 106.31 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 59.19 175.37 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.577 1.173 . . . . 61.43 110.999 -170.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -170.07 158.94 7.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 127.147 2.179 . . . . 53.67 106.027 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -162.91 153.33 16.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.094 -1.447 . . . . 50.46 107.094 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 p -174.68 103.51 0.09 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.695 -1.224 . . . . 42.5 107.695 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.28 163.52 40.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.343 -0.984 . . . . 37.81 108.343 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp -150.55 -175.84 5.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.397 1.879 . . . . 32.54 107.516 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -134.49 135.74 42.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.529 -1.656 . . . . 28.52 106.529 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.89 -175.46 0.31 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 126.405 1.882 . . . . 23.29 106.291 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -65.71 80.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.726 -0.472 . . . . 18.92 109.726 167.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -72.43 65.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.662 0.785 . . . . 18.09 109.456 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -170.96 161.51 6.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.34 1.056 . . . . 11.62 109.362 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -62.23 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.765 2.426 . . . . 6.48 109.763 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -58.95 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.991 -0.528 . . . . 13.23 109.671 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.0 mt 63.6 174.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.368 -0.975 . . . . 14.04 108.368 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -116.29 -52.76 2.57 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.084 -1.635 . . . . 19.43 110.739 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.43 -54.66 2.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.691 -0.855 . . . . 17.31 108.691 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -54.89 -8.34 0.25 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.101 1.76 . . . . 15.24 114.365 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.15 -47.61 45.52 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.38 1.445 . . . . 10.63 111.621 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -56.23 -41.66 76.05 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.049 1.34 . . . . 15.39 110.785 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -45.98 66.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.381 1.072 . . . . 13.58 109.558 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.52 -68.4 1.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.782 1.182 . . . . 8.89 111.914 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -72.41 -91.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.761 0.791 . . . . 9.22 111.034 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -168.37 153.69 6.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.192 0.997 . . . . 12.36 108.768 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -86.87 103.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.614 -1.63 . . . . 15.86 107.136 173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 65.91 -169.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.625 1.17 . . . . 15.5 111.519 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.55 78.11 1.46 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.73 -0.606 . . . . 18.58 109.751 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -145.57 105.74 4.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.789 0.435 . . . . 23.86 110.061 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -151.9 151.0 30.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.316 -0.624 . . . . 17.6 109.316 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -146.55 -55.32 0.26 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.315 1.046 . . . . 21.69 110.952 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 139.83 -37.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.661 2.784 . . . . 24.64 109.912 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -48.15 -43.88 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.509 1.124 . . . . 19.6 110.478 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.76 -158.06 8.51 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.657 -2.577 . . . . 12.53 106.657 172.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 64.41 41.45 5.74 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.31 1.444 . . . . 11.14 110.477 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 pt -143.07 154.91 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.021 1.329 . . . . 11.0 108.591 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 178.19 86.76 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.147 1.379 . . . . 4.47 110.641 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.79 -70.6 2.69 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 120.901 -1.125 . . . . 4.16 112.025 171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.35 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 5.05 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 3.88 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 2.71 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.97 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 5.38 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 3.18 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 2.32 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.76 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.67 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 2.19 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 7.42 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 2.29 110.242 161.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 2.1 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 4.35 108.447 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 6.39 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 1.0 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 3.57 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.24 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 3.66 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.08 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.59 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.88 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.65 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.89 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.1 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 1.3 114.957 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 6.45 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 2.07 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 2.57 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 3.68 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 2.07 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 2.37 107.188 -177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.14 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 4.12 112.662 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 2.34 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 2.01 113.799 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 7.23 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.08 107.16 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.9 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.72 107.569 -164.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.89 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 5.04 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.98 107.041 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 5.86 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 3.02 110.089 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 4.63 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 3.41 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 3.15 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.05 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 3.45 113.367 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.08 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 4.0 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 4.0 109.613 -163.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.98 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.89 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 2.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.99 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 2.15 109.047 176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 8.56 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 4.94 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.82 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 6.52 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 7.46 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 8.66 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 7.18 112.843 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 4.72 111.229 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 2.57 111.786 175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 3.81 109.737 153.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 3.39 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.99 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 2.1 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 2.26 109.409 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 3.02 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 8.51 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.44 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 3.31 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 3.32 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.68 108.563 168.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.92 111.13 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.58 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 4.31 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 2.95 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 1.89 107.659 -176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 4.2 109.771 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 6.11 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 3.66 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.86 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 4.12 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 2.13 112.92 171.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 3.5 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.11 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 2.25 105.993 172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 2.17 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.16 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 2.65 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 2.21 108.738 160.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.37 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 3.46 111.492 -177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 5.02 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 3.77 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.94 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.63 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.25 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 2.37 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 4.33 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 3.27 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 3.64 106.78 167.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.4 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 3.3 111.909 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 2.91 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 2.05 111.267 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 4.87 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.93 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.178 -1.786 . . . . 48.79 106.178 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 59.91 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.986 1.315 . . . . 43.0 108.325 -163.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -53.51 126.4 21.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.151 -0.685 . . . . 38.43 109.151 156.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -152.46 148.89 27.96 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.878 -1.527 . . . . 38.38 106.878 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t 70.35 142.68 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.881 1.272 . . . . 32.25 110.21 -166.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.34 -69.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.035 -1.468 . . . . 28.1 107.035 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.94 156.41 38.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.004 -1.48 . . . . 24.14 107.004 161.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -85.07 -168.41 2.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 24.04 110.633 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.78 -74.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.731 2.013 . . . . 23.08 113.489 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.5 t80 51.23 61.85 3.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.504 1.121 . . . . 21.63 112.173 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -79.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.026 -1.101 . . . . 20.39 108.026 168.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -173.19 179.12 2.28 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.585 1.154 . . . . 17.09 108.698 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 80.61 0.9 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.743 1.217 . . . . 11.19 107.825 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.86 -48.37 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.967 0.907 . . . . 16.9 110.699 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.6 mm -74.44 139.91 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 122.616 0.366 . . . . 18.98 110.064 -170.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -49.03 133.11 18.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.19 0.596 . . . . 20.13 110.545 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.55 -57.51 0.31 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.089 2.156 . . . . 15.55 112.74 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 t -57.93 -18.52 23.76 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.697 -0.627 . . . . 15.31 112.312 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -33.91 -58.51 0.44 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.457 1.103 . . . . 12.08 110.027 158.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -49.64 -56.28 10.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.5 1.52 . . . . 12.99 110.617 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 p -60.19 -45.73 92.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.418 -0.355 . . . . 13.38 110.463 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.99 26.55 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.671 -0.972 . . . . 11.76 110.671 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -70.62 -44.07 67.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 113.102 0.779 . . . . 9.27 113.102 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptp -147.74 76.64 1.4 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.297 0.851 . . . . 10.75 113.297 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -48.88 -48.74 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.53 -0.759 . . . . 16.06 109.124 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.91 106.61 2.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.043 -0.725 . . . . 16.77 109.043 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.6 72.85 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.385 1.474 . . . . 16.69 111.497 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 141.12 57.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.098 0.959 . . . . 19.28 110.542 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -39.16 126.67 1.68 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.756 2.022 . . . . 20.44 111.531 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -62.21 174.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.804 0.811 . . . . 17.99 112.737 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -162.12 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.401 -0.818 . . . . 19.05 109.375 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.9 mm 62.89 64.76 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.671 1.188 . . . . 12.51 110.887 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.17 -62.6 0.05 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.862 -2.095 . . . . 10.05 107.862 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.51 68.43 0.24 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.414 2.285 . . . . 10.67 109.255 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.15 -19.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.868 1.667 . . . . 8.27 110.588 -172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.27 172.34 12.6 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.001 0.52 . . . . 4.7 111.22 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.88 91.57 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 3.36 113.685 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.8 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 6.79 114.104 -174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 4.17 109.775 167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.95 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 5.04 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.45 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 4.63 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.81 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 4.76 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.53 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 3.3 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.17 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 6.18 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 2.44 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.87 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 4.44 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 6.63 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 3.16 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 1.74 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 3.62 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 1.03 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 4.06 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.67 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 2.23 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.09 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 1.08 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.81 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 2.48 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.73 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 3.75 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 2.07 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 3.15 108.934 160.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.22 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 3.55 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 2.83 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 2.86 114.884 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 5.05 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.95 107.025 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 3.37 110.661 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 6.28 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.92 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.16 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 4.33 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 3.6 110.654 -150.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 4.9 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 2.36 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.56 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.3 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 3.02 112.015 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 2.1 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.26 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 2.84 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 2.05 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 2.34 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 2.28 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.402 ' OD1' ' NZ ' ' A' ' 100' ' ' LYS . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.32 109.75 -174.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 2.06 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 7.14 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.434 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 5.24 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.51 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.05 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 6.52 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 6.81 109.431 -162.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 10.3 108.804 -160.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 3.87 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 2.47 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.96 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.58 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.81 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 3.47 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 1.97 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 3.7 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 5.38 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 3.27 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 2.09 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.43 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.91 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.64 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 1.27 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 3.66 110.59 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 2.39 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 2.19 109.603 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.67 111.498 -166.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 3.58 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 9.29 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 4.24 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.89 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 4.14 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 2.13 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 3.64 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.91 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 2.3 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 1.95 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.99 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 2.48 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.92 111.343 168.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.45 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 2.89 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 3.72 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 3.86 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 3.69 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.96 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.29 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 2.43 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 3.28 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.99 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 2.35 107.186 172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.12 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.89 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 2.54 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 2.25 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.91 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.24 109.828 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 104.94 -2.244 . . . . 60.82 104.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -55.73 -47.6 76.63 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.92 1.236 . . . . 53.85 108.488 162.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 m 51.78 -142.68 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.997 0.919 . . . . 50.67 111.004 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.32 170.54 17.43 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.815 -1.55 . . . . 46.08 106.815 177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -156.9 -52.79 0.08 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.436 0.695 . . . . 42.43 110.736 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.17 138.72 58.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.48 0.312 . . . . 38.01 110.809 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.11 153.3 45.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.795 1.638 . . . . 34.91 107.407 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.9 p -95.94 157.12 16.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.857 1.263 . . . . 29.53 110.867 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.09 166.16 33.92 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.983 -1.488 . . . . 25.25 106.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -150.85 147.56 27.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.238 0.615 . . . . 20.72 109.42 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -105.93 -140.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.984 1.714 . . . . 20.79 108.632 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p 71.69 177.68 0.26 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.008 1.723 . . . . 12.39 111.366 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.69 7.62 32.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.138 0.575 . . . . 10.02 110.458 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 60.84 -173.07 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.487 1.115 . . . . 16.71 111.049 -166.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.2 mt 70.62 92.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.421 1.488 . . . . 17.06 108.759 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.49 141.18 7.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.569 1.148 . . . . 19.61 111.178 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 65.51 -50.6 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.301 2.24 . . . . 15.02 112.918 -170.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -54.25 -29.48 46.95 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.221 -0.925 . . . . 13.7 111.609 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -38.49 -47.04 1.23 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.507 1.123 . . . . 13.02 112.808 165.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -58.78 -42.26 88.57 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.713 1.205 . . . . 13.53 111.402 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -53.63 15.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.393 0.677 . . . . 9.63 109.801 174.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.67 -71.11 0.99 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.474 0.559 . . . . 6.78 112.483 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -14.35 62.03 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.635 -0.921 . . . . 11.09 113.168 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.9 mmt 63.2 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 124.48 2.086 . . . . 11.57 115.304 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.7 t -145.19 -57.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 112.219 -2.264 . . . . 13.73 105.105 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.12 -151.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.558 1.143 . . . . 16.04 108.1 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 77.76 -59.37 0.45 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.514 1.926 . . . . 15.6 110.351 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 67.98 -7.61 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.369 1.468 . . . . 20.36 112.34 -156.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -70.81 115.44 9.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.541 -0.911 . . . . 18.61 108.541 162.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -88.11 -178.46 5.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.505 1.522 . . . . 17.76 106.922 162.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -79.12 44.69 0.58 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.78 -1.2 . . . . 16.77 110.724 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt 39.91 43.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.463 2.305 . . . . 15.55 114.302 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.02 47.37 0.02 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 121.412 -0.805 . . . . 11.05 113.218 166.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -147.03 20.58 1.25 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.689 1.196 . . . . 9.23 110.638 -155.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm -75.66 78.92 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 108.633 -0.877 . . . . 10.16 108.633 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.96 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.028 0.931 . . . . 4.46 108.995 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.58 -97.53 2.31 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 3.08 109.876 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.44 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 3.46 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 3.57 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 5.87 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.11 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 4.54 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 3.15 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 3.22 112.845 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.95 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 3.84 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 3.13 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 6.97 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 3.8 109.059 167.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 2.38 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 4.48 109.598 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 5.06 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.67 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 3.4 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 1.74 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 3.86 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.06 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.62 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.53 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.23 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 2.45 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 1.05 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.5 112.173 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 7.0 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 2.07 109.425 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 3.01 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 3.62 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.92 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 2.52 107.027 167.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.17 106.944 169.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 3.56 113.849 -169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.93 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 2.44 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 5.66 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 2.01 106.995 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.93 114.826 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.74 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 1.2 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 4.15 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 3.09 107.616 172.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.57 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 6.66 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 2.62 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 5.6 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 2.76 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 4.1 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.03 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 3.58 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 2.08 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 2.18 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.36 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 2.65 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 2.28 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 2.26 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.75 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.51 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.43 ' CG2' HG23 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 3.39 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 7.94 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 5.86 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.82 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.58 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 5.39 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 8.45 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.446 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 6.34 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 3.06 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.94 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.43 HG23 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 4.45 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 2.59 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.89 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 2.96 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 1.84 109.227 170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.93 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 6.79 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 6.58 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.93 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.92 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.77 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 1.59 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 4.18 108.888 -168.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 3.3 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 1.74 110.636 -171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.12 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.446 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 3.85 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 8.35 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 3.66 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.12 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 4.56 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 2.18 113.433 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 3.44 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.96 109.864 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 1.82 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.8 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 3.4 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 1.89 110.842 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 3.5 108.043 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 3.58 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 4.13 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 5.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.36 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.93 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 2.56 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.88 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 4.13 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 2.12 107.868 168.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.93 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 2.23 107.223 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 2.21 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 2.18 111.751 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 5.64 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.44 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.756 -1.202 . . . . 65.9 107.756 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -74.66 90.07 2.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.035 0.934 . . . . 60.62 109.252 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.6 p -143.57 87.08 1.91 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.13 0.572 . . . . 55.4 110.334 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -160.21 150.03 18.0 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.115 0.966 . . . . 50.2 108.821 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 p -167.12 161.02 14.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.041 1.736 . . . . 44.81 106.499 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.8 51.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.65 0.78 . . . . 39.68 110.217 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 tp -90.3 124.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.775 -0.824 . . . . 35.7 108.775 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 t -164.01 166.99 20.97 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.273 -1.38 . . . . 30.26 107.273 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.73 20.47 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.682 0.793 . . . . 25.27 112.151 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -80.12 68.8 6.37 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.204 -0.935 . . . . 23.99 111.149 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -122.68 31.82 5.95 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.19 . . . . 20.56 110.306 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -148.46 152.85 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.12 -1.807 . . . . 14.24 106.12 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -79.6 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.93 1.292 . . . . 8.61 110.803 -166.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -116.45 -19.2 10.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.135 0.974 . . . . 12.78 111.837 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.8 mt 73.26 158.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.045 1.738 . . . . 16.16 110.754 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 78.21 55.5 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.86 2.064 . . . . 18.79 109.722 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 74.52 -42.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.585 1.554 . . . . 14.46 112.384 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -39.95 -40.64 1.05 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.385 1.474 . . . . 13.62 111.663 163.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -43.71 -38.55 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.3 1.44 . . . . 11.25 113.233 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -49.33 -44.54 44.51 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 119.656 1.116 . . . . 13.16 111.264 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -68.24 -43.26 78.31 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.108 -0.33 . . . . 10.28 110.108 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.23 -75.97 0.51 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 123.587 0.613 . . . . 6.94 113.046 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -70.02 -35.76 74.58 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.808 -0.819 . . . . 12.85 111.674 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.2 mmt 63.8 -67.13 0.1 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.365 1.466 . . . . 11.93 113.928 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t 67.62 -74.83 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.054 1.341 . . . . 14.31 110.598 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.14 123.31 1.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.47 1.508 . . . . 15.93 107.426 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -145.33 58.63 1.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.14 -1.43 . . . . 15.95 107.14 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 63.92 77.35 0.32 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.096 1.358 . . . . 23.68 108.383 -157.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.16 -162.06 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.472 1.109 . . . . 20.05 109.367 -170.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -86.3 -178.49 6.48 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.075 0.464 . . . . 18.15 109.923 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -164.57 -52.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.963 -0.562 . . . . 17.32 110.189 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.6 mt 65.94 -72.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.368 1.467 . . . . 11.13 109.691 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.25 2.39 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.587 0.613 . . . . 10.63 111.573 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.21 172.07 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.342 1.457 . . . . 11.24 109.217 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt 67.15 -74.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 127.156 2.182 . . . . 12.07 110.729 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.29 -47.19 0.62 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.339 1.456 . . . . 5.1 113.767 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 21.78 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.663 2.554 . . . . 3.87 116.098 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.49 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.68 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.95 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 2.53 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 4.18 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 5.13 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 3.33 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 2.66 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.47 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 2.67 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 2.38 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 6.77 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 2.56 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 2.15 109.81 -168.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 4.6 109.083 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 5.03 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.83 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.93 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.88 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 3.73 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.94 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.86 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.36 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.86 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.96 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 1.03 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 4.63 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 2.11 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 3.22 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 3.46 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.86 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 2.17 108.753 158.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.33 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 3.37 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 2.38 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 2.41 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 5.13 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.25 110.318 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.9 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.32 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 4.17 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 4.58 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.74 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 4.78 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 3.21 111.054 -164.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 6.31 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 2.59 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.66 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 3.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.03 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 2.2 109.008 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.65 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.91 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 2.38 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 2.33 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.93 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.92 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 2.23 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 9.26 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 6.43 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 5.44 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 6.3 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 8.54 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 7.06 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 4.93 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 3.34 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 3.96 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 3.25 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 1.01 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 3.18 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 1.75 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 3.75 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 5.68 106.684 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.64 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.62 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 2.25 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 4.19 110.348 135.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.65 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 1.18 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 3.6 113.43 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.7 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 1.99 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.35 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 4.14 107.855 171.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 6.51 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.75 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 3.3 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.92 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 2.2 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 3.25 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 2.04 106.5 154.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 1.96 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 1.02 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 2.63 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 2.06 111.425 166.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 2.98 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.85 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 3.34 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 4.46 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.41 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.5 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.71 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 3.24 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 3.91 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 2.13 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.97 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 2.26 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 2.24 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 1.94 111.526 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.91 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.85 111.613 -170.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.311 -0.255 . . . . 51.27 110.311 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -162.52 150.03 13.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.505 -0.924 . . . . 44.82 108.505 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -61.2 163.68 6.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.304 1.042 . . . . 42.77 110.007 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -168.68 170.15 9.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.819 -1.549 . . . . 39.07 106.819 -173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 p -166.01 172.41 11.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.331 -0.988 . . . . 34.29 108.331 -170.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.83 12.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.665 1.186 . . . . 30.56 108.216 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -170.34 2.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.763 1.625 . . . . 25.95 108.916 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.1 t -154.53 -173.51 4.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.977 -1.12 . . . . 22.75 107.977 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.95 178.49 7.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.284 1.434 . . . . 18.67 108.565 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.55 171.13 8.21 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.126 1.37 . . . . 17.69 109.035 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -129.84 39.84 3.64 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.311 1.044 . . . . 14.42 109.509 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -115.7 175.85 5.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.869 1.268 . . . . 10.02 110.974 -165.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.98 -32.26 71.82 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.525 0.565 . . . . 8.54 112.525 -171.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -71.37 129.75 39.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.121 0.873 . . . . 14.76 111.151 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt 88.18 98.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 129.107 2.963 . . . . 18.23 110.402 168.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 3.64 -72.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.383 3.073 . . . . 18.35 115.462 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.05 -50.76 71.75 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.696 -0.627 . . . . 16.65 110.137 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -66.22 -39.22 89.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.883 1.273 . . . . 12.75 110.869 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -45.41 -52.41 10.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 125.206 1.402 . . . . 11.95 110.492 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -46.7 -63.66 0.96 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.054 1.342 . . . . 14.53 111.797 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.63 80.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.048 -0.407 . . . . 9.68 111.407 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.77 -63.14 5.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.132 -0.787 . . . . 6.75 111.132 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -60.59 -49.72 76.42 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.453 0.301 . . . . 12.73 110.427 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.3 ptt? 168.5 119.89 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.322 1.849 . . . . 14.64 108.905 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.97 -50.48 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.409 1.084 . . . . 13.86 109.508 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 158.25 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.349 2.66 . . . . 17.2 105.397 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -62.53 157.19 21.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.138 -0.937 . . . . 18.39 108.742 156.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -57.95 117.23 4.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.23 1.012 . . . . 22.61 110.226 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -74.5 161.16 30.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.534 -0.543 . . . . 17.16 109.534 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.34 -40.68 97.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.628 0.603 . . . . 20.04 112.628 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 38' ' ' GLU . 47.5 ttt180 69.23 22.97 6.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 21.68 111.173 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.42 -30.95 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 125.501 1.52 . . . . 16.31 112.786 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.6 -161.72 16.4 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 106.178 -2.769 . . . . 11.29 106.178 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 59.04 38.44 24.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.009 0.924 . . . . 9.13 110.828 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 131.59 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.767 0.827 . . . . 9.82 110.453 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -166.9 153.8 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 126.843 2.057 . . . . 3.81 105.484 168.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.14 0.64 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.231 0.923 . . . . 3.29 111.198 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 31' ' ' ARG . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.61 112.284 -174.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.59 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 4.25 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 3.23 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 4.02 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.11 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 5.22 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 3.64 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 2.59 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.01 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 2.66 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 2.4 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 5.97 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 2.52 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 2.3 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 4.29 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.94 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.84 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.85 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 1.64 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 3.33 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.14 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 2.19 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.95 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.44 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 2.7 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.12 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.99 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' HZ2' ' CD2' ' A' ' 84' ' ' HIS . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 4.41 107.352 174.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 1.87 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 3.04 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 3.86 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 2.39 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 2.62 105.287 152.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.38 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 3.93 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 2.14 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 2.05 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 5.39 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 2.14 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.81 112.098 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.68 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.96 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.98 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 3.1 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.66 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' CD2' ' HZ2' ' A' ' 66' ' ' LYS . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 4.82 116.805 -178.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 3.06 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.86 113.378 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 3.13 110.096 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 2.05 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 3.84 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 3.74 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.32 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 3.72 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 2.23 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.75 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 1.99 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 2.78 110.87 168.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 7.42 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 5.58 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.67 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 3.21 114.248 164.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 7.15 110.763 -171.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 10.34 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 7.06 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 5.66 113.268 171.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 4.03 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 4.4 108.319 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 2.76 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 1.04 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 2.81 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 1.81 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 4.26 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 8.0 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.38 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.86 113.029 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 2.8 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.81 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 4.37 108.681 141.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.73 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 2.01 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 3.47 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 2.48 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 2.12 109.567 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.15 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 3.4 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 5.64 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 3.62 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.45 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 4.6 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 2.02 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 3.59 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.95 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 2.09 107.516 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 2.46 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.95 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 2.6 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 1.58 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.31 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 3.48 109.43 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.97 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 3.42 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.97 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.83 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.1 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.81 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 6.42 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 2.77 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 2.46 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.88 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 2.27 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 2.58 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 2.14 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 4.46 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.24 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.235 -0.412 . . . . 52.29 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -160.84 141.88 11.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.725 -1.584 . . . . 49.61 106.725 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -178.33 173.03 1.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.42 2.288 . . . . 44.34 105.953 169.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 168.22 133.99 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.541 1.936 . . . . 41.43 109.26 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.3 t -165.09 154.57 12.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.846 -1.539 . . . . 35.86 106.846 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.86 86.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.524 1.53 . . . . 32.04 108.571 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.16 145.78 48.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.135 0.974 . . . . 30.6 108.875 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -167.63 172.7 9.13 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.858 1.663 . . . . 25.09 106.838 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 178.22 83.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.588 1.555 . . . . 21.55 109.597 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -159.23 128.46 5.4 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.803 -0.561 . . . . 17.56 109.897 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -165.76 140.27 4.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.393 -2.077 . . . . 17.34 105.393 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -179.07 165.19 1.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.772 1.629 . . . . 11.08 106.925 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.12 69.05 1.97 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.897 0.879 . . . . 8.03 110.491 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.67 -95.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.769 0.827 . . . . 12.63 111.81 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.45 143.78 17.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.604 0.761 . . . . 15.74 110.385 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 83.55 78.75 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.155 2.582 . . . . 16.98 110.197 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 t70 69.45 -56.67 0.55 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 128.332 2.653 . . . . 14.66 109.847 -172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -28.8 -50.56 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.859 2.864 . . . . 11.57 111.77 167.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -32.56 -67.48 0.11 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.691 1.596 . . . . 11.39 113.697 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.95 -55.25 6.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.369 0.604 . . . . 14.95 110.675 168.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -70.56 -9.5 56.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.631 1.715 . . . . 13.57 115.631 -156.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.83 -85.68 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.465 1.029 . . . . 10.66 111.921 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -31.4 65.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.094 -1.432 . . . . 12.78 111.577 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.64 58.35 0.94 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.898 1.226 . . . . 15.27 111.295 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.4 t -14.32 109.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 128.181 2.592 . . . . 18.07 114.158 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 48.04 75.86 0.13 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.634 1.574 . . . . 19.85 114.04 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -125.55 178.78 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.727 1.611 . . . . 23.62 107.581 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -85.95 147.93 26.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.572 -0.529 . . . . 28.05 109.572 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -65.48 161.71 19.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.035 0.445 . . . . 22.55 109.995 165.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.27 -71.01 0.52 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.873 -1.529 . . . . 27.06 106.873 165.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -164.74 55.0 0.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.039 -1.467 . . . . 26.01 107.039 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mm -95.88 91.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.44 -1.689 . . . . 19.62 106.44 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.19 -145.36 1.65 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.757 -0.937 . . . . 15.68 110.757 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -76.34 57.66 1.2 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.35 1.06 . . . . 12.27 110.819 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 mm -98.64 78.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.702 0.801 . . . . 12.18 110.088 -167.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 121.32 5.72 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.576 -1.268 . . . . 6.2 107.576 159.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.31 -49.39 0.89 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 4.05 108.18 -154.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.55 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 5.09 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 4.39 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 3.09 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 4.56 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.41 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 4.26 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 3.82 106.312 169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 2.46 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.48 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.42 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 2.02 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 6.81 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 3.54 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.72 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 6.05 115.083 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 7.4 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 1.25 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 3.18 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 1.82 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 3.18 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.05 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.87 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.97 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.76 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 2.56 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.9 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.63 113.206 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 7.09 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.97 108.127 -167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 4.57 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 3.43 112.02 -169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.67 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 3.35 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.1 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 4.1 114.826 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 2.91 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 2.23 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 5.07 110.204 167.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.66 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 2.3 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.3 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 5.7 111.622 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 3.27 107.708 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' GLU . 85.7 m-70 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 5.32 107.815 158.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 3.04 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 6.23 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 3.34 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.29 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.61 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 3.78 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 2.26 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 2.6 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 2.02 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 2.54 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 2.25 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 2.83 106.636 169.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 7.48 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 6.78 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.33 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.75 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 9.29 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 9.04 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 10.27 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 5.14 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 3.35 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 3.59 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.96 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.89 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 2.06 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 2.11 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 3.51 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 8.36 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.58 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 3.57 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 2.35 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.69 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.97 109.755 166.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 1.26 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 3.84 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 3.34 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 2.23 109.144 -170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 4.15 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 5.37 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.78 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.36 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 5.21 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 3.55 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 5.58 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.07 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 2.1 107.488 167.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 2.27 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.36 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 2.9 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.81 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.17 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 3.46 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 4.88 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 4.3 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 3.12 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.3 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 2.23 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 3.05 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 4.72 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 4.84 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 2.27 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.94 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 2.02 107.61 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 2.45 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.62 109.271 167.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 4.11 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.63 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.363 -0.977 . . . . 58.06 108.363 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -160.88 134.4 6.71 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.056 -1.461 . . . . 55.05 107.056 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -179.57 156.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.548 -1.279 . . . . 48.7 107.548 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.89 156.65 3.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.641 1.576 . . . . 46.41 107.039 172.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -171.46 142.97 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.667 -1.605 . . . . 40.11 106.667 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.09 105.62 0.24 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.309 1.044 . . . . 36.46 108.632 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 tp -153.26 119.76 5.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.606 -1.627 . . . . 33.01 106.606 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -167.24 134.92 2.46 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.465 -1.309 . . . . 28.27 107.465 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.44 135.73 0.12 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.684 1.594 . . . . 24.64 107.759 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -168.42 135.41 2.01 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.743 0.817 . . . . 20.51 108.832 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -167.35 134.75 2.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.709 -0.478 . . . . 17.59 109.709 172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -178.43 173.22 1.39 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 128.42 2.688 . . . . 13.36 105.206 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.5 74.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 7.87 111.99 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -129.55 175.63 8.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.886 2.074 . . . . 15.11 110.259 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' CG2' ' H ' ' A' ' 16' ' ' GLN 0.28 29.3 mm 56.7 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.925 1.69 . . . . 16.05 110.58 173.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.484 ' H ' ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -156.56 41.38 0.36 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.752 -1.218 . . . . 14.52 109.051 169.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -74.89 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.953 -1.869 . . . . 15.13 105.953 -172.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 m -62.73 -90.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.099 2.16 . . . . 14.91 111.104 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.82 -8.33 1.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.591 1.33 . . . . 12.96 114.591 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -43.15 -41.56 3.76 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.478 1.036 . . . . 12.28 111.178 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -56.93 1.46 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.653 1.581 . . . . 13.32 111.616 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.81 -49.85 27.12 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -47.24 -40.78 17.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.84 1.656 . . . . 10.47 114.359 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 33.5 tpp 60.01 59.57 2.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.002 -0.74 . . . . 12.77 109.002 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.8 t 67.29 -73.4 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.685 1.594 . . . . 13.07 111.298 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 53.54 86.34 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.01 1.724 . . . . 12.78 112.276 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -70.73 169.66 14.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.367 -0.833 . . . . 16.31 110.266 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -60.39 164.04 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.66 0.615 . . . . 23.43 112.66 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 67.6 -70.95 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.34 1.856 . . . . 22.38 110.9 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -158.75 -58.87 0.07 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.607 1.163 . . . . 21.98 109.618 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 56.15 74.45 0.39 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.003 -0.999 . . . . 18.96 109.441 -156.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.7 mt -49.5 130.76 7.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.878 -1.156 . . . . 16.99 107.878 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.14 -145.2 12.81 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 105.871 -2.891 . . . . 10.76 105.871 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.57 41.75 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.543 1.937 . . . . 9.36 112.793 -170.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.7 pt -88.31 151.91 3.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 123.892 0.877 . . . . 9.18 109.27 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.74 -127.88 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.748 1.219 . . . . 4.93 109.065 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -50.93 60.52 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 118.773 0.715 . . . . 3.61 112.654 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.24 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 7.16 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 4.02 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 2.43 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 4.13 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.06 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 4.33 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 3.67 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 2.49 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.33 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.45 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 2.04 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 7.71 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 2.7 111.509 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 2.19 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.423 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 4.15 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 5.92 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.84 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 3.46 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 1.85 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 3.84 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.87 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.58 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.58 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 2.44 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 1.01 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 6.48 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 2.02 109.374 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 3.07 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 3.6 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 2.41 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.423 HG21 ' CE2' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 2.82 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.83 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 3.96 112.711 -164.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 2.19 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' CB ' HE22 ' A' ' 77' ' ' GLN . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 2.27 112.71 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 5.52 113.159 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.418 HE22 ' CB ' ' A' ' 75' ' ' ALA . 7.9 mm-40 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.88 111.047 -172.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 2.25 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.86 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 8.03 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.419 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 4.17 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.82 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 6.96 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 2.44 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.94 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.83 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.6 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.24 111.667 174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 5.01 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.34 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 3.65 109.987 -157.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.58 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 2.95 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 2.01 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.96 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.42 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.41 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 2.24 111.293 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 8.04 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 5.45 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.09 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.1 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 6.13 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 7.36 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.92 109.434 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 3.7 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 2.35 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 3.77 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 2.37 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.2 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 3.0 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 2.06 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 3.2 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 5.51 104.702 168.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 3.54 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 4.55 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 2.23 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.78 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 5.68 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.66 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.47 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 3.39 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 3.33 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 1.97 111.124 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.35 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 3.32 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 5.64 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 3.87 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.68 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 4.72 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 2.17 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 3.38 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.81 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.83 107.605 157.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 2.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 2.5 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 2.13 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.14 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 3.88 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 4.53 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 3.04 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 3.71 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.88 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.32 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 2.85 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 5.74 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 4.09 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 2.43 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 1.01 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 2.17 106.907 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.94 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 2.03 113.224 -177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 6.64 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.92 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 105.934 -1.876 . . . . 50.33 105.934 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.93 150.33 45.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.649 1.113 . . . . 44.46 108.481 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 m -151.03 149.05 29.1 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.517 -1.66 . . . . 40.57 106.517 167.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -160.93 166.08 28.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.893 -1.521 . . . . 36.94 106.893 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -164.02 153.46 14.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.02 -1.474 . . . . 32.35 107.02 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.46 152.02 15.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.409 -1.7 . . . . 28.59 106.409 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 tp -158.62 137.56 11.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.502 -2.036 . . . . 24.69 105.502 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -161.82 155.55 21.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.541 -1.651 . . . . 21.63 106.541 168.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.24 153.52 5.44 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.28 -1.748 . . . . 18.05 106.28 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -162.05 158.23 24.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.219 -1.03 . . . . 14.85 108.219 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -174.83 160.43 2.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.824 1.65 . . . . 14.73 108.322 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -168.04 179.31 4.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.237 -1.023 . . . . 10.03 108.237 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -86.48 95.55 9.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.521 -1.288 . . . . 7.07 107.521 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 61.97 -68.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.574 2.064 . . . . 14.8 116.574 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.96 126.0 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 106.826 -1.546 . . . . 15.87 106.826 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.23 30.54 0.12 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.121 0.568 . . . . 14.49 112.481 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -148.87 -66.13 0.23 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.825 -1.546 . . . . 15.06 106.825 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -70.09 -86.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.616 1.167 . . . . 15.09 109.538 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -59.5 -33.87 71.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.204 1.002 . . . . 13.83 111.572 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -35.1 -62.74 0.36 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.715 0.806 . . . . 12.44 111.021 161.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -70.44 -15.93 62.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.301 -0.249 . . . . 12.89 111.435 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.5 -60.69 5.63 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.292 -1.123 . . . . 10.01 110.292 167.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -72.46 -64.51 0.94 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.229 1.411 . . . . 10.13 111.613 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.8 mtp -80.17 60.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.498 2.319 . . . . 12.17 109.652 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -47.1 -43.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.755 1.222 . . . . 15.88 109.646 164.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.72 167.8 21.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.07 1.348 . . . . 17.32 107.894 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.12 143.26 18.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.35 1.06 . . . . 19.74 112.232 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -129.69 152.41 49.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.747 -2.316 . . . . 18.08 104.747 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.94 -58.95 5.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.441 0.564 . . . . 22.15 110.098 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -146.73 -64.91 0.29 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.688 1.195 . . . . 20.67 107.97 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.32 49.51 16.88 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.444 1.098 . . . . 18.1 111.086 172.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.5 mt -61.31 147.0 11.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.043 -0.981 . . . . 15.19 109.183 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.7 -177.71 17.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.963 -2.055 . . . . 11.53 107.963 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.45 37.96 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.433 1.093 . . . . 11.47 113.461 146.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 mt -84.95 148.9 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.708 -1.219 . . . . 8.13 107.708 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 86.84 52.74 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 127.621 2.368 . . . . 4.6 108.689 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.5 75.79 0.14 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.43 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 4.54 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 3.85 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 2.46 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.99 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 5.28 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 3.11 108.193 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 2.46 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.83 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.87 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 2.65 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 5.53 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 2.16 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 2.73 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 6.31 112.335 172.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 6.8 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 1.07 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 3.73 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 1.55 105.549 170.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 3.98 110.28 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.37 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.82 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.06 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 2.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.47 110.449 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 1.36 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.476 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 5.26 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 2.17 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 4.23 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 3.58 112.252 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 2.39 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 2.77 105.923 166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.42 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 3.59 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 2.21 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 2.43 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 5.01 114.494 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.484 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.63 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.52 112.575 -137.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.41 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 1.07 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 5.57 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 3.92 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.93 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.476 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 7.04 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 3.36 110.876 -164.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 5.41 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.64 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.47 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.35 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 4.49 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 2.18 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 3.28 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.94 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.92 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.95 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.3 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 2.39 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 8.0 112.101 170.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.81 111.404 -169.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.99 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.63 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 6.76 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 7.24 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.49 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 5.16 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 3.12 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 3.65 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.92 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.9 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.8 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 1.8 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 3.08 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 6.37 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.67 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.7 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 2.48 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.91 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 4.33 109.961 131.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.69 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 1.54 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 3.95 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 3.69 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 1.83 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.06 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.91 109.889 -162.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 7.18 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 4.1 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.16 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 4.85 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 3.13 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 5.34 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.85 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 2.08 106.744 -176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 2.1 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.79 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 3.47 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.9 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.11 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 3.19 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 4.57 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 3.05 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 3.6 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.85 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.18 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 3.34 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.84 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 3.89 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 5.16 108.7 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 1.1 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.77 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 2.2 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 2.28 109.656 172.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 4.33 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.92 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.461 -1.681 . . . . 47.9 106.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -148.15 157.18 43.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.413 -1.699 . . . . 42.36 106.413 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -166.35 165.83 16.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 126.1 1.76 . . . . 38.76 106.554 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.49 141.05 49.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.671 -1.233 . . . . 35.03 107.671 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -75.03 168.79 19.29 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.06 0.457 . . . . 30.32 110.413 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.25 177.35 4.78 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.107 -1.442 . . . . 27.57 107.107 159.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -142.04 156.74 45.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.799 1.239 . . . . 23.83 107.783 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -79.35 -175.57 4.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.914 -1.143 . . . . 20.81 107.914 161.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -68.04 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.823 0.449 . . . . 18.09 109.789 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -151.23 67.68 0.91 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.702 0.801 . . . . 14.93 109.729 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 52.4 -116.39 1.03 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.715 0.806 . . . . 14.5 110.155 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 t -161.36 176.21 11.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.527 -2.027 . . . . 11.64 105.527 164.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.95 152.63 45.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.576 0.171 . . . . 6.82 110.588 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 173.18 -43.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.334 1.854 . . . . 12.31 108.842 -169.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.1 mt -126.83 99.27 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.74 1.216 . . . . 12.81 108.527 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.48 164.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.382 1.473 . . . . 18.05 112.74 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.52 -67.5 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.868 1.667 . . . . 14.8 110.615 -162.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -61.16 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.05 1.34 . . . . 10.7 111.123 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -68.08 -15.82 63.76 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.66 -1.275 . . . . 8.69 111.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -53.75 -56.11 20.39 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.38 -0.825 . . . . 16.01 109.239 161.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 t -54.51 -45.26 73.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.584 -0.895 . . . . 12.31 108.584 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -35.2 -66.02 0.38 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.924 1.25 . . . . 9.39 113.935 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -7.99 52.49 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.563 1.319 . . . . 12.98 114.563 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.3 mmm -93.34 137.86 32.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.087 0.858 . . . . 14.57 109.869 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.35 -65.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.881 -1.525 . . . . 19.42 106.881 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.3 106.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.275 -1.009 . . . . 21.24 108.275 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -52.05 -33.81 40.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.835 0.854 . . . . 22.73 112.636 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 61.44 61.0 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.931 0.892 . . . . 25.12 109.711 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -71.22 64.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.221 1.408 . . . . 22.65 111.816 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -111.17 -89.16 0.5 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.866 1.266 . . . . 25.92 108.272 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -67.43 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.065 -1.458 . . . . 23.25 107.065 -169.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -143.59 123.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.865 -1.902 . . . . 17.29 105.865 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.03 -139.74 5.3 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.134 -1.187 . . . . 13.16 110.134 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -70.8 71.74 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.091 1.756 . . . . 11.03 110.141 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -48.03 -67.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.895 0.878 . . . . 10.58 109.734 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.3 159.59 22.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 122.116 -0.365 . . . . 4.76 110.386 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.57 -46.25 4.07 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.629 1.585 . . . . 2.71 109.25 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.6 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.86 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 3.44 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.82 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 4.67 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 6.26 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 3.2 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 2.39 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.67 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 4.08 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.49 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 6.79 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 2.19 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 2.66 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 6.46 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 5.62 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 1.04 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 3.14 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 2.23 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 5.78 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.34 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 2.35 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.82 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.66 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 2.2 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 1.33 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 1.38 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 4.14 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 2.26 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.44 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 3.32 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 2.26 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 3.28 105.123 167.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.35 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 4.08 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.86 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 2.62 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 6.13 113.121 174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.12 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 2.5 110.73 171.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.57 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 1.25 109.553 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 6.47 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 4.0 110.087 -169.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 4.58 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 2.74 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 6.32 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 3.02 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.73 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.8 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 2.65 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 2.32 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.56 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 2.96 106.427 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.82 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 2.09 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 2.55 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.57 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 2.14 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 9.27 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 5.51 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.41 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.45 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 5.29 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 7.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 6.38 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 3.31 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.97 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 3.65 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 3.08 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.89 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 2.54 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 2.64 108.187 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 3.53 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 5.6 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.63 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.88 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 2.11 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 4.04 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 1.28 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 4.49 110.246 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 2.74 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.97 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 4.79 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 7.28 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 4.82 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.55 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 5.15 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.68 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 3.36 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.03 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 2.03 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 1.95 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.25 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 2.47 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 1.96 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 3.11 106.086 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 4.43 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.99 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 3.74 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.96 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.48 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.67 109.109 -173.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.62 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 3.46 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 2.36 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 3.37 112.235 -166.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 2.76 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 2.29 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.98 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.67 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.985 -0.746 . . . . 59.85 108.985 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -162.15 156.46 21.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.225 -1.028 . . . . 51.53 108.225 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -86.8 -174.53 5.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.545 1.538 . . . . 47.09 110.504 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -154.68 -175.03 5.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.19 1.796 . . . . 44.3 106.307 170.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -158.86 -165.97 1.76 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.954 -0.758 . . . . 37.76 108.954 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.69 176.19 13.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.552 1.541 . . . . 33.36 109.117 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.85 157.47 31.05 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.15 1.38 . . . . 28.71 109.546 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.0 p -97.12 163.02 13.1 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.824 1.249 . . . . 25.9 111.31 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.5 171.49 11.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.731 0.812 . . . . 21.92 109.372 165.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.52 150.04 34.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.349 1.06 . . . . 17.78 109.736 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -94.35 -134.3 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.631 1.172 . . . . 17.07 108.844 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p 70.63 -178.8 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.104 1.362 . . . . 10.42 110.495 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.69 73.59 0.8 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.346 0.594 . . . . 6.34 110.087 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -54.66 147.37 14.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.379 1.471 . . . . 13.6 109.979 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 mm 58.39 42.92 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.972 1.368 . . . . 13.6 110.01 -165.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.13 172.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.354 1.861 . . . . 13.07 111.529 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.42 -53.13 0.49 Allowed 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 127.245 2.218 . . . . 13.48 113.543 174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -74.5 -96.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.063 0.847 . . . . 12.84 110.927 163.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.54 -65.79 0.78 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.246 1.018 . . . . 11.96 112.866 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -70.93 -1.7 12.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.992 1.317 . . . . 13.1 113.608 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -28.28 -37.76 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.677 2.391 . . . . 11.41 115.735 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -28.52 -48.05 0.08 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.723 2.106 . . . . 10.37 115.247 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -55.28 -52.35 63.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.548 1.674 . . . . 11.79 112.482 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 97.4 mmm -146.0 70.88 1.24 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.902 1.281 . . . . 13.84 109.281 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.86 -79.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.184 -1.413 . . . . 16.6 107.184 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.77 140.72 38.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.302 -0.999 . . . . 19.12 108.302 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -81.46 70.64 8.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.984 -1.117 . . . . 17.97 107.984 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 47' ' ' GLU . 36.8 mmt180 -36.67 -64.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.18 2.192 . . . . 23.16 113.391 -166.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -160.66 125.7 3.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.973 -0.751 . . . . 23.66 108.973 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.92 -177.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.341 1.457 . . . . 23.98 111.631 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -78.02 56.25 1.58 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.425 -0.954 . . . . 16.87 108.425 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.9 mt -138.23 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.787 -1.19 . . . . 15.45 107.787 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.06 -71.09 0.13 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.733 -0.482 . . . . 12.21 112.06 -168.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -152.3 159.9 43.42 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.484 1.914 . . . . 9.6 107.733 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.09 -77.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.433 1.015 . . . . 11.18 110.557 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.14 -80.18 0.31 Allowed 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.26 0.482 . . . . 4.85 111.909 -165.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.16 -70.36 1.03 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 3.69 110.865 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 5.88 110.936 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 3.89 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 2.36 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 4.24 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.8 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 5.58 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 3.14 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.74 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 28' ' ' ARG . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.98 110.905 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 3.47 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 2.48 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 5.58 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 2.76 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 3.22 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 4.06 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 5.27 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.96 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 4.12 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.73 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 4.41 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 3.12 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.17 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.63 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 3.28 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.92 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 1.13 112.734 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 4.53 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 2.03 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 3.17 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 3.27 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 2.35 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 2.67 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 3.49 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 2.46 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 2.05 112.749 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 6.38 111.72 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7 105.528 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.63 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 5.64 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 2.63 106.895 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.37 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 5.6 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.99 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.75 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 2.47 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.87 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.59 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 3.05 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.51 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 1.89 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.66 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 2.75 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.92 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.26 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 2.7 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.56 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.73 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.99 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 6.14 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.23 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 5.19 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 5.23 110.92 163.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 6.56 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 7.51 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.96 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 2.43 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 4.26 107.58 150.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 2.31 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 1.08 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.86 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 1.88 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 3.33 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.83 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.39 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.71 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 2.38 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.32 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.8 107.77 167.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.68 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 1.43 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 5.33 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 2.33 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 1.76 112.933 -170.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.17 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 4.28 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 7.03 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 3.53 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.67 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 5.11 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.33 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 4.08 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 155' ' ' LYS . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2 107.076 -174.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 2.62 108.899 -177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 2.34 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.92 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 2.43 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 2.08 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.56 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 3.36 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.92 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 3.79 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 3.28 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.79 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.54 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.95 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.91 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 3.77 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 2.73 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.29 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.66 108.597 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 2.01 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.98 109.635 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 134' ' ' GLU . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.78 113.774 -173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.511 -1.663 . . . . 53.34 106.511 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.22 170.04 4.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.891 -1.522 . . . . 45.86 106.891 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -66.6 160.0 26.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.479 0.712 . . . . 41.76 109.811 169.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -148.81 171.4 16.32 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.738 -1.579 . . . . 39.67 106.738 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m 120.79 88.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 129.655 3.182 . . . . 33.25 109.66 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.47 33.64 1.66 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.564 0.745 . . . . 29.92 110.636 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.87 142.26 33.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.019 0.528 . . . . 27.14 109.599 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -176.28 -162.86 0.09 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.109 1.764 . . . . 23.18 106.755 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 86.11 114.72 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.22 2.608 . . . . 20.26 111.82 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -163.18 167.51 22.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.842 -1.54 . . . . 16.16 106.842 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.6 152.52 18.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.24 1.016 . . . . 14.08 109.511 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -162.1 0.86 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.9 -1.518 . . . . 9.91 106.9 162.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -13.83 61.73 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.867 3.667 . . . . 6.87 118.282 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 71.0 146.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.677 2.391 . . . . 14.18 113.349 167.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.3 mt 73.8 162.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.032 1.733 . . . . 15.12 109.071 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -74.45 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.026 -1.101 . . . . 17.69 108.026 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.87 -49.44 15.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.855 1.662 . . . . 16.95 112.582 -171.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 t -62.16 -13.55 28.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.128 -0.939 . . . . 14.12 113.36 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -53.24 -33.75 54.28 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 119.767 1.167 . . . . 10.26 110.831 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -66.49 -25.64 66.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.777 0.431 . . . . 14.75 111.415 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -72.5 -59.02 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.806 -1.183 . . . . 14.1 107.806 160.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -38.13 -60.98 1.25 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 126.624 2.059 . . . . 9.38 114.434 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -70.2 -6.6 35.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 114.769 1.396 . . . . 11.39 114.769 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.2 mtm 113.2 137.44 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 129.521 3.128 . . . . 11.93 106.659 -162.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.02 -39.52 50.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.801 1.64 . . . . 17.47 111.839 -170.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.69 172.31 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.868 0.842 . . . . 17.84 112.806 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.28 -1.748 . . . . 19.35 106.28 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 78.77 146.78 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.263 1.825 . . . . 23.99 109.343 -163.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.89 159.21 29.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.805 -1.554 . . . . 17.38 106.805 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -70.06 -57.11 5.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.569 0.348 . . . . 23.72 110.606 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -173.52 -56.98 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.028 1.331 . . . . 18.71 108.109 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.2 mt 62.75 -94.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.983 1.313 . . . . 15.3 109.396 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.36 -158.93 31.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.833 -2.107 . . . . 9.38 107.833 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.8 -23.57 61.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.242 1.417 . . . . 8.38 110.034 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.2 mt -62.69 76.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.533 1.533 . . . . 9.68 108.68 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.07 -11.01 56.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.228 1.011 . . . . 6.06 110.818 169.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.34 28.1 66.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.133 0.873 . . . . 2.56 112.346 -176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.82 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 5.03 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 4.4 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.62 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 5.38 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.36 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 6.67 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 3.62 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 3.03 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.83 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 4.21 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 2.72 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 6.26 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 2.63 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 2.56 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 6.12 110.027 162.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 5.46 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 1.25 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 4.06 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 1.64 104.584 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 3.27 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.16 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.78 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.38 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.99 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.99 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 1.42 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 4.09 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 2.37 108.419 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 3.03 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 3.83 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.87 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.97 106.41 163.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 5.16 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 2.8 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 2.73 114.012 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 6.49 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.54 107.785 168.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.86 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.88 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 7.42 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 2.65 109.18 -171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 4.51 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 2.87 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 4.79 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 2.08 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.78 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.12 111.039 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.95 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 2.1 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.95 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 3.49 106.433 175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 2.36 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.91 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.91 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.84 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.8 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.83 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.441 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 4.4 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.65 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 4.06 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 6.88 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 7.26 108.24 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.421 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 6.1 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 3.7 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 2.33 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 3.52 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 3.07 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.94 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.77 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 1.97 109.404 168.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 2.8 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 5.69 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 3.23 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.53 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 2.12 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.85 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 4.38 110.603 135.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.67 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.24 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 5.13 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.81 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 2.0 109.113 -174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.15 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.421 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 3.09 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 6.78 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 4.99 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.39 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 4.41 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 2.05 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 4.36 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.99 108.581 -170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 2.36 107.768 169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 2.27 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 3.28 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 1.69 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.11 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 3.12 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 4.55 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 3.18 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 2.92 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.38 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 2.41 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 3.24 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 4.48 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 2.39 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.94 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.88 107.91 -171.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.88 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 2.11 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.99 107.628 160.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.76 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.33 -1.73 . . . . 52.52 106.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 178.9 178.53 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.916 1.687 . . . . 45.08 106.571 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -153.89 156.72 38.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.917 -1.512 . . . . 42.26 106.917 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.5 171.95 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.702 1.601 . . . . 37.66 106.98 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -166.2 164.69 17.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.336 -1.357 . . . . 33.6 107.336 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.21 159.83 44.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.767 -1.197 . . . . 29.91 107.767 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -144.68 174.98 10.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.291 1.836 . . . . 26.98 106.911 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -152.51 170.42 20.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.743 -1.206 . . . . 22.68 107.743 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 -173.43 2.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.158 -1.423 . . . . 19.58 107.158 163.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -159.84 169.25 23.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.541 -1.652 . . . . 15.9 106.541 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 175.27 11.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.177 0.991 . . . . 17.22 108.882 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -159.67 -179.13 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.423 -1.325 . . . . 10.15 107.423 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 21.49 71.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.009 2.523 . . . . 8.02 114.71 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -96.66 -162.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.528 0.731 . . . . 14.14 109.685 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.34 169.03 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.815 1.246 . . . . 16.65 110.361 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 81.44 -54.29 0.28 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.828 2.451 . . . . 19.4 112.958 150.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -156.94 -47.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.323 1.449 . . . . 15.7 107.473 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -40.61 -38.35 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.66 1.184 . . . . 13.35 111.829 166.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -43.41 -42.95 4.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.649 0.981 . . . . 11.89 113.649 172.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -51.48 -48.29 62.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.769 0.828 . . . . 14.76 110.622 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -70.92 -43.1 68.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.931 0.492 . . . . 10.55 111.035 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.18 -71.93 0.94 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.582 1.087 . . . . 7.79 112.544 -169.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -71.76 -40.68 69.15 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 117.689 0.745 . . . . 11.44 110.299 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.8 ptp 49.51 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.74 1.616 . . . . 10.49 113.091 -170.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.79 -94.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.346 -2.094 . . . . 15.32 105.346 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.13 -179.39 0.57 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.39 1.876 . . . . 16.61 106.397 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -64.3 -19.7 65.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.798 0.666 . . . . 19.85 112.798 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -134.38 161.93 33.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.123 . . . . 26.96 107.969 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.92 67.23 3.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.968 0.907 . . . . 24.25 111.414 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -72.42 171.94 11.34 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.951 -0.389 . . . . 22.9 109.951 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -53.97 -64.22 0.9 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.58 0.752 . . . . 23.61 112.017 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mm 49.97 65.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 16.23 110.026 -174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.11 55.86 0.47 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.492 -1.843 . . . . 15.06 108.492 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -178.41 58.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.593 2.357 . . . . 13.96 110.118 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.2 mm -125.72 -57.48 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.799 0.84 . . . . 9.83 109.404 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.61 -82.34 0.13 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.903 -0.57 . . . . 4.04 110.781 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.41 -12.52 2.78 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 2.77 113.928 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.52 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.59 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.69 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.63 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 5.63 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.87 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 5.44 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 3.52 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 2.56 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.69 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 3.74 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 5.86 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 2.31 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 2.62 110.288 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 4.11 109.109 174.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 5.59 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.82 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.85 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 1.89 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 3.57 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.09 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.4 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.78 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 2.25 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 1.07 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 1.25 112.555 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.98 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 1.86 107.321 165.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 3.3 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 3.6 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 2.03 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.41 109.501 171.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.66 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 3.69 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 2.67 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.96 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.74 115.444 167.044 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.55 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.48 112.074 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 4.27 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 2.81 107.952 -169.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.89 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.493 ' CE1' ' H ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 7.5 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 2.53 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 4.82 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 2.14 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 3.62 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.94 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 1.91 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.58 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 2.79 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 2.76 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 2.27 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 2.01 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.66 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 2.39 111.394 174.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 7.72 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 5.27 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.14 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.7 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 7.36 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.9 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.571 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 6.45 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 3.14 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 2.02 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 3.94 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 3.08 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.72 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 2.42 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 2.04 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 4.18 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 6.36 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.28 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.99 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 2.16 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 4.17 108.365 170.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.75 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.12 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 3.42 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.98 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 1.82 109.419 -171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.16 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.571 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 3.25 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 5.58 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 3.71 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.33 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.93 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.87 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 4.61 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.01 108.07 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.84 109.21 172.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 1.84 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.8 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 3.59 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 2.57 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.14 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 3.57 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 4.55 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.76 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.83 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.78 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.28 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 3.76 108.143 -171.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 3.42 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 3.51 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 2.68 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.86 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.99 107.115 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 1.74 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.66 109.798 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.99 109.396 173.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.08 110.118 -157.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.022 -0.362 . . . . 53.79 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.68 164.02 12.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.499 -1.667 . . . . 45.44 106.499 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -168.81 -177.78 3.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.98 -1.489 . . . . 41.15 106.98 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.83 169.24 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.813 2.045 . . . . 37.45 107.436 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -164.6 169.29 17.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.205 -1.406 . . . . 33.13 107.205 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.57 160.68 32.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.276 -1.379 . . . . 29.6 107.276 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.5 tp -157.41 146.45 19.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.746 -2.316 . . . . 25.31 104.746 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -159.2 172.63 17.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.675 -1.232 . . . . 22.02 107.675 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.61 155.28 2.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.658 1.583 . . . . 18.4 108.199 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -153.28 139.15 18.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.407 -1.331 . . . . 14.93 107.407 162.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.61 -166.64 2.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.688 1.595 . . . . 13.47 108.53 -168.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -143.6 168.64 19.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.633 0.651 . . . . 10.56 110.326 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -171.84 54.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.896 -1.15 . . . . 6.2 107.896 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.59 110.72 6.93 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.612 0.765 . . . . 12.18 110.706 -170.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.3 mm -105.78 -56.62 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.254 1.421 . . . . 16.7 109.212 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -152.78 -106.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.34 -1.356 . . . . 21.24 107.34 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -45.65 -42.66 11.69 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.359 1.063 . . . . 18.49 110.316 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -29.84 0.93 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.455 1.902 . . . . 14.56 113.926 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -48.04 -46.45 33.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.511 1.124 . . . . 10.92 110.928 171.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.84 -70.33 0.22 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.986 -0.746 . . . . 15.28 108.986 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -66.07 -55.51 16.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.486 0.55 . . . . 14.21 112.486 -168.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.16 -61.94 5.33 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.173 -0.771 . . . . 8.62 111.173 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -70.07 -44.39 69.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 117.794 -1.098 . . . . 10.84 110.57 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.2 ptt? 37.42 66.92 0.41 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.787 1.235 . . . . 12.72 111.67 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.8 t 68.35 -67.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.525 1.53 . . . . 13.06 109.588 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.19 0.94 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.416 0.627 . . . . 13.38 111.915 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 79.39 0.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 18.87 109.252 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -58.98 105.29 0.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.879 1.272 . . . . 20.84 109.73 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -114.48 -74.46 0.62 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.89 -1.522 . . . . 21.64 106.89 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.54 -167.93 2.22 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.686 -2.709 . . . . 24.0 103.686 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -78.49 57.89 2.07 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.102 . . . . 18.18 109.745 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -144.46 164.14 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 105.766 -1.938 . . . . 16.25 105.766 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -127.17 3.88 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 103.266 -3.934 . . . . 10.4 103.266 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 76.92 -57.57 0.53 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.637 1.975 . . . . 7.9 111.339 158.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -53.31 -67.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.05 1.74 . . . . 10.42 109.799 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 169.32 168.47 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.281 2.232 . . . . 5.33 106.368 -172.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.28 -53.12 0.53 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 3.28 108.099 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.11 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.73 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 3.75 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 2.37 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 3.68 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 5.42 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.83 115.001 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 5.81 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.78 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.13 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 6.47 111.604 -165.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 2.04 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 2.0 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 4.08 110.925 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 6.23 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.97 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 3.81 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 2.18 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 3.75 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.18 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.83 112.943 173.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.35 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 2.72 105.701 153.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.05 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.82 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 5.29 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.97 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.87 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 3.78 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 2.32 108.355 168.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.479 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 2.68 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.44 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 4.9 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 3.11 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 2.2 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 6.28 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.91 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.69 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.94 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 1.13 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 4.63 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 3.15 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.65 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 5.0 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 2.68 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 6.27 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 2.68 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.82 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 3.04 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.87 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 2.08 109.793 -169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.24 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 2.7 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 2.05 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 2.99 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.68 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 2.19 108.764 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 9.06 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 4.95 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.05 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.97 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 5.24 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 7.63 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.87 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 4.86 105.771 -177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 2.29 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 3.7 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.54 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.89 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 2.96 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 1.77 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 3.04 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 5.21 106.622 170.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 3.33 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 3.07 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 2.5 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.13 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 4.08 108.669 163.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.81 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 1.16 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 4.64 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.72 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 2.07 112.892 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.49 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 3.13 106.044 155.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 6.84 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 4.78 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.33 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 4.2 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 2.05 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 4.8 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.62 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.84 107.694 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 2.7 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.13 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 1.84 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 3.02 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.68 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.92 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 4.09 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.16 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.32 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 3.59 109.364 -167.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 4.05 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 3.79 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 2.24 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 1.0 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 2.23 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 3.0 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.77 109.381 169.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.99 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.33 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.63 -1.618 . . . . 54.99 106.63 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -161.36 157.56 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.329 -1.73 . . . . 49.36 106.329 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -163.04 179.95 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.795 -1.557 . . . . 45.35 106.795 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.51 168.29 6.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.941 2.096 . . . . 40.8 107.459 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -166.74 -178.55 4.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.817 -1.549 . . . . 36.07 106.817 170.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.82 157.1 11.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.564 1.546 . . . . 31.82 107.802 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -142.7 159.24 42.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.569 -1.641 . . . . 29.35 106.569 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -163.58 166.94 21.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.837 -1.542 . . . . 24.01 106.837 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.24 175.84 8.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.331 -1.359 . . . . 19.87 107.331 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -159.38 -179.05 7.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.221 -1.4 . . . . 16.25 107.221 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -142.04 157.47 44.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.469 -1.678 . . . . 15.41 106.469 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 t -159.17 140.17 12.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.605 0.717 . . . . 10.47 110.444 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -57.15 -43.02 82.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.975 2.91 . . . . 7.21 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -135.73 177.51 7.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.393 1.477 . . . . 11.54 108.533 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -134.36 148.75 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.163 1.385 . . . . 14.18 109.631 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 90.6 63.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.971 2.508 . . . . 19.31 110.147 166.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.73 -53.91 0.68 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.893 2.077 . . . . 17.25 111.681 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.7 m -32.89 -43.12 0.09 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.551 1.94 . . . . 14.65 112.117 159.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -38.22 -50.65 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.685 1.594 . . . . 11.03 112.443 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -52.1 -48.11 64.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.245 1.018 . . . . 16.05 110.539 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -70.02 -51.51 31.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.483 0.713 . . . . 13.56 110.383 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.85 -57.02 10.29 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.26 0.933 . . . . 8.83 112.224 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -71.0 -5.52 31.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.257 1.206 . . . . 12.62 114.257 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.1 mtt 56.39 59.31 3.7 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.314 1.445 . . . . 12.46 111.28 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t 68.89 -69.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.779 1.632 . . . . 16.7 112.178 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.43 -95.45 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.665 -0.865 . . . . 15.64 108.665 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.4 166.56 0.61 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.359 2.264 . . . . 15.3 108.402 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -50.79 137.45 20.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.341 -0.614 . . . . 19.35 109.341 168.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 100.69 -35.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.784 2.834 . . . . 20.28 110.62 -171.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.6 116.54 31.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.475 -0.565 . . . . 18.46 109.475 -170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 69.81 -52.01 0.63 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.346 1.859 . . . . 19.7 111.082 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mt 59.53 48.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.028 1.331 . . . . 14.83 108.641 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.48 99.69 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.213 -1.155 . . . . 11.63 110.213 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -154.53 168.8 25.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.499 1.52 . . . . 9.34 106.943 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.58 148.92 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.216 -1.031 . . . . 10.44 108.216 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.71 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.992 0.517 . . . . 5.4 112.132 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.68 46.31 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 3.65 111.679 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.56 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 5.0 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 4.28 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 3.04 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 4.79 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.06 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 6.42 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 3.38 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 2.69 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.32 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 3.18 116.775 -160.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 2.5 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 9.31 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 3.54 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 2.45 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 5.54 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 6.37 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.5 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.99 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.69 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 3.49 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.31 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.21 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.47 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.72 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 2.84 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.43 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.46 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.98 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 2.62 109.629 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 2.55 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 3.99 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 2.19 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 2.87 106.833 158.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.24 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 4.38 113.437 172.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 2.39 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 2.28 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.89 114.268 169.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.441 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.7 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.89 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.49 111.704 -172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.86 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.7 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.93 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 4.97 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.72 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 6.1 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 2.96 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 5.17 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 3.01 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 3.34 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.15 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 2.12 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.08 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 3.3 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 3.23 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 2.29 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 2.12 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.31 112.887 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.92 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 4.83 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 4.72 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 7.98 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 9.47 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 6.19 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 3.55 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 2.31 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 3.47 107.895 164.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 2.06 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 1.04 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 3.24 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 1.91 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 3.25 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 8.65 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.76 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.67 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 3.86 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.9 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 7.09 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.1 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.31 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 4.0 111.942 -171.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 2.42 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 2.75 110.184 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 4.31 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 6.94 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 4.5 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.76 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 6.38 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 2.24 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 3.63 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.61 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 2.32 107.919 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 2.66 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.2 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 2.89 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 1.74 110.513 163.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.03 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.98 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 5.72 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.82 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 4.27 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.65 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.84 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 2.89 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 3.17 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 3.6 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 2.29 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.94 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.99 107.946 -171.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 1.96 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 2.28 110.85 174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 5.59 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.77 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 107.098 -1.445 . . . . 59.99 107.098 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 61.52 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.751 1.22 . . . . 54.79 111.639 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -96.9 101.04 12.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.109 1.364 . . . . 49.95 109.209 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -81.85 158.09 24.17 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.848 -0.797 . . . . 44.95 108.848 167.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.5 t -69.67 179.98 1.96 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.645 -0.502 . . . . 39.5 109.645 170.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -135.1 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.785 -1.561 . . . . 35.01 106.785 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.84 167.29 12.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.968 -1.493 . . . . 30.44 106.968 154.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -53.72 150.83 6.81 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.217 -0.29 . . . . 26.03 110.217 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.08 -44.74 61.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.429 0.692 . . . . 22.68 110.488 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -164.79 -176.09 4.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.684 -1.228 . . . . 17.97 107.684 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -84.3 175.01 9.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.597 1.159 . . . . 19.72 108.079 162.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.1 m 61.78 -170.21 0.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.581 -0.896 . . . . 11.42 108.581 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.32 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.055 1.298 . . . . 9.37 110.729 179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -154.72 171.1 20.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.939 1.296 . . . . 14.92 109.682 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.35 160.62 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 126.784 2.034 . . . . 18.61 110.965 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -70.3 0.16 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.012 1.725 . . . . 18.35 108.588 -175.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 100' ' ' LYS . 1.2 m-20 -61.81 -10.26 8.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.857 1.263 . . . . 16.82 110.241 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.9 t -27.64 -26.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 131.29 3.836 . . . . 12.15 115.55 163.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.13 -88.18 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.612 1.165 . . . . 11.43 109.248 168.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.25 -18.61 38.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.316 1.046 . . . . 14.16 113.251 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.2 p -55.42 -9.24 0.44 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.12 1.768 . . . . 9.5 113.678 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.46 -7.89 0.03 OUTLIER Glycine 0 CA--C 1.537 1.424 0 CA-C-O 119.03 -0.872 . . . . 7.75 114.166 160.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -26.04 -61.03 0.08 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.552 1.176 . . . . 10.53 111.651 150.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ttt 61.71 -72.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.85 1.66 . . . . 14.13 112.733 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.62 -36.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.864 1.266 . . . . 16.34 112.044 -167.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.37 105.55 1.29 Allowed 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.491 -0.756 . . . . 18.69 109.437 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -143.33 -33.5 0.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.743 -1.122 . . . . 18.77 113.651 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 66.04 81.58 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.371 1.068 . . . . 26.76 112.94 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -126.22 167.87 14.85 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.706 -1.22 . . . . 21.69 107.706 164.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -58.41 -51.69 68.76 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.792 0.806 . . . . 27.31 109.46 166.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 154.84 117.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 130.156 3.382 . . . . 22.65 104.475 -167.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.14 -71.01 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.568 -1.271 . . . . 18.02 107.568 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -132.83 -103.34 0.85 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 106.015 -2.834 . . . . 15.44 106.015 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.19 158.75 8.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.474 1.51 . . . . 12.0 109.759 164.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.6 pt -168.24 135.47 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 126.568 1.947 . . . . 12.34 106.74 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.67 26.72 1.39 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.559 1.072 . . . . 4.71 113.834 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.13 -55.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 3.62 111.185 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 12.6 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 4.71 109.213 -165.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.64 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 6.13 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 5.05 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 3.85 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 4.29 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.8 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 4.19 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 3.23 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 6.66 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 2.3 108.759 158.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 2.26 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 4.12 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 6.72 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 1.01 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.76 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 1.75 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 3.3 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 2.07 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.24 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.92 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 2.03 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.06 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.68 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 4.51 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 2.1 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.85 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 3.21 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 2.01 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 2.88 109.122 174.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 4.2 115.943 -167.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 2.79 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 2.02 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 5.46 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.91 106.668 177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.58 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.61 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.8 106.587 161.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 6.87 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 4.52 107.702 -177.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.69 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 5.16 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 3.23 109.859 -158.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 4.87 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.63 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 2.12 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.63 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 3.72 110.921 -173.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 1.84 109.08 -173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 2.64 109.134 -173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 2.64 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 2.04 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 2.36 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.09 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 2.34 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.405 ' NZ ' ' OD2' ' A' ' 17' ' ' ASP . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 7.9 111.976 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.96 113.642 177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.04 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 7.39 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 11.64 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.461 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 8.81 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 3.79 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 2.08 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 3.26 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 3.22 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 1.01 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.94 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 1.98 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 4.15 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 6.19 108.286 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.8 t30 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.66 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 115' ' ' TYR . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.45 109.201 177.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 2.35 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.87 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.61 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 1.23 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 3.81 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 3.63 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.78 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.3 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 4.14 108.547 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 5.54 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 3.42 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.85 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.99 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 2.15 113.241 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 3.97 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.08 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 3.0 108.42 170.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 3.37 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.4 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 3.5 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.78 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.03 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 3.14 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 4.71 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 3.67 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.92 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.93 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 1.11 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 2.18 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 4.15 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 3.5 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 2.48 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.42 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 2.0 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 2.0 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 1.95 108.835 171.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.79 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.03 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.02 -1.104 . . . . 54.99 108.02 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -161.82 169.99 20.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.113 -1.81 . . . . 47.06 106.113 176.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -151.39 164.04 37.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.452 -1.314 . . . . 44.26 107.452 171.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.4 171.65 16.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.472 1.909 . . . . 39.3 106.538 178.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -163.06 173.79 13.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.88 1.272 . . . . 35.41 107.597 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.11 172.83 16.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.795 -1.187 . . . . 31.08 107.795 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -136.74 173.69 11.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.631 1.572 . . . . 27.85 109.109 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -144.78 159.4 42.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 23.95 109.035 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.92 168.64 24.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.869 1.267 . . . . 19.6 107.6 173.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -163.55 159.54 22.05 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.242 -1.392 . . . . 16.37 107.242 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -161.87 172.42 16.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.635 1.174 . . . . 14.47 109.173 177.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -135.09 -157.37 0.79 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.668 1.587 . . . . 11.21 109.083 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.65 133.32 13.61 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.169 -1.049 . . . . 7.21 108.169 172.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 162.45 -81.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.734 2.414 . . . . 13.09 110.494 -175.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -152.46 142.69 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.351 1.06 . . . . 15.78 108.47 -170.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 76.91 -174.99 0.1 Allowed 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 126.819 2.048 . . . . 17.31 108.607 176.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.421 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 2.3 m-20 -43.94 -36.77 2.57 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.081 -1.012 . . . . 14.67 113.318 -177.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 m -35.6 -43.97 0.29 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.94 1.696 . . . . 10.51 113.684 169.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -39.65 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.075 1.75 . . . . 12.27 111.257 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.41 -49.31 50.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.978 -0.555 . . . . 13.07 110.339 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -64.58 -25.71 68.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.19 0.441 . . . . 10.59 112.19 -166.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.99 -68.93 1.49 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.768 -1.333 . . . . 9.43 109.768 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -53.83 13.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.149 0.796 . . . . 12.65 113.149 -169.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.62 76.58 0.99 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.395 1.478 . . . . 12.25 108.865 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.2 t -41.83 139.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.522 1.929 . . . . 15.18 112.563 -179.056 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.08 98.89 0.05 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.898 2.079 . . . . 17.46 110.959 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' NZ ' ' OD1' ' A' ' 17' ' ' ASP . 35.6 pttt -68.76 124.08 22.67 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.984 -0.448 . . . . 17.27 111.58 -177.198 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -107.01 58.77 0.63 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.941 -1.133 . . . . 21.14 107.941 166.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 49.09 40.7 17.99 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.269 1.428 . . . . 22.39 112.908 173.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -57.07 -60.37 3.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.799 0.666 . . . . 20.26 112.799 -167.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -165.53 61.18 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.236 -1.765 . . . . 19.16 106.236 -176.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.45 76.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 14.41 110.384 -163.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.54 85.53 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.061 -1.216 . . . . 10.14 110.061 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.05 69.27 0.67 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.821 1.248 . . . . 8.76 110.791 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.86 -74.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.308 -1.738 . . . . 9.34 106.308 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 33.77 78.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.767 1.627 . . . . 5.82 111.768 -171.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.06 1.49 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 3.7 113.483 -161.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.54 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.69 111.812 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 3.37 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.43 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 4.63 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.51 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 7.49 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 3.47 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.68 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.77 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.49 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 9.87 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 2.98 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 2.55 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 5.96 112.524 157.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 6.87 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.58 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.92 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 1.83 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 3.31 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.12 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.97 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.38 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.4 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 2.5 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 1.07 113.671 -174.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 4.31 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 2.07 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 2.91 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 4.51 112.398 -172.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 2.79 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 2.74 111.16 173.182 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.47 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 3.51 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 2.41 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.89 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 6.16 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.37 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.55 110.932 -175.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.97 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.07 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 4.52 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 2.69 107.504 178.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.22 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 4.27 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 2.81 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 4.51 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 2.09 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.85 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.06 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 3.32 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.84 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 2.12 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.28 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 3.61 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.82 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 2.34 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 2.08 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.49 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.75 103.619 166.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 8.21 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 4.13 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.07 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.14 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 6.18 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 10.16 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.86 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.65 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 2.35 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 3.14 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 2.31 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.97 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.87 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 1.96 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 3.17 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 6.29 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.81 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.83 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 2.07 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 4.07 109.438 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.71 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 1.34 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 3.99 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 2.24 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 1.95 111.96 -163.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2 113.064 -168.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 3.19 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 6.14 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 5.52 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.68 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 4.05 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.11 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 4.56 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.63 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 2.38 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 1.77 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.11 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 3.46 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 2.42 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 3.37 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.99 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.82 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 3.23 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.76 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 1.21 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 2.45 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 4.22 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 3.3 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 2.19 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.4 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 2.2 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 2.22 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 3.07 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 4.11 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.86 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 106.629 -1.619 . . . . 59.18 106.629 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.42 144.24 56.09 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.986 0.812 . . . . 52.3 109.3 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -161.6 157.69 25.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.87 -1.529 . . . . 47.32 106.87 171.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -173.24 157.06 3.3 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.941 1.697 . . . . 43.3 106.862 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -163.43 171.99 15.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.844 -1.539 . . . . 38.56 106.844 165.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.78 5.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.658 1.583 . . . . 34.78 107.642 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 pp -151.15 162.8 40.2 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.291 1.436 . . . . 29.85 107.996 178.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -165.33 -134.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.256 0.622 . . . . 26.47 109.455 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.42 163.35 0.17 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.009 2.524 . . . . 22.96 111.084 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -143.86 159.86 41.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.563 1.145 . . . . 19.08 109.88 -174.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.74 157.07 0.13 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.951 2.101 . . . . 18.9 108.099 170.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -159.78 179.41 8.85 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.586 -2.376 . . . . 11.49 104.586 169.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.88 77.55 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.443 1.497 . . . . 8.3 111.331 -170.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.52 -164.85 0.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.547 1.939 . . . . 16.08 108.907 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -133.88 146.69 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 106.407 -1.701 . . . . 16.47 106.407 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 85.87 73.33 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 128.103 2.561 . . . . 23.27 109.783 178.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.04 -53.13 0.67 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.146 2.178 . . . . 23.8 111.287 172.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.4 m -48.82 -22.37 0.81 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.06 1.344 . . . . 18.65 112.938 169.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.01 -49.53 50.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.751 0.82 . . . . 17.23 112.293 169.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -71.33 -36.03 71.42 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.829 -0.544 . . . . 23.42 112.407 -169.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -70.52 -50.12 41.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.685 -0.857 . . . . 18.31 108.685 169.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -34.85 -50.18 0.78 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 127.453 2.454 . . . . 13.58 113.273 173.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -31.52 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.646 2.778 . . . . 17.53 115.047 170.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.86 75.34 1.63 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.864 0.84 . . . . 18.46 110.809 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.0 t -55.61 80.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 127.21 2.204 . . . . 16.81 108.279 165.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.43 -41.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.351 1.46 . . . . 19.76 109.429 -168.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -52.41 40.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.349 0.87 . . . . 21.01 113.349 -175.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -155.97 174.53 15.21 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.306 1.442 . . . . 23.33 108.185 -174.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -138.12 -52.32 0.61 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 124.28 0.988 . . . . 17.8 108.688 157.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 61.84 -158.38 0.33 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.677 -0.86 . . . . 18.22 108.677 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -69.43 -39.52 77.81 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.654 -0.653 . . . . 21.84 110.215 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.7 mt -141.86 135.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.601 -2.0 . . . . 17.73 105.601 175.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.78 49.12 0.04 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.536 1.541 . . . . 12.0 109.713 178.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -159.36 56.21 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.305 1.042 . . . . 12.06 109.558 -148.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.4 mm -71.54 164.43 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.17 -1.048 . . . . 10.51 108.17 171.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.64 64.5 1.29 Allowed 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.866 -0.521 . . . . 8.16 111.115 -174.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.73 60.32 7.92 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.303 -0.873 . . . . 3.34 111.208 175.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.83 113.128 -175.487 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 5.1 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 3.69 111.17 165.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.99 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 5.65 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.03 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 4.65 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 4.17 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.6 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.85 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 4.33 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 2.91 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.92 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 2.24 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 2.02 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 5.26 116.967 -177.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 6.03 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 1.12 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 4.16 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 2.15 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 3.55 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.94 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 2.02 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.19 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.38 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 2.0 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.9 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.98 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 2.28 109.63 174.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.51 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 3.93 111.597 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 2.99 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 3.48 104.518 160.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.99 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 4.26 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.92 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 2.12 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 8.23 113.969 177.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.79 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.14 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.97 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 7.92 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 3.31 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.34 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 5.38 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 3.09 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 5.03 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 3.17 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.53 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.35 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.94 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.84 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 2.15 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.32 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 2.81 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 2.3 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 2.4 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 2.31 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.89 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 2.73 108.543 170.001 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 8.59 110.138 163.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 8.11 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.69 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 5.06 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 8.8 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 7.34 112.013 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 3.37 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 2.01 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 4.01 108.242 157.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 2.98 110.937 177.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.95 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 2.21 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 2.09 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 3.43 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 7.39 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 4.32 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 3.39 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 2.79 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.71 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.69 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.67 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 3.92 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 2.33 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 2.0 108.015 -174.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.17 111.402 -177.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 4.06 111.2 -174.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 8.6 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 4.14 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.36 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 6.78 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.89 107.117 -164.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 3.58 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.15 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 2.17 106.545 155.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 2.27 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.71 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 3.05 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 1.9 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.05 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 3.06 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.88 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 3.22 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.91 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.65 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.19 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 3.66 106.872 -171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 3.34 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 3.31 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 2.5 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.17 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.89 107.57 -175.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 2.37 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.79 109.879 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 5.18 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.37 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.156 -0.683 . . . . 65.58 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -166.87 154.25 9.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.087 -1.449 . . . . 56.23 107.087 -175.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -158.26 58.47 0.46 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.456 -0.942 . . . . 51.48 108.456 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -117.48 65.42 0.73 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.02 0.928 . . . . 49.53 108.658 -169.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -155.81 117.59 4.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.793 -0.818 . . . . 41.84 108.793 -177.153 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.37 62.87 1.22 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.183 0.993 . . . . 37.22 108.722 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.67 179.41 6.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.988 1.715 . . . . 32.72 108.762 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -150.99 161.43 42.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.744 -1.206 . . . . 27.93 107.744 169.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.18 113.89 0.56 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.074 -1.454 . . . . 23.86 107.074 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -74.18 71.61 1.68 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.618 -0.882 . . . . 20.18 108.618 177.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 68.0 -67.13 0.2 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.865 2.066 . . . . 17.76 109.741 -174.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m 56.45 22.09 6.17 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.811 1.645 . . . . 13.01 112.241 174.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 36.14 47.14 0.43 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.476 2.31 . . . . 9.69 113.164 -164.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 64.51 -173.0 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.058 1.343 . . . . 17.34 110.057 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm 66.53 -34.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.995 1.318 . . . . 16.1 114.446 -176.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 75.34 -48.13 0.61 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 128.165 2.586 . . . . 17.3 110.984 178.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.18 -104.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.015 -1.106 . . . . 14.06 108.015 167.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -28.88 -69.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.493 2.317 . . . . 11.98 113.876 -168.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.19 -4.93 8.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.765 1.765 . . . . 11.36 115.765 -169.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -46.61 -35.62 6.09 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.927 1.239 . . . . 10.96 110.258 159.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -49.65 -61.17 2.26 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.467 1.507 . . . . 8.98 111.461 168.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.72 -46.16 76.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 6.91 110.874 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.12 -45.68 92.17 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 116.967 -1.492 . . . . 13.57 112.048 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 146.51 -1.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.648 2.379 . . . . 9.89 115.418 172.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t 68.71 -68.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.312 1.415 . . . . 12.35 111.92 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.39 87.39 0.11 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 127.255 2.222 . . . . 14.82 111.32 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -167.35 -146.83 0.08 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.752 0.421 . . . . 17.2 110.388 -171.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -75.22 61.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.644 1.178 . . . . 21.84 110.94 -176.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -161.59 -66.66 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.772 -1.566 . . . . 16.55 106.772 169.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -140.68 175.67 9.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.198 0.999 . . . . 17.79 109.513 176.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.4 73.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.337 1.855 . . . . 18.94 106.167 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mt -130.4 128.75 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.503 -1.295 . . . . 12.71 107.503 -176.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.54 64.7 2.88 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.703 -1.359 . . . . 10.7 109.703 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -143.39 173.54 11.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.912 1.685 . . . . 9.31 107.68 -175.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt 68.36 -74.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.436 1.894 . . . . 8.5 110.762 173.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 28.93 61.81 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.097 2.159 . . . . 6.06 112.89 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -73.12 90.65 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 3.01 111.052 -170.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.07 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.35 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 3.26 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 2.08 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 4.66 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.02 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 6.57 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 4.19 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 2.67 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.59 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 2.74 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 2.44 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 6.29 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 3.12 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.35 109.202 176.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 4.13 108.053 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 6.05 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.8 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 3.04 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 1.85 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 3.49 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.12 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.43 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.51 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.82 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.87 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 1.07 112.32 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 4.51 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 2.3 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 3.06 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 3.53 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.87 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 2.74 106.605 170.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.28 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 3.67 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 2.67 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 2.35 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.89 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 3.27 107.194 172.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.75 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.26 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 6.1 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 2.64 106.56 172.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.49 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 4.77 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 2.66 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 4.27 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 2.44 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.12 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.53 110.277 -172.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 3.12 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.24 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 2.16 108.465 -174.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.06 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 2.82 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 2.79 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 2.44 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.95 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.13 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 2.38 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 9.22 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 5.19 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.98 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 5.41 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 10.31 110.912 -174.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.75 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.93 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 4.87 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 2.19 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 3.67 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.98 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.95 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 2.42 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 2.08 113.656 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 3.04 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 5.64 104.711 174.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.45 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 2.02 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' H ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 8.92 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.32 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 1.33 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 3.87 109.695 -176.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 2.91 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 1.98 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.17 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 3.33 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 6.09 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 4.97 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.55 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 6.36 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 2.73 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 5.12 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 2.24 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 2.05 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.9 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 3.58 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 1.87 112.069 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.44 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 3.11 106.559 -166.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 4.18 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 3.01 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 2.75 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.58 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.3 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 2.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 3.18 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 4.78 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 2.25 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 1.0 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 2.38 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 2.15 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 2.64 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 4.36 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.33 110.752 -177.22 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.332 -1.729 . . . . 52.39 106.332 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.88 175.63 9.57 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 106.948 -1.501 . . . . 45.93 106.948 174.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 p -155.08 169.63 23.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.155 -1.054 . . . . 42.18 108.155 -177.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -145.26 -179.76 6.85 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 39.12 107.381 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -157.61 162.88 38.74 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.904 1.282 . . . . 34.76 107.549 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.44 171.11 7.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.636 1.175 . . . . 30.41 109.941 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.56 -179.07 3.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 26.97 109.47 175.341 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -139.04 174.95 9.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.802 1.241 . . . . 23.65 107.99 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.37 20.42 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.911 1.284 . . . . 20.01 107.666 177.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -134.31 136.75 43.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.661 0.785 . . . . 20.67 110.85 -173.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -175.63 3.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.582 0.706 . . . . 15.48 109.625 158.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 t -164.24 -161.53 0.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.349 -2.093 . . . . 11.32 105.349 168.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -74.17 62.4 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.74 1.616 . . . . 7.55 109.338 175.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 62.23 165.85 0.11 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.654 1.982 . . . . 12.32 114.077 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 pt -172.14 97.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 127.042 2.137 . . . . 14.9 108.885 176.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -123.32 71.11 1.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.761 -1.2 . . . . 16.4 107.761 148.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.0 t70 64.13 -67.79 0.1 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.543 1.937 . . . . 15.72 111.063 -176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 m -32.42 -68.8 0.09 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.828 2.051 . . . . 14.48 112.366 172.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.25 -9.89 36.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.205 0.602 . . . . 11.21 112.411 -173.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -57.22 -28.15 62.64 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.659 1.118 . . . . 14.36 110.567 171.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.7 p -69.4 -74.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.747 -0.835 . . . . 13.15 108.747 165.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -31.71 -50.88 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 127.711 2.577 . . . . 9.0 114.57 -177.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -18.58 61.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 114.934 1.457 . . . . 12.91 114.934 -174.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.8 mmt 40.1 53.96 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.348 0.976 . . . . 14.71 111.777 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.39 16.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 16.18 112.504 169.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.13 14.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.29 1.589 . . . . 14.96 115.29 -162.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -62.44 170.45 2.4 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.915 2.086 . . . . 21.76 112.744 -168.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.38 118.42 22.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.077 -1.453 . . . . 18.87 107.077 165.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.49 136.9 14.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.101 -1.074 . . . . 20.38 108.101 161.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.06 -71.13 0.48 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.499 0.32 . . . . 21.07 110.429 -170.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 50.17 31.73 5.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.429 1.091 . . . . 20.86 111.592 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp 59.72 104.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.147 1.379 . . . . 17.32 109.655 -163.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.34 74.12 0.2 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.642 1.115 . . . . 12.62 111.34 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.29 -51.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.78 2.432 . . . . 9.66 108.197 -171.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mt -75.51 68.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.065 0.946 . . . . 11.57 109.117 -178.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.8 118.38 6.11 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.371 0.669 . . . . 6.2 109.523 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.43 -56.81 2.74 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 5.01 109.788 -177.413 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.94 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 7.08 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 4.48 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 3.17 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 4.35 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.14 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 4.57 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 3.13 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 2.3 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.02 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.49 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 2.44 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 7.29 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 2.32 111.5 -178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.95 110.611 -165.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 4.57 110.031 -178.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 6.17 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.82 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 3.63 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.62 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 3.63 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.34 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.55 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.24 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.28 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 2.65 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.19 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 1.4 111.987 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.97 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 1.79 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 3.46 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 3.53 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 2.72 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.426 ' CG2' ' HA2' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 2.42 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.55 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 4.22 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 3.31 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 2.67 114.021 -162.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 5.39 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.54 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.63 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.88 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 5.12 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.81 106.647 172.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.35 104.082 153.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 6.54 107.493 37.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 3.0 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 5.4 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 3.05 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.53 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 3.52 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.94 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 2.42 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.19 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 3.03 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 3.25 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 2.27 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 2.07 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.47 110.302 -179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.13 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.91 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 5.62 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.1 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.44 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 6.64 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 7.29 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 6.54 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 3.53 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 2.13 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 3.54 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 2.31 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.91 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 2.12 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 1.83 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 2.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 7.33 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.89 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.95 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 3.7 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 5.4 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.65 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 1.39 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 3.46 109.87 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 2.67 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 2.7 107.404 -176.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 4.08 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 5.59 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 3.59 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.95 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 4.84 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 2.04 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 4.29 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 2.05 106.356 170.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 2.06 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.41 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.83 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 2.01 109.783 165.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.35 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 3.24 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 3.35 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.9 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.98 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.62 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 2.45 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 3.1 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 2.93 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 3.75 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.23 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 3.53 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 2.61 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 2.01 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 5.01 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 5.4 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.464 -0.939 . . . . 68.3 108.464 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -173.29 -171.43 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.218 -1.771 . . . . 61.33 106.218 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.17 -172.58 4.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.116 -1.809 . . . . 57.11 106.116 159.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 166.78 3.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.266 1.826 . . . . 52.64 107.927 -176.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 t -152.94 -172.41 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.709 -1.219 . . . . 47.3 107.709 168.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.05 140.28 46.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.85 1.26 . . . . 43.06 109.4 -178.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.44 150.62 43.17 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.388 -0.597 . . . . 37.7 109.388 170.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -70.09 157.57 37.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.997 0.427 . . . . 34.79 110.001 174.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 165.74 23.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.552 -0.907 . . . . 29.55 108.552 160.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -133.56 175.6 9.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.923 1.289 . . . . 27.74 108.146 178.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -51.36 -60.33 3.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.683 0.793 . . . . 22.8 109.679 -176.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m 68.58 158.85 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.043 1.337 . . . . 16.6 111.409 175.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -49.59 -55.51 13.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.321 1.849 . . . . 11.16 110.434 -173.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.83 -178.52 4.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.583 -1.636 . . . . 14.16 106.583 164.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.34 150.31 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.114 -1.81 . . . . 20.47 106.114 177.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 87.43 0.12 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.955 1.302 . . . . 21.71 110.87 173.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.42 -62.41 0.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.546 1.938 . . . . 18.69 111.973 174.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.01 -41.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.403 1.881 . . . . 15.13 111.507 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -36.19 -56.12 0.77 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.45 1.5 . . . . 19.25 111.496 170.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -63.03 -43.81 97.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.589 0.756 . . . . 20.03 109.645 -175.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -43.98 96.52 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.374 -0.204 . . . . 12.11 110.57 178.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.41 -65.41 2.52 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.093 -0.803 . . . . 9.81 111.093 -178.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -70.7 -32.15 69.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.577 1.551 . . . . 17.17 112.726 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.324 0.0 OUTLIER 30.81 -124.4 0.04 OUTLIER 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.274 1.83 . . . . 15.24 114.568 -171.606 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t 48.27 61.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.708 0.803 . . . . 20.61 109.695 170.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.09 70.6 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.736 -1.579 . . . . 21.13 106.736 -174.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttp 68.06 169.87 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.784 -1.553 . . . . 25.95 108.225 -153.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -145.79 143.84 29.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.001 -2.592 . . . . 20.47 104.001 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -166.46 -64.65 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.085 0 N-CA-C 108.834 -0.802 . . . . 23.38 108.834 -171.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.22 178.14 4.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.351 0.66 . . . . 21.54 110.295 -178.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -74.67 64.58 1.24 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.971 0.909 . . . . 22.05 110.758 -177.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.9 mt -83.94 147.03 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.406 1.482 . . . . 13.94 107.783 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 -154.4 5.41 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.551 0.528 . . . . 12.88 111.884 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -91.66 -37.32 13.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 128.952 2.901 . . . . 11.99 110.166 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -28.14 132.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 128.816 2.846 . . . . 9.96 114.032 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.51 -63.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.842 2.057 . . . . 5.24 107.364 161.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.54 61.98 3.88 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 3.66 110.616 176.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.15 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 5.09 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 3.58 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.66 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 4.09 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.91 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 6.1 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 3.22 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 2.54 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.19 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.59 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 2.19 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.77 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 2.57 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 2.17 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 4.34 108.234 -177.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.82 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 1.36 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 3.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.78 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 3.66 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 2.13 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.42 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 2.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.32 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 4.44 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 2.16 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.79 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 3.34 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.83 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 2.3 104.621 163.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 5.13 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 2.19 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 2.28 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.94 110.169 165.216 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.87 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.72 111.912 -162.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.92 109.13 -172.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.89 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 2.68 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.64 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 4.36 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 2.62 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 4.66 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 2.32 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.8 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.08 113.534 175.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 3.07 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.84 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 2.15 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 3.07 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 2.15 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 2.54 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 2.31 111.179 -167.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.96 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 7.46 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 5.4 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 3.01 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 6.67 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 8.42 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 7.51 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 3.38 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 2.14 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 4.03 104.921 155.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 3.21 109.713 176.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.22 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.86 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 1.88 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 3.2 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.99 106.415 176.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.58 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.42 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 2.15 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.99 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 4.31 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.63 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 1.25 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 3.99 113.022 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 2.74 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.86 108.209 -174.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.13 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 3.51 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 6.28 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 4.37 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 3.42 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 5.61 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.43 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 4.97 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.17 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 2.38 106.153 165.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 2.14 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.07 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 2.53 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 1.86 111.024 169.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 3.25 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.7 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 3.5 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 2.87 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.39 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 3.25 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.92 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 3.53 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 2.21 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 1.03 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 3.16 112.458 173.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 2.36 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.97 107.27 178.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 5.01 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.39 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 106.034 -1.839 . . . . 49.52 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.45 151.95 42.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.587 1.085 . . . . 42.79 109.926 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 p -161.77 127.58 3.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.863 -1.162 . . . . 38.45 107.863 -178.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -133.15 165.28 25.13 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.64 1.176 . . . . 35.77 108.359 176.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 m -164.11 172.36 13.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.738 2.015 . . . . 31.44 106.37 177.535 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.19 15.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.087 0.955 . . . . 27.55 108.706 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.08 -174.34 3.9 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.33 1.852 . . . . 23.67 108.215 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -156.63 -175.08 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.345 -0.983 . . . . 20.68 108.345 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.12 176.3 11.46 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.859 1.664 . . . . 17.66 108.356 -178.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -163.72 174.83 11.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.575 -1.268 . . . . 15.26 107.575 -178.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -145.21 145.75 31.45 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.386 -0.968 . . . . 13.87 108.386 166.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -157.06 -158.08 0.74 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.091 1.756 . . . . 9.58 107.834 173.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 5.45 10.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.628 1.171 . . . . 5.8 113.001 -166.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.49 154.26 18.41 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.045 -1.034 . . . . 10.54 109.346 -175.839 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.9 mm 61.35 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.692 1.997 . . . . 15.16 111.067 -173.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 67.27 -56.31 0.45 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.985 1.714 . . . . 14.57 110.376 -167.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.82 25.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.578 1.151 . . . . 11.63 113.542 -177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 t -67.26 -16.46 64.3 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.959 -1.088 . . . . 12.55 110.294 163.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -71.71 -57.64 4.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.206 0.603 . . . . 12.24 109.423 165.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -68.62 -20.38 64.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.365 0.876 . . . . 11.18 113.365 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 p -50.56 -8.5 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.842 2.534 . . . . 11.19 117.842 -168.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.06 72.8 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 121.108 -0.995 . . . . 9.76 113.604 166.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -53.22 -33.83 54.52 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.106 1.453 . . . . 11.89 111.777 177.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.0 ttt -53.89 84.14 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 125.154 1.382 . . . . 13.18 112.019 172.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.6 t 74.58 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 127.942 2.497 . . . . 20.27 109.706 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 92.87 93.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.127 2.171 . . . . 18.55 108.85 -166.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -69.54 78.61 0.41 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.706 1.202 . . . . 23.22 110.143 -173.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -69.24 0.61 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.21 -0.424 . . . . 22.49 110.692 -177.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -169.78 -171.22 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.196 1.398 . . . . 17.92 109.474 -169.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 71.63 -163.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.387 1.875 . . . . 16.6 110.702 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -55.46 133.14 49.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.423 -1.325 . . . . 17.25 107.423 163.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mt -123.19 80.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.335 -2.098 . . . . 13.26 105.335 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 56.84 0.06 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.487 -2.245 . . . . 10.53 107.487 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 170.17 65.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.171 1.788 . . . . 7.99 107.663 -158.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.72 -37.09 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.64 -0.709 . . . . 9.02 109.524 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.47 -159.33 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.573 1.149 . . . . 5.85 110.925 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.51 83.84 0.07 OUTLIER Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.672 -0.775 . . . . 3.67 113.224 -174.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' CD ' ' HD1' ' A' ' 39' ' ' HIS 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.69 114.57 -178.155 . . . . . . . . 4 4 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.425 ' HD1' ' CD ' ' A' ' 38' ' ' GLU . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.53 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 4.3 111.166 176.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.47 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 5.32 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 4.3 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 6.14 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 6.02 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 4.46 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.63 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.13 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.9 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 7.57 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 3.21 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 2.54 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 3.9 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 5.71 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.82 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 4.09 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 2.31 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 4.45 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 3.36 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.09 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.47 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 3.22 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.9 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.78 113.426 -168.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.97 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 1.83 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 2.57 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 3.43 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 1.95 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 2.9 109.374 167.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.72 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 4.55 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 2.27 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 2.57 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 6.61 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.66 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 4.19 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.52 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.9 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 5.33 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 3.26 107.923 -179.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.43 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 6.19 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 3.49 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.98 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 2.41 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.74 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.35 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 4.73 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 2.01 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 2.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.43 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 2.99 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.98 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 2.46 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.86 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.95 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.93 107.896 -178.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 8.05 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 4.45 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.24 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 5.36 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 12.27 113.561 169.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 10.02 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 3.49 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 2.08 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 3.82 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 2.3 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.97 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 2.63 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 2.32 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 3.49 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 7.11 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 7.17 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 3.3 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.97 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.68 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 5.03 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 1.33 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 4.23 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.87 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 2.32 109.551 -176.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 4.19 108.416 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 8.85 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 3.28 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.59 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.95 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.5 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 3.86 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 2.22 108.408 165.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 1.98 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.74 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 3.01 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 1.87 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.51 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 3.11 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 7.34 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 4.01 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 4.6 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.1 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.21 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 4.63 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 4.22 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 3.35 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 2.57 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.56 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 2.53 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 2.12 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 2.32 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 4.39 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.807 0.337 . . . . 53.28 111.624 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -172.98 -50.91 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.997 -1.853 . . . . 49.32 105.997 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -110.58 -167.6 1.21 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.543 -1.651 . . . . 46.0 106.543 139.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -113.37 137.77 51.03 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.398 1.879 . . . . 42.47 107.095 169.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 p -170.49 105.13 0.28 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.229 -1.026 . . . . 36.9 108.229 -171.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 58.4 2.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.35 0.523 . . . . 32.61 111.026 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.78 172.78 12.92 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.162 -0.336 . . . . 28.27 110.586 172.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -147.28 151.3 36.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.746 -1.205 . . . . 23.02 107.746 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.7 169.78 2.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 127.054 2.142 . . . . 19.08 106.203 -176.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -156.72 34.92 0.31 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.339 0.518 . . . . 18.0 110.859 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.22 -162.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.812 2.045 . . . . 13.04 107.13 -176.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.11 13.06 0.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 117.851 2.538 . . . . 12.71 117.851 -166.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -81.27 -73.75 0.36 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 126.825 2.05 . . . . 6.95 108.223 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -178.4 161.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 104.732 -2.321 . . . . 13.65 104.732 -173.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.25 153.3 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.728 -1.212 . . . . 13.04 107.728 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 86.15 87.91 0.02 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.402 1.881 . . . . 16.67 110.039 169.382 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 65.37 -65.19 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.624 2.37 . . . . 16.06 112.504 172.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -31.35 -45.33 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.673 2.789 . . . . 13.41 112.554 165.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -54.84 -30.37 57.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.713 1.205 . . . . 9.7 112.438 -177.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -53.96 -51.49 63.69 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 118.548 0.613 . . . . 15.46 110.299 172.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -70.12 -39.45 75.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.424 -0.172 . . . . 14.31 110.699 -178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -74.93 0.62 Allowed Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.625 -0.59 . . . . 9.45 111.625 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -73.56 -76.15 0.13 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.216 2.207 . . . . 9.27 110.888 176.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptm 139.32 171.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 131.209 3.804 . . . . 12.3 105.783 -158.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t 124.81 171.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 1 C-N-CA 131.834 4.053 . . . . 13.56 107.188 -166.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 76.5 -69.48 0.16 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.242 1.817 . . . . 16.42 113.639 166.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -69.42 138.31 53.44 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.517 -0.473 . . . . 20.7 111.231 -171.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -76.34 61.38 1.67 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.979 0.912 . . . . 25.28 109.235 172.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -87.95 -171.4 3.39 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.564 1.146 . . . . 21.3 108.694 173.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.94 175.71 1.13 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.422 0.689 . . . . 25.07 111.376 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -73.74 62.69 0.82 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.814 0.846 . . . . 19.78 110.826 178.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.1 mt -77.56 143.46 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.956 -1.868 . . . . 16.21 105.956 166.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.69 29.13 0.26 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.06 -0.856 . . . . 9.95 113.508 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -161.63 150.27 15.64 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.733 -1.21 . . . . 8.21 107.733 170.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.2 mm -144.76 123.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.77 2.028 . . . . 9.04 108.378 -176.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.84 -60.85 1.98 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.985 0.422 . . . . 5.97 110.525 174.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.55 47.48 3.01 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 3.77 115.616 -163.524 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.01 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.8 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 4.12 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.66 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 4.04 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.01 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 4.19 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 3.58 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 2.55 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.3 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.6 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 2.33 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 6.1 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 2.58 111.758 178.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 2.73 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 4.55 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 5.0 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.97 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.88 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 1.84 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 3.48 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.18 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.51 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.39 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.31 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 2.39 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 1.41 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.99 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 2.03 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 2.59 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 3.54 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.99 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.416 HG12 ' CE2' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 2.6 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 4.69 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 2.54 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 2.12 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 6.16 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.66 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.14 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 4.64 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 3.0 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 5.84 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 2.5 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 5.27 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 2.75 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.37 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.41 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 3.76 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.17 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 2.22 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.44 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 4.35 111.015 177.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 2.5 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.94 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 2.07 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.03 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 2.67 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 9.69 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 5.14 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.3 113.134 -176.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.15 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 5.32 109.254 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 8.04 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 8.31 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 4.18 110.579 -176.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 2.37 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 3.52 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.92 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.89 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 1.98 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 2.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 8.64 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.74 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.94 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.93 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.61 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 5.19 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.92 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 1.43 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 3.4 111.042 164.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 3.04 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 2.87 109.426 -178.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 3.43 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 6.8 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 4.99 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.03 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 4.54 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 2.09 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 4.32 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.89 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 2.2 104.563 162.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 1.9 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.94 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 3.19 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 2.03 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.93 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 3.63 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 5.44 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 4.5 108.054 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 3.74 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.66 109.156 174.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 2.33 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 3.9 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 6.2 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 2.99 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 2.6 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.96 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 2.08 108.25 -173.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 1.87 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 1.64 111.847 175.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.99 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 107.527 -1.286 . . . . 57.72 107.527 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -170.19 154.45 4.95 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.241 -1.763 . . . . 49.03 106.241 -173.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -78.51 162.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.869 0.867 . . . . 45.35 109.805 168.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -164.92 170.9 14.73 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.008 1.723 . . . . 42.33 106.526 170.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.2 p -150.74 111.94 4.37 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.122 -1.066 . . . . 36.22 108.122 -176.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.21 164.59 20.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.91 0.323 . . . . 32.16 110.182 173.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -128.38 166.1 19.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 29.18 108.524 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -101.19 -172.71 2.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.694 0.797 . . . . 24.04 109.842 177.503 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.81 113.33 2.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.478 1.111 . . . . 21.01 109.142 -178.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -129.96 136.6 49.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.257 -1.016 . . . . 17.19 108.257 169.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -156.55 166.86 32.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.705 2.402 . . . . 19.41 105.54 171.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 p -51.87 121.67 7.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.344 -0.984 . . . . 10.94 108.344 164.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 60.08 31.49 20.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 8.11 112.994 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.26 122.7 16.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.293 -0.88 . . . . 14.83 108.809 171.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.9 -46.64 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.097 0.959 . . . . 16.27 111.553 -166.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -69.69 99.32 1.31 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.766 -0.584 . . . . 19.49 110.063 -171.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 71.1 -58.1 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.239 3.016 . . . . 16.12 111.923 170.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.5 m -33.64 -46.18 0.2 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.095 2.558 . . . . 12.76 112.92 173.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -34.42 -38.38 0.07 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.301 2.641 . . . . 11.39 114.845 -173.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -48.99 -63.99 0.94 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.449 1.1 . . . . 13.32 109.851 175.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 m -73.8 -31.2 63.15 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.783 -0.573 . . . . 9.76 112.531 170.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.71 -36.4 59.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.44 1.495 . . . . 7.26 113.248 -174.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -9.56 58.79 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.78 1.4 . . . . 11.0 114.78 174.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 52.09 59.56 4.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.59 1.156 . . . . 9.49 111.235 -171.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -33.83 -54.71 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.466 1.906 . . . . 14.56 112.775 175.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.21 -70.72 0.1 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.999 -0.741 . . . . 15.37 108.999 177.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 66.02 -37.57 0.27 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.058 2.143 . . . . 14.21 114.501 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -135.75 -45.24 0.66 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.703 1.601 . . . . 19.09 110.29 174.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.29 61.03 1.34 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.561 0.744 . . . . 19.53 109.834 -178.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.87 165.58 14.99 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.476 -1.676 . . . . 19.13 106.476 167.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -62.86 -37.43 86.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.001 0.364 . . . . 19.49 110.901 178.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.0 mt 60.12 -79.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.795 2.038 . . . . 13.63 109.847 -178.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.99 44.66 0.34 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.147 -1.581 . . . . 12.76 109.147 177.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.31 47.24 11.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.263 1.03 . . . . 12.82 109.745 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.8 143.18 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.128 -0.942 . . . . 9.9 110.043 -172.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -153.76 -90.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.895 -1.52 . . . . 5.47 106.895 166.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.24 -75.0 1.61 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 4.0 109.975 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.92 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.77 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 3.73 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.53 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 5.31 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.4 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 4.19 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 3.34 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 2.31 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.22 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.45 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 2.24 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.8 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 2.23 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 2.77 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 4.24 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 8.74 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.84 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 3.71 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.76 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 3.55 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.98 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 2.14 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.49 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.3 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 2.3 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.06 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 1.19 113.559 -169.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 4.83 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 2.46 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 3.43 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 3.48 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 2.23 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 2.44 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 3.63 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 2.41 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 2.13 115.032 169.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 7.36 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.72 111.602 -170.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 2.65 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.08 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 4.62 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 2.88 107.983 -174.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.38 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 5.5 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 4.13 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 5.8 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 2.23 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 2.05 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.96 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 4.3 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 2.42 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.8 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 2.82 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 2.18 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 2.39 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 2.54 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.51 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 2.36 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 10.25 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 4.98 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.52 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.65 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.78 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 7.63 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 7.81 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 4.59 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 2.47 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 3.72 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 3.16 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.92 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 2.29 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 2.35 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 3.46 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 6.67 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 4.1 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.59 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 3.65 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 6.67 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.87 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.23 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 5.73 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 3.15 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 2.06 108.004 -175.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.06 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 3.84 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 5.25 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 3.61 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.82 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 5.05 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.94 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 3.66 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.57 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 2.24 106.77 164.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 1.97 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.9 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 2.48 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 2.34 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.18 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 5.53 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' H ' ' CG2' ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 4.82 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 4.35 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 2.79 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.99 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.92 108.263 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 2.49 107.84 174.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.97 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 3.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 2.67 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 1.06 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 2.59 107.056 178.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 2.1 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 2.01 108.838 175.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 6.3 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.17 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.592 -1.633 . . . . 49.42 106.592 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -145.18 138.93 26.87 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.773 -1.195 . . . . 42.68 107.773 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -174.32 176.7 2.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.537 1.935 . . . . 39.15 106.616 169.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 170.67 148.55 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.753 2.021 . . . . 35.47 108.751 -176.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -165.93 173.4 10.54 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.719 -1.215 . . . . 31.66 107.719 169.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.93 155.11 3.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.248 1.819 . . . . 28.09 107.927 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.56 171.88 19.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.095 1.358 . . . . 26.39 109.64 -178.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 t -169.4 179.77 3.75 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.208 1.803 . . . . 21.94 107.059 173.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.92 20.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.389 0.885 . . . . 20.18 113.389 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.31 110.68 3.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.998 0.817 . . . . 15.87 109.514 176.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -124.46 16.67 8.93 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 19.02 111.631 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -167.89 174.69 7.29 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.407 -1.331 . . . . 11.49 107.407 177.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.57 54.27 1.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.879 0.871 . . . . 6.65 111.42 -177.825 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.87 146.41 41.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.247 -1.39 . . . . 14.1 107.247 165.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm 50.16 50.41 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 122.313 1.054 . . . . 14.82 110.49 -168.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -171.49 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.702 -0.681 . . . . 15.59 109.676 162.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 66.33 -61.46 0.29 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.034 1.734 . . . . 15.15 111.225 -172.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.9 t -75.22 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.167 0.587 . . . . 13.49 112.108 164.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.03 -64.91 0.81 Allowed 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.313 -0.867 . . . . 11.51 111.306 -163.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.28 7.7 m-70 -70.0 0.86 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.034 1.733 . . . . 11.09 114.362 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -26.05 -39.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.434 2.694 . . . . 11.25 115.326 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -27.45 -46.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.976 1.75 . . . . 9.4 112.23 167.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -27.49 -46.97 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.669 2.788 . . . . 10.69 113.693 174.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.4 mmt -152.95 60.6 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.692 0.758 . . . . 13.78 110.116 169.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -54.54 -69.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.819 -0.551 . . . . 17.2 110.823 170.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.83 -174.68 4.86 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 19.45 109.187 -169.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 54.23 29.8 11.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.521 1.128 . . . . 22.18 110.971 -172.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.58 -45.12 92.81 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.489 0.716 . . . . 21.81 111.439 -161.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -77.65 -22.0 51.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.636 0.774 . . . . 24.33 112.671 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.11 171.65 14.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.666 0.666 . . . . 24.5 110.271 -171.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -64.28 133.55 52.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.24 -1.022 . . . . 20.77 108.24 163.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.2 124.47 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 101.812 -3.403 . . . . 14.98 101.812 159.504 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.36 -44.96 9.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.736 -2.146 . . . . 12.12 107.736 170.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.0 170.53 0.43 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.691 2.397 . . . . 9.47 110.624 172.098 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.1 mm 68.57 157.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.627 1.971 . . . . 8.3 112.896 174.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 78.74 172.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.986 1.715 . . . . 4.87 113.092 167.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.92 -54.59 0.05 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 3.61 108.154 -177.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.69 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.442 ' CD2' ' H ' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.51 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 4.16 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 2.54 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 4.77 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.511 ' CG ' ' HZ1' ' A' ' 44' ' ' LYS . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.8 109.837 -177.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HZ1' ' CG ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 5.24 110.913 -178.447 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 3.88 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.71 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.31 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 3.1 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 2.6 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 6.08 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 3.56 108.027 168.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.43 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.99 114.463 -172.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 5.46 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.94 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.81 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 1.68 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 3.78 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.97 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.75 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.58 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.56 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 2.29 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.19 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 1.23 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 4.28 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 2.07 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 4.27 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 4.02 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 2.21 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 2.4 106.284 175.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.92 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 4.4 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 2.14 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 2.17 112.779 173.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 6.02 115.087 178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 2.19 114.131 167.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.99 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 1.07 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 4.76 111.432 -176.6 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 5.98 107.097 177.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.34 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 5.53 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 4.22 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.92 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 2.84 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 2.07 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.13 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 3.47 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.49 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.28 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.97 107.486 167.306 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 2.77 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 2.15 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 2.42 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 2.5 108.728 171.004 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.7 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 4.91 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.66 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.4 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 6.19 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 7.53 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 6.56 110.896 -172.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 3.36 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 2.08 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 3.44 107.223 158.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 2.54 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.74 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 2.28 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 2.21 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 3.27 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 8.42 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.88 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 2.49 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.45 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 4.39 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.63 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 1.34 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 4.05 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 2.8 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 2.0 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.01 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 3.71 109.517 157.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 5.77 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 4.17 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.82 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 6.11 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 3.32 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.82 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.39 108.02 170.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 2.64 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.99 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 2.54 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 1.62 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.44 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 3.37 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 4.12 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 3.51 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.93 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.4 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 1.1 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 2.31 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.97 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 3.59 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 2.32 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 1.08 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.72 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 1.89 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 2.56 107.172 161.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 5.93 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.69 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 119.532 -0.271 . . . . 49.62 111.151 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -147.88 55.73 1.06 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 106.789 -1.559 . . . . 44.69 106.789 177.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -163.33 143.63 8.95 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.109 -1.441 . . . . 41.23 107.109 -173.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -165.62 156.57 13.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.647 -1.242 . . . . 36.32 107.647 177.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -163.23 162.59 25.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.726 -1.583 . . . . 32.71 106.726 166.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.81 54.81 0.2 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.816 0.846 . . . . 28.17 109.249 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.44 131.63 35.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.645 -0.872 . . . . 25.78 108.645 -178.281 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -159.83 179.01 9.18 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.282 -1.377 . . . . 21.79 107.282 170.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.28 178.55 2.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.116 1.366 . . . . 18.68 109.01 -175.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -159.95 -179.97 8.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.511 1.924 . . . . 14.88 106.418 173.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -153.88 156.9 38.43 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.794 0.725 . . . . 15.11 110.576 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 t 158.98 -154.35 0.0 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 131.282 3.833 . . . . 9.72 103.957 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.68 28.33 0.13 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.279 1.832 . . . . 6.06 110.023 -170.633 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -130.01 114.98 16.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.364 -1.347 . . . . 11.84 107.364 177.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.314 40.7 pt 42.05 -137.53 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.518 1.927 . . . . 16.18 113.407 -172.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 8.08 83.19 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.091 2.957 . . . . 16.44 116.437 -170.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 66.46 -58.55 0.36 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.693 2.397 . . . . 12.64 112.357 -177.338 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -42.04 -32.41 0.45 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.237 2.215 . . . . 10.22 113.463 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -33.18 -57.82 0.39 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.515 1.926 . . . . 11.55 111.89 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.68 -68.01 0.42 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.463 1.105 . . . . 13.25 109.074 174.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -71.23 -56.95 5.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.81 1.244 . . . . 10.45 112.465 -159.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.9 -55.01 7.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.496 1.046 . . . . 7.88 111.545 -176.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -9.03 57.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.696 1.199 . . . . 9.56 112.173 -178.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 58.51 78.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.784 1.633 . . . . 14.48 111.325 173.381 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.75 92.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.463 -0.939 . . . . 15.1 108.463 165.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.62 175.15 0.29 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.419 1.488 . . . . 19.02 111.206 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.95 45.33 25.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.236 1.014 . . . . 23.22 111.692 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.0 71.75 1.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.208 -0.664 . . . . 20.89 109.208 172.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -143.16 55.02 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.935 1.694 . . . . 27.26 108.024 -177.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -141.73 -167.74 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.132 1.373 . . . . 22.51 108.243 -178.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -72.4 67.74 0.74 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.034 0.934 . . . . 23.87 110.638 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -77.5 72.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.186 -1.413 . . . . 18.32 107.186 174.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.8 55.81 0.32 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 107.655 -2.178 . . . . 15.22 107.655 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.12 -63.74 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.422 1.889 . . . . 12.54 107.311 -173.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.16 134.59 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.151 0.981 . . . . 10.13 109.615 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.1 168.88 11.06 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.334 1.053 . . . . 4.42 110.452 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.75 -68.62 2.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 3.38 111.942 168.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.66 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 5.48 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.78 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 4.44 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 3.82 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.64 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 4.7 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 5.42 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 2.59 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.8 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.3 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 2.02 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 7.44 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 2.66 111.084 168.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 2.39 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 5.3 109.223 167.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 7.18 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 1.25 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.64 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 1.55 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 3.44 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.08 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.84 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.95 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.99 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.13 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 1.0 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 4.68 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 1.61 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 3.34 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 3.39 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.91 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 2.48 108.533 177.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.65 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 3.88 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.98 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 2.46 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 6.43 114.415 178.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.83 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.63 111.165 -169.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.91 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 4.11 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.82 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.91 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 4.84 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 2.33 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 4.08 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.89 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.67 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.27 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.81 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 2.09 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.01 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 2.78 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 1.91 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.82 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.9 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.16 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 2.05 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 9.15 114.378 176.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 5.07 112.989 -166.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.61 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.31 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 5.69 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 6.53 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 7.16 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 3.2 110.996 178.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 2.38 110.403 -177.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 3.32 108.883 159.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 2.04 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.85 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.69 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 1.85 112.353 -160.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 3.48 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.72 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 4.08 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.44 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 2.41 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 4.99 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.9 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.29 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 3.57 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 2.33 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 2.01 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.06 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 3.4 108.35 175.719 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 8.61 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 3.81 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.53 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.93 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 2.24 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 3.31 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.72 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 2.14 107.81 167.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 1.8 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 2.23 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.82 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 3.47 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 3.55 104.935 168.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 5.56 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 3.63 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 3.53 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.36 107.484 170.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.63 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 2.77 108.73 179.023 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 3.3 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 3.53 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 2.4 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.49 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.97 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 2.46 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 2.22 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.91 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.32 111.988 177.335 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 2.5699999999999998 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.9299999999999997 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 5.7599999999999998 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 3.9199999999999999 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.0600000000000001 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 2.9100000000000001 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 3.48 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HG3' ' A' ' 76' ' ' LYS . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 3.6099999999999999 106.616 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.04 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.7999999999999998 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.0099999999999998 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 4.6699999999999999 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 1.79 111.905 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 156' ' ' GLN . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 1.3700000000000001 112.155 -161.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 3.5800000000000001 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 4.6200000000000001 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.76000000000000001 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.0099999999999998 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 0.89000000000000001 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 2.8300000000000001 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.78 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.6499999999999999 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.9900000000000002 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 1.27 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.1299999999999999 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 0.76000000000000001 112.735 -173.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 3.6699999999999999 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 0.88 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 1.8999999999999999 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 2.1099999999999999 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 0.89000000000000001 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 1.5600000000000001 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.3599999999999999 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 3.5600000000000001 110.683 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 1.6200000000000001 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.3100000000000001 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 71' ' ' ILE . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 4.4100000000000001 113.247 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.0 108.726 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.6599999999999999 112.638 -173.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.8799999999999999 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89000000000000001 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 4.0300000000000002 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.573 HG23 ' HA3' ' A' ' 65' ' ' GLY . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 1.8200000000000001 107.072 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7000000000000002 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' H ' HD12 ' A' ' 85' ' ' LEU . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 3.79 112.691 -170.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 84' ' ' HIS . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 1.53 111.028 -174.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.2999999999999998 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.3200000000000001 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.4299999999999999 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 1.99 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.5800000000000001 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 115' ' ' TYR . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.0700000000000001 106.721 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.8999999999999999 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 2.9900000000000002 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 1.1200000000000001 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 1.27 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 1.1299999999999999 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 1.6499999999999999 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 7.2000000000000002 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 5.4100000000000001 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.4100000000000001 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 3.4100000000000001 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 6.8300000000000001 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 7.3200000000000003 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 9.1699999999999999 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 4.4800000000000004 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 1.95 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 2.54 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 1.8400000000000001 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 1.4299999999999999 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 0.95999999999999996 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 2.0699999999999998 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 92' ' ' VAL . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 6.5499999999999998 107.453 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 3.71 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 2.6099999999999999 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 1.51 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.2400000000000002 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.2599999999999998 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.84999999999999998 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 0.84999999999999998 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 5.3399999999999999 108.629 172.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 2.5299999999999998 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.3 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.1499999999999999 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 2.9700000000000002 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 5.1500000000000004 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.2599999999999998 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.7599999999999998 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 4.6299999999999999 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 1.8300000000000001 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 3.8199999999999998 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.4100000000000001 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 1.4199999999999999 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 1.03 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 0.96999999999999997 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 1.98 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 123' ' ' TYR . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.1000000000000001 110.032 158.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.4100000000000001 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 2.5600000000000001 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 4.3899999999999997 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.0899999999999999 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 2.77 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.1900000000000004 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.3200000000000001 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 1.8899999999999999 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 2.7000000000000002 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 2.2599999999999998 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 1.48 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.52 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 1.4199999999999999 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 1.71 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 1.24 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.1699999999999999 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.2699999999999996 105.071 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 2.3399999999999999 112.325 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.6399999999999997 111.315 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 4.9400000000000004 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 2.4900000000000002 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.1899999999999999 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 3.6299999999999999 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.4100000000000001 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 3.6200000000000001 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 2.96 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.1099999999999999 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.8600000000000003 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.1600000000000001 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 1.54 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 5.6100000000000003 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 1.49 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 1.99 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 4.3799999999999999 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 6.9500000000000002 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.70999999999999996 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 2.4399999999999999 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.1499999999999999 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 2.5099999999999998 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.1499999999999999 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.2400000000000002 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 1.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.3400000000000001 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' HG23 ' A' ' 82' ' ' ILE . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.25 113.211 -175.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 6.5700000000000003 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 0.93999999999999995 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.1699999999999999 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 2.5899999999999999 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 1.1599999999999999 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 2.0 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 3.1600000000000001 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 2.0600000000000001 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 1.23 109.915 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 3.6899999999999999 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 2.3999999999999999 107.156 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.27 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.1499999999999999 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.93999999999999995 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.0499999999999998 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 82' ' ' ILE . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 2.4100000000000001 106.571 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.6600000000000001 104.568 157.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 5.8399999999999999 104.986 31.14 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 1.6899999999999999 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 4.4900000000000002 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 1.7 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 1.79 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.7799999999999998 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 2.1000000000000001 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.8200000000000001 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 1.0800000000000001 109.572 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.7599999999999998 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 2.1400000000000001 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.1599999999999999 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 1.73 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.1299999999999999 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.0099999999999998 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.4500000000000002 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.0199999999999996 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 4.8300000000000001 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.5499999999999998 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.8999999999999999 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CB ' ' HZ3' ' A' ' 104' ' ' LYS . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 4.7300000000000004 111.671 -158.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 7.9299999999999997 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 5.6200000000000001 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 2.3999999999999999 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 1.28 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 2.2200000000000002 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 1.6699999999999999 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.76000000000000001 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.1899999999999999 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 1.0900000000000001 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 3.1200000000000001 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.639 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.1500000000000004 107.562 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 2.96 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.1600000000000001 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 1.6100000000000001 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.6099999999999999 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 3.8900000000000001 111.123 140.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.51000000000000001 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 0.97999999999999998 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 2.2799999999999998 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 2.21 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 152' ' ' LEU . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 0.85999999999999999 108.426 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.3799999999999999 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 2.79 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 6.8300000000000001 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.8100000000000001 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.7300000000000004 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 4.25 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 1.79 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 3.6299999999999999 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.5600000000000001 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 1.8 107.301 163.06 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 1.0900000000000001 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.0900000000000001 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 1.79 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 0.93999999999999995 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.4399999999999999 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 2.1899999999999999 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 3.7999999999999998 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 2.1099999999999999 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 2.1600000000000001 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.22 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 1.5700000000000001 109.69 -174.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 2.98 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 2.27 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 1.1699999999999999 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 0.93000000000000005 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 125' ' ' LEU . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 2.0299999999999998 112.403 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 1.53 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 1.1200000000000001 111.317 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 3.5699999999999998 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 2.4399999999999999 108.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.5099999999999998 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 2.5600000000000001 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 1.9199999999999999 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 2.6099999999999999 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.7400000000000002 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 4.5300000000000002 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7000000000000002 115.112 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 4.0999999999999996 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.0499999999999998 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 5.4299999999999997 111.365 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 1.23 112.692 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 1.3799999999999999 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.665 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 2.98 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 4.9500000000000002 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.0800000000000001 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 2.8500000000000001 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.0600000000000001 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 2.6400000000000001 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.3599999999999999 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.9500000000000002 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.1200000000000001 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 1.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.9099999999999999 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.1799999999999999 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.2400000000000002 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 80' ' ' GLY . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 1.73 105.686 169.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.52 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 2.3500000000000001 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 1.3999999999999999 109.011 168.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.721 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 1.55 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.3799999999999999 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 3.1699999999999999 113.126 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.1600000000000001 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 1.46 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 5.2999999999999998 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.75 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.721 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.0099999999999998 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.0 110.273 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 3.9700000000000002 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 1.97 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.2999999999999998 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 3.52 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 1.8300000000000001 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 4.96 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 1.8100000000000001 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.54 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.0499999999999998 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 2.1000000000000001 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 0.90000000000000002 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.1400000000000001 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 1.6699999999999999 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.1799999999999999 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 1.6000000000000001 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.04 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.4399999999999999 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 1.51 108.152 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 8.3300000000000001 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 3.8599999999999999 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.0800000000000001 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.8399999999999999 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 4.7000000000000002 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 6.8200000000000003 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.2400000000000002 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.443 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 3.79 105.792 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 1.48 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 2.4100000000000001 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 1.8899999999999999 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.73999999999999999 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 2.1200000000000001 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 0.77000000000000002 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 2.04 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 4.5700000000000003 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 2.75 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 2.3300000000000001 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 1.47 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.1099999999999999 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.0800000000000001 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.5 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 0.93999999999999995 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 3.7200000000000002 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 1.8999999999999999 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 126' ' ' GLY . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 0.96999999999999997 112.359 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.467 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 2.1299999999999999 106.222 154.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 5.7699999999999996 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 3.5800000000000001 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.3700000000000001 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 3.5899999999999999 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 1.4299999999999999 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 3.3399999999999999 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.6400000000000001 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 125' ' ' LEU . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.3999999999999999 107.391 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 1.3 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 1.7 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 0.69999999999999996 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 2.0499999999999998 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 3.5600000000000001 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.3399999999999999 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 2.98 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.8999999999999999 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 0.96999999999999997 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 2.3199999999999998 108.319 -167.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 3.5800000000000001 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 1.1499999999999999 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 0.82999999999999996 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.1799999999999999 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 0.97999999999999998 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 0.97999999999999998 109.097 173.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 5.3899999999999997 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.3099999999999996 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 2.46 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.0300000000000002 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 4.9299999999999997 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 2.7400000000000002 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.1699999999999999 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 2.9500000000000002 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.7999999999999998 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 5.1600000000000001 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 2.3300000000000001 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 1.8300000000000001 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.1099999999999999 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 1.8799999999999999 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.21 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 1.4099999999999999 109.578 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 1.6699999999999999 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 3.2599999999999998 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 4.9900000000000002 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.1200000000000001 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 2.2799999999999998 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.1100000000000001 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 2.5099999999999998 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.3300000000000001 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 1.95 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.5699999999999998 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.3900000000000001 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 1.49 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.4299999999999999 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.0600000000000001 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 3.71 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 1.3200000000000001 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.4300000000000002 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 2.0499999999999998 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.3 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.466 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 1.74 104.217 159.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.5099999999999998 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 3.6099999999999999 114.0 -171.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 1.4099999999999999 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 1.3200000000000001 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.1100000000000003 110.591 164.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.6499999999999999 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.2 112.343 -158.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.9700000000000002 108.933 -171.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.1699999999999999 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.1799999999999997 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 1.9199999999999999 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.5899999999999999 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 3.3500000000000001 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 1.5600000000000001 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 3.96 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 1.3700000000000001 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.6000000000000001 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.0800000000000001 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 2.0600000000000001 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.8799999999999999 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 1.1000000000000001 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.9299999999999999 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 1.9299999999999999 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 0.96999999999999997 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 1.97 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 1.3999999999999999 111.962 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.2599999999999998 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.78 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.0 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 4.2300000000000004 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.8300000000000001 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 2.9700000000000002 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 5.79 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 7.3300000000000001 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 6.0700000000000003 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 2.5600000000000001 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 1.1499999999999999 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 2.98 106.063 158.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 109' ' ' ILE . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 1.6499999999999999 109.667 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.03 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.51 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 0.77000000000000002 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 2.1499999999999999 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.0700000000000003 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.0699999999999998 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.5299999999999998 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 1.28 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.9100000000000001 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 3.4399999999999999 109.839 133.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.52000000000000002 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 0.72999999999999998 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.514 ' HE1' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 2.3999999999999999 112.197 174.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 1.8200000000000001 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 135' ' ' VAL . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 0.81000000000000005 107.791 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.1499999999999999 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 2.5699999999999998 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 5.1600000000000001 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 2.9300000000000002 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 2.7000000000000002 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 4.6200000000000001 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 1.8300000000000001 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 3.9300000000000002 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.1699999999999999 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.565 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 1.48 105.251 166.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 0.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 1.75 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 0.69999999999999996 111.291 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.0699999999999998 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 2.1800000000000002 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.2400000000000002 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 2.3300000000000001 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 2.0800000000000001 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.0099999999999998 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.21 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 2.6099999999999999 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.3700000000000001 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 2.1899999999999999 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 1.3500000000000001 106.618 162.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.75 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 1.8200000000000001 112.707 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 1.6799999999999999 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 1.1899999999999999 107.667 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 4.3200000000000003 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.1699999999999999 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 2.77 111.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.6699999999999999 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 4.4800000000000004 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.0800000000000001 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 3.6299999999999999 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 2.9399999999999999 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6000000000000001 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 3.75 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 4.3399999999999999 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 1.97 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.7599999999999998 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.1000000000000001 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 1.5900000000000001 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 6.3399999999999999 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 1.6399999999999999 111.147 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 1.71 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 135' ' ' VAL . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 4.3799999999999999 109.47 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 6.3399999999999999 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 0.93000000000000005 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.1800000000000002 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 0.95999999999999996 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 2.1499999999999999 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.97999999999999998 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.5099999999999998 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.5299999999999998 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.1799999999999999 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.1799999999999999 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 0.72999999999999998 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 3.8599999999999999 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 0.95999999999999996 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 2.2200000000000002 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 2.1400000000000001 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.1599999999999999 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 1.3600000000000001 108.302 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.6099999999999999 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 2.54 112.653 -172.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 1.3100000000000001 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 1.3400000000000001 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 5.5099999999999998 114.062 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.8799999999999999 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.3400000000000001 110.656 -169.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.5800000000000001 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HZ3' ' HB3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 3.3900000000000001 114.08 -164.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.0800000000000001 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.1400000000000001 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' H ' HD12 ' A' ' 85' ' ' LEU . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 3.5800000000000001 112.334 153.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 84' ' ' HIS . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 1.49 111.202 -166.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 3.29 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.51 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.49 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.2199999999999998 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.0 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.0600000000000001 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.8700000000000001 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 1.76 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 0.93000000000000005 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.1299999999999999 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.1200000000000001 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.1099999999999999 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 1.5600000000000001 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 8.1899999999999995 114.409 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 3.96 112.984 -166.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.6299999999999999 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.2599999999999998 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 4.9100000000000001 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 5.9299999999999997 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 5.8099999999999996 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 2.4100000000000001 110.733 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' ALA . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 1.4299999999999999 111.007 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.54 HD11 ' H ' ' A' ' 78' ' ' GLY . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 2.1699999999999999 108.928 162.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.02 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 0.83999999999999997 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 2.6000000000000001 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.2999999999999998 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 3.8799999999999999 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.4399999999999999 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 1.3600000000000001 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 3.29 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.65000000000000002 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 0.81999999999999995 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 2.3100000000000001 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 1.5 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 1.2 112.635 -170.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.0800000000000001 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 2.5 108.275 176.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 7.0700000000000003 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 2.8399999999999999 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.1200000000000001 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 1.71 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 2.3199999999999998 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.7200000000000002 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 127' ' ' ILE . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 1.1299999999999999 107.822 167.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.81999999999999995 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.94999999999999996 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 1.55 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 0.69999999999999996 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 2.9300000000000002 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 2.4100000000000001 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 4.9800000000000004 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 2.9900000000000002 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 2.79 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.8399999999999999 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.4299999999999999 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 1.5700000000000001 108.754 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.4900000000000002 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 2.6099999999999999 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 1.4199999999999999 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.02 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.1299999999999999 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 1.3100000000000001 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 135' ' ' VAL . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 1.01 110.972 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.1200000000000001 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.3399999999999999 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . . . . . . 0 CA--C 1.517 0.189 0 N-CA-C 112.025 -0.43 . . . . 2.98 112.025 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.3499999999999996 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 4.75 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 2.75 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 1.8700000000000001 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.0299999999999998 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 4.6699999999999999 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 2.1699999999999999 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 1.6799999999999999 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.7599999999999998 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.1299999999999999 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 1.75 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 6.4800000000000004 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 1.26 110.242 161.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 1.4099999999999999 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 3.6000000000000001 108.447 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 5.5300000000000002 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 0.79000000000000004 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 2.9199999999999999 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.1699999999999999 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 2.5699999999999998 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.0800000000000001 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.1400000000000001 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.8799999999999999 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.6499999999999999 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.02 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.03 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 0.91000000000000003 114.957 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 5.7199999999999998 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 1.0700000000000001 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 1.8500000000000001 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 2.2999999999999998 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 1.3300000000000001 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 1.23 107.188 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.1400000000000001 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 2.6800000000000002 112.662 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 1.6299999999999999 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 1.01 113.799 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 6.5999999999999996 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.0800000000000001 107.16 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.51 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 71' ' ' ILE . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.7200000000000002 107.569 -164.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.79000000000000004 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 4.1399999999999997 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 4.79 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 90' ' ' LEU . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 1.78 110.089 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 3.7000000000000002 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 2.2400000000000002 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 2.7599999999999998 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.0499999999999998 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 2.4300000000000002 113.367 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.0800000000000001 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 2.48 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2000000000000002 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 2.96 109.613 -163.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.1499999999999999 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.5 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 1.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.9900000000000002 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 1.47 109.047 176.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 7.6600000000000001 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 3.8399999999999999 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.8200000000000003 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 4.96 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 6.3700000000000001 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 7.8099999999999996 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.434 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 6.4100000000000001 112.843 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 3.4399999999999999 111.229 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 1.6299999999999999 111.786 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 99' ' ' ILE . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 2.8500000000000001 109.737 153.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 2.6000000000000001 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.98999999999999999 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 1.51 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 1.1399999999999999 109.409 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 7.4000000000000004 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.3700000000000001 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 2.3900000000000001 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 2.2599999999999998 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.0099999999999998 108.563 168.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 141' ' ' VAL . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.91000000000000003 111.13 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.21 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 2.7799999999999998 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 1.98 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 125' ' ' LEU . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 0.85999999999999999 107.659 -176.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 3.0099999999999998 109.771 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 4.8600000000000003 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 2.71 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.8599999999999999 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 3.3799999999999999 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 1.3899999999999999 112.92 171.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 2.4900000000000002 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.1099999999999999 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 154' ' ' ALA . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 1.54 105.993 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 1.0900000000000001 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.1599999999999999 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 1.76 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 1.3300000000000001 108.738 160.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.3700000000000001 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.668 HG13 ' HB1' ' A' ' 139' ' ' ALA . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 2.1400000000000001 111.492 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 3.9500000000000002 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 2.8999999999999999 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.0699999999999998 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.6299999999999999 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.0700000000000001 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 1.3899999999999999 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 3.8700000000000001 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 2.1800000000000002 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 139' ' ' ALA . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 2.3700000000000001 106.78 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.01 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 125' ' ' LEU . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 2.0299999999999998 111.909 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 1.55 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 1.1299999999999999 111.267 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 3.9500000000000002 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.9299999999999997 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 2.8100000000000001 113.685 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.7999999999999998 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CE1' ' H ' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 5.2800000000000002 114.104 -174.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 106' ' ' HIS . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 3.0099999999999998 109.775 167.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.6400000000000001 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 3.7599999999999998 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.4500000000000002 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 3.8999999999999999 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.0 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 3.3199999999999998 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.529999999999999 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 2.8799999999999999 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.0800000000000001 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 5.5499999999999998 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 1.3899999999999999 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.29 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 3.5800000000000001 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 5.79 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 2.5699999999999998 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 0.96999999999999997 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 2.27 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 0.95999999999999996 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 3.3199999999999998 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.6699999999999999 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 1.1399999999999999 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.0900000000000001 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 0.84999999999999998 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.0099999999999998 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 1.24 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.1899999999999999 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 2.3500000000000001 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 1.1799999999999999 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HA3' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 2.0699999999999998 108.934 160.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.2199999999999998 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 2.2400000000000002 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 1.79 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 1.8700000000000001 114.884 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 4.1799999999999997 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.9500000000000002 107.025 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA3' HG22 ' A' ' 71' ' ' ILE . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 2.5600000000000001 110.661 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93000000000000005 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 5.3399999999999999 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.1000000000000001 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.1600000000000001 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 3.3900000000000001 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 90' ' ' LEU . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 2.2400000000000002 110.654 -150.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 3.8799999999999999 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 1.6799999999999999 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.4099999999999999 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.2999999999999998 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 2.0299999999999998 112.015 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 0.96999999999999997 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.2599999999999998 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 1.8700000000000001 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 1.0900000000000001 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 1.21 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 1.29 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 109.75 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 1.45 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 6.2300000000000004 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 4.3700000000000001 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.5099999999999998 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.0499999999999998 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 5.5599999999999996 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.461 ' H ' ' CE1' ' A' ' 39' ' ' HIS . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 5.96 109.431 -162.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.62 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 8.75 108.804 -160.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 2.6499999999999999 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 1.3899999999999999 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.0099999999999998 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.1400000000000001 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.70999999999999996 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 2.5099999999999998 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 0.93000000000000005 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 2.6099999999999999 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 4.6500000000000004 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 2.75 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 1.3400000000000001 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.4300000000000002 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.1099999999999999 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.57999999999999996 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 0.82999999999999996 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 2.4399999999999999 110.59 174.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 1.53 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 1.1399999999999999 109.603 -170.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.511 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.6699999999999999 111.498 -166.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 2.6699999999999999 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 7.6600000000000001 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 3.25 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.8900000000000001 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 3.3100000000000001 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 1.3300000000000001 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 2.77 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.9100000000000001 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 1.8999999999999999 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.97999999999999998 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.90000000000000002 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 1.6699999999999999 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.0700000000000001 111.343 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.4500000000000002 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 1.8999999999999999 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 2.9300000000000002 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 2.5899999999999999 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 2.6800000000000002 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.8399999999999999 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.04 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 1.47 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 2.73 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.02 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 1.26 107.186 172.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.1200000000000001 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.1799999999999999 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 1.3200000000000001 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 1.48 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.1200000000000001 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.2400000000000002 109.828 175.86 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 2.0699999999999998 109.876 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7000000000000002 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.0599999999999996 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 2.9500000000000002 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 2.9500000000000002 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 4.5899999999999999 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.1099999999999999 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 3.8900000000000001 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 2.4700000000000002 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 73' ' ' PHE . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 2.4300000000000002 112.845 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.9500000000000002 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 2.5800000000000001 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 2.1200000000000001 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 5.8899999999999997 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 2.6000000000000001 109.059 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 1.5900000000000001 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' HD13 ' A' ' 127' ' ' ILE . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 3.1899999999999999 109.598 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 4.1500000000000004 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.25 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 2.6600000000000001 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 0.98999999999999999 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 2.48 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.0600000000000001 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.1600000000000001 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.5299999999999998 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.2300000000000004 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 1.47 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 0.95999999999999996 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.28 112.173 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 6.2599999999999998 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 152' ' ' LEU . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 1.1499999999999999 109.425 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 1.9399999999999999 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 2.27 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.05 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 1.3999999999999999 107.027 167.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.1699999999999999 106.944 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 71' ' ' ILE . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 2.2999999999999998 113.849 -169.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.0800000000000001 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 1.51 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 4.6200000000000001 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 1.6799999999999999 106.995 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.51 114.826 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.7400000000000002 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 0.97999999999999998 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 3.4900000000000002 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.704 HG23 ' HA3' ' A' ' 65' ' ' GLY . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 2.0 107.616 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.5700000000000003 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 5.1200000000000001 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 1.55 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 4.6699999999999999 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 1.9299999999999999 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 3.6000000000000001 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.0300000000000002 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 2.5499999999999998 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 1.8700000000000001 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 1.0700000000000001 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.3599999999999999 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 1.6200000000000001 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 1.21 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 1.3899999999999999 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.3600000000000001 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.5099999999999998 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.425 ' CG2' HG22 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 2.2599999999999998 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 6.9900000000000002 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 4.4400000000000004 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.8200000000000003 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.5800000000000001 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 4.7000000000000002 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 7.6799999999999997 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 5.1699999999999999 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 2.29 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.1000000000000001 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 3.52 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 1.8799999999999999 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.76000000000000001 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 1.97 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG21 HG12 ' A' ' 141' ' ' VAL . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 0.84999999999999998 109.227 170.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.0299999999999998 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 5.8600000000000003 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 5.8899999999999997 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.25 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.1499999999999999 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.63 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 0.76000000000000001 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 139' ' ' ALA . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 2.8599999999999999 108.888 -168.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 2.2799999999999998 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.589 HD23 HD12 ' A' ' 152' ' ' LEU . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 0.73999999999999999 110.636 -171.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.1200000000000001 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 132' ' ' ALA . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 2.7799999999999998 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 6.8600000000000003 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 2.6200000000000001 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.1200000000000001 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 3.5899999999999999 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HA ' HD11 ' A' ' 127' ' ' ILE . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 1.6000000000000001 113.433 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 2.4199999999999999 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6000000000000001 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 154' ' ' ALA 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.2 109.864 173.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 0.82999999999999996 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.76000000000000001 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 2.6099999999999999 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 0.81999999999999995 110.842 167.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 113' ' ' VAL . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 2.4199999999999999 108.043 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 2.8199999999999998 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 3.2400000000000002 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 4.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.3599999999999999 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.73 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 1.51 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.46 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 2.6499999999999999 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 1.1100000000000001 107.868 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.78000000000000003 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.589 HD12 HD23 ' A' ' 125' ' ' LEU . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 1.1499999999999999 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 0.97999999999999998 111.751 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 4.6100000000000003 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.4400000000000004 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 116.098 1.199 . . . . 3.02 116.098 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.4900000000000002 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.25 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.1099999999999999 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 1.8899999999999999 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 3.2999999999999998 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 4.1100000000000003 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 2.29 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 1.9199999999999999 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.4699999999999998 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 1.79 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 1.55 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 5.6799999999999997 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 1.4399999999999999 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 1.6399999999999999 109.81 -168.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 71' ' ' ILE . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 3.4700000000000002 109.083 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 4.3700000000000001 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.69999999999999996 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.3900000000000001 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.0900000000000001 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 2.4900000000000002 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.93999999999999995 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.6699999999999999 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.3599999999999999 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.02 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.95999999999999996 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 0.69999999999999996 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 3.7799999999999998 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 0.93000000000000005 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 2.4399999999999999 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 2.2200000000000002 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.1499999999999999 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 1.25 108.753 158.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.3300000000000001 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 2.1699999999999999 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 1.4299999999999999 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 1.3700000000000001 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 4.2199999999999998 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.1000000000000001 110.318 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.4299999999999999 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.3199999999999998 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93000000000000005 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 3.48 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 3.3100000000000001 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.7400000000000002 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 3.5800000000000001 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 2.0 111.054 -164.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 5.3899999999999997 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 1.8899999999999999 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.51 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 2.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.0299999999999998 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 115' ' ' TYR . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 1.02 109.008 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.6499999999999999 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.0600000000000001 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 1.27 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 1.47 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.29 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.9199999999999999 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 1.6699999999999999 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 8.2300000000000004 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 5.1699999999999999 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 4.6600000000000001 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 5.4900000000000002 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 7.5 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 6.5099999999999998 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 3.8700000000000001 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 2.1400000000000001 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 2.98 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 2.3700000000000001 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 0.70999999999999996 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 2.3399999999999999 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 0.73999999999999999 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 2.6899999999999999 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.449 ' HA ' HG22 ' A' ' 92' ' ' VAL . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 4.8300000000000001 106.684 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.0600000000000001 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.4199999999999999 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 1.3100000000000001 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 3.5299999999999998 110.348 135.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.55000000000000004 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 0.85999999999999999 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 2.6600000000000001 113.43 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.0899999999999999 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 0.95999999999999996 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.3500000000000001 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 ' HE1' ' A' ' 53' ' ' TYR . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 2.8999999999999999 107.855 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 5.2999999999999998 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.0099999999999998 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 2.8700000000000001 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.0499999999999998 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 1.52 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 2.5099999999999998 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 1.1200000000000001 106.5 154.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 0.94999999999999996 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 0.81999999999999995 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 1.98 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 0.94999999999999996 111.425 166.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6000000000000001 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 1.8600000000000001 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.0699999999999998 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 2.27 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 3.29 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.4100000000000001 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.22 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.0499999999999998 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 2.7400000000000002 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 2.7200000000000002 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 1.27 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.96999999999999997 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 1.3500000000000001 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 1.0700000000000001 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.76 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 0.89000000000000001 111.526 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.1200000000000001 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.715 ' HB3' HG23 ' A' ' 52' ' ' THR . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.8499999999999996 111.613 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.198 -0.761 . . . . 2.5 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.6100000000000003 112.284 -174.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.3099999999999996 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 3.1499999999999999 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 2.6800000000000002 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 2.9100000000000001 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.1099999999999999 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 4.3399999999999999 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 2.5800000000000001 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 1.8700000000000001 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.0099999999999998 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 1.78 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 1.8 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 4.96 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 1.3300000000000001 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 1.5 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 3.48 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.2199999999999998 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.76000000000000001 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.1299999999999999 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 0.87 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 2.1099999999999999 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.1399999999999999 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 1.76 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.9500000000000002 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.4399999999999999 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 1.6799999999999999 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.04 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.75 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 3.6699999999999999 107.352 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 0.90000000000000002 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 1.96 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 2.48 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 1.1000000000000001 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.599 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 1.95 105.287 152.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.3799999999999999 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 2.6699999999999999 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 1.5600000000000001 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 1.1799999999999999 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 4.3499999999999996 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 1.6799999999999999 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.3999999999999999 112.098 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.6800000000000002 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.87 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.0999999999999996 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 2.2599999999999998 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.6600000000000001 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 3.75 116.805 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 1.8999999999999999 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.0499999999999998 113.378 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 2.2000000000000002 110.096 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 1.8400000000000001 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 2.8100000000000001 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 2.1699999999999999 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.3199999999999998 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 2.73 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 1.1000000000000001 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.1000000000000001 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 0.97999999999999998 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' HG13 ' A' ' 109' ' ' ILE . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 1.6599999999999999 110.87 168.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 6.6799999999999997 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 4.46 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.6699999999999999 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 107' ' ' ALA . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 2.75 114.248 164.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HZ2' ' CB ' ' A' ' 104' ' ' LYS . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 6.4000000000000004 110.763 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 9.0899999999999999 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 6.8099999999999996 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 103' ' ' GLY . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 4.6399999999999997 113.268 171.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 2.6600000000000001 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 99' ' ' ILE . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 3.3399999999999999 108.319 169.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 1.5700000000000001 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 0.89000000000000001 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 1.72 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 0.69999999999999996 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 3.2200000000000002 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 6.9199999999999999 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.1000000000000001 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.8599999999999999 113.029 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 1.8799999999999999 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.8100000000000001 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 3.46 108.681 141.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.70999999999999996 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 1.1799999999999999 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 2.52 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 1.8600000000000001 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.485 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 1.1499999999999999 109.567 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.1499999999999999 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 2.3700000000000001 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 4.4199999999999999 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 2.7000000000000002 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.4500000000000002 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 3.6899999999999999 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 1.26 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 2.52 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.9500000000000002 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.485 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 1.96 107.516 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.92000000000000004 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 1.77 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 0.70999999999999996 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.3099999999999996 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 2.25 109.43 -174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.1600000000000001 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 2.3300000000000001 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.0499999999999998 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.8300000000000001 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.0 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.1299999999999999 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 4.9500000000000002 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 1.8200000000000001 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 1.29 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.84999999999999998 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 1.3799999999999999 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 1.5 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 1.3200000000000001 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 3.6400000000000001 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.2400000000000002 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 3.23 108.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.5499999999999998 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 4.79 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 3.6099999999999999 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 2.4500000000000002 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 3.3799999999999999 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.4100000000000001 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 3.5 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HZ3' ' A' ' 76' ' ' LYS . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 2.8599999999999999 106.312 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 1.8300000000000001 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.4800000000000004 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.2200000000000002 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 1.96 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 5.9400000000000004 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 2.4300000000000002 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.1799999999999997 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 5.1100000000000003 115.083 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 6.3899999999999997 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 0.87 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 2.7400000000000002 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 0.95999999999999996 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 2.0299999999999998 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.0 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.2599999999999998 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.9700000000000002 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.7599999999999998 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 1.3400000000000001 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.90000000000000002 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.1799999999999999 113.206 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 6.3700000000000001 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.26 108.127 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 3.6899999999999999 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 2.1400000000000001 112.02 -169.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.01 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 2.1400000000000001 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.0999999999999996 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.403 ' CE1' HD23 ' A' ' 45' ' ' LEU . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 2.77 114.826 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 1.77 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 1.9099999999999999 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 4.2000000000000002 110.204 167.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.6600000000000001 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 1.54 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 4.75 111.622 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 65' ' ' GLY . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 2.0899999999999999 107.708 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 4.1299999999999999 107.815 158.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 2.1099999999999999 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 5.4400000000000004 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 2.52 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.02 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.6100000000000003 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 2.7799999999999998 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6000000000000001 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 1.71 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 1.5900000000000001 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 1.21 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 1.48 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 1.8600000000000001 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' LYS 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 1.9399999999999999 106.636 169.91 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 6.8399999999999999 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 5.5300000000000002 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.3300000000000001 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.6200000000000001 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 8.2300000000000004 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 8.0899999999999999 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 8.9600000000000009 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 4.0 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 2.1099999999999999 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 2.5 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.1800000000000002 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.77000000000000002 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 1.53 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 0.97999999999999998 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 2.3700000000000001 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 7.0899999999999999 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.23 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 2.6400000000000001 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 1.3600000000000001 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.6899999999999999 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.3199999999999998 109.755 166.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 0.81000000000000005 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 0.79000000000000004 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 2.46 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 2.3900000000000001 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 1.3600000000000001 109.144 -170.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 2.9700000000000002 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 4.46 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.7799999999999998 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.3600000000000003 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 4.4800000000000004 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 2.4399999999999999 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 4.2000000000000002 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.0699999999999998 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 1.29 107.488 167.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 1.3400000000000001 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.1699999999999999 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 1.6899999999999999 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.26 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.1699999999999999 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 2.3199999999999998 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 3.8799999999999999 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 3.2200000000000002 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 2.02 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.2999999999999998 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 1.8400000000000001 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 1.78 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 3.8799999999999999 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 3.5299999999999998 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 1.26 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.77000000000000002 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 1.1100000000000001 107.61 -175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 1.22 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.879 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.53 109.271 167.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 3.2799999999999998 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.6299999999999999 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 CA-C-O 120.095 -0.281 . . . . 2.46 112.654 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.2400000000000002 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 6.1100000000000003 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 2.9199999999999999 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 1.97 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 2.9700000000000002 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.0599999999999996 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 3.6299999999999999 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 2.5099999999999998 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 1.78 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.3300000000000001 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.1499999999999999 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 1.72 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 6.6699999999999999 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 1.6499999999999999 111.509 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 1.47 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 3.5600000000000001 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 4.9000000000000004 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.70999999999999996 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 2.8700000000000001 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 0.90000000000000002 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 2.4500000000000002 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89000000000000001 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.71 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.5800000000000001 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.5800000000000001 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 1.3600000000000001 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 0.91000000000000003 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 5.7000000000000002 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 152' ' ' LEU . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 0.93999999999999995 109.374 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 1.8700000000000001 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 2.23 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 1.49 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 1.46 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.8300000000000001 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 2.6600000000000001 112.711 -164.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 1.3500000000000001 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 1.3300000000000001 112.71 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 4.5800000000000001 113.159 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.8799999999999999 111.047 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 1.54 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.8599999999999999 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 7.0700000000000003 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 3.1400000000000001 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.8200000000000003 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 5.4100000000000001 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 1.48 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.29 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.3799999999999999 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.46 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.2400000000000002 111.667 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 4.0199999999999996 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.3399999999999999 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG13 ' HB ' ' A' ' 82' ' ' ILE . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 2.1000000000000001 109.987 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.5800000000000001 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 1.8400000000000001 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 1.05 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.53 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.3100000000000001 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.4100000000000001 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 1.8500000000000001 111.293 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 7.1299999999999999 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 4.2999999999999998 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.0899999999999999 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.0999999999999996 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 5.2999999999999998 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 6.5499999999999998 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.46 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.0599999999999996 109.434 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.7999999999999998 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 1.48 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 2.6800000000000002 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 1.5700000000000001 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.0900000000000001 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 2.23 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 0.80000000000000004 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 2.27 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 4.6100000000000003 104.702 168.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 2.8999999999999999 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 3.9900000000000002 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 1.3600000000000001 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.7800000000000002 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 4.8799999999999999 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.62 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.1399999999999999 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 2.2200000000000002 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 2.27 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 0.81999999999999995 111.124 -171.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.3500000000000001 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 2.2599999999999998 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 4.7000000000000002 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 2.9300000000000002 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.6800000000000002 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 3.7200000000000002 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 1.3799999999999999 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 2.3399999999999999 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.8100000000000001 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.754 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.24 107.605 157.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 1.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91000000000000003 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 1.8300000000000001 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 1.1299999999999999 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.1399999999999997 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 2.4700000000000002 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 3.5 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 2.1000000000000001 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 2.6099999999999999 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.6400000000000001 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.0 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 1.9299999999999999 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 4.9199999999999999 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 2.8999999999999999 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 1.3899999999999999 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 0.82999999999999996 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 125' ' ' LEU . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 1.1200000000000001 106.907 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.03 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.754 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 0.82999999999999996 113.224 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 5.75 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.9199999999999999 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.4299999999999997 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 3.98 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 2.8900000000000001 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 1.8 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.0 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 4.5700000000000003 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 127' ' ' ILE . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 2.3500000000000001 108.193 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 1.8799999999999999 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.8300000000000001 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.0499999999999998 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 1.72 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 4.5800000000000001 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 1.48 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 1.8700000000000001 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 5.4100000000000001 112.335 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 5.8300000000000001 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 0.93000000000000005 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 2.79 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 150' ' ' ILE . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 0.92000000000000004 105.549 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.423 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 2.5600000000000001 110.28 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.0800000000000001 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.8199999999999998 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.0600000000000001 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 1.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.1799999999999999 110.449 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 0.96999999999999997 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 4.4500000000000002 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 1.1499999999999999 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 3.3500000000000001 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 2.3300000000000001 112.252 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 1.0800000000000001 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 76' ' ' LYS . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 1.6499999999999999 105.923 166.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.4199999999999999 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 2.3599999999999999 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 1.24 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 1.3500000000000001 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 71' ' ' ILE . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 4.3099999999999996 114.494 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.6299999999999999 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.596 ' CA ' HG22 ' A' ' 71' ' ' ILE . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.04 112.575 -137.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.4100000000000001 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 0.87 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 4.5899999999999999 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 2.6899999999999999 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.9300000000000002 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.549 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 5.4100000000000001 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 85' ' ' LEU . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 2.2599999999999998 110.876 -164.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 4.5199999999999996 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.1099999999999999 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.1299999999999999 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.3500000000000001 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 3.4199999999999999 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 1.02 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 2.1400000000000001 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.0700000000000001 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.3700000000000001 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.1200000000000001 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.2999999999999998 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 1.6200000000000001 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 6.9800000000000004 112.101 170.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.0199999999999996 111.404 -169.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.9900000000000002 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.6299999999999999 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 5.7999999999999998 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 6.4800000000000004 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.0999999999999996 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 4.4500000000000002 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 1.9099999999999999 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 2.71 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.29 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.68000000000000005 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.45 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 0.72999999999999998 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 2.0 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 5.5800000000000001 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.0699999999999998 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.2799999999999998 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 1.4399999999999999 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.9100000000000001 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 3.3799999999999999 109.961 131.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.68000000000000005 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 0.83999999999999997 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 2.7599999999999998 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 2.96 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 0.85999999999999999 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.0600000000000001 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.673 HD12 HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.04 109.889 -162.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 5.9400000000000004 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 2.8799999999999999 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.1600000000000001 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 3.7200000000000002 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 2.8500000000000001 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 3.96 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.8500000000000001 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 1.27 106.744 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 1.03 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.75 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 2.2599999999999998 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.0600000000000001 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.1099999999999999 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 1.98 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 3.5699999999999998 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 2.1200000000000001 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 2.5699999999999998 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.52 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.0 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 2.25 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.1499999999999999 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 2.7799999999999998 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.42 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 3.96 108.7 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 0.87 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.0800000000000001 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 1.23 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 1.5700000000000001 109.656 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 3.48 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.9199999999999999 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 109.25 -1.54 . . . . 2.71 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.5999999999999996 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.3700000000000001 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 2.2999999999999998 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.4100000000000001 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 3.4900000000000002 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 5.3899999999999997 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 2.29 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 1.8100000000000001 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.6699999999999999 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 2.6899999999999999 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.4900000000000002 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 5.96 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 1.3300000000000001 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 1.6499999999999999 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.455 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 5.3099999999999996 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 4.9299999999999997 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 0.92000000000000004 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 2.4700000000000002 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 1.0700000000000001 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 4.3399999999999999 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.1000000000000001 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 1.6399999999999999 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.8199999999999998 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.6600000000000001 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 1.22 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 0.95999999999999996 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 0.97999999999999998 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 3.4100000000000001 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 0.97999999999999998 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.1200000000000001 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 2.04 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 1.4299999999999999 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 2.23 105.123 167.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.3500000000000001 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 2.79 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.0299999999999998 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 1.54 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 5.1100000000000003 113.121 174.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.1200000000000001 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 1.6499999999999999 110.73 171.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.5699999999999998 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 0.79000000000000004 109.553 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 5.3600000000000003 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 2.6699999999999999 110.087 -169.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.4199999999999999 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 3.5800000000000001 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 1.6000000000000001 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 5.2300000000000004 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 1.8899999999999999 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.5600000000000001 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.7999999999999998 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 1.78 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 1.2 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.5600000000000001 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 123' ' ' TYR . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 1.8 106.427 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.03 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 1.27 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 1.4399999999999999 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.5700000000000003 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 1.4099999999999999 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 8.3300000000000001 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 4.4400000000000004 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.4100000000000001 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.0699999999999998 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 4.7300000000000004 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 6.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 5.5300000000000002 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 2.5299999999999998 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.1699999999999999 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 2.6899999999999999 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 2.2400000000000002 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.68999999999999995 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 1.5 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 141' ' ' VAL . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 1.21 108.187 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 2.46 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 4.75 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.6299999999999999 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.8799999999999999 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 1.2 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 3.2400000000000002 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 0.93000000000000005 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 94' ' ' LEU . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 3.0299999999999998 110.246 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 1.8799999999999999 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.1399999999999999 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 3.8199999999999998 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 6.0 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 3.5699999999999998 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.5499999999999998 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 4.3799999999999999 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.3700000000000001 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 2.5299999999999998 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.0299999999999998 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 1.3700000000000001 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 0.91000000000000003 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.04 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 1.6200000000000001 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.73999999999999999 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 113' ' ' VAL . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 2.48 106.086 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 3.6099999999999999 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.1800000000000002 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 2.71 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.8599999999999999 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.29 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.2200000000000002 109.109 -173.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.1299999999999999 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 2.4700000000000002 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 1.45 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 152' ' ' LEU . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 2.1200000000000001 112.235 -166.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 1.4199999999999999 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 1.03 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.21 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.6699999999999999 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 2.5699999999999998 110.865 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7000000000000002 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 104' ' ' LYS . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 4.8300000000000001 110.936 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 2.8500000000000001 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 1.8200000000000001 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 3.1299999999999999 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.7999999999999998 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 4.9400000000000004 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 2.1600000000000001 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.0 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.9800000000000004 110.905 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 2.1600000000000001 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 1.71 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 4.9100000000000001 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 2.0499999999999998 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 3.3700000000000001 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 4.4100000000000001 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.78000000000000003 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 3.1099999999999999 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.0600000000000001 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 3.0 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 2.25 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.1699999999999999 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.2799999999999998 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 2.2000000000000002 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.26 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.823 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 0.92000000000000004 112.734 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 3.7999999999999998 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 0.97999999999999998 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 2.2999999999999998 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 2.0699999999999998 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 1.3400000000000001 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 1.6599999999999999 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 2.23 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 1.7 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 1.1399999999999999 112.749 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 109' ' ' ILE . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 5.4900000000000002 111.72 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7000000000000002 105.528 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.3100000000000001 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 4.7800000000000002 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.823 HG23 ' HA3' ' A' ' 65' ' ' GLY . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 1.8300000000000001 106.895 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.3700000000000001 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 4.2800000000000002 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.9900000000000002 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.04 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 1.76 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.7 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.5899999999999999 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 2.1899999999999999 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.5099999999999998 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 0.92000000000000004 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.6600000000000001 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 1.8100000000000001 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.1000000000000001 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.0099999999999998 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 1.45 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.5599999999999996 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.0499999999999998 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.2699999999999996 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 5.1299999999999999 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.2300000000000004 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 4.3799999999999999 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 4.5899999999999999 110.92 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 5.6500000000000004 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 6.1799999999999997 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.2799999999999998 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 1.4299999999999999 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 3.0299999999999998 107.58 150.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 1.5800000000000001 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 0.81000000000000005 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.48 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 0.76000000000000001 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 2.23 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.21 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.0499999999999998 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.6600000000000001 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 1.3899999999999999 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.3199999999999998 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.0600000000000001 107.77 167.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.59999999999999998 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 0.90000000000000002 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 3.73 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 1.6000000000000001 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 0.97999999999999998 112.933 -170.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.0800000000000001 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 3.3199999999999998 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 5.6900000000000004 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 2.79 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.6699999999999999 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 4.1100000000000003 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.3300000000000001 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 2.9100000000000001 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2000000000000002 107.076 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 154' ' ' ALA . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 1.79 108.899 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 1.25 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.85999999999999999 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 1.6499999999999999 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 0.82999999999999996 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.5600000000000001 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 2.2400000000000002 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.3500000000000001 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 2.8500000000000001 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 2.3999999999999999 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.6800000000000002 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.3400000000000001 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.0699999999999998 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.4500000000000002 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 2.6499999999999999 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 1.5600000000000001 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.03 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.03 108.597 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 1.05 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.02 109.635 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.1699999999999999 113.774 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9000000000000004 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 CA-C-O 119.377 -0.679 . . . . 2.0699999999999998 112.346 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.8200000000000003 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 4.4000000000000004 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 3.5600000000000001 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.1699999999999999 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 3.9500000000000002 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.3599999999999999 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 5.79 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 2.6400000000000001 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 1.9099999999999999 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.8300000000000001 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 2.71 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 1.6000000000000001 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 4.9900000000000002 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 1.8 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 1.49 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.723 ' CZ ' HG13 ' A' ' 135' ' ' VAL . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 5.0199999999999996 110.027 162.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 4.7699999999999996 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 0.98999999999999999 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 3.52 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 152' ' ' LEU . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 0.93999999999999995 104.584 171.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 2.0499999999999998 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.1599999999999999 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.5499999999999998 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.3799999999999999 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.9900000000000002 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.1000000000000001 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 0.95999999999999996 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 3.4300000000000002 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 152' ' ' LEU . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 1.3200000000000001 108.419 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 2.4500000000000002 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.23 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.04 106.41 163.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 3.75 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 1.78 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 1.6799999999999999 114.012 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 5.5899999999999999 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.02 107.785 168.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.6000000000000001 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.8799999999999999 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 6.1399999999999997 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 82' ' ' ILE . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 1.8799999999999999 109.18 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 3.5699999999999998 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 1.8 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 3.8700000000000001 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 1.4099999999999999 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.5700000000000001 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.1200000000000001 111.039 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.04 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 1.1399999999999999 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.9500000000000002 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 80' ' ' GLY . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 2.4199999999999999 106.433 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 1.53 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.73 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.0900000000000001 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.8399999999999999 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.04 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.0199999999999996 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 3.3900000000000001 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.6500000000000004 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 3.1699999999999999 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 5.9100000000000001 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.566 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 6.2999999999999998 108.24 -163.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 4.9699999999999998 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 2.73 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 1.3600000000000001 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 2.5 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 2.2400000000000002 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.65000000000000002 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.4299999999999999 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 0.93999999999999995 109.404 168.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 1.9199999999999999 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 4.8499999999999996 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 2.7999999999999998 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.4700000000000002 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 1.1899999999999999 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.8500000000000001 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 3.5 110.603 135.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.53000000000000003 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 3.5699999999999998 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.1200000000000001 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 152' ' ' LEU . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 0.77000000000000002 109.113 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.1499999999999999 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 2.0699999999999998 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 5.7300000000000004 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 3.71 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.3900000000000001 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 3.5499999999999998 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 1.3999999999999999 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 3.1000000000000001 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 155' ' ' LYS . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.9900000000000002 108.581 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 53' ' ' TYR . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 1.3 107.768 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 1.24 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 2.1899999999999999 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 0.68999999999999995 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.1100000000000003 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 1.99 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 3.5899999999999999 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 2.7799999999999998 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 1.8700000000000001 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.1299999999999999 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 1.6100000000000001 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 2.7999999999999998 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 3.1899999999999999 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 1.3700000000000001 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.81999999999999995 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.1399999999999999 107.91 -171.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.02 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 0.93999999999999995 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 134' ' ' GLU . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.25 107.628 160.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.7599999999999998 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 1.96 113.928 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.5199999999999996 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.3499999999999996 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.0299999999999998 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.0899999999999999 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 4.46 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.8700000000000001 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 4.4800000000000004 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 2.4700000000000002 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 1.8300000000000001 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.6900000000000004 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 2.73 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 4.8799999999999999 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 1.3 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 1.95 110.288 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 71' ' ' ILE . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 3.21 109.109 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 4.9000000000000004 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.66000000000000003 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.2200000000000002 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 0.93999999999999995 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 2.3199999999999998 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.0900000000000001 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.1899999999999999 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.7799999999999998 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 1.26 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 0.94999999999999996 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.727 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 0.89000000000000001 112.555 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.2199999999999998 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 152' ' ' LEU . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 0.88 107.321 165.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 2.3500000000000001 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 2.3199999999999998 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 1.0700000000000001 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 1.6699999999999999 109.501 171.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.6600000000000001 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 2.3500000000000001 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 1.49 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.26 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HG3' HD12 ' A' ' 71' ' ' ILE 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.0099999999999998 115.444 167.044 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.5499999999999998 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.1699999999999999 112.074 -167.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92000000000000004 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 3.6000000000000001 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.727 HG23 ' HA3' ' A' ' 65' ' ' GLY . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 1.8400000000000001 107.952 -169.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.8900000000000001 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 5.79 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 1.6200000000000001 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 3.9700000000000002 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 1.5600000000000001 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2000000000000002 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 2.5099999999999998 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.9399999999999999 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 0.96999999999999997 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.5800000000000001 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 1.72 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 1.8 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.3100000000000001 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 1.0600000000000001 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.6600000000000001 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 1.55 111.394 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 6.9400000000000004 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 4.0599999999999996 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.1399999999999997 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.0899999999999999 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 6.5199999999999996 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.04 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 5.2300000000000004 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 2.3999999999999999 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 1.1000000000000001 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 2.75 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 2.2200000000000002 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.68000000000000005 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 1.4099999999999999 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 0.85999999999999999 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 3.0499999999999998 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 5.4299999999999997 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.1400000000000001 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.4399999999999999 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 1.23 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 3.4500000000000002 108.365 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.64000000000000001 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.1200000000000001 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 2.2999999999999998 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.1099999999999999 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 152' ' ' LEU . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 0.77000000000000002 109.419 -171.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.1599999999999999 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.592 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 2.2200000000000002 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 4.5599999999999996 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 2.79 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.3300000000000001 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.2599999999999998 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.26 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 3.2999999999999998 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 155' ' ' LYS . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.0099999999999998 108.07 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 125' ' ' LEU . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.1899999999999999 109.21 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 0.90000000000000002 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.71999999999999997 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 2.6099999999999999 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 1.3999999999999999 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.1400000000000001 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 2.54 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 3.8999999999999999 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.3100000000000001 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.0099999999999998 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.7799999999999998 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.0800000000000001 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 2.3199999999999998 108.143 -171.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 2.9199999999999999 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 2.3799999999999999 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 1.5600000000000001 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.68999999999999995 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.0600000000000001 107.115 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 0.92000000000000004 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.05 109.798 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 134' ' ' GLU . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.2400000000000002 109.396 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.0800000000000001 110.118 -157.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 2.5 108.099 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.1100000000000003 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.4800000000000004 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 2.5499999999999998 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 1.9299999999999999 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 2.6499999999999999 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7000000000000002 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 4.4699999999999998 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.8300000000000001 115.001 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 4.0099999999999998 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.779999999999999 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.0899999999999999 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.437 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 5.4400000000000004 111.604 -165.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 1.25 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 1.46 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 2.98 110.925 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 5.4100000000000001 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.96999999999999997 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 2.98 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 1.24 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 2.3700000000000001 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.1800000000000002 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.8300000000000001 112.943 173.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.3500000000000001 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 1.5900000000000001 105.701 153.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.0499999999999998 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.28 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 4.6699999999999999 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.72 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.5 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 2.3999999999999999 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.437 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 1.3999999999999999 108.355 168.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.679 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 1.49 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.4400000000000004 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 3.3900000000000001 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 2.29 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 1.52 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 5.3499999999999996 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.8899999999999999 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.25 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.9399999999999999 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 0.98999999999999999 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 3.9100000000000001 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 2.0499999999999998 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.6499999999999999 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 3.9300000000000002 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 1.74 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 5.4400000000000004 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 1.51 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.6200000000000001 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 2.0099999999999998 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.8700000000000001 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 0.93999999999999995 109.793 -169.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.2400000000000002 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 1.6100000000000001 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 1.29 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 1.6699999999999999 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.0800000000000001 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 1.51 108.764 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 8.3499999999999996 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 3.8700000000000001 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.0499999999999998 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.8199999999999998 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 4.6500000000000004 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 6.7999999999999998 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.2300000000000004 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 3.79 105.771 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 1.48 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 2.4199999999999999 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.02 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.79000000000000004 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 1.97 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 0.73999999999999999 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 2.0899999999999999 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 4.5 106.622 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 2.79 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 2.4900000000000002 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 1.3600000000000001 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.1299999999999999 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 3.29 108.669 163.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.69999999999999996 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 0.87 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 3.5499999999999998 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.1600000000000001 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 0.97999999999999998 112.892 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.4900000000000002 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 2.1400000000000001 106.044 155.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 5.8200000000000003 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 3.54 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.3300000000000001 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 3.4399999999999999 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 1.47 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 3.48 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.6200000000000001 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 125' ' ' LEU . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.5700000000000001 107.694 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 1.6499999999999999 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.04 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 1.79 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 0.84999999999999998 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 1.9199999999999999 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.0099999999999998 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.3900000000000001 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 3.0899999999999999 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.1600000000000001 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.1200000000000001 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 2.3500000000000001 109.364 -167.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 2.8300000000000001 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 2.5800000000000001 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 1.1899999999999999 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 0.93999999999999995 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 1.4199999999999999 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 1.7 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.04 109.381 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.29 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.3300000000000001 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 2.79 111.679 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.5599999999999996 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 4.1500000000000004 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 3.4100000000000001 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 2.3399999999999999 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 3.7599999999999998 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.0600000000000001 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 5.5999999999999996 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 2.2599999999999998 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 1.9399999999999999 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.3200000000000003 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 73' ' ' PHE . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 2.9900000000000002 116.775 -160.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 1.73 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 7.79 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 2.3500000000000001 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 1.6200000000000001 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 4.4500000000000002 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 5.54 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.0 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.46 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.0600000000000001 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 2.3100000000000001 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.3100000000000001 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.1899999999999999 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.4699999999999998 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.7200000000000002 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 1.6000000000000001 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.2 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.03 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.21 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 1.52 109.629 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 1.8500000000000001 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 2.6299999999999999 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 0.92000000000000004 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 1.74 106.833 158.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.2400000000000002 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 3.04 113.437 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 1.3999999999999999 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 1.5900000000000001 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.1900000000000004 114.268 169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.402 ' CD ' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.8899999999999999 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.1399999999999999 111.704 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.8599999999999999 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.3200000000000001 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.0899999999999999 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 3.8900000000000001 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.7200000000000002 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 4.6799999999999997 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 1.8200000000000001 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 4.2999999999999998 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 1.98 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6000000000000001 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2000000000000002 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 2.29 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.1499999999999999 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 1.0 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.0800000000000001 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 2.21 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 2.3999999999999999 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 1.3999999999999999 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 1.24 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7000000000000002 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.1299999999999999 112.887 -176.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.0800000000000001 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 3.8999999999999999 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 3.7000000000000002 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 6.8300000000000001 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 8.3699999999999992 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 5.5199999999999996 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 2.6699999999999999 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 1.53 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 2.6699999999999999 107.895 164.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 1.4299999999999999 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 0.92000000000000004 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 2.48 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 0.80000000000000004 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 2.3399999999999999 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 7.5 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.3899999999999997 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.3599999999999999 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 2.8100000000000001 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.8999999999999999 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 6.1799999999999997 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.0 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.1499999999999999 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 2.54 111.942 -171.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 1.5800000000000001 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 152' ' ' LEU . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 1.54 110.184 -171.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 3.2999999999999998 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 5.9699999999999998 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 3.21 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.6099999999999999 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 5.6600000000000001 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 1.6699999999999999 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 2.6299999999999999 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.6100000000000003 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 154' ' ' ALA . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 1.79 107.919 -173.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 1.54 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.01 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 1.77 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 0.80000000000000004 110.513 163.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.0299999999999998 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.1000000000000001 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 4.8399999999999999 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.0099999999999998 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 3.1899999999999999 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.6499999999999999 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.5700000000000001 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 1.6799999999999999 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 2.6200000000000001 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 2.4399999999999999 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 1.23 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.77000000000000002 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.464 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.1200000000000001 107.946 -171.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 0.97999999999999998 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 1.26 110.85 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 4.6100000000000003 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.7699999999999996 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 40' ' ' THR . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 2.73 111.185 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 10.76 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.495 HG22 ' CA ' ' A' ' 37' ' ' GLY . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 3.8199999999999998 109.213 -165.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.1400000000000001 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 5.21 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7000000000000002 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 4.1299999999999999 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 2.7799999999999998 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 3.21 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.7999999999999998 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 2.7599999999999998 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 1.99 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 5.5499999999999998 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' H ' HG13 ' A' ' 71' ' ' ILE . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 1.49 108.759 158.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 1.5600000000000001 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 2.9199999999999999 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 5.7599999999999998 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 0.85999999999999999 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.1600000000000001 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 0.90000000000000002 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 2.0899999999999999 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 1.8700000000000001 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.2400000000000002 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.9199999999999999 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 1.0600000000000001 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.0600000000000001 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.1000000000000001 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 3.5800000000000001 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 1.04 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.52 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 1.99 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 1.1200000000000001 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 1.6599999999999999 109.122 174.085 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 71' ' ' ILE . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 2.8799999999999999 115.943 -167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 1.74 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 1.2 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 4.4699999999999998 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.3199999999999998 106.668 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.27 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.6099999999999999 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 94' ' ' LEU . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.79000000000000004 106.587 161.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 5.8600000000000003 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB ' ' A' ' 92' ' ' VAL 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 3.3799999999999999 107.702 -177.093 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.6899999999999999 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 3.8399999999999999 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 90' ' ' LEU . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 1.9199999999999999 109.859 -158.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 3.8799999999999999 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.02 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 1.8300000000000001 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.6299999999999999 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 85' ' ' LEU . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 2.5899999999999999 110.921 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1000000000000001 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' A' ' 82' ' ' ILE . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 0.94999999999999996 109.08 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 80' ' ' GLY . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 1.6299999999999999 109.134 -173.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 1.48 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 1.95 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 1.1000000000000001 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.0899999999999999 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 1.72 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 6.9800000000000004 111.976 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.411 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.0700000000000003 113.642 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.0099999999999998 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 6.7000000000000002 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 10.85 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 7.6900000000000004 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 2.7400000000000002 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 1.1699999999999999 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 2.3700000000000001 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 2.3399999999999999 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 0.90000000000000002 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.5800000000000001 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 0.79000000000000004 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 2.98 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 5.8399999999999999 108.286 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.6600000000000001 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.2599999999999998 109.201 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 1.47 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.0600000000000001 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.59999999999999998 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 0.81999999999999995 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 2.3300000000000001 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 2.52 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.1000000000000001 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.0800000000000001 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 3.0 108.547 176.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 4.5099999999999998 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 2.4900000000000002 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.8500000000000001 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.27 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 1.3100000000000001 113.241 172.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 2.9100000000000001 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.0800000000000001 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 154' ' ' ALA . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 1.8600000000000001 108.42 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 2.23 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.27 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 2.2799999999999998 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.01 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.0300000000000002 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 1.97 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 3.7599999999999998 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 2.4399999999999999 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.0699999999999998 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.9300000000000002 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 0.94999999999999996 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 1.4199999999999999 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 3.7000000000000002 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 2.2999999999999998 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 1.3400000000000001 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.0800000000000001 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 1.1699999999999999 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 1.03 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 0.88 108.835 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.1500000000000004 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.0300000000000002 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 2.8300000000000001 113.483 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.3899999999999997 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' NE2' HD11 ' A' ' 99' ' ' ILE . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.4199999999999999 111.812 -170.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 2.7000000000000002 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.1600000000000001 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 3.5099999999999998 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.4800000000000004 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 6.6900000000000004 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 2.3300000000000001 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.1000000000000001 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.6499999999999999 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.0 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 8.7100000000000009 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 1.8300000000000001 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 1.8999999999999999 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 4.9100000000000001 112.524 157.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 5.96 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.0700000000000001 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.3100000000000001 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 0.94999999999999996 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 2.1400000000000001 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.6599999999999999 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.3799999999999999 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.3999999999999999 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 1.3600000000000001 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 0.89000000000000001 113.671 -174.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 3.6699999999999999 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 1.3899999999999999 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 1.75 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 3.0899999999999999 112.398 -172.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 1.3500000000000001 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.591 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 1.6000000000000001 111.16 173.182 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.4699999999999998 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 2.2999999999999998 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 1.5700000000000001 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.1200000000000001 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 5.2699999999999996 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.3599999999999999 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.1799999999999999 110.932 -175.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.9700000000000002 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.04 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 3.6299999999999999 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 82' ' ' ILE . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 1.9199999999999999 107.504 178.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.2200000000000002 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 3.2799999999999998 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 1.76 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 3.5600000000000001 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 1.3899999999999999 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.6200000000000001 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.0600000000000001 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 2.3700000000000001 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.72 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 1.1100000000000001 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.2799999999999998 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 2.5800000000000001 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.01 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 1.1499999999999999 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 1.1200000000000001 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.4900000000000002 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.21 103.619 166.862 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 7.3399999999999999 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 3.1800000000000002 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.0700000000000003 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.1399999999999997 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 5.4900000000000002 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 9.0399999999999991 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.4800000000000004 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.0600000000000001 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 1.1799999999999999 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 2.1800000000000002 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 1.8500000000000001 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.96999999999999997 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.3600000000000001 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 0.81000000000000005 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 2.1200000000000001 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 5.4100000000000001 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.1400000000000001 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.0699999999999998 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 1.4299999999999999 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 3.25 109.438 165.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.63 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 0.82999999999999996 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 2.54 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 1.49 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 0.91000000000000003 111.96 -163.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2000000000000002 113.064 -168.254 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 2.29 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 4.9500000000000002 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 4.1600000000000001 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.6800000000000002 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 3.4900000000000002 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.04 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 3.4399999999999999 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.6299999999999999 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 1.8700000000000001 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 0.84999999999999998 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.1100000000000001 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 2.25 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 1.1799999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 2.0899999999999999 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.2400000000000002 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.2999999999999998 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 2.2799999999999998 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.5800000000000001 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 0.98999999999999999 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 1.52 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 2.8199999999999998 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 2.2000000000000002 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 1.22 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.1200000000000001 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 1.29 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 1.1799999999999999 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 1.5900000000000001 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 3.3900000000000001 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.8599999999999999 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.208 -0.757 . . . . 2.9300000000000002 111.208 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.8300000000000001 113.128 -175.487 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 4.2699999999999996 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' LYS . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 2.6499999999999999 111.17 165.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.1000000000000001 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 4.4900000000000002 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.0300000000000002 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 3.9100000000000001 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 3.3199999999999998 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.0499999999999998 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.8499999999999996 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 2.9399999999999999 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 1.8799999999999999 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.1799999999999997 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 1.3999999999999999 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 1.8 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' H ' ' HB3' ' A' ' 69' ' ' TYR 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 4.4400000000000004 116.967 -177.832 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 4.9299999999999997 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 0.94999999999999996 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 3.6200000000000001 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 1.24 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 2.3399999999999999 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.93999999999999995 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 1.8300000000000001 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.1899999999999999 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.3799999999999999 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 1.0600000000000001 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.04 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.1900000000000004 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD13 HD21 ' A' ' 152' ' ' LEU . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 1.6200000000000001 109.63 174.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.2400000000000002 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 2.6899999999999999 111.597 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 1.73 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 2.2999999999999998 104.518 160.3 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.9900000000000002 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 3.0600000000000001 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.3100000000000001 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 1.5800000000000001 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HG2' HG21 ' A' ' 40' ' ' THR . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 7.6600000000000001 113.969 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.7000000000000002 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.1400000000000001 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.85999999999999999 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 6.6500000000000004 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 1.98 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.3399999999999999 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 4.3799999999999999 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 2.9500000000000002 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 4.0999999999999996 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 2.4399999999999999 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.5299999999999998 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.3499999999999996 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.0600000000000001 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.8399999999999999 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 1.1000000000000001 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.3199999999999998 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 1.78 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 1.0800000000000001 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 1.5700000000000001 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 1.1299999999999999 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.8900000000000001 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 1.9399999999999999 108.543 170.001 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 7.7599999999999998 110.138 163.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 6.3899999999999997 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.6800000000000002 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 4.4000000000000004 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 7.5999999999999996 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.436 ' CB ' HG23 ' A' ' 40' ' ' THR 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 6.1900000000000004 112.013 -178.121 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 2.5600000000000001 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 1.45 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 110' ' ' SER . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 2.96 108.242 157.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 109' ' ' ILE . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 1.8999999999999999 110.937 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.77000000000000002 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 1.3600000000000001 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.89000000000000001 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 2.3399999999999999 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 6.3499999999999996 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 3.6299999999999999 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 2.0699999999999998 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 1.8400000000000001 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.04 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.63 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.05 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 2.5499999999999998 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 1.5600000000000001 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD23 HD12 ' A' ' 152' ' ' LEU . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 0.79000000000000004 108.015 -174.684 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.1100000000000001 111.402 -177.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 3.1899999999999999 111.2 -174.261 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 7.0599999999999996 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 3.2400000000000002 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.3599999999999999 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 5.8499999999999996 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.406 ' H ' HD11 ' A' ' 127' ' ' ILE . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.47 107.117 -164.026 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 2.6800000000000002 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.1499999999999999 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 154' ' ' ALA . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 1.2 106.545 155.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 1.1299999999999999 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.70999999999999996 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 1.9099999999999999 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 0.69999999999999996 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.0499999999999998 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 2.1000000000000001 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.2000000000000002 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 2.5 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.1099999999999999 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.6499999999999999 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.03 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 2.21 106.872 -171.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 2.8599999999999999 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 2.2799999999999998 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 1.48 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.1299999999999999 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.672 HD12 HD23 ' A' ' 125' ' ' LEU . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.25 107.57 -175.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 1.1200000000000001 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.1799999999999999 109.879 174.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 4.5199999999999996 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.3700000000000001 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 2.96 111.052 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.0700000000000003 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.3200000000000003 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 2.27 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 1.7 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 3.4500000000000002 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.0199999999999996 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 5.6500000000000004 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 3.02 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 1.95 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.5899999999999999 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 1.8200000000000001 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 1.8300000000000001 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 5.4500000000000002 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 1.77 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 156' ' ' GLN . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.2200000000000002 109.202 176.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' CE1' HD13 ' A' ' 71' ' ' ILE . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 3.3900000000000001 108.053 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 5.3799999999999999 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 2.21 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.90000000000000002 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 2.25 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.1200000000000001 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.1200000000000001 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.5099999999999998 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.8199999999999998 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.04 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 0.70999999999999996 112.32 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 3.7400000000000002 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 1.3300000000000001 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 2.04 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 2.2000000000000002 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.8700000000000001 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 1.51 106.605 170.242 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.2799999999999998 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 2.4700000000000002 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 1.6200000000000001 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 1.3799999999999999 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.0499999999999998 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 2.3199999999999998 107.194 172.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.4099999999999999 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.2599999999999998 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 5.1200000000000001 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.783 HG23 ' HA3' ' A' ' 65' ' ' GLY . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 1.8300000000000001 106.56 172.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.4900000000000002 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 3.73 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 1.8100000000000001 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 3.6499999999999999 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 1.8700000000000001 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.1200000000000001 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.5300000000000002 110.277 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 2.1299999999999999 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.2400000000000002 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 115' ' ' TYR . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 1.05 108.465 -174.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.0600000000000001 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 1.8100000000000001 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 1.95 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.04 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.1299999999999999 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 1.3999999999999999 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 8.3300000000000001 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 3.9700000000000002 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.9800000000000004 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 4.0300000000000002 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 9.5099999999999998 110.912 -174.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.039999999999999 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.0 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 3.8199999999999998 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 1.47 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 2.6499999999999999 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.3799999999999999 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.68999999999999995 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 1.4299999999999999 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 141' ' ' VAL . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 1.0900000000000001 113.656 178.878 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 2.1099999999999999 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 4.7800000000000002 104.711 174.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.4399999999999999 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 1.21 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 7.8300000000000001 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.0900000000000001 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 0.78000000000000003 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 2.73 109.695 -176.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 1.9299999999999999 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 0.76000000000000001 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.1699999999999999 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 2.3500000000000001 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 5.0199999999999996 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 3.5600000000000001 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.5499999999999998 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 5.3899999999999997 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 1.55 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 3.9900000000000002 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 1.5800000000000001 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 0.92000000000000004 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.90000000000000002 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 2.5600000000000001 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 0.78000000000000003 112.069 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.4399999999999999 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 113' ' ' VAL . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 2.2000000000000002 106.559 -166.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 3.3700000000000001 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 2.7200000000000002 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 1.8 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.5800000000000001 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.05 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 1.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 2.5899999999999999 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 3.3799999999999999 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 1.3100000000000001 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 0.83999999999999997 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 1.3899999999999999 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 1.05 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 1.27 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 3.5800000000000001 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' A' ' 52' ' ' THR . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.3300000000000001 110.752 -177.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 3.9900000000000002 109.788 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.9400000000000004 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 5.6100000000000003 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 3.7999999999999998 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 2.48 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 2.98 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.1400000000000001 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 3.8500000000000001 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 2.1400000000000001 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 1.6399999999999999 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.0199999999999996 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.4199999999999999 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 1.8500000000000001 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 6.2599999999999998 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 1.47 111.5 -178.514 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 52' ' ' THR . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.27 110.611 -165.526 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 3.6200000000000001 110.031 -178.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 4.96 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.65000000000000002 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 2.96 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.6200000000000001 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 2.46 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.29 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.2200000000000002 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.2400000000000002 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.2800000000000002 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.0600000000000001 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.806 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 0.93999999999999995 111.987 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.2000000000000002 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 0.81000000000000005 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 2.52 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 2.2200000000000002 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 1.6599999999999999 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.614 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 1.28 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.5499999999999998 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 2.8199999999999998 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 2.6299999999999999 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' A' ' 98' ' ' ASP . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 1.9199999999999999 114.021 -162.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 4.6200000000000001 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.3200000000000001 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.6299999999999999 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.87 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 4.2800000000000002 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.806 HG23 ' HA3' ' A' ' 65' ' ' GLY . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.1000000000000001 106.647 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.3499999999999996 104.082 153.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 5.0099999999999998 107.493 37.135 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 1.8899999999999999 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 4.5 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 2.1200000000000001 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.1099999999999999 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 2.7200000000000002 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.9399999999999999 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 1.0700000000000001 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.1899999999999999 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 1.9299999999999999 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 1.97 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 1.25 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 1.02 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.443 ' OD1' ' HB1' ' A' ' 75' ' ' ALA . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.4699999999999998 110.302 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.1299999999999999 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.1500000000000004 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 4.5700000000000003 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.0999999999999996 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.3700000000000001 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 5.7800000000000002 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 6.2599999999999998 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 5.5499999999999998 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 2.6600000000000001 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 1.74 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 2.6099999999999999 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 1.6000000000000001 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.83999999999999997 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 1.3200000000000001 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 0.85999999999999999 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 1.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 6.79 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.2000000000000002 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.9500000000000002 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 2.6800000000000002 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 4.5199999999999996 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.55000000000000004 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 0.95999999999999996 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 2.29 109.87 178.978 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 1.95 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 126' ' ' GLY . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 1.3200000000000001 107.404 -176.29 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' HD13 ' A' ' 125' ' ' LEU . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 3.0 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 4.6399999999999997 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 2.7200000000000002 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.9500000000000002 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 3.7999999999999998 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 1.9099999999999999 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 3.0800000000000001 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7000000000000002 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 1.4099999999999999 106.356 170.101 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 1.24 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.3100000000000001 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.0 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 0.87 109.783 165.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.3500000000000001 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 2.1200000000000001 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 2.7400000000000002 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.0099999999999998 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.0499999999999998 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.3300000000000001 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 1.3999999999999999 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 2.6400000000000001 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 1.9199999999999999 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 2.3100000000000001 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.01 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 2.2799999999999998 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 1.3899999999999999 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 1.0600000000000001 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 4.0599999999999996 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 4.5099999999999998 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 2.5 110.616 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.1500000000000004 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 4.8600000000000003 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 2.71 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.21 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 3.0600000000000001 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.9100000000000001 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 5.1699999999999999 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 2.3300000000000001 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 1.8700000000000001 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.1900000000000004 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.0899999999999999 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 1.96 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.25 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 1.5600000000000001 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 1.9199999999999999 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 135' ' ' VAL . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 3.3500000000000001 108.234 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.0099999999999998 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 0.93000000000000005 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 2.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.1499999999999999 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 2.27 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 1.6899999999999999 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.4199999999999999 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 1.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.1000000000000001 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 3.77 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 1.0600000000000001 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.3300000000000001 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 2.0299999999999998 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.24 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 1.8 104.621 163.105 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 3.6200000000000001 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 1.3899999999999999 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 1.3400000000000001 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.1200000000000001 110.169 165.216 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.6699999999999999 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.27 111.912 -162.109 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.9199999999999999 109.13 -172.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.1200000000000001 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 1.9099999999999999 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.6400000000000001 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 3.3399999999999999 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 1.5600000000000001 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 3.9399999999999999 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 1.6100000000000001 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.6100000000000001 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.0800000000000001 113.534 175.481 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 2.1400000000000001 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.8400000000000001 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 1.0800000000000001 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 1.99 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 0.98999999999999999 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 1.98 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 1.3600000000000001 111.179 -167.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.5800000000000001 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 6.8700000000000001 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 4.3399999999999999 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 2.9300000000000002 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 5.79 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 7.3899999999999997 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 6.0199999999999996 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 2.5800000000000001 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 1.1499999999999999 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 3.1000000000000001 104.921 155.672 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 109' ' ' ILE . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 2.2799999999999998 109.713 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.0800000000000001 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.46 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 0.77000000000000002 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.1400000000000001 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.1200000000000001 106.415 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.0099999999999998 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.3900000000000001 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 1.27 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.9900000000000002 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 3.46 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.53000000000000003 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 0.80000000000000004 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 2.48 113.022 177.971 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 1.9199999999999999 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 152' ' ' LEU . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.02 108.209 -174.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.1299999999999999 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 2.52 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 5.1200000000000001 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 3.1200000000000001 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 2.8500000000000001 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 4.6699999999999999 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.1299999999999999 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 3.9399999999999999 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.1699999999999999 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 125' ' ' LEU . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 1.5700000000000001 106.153 165.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 1.0700000000000001 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.0700000000000001 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 1.78 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 0.68000000000000005 111.024 169.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 2.1299999999999999 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.1699999999999999 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 2.3100000000000001 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 1.99 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.1599999999999999 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 2.1800000000000002 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.4399999999999999 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 2.3900000000000001 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 1.3500000000000001 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 0.94999999999999996 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.505 HD11 HD23 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 1.78 112.458 173.08 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 1.25 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HB3' ' H ' ' A' ' 135' ' ' VAL . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.0900000000000001 107.27 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 3.98 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.3899999999999997 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 CA-C-O 119.575 -0.57 . . . . 2.6299999999999999 113.224 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.6900000000000004 114.57 -178.155 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.5 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.537 HG23 HD12 ' A' ' 127' ' ' ILE . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 3.4199999999999999 111.166 176.849 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.4300000000000002 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 4.2000000000000002 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 3.6600000000000001 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 5.2199999999999998 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 4.9699999999999998 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 3.9900000000000002 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.630000000000001 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.1299999999999999 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.3100000000000001 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 6.2400000000000002 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 71' ' ' ILE . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 2.27 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 1.6499999999999999 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.822 ' CE1' HG11 ' A' ' 135' ' ' VAL . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 2.8599999999999999 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 4.8200000000000003 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.70999999999999996 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 3.1299999999999999 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 1.24 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 3.2200000000000002 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 2.5899999999999999 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.0899999999999999 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.4700000000000002 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 2.1499999999999999 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.8100000000000001 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.5 113.426 -168.661 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.2799999999999998 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 0.90000000000000002 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 1.8799999999999999 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 2.0499999999999998 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 0.97999999999999998 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 51' ' ' ALA . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 1.6000000000000001 109.374 167.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.7200000000000002 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 3.0899999999999999 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 1.6799999999999999 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 1.77 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 5.71 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.4300000000000002 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 3.1899999999999999 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.5199999999999996 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.90000000000000002 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 4.7300000000000004 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.669 HG23 ' HA3' ' A' ' 65' ' ' GLY . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 2.3700000000000001 107.923 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.4300000000000002 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 4.7999999999999998 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 2.1699999999999999 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.2400000000000002 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 1.8899999999999999 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.5 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.3499999999999996 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 3.98 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 1.7 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 1.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.4300000000000002 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 1.9299999999999999 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.2 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 1.3999999999999999 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.23 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.9500000000000002 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HH22 ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.0 107.896 -178.679 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 7.2800000000000002 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 3.5499999999999998 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.2400000000000002 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7000000000000002 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 4.6299999999999999 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.485 HH22 HD11 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 11.02 113.561 169.022 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 8.4600000000000009 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 2.6699999999999999 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 1.1200000000000001 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 2.71 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 1.96 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.71999999999999997 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 1.6599999999999999 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 1.1200000000000001 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 2.46 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 6.1200000000000001 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 6.0300000000000002 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 2.8199999999999998 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.1099999999999999 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.6800000000000002 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 3.98 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 0.90000000000000002 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 3.0499999999999998 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.1499999999999999 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.606 HD21 ' HB ' ' A' ' 135' ' ' VAL . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 1.03 109.551 -176.89 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.537 HD12 HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 3.25 108.416 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 7.3200000000000003 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 2.52 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.5899999999999999 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.0700000000000003 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.0299999999999998 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 2.6600000000000001 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.7200000000000002 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' CE1' ' A' ' 53' ' ' TYR . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 1.29 108.408 165.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 0.90000000000000002 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.73999999999999999 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 2.1200000000000001 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 0.76000000000000001 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.5099999999999998 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 2.4199999999999999 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 6.0800000000000001 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 3.3999999999999999 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 3.52 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.0999999999999996 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.1600000000000001 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 3.3199999999999998 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 3.1000000000000001 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 2.2999999999999998 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 1.52 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.26 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 1.26 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 1.1000000000000001 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 1.0600000000000001 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 3.5800000000000001 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 2.8700000000000001 115.616 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.0099999999999998 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.4100000000000001 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 2.7999999999999998 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.29 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 2.9700000000000002 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.0099999999999998 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 3.3799999999999999 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 2.6600000000000001 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 1.9099999999999999 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.2999999999999998 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.0 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 1.8600000000000001 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 5.21 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 1.6799999999999999 111.758 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 1.8700000000000001 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 3.4399999999999999 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 4.2199999999999998 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.78000000000000003 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.2599999999999998 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 0.94999999999999996 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 2.1699999999999999 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.1499999999999999 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.4300000000000002 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.3900000000000001 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.3099999999999996 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 1.3400000000000001 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 0.93999999999999995 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.3300000000000001 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 0.89000000000000001 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 1.9299999999999999 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 2.27 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.1399999999999999 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 1.3300000000000001 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 3.3500000000000001 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 1.1599999999999999 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 5.2400000000000002 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.3500000000000001 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.05 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 3.9300000000000002 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 2.0899999999999999 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 4.4800000000000004 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 1.49 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 4.3499999999999996 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 1.8200000000000001 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.3700000000000001 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.4100000000000001 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 2.6400000000000001 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.1699999999999999 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.4399999999999999 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 3.21 111.015 177.854 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 1.5600000000000001 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.1799999999999999 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 1.2 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.0300000000000002 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 8.8399999999999999 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 4.3799999999999999 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.411 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.2999999999999998 113.134 -176.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.0700000000000003 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.411 ' NZ ' ' OD1' ' A' ' 102' ' ' ASP . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 4.6699999999999999 109.254 -176.788 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 7.1299999999999999 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 6.8600000000000003 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 3.23 110.579 -176.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 1.3600000000000001 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 2.1899999999999999 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.2400000000000002 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.6200000000000001 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 0.92000000000000004 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 1.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 7.54 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.1899999999999999 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.5 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.27 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.6099999999999999 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 4.1699999999999999 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.85999999999999999 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 0.95999999999999996 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.429 ' OH ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 2.27 111.042 164.037 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 2.0299999999999998 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 135' ' ' VAL . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 1.5700000000000001 109.426 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 2.29 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 5.4900000000000002 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 3.6499999999999999 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.0299999999999998 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 3.7999999999999998 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 1.25 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 3.2400000000000002 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.8900000000000001 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 154' ' ' ALA . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 1.1000000000000001 104.563 162.3 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 0.90000000000000002 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.81999999999999995 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 2.2400000000000002 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 0.82999999999999996 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.9300000000000002 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 2.5499999999999998 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 4.2800000000000002 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 145' ' ' ASN . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 3.7400000000000002 108.054 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 2.75 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.666 ' H ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.6600000000000001 109.156 174.618 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 1.9299999999999999 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 2.3199999999999998 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 5.2699999999999996 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 1.8999999999999999 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 1.46 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.83999999999999997 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 1.1399999999999999 108.25 -173.325 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 0.98999999999999999 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 0.84999999999999998 111.847 175.23 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.2000000000000002 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2000000000000002 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 2.7799999999999998 109.975 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.9199999999999999 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.2599999999999998 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 2.8199999999999998 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.0099999999999998 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 3.9700000000000002 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.3999999999999999 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 3.3599999999999999 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 2.3999999999999999 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 1.9199999999999999 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.2199999999999998 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.0099999999999998 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 1.54 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.0599999999999996 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 1.4199999999999999 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 1.5800000000000001 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 3.0800000000000001 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 7.5800000000000001 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.68000000000000005 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 2.3700000000000001 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.1100000000000001 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 2.1899999999999999 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.89000000000000001 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 1.74 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.4900000000000002 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.2999999999999998 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 1.4199999999999999 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.0600000000000001 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 0.77000000000000002 113.559 -169.157 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 3.98 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 1.3100000000000001 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 2.4399999999999999 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 2.2000000000000002 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 1.1899999999999999 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 1.4199999999999999 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.3700000000000001 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 2.3700000000000001 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 1.6399999999999999 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 1.0800000000000001 115.032 169.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 6.5300000000000002 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.7200000000000002 111.602 -170.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 1.3200000000000001 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.0800000000000001 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 3.8999999999999999 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.689 HG23 ' HA3' ' A' ' 65' ' ' GLY . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 1.9099999999999999 107.983 -174.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.3799999999999999 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 4.1200000000000001 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 2.73 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 4.96 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 1.71 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 1.8999999999999999 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.3799999999999999 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 3.1499999999999999 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 1.4299999999999999 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.7999999999999998 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 1.71 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 1.1699999999999999 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 1.96 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 1.6200000000000001 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.5099999999999998 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 1.3500000000000001 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 9.2300000000000004 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 3.8999999999999999 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.5199999999999996 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.6499999999999999 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.0199999999999996 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 6.71 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 6.3899999999999997 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 3.7200000000000002 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 1.4299999999999999 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 2.6699999999999999 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 2.21 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.85999999999999999 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 1.8700000000000001 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 1.22 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 2.4100000000000001 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 5.71 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 3.52 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.5899999999999999 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 2.4100000000000001 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.582 ' CD ' HG21 ' A' ' 141' ' ' VAL . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 5.7800000000000002 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.29 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.1899999999999999 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 4.2199999999999998 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 2.3500000000000001 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -175.756 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.0600000000000001 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 2.79 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 4.2699999999999996 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 2.6299999999999999 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.8199999999999998 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 3.98 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.4299999999999999 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 2.5699999999999998 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.5699999999999998 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 154' ' ' ALA . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 1.28 106.77 164.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 0.90000000000000002 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.90000000000000002 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 1.5700000000000001 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 1.04 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.1799999999999997 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.869 HG22 ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 4.2999999999999998 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 3.8399999999999999 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 3.4199999999999999 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 1.9299999999999999 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.3399999999999999 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 141' ' ' VAL . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.5700000000000001 108.263 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 1.6100000000000001 107.84 174.171 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.5699999999999998 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 2.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 1.48 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 0.94999999999999996 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.605 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 1.47 107.056 178.044 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 1.3300000000000001 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 1.2 108.838 175.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 5.3300000000000001 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.1699999999999999 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 2.7999999999999998 108.154 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.6900000000000004 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.486 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.3099999999999996 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 3.1499999999999999 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 1.8899999999999999 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 3.6400000000000001 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.7999999999999998 109.837 -177.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 4.1100000000000003 110.913 -178.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 2.7999999999999998 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.0099999999999998 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.3099999999999996 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 2.75 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 1.6200000000000001 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 5.0700000000000003 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.699 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 2.5499999999999998 108.027 168.303 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.4300000000000002 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.1600000000000001 114.463 -172.429 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 4.4299999999999997 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.82999999999999996 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.25 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 0.96999999999999997 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 2.3900000000000001 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.96999999999999997 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.2400000000000002 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.5800000000000001 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.5599999999999996 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 1.3700000000000001 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.0700000000000001 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 0.88 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 3.52 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 1.0700000000000001 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 3.3399999999999999 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 2.9399999999999999 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 0.97999999999999998 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 1.22 106.284 175.657 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.9199999999999999 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 3.1899999999999999 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 1.3 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 1.1499999999999999 112.779 173.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 109' ' ' ILE . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 5.0499999999999998 115.087 178.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 109' ' ' ILE . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 1.3500000000000001 114.131 167.251 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.9900000000000002 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 0.93000000000000005 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 3.9300000000000002 111.432 -176.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 4.75 107.097 177.478 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.3399999999999999 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 4.2400000000000002 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 3.23 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.04 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 1.79 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 1.8999999999999999 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.1299999999999999 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 2.4399999999999999 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.4900000000000002 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 1.0900000000000001 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.9700000000000002 107.486 167.306 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 1.6899999999999999 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 1.1599999999999999 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 1.5 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1000000000000001 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 1.71 108.728 171.004 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 3.7799999999999998 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.6600000000000001 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.0299999999999998 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 5.3399999999999999 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 6.5800000000000001 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 5.5499999999999998 110.896 -172.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 2.6299999999999999 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 1.1599999999999999 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 76' ' ' LYS . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 2.48 107.223 158.35 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 1.8400000000000001 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.73999999999999999 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 1.45 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 0.89000000000000001 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 2.3300000000000001 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 7.2599999999999998 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.29 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 1.54 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.4500000000000002 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 3.5600000000000001 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.55000000000000004 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 0.79000000000000004 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 2.8700000000000001 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 1.8799999999999999 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 0.85999999999999999 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.0099999999999998 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 127' ' ' ILE . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 2.6699999999999999 109.517 157.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 4.6799999999999997 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 3.2799999999999998 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.8199999999999998 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 5.2800000000000002 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1000000000000001 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 2.5899999999999999 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.8200000000000003 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 154' ' ' ALA . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.0299999999999998 108.02 170.154 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 1.45 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.93000000000000005 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 1.6899999999999999 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 0.70999999999999996 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.4399999999999999 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 2.1499999999999999 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 3.4199999999999999 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 2.6200000000000001 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.1600000000000001 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.3999999999999999 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 0.96999999999999997 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 1.52 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.4300000000000002 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 2.5 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 1.3400000000000001 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 0.88 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.0900000000000001 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 0.93000000000000005 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 1.27 107.172 161.417 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 4.8799999999999999 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.6900000000000004 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 2.71 111.942 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.6600000000000001 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 4.46 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.0499999999999998 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 3.6000000000000001 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 2.9100000000000001 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.6400000000000001 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 3.7799999999999998 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 4.3499999999999996 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 1.98 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.7999999999999998 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.1899999999999999 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 1.6200000000000001 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 6.3899999999999997 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 1.6200000000000001 111.084 168.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 1.74 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 135' ' ' VAL . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 4.2999999999999998 109.223 167.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 6.3499999999999996 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 0.95999999999999996 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.1400000000000001 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 0.93000000000000005 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 2.2599999999999998 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.0800000000000001 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.6600000000000001 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.9500000000000002 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.1399999999999999 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.1299999999999999 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 0.70999999999999996 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 3.8399999999999999 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 2.2400000000000002 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 2.1400000000000001 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.21 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 1.3799999999999999 108.533 177.035 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.6499999999999999 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 2.5800000000000001 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.26 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 1.28 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 5.4900000000000002 114.415 178.6 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.8300000000000001 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.29 111.165 -169.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.82999999999999996 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 3.3999999999999999 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.0699999999999998 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.9100000000000001 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 3.6400000000000001 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 1.47 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 3.2999999999999998 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.4299999999999999 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.49 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.2699999999999996 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.0 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 1.0700000000000001 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.0099999999999998 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 1.77 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 0.93000000000000005 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.1200000000000001 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.1399999999999999 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.1600000000000001 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 1.5800000000000001 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 8.2300000000000004 114.378 176.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 3.9100000000000001 112.989 -166.376 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.6100000000000003 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.27 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 4.9000000000000004 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 5.9299999999999997 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 5.7999999999999998 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 2.4300000000000002 110.996 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 1.3799999999999999 110.403 -177.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 78' ' ' GLY . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 2.1499999999999999 108.883 159.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 1.6799999999999999 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.84999999999999998 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.0600000000000001 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 141' ' ' VAL . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 0.81000000000000005 112.353 -160.026 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 2.4900000000000002 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.4500000000000002 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 3.6800000000000002 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.4399999999999999 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 1.52 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 3.9300000000000002 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.78000000000000003 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.03 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 2.3199999999999998 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 1.5700000000000001 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 1.26 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.0600000000000001 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 2.4900000000000002 108.35 175.719 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 7.0099999999999998 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 2.8500000000000001 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.5299999999999998 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.1000000000000001 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 1.6699999999999999 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 2.2999999999999998 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.7200000000000002 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 127' ' ' ILE . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 1.1200000000000001 107.81 167.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 1.47 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.01 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 2.9500000000000002 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 113' ' ' VAL . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 2.5499999999999998 104.935 168.719 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 4.7699999999999996 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 2.77 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 2.52 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.3600000000000003 107.484 170.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.53 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 1.6399999999999999 108.73 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 2.7400000000000002 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 2.3500000000000001 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 1.4099999999999999 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.2 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.1299999999999999 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 1.4399999999999999 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 1.01 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.0899999999999999 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.3200000000000003 111.988 177.335 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 106.185 -1.783 . . . . 53.799999999999997 106.185 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.83 95.56 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.214 -1.773 . . . . 48.909999999999997 106.214 155.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -159.09 118.25 2.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.426 -0.953 . . . . 46.060000000000002 108.426 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -163.63 156.02 17.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.329 -0.989 . . . . 40.979999999999997 108.329 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -173.07 153.63 2.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.745 2.418 . . . . 36.710000000000001 105.854 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.43 136.09 5.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.138 -1.06 . . . . 32.380000000000003 108.138 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.7 mt -148.93 153.15 37.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.394 -1.706 . . . . 28.41 106.394 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -168.43 166.61 12.22 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.48 -1.304 . . . . 24.5 107.48 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.41 148.65 1.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.157 1.783 . . . . 20.670000000000002 107.612 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -169.56 156.75 6.78 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.533 -1.284 . . . . 16.600000000000001 107.533 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.17 159.74 15.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.27 1.428 . . . . 15.44 108.206 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -176.18 173.61 2.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.214 1.806 . . . . 10.449999999999999 106.403 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.41 73.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.767 1.627 . . . . 7.7800000000000002 111.359 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -166.62 -43.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.745 2.418 . . . . 14.57 107.093 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.11 100.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.482 -0.562 . . . . 15.51 109.482 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -41.18 138.18 1.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.447 1.499 . . . . 17.010000000000002 111.783 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t0 69.32 -53.92 0.59 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.265 2.226 . . . . 13.17 113.153 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -49.31 -36.52 21.3 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.611 -0.68 . . . . 11.92 109.943 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -34.2 -42.2 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.012 2.125 . . . . 9.9000000000000004 113.837 167.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -58.93 -46.35 88.18 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.309 -0.869 . . . . 11.17 109.883 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.8 m -61.03 -52.2 65.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.023 -1.103 . . . . 10.529999999999999 108.023 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -40.98 -83.9 0.01 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.881 1.705 . . . . 7.6399999999999997 114.596 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -72.11 -98.36 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.502 1.151 . . . . 8.7799999999999994 112.806 -164.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 72.5 mtm -137.19 -87.89 0.28 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 119.382 -2.074 . . . . 12.73 109.133 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t 69.27 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 125.314 1.634 . . . . 14.23 110.496 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 179.21 108.5 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.045 1.338 . . . . 15.98 108.122 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -166.57 153.77 9.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.326 -1.361 . . . . 16.57 107.326 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -71.34 -63.2 1.16 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.487 -0.931 . . . . 24.239999999999998 108.487 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 52.97 -144.24 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.058 0.943 . . . . 19.190000000000001 110.586 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -153.34 -70.31 0.14 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.485 1.914 . . . . 21.440000000000001 108.59 -169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -170.61 22.03 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.477 1.111 . . . . 23.039999999999999 111.413 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.0 mt -125.25 112.3 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.951 -1.87 . . . . 14.279999999999999 105.951 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.82 174.27 26.72 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 106.815 -2.514 . . . . 10.99 106.815 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.09 -64.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.925 1.69 . . . . 8.5800000000000001 112.027 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 mt 49.03 41.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.98 1.312 . . . . 10.52 111.614 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.57 -61.55 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.605 1.162 . . . . 3.9199999999999999 109.978 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.52 -5.0 54.6 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 2.5699999999999998 113.064 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.9299999999999997 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 5.7599999999999998 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 3.9199999999999999 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.0600000000000001 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 2.9100000000000001 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 3.48 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HG3' ' A' ' 76' ' ' LYS . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 3.6099999999999999 106.616 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.04 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.7999999999999998 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.0099999999999998 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 4.6699999999999999 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 1.79 111.905 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 156' ' ' GLN . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 1.3700000000000001 112.155 -161.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 3.5800000000000001 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 4.6200000000000001 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.76000000000000001 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.0099999999999998 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 0.89000000000000001 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 2.8300000000000001 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.78 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.6499999999999999 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.9900000000000002 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 1.27 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.1299999999999999 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 0.76000000000000001 112.735 -173.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 3.6699999999999999 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 0.88 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 1.8999999999999999 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 2.1099999999999999 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 0.89000000000000001 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 1.5600000000000001 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.3599999999999999 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 3.5600000000000001 110.683 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 1.6200000000000001 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.3100000000000001 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 71' ' ' ILE . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 4.4100000000000001 113.247 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.0 108.726 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.6599999999999999 112.638 -173.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.8799999999999999 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89000000000000001 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 4.0300000000000002 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.573 HG23 ' HA3' ' A' ' 65' ' ' GLY . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 1.8200000000000001 107.072 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7000000000000002 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' H ' HD12 ' A' ' 85' ' ' LEU . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 3.79 112.691 -170.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 84' ' ' HIS . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 1.53 111.028 -174.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.2999999999999998 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.3200000000000001 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.4299999999999999 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 1.99 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.5800000000000001 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 115' ' ' TYR . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.0700000000000001 106.721 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.8999999999999999 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 2.9900000000000002 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 1.1200000000000001 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 1.27 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 1.1299999999999999 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 1.6499999999999999 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 7.2000000000000002 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 5.4100000000000001 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.4100000000000001 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 3.4100000000000001 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 6.8300000000000001 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 7.3200000000000003 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 9.1699999999999999 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 4.4800000000000004 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 1.95 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 2.54 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 1.8400000000000001 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 1.4299999999999999 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 0.95999999999999996 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 2.0699999999999998 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 92' ' ' VAL . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 6.5499999999999998 107.453 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 3.71 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 2.6099999999999999 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 1.51 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.2400000000000002 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.2599999999999998 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.84999999999999998 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 0.84999999999999998 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 5.3399999999999999 108.629 172.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 2.5299999999999998 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.3 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.1499999999999999 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 2.9700000000000002 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 5.1500000000000004 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.2599999999999998 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.7599999999999998 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 4.6299999999999999 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 1.8300000000000001 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 3.8199999999999998 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.4100000000000001 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 1.4199999999999999 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 1.03 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 0.96999999999999997 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 1.98 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 123' ' ' TYR . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.1000000000000001 110.032 158.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.4100000000000001 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 2.5600000000000001 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 4.3899999999999997 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.0899999999999999 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 2.77 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.1900000000000004 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.3200000000000001 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 1.8899999999999999 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 2.7000000000000002 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 2.2599999999999998 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 1.48 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.52 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 1.4199999999999999 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 1.71 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 1.24 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.1699999999999999 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.2699999999999996 105.071 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 107.272 -1.381 . . . . 60.170000000000002 107.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.2 98.61 0.33 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.871 -1.159 . . . . 55.700000000000003 107.871 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -156.2 126.86 6.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.892 -1.151 . . . . 49.490000000000002 107.892 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.47 170.19 22.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.526 1.53 . . . . 45.369999999999997 107.295 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -166.5 178.54 6.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.026 -1.472 . . . . 39.719999999999999 107.026 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.49 38.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.57 -1.27 . . . . 34.979999999999997 107.57 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.7 tp -147.41 137.99 23.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.264 -2.125 . . . . 30.170000000000002 105.264 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.6 t -85.24 140.61 30.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.651 -0.87 . . . . 25.82 108.651 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.51 174.17 11.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.839 0.456 . . . . 21.719999999999999 110.53 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -170.73 161.58 7.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.607 -1.627 . . . . 19.329999999999998 106.607 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.3 176.66 0.23 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.613 0.765 . . . . 15.529999999999999 109.392 -169.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 p 56.59 -167.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.896 0.879 . . . . 11.59 109.945 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.33 70.57 0.41 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.793 1.637 . . . . 8.0 112.198 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -67.25 176.8 2.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.776 1.63 . . . . 13.6 111.295 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -130.6 153.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.474 -1.306 . . . . 14.119999999999999 107.474 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.0 100.08 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.822 1.649 . . . . 17.59 110.281 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 62.77 -68.84 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.84 2.056 . . . . 15.4 111.703 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -42.74 -34.61 0.95 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.467 1.907 . . . . 12.74 111.876 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -30.18 -56.21 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.702 2.001 . . . . 9.5299999999999994 111.39 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -55.74 -45.43 78.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.749 0.42 . . . . 11.52 110.988 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.5 m -64.98 -58.51 5.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.917 -0.771 . . . . 10.119999999999999 108.917 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.0 36.99 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.304 0.954 . . . . 7.1399999999999997 112.989 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 32.0 tttp -53.47 -40.86 65.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.287 1.435 . . . . 9.3399999999999999 111.979 -170.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptp 169.97 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.502 1.921 . . . . 10.52 112.715 165.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t 68.9 -52.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.923 1.689 . . . . 13.24 114.013 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.61 -174.5 4.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.222 0.919 . . . . 13.94 110.194 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -122.21 168.54 11.89 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.225 1.41 . . . . 15.68 107.367 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 75.38 -60.92 0.49 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.49 1.916 . . . . 20.109999999999999 108.598 -167.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -118.88 158.29 25.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.006 -1.85 . . . . 19.539999999999999 106.006 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.88 171.14 18.21 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.406 -0.59 . . . . 17.739999999999998 109.406 -171.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.45 74.23 2.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.511 1.124 . . . . 14.880000000000001 110.671 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.78 155.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.238 -1.347 . . . . 13.19 113.229 168.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.2 56.97 10.87 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.829 1.204 . . . . 10.18 111.347 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -171.98 -175.05 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.937 -1.875 . . . . 8.1199999999999992 105.937 -172.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt 68.72 158.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.767 1.627 . . . . 7.3499999999999996 110.365 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.19 -84.03 0.18 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.929 -1.107 . . . . 4.3700000000000001 110.226 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.47 49.31 3.67 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 2.3399999999999999 112.325 -162.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.6399999999999997 111.315 -174.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 4.9400000000000004 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 2.4900000000000002 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.1899999999999999 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 3.6299999999999999 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.4100000000000001 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 3.6200000000000001 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 2.96 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.1099999999999999 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.8600000000000003 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.1600000000000001 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 1.54 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 5.6100000000000003 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 1.49 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 1.99 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 4.3799999999999999 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 6.9500000000000002 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.70999999999999996 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 2.4399999999999999 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.1499999999999999 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 2.5099999999999998 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.1499999999999999 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.2400000000000002 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 1.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.3400000000000001 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' HG23 ' A' ' 82' ' ' ILE . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.25 113.211 -175.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 6.5700000000000003 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 0.93999999999999995 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.1699999999999999 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 2.5899999999999999 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 1.1599999999999999 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 2.0 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 3.1600000000000001 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 2.0600000000000001 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 1.23 109.915 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 3.6899999999999999 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 2.3999999999999999 107.156 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.27 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.1499999999999999 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.93999999999999995 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.0499999999999998 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 82' ' ' ILE . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 2.4100000000000001 106.571 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.6600000000000001 104.568 157.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 5.8399999999999999 104.986 31.14 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 1.6899999999999999 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 4.4900000000000002 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 1.7 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 1.79 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.7799999999999998 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 2.1000000000000001 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.8200000000000001 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 1.0800000000000001 109.572 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.7599999999999998 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 2.1400000000000001 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.1599999999999999 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 1.73 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.1299999999999999 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.0099999999999998 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.4500000000000002 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.0199999999999996 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 4.8300000000000001 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.5499999999999998 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.8999999999999999 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CB ' ' HZ3' ' A' ' 104' ' ' LYS . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 4.7300000000000004 111.671 -158.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 7.9299999999999997 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 5.6200000000000001 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 2.3999999999999999 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 1.28 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 2.2200000000000002 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 1.6699999999999999 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.76000000000000001 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.1899999999999999 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 1.0900000000000001 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 3.1200000000000001 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.639 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.1500000000000004 107.562 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 2.96 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.1600000000000001 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 1.6100000000000001 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.6099999999999999 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 3.8900000000000001 111.123 140.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.51000000000000001 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 0.97999999999999998 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 2.2799999999999998 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 2.21 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 152' ' ' LEU . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 0.85999999999999999 108.426 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.3799999999999999 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 2.79 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 6.8300000000000001 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.8100000000000001 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.7300000000000004 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 4.25 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 1.79 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 3.6299999999999999 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.5600000000000001 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 1.8 107.301 163.06 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 1.0900000000000001 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.0900000000000001 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 1.79 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 0.93999999999999995 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.4399999999999999 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 2.1899999999999999 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 3.7999999999999998 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 2.1099999999999999 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 2.1600000000000001 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.22 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 1.5700000000000001 109.69 -174.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 2.98 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 2.27 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 1.1699999999999999 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 0.93000000000000005 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 125' ' ' LEU . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 2.0299999999999998 112.403 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 1.53 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 1.1200000000000001 111.317 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 3.5699999999999998 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.9 -0.407 . . . . 53.240000000000002 109.9 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.03 162.72 13.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.516 -1.661 . . . . 45.43 106.516 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -168.87 179.79 4.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.029 -1.471 . . . . 41.280000000000001 107.029 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.95 169.33 8.23 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 127.16 2.184 . . . . 37.340000000000003 107.281 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -165.17 170.41 14.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.456 -1.313 . . . . 33.25 107.456 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.35 162.34 33.4 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.248 -1.39 . . . . 29.370000000000001 107.248 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -157.17 146.58 20.29 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.764 -2.31 . . . . 25.420000000000002 104.764 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -159.73 170.76 20.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.947 -1.131 . . . . 21.960000000000001 107.947 172.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.86 154.57 1.53 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.953 1.701 . . . . 18.399999999999999 108.128 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -155.45 138.9 15.86 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.92 -1.141 . . . . 14.85 107.92 163.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -165.65 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.004 1.721 . . . . 13.07 108.405 -167.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 t -142.18 170.86 14.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.823 0.738 . . . . 9.9199999999999999 109.934 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -173.97 48.71 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.494 1.518 . . . . 6.2300000000000004 107.875 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -134.54 100.12 4.55 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.446 0.698 . . . . 11.699999999999999 111.108 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.1 mm -94.86 -54.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.781 1.233 . . . . 15.73 109.411 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.82 -104.28 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.642 -1.244 . . . . 20.629999999999999 107.642 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -45.81 -42.69 12.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.546 1.138 . . . . 18.25 110.325 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.7 -29.15 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.942 2.097 . . . . 13.210000000000001 113.999 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -49.24 -45.79 45.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.413 1.085 . . . . 10.779999999999999 110.958 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.44 -76.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.78 -0.822 . . . . 15.01 108.78 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -68.35 -49.07 62.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.634 0.605 . . . . 13.99 112.634 -166.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.14 -60.03 6.81 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.86 -0.896 . . . . 8.3800000000000008 110.86 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -70.41 -41.83 72.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 118.012 -0.994 . . . . 10.31 110.993 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.8 ptt? 38.31 66.41 0.5 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.053 1.341 . . . . 12.15 111.659 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t 68.01 -65.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 126.0 1.72 . . . . 12.289999999999999 109.581 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.16 96.21 1.19 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.349 0.66 . . . . 12.85 110.925 172.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 80.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.261 1.025 . . . . 18.41 109.212 168.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -59.09 107.55 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.871 1.269 . . . . 20.149999999999999 109.959 169.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.06 -76.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.237 -1.394 . . . . 20.82 107.237 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -140.9 -169.38 2.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 103.77 -2.678 . . . . 22.640000000000001 103.77 166.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -78.41 58.24 2.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.726 1.148 . . . . 17.66 109.876 167.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.7 mm -144.09 160.25 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 106.34 -1.726 . . . . 15.35 106.34 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.06 -127.95 2.93 Favored Glycine 0 N--CA 1.449 -0.452 1 N-CA-C 103.015 -4.034 . . . . 10.369999999999999 103.015 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 76.46 -56.0 0.57 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.678 1.991 . . . . 7.9100000000000001 111.825 156.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.2 mt -53.34 -67.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 126.161 1.785 . . . . 9.7200000000000006 109.722 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 164.5 168.67 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.715 2.406 . . . . 4.5300000000000002 106.201 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.79 -54.65 0.49 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 2.4399999999999999 108.499 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.5099999999999998 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 2.5600000000000001 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 1.9199999999999999 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 2.6099999999999999 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.7400000000000002 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 4.5300000000000002 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7000000000000002 115.112 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 4.0999999999999996 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.0499999999999998 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 5.4299999999999997 111.365 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 1.23 112.692 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 1.3799999999999999 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.665 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 2.98 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 4.9500000000000002 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.0800000000000001 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 2.8500000000000001 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.0600000000000001 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 2.6400000000000001 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.3599999999999999 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.9500000000000002 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.1200000000000001 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 1.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.9099999999999999 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.1799999999999999 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.2400000000000002 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 80' ' ' GLY . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 1.73 105.686 169.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.52 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 2.3500000000000001 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 1.3999999999999999 109.011 168.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.721 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 1.55 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.3799999999999999 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 3.1699999999999999 113.126 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.1600000000000001 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 1.46 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 5.2999999999999998 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.75 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.721 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.1899999999999999 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.0099999999999998 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.0 110.273 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 3.9700000000000002 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 1.97 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.2999999999999998 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 3.52 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 1.8300000000000001 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 4.96 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 1.8100000000000001 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.54 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.0499999999999998 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 2.1000000000000001 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 0.90000000000000002 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.1400000000000001 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 1.6699999999999999 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.1799999999999999 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 1.6000000000000001 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.04 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.4399999999999999 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 1.51 108.152 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 8.3300000000000001 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 3.8599999999999999 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.0800000000000001 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.8399999999999999 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 4.7000000000000002 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 6.8200000000000003 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.2400000000000002 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.443 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 3.79 105.792 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 1.48 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 2.4100000000000001 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 1.8899999999999999 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.73999999999999999 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 2.1200000000000001 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 0.77000000000000002 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 2.04 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 4.5700000000000003 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 2.75 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 2.3300000000000001 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 1.47 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.1099999999999999 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.0800000000000001 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.5 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 0.93999999999999995 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 3.7200000000000002 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 1.8999999999999999 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 126' ' ' GLY . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 0.96999999999999997 112.359 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.467 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 2.1299999999999999 106.222 154.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 5.7699999999999996 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 3.5800000000000001 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.3700000000000001 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 3.5899999999999999 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 1.4299999999999999 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 3.3399999999999999 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.6400000000000001 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 125' ' ' LEU . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.3999999999999999 107.391 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 1.3 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 1.7 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 0.69999999999999996 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 2.0499999999999998 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 3.5600000000000001 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.3399999999999999 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 2.98 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.8999999999999999 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 0.96999999999999997 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 2.3199999999999998 108.319 -167.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 3.5800000000000001 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 2.5800000000000001 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 1.1499999999999999 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 0.82999999999999996 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.1799999999999999 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 0.97999999999999998 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 0.97999999999999998 109.097 173.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 5.3899999999999997 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.3099999999999996 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.444 -0.947 . . . . 67.400000000000006 108.444 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -172.02 -171.83 0.91 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.432 -1.692 . . . . 61.149999999999999 106.432 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -147.83 -173.64 4.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.182 -1.784 . . . . 57.060000000000002 106.182 159.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.06 164.79 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.073 1.749 . . . . 52.240000000000002 108.17 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -154.86 -170.84 3.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.577 -1.268 . . . . 47.240000000000002 107.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.9 146.05 39.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.887 1.275 . . . . 42.5 109.547 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 153.27 35.64 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.311 -0.626 . . . . 37.630000000000003 109.311 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -70.79 158.72 35.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.861 0.362 . . . . 34.210000000000001 110.097 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 166.55 22.41 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.515 -0.921 . . . . 29.120000000000001 108.515 160.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.23 174.19 10.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.055 1.342 . . . . 26.690000000000001 108.165 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -51.65 -60.69 2.87 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.64 0.776 . . . . 22.329999999999998 109.85 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m 69.2 158.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.009 1.324 . . . . 16.030000000000001 111.612 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -48.05 -56.93 6.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.843 2.057 . . . . 11.08 110.234 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.38 -179.01 5.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.5 -1.667 . . . . 14.109999999999999 106.5 165.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 149.94 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.171 -1.789 . . . . 19.77 106.171 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.6 88.32 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.975 1.31 . . . . 21.68 110.87 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.37 -62.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.495 1.918 . . . . 18.149999999999999 111.935 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.45 -41.07 1.34 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.318 1.847 . . . . 14.359999999999999 111.357 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -36.65 -56.29 0.83 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.232 1.413 . . . . 19.129999999999999 111.463 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -62.74 -43.92 97.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.493 0.717 . . . . 18.920000000000002 109.643 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.03 -44.6 94.52 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.227 0.211 . . . . 11.52 110.573 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.05 2.32 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.258 -0.737 . . . . 9.0399999999999991 111.258 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -70.65 -32.3 69.55 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.874 1.67 . . . . 16.350000000000001 112.924 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.371 0.0 OUTLIER 31.71 -124.48 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.339 1.855 . . . . 15.109999999999999 115.452 -170.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t 54.08 57.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.223 0.92 . . . . 19.469999999999999 109.419 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -174.48 72.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.773 -1.566 . . . . 20.100000000000001 106.773 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.0 tttp 67.58 169.31 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.086 -1.416 . . . . 25.129999999999999 108.367 -155.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -145.58 143.7 30.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.083 -2.562 . . . . 20.010000000000002 104.083 163.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -166.71 -64.41 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.892 -0.781 . . . . 22.440000000000001 108.892 -171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -73.21 178.32 4.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.451 0.7 . . . . 20.149999999999999 110.31 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.69 64.47 1.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.01 0.924 . . . . 20.920000000000002 110.656 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -84.26 146.36 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.281 1.432 . . . . 13.210000000000001 107.827 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.13 -154.64 5.31 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.767 -0.583 . . . . 11.73 111.744 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -89.41 -37.42 14.84 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 128.724 2.81 . . . . 12.01 110.135 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mt -28.54 133.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.828 2.851 . . . . 9.0199999999999996 114.137 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.35 -63.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.239 2.216 . . . . 4.25 107.095 161.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 62.12 3.76 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 2.46 110.511 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.0300000000000002 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 4.9299999999999997 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 2.7400000000000002 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.1699999999999999 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 2.9500000000000002 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.7999999999999998 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 5.1600000000000001 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 2.3300000000000001 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 1.8300000000000001 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.1099999999999999 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 1.8799999999999999 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.21 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 1.4099999999999999 109.578 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 1.6699999999999999 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 3.2599999999999998 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 4.9900000000000002 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.1200000000000001 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 2.2799999999999998 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.1100000000000001 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 2.5099999999999998 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.3300000000000001 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 1.95 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.5699999999999998 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.3900000000000001 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 1.49 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.4299999999999999 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.0600000000000001 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 3.71 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 1.3200000000000001 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.4300000000000002 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 2.0499999999999998 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.3 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.466 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 1.74 104.217 159.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.5099999999999998 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 3.6099999999999999 114.0 -171.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 1.4099999999999999 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 1.3200000000000001 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.1100000000000003 110.591 164.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.6499999999999999 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.2 112.343 -158.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.9700000000000002 108.933 -171.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.1699999999999999 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.1799999999999997 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 1.9199999999999999 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.5899999999999999 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 3.3500000000000001 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 1.5600000000000001 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 3.96 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 1.3700000000000001 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.6000000000000001 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.0800000000000001 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 2.0600000000000001 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.8799999999999999 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 1.1000000000000001 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.9299999999999999 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 1.9299999999999999 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 0.96999999999999997 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 1.97 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 1.3999999999999999 111.962 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.2599999999999998 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.78 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.0 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 4.2300000000000004 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.8300000000000001 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 2.9700000000000002 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 5.79 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 7.3300000000000001 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 6.0700000000000003 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 2.5600000000000001 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 1.1499999999999999 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 2.98 106.063 158.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 109' ' ' ILE . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 1.6499999999999999 109.667 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.03 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.51 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 0.77000000000000002 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 2.1499999999999999 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.0700000000000003 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.0699999999999998 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.5299999999999998 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 1.28 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.9100000000000001 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 3.4399999999999999 109.839 133.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.52000000000000002 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 0.72999999999999998 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.514 ' HE1' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 2.3999999999999999 112.197 174.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 1.8200000000000001 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 135' ' ' VAL . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 0.81000000000000005 107.791 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.1499999999999999 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 2.5699999999999998 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 5.1600000000000001 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 2.9300000000000002 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 2.7000000000000002 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 4.6200000000000001 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 1.8300000000000001 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 3.9300000000000002 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.1699999999999999 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.565 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 1.48 105.251 166.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 0.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 1.75 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 0.69999999999999996 111.291 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.0699999999999998 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 2.1800000000000002 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.2400000000000002 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 2.3300000000000001 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 2.0800000000000001 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.0099999999999998 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.21 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 2.6099999999999999 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.3700000000000001 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 2.1899999999999999 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 1.3500000000000001 106.618 162.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.75 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 1.8200000000000001 112.707 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 1.6799999999999999 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 1.1899999999999999 107.667 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 4.3200000000000003 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.1699999999999999 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.537 -0.268 . . . . 48.909999999999997 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -147.36 56.09 1.1 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.69 -1.596 . . . . 43.990000000000002 106.69 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -163.47 143.19 8.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.079 -1.452 . . . . 41.020000000000003 107.079 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.57 156.54 13.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.61 -1.256 . . . . 36.119999999999997 107.61 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.4 p -163.01 162.71 26.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.746 -1.575 . . . . 32.189999999999998 106.746 166.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.3 53.94 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.83 0.852 . . . . 28.109999999999999 109.219 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.52 130.6 35.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.575 -0.898 . . . . 25.260000000000002 108.575 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -159.5 178.37 9.96 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.249 -1.389 . . . . 21.780000000000001 107.249 170.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.41 178.79 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.083 1.353 . . . . 18.41 109.093 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -158.09 179.53 9.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.419 1.888 . . . . 14.869999999999999 106.395 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -153.61 155.73 36.64 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.725 0.693 . . . . 15.15 110.312 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 t 158.11 -152.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 131.177 3.791 . . . . 9.2200000000000006 104.166 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.21 24.05 0.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.571 1.948 . . . . 6.0 110.456 -170.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -116.65 104.28 11.22 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.185 -1.413 . . . . 11.91 107.185 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.305 40.5 pt 43.37 -136.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.522 1.929 . . . . 15.279999999999999 113.114 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 14.95 85.17 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.775 2.83 . . . . 16.5 116.19 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.99 -59.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.608 2.363 . . . . 12.109999999999999 112.063 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.1 m -48.56 -27.7 2.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.98 1.712 . . . . 10.0 112.759 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -29.57 -57.33 0.16 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.141 2.176 . . . . 11.640000000000001 111.916 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -70.26 -67.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.476 1.11 . . . . 12.699999999999999 109.121 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -71.05 -57.91 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.917 1.287 . . . . 10.25 112.718 -158.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 -52.61 10.92 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.486 1.041 . . . . 7.2599999999999998 111.473 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -8.89 56.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.184 1.393 . . . . 8.8000000000000007 111.819 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 55.89 77.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.88 1.672 . . . . 13.57 111.529 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.29 93.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.489 -0.93 . . . . 14.74 108.489 163.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 70.6 175.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.176 1.39 . . . . 18.02 111.274 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.57 45.07 24.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.176 0.99 . . . . 22.489999999999998 111.84 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -74.09 71.79 1.64 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.245 -0.65 . . . . 20.469999999999999 109.245 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -143.35 54.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.916 1.686 . . . . 26.379999999999999 107.926 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -141.69 -167.83 2.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.174 1.39 . . . . 21.73 108.185 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -72.0 68.36 0.68 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.915 0.886 . . . . 22.670000000000002 110.643 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -77.7 71.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.999 -1.482 . . . . 17.719999999999999 106.999 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.52 57.27 0.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.418 -2.273 . . . . 14.16 107.418 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -169.82 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.718 2.007 . . . . 11.68 107.103 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.96 139.96 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.085 0.954 . . . . 9.2400000000000002 109.396 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.04 170.87 7.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.553 1.141 . . . . 4.5 110.319 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.08 2.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 2.77 111.389 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.6699999999999999 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 4.4800000000000004 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.0800000000000001 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 3.6299999999999999 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 2.9399999999999999 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6000000000000001 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 3.75 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 4.3399999999999999 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 1.97 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.7599999999999998 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.1000000000000001 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 1.5900000000000001 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 6.3399999999999999 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 1.6399999999999999 111.147 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 1.71 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 135' ' ' VAL . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 4.3799999999999999 109.47 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 6.3399999999999999 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 0.93000000000000005 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.1800000000000002 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 0.95999999999999996 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 2.1499999999999999 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.97999999999999998 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.5099999999999998 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.5299999999999998 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.1799999999999999 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.1799999999999999 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 0.72999999999999998 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 3.8599999999999999 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 0.95999999999999996 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 2.2200000000000002 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 2.1400000000000001 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.1599999999999999 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 1.3600000000000001 108.302 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.6099999999999999 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 2.54 112.653 -172.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 1.3100000000000001 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 1.3400000000000001 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 5.5099999999999998 114.062 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.8799999999999999 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.3400000000000001 110.656 -169.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.5800000000000001 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HZ3' ' HB3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 3.3900000000000001 114.08 -164.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.0800000000000001 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.1400000000000001 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' H ' HD12 ' A' ' 85' ' ' LEU . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 3.5800000000000001 112.334 153.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 84' ' ' HIS . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 1.49 111.202 -166.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 3.29 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.51 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.49 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.2199999999999998 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.0 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.0600000000000001 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.8700000000000001 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 1.76 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 0.93000000000000005 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.1299999999999999 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.1200000000000001 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.1099999999999999 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 1.5600000000000001 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 8.1899999999999995 114.409 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 3.96 112.984 -166.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.6299999999999999 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.2599999999999998 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 4.9100000000000001 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 5.9299999999999997 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 5.8099999999999996 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 2.4100000000000001 110.733 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' ALA . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 1.4299999999999999 111.007 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.54 HD11 ' H ' ' A' ' 78' ' ' GLY . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 2.1699999999999999 108.928 162.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.02 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 0.83999999999999997 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 2.6000000000000001 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.2999999999999998 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 3.8799999999999999 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.4399999999999999 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 1.3600000000000001 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 3.29 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.65000000000000002 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 0.81999999999999995 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 2.3100000000000001 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 1.5 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 1.2 112.635 -170.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.0800000000000001 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 2.5 108.275 176.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 7.0700000000000003 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 2.8399999999999999 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.1200000000000001 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 1.71 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 2.3199999999999998 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.7200000000000002 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 127' ' ' ILE . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 1.1299999999999999 107.822 167.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.81999999999999995 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.94999999999999996 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 1.55 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 0.69999999999999996 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 2.9300000000000002 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 2.4100000000000001 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 4.9800000000000004 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 2.9900000000000002 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 2.79 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.8399999999999999 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.4299999999999999 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 1.5700000000000001 108.754 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.4900000000000002 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 2.6099999999999999 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 1.4199999999999999 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.02 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.1299999999999999 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 1.3100000000000001 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 135' ' ' VAL . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 1.01 110.972 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.1200000000000001 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.3399999999999999 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 106.31 -1.737 . . . . 67.549999999999997 106.31 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 59.19 175.37 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.577 1.173 . . . . 60.530000000000001 110.999 -170.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -170.07 158.94 7.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 127.147 2.179 . . . . 53.670000000000002 106.027 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -162.91 153.33 16.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.094 -1.447 . . . . 49.270000000000003 107.094 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 p -174.68 103.51 0.09 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.695 -1.224 . . . . 42.5 107.695 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.28 163.52 40.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.343 -0.984 . . . . 37.509999999999998 108.343 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp -150.55 -175.84 5.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.397 1.879 . . . . 32.539999999999999 107.516 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -134.49 135.74 42.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.529 -1.656 . . . . 28.27 106.529 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.89 -175.46 0.31 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 126.405 1.882 . . . . 23.289999999999999 106.291 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -65.71 80.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.726 -0.472 . . . . 18.550000000000001 109.726 167.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -72.43 65.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.662 0.785 . . . . 18.09 109.456 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -170.96 161.51 6.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.34 1.056 . . . . 11.300000000000001 109.362 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -62.23 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.765 2.426 . . . . 6.4800000000000004 109.763 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -58.95 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.991 -0.528 . . . . 12.449999999999999 109.671 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.0 mt 63.6 174.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.368 -0.975 . . . . 13.16 108.368 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -116.29 -52.76 2.57 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.084 -1.635 . . . . 19.43 110.739 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.43 -54.66 2.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.691 -0.855 . . . . 17.309999999999999 108.691 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -54.89 -8.34 0.25 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.101 1.76 . . . . 15.029999999999999 114.365 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.15 -47.61 45.52 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.38 1.445 . . . . 10.07 111.621 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -56.23 -41.66 76.05 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.049 1.34 . . . . 15.06 110.785 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -45.98 66.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.381 1.072 . . . . 13.039999999999999 109.558 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.52 -68.4 1.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.782 1.182 . . . . 8.7899999999999991 111.914 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -72.41 -91.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.761 0.791 . . . . 8.6199999999999992 111.034 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -168.37 153.69 6.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.192 0.997 . . . . 11.470000000000001 108.768 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -86.87 103.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.614 -1.63 . . . . 15.0 107.136 173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 65.91 -169.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.625 1.17 . . . . 14.77 111.519 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.55 78.11 1.46 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.73 -0.606 . . . . 17.899999999999999 109.751 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -145.57 105.74 4.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.789 0.435 . . . . 22.789999999999999 110.061 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -151.9 151.0 30.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.316 -0.624 . . . . 17.600000000000001 109.316 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -146.55 -55.32 0.26 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.315 1.046 . . . . 20.66 110.952 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 139.83 -37.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.661 2.784 . . . . 23.469999999999999 109.912 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -48.15 -43.88 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.509 1.124 . . . . 18.710000000000001 110.478 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.76 -158.06 8.51 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.657 -2.577 . . . . 12.529999999999999 106.657 172.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 64.41 41.45 5.74 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.31 1.444 . . . . 11.140000000000001 110.477 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 pt -143.07 154.91 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.021 1.329 . . . . 10.279999999999999 108.591 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 178.19 86.76 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.147 1.379 . . . . 3.6899999999999999 110.641 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . 78.79 -70.6 2.69 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 120.901 -1.125 . . . . 2.98 112.025 171.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.3499999999999996 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 4.75 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 2.75 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 1.8700000000000001 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.0299999999999998 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 4.6699999999999999 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 2.1699999999999999 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 1.6799999999999999 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.7599999999999998 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.1299999999999999 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 1.75 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 6.4800000000000004 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 1.26 110.242 161.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 1.4099999999999999 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 3.6000000000000001 108.447 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 5.5300000000000002 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 0.79000000000000004 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 2.9199999999999999 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.1699999999999999 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 2.5699999999999998 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.0800000000000001 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.1400000000000001 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.8799999999999999 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.6499999999999999 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.02 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.03 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 0.91000000000000003 114.957 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 5.7199999999999998 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 1.0700000000000001 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 1.8500000000000001 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 2.2999999999999998 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 1.3300000000000001 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 1.23 107.188 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.1400000000000001 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 2.6800000000000002 112.662 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 1.6299999999999999 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 1.01 113.799 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 6.5999999999999996 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.0800000000000001 107.16 177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.51 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 71' ' ' ILE . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.7200000000000002 107.569 -164.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.79000000000000004 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 4.1399999999999997 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.1099999999999999 107.041 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 4.79 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 90' ' ' LEU . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 1.78 110.089 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 3.7000000000000002 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 2.2400000000000002 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 2.7599999999999998 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.0499999999999998 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 2.4300000000000002 113.367 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.0800000000000001 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 2.48 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2000000000000002 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 2.96 109.613 -163.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.1499999999999999 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.5 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 1.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.9900000000000002 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 1.47 109.047 176.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 7.6600000000000001 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 3.8399999999999999 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.8200000000000003 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 4.96 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 6.3700000000000001 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 7.8099999999999996 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 6.4100000000000001 112.843 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 3.4399999999999999 111.229 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 1.6299999999999999 111.786 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 99' ' ' ILE . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 2.8500000000000001 109.737 153.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 2.6000000000000001 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.98999999999999999 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 1.51 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 1.1399999999999999 109.409 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 2.1200000000000001 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 7.4000000000000004 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.3700000000000001 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 2.3900000000000001 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 2.2599999999999998 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.0099999999999998 108.563 168.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 141' ' ' VAL . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.91000000000000003 111.13 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.21 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 2.7799999999999998 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 1.98 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 125' ' ' LEU . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 0.85999999999999999 107.659 -176.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 3.0099999999999998 109.771 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 4.8600000000000003 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 2.71 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.8599999999999999 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 3.3799999999999999 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 1.3899999999999999 112.92 171.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 2.4900000000000002 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.1099999999999999 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 154' ' ' ALA . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 1.54 105.993 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 1.0900000000000001 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.1599999999999999 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 1.76 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 1.3300000000000001 108.738 160.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.3700000000000001 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.668 HG13 ' HB1' ' A' ' 139' ' ' ALA . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 2.1400000000000001 111.492 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 3.9500000000000002 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 2.8999999999999999 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.0699999999999998 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.6299999999999999 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.0700000000000001 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 1.3899999999999999 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 3.8700000000000001 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 2.1800000000000002 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 139' ' ' ALA . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 2.3700000000000001 106.78 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.01 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 125' ' ' LEU . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 2.0299999999999998 111.909 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 1.55 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 1.1299999999999999 111.267 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 3.9500000000000002 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.9299999999999997 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.178 -1.786 . . . . 48.32 106.178 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 59.91 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.986 1.315 . . . . 42.240000000000002 108.325 -163.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -53.51 126.4 21.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.151 -0.685 . . . . 38.43 109.151 156.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -152.46 148.89 27.96 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.878 -1.527 . . . . 37.630000000000003 106.878 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t 70.35 142.68 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.881 1.272 . . . . 32.119999999999997 110.21 -166.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.34 -69.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.035 -1.468 . . . . 27.899999999999999 107.035 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.94 156.41 38.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.004 -1.48 . . . . 24.140000000000001 107.004 161.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -85.07 -168.41 2.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 23.82 110.633 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.78 -74.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.731 2.013 . . . . 22.530000000000001 113.489 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.5 t80 51.23 61.85 3.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.504 1.121 . . . . 20.77 112.173 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -79.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.026 -1.101 . . . . 20.079999999999998 108.026 168.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -173.19 179.12 2.28 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.585 1.154 . . . . 16.129999999999999 108.698 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 80.61 0.9 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.743 1.217 . . . . 10.73 107.825 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.86 -48.37 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.967 0.907 . . . . 16.899999999999999 110.699 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.6 mm -74.44 139.91 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 122.616 0.366 . . . . 18.260000000000002 110.064 -170.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -49.03 133.11 18.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.19 0.596 . . . . 20.129999999999999 110.545 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.55 -57.51 0.31 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.089 2.156 . . . . 15.35 112.74 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 t -57.93 -18.52 23.76 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.697 -0.627 . . . . 15.31 112.312 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -33.91 -58.51 0.44 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.457 1.103 . . . . 11.23 110.027 158.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -49.64 -56.28 10.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.5 1.52 . . . . 11.789999999999999 110.617 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 p -60.19 -45.73 92.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.418 -0.355 . . . . 13.380000000000001 110.463 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.99 26.55 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.671 -0.972 . . . . 10.49 110.671 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -70.62 -44.07 67.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 113.102 0.779 . . . . 9.2699999999999996 113.102 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptp -147.74 76.64 1.4 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.297 0.851 . . . . 10.609999999999999 113.297 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -48.88 -48.74 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.53 -0.759 . . . . 15.16 109.124 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.91 106.61 2.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.043 -0.725 . . . . 15.699999999999999 109.043 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.6 72.85 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.385 1.474 . . . . 16.07 111.497 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 141.12 57.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.098 0.959 . . . . 18.309999999999999 110.542 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -39.16 126.67 1.68 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.756 2.022 . . . . 19.670000000000002 111.531 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -62.21 174.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.804 0.811 . . . . 17.120000000000001 112.737 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -162.12 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.401 -0.818 . . . . 17.960000000000001 109.375 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.9 mm 62.89 64.76 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.671 1.188 . . . . 12.0 110.887 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.17 -62.6 0.05 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.862 -2.095 . . . . 9.3100000000000005 107.862 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.51 68.43 0.24 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.414 2.285 . . . . 10.67 109.255 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.15 -19.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.868 1.667 . . . . 7.4699999999999998 110.588 -172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.27 172.34 12.6 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.001 0.52 . . . . 4.0 111.22 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.88 91.57 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 2.8100000000000001 113.685 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.7999999999999998 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CE1' ' H ' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 5.2800000000000002 114.104 -174.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 106' ' ' HIS . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 3.0099999999999998 109.775 167.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.6400000000000001 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 3.7599999999999998 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.4500000000000002 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 3.8999999999999999 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.0 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 3.3199999999999998 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.529999999999999 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 2.8799999999999999 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.0800000000000001 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 5.5499999999999998 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 1.3899999999999999 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.29 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 3.5800000000000001 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 5.79 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 2.5699999999999998 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 0.96999999999999997 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 2.27 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 0.95999999999999996 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 3.3199999999999998 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.6699999999999999 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 1.1399999999999999 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.0900000000000001 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 0.84999999999999998 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.0099999999999998 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 1.24 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.1899999999999999 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 2.3500000000000001 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 1.1799999999999999 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HA3' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 2.0699999999999998 108.934 160.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.2199999999999998 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 2.2400000000000002 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 1.79 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 1.8700000000000001 114.884 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 4.1799999999999997 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.9500000000000002 107.025 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA3' HG22 ' A' ' 71' ' ' ILE . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 2.5600000000000001 110.661 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93000000000000005 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 5.3399999999999999 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.1000000000000001 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.1600000000000001 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 3.3900000000000001 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 90' ' ' LEU . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 2.2400000000000002 110.654 -150.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 3.8799999999999999 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 1.6799999999999999 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.4099999999999999 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.2999999999999998 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 2.0299999999999998 112.015 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 0.96999999999999997 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.2599999999999998 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 1.8700000000000001 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 1.0900000000000001 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 1.21 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 1.29 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.3200000000000003 109.75 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 1.45 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 6.2300000000000004 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 4.3700000000000001 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.5099999999999998 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.0499999999999998 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 5.5599999999999996 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.461 ' H ' ' CE1' ' A' ' 39' ' ' HIS . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 5.96 109.431 -162.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.62 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 8.75 108.804 -160.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 2.6499999999999999 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 1.3899999999999999 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.0099999999999998 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.1400000000000001 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.70999999999999996 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 2.5099999999999998 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 0.93000000000000005 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 2.6099999999999999 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 4.6500000000000004 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 2.75 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 1.3400000000000001 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.4300000000000002 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.1099999999999999 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.57999999999999996 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 0.82999999999999996 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 2.4399999999999999 110.59 174.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 1.53 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 1.1399999999999999 109.603 -170.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.511 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.6699999999999999 111.498 -166.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 2.6699999999999999 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 7.6600000000000001 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 3.25 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.8900000000000001 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 3.3100000000000001 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 1.3300000000000001 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 2.77 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.9100000000000001 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 1.8999999999999999 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.97999999999999998 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.90000000000000002 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 1.6699999999999999 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.0700000000000001 111.343 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.4500000000000002 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 1.8999999999999999 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 2.9300000000000002 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 2.5899999999999999 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 2.6800000000000002 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.8399999999999999 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.04 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 1.47 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 2.73 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.02 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 1.26 107.186 172.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.1200000000000001 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.1799999999999999 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 1.3200000000000001 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 1.48 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.1200000000000001 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.2400000000000002 109.828 175.86 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 104.94 -2.244 . . . . 60.18 104.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -55.73 -47.6 76.63 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.92 1.236 . . . . 53.270000000000003 108.488 162.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 m 51.78 -142.68 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.997 0.919 . . . . 50.520000000000003 111.004 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.32 170.54 17.43 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.815 -1.55 . . . . 45.719999999999999 106.815 177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -156.9 -52.79 0.08 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.436 0.695 . . . . 41.920000000000002 110.736 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.17 138.72 58.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.48 0.312 . . . . 37.579999999999998 110.809 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.11 153.3 45.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.795 1.638 . . . . 33.899999999999999 107.407 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.9 p -95.94 157.12 16.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.857 1.263 . . . . 29.289999999999999 110.867 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.09 166.16 33.92 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.983 -1.488 . . . . 25.140000000000001 106.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -150.85 147.56 27.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.238 0.615 . . . . 20.68 109.42 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -105.93 -140.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.984 1.714 . . . . 19.760000000000002 108.632 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p 71.69 177.68 0.26 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.008 1.723 . . . . 11.859999999999999 111.366 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.69 7.62 32.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.138 0.575 . . . . 10.02 110.458 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 60.84 -173.07 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.487 1.115 . . . . 16.010000000000002 111.049 -166.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.2 mt 70.62 92.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.421 1.488 . . . . 15.960000000000001 108.759 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.49 141.18 7.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.569 1.148 . . . . 19.609999999999999 111.178 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 65.51 -50.6 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.301 2.24 . . . . 14.15 112.918 -170.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -54.25 -29.48 46.95 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.221 -0.925 . . . . 13.1 111.609 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -38.49 -47.04 1.23 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.507 1.123 . . . . 13.02 112.808 165.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -58.78 -42.26 88.57 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.713 1.205 . . . . 12.48 111.402 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -53.63 15.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.393 0.677 . . . . 9.5999999999999996 109.801 174.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.67 -71.11 0.99 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.474 0.559 . . . . 6.3399999999999999 112.483 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -14.35 62.03 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.635 -0.921 . . . . 10.460000000000001 113.168 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.9 mmt 63.2 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 124.48 2.086 . . . . 10.82 115.304 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.7 t -145.19 -57.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 112.219 -2.264 . . . . 13.380000000000001 105.105 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.12 -151.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.558 1.143 . . . . 15.16 108.1 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 77.76 -59.37 0.45 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.514 1.926 . . . . 15.6 110.351 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 67.98 -7.61 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.369 1.468 . . . . 19.690000000000001 112.34 -156.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -70.81 115.44 9.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.541 -0.911 . . . . 17.989999999999998 108.541 162.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -88.11 -178.46 5.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.505 1.522 . . . . 16.68 106.922 162.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -79.12 44.69 0.58 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.78 -1.2 . . . . 15.85 110.724 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt 39.91 43.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.463 2.305 . . . . 14.81 114.302 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.02 47.37 0.02 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 121.412 -0.805 . . . . 10.449999999999999 113.218 166.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -147.03 20.58 1.25 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.689 1.196 . . . . 9.2300000000000004 110.638 -155.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm -75.66 78.92 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 108.633 -0.877 . . . . 9.3399999999999999 108.633 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.96 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.028 0.931 . . . . 3.6299999999999999 108.995 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.58 -97.53 2.31 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 2.0699999999999998 109.876 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7000000000000002 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.0599999999999996 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 2.9500000000000002 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 2.9500000000000002 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 4.5899999999999999 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.1099999999999999 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 3.8900000000000001 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 2.4700000000000002 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 73' ' ' PHE . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 2.4300000000000002 112.845 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.9500000000000002 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 2.5800000000000001 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 2.1200000000000001 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 5.8899999999999997 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 2.6000000000000001 109.059 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 1.5900000000000001 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' HD13 ' A' ' 127' ' ' ILE . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 3.1899999999999999 109.598 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 4.1500000000000004 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.25 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 2.6600000000000001 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 0.98999999999999999 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 2.48 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.0600000000000001 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.1600000000000001 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.5299999999999998 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.2300000000000004 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 1.47 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 0.95999999999999996 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.28 112.173 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 6.2599999999999998 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 152' ' ' LEU . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 1.1499999999999999 109.425 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 1.9399999999999999 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 2.27 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.05 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 1.3999999999999999 107.027 167.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.1699999999999999 106.944 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 71' ' ' ILE . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 2.2999999999999998 113.849 -169.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.0800000000000001 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 1.51 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 4.6200000000000001 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 1.6799999999999999 106.995 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.51 114.826 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.7400000000000002 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 0.97999999999999998 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 3.4900000000000002 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.704 HG23 ' HA3' ' A' ' 65' ' ' GLY . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 2.0 107.616 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.5700000000000003 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 5.1200000000000001 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 1.55 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 4.6699999999999999 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 1.9299999999999999 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 3.6000000000000001 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.0300000000000002 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 2.5499999999999998 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 1.8700000000000001 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 1.0700000000000001 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.3599999999999999 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 1.6200000000000001 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 1.21 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 1.3899999999999999 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.3600000000000001 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.5099999999999998 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.425 ' CG2' HG22 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 2.2599999999999998 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 6.9900000000000002 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 4.4400000000000004 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.8200000000000003 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.5800000000000001 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 4.7000000000000002 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 7.6799999999999997 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 5.1699999999999999 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 2.29 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.1000000000000001 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 3.52 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 1.8799999999999999 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.76000000000000001 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 1.97 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG21 HG12 ' A' ' 141' ' ' VAL . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 0.84999999999999998 109.227 170.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.0299999999999998 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 5.8600000000000003 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 5.8899999999999997 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.25 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.1499999999999999 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.63 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 0.76000000000000001 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 139' ' ' ALA . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 2.8599999999999999 108.888 -168.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 2.2799999999999998 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.589 HD23 HD12 ' A' ' 152' ' ' LEU . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 0.73999999999999999 110.636 -171.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.1200000000000001 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 132' ' ' ALA . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 2.7799999999999998 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 6.8600000000000003 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 2.6200000000000001 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.1200000000000001 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 3.5899999999999999 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HA ' HD11 ' A' ' 127' ' ' ILE . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 1.6000000000000001 113.433 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 2.4199999999999999 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6000000000000001 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 154' ' ' ALA 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.2 109.864 173.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 0.82999999999999996 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.76000000000000001 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 2.6099999999999999 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 0.81999999999999995 110.842 167.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 113' ' ' VAL . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 2.4199999999999999 108.043 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 2.8199999999999998 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 3.2400000000000002 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 4.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.3599999999999999 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.73 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 1.51 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.46 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 2.6499999999999999 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 1.1100000000000001 107.868 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.78000000000000003 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.589 HD12 HD23 ' A' ' 125' ' ' LEU . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 1.1499999999999999 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 0.97999999999999998 111.751 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 4.6100000000000003 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.4400000000000004 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.756 -1.202 . . . . 65.900000000000006 107.756 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -74.66 90.07 2.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.035 0.934 . . . . 59.810000000000002 109.252 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.6 p -143.57 87.08 1.91 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.13 0.572 . . . . 55.399999999999999 110.334 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -160.21 150.03 18.0 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.115 0.966 . . . . 50.200000000000003 108.821 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 p -167.12 161.02 14.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.041 1.736 . . . . 44.799999999999997 106.499 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.8 51.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.65 0.78 . . . . 39.68 110.217 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 tp -90.3 124.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.775 -0.824 . . . . 35.219999999999999 108.775 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 t -164.01 166.99 20.97 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.273 -1.38 . . . . 30.260000000000002 107.273 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.73 20.47 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.682 0.793 . . . . 25.27 112.151 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -80.12 68.8 6.37 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.204 -0.935 . . . . 23.010000000000002 111.149 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -122.68 31.82 5.95 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.19 . . . . 20.530000000000001 110.306 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -148.46 152.85 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.12 -1.807 . . . . 13.57 106.12 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -79.6 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.93 1.292 . . . . 8.6099999999999994 110.803 -166.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -116.45 -19.2 10.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.135 0.974 . . . . 12.779999999999999 111.837 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.8 mt 73.26 158.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.045 1.738 . . . . 15.369999999999999 110.754 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 78.21 55.5 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.86 2.064 . . . . 18.789999999999999 109.722 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 74.52 -42.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.585 1.554 . . . . 14.390000000000001 112.384 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -39.95 -40.64 1.05 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.385 1.474 . . . . 13.06 111.663 163.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -43.71 -38.55 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.3 1.44 . . . . 11.25 113.233 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -49.33 -44.54 44.51 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 119.656 1.116 . . . . 12.1 111.264 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -68.24 -43.26 78.31 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.108 -0.33 . . . . 10.279999999999999 110.108 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.23 -75.97 0.51 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 123.587 0.613 . . . . 6.5599999999999996 113.046 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -70.02 -35.76 74.58 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.808 -0.819 . . . . 12.09 111.674 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.2 mmt 63.8 -67.13 0.1 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.365 1.466 . . . . 11.039999999999999 113.928 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t 67.62 -74.83 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.054 1.341 . . . . 13.65 110.598 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.14 123.31 1.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.47 1.508 . . . . 15.289999999999999 107.426 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -145.33 58.63 1.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.14 -1.43 . . . . 15.4 107.14 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 63.92 77.35 0.32 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.096 1.358 . . . . 22.780000000000001 108.383 -157.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.16 -162.06 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.472 1.109 . . . . 19.350000000000001 109.367 -170.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -86.3 -178.49 6.48 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.075 0.464 . . . . 17.07 109.923 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -164.57 -52.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.963 -0.562 . . . . 16.5 110.189 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.6 mt 65.94 -72.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.368 1.467 . . . . 10.710000000000001 109.691 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.25 2.39 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.587 0.613 . . . . 9.9199999999999999 111.573 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.21 172.07 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.342 1.457 . . . . 11.24 109.217 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt 67.15 -74.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 127.156 2.182 . . . . 11.119999999999999 110.729 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.29 -47.19 0.62 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.339 1.456 . . . . 4.54 113.767 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 21.78 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.663 2.554 . . . . 3.02 116.098 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.4900000000000002 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.25 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.1099999999999999 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 1.8899999999999999 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 3.2999999999999998 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 4.1100000000000003 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 2.29 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 1.9199999999999999 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.4699999999999998 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 1.79 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 1.55 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 5.6799999999999997 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 1.4399999999999999 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 1.6399999999999999 109.81 -168.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 71' ' ' ILE . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 3.4700000000000002 109.083 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 4.3700000000000001 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.69999999999999996 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.3900000000000001 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.0900000000000001 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 2.4900000000000002 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.93999999999999995 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.6699999999999999 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.3599999999999999 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.02 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.95999999999999996 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 0.69999999999999996 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 3.7799999999999998 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 0.93000000000000005 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 2.4399999999999999 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 2.2200000000000002 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.1499999999999999 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 1.25 108.753 158.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.3300000000000001 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 2.1699999999999999 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 1.4299999999999999 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 1.3700000000000001 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 4.2199999999999998 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.1000000000000001 110.318 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.4299999999999999 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.3199999999999998 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93000000000000005 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 3.48 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 3.3100000000000001 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.7400000000000002 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 3.5800000000000001 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 2.0 111.054 -164.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 5.3899999999999997 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 1.8899999999999999 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.51 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 2.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.0299999999999998 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 115' ' ' TYR . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 1.02 109.008 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.6499999999999999 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.0600000000000001 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 1.27 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 1.47 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.29 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.9199999999999999 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 1.6699999999999999 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 8.2300000000000004 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 5.1699999999999999 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 4.6600000000000001 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 5.4900000000000002 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 7.5 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 6.5099999999999998 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 3.8700000000000001 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 2.1400000000000001 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 2.98 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 2.3700000000000001 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 0.70999999999999996 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 2.3399999999999999 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 0.73999999999999999 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 2.6899999999999999 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.449 ' HA ' HG22 ' A' ' 92' ' ' VAL . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 4.8300000000000001 106.684 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.0600000000000001 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.4199999999999999 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 1.3100000000000001 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 3.5299999999999998 110.348 135.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.55000000000000004 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 0.85999999999999999 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 2.6600000000000001 113.43 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.0899999999999999 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 0.95999999999999996 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.3500000000000001 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 ' HE1' ' A' ' 53' ' ' TYR . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 2.8999999999999999 107.855 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 5.2999999999999998 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.0099999999999998 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 2.8700000000000001 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.0499999999999998 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 1.52 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 2.5099999999999998 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 1.1200000000000001 106.5 154.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 0.94999999999999996 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 0.81999999999999995 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 1.98 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 0.94999999999999996 111.425 166.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6000000000000001 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 1.8600000000000001 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.0699999999999998 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 2.27 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 3.29 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.4100000000000001 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.22 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.0499999999999998 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 2.7400000000000002 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 2.7200000000000002 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 1.27 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.96999999999999997 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 1.3500000000000001 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 1.0700000000000001 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.76 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 0.89000000000000001 111.526 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.1200000000000001 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.715 ' HB3' HG23 ' A' ' 52' ' ' THR . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.8499999999999996 111.613 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.311 -0.255 . . . . 50.420000000000002 110.311 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -162.52 150.03 13.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.505 -0.924 . . . . 44.82 108.505 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -61.2 163.68 6.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.304 1.042 . . . . 42.380000000000003 110.007 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -168.68 170.15 9.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.819 -1.549 . . . . 38.25 106.819 -173.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 p -166.01 172.41 11.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.331 -0.988 . . . . 34.020000000000003 108.331 -170.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.83 12.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.665 1.186 . . . . 30.07 108.216 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -170.34 2.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.763 1.625 . . . . 25.949999999999999 108.916 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.1 t -154.53 -173.51 4.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.977 -1.12 . . . . 22.559999999999999 107.977 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.95 178.49 7.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.284 1.434 . . . . 18.670000000000002 108.565 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.55 171.13 8.21 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.126 1.37 . . . . 16.710000000000001 109.035 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -129.84 39.84 3.64 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.311 1.044 . . . . 13.720000000000001 109.509 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -115.7 175.85 5.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.869 1.268 . . . . 9.5299999999999994 110.974 -165.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.98 -32.26 71.82 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.525 0.565 . . . . 8.5399999999999991 112.525 -171.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -71.37 129.75 39.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.121 0.873 . . . . 14.32 111.151 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt 88.18 98.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 129.107 2.963 . . . . 17.289999999999999 110.402 168.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 3.64 -72.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.383 3.073 . . . . 18.09 115.462 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.05 -50.76 71.75 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.696 -0.627 . . . . 16.649999999999999 110.137 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -66.22 -39.22 89.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.883 1.273 . . . . 12.6 110.869 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -45.41 -52.41 10.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 125.206 1.402 . . . . 11.949999999999999 110.492 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -46.7 -63.66 0.96 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.054 1.342 . . . . 13.609999999999999 111.797 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.63 80.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.048 -0.407 . . . . 9.2699999999999996 111.407 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.77 -63.14 5.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.132 -0.787 . . . . 6.4299999999999997 111.132 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -60.59 -49.72 76.42 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.453 0.301 . . . . 11.890000000000001 110.427 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.3 ptt? 168.5 119.89 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.322 1.849 . . . . 13.83 108.905 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.97 -50.48 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.409 1.084 . . . . 13.41 109.508 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 158.25 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.349 2.66 . . . . 16.109999999999999 105.397 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -62.53 157.19 21.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.138 -0.937 . . . . 17.739999999999998 108.742 156.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -57.95 117.23 4.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.23 1.012 . . . . 22.100000000000001 110.226 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -74.5 161.16 30.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.534 -0.543 . . . . 16.739999999999998 109.534 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.34 -40.68 97.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.628 0.603 . . . . 19.050000000000001 112.628 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 38' ' ' GLU . 47.5 ttt180 69.23 22.97 6.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 20.489999999999998 111.173 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.42 -30.95 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 125.501 1.52 . . . . 15.699999999999999 112.786 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.6 -161.72 16.4 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 106.178 -2.769 . . . . 11.289999999999999 106.178 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 59.04 38.44 24.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.009 0.924 . . . . 9.1300000000000008 110.828 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 131.59 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.767 0.827 . . . . 9.0399999999999991 110.453 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -166.9 153.8 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 126.843 2.057 . . . . 3.29 105.484 168.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.14 0.64 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.231 0.923 . . . . 2.5 111.198 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 31' ' ' ARG . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.6100000000000003 112.284 -174.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.3099999999999996 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 3.1499999999999999 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 2.6800000000000002 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 2.9100000000000001 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.1099999999999999 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 4.3399999999999999 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 2.5800000000000001 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 1.8700000000000001 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.0099999999999998 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 1.78 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 1.8 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 4.96 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 1.3300000000000001 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 1.5 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 3.48 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.2199999999999998 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.76000000000000001 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.1299999999999999 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 0.87 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 2.1099999999999999 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.1399999999999999 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 1.76 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.9500000000000002 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.4399999999999999 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 1.6799999999999999 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.04 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.75 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 3.6699999999999999 107.352 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 0.90000000000000002 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 1.96 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 2.48 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 1.1000000000000001 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.599 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 1.95 105.287 152.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.3799999999999999 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 2.6699999999999999 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 1.5600000000000001 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 1.1799999999999999 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 4.3499999999999996 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 1.6799999999999999 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.3999999999999999 112.098 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.6800000000000002 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.87 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.0999999999999996 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 2.2599999999999998 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.6600000000000001 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 3.75 116.805 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 1.8999999999999999 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.0499999999999998 113.378 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 2.2000000000000002 110.096 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 1.8400000000000001 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 2.8100000000000001 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 2.1699999999999999 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.3199999999999998 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 2.73 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 1.1000000000000001 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.1000000000000001 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 0.97999999999999998 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' HG13 ' A' ' 109' ' ' ILE . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 1.6599999999999999 110.87 168.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 6.6799999999999997 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 4.46 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.6699999999999999 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 107' ' ' ALA . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 2.75 114.248 164.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HZ2' ' CB ' ' A' ' 104' ' ' LYS . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 6.4000000000000004 110.763 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 9.0899999999999999 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 6.8099999999999996 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 103' ' ' GLY . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 4.6399999999999997 113.268 171.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 2.6600000000000001 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 99' ' ' ILE . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 3.3399999999999999 108.319 169.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 1.5700000000000001 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 0.89000000000000001 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 1.72 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 0.69999999999999996 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 3.2200000000000002 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 6.9199999999999999 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.1000000000000001 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.8599999999999999 113.029 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 1.8799999999999999 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.8100000000000001 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 3.46 108.681 141.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.70999999999999996 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 1.1799999999999999 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 2.52 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 1.8600000000000001 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.485 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 1.1499999999999999 109.567 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.1499999999999999 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 2.3700000000000001 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 4.4199999999999999 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 2.7000000000000002 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.4500000000000002 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 3.6899999999999999 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 1.26 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 2.52 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.9500000000000002 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.485 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 1.96 107.516 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.92000000000000004 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 1.77 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 0.70999999999999996 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.3099999999999996 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 2.25 109.43 -174.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.1600000000000001 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 2.3300000000000001 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.0499999999999998 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.8300000000000001 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.0 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.1299999999999999 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 4.9500000000000002 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 1.8200000000000001 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 1.29 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.84999999999999998 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 1.3799999999999999 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 1.5 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 1.3200000000000001 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 3.6400000000000001 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.2400000000000002 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.235 -0.412 . . . . 52.0 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -160.84 141.88 11.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.725 -1.584 . . . . 48.939999999999998 106.725 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -178.33 173.03 1.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.42 2.288 . . . . 44.240000000000002 105.953 169.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 168.22 133.99 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.541 1.936 . . . . 41.259999999999998 109.26 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.3 t -165.09 154.57 12.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.846 -1.539 . . . . 35.859999999999999 106.846 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.86 86.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.524 1.53 . . . . 31.84 108.571 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.16 145.78 48.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.135 0.974 . . . . 29.649999999999999 108.875 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -167.63 172.7 9.13 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.858 1.663 . . . . 24.59 106.838 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 178.22 83.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.588 1.555 . . . . 20.809999999999999 109.597 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -159.23 128.46 5.4 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.803 -0.561 . . . . 17.32 109.897 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -165.76 140.27 4.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.393 -2.077 . . . . 16.399999999999999 105.393 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -179.07 165.19 1.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.772 1.629 . . . . 10.800000000000001 106.925 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.12 69.05 1.97 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.897 0.879 . . . . 8.0299999999999994 110.491 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.67 -95.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.769 0.827 . . . . 11.949999999999999 111.81 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.45 143.78 17.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.604 0.761 . . . . 14.75 110.385 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 83.55 78.75 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.155 2.582 . . . . 16.98 110.197 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 t70 69.45 -56.67 0.55 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 128.332 2.653 . . . . 14.66 109.847 -172.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -28.8 -50.56 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.859 2.864 . . . . 11.220000000000001 111.77 167.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -32.56 -67.48 0.11 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.691 1.596 . . . . 11.390000000000001 113.697 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.95 -55.25 6.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.369 0.604 . . . . 14.140000000000001 110.675 168.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -70.56 -9.5 56.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.631 1.715 . . . . 13.41 115.631 -156.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.83 -85.68 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.465 1.029 . . . . 10.66 111.921 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -31.4 65.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.094 -1.432 . . . . 11.85 111.577 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.64 58.35 0.94 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.898 1.226 . . . . 14.470000000000001 111.295 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.4 t -14.32 109.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 128.181 2.592 . . . . 17.25 114.158 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 48.04 75.86 0.13 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.634 1.574 . . . . 19.059999999999999 114.04 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -125.55 178.78 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.727 1.611 . . . . 23.039999999999999 107.581 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -85.95 147.93 26.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.572 -0.529 . . . . 27.120000000000001 109.572 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -65.48 161.71 19.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.035 0.445 . . . . 22.550000000000001 109.995 165.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.27 -71.01 0.52 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.873 -1.529 . . . . 25.920000000000002 106.873 165.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -164.74 55.0 0.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.039 -1.467 . . . . 25.010000000000002 107.039 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mm -95.88 91.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.44 -1.689 . . . . 18.48 106.44 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.19 -145.36 1.65 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.757 -0.937 . . . . 15.08 110.757 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -76.34 57.66 1.2 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.35 1.06 . . . . 11.99 110.819 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 mm -98.64 78.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.702 0.801 . . . . 11.1 110.088 -167.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 121.32 5.72 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.576 -1.268 . . . . 5.1600000000000001 107.576 159.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.31 -49.39 0.89 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 3.23 108.18 -154.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.5499999999999998 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 4.79 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 3.6099999999999999 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 2.4500000000000002 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 3.3799999999999999 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.4100000000000001 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 3.5 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HZ3' ' A' ' 76' ' ' LYS . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 2.8599999999999999 106.312 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 1.8300000000000001 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.4800000000000004 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.2200000000000002 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 1.96 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 5.9400000000000004 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 2.4300000000000002 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.1799999999999997 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 5.1100000000000003 115.083 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 6.3899999999999997 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 0.87 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 2.7400000000000002 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 0.95999999999999996 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 2.0299999999999998 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.0 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.2599999999999998 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.9700000000000002 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.7599999999999998 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 1.3400000000000001 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.90000000000000002 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.1799999999999999 113.206 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 6.3700000000000001 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.26 108.127 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 3.6899999999999999 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 2.1400000000000001 112.02 -169.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.01 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 2.1400000000000001 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.0999999999999996 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.403 ' CE1' HD23 ' A' ' 45' ' ' LEU . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 2.77 114.826 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 1.77 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 1.9099999999999999 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 4.2000000000000002 110.204 167.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.6600000000000001 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 1.54 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 4.75 111.622 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 65' ' ' GLY . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 2.0899999999999999 107.708 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 4.1299999999999999 107.815 158.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 2.1099999999999999 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 5.4400000000000004 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 2.52 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.02 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.6100000000000003 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 2.7799999999999998 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6000000000000001 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 1.71 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 1.5900000000000001 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 1.21 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 1.48 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 1.8600000000000001 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' LYS 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 1.9399999999999999 106.636 169.91 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 6.8399999999999999 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 5.5300000000000002 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.3300000000000001 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.6200000000000001 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 8.2300000000000004 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 8.0899999999999999 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 8.9600000000000009 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 4.0 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 2.1099999999999999 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 2.5 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.1800000000000002 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.77000000000000002 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 1.53 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 0.97999999999999998 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 2.3700000000000001 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 7.0899999999999999 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.23 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 2.6400000000000001 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 1.3600000000000001 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.6899999999999999 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.3199999999999998 109.755 166.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 0.81000000000000005 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 0.79000000000000004 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 2.46 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 2.3900000000000001 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 1.3600000000000001 109.144 -170.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 2.9700000000000002 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 4.46 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.7799999999999998 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.3600000000000003 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 4.4800000000000004 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 2.4399999999999999 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 4.2000000000000002 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.0699999999999998 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 1.29 107.488 167.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 1.3400000000000001 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.1699999999999999 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 1.6899999999999999 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.26 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.1699999999999999 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 2.3199999999999998 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 3.8799999999999999 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 3.2200000000000002 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 2.02 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.2999999999999998 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 1.8400000000000001 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 1.78 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 3.8799999999999999 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 3.5299999999999998 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 1.26 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.77000000000000002 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 1.1100000000000001 107.61 -175.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 1.22 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.879 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.53 109.271 167.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 3.2799999999999998 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.6299999999999999 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.363 -0.977 . . . . 57.460000000000001 108.363 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -160.88 134.4 6.71 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.056 -1.461 . . . . 54.299999999999997 107.056 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -179.57 156.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.548 -1.279 . . . . 48.700000000000003 107.548 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.89 156.65 3.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.641 1.576 . . . . 45.509999999999998 107.039 172.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -171.46 142.97 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.667 -1.605 . . . . 40.109999999999999 106.667 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.09 105.62 0.24 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.309 1.044 . . . . 36.100000000000001 108.632 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 tp -153.26 119.76 5.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.606 -1.627 . . . . 32.189999999999998 106.606 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -167.24 134.92 2.46 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.465 -1.309 . . . . 28.25 107.465 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.44 135.73 0.12 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.684 1.594 . . . . 24.43 107.759 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -168.42 135.41 2.01 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.743 0.817 . . . . 20.260000000000002 108.832 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -167.35 134.75 2.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.709 -0.478 . . . . 17.0 109.709 172.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -178.43 173.22 1.39 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 128.42 2.688 . . . . 12.59 105.206 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.5 74.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 7.7199999999999998 111.99 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -129.55 175.63 8.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.886 2.074 . . . . 14.08 110.259 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' H ' ' A' ' 16' ' ' GLN 0.28 29.3 mm 56.7 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.925 1.69 . . . . 15.09 110.58 173.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.763 ' H ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -156.56 41.38 0.36 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.752 -1.218 . . . . 14.52 109.051 169.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -74.89 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.953 -1.869 . . . . 15.130000000000001 105.953 -172.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 m -62.73 -90.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.099 2.16 . . . . 14.91 111.104 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.82 -8.33 1.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.591 1.33 . . . . 12.960000000000001 114.591 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -43.15 -41.56 3.76 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.478 1.036 . . . . 11.34 111.178 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -56.93 1.46 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.653 1.581 . . . . 12.699999999999999 111.616 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.81 -49.85 27.12 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.342 -0.703 . . . . 9.8100000000000005 111.342 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -47.24 -40.78 17.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.84 1.656 . . . . 9.8599999999999994 114.359 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 33.5 tpp 60.01 59.57 2.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.002 -0.74 . . . . 11.84 109.002 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.8 t 67.29 -73.4 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.685 1.594 . . . . 12.4 111.298 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 53.54 86.34 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.01 1.724 . . . . 12.02 112.276 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -70.73 169.66 14.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.367 -0.833 . . . . 15.51 110.266 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -60.39 164.04 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.66 0.615 . . . . 22.5 112.66 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 67.6 -70.95 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.34 1.856 . . . . 21.600000000000001 110.9 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -158.75 -58.87 0.07 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.607 1.163 . . . . 20.75 109.618 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 56.15 74.45 0.39 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.003 -0.999 . . . . 17.93 109.441 -156.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.7 mt -49.5 130.76 7.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.878 -1.156 . . . . 16.460000000000001 107.878 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.14 -145.2 12.81 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 105.871 -2.891 . . . . 10.66 105.871 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.57 41.75 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.543 1.937 . . . . 9.3599999999999994 112.793 -170.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.7 pt -88.31 151.91 3.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 123.892 0.877 . . . . 8.3399999999999999 109.27 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.74 -127.88 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.748 1.219 . . . . 4.0599999999999996 109.065 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -50.93 60.52 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 118.773 0.715 . . . . 2.46 112.654 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.2400000000000002 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 6.1100000000000003 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 2.9199999999999999 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 1.97 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 2.9700000000000002 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.0599999999999996 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 3.6299999999999999 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 2.5099999999999998 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 1.78 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.3300000000000001 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.1499999999999999 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 1.72 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 6.6699999999999999 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 1.6499999999999999 111.509 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 1.47 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 3.5600000000000001 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 4.9000000000000004 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.70999999999999996 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 2.8700000000000001 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 0.90000000000000002 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 2.4500000000000002 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89000000000000001 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.71 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.5800000000000001 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.5800000000000001 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 1.3600000000000001 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 0.91000000000000003 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 5.7000000000000002 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 152' ' ' LEU . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 0.93999999999999995 109.374 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 1.8700000000000001 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 2.23 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 1.49 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 1.46 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.8300000000000001 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 2.6600000000000001 112.711 -164.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 1.3500000000000001 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 1.3300000000000001 112.71 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 4.5800000000000001 113.159 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.8799999999999999 111.047 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 1.54 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.8599999999999999 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 7.0700000000000003 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 3.1400000000000001 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.8200000000000003 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 5.4100000000000001 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 1.48 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.29 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.3799999999999999 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.46 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.2400000000000002 111.667 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 4.0199999999999996 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.3399999999999999 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG13 ' HB ' ' A' ' 82' ' ' ILE . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 2.1000000000000001 109.987 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.5800000000000001 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 1.8400000000000001 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 1.05 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.53 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.3100000000000001 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.4100000000000001 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 1.8500000000000001 111.293 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 7.1299999999999999 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 4.2999999999999998 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.0899999999999999 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.0999999999999996 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 5.2999999999999998 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 6.5499999999999998 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.46 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.0599999999999996 109.434 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.7999999999999998 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 1.48 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 2.6800000000000002 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 1.5700000000000001 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.0900000000000001 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 2.23 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 0.80000000000000004 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 2.27 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 4.6100000000000003 104.702 168.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 2.8999999999999999 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 3.9900000000000002 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 1.3600000000000001 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.7800000000000002 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 4.8799999999999999 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.62 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.1399999999999999 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 2.2200000000000002 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 2.27 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 0.81999999999999995 111.124 -171.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.3500000000000001 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 2.2599999999999998 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 4.7000000000000002 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 2.9300000000000002 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.6800000000000002 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 3.7200000000000002 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 1.3799999999999999 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 2.3399999999999999 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.8100000000000001 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.754 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.24 107.605 157.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 1.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91000000000000003 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 1.8300000000000001 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 1.1299999999999999 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.1399999999999997 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 2.4700000000000002 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 3.5 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 2.1000000000000001 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 2.6099999999999999 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.6400000000000001 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.0 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 1.9299999999999999 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 4.9199999999999999 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 2.8999999999999999 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 1.3899999999999999 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 0.82999999999999996 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 125' ' ' LEU . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 1.1200000000000001 106.907 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.03 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.754 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 0.82999999999999996 113.224 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 5.75 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.9199999999999999 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 105.934 -1.876 . . . . 49.710000000000001 105.934 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.93 150.33 45.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.649 1.113 . . . . 43.990000000000002 108.481 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 m -151.03 149.05 29.1 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.517 -1.66 . . . . 40.25 106.517 167.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -160.93 166.08 28.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.893 -1.521 . . . . 36.340000000000003 106.893 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -164.02 153.46 14.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.02 -1.474 . . . . 32.350000000000001 107.02 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.46 152.02 15.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.409 -1.7 . . . . 28.48 106.409 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 tp -158.62 137.56 11.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.502 -2.036 . . . . 24.690000000000001 105.502 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -161.82 155.55 21.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.541 -1.651 . . . . 21.469999999999999 106.541 168.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.24 153.52 5.44 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.28 -1.748 . . . . 18.050000000000001 106.28 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -162.05 158.23 24.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.219 -1.03 . . . . 14.73 108.219 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -174.83 160.43 2.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.824 1.65 . . . . 14.199999999999999 108.322 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -168.04 179.31 4.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.237 -1.023 . . . . 9.3900000000000006 108.237 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -86.48 95.55 9.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.521 -1.288 . . . . 7.0700000000000003 107.521 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 61.97 -68.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.574 2.064 . . . . 14.02 116.574 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.96 126.0 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 106.826 -1.546 . . . . 15.16 106.826 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.23 30.54 0.12 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.121 0.568 . . . . 14.289999999999999 112.481 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -148.87 -66.13 0.23 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.825 -1.546 . . . . 15.06 106.825 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -70.09 -86.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.616 1.167 . . . . 15.09 109.538 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -59.5 -33.87 71.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.204 1.002 . . . . 13.83 111.572 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -35.1 -62.74 0.36 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.715 0.806 . . . . 11.32 111.021 161.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -70.44 -15.93 62.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.301 -0.249 . . . . 12.27 111.435 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.5 -60.69 5.63 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.292 -1.123 . . . . 9.1300000000000008 110.292 167.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -72.46 -64.51 0.94 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.229 1.411 . . . . 9.5099999999999998 111.613 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.8 mtp -80.17 60.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.498 2.319 . . . . 11.59 109.652 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -47.1 -43.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.755 1.222 . . . . 15.09 109.646 164.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.72 167.8 21.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.07 1.348 . . . . 16.41 107.894 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.12 143.26 18.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.35 1.06 . . . . 19.039999999999999 112.232 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -129.69 152.41 49.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.747 -2.316 . . . . 17.449999999999999 104.747 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.94 -58.95 5.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.441 0.564 . . . . 21.280000000000001 110.098 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -146.73 -64.91 0.29 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.688 1.195 . . . . 19.559999999999999 107.97 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.32 49.51 16.88 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.444 1.098 . . . . 17.670000000000002 111.086 172.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.5 mt -61.31 147.0 11.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.043 -0.981 . . . . 14.42 109.183 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.7 -177.71 17.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.963 -2.055 . . . . 10.77 107.963 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.45 37.96 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.433 1.093 . . . . 11.470000000000001 113.461 146.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 mt -84.95 148.9 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.708 -1.219 . . . . 7.5199999999999996 107.708 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 86.84 52.74 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 127.621 2.368 . . . . 3.8700000000000001 108.689 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.5 75.79 0.14 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.4299999999999997 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 3.98 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 2.8900000000000001 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 1.8 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.0 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 4.5700000000000003 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 127' ' ' ILE . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 2.3500000000000001 108.193 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 1.8799999999999999 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.8300000000000001 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.0499999999999998 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 1.72 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 4.5800000000000001 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 1.48 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 1.8700000000000001 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 5.4100000000000001 112.335 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 5.8300000000000001 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 0.93000000000000005 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 2.79 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 150' ' ' ILE . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 0.92000000000000004 105.549 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.423 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 2.5600000000000001 110.28 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.0800000000000001 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.8199999999999998 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.0600000000000001 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 1.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.1799999999999999 110.449 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 0.96999999999999997 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 4.4500000000000002 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 1.1499999999999999 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 3.3500000000000001 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 2.3300000000000001 112.252 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 1.0800000000000001 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 76' ' ' LYS . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 1.6499999999999999 105.923 166.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.4199999999999999 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 2.3599999999999999 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 1.24 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 1.3500000000000001 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 71' ' ' ILE . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 4.3099999999999996 114.494 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.6299999999999999 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.596 ' CA ' HG22 ' A' ' 71' ' ' ILE . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.04 112.575 -137.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.4100000000000001 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 0.87 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 4.5899999999999999 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 2.6899999999999999 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.9300000000000002 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.549 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 5.4100000000000001 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 85' ' ' LEU . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 2.2599999999999998 110.876 -164.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 4.5199999999999996 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.1099999999999999 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.1299999999999999 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.3500000000000001 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 3.4199999999999999 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 1.02 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 2.1400000000000001 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.0700000000000001 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.3700000000000001 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.1200000000000001 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.2999999999999998 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 1.6200000000000001 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 6.9800000000000004 112.101 170.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.0199999999999996 111.404 -169.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.9900000000000002 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.6299999999999999 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 5.7999999999999998 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 6.4800000000000004 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.0999999999999996 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 4.4500000000000002 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 1.9099999999999999 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 2.71 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.29 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.68000000000000005 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.45 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 0.72999999999999998 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 2.0 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 5.5800000000000001 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.0699999999999998 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.2799999999999998 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 1.4399999999999999 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.9100000000000001 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 3.3799999999999999 109.961 131.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.68000000000000005 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 0.83999999999999997 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 2.7599999999999998 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 2.96 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 0.85999999999999999 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.0600000000000001 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.673 HD12 HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.04 109.889 -162.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 5.9400000000000004 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 2.8799999999999999 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.1600000000000001 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 3.7200000000000002 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 2.8500000000000001 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 3.96 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.8500000000000001 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 1.27 106.744 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 1.03 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.75 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 2.2599999999999998 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.0600000000000001 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.1099999999999999 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 1.98 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 3.5699999999999998 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 2.1200000000000001 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 2.5699999999999998 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.52 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.0 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 2.25 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.1499999999999999 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 2.7799999999999998 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.42 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 3.96 108.7 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 0.87 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.0800000000000001 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 1.23 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 1.5700000000000001 109.656 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 3.48 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.9199999999999999 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.461 -1.681 . . . . 47.509999999999998 106.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -148.15 157.18 43.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.413 -1.699 . . . . 41.859999999999999 106.413 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -166.35 165.83 16.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 126.1 1.76 . . . . 38.32 106.554 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.49 141.05 49.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.671 -1.233 . . . . 34.390000000000001 107.671 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -75.03 168.79 19.29 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.06 0.457 . . . . 30.32 110.413 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.25 177.35 4.78 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.107 -1.442 . . . . 27.379999999999999 107.107 159.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -142.04 156.74 45.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.799 1.239 . . . . 23.68 107.783 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -79.35 -175.57 4.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.914 -1.143 . . . . 20.640000000000001 107.914 161.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -68.04 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.823 0.449 . . . . 17.780000000000001 109.789 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -151.23 67.68 0.91 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.702 0.801 . . . . 14.08 109.729 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 52.4 -116.39 1.03 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.715 0.806 . . . . 14.5 110.155 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 t -161.36 176.21 11.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.527 -2.027 . . . . 10.720000000000001 105.527 164.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.95 152.63 45.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.576 0.171 . . . . 6.2800000000000002 110.588 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 173.18 -43.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.334 1.854 . . . . 12.07 108.842 -169.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.1 mt -126.83 99.27 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.74 1.216 . . . . 12.02 108.527 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.48 164.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.382 1.473 . . . . 17.48 112.74 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.52 -67.5 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.868 1.667 . . . . 14.800000000000001 110.615 -162.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -61.16 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.05 1.34 . . . . 10.140000000000001 111.123 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -68.08 -15.82 63.76 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.66 -1.275 . . . . 8.6899999999999995 111.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -53.75 -56.11 20.39 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.38 -0.825 . . . . 14.789999999999999 109.239 161.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 t -54.51 -45.26 73.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.584 -0.895 . . . . 11.73 108.584 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -35.2 -66.02 0.38 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.924 1.25 . . . . 9.3900000000000006 113.935 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -7.99 52.49 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.563 1.319 . . . . 12.140000000000001 114.563 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.3 mmm -93.34 137.86 32.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.087 0.858 . . . . 13.75 109.869 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.35 -65.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.881 -1.525 . . . . 18.579999999999998 106.881 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.3 106.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.275 -1.009 . . . . 20.379999999999999 108.275 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -52.05 -33.81 40.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.835 0.854 . . . . 22.030000000000001 112.636 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 61.44 61.0 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.931 0.892 . . . . 24.379999999999999 109.711 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -71.22 64.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.221 1.408 . . . . 22.649999999999999 111.816 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -111.17 -89.16 0.5 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.866 1.266 . . . . 24.699999999999999 108.272 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -67.43 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.065 -1.458 . . . . 22.489999999999998 107.065 -169.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -143.59 123.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.865 -1.902 . . . . 16.34 105.865 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.03 -139.74 5.3 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.134 -1.187 . . . . 12.539999999999999 110.134 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -70.8 71.74 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.091 1.756 . . . . 10.380000000000001 110.141 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -48.03 -67.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.895 0.878 . . . . 9.6199999999999992 109.734 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.3 159.59 22.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 122.116 -0.365 . . . . 3.6800000000000002 110.386 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.57 -46.25 4.07 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.629 1.585 . . . . 2.71 109.25 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.5999999999999996 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.3700000000000001 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 2.2999999999999998 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.4100000000000001 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 3.4900000000000002 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 5.3899999999999997 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 2.29 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 1.8100000000000001 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.6699999999999999 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 2.6899999999999999 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.4900000000000002 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 5.96 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 1.3300000000000001 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 1.6499999999999999 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.455 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 5.3099999999999996 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 4.9299999999999997 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 0.92000000000000004 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 2.4700000000000002 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 1.0700000000000001 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 4.3399999999999999 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.1000000000000001 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 1.6399999999999999 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.8199999999999998 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.6600000000000001 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 1.22 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 0.95999999999999996 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 0.97999999999999998 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 3.4100000000000001 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 0.97999999999999998 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.1200000000000001 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 2.04 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 1.4299999999999999 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 2.23 105.123 167.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.3500000000000001 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 2.79 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.0299999999999998 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 1.54 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 5.1100000000000003 113.121 174.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.1200000000000001 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 1.6499999999999999 110.73 171.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.5699999999999998 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 0.79000000000000004 109.553 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 5.3600000000000003 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 2.6699999999999999 110.087 -169.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.4199999999999999 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 3.5800000000000001 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 1.6000000000000001 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 5.2300000000000004 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 1.8899999999999999 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.5600000000000001 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.7999999999999998 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 1.78 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 1.2 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.5600000000000001 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 123' ' ' TYR . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 1.8 106.427 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.03 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 1.27 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 1.4399999999999999 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.5700000000000003 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 1.4099999999999999 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 8.3300000000000001 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 4.4400000000000004 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.4100000000000001 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.0699999999999998 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 4.7300000000000004 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 6.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 5.5300000000000002 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 2.5299999999999998 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.1699999999999999 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 2.6899999999999999 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 2.2400000000000002 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.68999999999999995 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 1.5 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 141' ' ' VAL . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 1.21 108.187 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 2.46 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 4.75 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.6299999999999999 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.8799999999999999 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 1.2 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 3.2400000000000002 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 0.93000000000000005 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 94' ' ' LEU . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 3.0299999999999998 110.246 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 1.8799999999999999 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.1399999999999999 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 3.8199999999999998 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 6.0 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 3.5699999999999998 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.5499999999999998 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 4.3799999999999999 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.3700000000000001 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 2.5299999999999998 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.0299999999999998 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 1.3700000000000001 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 0.91000000000000003 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.04 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 1.6200000000000001 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.73999999999999999 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 113' ' ' VAL . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 2.48 106.086 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 3.6099999999999999 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.1800000000000002 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 2.71 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.8599999999999999 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.29 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.2200000000000002 109.109 -173.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.1299999999999999 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 2.4700000000000002 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 1.45 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.407 HD12 ' C ' ' A' ' 152' ' ' LEU . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 2.1200000000000001 112.235 -166.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 1.4199999999999999 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 1.03 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.21 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.6699999999999999 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.985 -0.746 . . . . 59.170000000000002 108.985 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -162.15 156.46 21.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.225 -1.028 . . . . 51.310000000000002 108.225 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -86.8 -174.53 5.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.545 1.538 . . . . 47.090000000000003 110.504 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -154.68 -175.03 5.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.19 1.796 . . . . 43.229999999999997 106.307 170.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -158.86 -165.97 1.76 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.954 -0.758 . . . . 37.759999999999998 108.954 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.69 176.19 13.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.552 1.541 . . . . 33.359999999999999 109.117 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.85 157.47 31.05 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.15 1.38 . . . . 28.699999999999999 109.546 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.0 p -97.12 163.02 13.1 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.824 1.249 . . . . 25.210000000000001 111.31 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.5 171.49 11.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.731 0.812 . . . . 21.379999999999999 109.372 165.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.52 150.04 34.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.349 1.06 . . . . 16.949999999999999 109.736 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -94.35 -134.3 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.631 1.172 . . . . 16.420000000000002 108.844 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p 70.63 -178.8 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.104 1.362 . . . . 9.8200000000000003 110.495 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.69 73.59 0.8 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.346 0.594 . . . . 6.3399999999999999 110.087 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -54.66 147.37 14.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.379 1.471 . . . . 12.77 109.979 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 mm 58.39 42.92 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.972 1.368 . . . . 12.789999999999999 110.01 -165.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.13 172.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.354 1.861 . . . . 13.07 111.529 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.42 -53.13 0.49 Allowed 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 127.245 2.218 . . . . 13.48 113.543 174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -74.5 -96.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.063 0.847 . . . . 12.6 110.927 163.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.54 -65.79 0.78 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.246 1.018 . . . . 11.960000000000001 112.866 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -70.93 -1.7 12.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.992 1.317 . . . . 11.93 113.608 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -28.28 -37.76 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.677 2.391 . . . . 11.41 115.735 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -28.52 -48.05 0.08 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.723 2.106 . . . . 9.6999999999999993 115.247 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -55.28 -52.35 63.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.548 1.674 . . . . 11.1 112.482 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 97.4 mmm -146.0 70.88 1.24 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.902 1.281 . . . . 12.91 109.281 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.86 -79.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.184 -1.413 . . . . 15.720000000000001 107.184 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.77 140.72 38.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.302 -0.999 . . . . 18.18 108.302 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -81.46 70.64 8.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.984 -1.117 . . . . 17.969999999999999 107.984 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 47' ' ' GLU . 36.8 mmt180 -36.67 -64.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.18 2.192 . . . . 22.210000000000001 113.391 -166.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -160.66 125.7 3.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.973 -0.751 . . . . 23.489999999999998 108.973 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.92 -177.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.341 1.457 . . . . 22.48 111.631 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -78.02 56.25 1.58 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.425 -0.954 . . . . 16.190000000000001 108.425 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.9 mt -138.23 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.787 -1.19 . . . . 14.859999999999999 107.787 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.06 -71.09 0.13 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.733 -0.482 . . . . 11.17 112.06 -168.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 1.6 p-10 -152.3 159.9 43.42 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.484 1.914 . . . . 8.8699999999999992 107.733 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.09 -77.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.433 1.015 . . . . 9.9900000000000002 110.557 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.14 -80.18 0.31 Allowed 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.26 0.482 . . . . 3.8100000000000001 111.909 -165.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.16 -70.36 1.03 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 2.5699999999999998 110.865 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7000000000000002 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 104' ' ' LYS . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 4.8300000000000001 110.936 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 2.8500000000000001 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 1.8200000000000001 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 3.1299999999999999 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.7999999999999998 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 4.9400000000000004 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 2.1600000000000001 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.0 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 28' ' ' ARG . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.9800000000000004 110.905 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 2.1600000000000001 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 1.71 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 4.9100000000000001 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 2.0499999999999998 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 3.3700000000000001 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 4.4100000000000001 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.78000000000000003 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 3.1099999999999999 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.0600000000000001 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 3.0 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 2.25 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.1699999999999999 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.2799999999999998 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 2.2000000000000002 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.26 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.823 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 0.92000000000000004 112.734 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 3.7999999999999998 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 0.97999999999999998 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 2.2999999999999998 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 2.0699999999999998 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 1.3400000000000001 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 1.6599999999999999 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 2.23 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 1.7 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 34' ' ' ASP . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 1.1399999999999999 112.749 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 109' ' ' ILE . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 5.4900000000000002 111.72 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7000000000000002 105.528 170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.3100000000000001 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 4.7800000000000002 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.823 HG23 ' HA3' ' A' ' 65' ' ' GLY . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 1.8300000000000001 106.895 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.3700000000000001 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 4.2800000000000002 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.9900000000000002 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.04 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 1.76 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.7 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.5899999999999999 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 2.1899999999999999 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.5099999999999998 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 0.92000000000000004 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.6600000000000001 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 1.8100000000000001 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.1000000000000001 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.0099999999999998 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 1.45 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.5599999999999996 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.0499999999999998 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.2699999999999996 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 5.1299999999999999 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.2300000000000004 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 4.3799999999999999 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 4.5899999999999999 110.92 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 5.6500000000000004 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 6.1799999999999997 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.2799999999999998 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 1.4299999999999999 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 3.0299999999999998 107.58 150.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 1.5800000000000001 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 0.81000000000000005 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.48 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 0.76000000000000001 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 2.23 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.21 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.0499999999999998 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.6600000000000001 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 1.3899999999999999 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.3199999999999998 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.0600000000000001 107.77 167.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.59999999999999998 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 0.90000000000000002 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 3.73 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 1.6000000000000001 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 0.97999999999999998 112.933 -170.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.0800000000000001 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 3.3199999999999998 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 5.6900000000000004 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 2.79 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.6699999999999999 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 4.1100000000000003 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.3300000000000001 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 2.9100000000000001 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2000000000000002 107.076 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 154' ' ' ALA . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 1.79 108.899 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 1.25 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.85999999999999999 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 1.6499999999999999 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 0.82999999999999996 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.5600000000000001 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 2.2400000000000002 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.3500000000000001 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 2.8500000000000001 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 2.3999999999999999 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.6800000000000002 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.3400000000000001 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.0699999999999998 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.4500000000000002 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 2.6499999999999999 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 1.5600000000000001 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.03 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.03 108.597 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 1.05 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.02 109.635 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.1699999999999999 113.774 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9000000000000004 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.511 -1.663 . . . . 52.649999999999999 106.511 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.22 170.04 4.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.891 -1.522 . . . . 45.460000000000001 106.891 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -66.6 160.0 26.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.479 0.712 . . . . 41.649999999999999 109.811 169.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -148.81 171.4 16.32 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.738 -1.579 . . . . 38.729999999999997 106.738 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m 120.79 88.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 129.655 3.182 . . . . 33.25 109.66 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.47 33.64 1.66 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.564 0.745 . . . . 29.690000000000001 110.636 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.87 142.26 33.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.019 0.528 . . . . 26.399999999999999 109.599 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -176.28 -162.86 0.09 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.109 1.764 . . . . 22.850000000000001 106.755 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 86.11 114.72 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.22 2.608 . . . . 19.57 111.82 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -163.18 167.51 22.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.842 -1.54 . . . . 16.16 106.842 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.6 152.52 18.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.24 1.016 . . . . 13.85 109.511 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -162.1 0.86 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.9 -1.518 . . . . 9.5399999999999991 106.9 162.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -13.83 61.73 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.867 3.667 . . . . 6.8700000000000001 118.282 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 71.0 146.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.677 2.391 . . . . 14.0 113.349 167.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.3 mt 73.8 162.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.032 1.733 . . . . 14.33 109.071 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -74.45 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.026 -1.101 . . . . 17.02 108.026 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.87 -49.44 15.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.855 1.662 . . . . 16.949999999999999 112.582 -171.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 t -62.16 -13.55 28.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.128 -0.939 . . . . 14.119999999999999 113.36 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -53.24 -33.75 54.28 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 119.767 1.167 . . . . 9.7799999999999994 110.831 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -66.49 -25.64 66.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.777 0.431 . . . . 14.0 111.415 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -72.5 -59.02 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.806 -1.183 . . . . 14.1 107.806 160.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -38.13 -60.98 1.25 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 126.624 2.059 . . . . 9.0399999999999991 114.434 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -70.2 -6.6 35.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 114.769 1.396 . . . . 10.51 114.769 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.2 mtm 113.2 137.44 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 129.521 3.128 . . . . 11.609999999999999 106.659 -162.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.02 -39.52 50.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.801 1.64 . . . . 16.52 111.839 -170.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.69 172.31 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.868 0.842 . . . . 17.0 112.806 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.28 -1.748 . . . . 18.550000000000001 106.28 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 78.77 146.78 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.263 1.825 . . . . 22.940000000000001 109.343 -163.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.89 159.21 29.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.805 -1.554 . . . . 17.09 106.805 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -70.06 -57.11 5.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.569 0.348 . . . . 22.390000000000001 110.606 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -173.52 -56.98 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.028 1.331 . . . . 17.75 108.109 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.2 mt 62.75 -94.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.983 1.313 . . . . 14.289999999999999 109.396 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.36 -158.93 31.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.833 -2.107 . . . . 9.3800000000000008 107.833 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.8 -23.57 61.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.242 1.417 . . . . 8.3800000000000008 110.034 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.2 mt -62.69 76.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.533 1.533 . . . . 8.9299999999999997 108.68 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.07 -11.01 56.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.228 1.011 . . . . 5.0300000000000002 110.818 169.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.34 28.1 66.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.133 0.873 . . . . 2.0699999999999998 112.346 -176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.8200000000000003 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 4.4000000000000004 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 3.5600000000000001 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.1699999999999999 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 3.9500000000000002 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.3599999999999999 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 5.79 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 2.6400000000000001 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 1.9099999999999999 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.8300000000000001 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 2.71 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 1.6000000000000001 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 4.9900000000000002 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 1.8 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 1.49 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.723 ' CZ ' HG13 ' A' ' 135' ' ' VAL . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 5.0199999999999996 110.027 162.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 4.7699999999999996 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 0.98999999999999999 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 3.52 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 152' ' ' LEU . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 0.93999999999999995 104.584 171.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 2.0499999999999998 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.1599999999999999 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.5499999999999998 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.3799999999999999 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.9900000000000002 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.1000000000000001 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 0.95999999999999996 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 3.4300000000000002 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 152' ' ' LEU . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 1.3200000000000001 108.419 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 2.2799999999999998 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 2.4500000000000002 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.23 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.04 106.41 163.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 3.75 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 1.78 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 1.6799999999999999 114.012 -170.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 5.5899999999999999 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.02 107.785 168.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.6000000000000001 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.8799999999999999 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 6.1399999999999997 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 82' ' ' ILE . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 1.8799999999999999 109.18 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 3.5699999999999998 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 1.8 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 3.8700000000000001 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 1.4099999999999999 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.5700000000000001 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.1200000000000001 111.039 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.04 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 1.1399999999999999 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.9500000000000002 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 80' ' ' GLY . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 2.4199999999999999 106.433 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 1.53 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.73 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.0900000000000001 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.8399999999999999 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.04 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.0199999999999996 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 3.3900000000000001 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.6500000000000004 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 3.1699999999999999 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 5.9100000000000001 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.566 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 6.2999999999999998 108.24 -163.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 4.9699999999999998 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 2.73 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 1.3600000000000001 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 2.5 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 2.2400000000000002 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.65000000000000002 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.4299999999999999 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 0.93999999999999995 109.404 168.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 1.9199999999999999 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 4.8499999999999996 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 2.7999999999999998 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.4700000000000002 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 1.1899999999999999 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.8500000000000001 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 120' ' ' LYS . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 3.5 110.603 135.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.53000000000000003 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 3.5699999999999998 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.1200000000000001 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 152' ' ' LEU . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 0.77000000000000002 109.113 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.1499999999999999 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 2.0699999999999998 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 5.7300000000000004 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 3.71 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.3900000000000001 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 3.5499999999999998 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 1.3999999999999999 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 3.1000000000000001 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 155' ' ' LYS . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.9900000000000002 108.581 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 53' ' ' TYR . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 1.3 107.768 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 1.24 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 2.1899999999999999 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 0.68999999999999995 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.1100000000000003 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 1.99 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 3.5899999999999999 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 2.7799999999999998 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 1.8700000000000001 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.1299999999999999 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 1.6100000000000001 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 2.7999999999999998 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 3.1899999999999999 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 1.3700000000000001 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.81999999999999995 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.1399999999999999 107.91 -171.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.02 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 0.93999999999999995 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 134' ' ' GLU . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.25 107.628 160.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.7599999999999998 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.33 -1.73 . . . . 51.840000000000003 106.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 178.9 178.53 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.916 1.687 . . . . 44.859999999999999 106.571 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -153.89 156.72 38.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.917 -1.512 . . . . 41.920000000000002 106.917 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.5 171.95 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.702 1.601 . . . . 37.390000000000001 106.98 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -166.2 164.69 17.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.336 -1.357 . . . . 33.369999999999997 107.336 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.21 159.83 44.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.767 -1.197 . . . . 29.510000000000002 107.767 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -144.68 174.98 10.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.291 1.836 . . . . 26.239999999999998 106.911 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -152.51 170.42 20.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.743 -1.206 . . . . 22.390000000000001 107.743 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 -173.43 2.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.158 -1.423 . . . . 19.149999999999999 107.158 163.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -159.84 169.25 23.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.541 -1.652 . . . . 15.73 106.541 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 175.27 11.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.177 0.991 . . . . 16.190000000000001 108.882 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -159.67 -179.13 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.423 -1.325 . . . . 9.6899999999999995 107.423 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 21.49 71.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.009 2.523 . . . . 8.0199999999999996 114.71 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -96.66 -162.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.528 0.731 . . . . 13.17 109.685 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.34 169.03 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.815 1.246 . . . . 15.91 110.361 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 81.44 -54.29 0.28 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.828 2.451 . . . . 19.399999999999999 112.958 150.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -156.94 -47.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.323 1.449 . . . . 15.18 107.473 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -40.61 -38.35 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.66 1.184 . . . . 13.19 111.829 166.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -43.41 -42.95 4.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.649 0.981 . . . . 11.890000000000001 113.649 172.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -51.48 -48.29 62.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.769 0.828 . . . . 13.550000000000001 110.622 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -70.92 -43.1 68.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.931 0.492 . . . . 10.539999999999999 111.035 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.18 -71.93 0.94 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.582 1.087 . . . . 7.3700000000000001 112.544 -169.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -71.76 -40.68 69.15 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 117.689 0.745 . . . . 10.69 110.299 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.8 ptp 49.51 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.74 1.616 . . . . 10.26 113.091 -170.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.79 -94.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.346 -2.094 . . . . 14.529999999999999 105.346 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.13 -179.39 0.57 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.39 1.876 . . . . 15.77 106.397 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -64.3 -19.7 65.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.798 0.666 . . . . 19.07 112.798 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -134.38 161.93 33.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.123 . . . . 25.940000000000001 107.969 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.92 67.23 3.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.968 0.907 . . . . 23.32 111.414 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -72.42 171.94 11.34 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.951 -0.389 . . . . 21.84 109.951 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -53.97 -64.22 0.9 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.58 0.752 . . . . 22.710000000000001 112.017 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mm 49.97 65.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 15.800000000000001 110.026 -174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.11 55.86 0.47 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.492 -1.843 . . . . 13.779999999999999 108.492 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -178.41 58.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.593 2.357 . . . . 13.960000000000001 110.118 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.2 mm -125.72 -57.48 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.799 0.84 . . . . 8.9399999999999995 109.404 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.61 -82.34 0.13 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.903 -0.57 . . . . 3.3199999999999998 110.781 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.41 -12.52 2.78 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 1.96 113.928 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.5199999999999996 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.3499999999999996 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.0299999999999998 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.0899999999999999 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 4.46 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.8700000000000001 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 4.4800000000000004 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 2.4700000000000002 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 1.8300000000000001 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.6900000000000004 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 2.73 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 4.8799999999999999 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 1.3 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 1.95 110.288 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 71' ' ' ILE . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 3.21 109.109 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 4.9000000000000004 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.66000000000000003 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.2200000000000002 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 0.93999999999999995 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 2.3199999999999998 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.0900000000000001 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.1899999999999999 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.7799999999999998 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 1.26 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 0.94999999999999996 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.727 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 0.89000000000000001 112.555 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.2199999999999998 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 152' ' ' LEU . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 0.88 107.321 165.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 2.3500000000000001 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 2.3199999999999998 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 1.0700000000000001 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 1.6699999999999999 109.501 171.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.6600000000000001 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 2.3500000000000001 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 1.49 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.26 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HG3' HD12 ' A' ' 71' ' ' ILE 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.0099999999999998 115.444 167.044 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.5499999999999998 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.1699999999999999 112.074 -167.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92000000000000004 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 3.6000000000000001 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.727 HG23 ' HA3' ' A' ' 65' ' ' GLY . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 1.8400000000000001 107.952 -169.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.8900000000000001 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 5.79 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 1.6200000000000001 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 3.9700000000000002 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 1.5600000000000001 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2000000000000002 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 2.5099999999999998 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.9399999999999999 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 0.96999999999999997 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.5800000000000001 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 1.72 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 1.8 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.3100000000000001 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 1.0600000000000001 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.6600000000000001 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 1.55 111.394 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 6.9400000000000004 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 4.0599999999999996 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.1399999999999997 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.0899999999999999 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 6.5199999999999996 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.04 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 5.2300000000000004 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 2.3999999999999999 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 1.1000000000000001 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 2.75 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 2.2200000000000002 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.68000000000000005 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 1.4099999999999999 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 0.85999999999999999 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 3.0499999999999998 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 5.4299999999999997 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.1400000000000001 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.4399999999999999 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 1.23 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 3.4500000000000002 108.365 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.64000000000000001 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.1200000000000001 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 2.2999999999999998 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.1099999999999999 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 152' ' ' LEU . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 0.77000000000000002 109.419 -171.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.1599999999999999 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.592 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 2.2200000000000002 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 4.5599999999999996 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 2.79 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.3300000000000001 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.2599999999999998 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.26 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 3.2999999999999998 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 155' ' ' LYS . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.0099999999999998 108.07 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 125' ' ' LEU . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.1899999999999999 109.21 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 0.90000000000000002 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.71999999999999997 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 2.6099999999999999 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 1.3999999999999999 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.1400000000000001 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 2.54 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 3.8999999999999999 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.3100000000000001 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.0099999999999998 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.7799999999999998 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.0800000000000001 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 2.3199999999999998 108.143 -171.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 2.9199999999999999 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 2.3799999999999999 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 1.5600000000000001 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.68999999999999995 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.0600000000000001 107.115 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 0.92000000000000004 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.05 109.798 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 134' ' ' GLU . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.2400000000000002 109.396 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.0800000000000001 110.118 -157.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.022 -0.362 . . . . 53.140000000000001 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.68 164.02 12.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.499 -1.667 . . . . 45.270000000000003 106.499 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -168.81 -177.78 3.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.98 -1.489 . . . . 41.149999999999999 106.98 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.83 169.24 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.813 2.045 . . . . 37.219999999999999 107.436 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -164.6 169.29 17.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.205 -1.406 . . . . 33.130000000000003 107.205 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.57 160.68 32.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.276 -1.379 . . . . 29.25 107.276 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.5 tp -157.41 146.45 19.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.746 -2.316 . . . . 25.309999999999999 104.746 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -159.2 172.63 17.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.675 -1.232 . . . . 21.84 107.675 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.61 155.28 2.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.658 1.583 . . . . 18.280000000000001 108.199 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -153.28 139.15 18.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.407 -1.331 . . . . 14.73 107.407 162.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.61 -166.64 2.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.688 1.595 . . . . 13.02 108.53 -168.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -143.6 168.64 19.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.633 0.651 . . . . 9.8499999999999996 110.326 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -171.84 54.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.896 -1.15 . . . . 6.2000000000000002 107.896 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.59 110.72 6.93 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.612 0.765 . . . . 11.699999999999999 110.706 -170.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.3 mm -105.78 -56.62 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.254 1.421 . . . . 15.91 109.212 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -152.78 -106.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.34 -1.356 . . . . 20.879999999999999 107.34 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -45.65 -42.66 11.69 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.359 1.063 . . . . 18.489999999999998 110.316 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -29.84 0.93 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.455 1.902 . . . . 13.529999999999999 113.926 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -48.04 -46.45 33.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.511 1.124 . . . . 10.779999999999999 110.928 171.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.84 -70.33 0.22 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.986 -0.746 . . . . 15.130000000000001 108.986 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -66.07 -55.51 16.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.486 0.55 . . . . 14.01 112.486 -168.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.16 -61.94 5.33 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.173 -0.771 . . . . 8.3000000000000007 111.173 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -70.07 -44.39 69.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 117.794 -1.098 . . . . 10.33 110.57 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.2 ptt? 37.42 66.92 0.41 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.787 1.235 . . . . 12.130000000000001 111.67 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.8 t 68.35 -67.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.525 1.53 . . . . 12.26 109.588 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.19 0.94 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.416 0.627 . . . . 12.76 111.915 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 79.39 0.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 18.32 109.252 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -58.98 105.29 0.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.879 1.272 . . . . 19.98 109.73 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -114.48 -74.46 0.62 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.89 -1.522 . . . . 20.829999999999998 106.89 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.54 -167.93 2.22 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.686 -2.709 . . . . 22.640000000000001 103.686 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -78.49 57.89 2.07 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.102 . . . . 17.5 109.745 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -144.46 164.14 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 105.766 -1.938 . . . . 15.369999999999999 105.766 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -127.17 3.88 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 103.266 -3.934 . . . . 10.4 103.266 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 76.92 -57.57 0.53 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.637 1.975 . . . . 7.9000000000000004 111.339 158.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -53.31 -67.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.05 1.74 . . . . 9.6799999999999997 109.799 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 169.32 168.47 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.281 2.232 . . . . 4.5999999999999996 106.368 -172.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.28 -53.12 0.53 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 2.5 108.099 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.1100000000000003 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.4800000000000004 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 2.5499999999999998 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 1.9299999999999999 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 2.6499999999999999 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7000000000000002 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 4.4699999999999998 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.8300000000000001 115.001 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 4.0099999999999998 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.779999999999999 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.0899999999999999 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.437 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 5.4400000000000004 111.604 -165.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 1.25 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 1.46 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 2.98 110.925 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 5.4100000000000001 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.96999999999999997 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 2.98 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 1.24 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 2.3700000000000001 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.1800000000000002 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.8300000000000001 112.943 173.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.3500000000000001 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 1.5900000000000001 105.701 153.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.0499999999999998 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.28 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 4.6699999999999999 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.72 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.5 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 2.3999999999999999 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.437 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 1.3999999999999999 108.355 168.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.679 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 1.49 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.4400000000000004 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 3.3900000000000001 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 2.29 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 1.52 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 5.3499999999999996 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.8899999999999999 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.25 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.9399999999999999 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 0.98999999999999999 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 3.9100000000000001 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 2.0499999999999998 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.6499999999999999 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 3.9300000000000002 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 1.74 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 5.4400000000000004 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 1.51 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.6200000000000001 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 2.0099999999999998 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.8700000000000001 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 0.93999999999999995 109.793 -169.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.2400000000000002 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 1.6100000000000001 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 1.29 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 1.6699999999999999 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.0800000000000001 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 1.51 108.764 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 8.3499999999999996 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 3.8700000000000001 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.0499999999999998 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.8199999999999998 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 4.6500000000000004 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 6.7999999999999998 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.2300000000000004 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 3.79 105.771 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 1.48 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 2.4199999999999999 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.02 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.79000000000000004 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 1.97 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 0.73999999999999999 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 2.0899999999999999 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 4.5 106.622 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 2.79 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 2.4900000000000002 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 1.3600000000000001 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.1299999999999999 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 3.29 108.669 163.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.69999999999999996 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 0.87 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 3.5499999999999998 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.1600000000000001 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 0.97999999999999998 112.892 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.4900000000000002 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 2.1400000000000001 106.044 155.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 5.8200000000000003 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 3.54 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.3300000000000001 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 3.4399999999999999 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 1.47 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 3.48 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.6200000000000001 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 125' ' ' LEU . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.5700000000000001 107.694 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 1.6499999999999999 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.04 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 1.79 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 0.84999999999999998 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 1.9199999999999999 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.0099999999999998 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.3900000000000001 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 3.0899999999999999 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.1600000000000001 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.1200000000000001 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 2.3500000000000001 109.364 -167.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 2.8300000000000001 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 2.5800000000000001 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 1.1899999999999999 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 0.93999999999999995 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 1.4199999999999999 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 1.7 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.04 109.381 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.29 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.3300000000000001 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.63 -1.618 . . . . 54.420000000000002 106.63 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -161.36 157.56 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.329 -1.73 . . . . 49.049999999999997 106.329 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -163.04 179.95 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.795 -1.557 . . . . 44.939999999999998 106.795 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.51 168.29 6.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.941 2.096 . . . . 40.520000000000003 107.459 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -166.74 -178.55 4.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.817 -1.549 . . . . 36.009999999999998 106.817 170.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.82 157.1 11.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.564 1.546 . . . . 31.640000000000001 107.802 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -142.7 159.24 42.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.569 -1.641 . . . . 28.469999999999999 106.569 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -163.58 166.94 21.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.837 -1.542 . . . . 23.800000000000001 106.837 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.24 175.84 8.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.331 -1.359 . . . . 19.829999999999998 107.331 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -159.38 -179.05 7.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.221 -1.4 . . . . 16.07 107.221 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -142.04 157.47 44.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.469 -1.678 . . . . 14.949999999999999 106.469 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 t -159.17 140.17 12.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.605 0.717 . . . . 9.7899999999999991 110.444 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -57.15 -43.02 82.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.975 2.91 . . . . 7.21 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -135.73 177.51 7.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.393 1.477 . . . . 10.720000000000001 108.533 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -134.36 148.75 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.163 1.385 . . . . 13.32 109.631 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 90.6 63.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.971 2.508 . . . . 19.309999999999999 110.147 166.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.73 -53.91 0.68 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.893 2.077 . . . . 17.25 111.681 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.7 m -32.89 -43.12 0.09 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.551 1.94 . . . . 14.07 112.117 159.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -38.22 -50.65 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.685 1.594 . . . . 11.029999999999999 112.443 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -52.1 -48.11 64.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.245 1.018 . . . . 14.92 110.539 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -70.02 -51.51 31.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.483 0.713 . . . . 13.220000000000001 110.383 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.85 -57.02 10.29 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.26 0.933 . . . . 8.5299999999999994 112.224 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -71.0 -5.52 31.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.257 1.206 . . . . 11.92 114.257 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.1 mtt 56.39 59.31 3.7 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.314 1.445 . . . . 11.84 111.28 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t 68.89 -69.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.779 1.632 . . . . 15.58 112.178 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.43 -95.45 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.665 -0.865 . . . . 15.050000000000001 108.665 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.4 166.56 0.61 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.359 2.264 . . . . 14.82 108.402 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -50.79 137.45 20.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.341 -0.614 . . . . 18.52 109.341 168.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 100.69 -35.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.784 2.834 . . . . 19.59 110.62 -171.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.6 116.54 31.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.475 -0.565 . . . . 17.43 109.475 -170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 69.81 -52.01 0.63 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.346 1.859 . . . . 18.66 111.082 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mt 59.53 48.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.028 1.331 . . . . 14.1 108.641 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.48 99.69 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.213 -1.155 . . . . 10.630000000000001 110.213 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -154.53 168.8 25.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.499 1.52 . . . . 9.3399999999999999 106.943 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.58 148.92 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.216 -1.031 . . . . 9.3300000000000001 108.216 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.71 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.992 0.517 . . . . 4.4400000000000004 112.132 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.68 46.31 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 2.79 111.679 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.5599999999999996 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 4.1500000000000004 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 3.4100000000000001 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 2.3399999999999999 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 3.7599999999999998 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.0600000000000001 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 5.5999999999999996 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 2.2599999999999998 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 1.9399999999999999 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.3200000000000003 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 73' ' ' PHE . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 2.9900000000000002 116.775 -160.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 1.73 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 7.79 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 2.3500000000000001 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 1.6200000000000001 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 4.4500000000000002 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 5.54 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.0 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.46 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.0600000000000001 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 2.3100000000000001 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.3100000000000001 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.1899999999999999 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.4699999999999998 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.7200000000000002 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 1.6000000000000001 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.2 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.03 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.21 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 1.52 109.629 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 1.8500000000000001 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 2.6299999999999999 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 0.92000000000000004 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 1.74 106.833 158.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.2400000000000002 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 3.04 113.437 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 1.3999999999999999 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 1.5900000000000001 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.1900000000000004 114.268 169.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.402 ' CD ' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.8899999999999999 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.1399999999999999 111.704 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.8599999999999999 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.3200000000000001 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.0899999999999999 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 3.8900000000000001 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.7200000000000002 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 4.6799999999999997 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 1.8200000000000001 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 4.2999999999999998 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 1.98 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6000000000000001 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2000000000000002 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 2.29 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.1499999999999999 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 1.0 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.0800000000000001 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 2.21 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 2.3999999999999999 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 1.3999999999999999 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 1.24 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7000000000000002 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.1299999999999999 112.887 -176.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.0800000000000001 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 3.8999999999999999 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 3.7000000000000002 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 6.8300000000000001 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 8.3699999999999992 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 5.5199999999999996 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 2.6699999999999999 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 1.53 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 2.6699999999999999 107.895 164.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 1.4299999999999999 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 0.92000000000000004 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 2.48 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 0.80000000000000004 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 2.3399999999999999 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 7.5 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.3899999999999997 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.3599999999999999 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 2.8100000000000001 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.8999999999999999 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 6.1799999999999997 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.0 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.1499999999999999 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 2.54 111.942 -171.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 1.5800000000000001 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 152' ' ' LEU . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 1.54 110.184 -171.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 3.2999999999999998 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 5.9699999999999998 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 3.21 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.6099999999999999 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 5.6600000000000001 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 1.6699999999999999 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 2.6299999999999999 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.6100000000000003 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 154' ' ' ALA . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 1.79 107.919 -173.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 1.54 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.01 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 1.77 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 0.80000000000000004 110.513 163.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.0299999999999998 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.1000000000000001 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 4.8399999999999999 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.0099999999999998 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 3.1899999999999999 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.6499999999999999 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.5700000000000001 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 1.6799999999999999 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 2.6200000000000001 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 2.4399999999999999 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 1.23 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.77000000000000002 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.464 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.1200000000000001 107.946 -171.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 0.97999999999999998 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 1.26 110.85 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 4.6100000000000003 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.7699999999999996 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 107.098 -1.445 . . . . 59.299999999999997 107.098 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 61.52 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.751 1.22 . . . . 54.420000000000002 111.639 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -96.9 101.04 12.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.109 1.364 . . . . 49.579999999999998 109.209 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -81.85 158.09 24.17 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.848 -0.797 . . . . 44.740000000000002 108.848 167.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.5 t -69.67 179.98 1.96 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.645 -0.502 . . . . 39.5 109.645 170.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -135.1 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.785 -1.561 . . . . 35.009999999999998 106.785 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -90.84 167.29 12.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.968 -1.493 . . . . 30.440000000000001 106.968 154.178 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -53.72 150.83 6.81 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.217 -0.29 . . . . 26.030000000000001 110.217 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.08 -44.74 61.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.429 0.692 . . . . 22.420000000000002 110.488 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -164.79 -176.09 4.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.684 -1.228 . . . . 17.920000000000002 107.684 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -84.3 175.01 9.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.597 1.159 . . . . 18.809999999999999 108.079 162.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 13' ' ' GLU . 35.1 m 61.78 -170.21 0.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.581 -0.896 . . . . 10.859999999999999 108.581 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 12' ' ' THR . 11.2 mt-10 -62.32 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.055 1.298 . . . . 9.3699999999999992 110.729 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -154.72 171.1 20.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.939 1.296 . . . . 14.51 109.682 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.35 160.62 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 126.784 2.034 . . . . 17.760000000000002 110.965 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -70.3 0.16 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.012 1.725 . . . . 17.690000000000001 108.588 -175.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 100' ' ' LYS . 1.2 m-20 -61.81 -10.26 8.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.857 1.263 . . . . 16.82 110.241 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 11.9 t -27.64 -26.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 131.29 3.836 . . . . 11.56 115.55 163.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.13 -88.18 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.612 1.165 . . . . 11.43 109.248 168.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.25 -18.61 38.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.316 1.046 . . . . 12.949999999999999 113.251 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 18' ' ' SER . 80.2 p -55.42 -9.24 0.44 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.12 1.768 . . . . 9.0 113.678 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.46 -7.89 0.03 OUTLIER Glycine 0 CA--C 1.537 1.424 0 CA-C-O 119.03 -0.872 . . . . 7.75 114.166 160.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -26.04 -61.03 0.08 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.552 1.176 . . . . 9.8399999999999999 111.651 150.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ttt 61.71 -72.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.85 1.66 . . . . 13.58 112.733 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.62 -36.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.864 1.266 . . . . 16.02 112.044 -167.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.37 105.55 1.29 Allowed 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.491 -0.756 . . . . 17.859999999999999 109.437 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -143.33 -33.5 0.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.743 -1.122 . . . . 18.77 113.651 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 66.04 81.58 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.371 1.068 . . . . 25.809999999999999 112.94 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -126.22 167.87 14.85 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.706 -1.22 . . . . 20.780000000000001 107.706 164.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -58.41 -51.69 68.76 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.792 0.806 . . . . 26.219999999999999 109.46 166.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 154.84 117.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 130.156 3.382 . . . . 22.050000000000001 104.475 -167.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.14 -71.01 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.568 -1.271 . . . . 17.309999999999999 107.568 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -132.83 -103.34 0.85 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 106.015 -2.834 . . . . 14.82 106.015 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.1 m-20 -59.19 158.75 8.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.474 1.51 . . . . 12.0 109.759 164.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 34' ' ' ASP . 15.6 pt -168.24 135.47 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 126.568 1.947 . . . . 11.66 106.74 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.67 26.72 1.39 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.559 1.072 . . . . 4.2999999999999998 113.834 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 40' ' ' THR . . . -166.13 -55.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 2.73 111.185 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 10.76 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.495 HG22 ' CA ' ' A' ' 37' ' ' GLY . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 3.8199999999999998 109.213 -165.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.1400000000000001 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 5.21 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7000000000000002 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 4.1299999999999999 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 2.7799999999999998 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 3.21 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.7999999999999998 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 2.7599999999999998 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 1.99 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 5.5499999999999998 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' H ' HG13 ' A' ' 71' ' ' ILE . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 1.49 108.759 158.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 1.5600000000000001 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 2.9199999999999999 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 5.7599999999999998 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 0.85999999999999999 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.1600000000000001 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 0.90000000000000002 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 2.0899999999999999 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 1.8700000000000001 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.2400000000000002 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.9199999999999999 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 1.0600000000000001 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.0600000000000001 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.1000000000000001 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 3.5800000000000001 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 1.04 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.52 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 1.99 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 1.1200000000000001 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 1.6599999999999999 109.122 174.085 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 71' ' ' ILE . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 2.8799999999999999 115.943 -167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 1.74 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 1.2 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 4.4699999999999998 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.3199999999999998 106.668 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.27 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.6099999999999999 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 94' ' ' LEU . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.79000000000000004 106.587 161.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 5.8600000000000003 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB ' ' A' ' 92' ' ' VAL 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 3.3799999999999999 107.702 -177.093 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.6899999999999999 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 3.8399999999999999 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 90' ' ' LEU . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 1.9199999999999999 109.859 -158.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 3.8799999999999999 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.02 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 1.8300000000000001 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.6299999999999999 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 85' ' ' LEU . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 2.5899999999999999 110.921 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1000000000000001 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' A' ' 82' ' ' ILE . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 0.94999999999999996 109.08 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 80' ' ' GLY . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 1.6299999999999999 109.134 -173.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 1.48 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 1.95 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 1.1000000000000001 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.0899999999999999 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 1.72 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 6.9800000000000004 111.976 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.411 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.0700000000000003 113.642 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.0099999999999998 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 6.7000000000000002 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 10.85 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 7.6900000000000004 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 2.7400000000000002 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 1.1699999999999999 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 2.3700000000000001 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 2.3399999999999999 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 0.90000000000000002 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.5800000000000001 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 0.79000000000000004 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 2.98 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 5.8399999999999999 108.286 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.6600000000000001 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.2599999999999998 109.201 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 1.47 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.0600000000000001 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.59999999999999998 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 0.81999999999999995 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 2.3300000000000001 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 2.52 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.1000000000000001 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.0800000000000001 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 3.0 108.547 176.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 4.5099999999999998 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 2.4900000000000002 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.8500000000000001 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.27 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 1.3100000000000001 113.241 172.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 2.9100000000000001 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.0800000000000001 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 154' ' ' ALA . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 1.8600000000000001 108.42 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 2.23 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.27 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 2.2799999999999998 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.01 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.0300000000000002 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 1.97 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 3.7599999999999998 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 2.4399999999999999 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.0699999999999998 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.9300000000000002 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 0.94999999999999996 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 1.4199999999999999 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 3.7000000000000002 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 2.2999999999999998 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 1.3400000000000001 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.0800000000000001 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 1.1699999999999999 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 1.03 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 0.88 108.835 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.1500000000000004 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.0300000000000002 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.02 -1.104 . . . . 54.350000000000001 108.02 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -161.82 169.99 20.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.113 -1.81 . . . . 46.850000000000001 106.113 176.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -151.39 164.04 37.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.452 -1.314 . . . . 44.049999999999997 107.452 171.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.4 171.65 16.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.472 1.909 . . . . 39.009999999999998 106.538 178.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -163.06 173.79 13.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.88 1.272 . . . . 34.960000000000001 107.597 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.11 172.83 16.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.795 -1.187 . . . . 30.739999999999998 107.795 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -136.74 173.69 11.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.631 1.572 . . . . 26.960000000000001 109.109 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -144.78 159.4 42.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 23.48 109.035 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.92 168.64 24.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.869 1.267 . . . . 19.600000000000001 107.6 173.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -163.55 159.54 22.05 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.242 -1.392 . . . . 16.23 107.242 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -161.87 172.42 16.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.635 1.174 . . . . 14.039999999999999 109.173 177.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -135.09 -157.37 0.79 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.668 1.587 . . . . 10.550000000000001 109.083 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.65 133.32 13.61 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.169 -1.049 . . . . 7.21 108.169 172.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 162.45 -81.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.734 2.414 . . . . 13.09 110.494 -175.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -152.46 142.69 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.351 1.06 . . . . 14.99 108.47 -170.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 38.1 tp60 76.91 -174.99 0.1 Allowed 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 126.819 2.048 . . . . 16.989999999999998 108.607 176.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 2.3 m-20 -43.94 -36.77 2.57 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.081 -1.012 . . . . 14.67 113.318 -177.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 m -35.6 -43.97 0.29 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.94 1.696 . . . . 10.43 113.684 169.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -39.65 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.075 1.75 . . . . 12.27 111.257 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.41 -49.31 50.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.978 -0.555 . . . . 13.06 110.339 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -64.58 -25.71 68.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.19 0.441 . . . . 10.34 112.19 -166.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.99 -68.93 1.49 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.768 -1.333 . . . . 9.4299999999999997 109.768 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -53.83 13.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.149 0.796 . . . . 11.92 113.149 -169.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.62 76.58 0.99 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.395 1.478 . . . . 11.69 108.865 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.2 t -41.83 139.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.522 1.929 . . . . 14.99 112.563 -179.056 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.08 98.89 0.05 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.898 2.079 . . . . 16.870000000000001 110.959 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -68.76 124.08 22.67 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.984 -0.448 . . . . 17.27 111.58 -177.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -107.01 58.77 0.63 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.941 -1.133 . . . . 20.699999999999999 107.941 166.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 49.09 40.7 17.99 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.269 1.428 . . . . 21.640000000000001 112.908 173.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -57.07 -60.37 3.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.799 0.666 . . . . 19.25 112.799 -167.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -165.53 61.18 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.236 -1.765 . . . . 18.350000000000001 106.236 -176.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.45 76.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 13.539999999999999 110.384 -163.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.54 85.53 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.061 -1.216 . . . . 9.6400000000000006 110.061 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.05 69.27 0.67 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.821 1.248 . . . . 8.7599999999999998 110.791 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.86 -74.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.308 -1.738 . . . . 8.5500000000000007 106.308 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 33.77 78.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.767 1.627 . . . . 4.7999999999999998 111.768 -171.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.06 1.49 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 2.8300000000000001 113.483 -161.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.3899999999999997 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' NE2' HD11 ' A' ' 99' ' ' ILE . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.4199999999999999 111.812 -170.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 2.7000000000000002 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.1600000000000001 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 3.5099999999999998 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.4800000000000004 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 6.6900000000000004 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 2.3300000000000001 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.1000000000000001 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.6499999999999999 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.0 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 8.7100000000000009 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 1.8300000000000001 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 1.8999999999999999 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 4.9100000000000001 112.524 157.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 5.96 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.0700000000000001 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.3100000000000001 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 0.94999999999999996 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 2.1400000000000001 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.6599999999999999 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.3799999999999999 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.3999999999999999 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 1.3600000000000001 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 0.89000000000000001 113.671 -174.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 3.6699999999999999 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 1.3899999999999999 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 1.75 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 3.0899999999999999 112.398 -172.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 1.3500000000000001 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.591 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 1.6000000000000001 111.16 173.182 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.4699999999999998 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 2.2999999999999998 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 1.5700000000000001 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.1200000000000001 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 5.2699999999999996 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.3599999999999999 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.1799999999999999 110.932 -175.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.9700000000000002 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.04 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 3.6299999999999999 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.523 ' O ' HG22 ' A' ' 82' ' ' ILE . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 1.9199999999999999 107.504 178.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.2200000000000002 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 3.2799999999999998 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 1.76 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 3.5600000000000001 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 1.3899999999999999 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.6200000000000001 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.0600000000000001 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 2.3700000000000001 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.72 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 1.1100000000000001 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.2799999999999998 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 2.5800000000000001 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.01 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 1.1499999999999999 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 1.1200000000000001 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.4900000000000002 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.21 103.619 166.862 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 7.3399999999999999 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 3.1800000000000002 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.0700000000000003 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.1399999999999997 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 5.4900000000000002 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 9.0399999999999991 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.4800000000000004 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.0600000000000001 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 1.1799999999999999 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 2.1800000000000002 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 1.8500000000000001 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.96999999999999997 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.3600000000000001 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 0.81000000000000005 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 2.1200000000000001 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 5.4100000000000001 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.1400000000000001 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.0699999999999998 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 1.4299999999999999 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 3.25 109.438 165.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.63 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 0.82999999999999996 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 2.54 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 1.49 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 0.91000000000000003 111.96 -163.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2000000000000002 113.064 -168.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 2.29 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 4.9500000000000002 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 4.1600000000000001 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.6800000000000002 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 3.4900000000000002 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.04 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 3.4399999999999999 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.6299999999999999 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 1.8700000000000001 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 0.84999999999999998 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.1100000000000001 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 2.25 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 1.1799999999999999 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 2.0899999999999999 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.2400000000000002 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.2999999999999998 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 2.2799999999999998 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.5800000000000001 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 0.98999999999999999 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 1.52 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 2.8199999999999998 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 2.2000000000000002 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 1.22 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.1200000000000001 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 1.29 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 1.1799999999999999 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 1.5900000000000001 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 3.3900000000000001 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.8599999999999999 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 106.629 -1.619 . . . . 58.609999999999999 106.629 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.42 144.24 56.09 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.986 0.812 . . . . 51.659999999999997 109.3 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -161.6 157.69 25.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.87 -1.529 . . . . 47.32 106.87 171.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -173.24 157.06 3.3 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.941 1.697 . . . . 43.039999999999999 106.862 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -163.43 171.99 15.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.844 -1.539 . . . . 38.560000000000002 106.844 165.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.78 5.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.658 1.583 . . . . 34.350000000000001 107.642 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 pp -151.15 162.8 40.2 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.291 1.436 . . . . 29.850000000000001 107.996 178.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -165.33 -134.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.256 0.622 . . . . 26.0 109.455 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.42 163.35 0.17 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.009 2.524 . . . . 22.379999999999999 111.084 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -143.86 159.86 41.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.563 1.145 . . . . 18.289999999999999 109.88 -174.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.74 157.07 0.13 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.951 2.101 . . . . 17.989999999999998 108.099 170.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -159.78 179.41 8.85 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.586 -2.376 . . . . 11.17 104.586 169.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.88 77.55 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.443 1.497 . . . . 8.1600000000000001 111.331 -170.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.52 -164.85 0.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.547 1.939 . . . . 15.07 108.907 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -133.88 146.69 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 106.407 -1.701 . . . . 15.59 106.407 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 85.87 73.33 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 128.103 2.561 . . . . 22.539999999999999 109.783 178.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.04 -53.13 0.67 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.146 2.178 . . . . 23.800000000000001 111.287 172.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.4 m -48.82 -22.37 0.81 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.06 1.344 . . . . 17.890000000000001 112.938 169.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.01 -49.53 50.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.751 0.82 . . . . 17.23 112.293 169.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -71.33 -36.03 71.42 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.829 -0.544 . . . . 22.239999999999998 112.407 -169.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -70.52 -50.12 41.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.685 -0.857 . . . . 17.289999999999999 108.685 169.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -34.85 -50.18 0.78 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 127.453 2.454 . . . . 13.109999999999999 113.273 173.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -31.52 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.646 2.778 . . . . 16.870000000000001 115.047 170.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.86 75.34 1.63 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.864 0.84 . . . . 17.5 110.809 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.0 t -55.61 80.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 127.21 2.204 . . . . 16.809999999999999 108.279 165.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.43 -41.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.351 1.46 . . . . 18.879999999999999 109.429 -168.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -52.41 40.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.349 0.87 . . . . 20.170000000000002 113.349 -175.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -155.97 174.53 15.21 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.306 1.442 . . . . 22.370000000000001 108.185 -174.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -138.12 -52.32 0.61 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 124.28 0.988 . . . . 17.379999999999999 108.688 157.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 61.84 -158.38 0.33 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.677 -0.86 . . . . 17.370000000000001 108.677 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -69.43 -39.52 77.81 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.654 -0.653 . . . . 21.210000000000001 110.215 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.7 mt -141.86 135.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.601 -2.0 . . . . 16.989999999999998 105.601 175.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.78 49.12 0.04 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.536 1.541 . . . . 12.0 109.713 178.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -159.36 56.21 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.305 1.042 . . . . 12.06 109.558 -148.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.4 mm -71.54 164.43 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.17 -1.048 . . . . 9.8200000000000003 108.17 171.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.64 64.5 1.29 Allowed 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.866 -0.521 . . . . 7.29 111.115 -174.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.73 60.32 7.92 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.303 -0.873 . . . . 2.9300000000000002 111.208 175.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.8300000000000001 113.128 -175.487 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 4.2699999999999996 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' LYS . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 2.6499999999999999 111.17 165.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.1000000000000001 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 4.4900000000000002 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.0300000000000002 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 3.9100000000000001 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 3.3199999999999998 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.0499999999999998 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.8499999999999996 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 2.9399999999999999 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 1.8799999999999999 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.1799999999999997 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 1.3999999999999999 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 1.8 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' H ' ' HB3' ' A' ' 69' ' ' TYR 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 4.4400000000000004 116.967 -177.832 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 4.9299999999999997 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 0.94999999999999996 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 3.6200000000000001 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 1.24 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 2.3399999999999999 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.93999999999999995 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 1.8300000000000001 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.1899999999999999 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.3799999999999999 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 1.0600000000000001 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.04 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.1900000000000004 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD13 HD21 ' A' ' 152' ' ' LEU . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 1.6200000000000001 109.63 174.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.2400000000000002 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 2.6899999999999999 111.597 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 1.73 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 2.2999999999999998 104.518 160.3 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.9900000000000002 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 3.0600000000000001 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.3100000000000001 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 1.5800000000000001 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HG2' HG21 ' A' ' 40' ' ' THR . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 7.6600000000000001 113.969 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.7000000000000002 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.1400000000000001 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.85999999999999999 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 6.6500000000000004 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 1.98 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.3399999999999999 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 4.3799999999999999 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 2.9500000000000002 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 4.0999999999999996 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 2.4399999999999999 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.5299999999999998 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.3499999999999996 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.0600000000000001 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.8399999999999999 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 1.1000000000000001 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.3199999999999998 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 1.78 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 1.0800000000000001 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 1.5700000000000001 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 1.1299999999999999 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.8900000000000001 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 1.9399999999999999 108.543 170.001 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 7.7599999999999998 110.138 163.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 6.3899999999999997 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.6800000000000002 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 4.4000000000000004 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 7.5999999999999996 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.436 ' CB ' HG23 ' A' ' 40' ' ' THR 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 6.1900000000000004 112.013 -178.121 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 2.5600000000000001 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 1.45 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 110' ' ' SER . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 2.96 108.242 157.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 109' ' ' ILE . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 1.8999999999999999 110.937 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.77000000000000002 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 1.3600000000000001 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.89000000000000001 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 2.3399999999999999 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 6.3499999999999996 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 3.6299999999999999 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 2.0699999999999998 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 1.8400000000000001 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.04 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.63 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.05 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 2.5499999999999998 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 1.5600000000000001 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD23 HD12 ' A' ' 152' ' ' LEU . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 0.79000000000000004 108.015 -174.684 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.1100000000000001 111.402 -177.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 3.1899999999999999 111.2 -174.261 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 7.0599999999999996 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 3.2400000000000002 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.3599999999999999 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 5.8499999999999996 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' H ' HD11 ' A' ' 127' ' ' ILE . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.47 107.117 -164.026 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 2.6800000000000002 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.1499999999999999 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 154' ' ' ALA . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 1.2 106.545 155.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 1.1299999999999999 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.70999999999999996 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 1.9099999999999999 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 0.69999999999999996 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.0499999999999998 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 2.1000000000000001 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.2000000000000002 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 2.5 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.1099999999999999 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.6499999999999999 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.03 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 2.21 106.872 -171.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 2.8599999999999999 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 2.2799999999999998 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 1.48 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.1299999999999999 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.672 HD12 HD23 ' A' ' 125' ' ' LEU . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.25 107.57 -175.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 1.1200000000000001 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.1799999999999999 109.879 174.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 4.5199999999999996 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.3700000000000001 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.156 -0.683 . . . . 64.819999999999993 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -166.87 154.25 9.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.087 -1.449 . . . . 56.079999999999998 107.087 -175.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -158.26 58.47 0.46 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.456 -0.942 . . . . 51.479999999999997 108.456 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -117.48 65.42 0.73 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.02 0.928 . . . . 48.460000000000001 108.658 -169.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -155.81 117.59 4.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.793 -0.818 . . . . 41.450000000000003 108.793 -177.153 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.37 62.87 1.22 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.183 0.993 . . . . 36.82 108.722 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD13 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.67 179.41 6.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.988 1.715 . . . . 32.409999999999997 108.762 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -150.99 161.43 42.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.744 -1.206 . . . . 27.620000000000001 107.744 169.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.18 113.89 0.56 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.074 -1.454 . . . . 23.359999999999999 107.074 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -74.18 71.61 1.68 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.618 -0.882 . . . . 19.5 108.618 177.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 68.0 -67.13 0.2 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.865 2.066 . . . . 17.0 109.741 -174.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m 56.45 22.09 6.17 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.811 1.645 . . . . 12.960000000000001 112.241 174.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 104' ' ' LYS . 20.7 mm-40 36.14 47.14 0.43 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.476 2.31 . . . . 9.6799999999999997 113.164 -164.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 64.51 -173.0 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.058 1.343 . . . . 16.539999999999999 110.057 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm 66.53 -34.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.995 1.318 . . . . 15.34 114.446 -176.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 75.34 -48.13 0.61 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 128.165 2.586 . . . . 17.300000000000001 110.984 178.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.18 -104.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.015 -1.106 . . . . 13.73 108.015 167.331 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -28.88 -69.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.493 2.317 . . . . 11.92 113.876 -168.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.19 -4.93 8.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.765 1.765 . . . . 11.32 115.765 -169.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -46.61 -35.62 6.09 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.927 1.239 . . . . 10.17 110.258 159.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -49.65 -61.17 2.26 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.467 1.507 . . . . 8.7799999999999994 111.461 168.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.72 -46.16 76.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 6.5199999999999996 110.874 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.12 -45.68 92.17 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 116.967 -1.492 . . . . 12.66 112.048 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 146.51 -1.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.648 2.379 . . . . 9.75 115.418 172.338 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t 68.71 -68.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.312 1.415 . . . . 12.039999999999999 111.92 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.39 87.39 0.11 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 127.255 2.222 . . . . 14.06 111.32 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -167.35 -146.83 0.08 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.752 0.421 . . . . 16.43 110.388 -171.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -75.22 61.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.644 1.178 . . . . 21.199999999999999 110.94 -176.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -161.59 -66.66 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.772 -1.566 . . . . 16.109999999999999 106.772 169.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -140.68 175.67 9.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.198 0.999 . . . . 16.57 109.513 176.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.4 73.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.337 1.855 . . . . 17.870000000000001 106.167 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mt -130.4 128.75 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.503 -1.295 . . . . 12.06 107.503 -176.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.54 64.7 2.88 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.703 -1.359 . . . . 9.6699999999999999 109.703 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -143.39 173.54 11.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.912 1.685 . . . . 9.3100000000000005 107.68 -175.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt 68.36 -74.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.436 1.894 . . . . 7.5899999999999999 110.762 173.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 28.93 61.81 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.097 2.159 . . . . 4.9299999999999997 112.89 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -73.12 90.65 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 2.96 111.052 -170.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.0700000000000003 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.3200000000000003 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 2.27 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 1.7 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 3.4500000000000002 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.0199999999999996 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 5.6500000000000004 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 3.02 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 1.95 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.5899999999999999 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 1.8200000000000001 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 1.8300000000000001 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 5.4500000000000002 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 1.77 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 156' ' ' GLN . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.2200000000000002 109.202 176.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' CE1' HD13 ' A' ' 71' ' ' ILE . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 3.3900000000000001 108.053 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 5.3799999999999999 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 2.21 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.90000000000000002 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 2.25 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.1200000000000001 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.1200000000000001 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.5099999999999998 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.8199999999999998 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.04 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 0.70999999999999996 112.32 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 3.7400000000000002 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 1.3300000000000001 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 2.04 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 2.2000000000000002 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.8700000000000001 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 1.51 106.605 170.242 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.2799999999999998 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 2.4700000000000002 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 1.6200000000000001 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 1.3799999999999999 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.0499999999999998 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 2.3199999999999998 107.194 172.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.4099999999999999 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.2599999999999998 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 5.1200000000000001 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.783 HG23 ' HA3' ' A' ' 65' ' ' GLY . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 1.8300000000000001 106.56 172.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.4900000000000002 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 3.73 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 1.8100000000000001 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 3.6499999999999999 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 1.8700000000000001 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.1200000000000001 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.5300000000000002 110.277 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 2.1299999999999999 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.2400000000000002 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 115' ' ' TYR . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 1.05 108.465 -174.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.0600000000000001 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 1.8100000000000001 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 1.95 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.04 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.1299999999999999 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 1.3999999999999999 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 8.3300000000000001 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 3.9700000000000002 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.9800000000000004 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 4.0300000000000002 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 9.5099999999999998 110.912 -174.519 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.039999999999999 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.0 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 3.8199999999999998 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 1.47 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 2.6499999999999999 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.3799999999999999 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.68999999999999995 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 1.4299999999999999 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 141' ' ' VAL . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 1.0900000000000001 113.656 178.878 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 2.1099999999999999 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 4.7800000000000002 104.711 174.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.4399999999999999 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 1.21 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 7.8300000000000001 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.0900000000000001 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 0.78000000000000003 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 2.73 109.695 -176.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 1.9299999999999999 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 0.76000000000000001 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.1699999999999999 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 2.3500000000000001 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 5.0199999999999996 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 3.5600000000000001 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.5499999999999998 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 5.3899999999999997 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 1.55 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 3.9900000000000002 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 1.5800000000000001 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 0.92000000000000004 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.90000000000000002 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 2.5600000000000001 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 0.78000000000000003 112.069 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.4399999999999999 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 113' ' ' VAL . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 2.2000000000000002 106.559 -166.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 3.3700000000000001 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 2.7200000000000002 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 1.8 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.5800000000000001 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.05 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 1.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 2.5899999999999999 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 3.3799999999999999 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 1.3100000000000001 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 0.83999999999999997 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 1.3899999999999999 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 1.05 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 1.27 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 3.5800000000000001 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' A' ' 52' ' ' THR . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.3300000000000001 110.752 -177.22 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.332 -1.729 . . . . 51.829999999999998 106.332 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.88 175.63 9.57 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 106.948 -1.501 . . . . 45.789999999999999 106.948 174.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 p -155.08 169.63 23.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.155 -1.054 . . . . 42.07 108.155 -177.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -145.26 -179.76 6.85 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 38.310000000000002 107.381 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -157.61 162.88 38.74 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.904 1.282 . . . . 34.240000000000002 107.549 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.44 171.11 7.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.636 1.175 . . . . 30.18 109.941 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.56 -179.07 3.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 26.559999999999999 109.47 175.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -139.04 174.95 9.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.802 1.241 . . . . 23.370000000000001 107.99 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.37 20.42 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.911 1.284 . . . . 19.98 107.666 177.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -134.31 136.75 43.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.661 0.785 . . . . 19.489999999999998 110.85 -173.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -175.63 3.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.582 0.706 . . . . 15.48 109.625 158.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 t -164.24 -161.53 0.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.349 -2.093 . . . . 10.67 105.349 168.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -74.17 62.4 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.74 1.616 . . . . 7.2000000000000002 109.338 175.19 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 62.23 165.85 0.11 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.654 1.982 . . . . 11.550000000000001 114.077 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 pt -172.14 97.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 127.042 2.137 . . . . 13.98 108.885 176.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -123.32 71.11 1.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.761 -1.2 . . . . 16.399999999999999 107.761 148.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.0 t70 64.13 -67.79 0.1 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.543 1.937 . . . . 15.720000000000001 111.063 -176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 m -32.42 -68.8 0.09 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.828 2.051 . . . . 14.27 112.366 172.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.25 -9.89 36.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.205 0.602 . . . . 11.210000000000001 112.411 -173.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -57.22 -28.15 62.64 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.659 1.118 . . . . 13.24 110.567 171.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.7 p -69.4 -74.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.747 -0.835 . . . . 12.48 108.747 165.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -31.71 -50.88 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 127.711 2.577 . . . . 8.6199999999999992 114.57 -177.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -18.58 61.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 114.934 1.457 . . . . 12.369999999999999 114.934 -174.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.8 mmt 40.1 53.96 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.348 0.976 . . . . 13.74 111.777 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.39 16.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 15.24 112.504 169.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.13 14.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.29 1.589 . . . . 14.19 115.29 -162.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -62.44 170.45 2.4 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.915 2.086 . . . . 20.870000000000001 112.744 -168.44 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.38 118.42 22.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.077 -1.453 . . . . 18.399999999999999 107.077 165.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.49 136.9 14.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.101 -1.074 . . . . 19.699999999999999 108.101 161.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.06 -71.13 0.48 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.499 0.32 . . . . 20.109999999999999 110.429 -170.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 50.17 31.73 5.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.429 1.091 . . . . 19.850000000000001 111.592 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp 59.72 104.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.147 1.379 . . . . 16.440000000000001 109.655 -163.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.34 74.12 0.2 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.642 1.115 . . . . 12.029999999999999 111.34 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.29 -51.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.78 2.432 . . . . 8.8699999999999992 108.197 -171.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mt -75.51 68.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.065 0.946 . . . . 10.99 109.117 -178.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.8 118.38 6.11 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.371 0.669 . . . . 5.1399999999999997 109.523 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.43 -56.81 2.74 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 3.9900000000000002 109.788 -177.413 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.9400000000000004 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 5.6100000000000003 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 3.7999999999999998 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 2.48 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 2.98 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.1400000000000001 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 3.8500000000000001 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 2.1400000000000001 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 1.6399999999999999 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.0199999999999996 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.4199999999999999 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 1.8500000000000001 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 6.2599999999999998 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 1.47 111.5 -178.514 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 52' ' ' THR . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.27 110.611 -165.526 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 3.6200000000000001 110.031 -178.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 4.96 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.65000000000000002 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 2.96 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.6200000000000001 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 2.46 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.29 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.2200000000000002 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.2400000000000002 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.2800000000000002 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.0600000000000001 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.806 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 0.93999999999999995 111.987 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.2000000000000002 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 0.81000000000000005 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 2.52 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 2.2200000000000002 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 1.6599999999999999 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.614 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 1.28 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.5499999999999998 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 2.8199999999999998 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 2.6299999999999999 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' A' ' 98' ' ' ASP . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 1.9199999999999999 114.021 -162.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 4.6200000000000001 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.3200000000000001 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.6299999999999999 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.87 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 4.2800000000000002 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.806 HG23 ' HA3' ' A' ' 65' ' ' GLY . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.1000000000000001 106.647 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.3499999999999996 104.082 153.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 5.0099999999999998 107.493 37.135 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 1.8899999999999999 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 4.5 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 2.1200000000000001 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.1099999999999999 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 2.7200000000000002 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.9399999999999999 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 1.0700000000000001 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.1899999999999999 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 1.9299999999999999 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 1.97 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 1.25 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 1.02 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.443 ' OD1' ' HB1' ' A' ' 75' ' ' ALA . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.4699999999999998 110.302 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.1299999999999999 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.1500000000000004 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 4.5700000000000003 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.0999999999999996 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.3700000000000001 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 5.7800000000000002 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 6.2599999999999998 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 5.5499999999999998 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 2.6600000000000001 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 1.74 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 2.6099999999999999 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 1.6000000000000001 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.83999999999999997 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 1.3200000000000001 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 0.85999999999999999 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 1.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 6.79 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.2000000000000002 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.9500000000000002 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 2.6800000000000002 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 4.5199999999999996 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.55000000000000004 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 0.95999999999999996 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 2.29 109.87 178.978 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 1.95 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 126' ' ' GLY . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 1.3200000000000001 107.404 -176.29 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' HD13 ' A' ' 125' ' ' LEU . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 3.0 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 4.6399999999999997 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 2.7200000000000002 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.9500000000000002 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 3.7999999999999998 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 1.9099999999999999 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 3.0800000000000001 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7000000000000002 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 1.4099999999999999 106.356 170.101 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 1.24 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.3100000000000001 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.0 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 0.87 109.783 165.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.3500000000000001 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 2.1200000000000001 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 2.7400000000000002 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.0099999999999998 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.0499999999999998 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.3300000000000001 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 1.3999999999999999 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 2.6400000000000001 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 1.9199999999999999 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 2.3100000000000001 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.01 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 2.2799999999999998 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 1.3899999999999999 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 1.0600000000000001 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 4.0599999999999996 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 4.5099999999999998 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.464 -0.939 . . . . 67.420000000000002 108.464 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -173.29 -171.43 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.218 -1.771 . . . . 61.25 106.218 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.17 -172.58 4.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.116 -1.809 . . . . 57.109999999999999 106.116 159.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 166.78 3.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.266 1.826 . . . . 52.280000000000001 107.927 -176.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 t -152.94 -172.41 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.709 -1.219 . . . . 47.299999999999997 107.709 168.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.05 140.28 46.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.85 1.26 . . . . 42.560000000000002 109.4 -178.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.44 150.62 43.17 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.388 -0.597 . . . . 37.700000000000003 109.388 170.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -70.09 157.57 37.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.997 0.427 . . . . 34.25 110.001 174.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 165.74 23.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.552 -0.907 . . . . 29.129999999999999 108.552 160.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -133.56 175.6 9.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.923 1.289 . . . . 26.760000000000002 108.146 178.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -51.36 -60.33 3.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.683 0.793 . . . . 22.23 109.679 -176.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m 68.58 158.85 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.043 1.337 . . . . 16.07 111.409 175.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -49.59 -55.51 13.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.321 1.849 . . . . 11.16 110.434 -173.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.83 -178.52 4.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.583 -1.636 . . . . 14.16 106.583 164.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.34 150.31 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.114 -1.81 . . . . 19.760000000000002 106.114 177.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 87.43 0.12 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.955 1.302 . . . . 21.690000000000001 110.87 173.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.42 -62.41 0.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.546 1.938 . . . . 18.280000000000001 111.973 174.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.01 -41.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.403 1.881 . . . . 14.43 111.507 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -36.19 -56.12 0.77 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.45 1.5 . . . . 19.25 111.496 170.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -63.03 -43.81 97.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.589 0.756 . . . . 19.050000000000001 109.645 -175.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -43.98 96.52 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.374 -0.204 . . . . 11.67 110.57 178.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.41 -65.41 2.52 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.093 -0.803 . . . . 9.1699999999999999 111.093 -178.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -70.7 -32.15 69.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.577 1.551 . . . . 16.460000000000001 112.726 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.324 0.0 OUTLIER 30.81 -124.4 0.04 OUTLIER 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.274 1.83 . . . . 15.24 114.568 -171.606 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t 48.27 61.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.708 0.803 . . . . 19.629999999999999 109.695 170.362 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.09 70.6 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.736 -1.579 . . . . 20.140000000000001 106.736 -174.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttp 68.06 169.87 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.784 -1.553 . . . . 25.32 108.225 -153.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -145.79 143.84 29.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.001 -2.592 . . . . 20.120000000000001 104.001 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -166.46 -64.65 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.085 0 N-CA-C 108.834 -0.802 . . . . 22.57 108.834 -171.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.22 178.14 4.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.351 0.66 . . . . 20.289999999999999 110.295 -178.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -74.67 64.58 1.24 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.971 0.909 . . . . 20.949999999999999 110.758 -177.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.9 mt -83.94 147.03 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.406 1.482 . . . . 13.27 107.783 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 -154.4 5.41 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.551 0.528 . . . . 11.710000000000001 111.884 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -91.66 -37.32 13.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 128.952 2.901 . . . . 11.99 110.166 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -28.14 132.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 128.816 2.846 . . . . 8.9700000000000006 114.032 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.51 -63.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.842 2.057 . . . . 4.3300000000000001 107.364 161.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.54 61.98 3.88 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 2.5 110.616 176.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.1500000000000004 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 4.8600000000000003 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 2.71 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.21 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 3.0600000000000001 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.9100000000000001 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 5.1699999999999999 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 2.3300000000000001 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 1.8700000000000001 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.1900000000000004 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.0899999999999999 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 1.96 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.25 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 1.5600000000000001 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 1.9199999999999999 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 135' ' ' VAL . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 3.3500000000000001 108.234 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.0099999999999998 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 0.93000000000000005 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 2.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.1499999999999999 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 2.27 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 1.6899999999999999 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.4199999999999999 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 1.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.1000000000000001 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 3.77 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 1.0600000000000001 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.3300000000000001 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 2.0299999999999998 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.24 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 1.8 104.621 163.105 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 3.6200000000000001 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 1.3899999999999999 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 1.3400000000000001 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.1200000000000001 110.169 165.216 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.6699999999999999 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.27 111.912 -162.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.9199999999999999 109.13 -172.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.1200000000000001 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 1.9099999999999999 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.6400000000000001 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 3.3399999999999999 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 1.5600000000000001 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 3.9399999999999999 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 1.6100000000000001 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.6100000000000001 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.0800000000000001 113.534 175.481 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 2.1400000000000001 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.8400000000000001 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 1.0800000000000001 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 1.99 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 0.98999999999999999 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 1.98 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 1.3600000000000001 111.179 -167.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.5800000000000001 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 6.8700000000000001 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 4.3399999999999999 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 2.9300000000000002 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 5.79 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 7.3899999999999997 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 6.0199999999999996 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 2.5800000000000001 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 1.1499999999999999 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 3.1000000000000001 104.921 155.672 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 109' ' ' ILE . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 2.2799999999999998 109.713 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.0800000000000001 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.46 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 0.77000000000000002 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.1400000000000001 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.1200000000000001 106.415 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.0099999999999998 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.3900000000000001 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 1.27 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.9900000000000002 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 3.46 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.53000000000000003 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 0.80000000000000004 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 2.48 113.022 177.971 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 1.9199999999999999 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 152' ' ' LEU . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.02 108.209 -174.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.1299999999999999 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 2.52 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 5.1200000000000001 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 3.1200000000000001 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 2.8500000000000001 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 4.6699999999999999 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.1299999999999999 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 3.9399999999999999 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.1699999999999999 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 125' ' ' LEU . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 1.5700000000000001 106.153 165.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 1.0700000000000001 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.0700000000000001 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 1.78 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 0.68000000000000005 111.024 169.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 2.1299999999999999 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.1699999999999999 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 2.3100000000000001 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 1.99 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.1599999999999999 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 2.1800000000000002 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.4399999999999999 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 2.3900000000000001 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 1.3500000000000001 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 0.94999999999999996 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.505 HD11 HD23 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 1.78 112.458 173.08 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 1.25 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HB3' ' H ' ' A' ' 135' ' ' VAL . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.0900000000000001 107.27 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 3.98 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.3899999999999997 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 106.034 -1.839 . . . . 49.020000000000003 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.45 151.95 42.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.587 1.085 . . . . 42.119999999999997 109.926 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 p -161.77 127.58 3.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.863 -1.162 . . . . 38.450000000000003 107.863 -178.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -133.15 165.28 25.13 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.64 1.176 . . . . 35.159999999999997 108.359 176.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 m -164.11 172.36 13.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.738 2.015 . . . . 31.039999999999999 106.37 177.535 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.19 15.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.087 0.955 . . . . 27.350000000000001 108.706 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.08 -174.34 3.9 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.33 1.852 . . . . 23.670000000000002 108.215 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -156.63 -175.08 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.345 -0.983 . . . . 20.489999999999998 108.345 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.12 176.3 11.46 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.859 1.664 . . . . 17.370000000000001 108.356 -178.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -163.72 174.83 11.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.575 -1.268 . . . . 14.460000000000001 107.575 -178.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -145.21 145.75 31.45 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.386 -0.968 . . . . 13.26 108.386 166.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -157.06 -158.08 0.74 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.091 1.756 . . . . 8.8300000000000001 107.834 173.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 5.45 10.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.628 1.171 . . . . 5.7999999999999998 113.001 -166.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.49 154.26 18.41 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.045 -1.034 . . . . 10.539999999999999 109.346 -175.839 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.9 mm 61.35 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.692 1.997 . . . . 14.19 111.067 -173.313 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 67.27 -56.31 0.45 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.985 1.714 . . . . 14.57 110.376 -167.479 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.82 25.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.578 1.151 . . . . 11.630000000000001 113.542 -177.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 t -67.26 -16.46 64.3 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.959 -1.088 . . . . 12.44 110.294 163.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -71.71 -57.64 4.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.206 0.603 . . . . 12.24 109.423 165.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -68.62 -20.38 64.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.365 0.876 . . . . 10.720000000000001 113.365 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 p -50.56 -8.5 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.842 2.534 . . . . 10.74 117.842 -168.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.06 72.8 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 121.108 -0.995 . . . . 9.6699999999999999 113.604 166.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -53.22 -33.83 54.52 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.106 1.453 . . . . 11.029999999999999 111.777 177.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.0 ttt -53.89 84.14 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 125.154 1.382 . . . . 13.01 112.019 172.024 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.6 t 74.58 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 127.942 2.497 . . . . 19.289999999999999 109.706 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 92.87 93.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.127 2.171 . . . . 17.890000000000001 108.85 -166.427 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -69.54 78.61 0.41 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.706 1.202 . . . . 22.390000000000001 110.143 -173.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -69.24 0.61 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.21 -0.424 . . . . 21.620000000000001 110.692 -177.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -169.78 -171.22 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.196 1.398 . . . . 17.289999999999999 109.474 -169.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 71.63 -163.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.387 1.875 . . . . 15.720000000000001 110.702 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -55.46 133.14 49.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.423 -1.325 . . . . 16.23 107.423 163.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mt -123.19 80.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.335 -2.098 . . . . 12.710000000000001 105.335 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 56.84 0.06 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.487 -2.245 . . . . 9.6799999999999997 107.487 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 170.17 65.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.171 1.788 . . . . 7.9400000000000004 107.663 -158.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.72 -37.09 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.64 -0.709 . . . . 8.3900000000000006 109.524 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.47 -159.33 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.573 1.149 . . . . 4.6900000000000004 110.925 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.51 83.84 0.07 OUTLIER Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.672 -0.775 . . . . 2.6299999999999999 113.224 -174.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.6900000000000004 114.57 -178.155 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.5 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.537 HG23 HD12 ' A' ' 127' ' ' ILE . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 3.4199999999999999 111.166 176.849 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.4300000000000002 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 4.2000000000000002 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 3.6600000000000001 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 5.2199999999999998 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 4.9699999999999998 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 3.9900000000000002 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.630000000000001 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.1299999999999999 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.3100000000000001 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 6.2400000000000002 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 71' ' ' ILE . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 2.27 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 1.6499999999999999 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.822 ' CE1' HG11 ' A' ' 135' ' ' VAL . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 2.8599999999999999 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 4.8200000000000003 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.70999999999999996 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 3.1299999999999999 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 1.24 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 3.2200000000000002 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 2.5899999999999999 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.0899999999999999 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.4700000000000002 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 2.1499999999999999 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.8100000000000001 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.5 113.426 -168.661 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.2799999999999998 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 0.90000000000000002 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 1.8799999999999999 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 2.0499999999999998 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 0.97999999999999998 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 51' ' ' ALA . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 1.6000000000000001 109.374 167.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.7200000000000002 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 3.0899999999999999 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 1.6799999999999999 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 1.77 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 5.71 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.4300000000000002 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 3.1899999999999999 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.5199999999999996 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.90000000000000002 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 4.7300000000000004 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.669 HG23 ' HA3' ' A' ' 65' ' ' GLY . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 2.3700000000000001 107.923 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.4300000000000002 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 4.7999999999999998 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 2.1699999999999999 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.2400000000000002 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 1.8899999999999999 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.5 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.3499999999999996 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 3.98 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 1.7 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 1.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.4300000000000002 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 1.9299999999999999 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.2 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 1.3999999999999999 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.23 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.9500000000000002 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HH22 ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.0 107.896 -178.679 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 7.2800000000000002 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 3.5499999999999998 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.2400000000000002 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7000000000000002 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 4.6299999999999999 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.485 HH22 HD11 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 11.02 113.561 169.022 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 8.4600000000000009 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 2.6699999999999999 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 1.1200000000000001 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 2.71 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 1.96 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.71999999999999997 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 1.6599999999999999 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 1.1200000000000001 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 2.46 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 6.1200000000000001 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 6.0300000000000002 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 2.8199999999999998 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.1099999999999999 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.6800000000000002 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 3.98 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 0.90000000000000002 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 3.0499999999999998 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.1499999999999999 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.606 HD21 ' HB ' ' A' ' 135' ' ' VAL . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 1.03 109.551 -176.89 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.537 HD12 HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 3.25 108.416 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 7.3200000000000003 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 2.52 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.5899999999999999 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.0700000000000003 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.0299999999999998 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 2.6600000000000001 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.7200000000000002 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' CE1' ' A' ' 53' ' ' TYR . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 1.29 108.408 165.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 0.90000000000000002 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.73999999999999999 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 2.1200000000000001 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 0.76000000000000001 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.5099999999999998 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 2.4199999999999999 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 6.0800000000000001 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 3.3999999999999999 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 3.52 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.0999999999999996 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.1600000000000001 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 3.3199999999999998 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 3.1000000000000001 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 2.2999999999999998 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 1.52 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.26 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 1.26 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 1.1000000000000001 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 1.0600000000000001 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 3.5800000000000001 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.807 0.337 . . . . 52.780000000000001 111.624 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -172.98 -50.91 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.997 -1.853 . . . . 48.869999999999997 105.997 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -110.58 -167.6 1.21 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.543 -1.651 . . . . 46.0 106.543 139.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -113.37 137.77 51.03 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.398 1.879 . . . . 42.229999999999997 107.095 169.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 p -170.49 105.13 0.28 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.229 -1.026 . . . . 36.899999999999999 108.229 -171.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 58.4 2.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.35 0.523 . . . . 32.289999999999999 111.026 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.78 172.78 12.92 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.162 -0.336 . . . . 27.870000000000001 110.586 172.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -147.28 151.3 36.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.746 -1.205 . . . . 23.02 107.746 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.7 169.78 2.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 127.054 2.142 . . . . 18.84 106.203 -176.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -156.72 34.92 0.31 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.339 0.518 . . . . 17.079999999999998 110.859 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.22 -162.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.812 2.045 . . . . 12.449999999999999 107.13 -176.001 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.11 13.06 0.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 117.851 2.538 . . . . 11.970000000000001 117.851 -166.023 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -81.27 -73.75 0.36 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 126.825 2.05 . . . . 6.9500000000000002 108.223 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -178.4 161.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 104.732 -2.321 . . . . 12.56 104.732 -173.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.25 153.3 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.728 -1.212 . . . . 12.460000000000001 107.728 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? 86.15 87.91 0.02 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.402 1.881 . . . . 16.670000000000002 110.039 169.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 65.37 -65.19 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.624 2.37 . . . . 16.059999999999999 112.504 172.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -31.35 -45.33 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.673 2.789 . . . . 13.41 112.554 165.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -54.84 -30.37 57.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.713 1.205 . . . . 9.3800000000000008 112.438 -177.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -53.96 -51.49 63.69 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 118.548 0.613 . . . . 15.390000000000001 110.299 172.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -70.12 -39.45 75.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.424 -0.172 . . . . 13.93 110.699 -178.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -74.93 0.62 Allowed Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.625 -0.59 . . . . 9.4499999999999993 111.625 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -73.56 -76.15 0.13 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.216 2.207 . . . . 8.8599999999999994 110.888 176.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptm 139.32 171.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 131.209 3.804 . . . . 11.75 105.783 -158.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t 124.81 171.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 1 C-N-CA 131.834 4.053 . . . . 13.56 107.188 -166.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 76.5 -69.48 0.16 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.242 1.817 . . . . 16.02 113.639 166.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -69.42 138.31 53.44 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.517 -0.473 . . . . 20.059999999999999 111.231 -171.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -76.34 61.38 1.67 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.979 0.912 . . . . 24.370000000000001 109.235 172.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -87.95 -171.4 3.39 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.564 1.146 . . . . 20.550000000000001 108.694 173.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.94 175.71 1.13 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.422 0.689 . . . . 23.68 111.376 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -73.74 62.69 0.82 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.814 0.846 . . . . 19.050000000000001 110.826 178.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.1 mt -77.56 143.46 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.956 -1.868 . . . . 15.23 105.956 166.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.69 29.13 0.26 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.06 -0.856 . . . . 9.9499999999999993 113.508 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -161.63 150.27 15.64 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.733 -1.21 . . . . 8.2100000000000009 107.733 170.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.2 mm -144.76 123.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.77 2.028 . . . . 8.3200000000000003 108.378 -176.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.84 -60.85 1.98 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.985 0.422 . . . . 5.1900000000000004 110.525 174.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.55 47.48 3.01 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 2.8700000000000001 115.616 -163.524 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.0099999999999998 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.4100000000000001 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 2.7999999999999998 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.29 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 2.9700000000000002 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.0099999999999998 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 3.3799999999999999 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 2.6600000000000001 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 1.9099999999999999 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.2999999999999998 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.0 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 1.8600000000000001 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 5.21 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 1.6799999999999999 111.758 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 1.8700000000000001 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 3.4399999999999999 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 4.2199999999999998 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.78000000000000003 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.2599999999999998 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 0.94999999999999996 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 2.1699999999999999 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.1499999999999999 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.4300000000000002 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.3900000000000001 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.3099999999999996 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 1.3400000000000001 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 0.93999999999999995 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.3300000000000001 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 0.89000000000000001 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 1.9299999999999999 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 2.27 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.1399999999999999 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 1.3300000000000001 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 3.3500000000000001 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 1.1599999999999999 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 5.2400000000000002 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.3500000000000001 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.05 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 3.9300000000000002 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 2.0899999999999999 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 4.4800000000000004 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 1.49 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 4.3499999999999996 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 1.8200000000000001 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.3700000000000001 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.4100000000000001 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 2.6400000000000001 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.1699999999999999 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.4399999999999999 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' H ' HD22 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 3.21 111.015 177.854 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 1.5600000000000001 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.1799999999999999 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 1.2 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.0300000000000002 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 8.8399999999999999 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 4.3799999999999999 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.411 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.2999999999999998 113.134 -176.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.0700000000000003 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' NZ ' ' OD1' ' A' ' 102' ' ' ASP . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 4.6699999999999999 109.254 -176.788 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 7.1299999999999999 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 6.8600000000000003 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 3.23 110.579 -176.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 1.3600000000000001 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 2.1899999999999999 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.2400000000000002 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.6200000000000001 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 0.92000000000000004 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 1.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 7.54 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.1899999999999999 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.5 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.27 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.6099999999999999 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 4.1699999999999999 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.85999999999999999 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 0.95999999999999996 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.429 ' OH ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 2.27 111.042 164.037 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 2.0299999999999998 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 135' ' ' VAL . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 1.5700000000000001 109.426 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 2.29 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 5.4900000000000002 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 3.6499999999999999 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.0299999999999998 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 3.7999999999999998 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 1.25 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 3.2400000000000002 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.8900000000000001 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 154' ' ' ALA . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 1.1000000000000001 104.563 162.3 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 0.90000000000000002 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.81999999999999995 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 2.2400000000000002 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 0.82999999999999996 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.9300000000000002 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 2.5499999999999998 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 4.2800000000000002 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 145' ' ' ASN . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 3.7400000000000002 108.054 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 2.75 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.666 ' H ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.6600000000000001 109.156 174.618 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 1.9299999999999999 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 2.3199999999999998 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 5.2699999999999996 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 1.8999999999999999 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 1.46 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.83999999999999997 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 1.1399999999999999 108.25 -173.325 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 0.98999999999999999 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 0.84999999999999998 111.847 175.23 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.2000000000000002 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2000000000000002 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 107.527 -1.286 . . . . 56.780000000000001 107.527 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -170.19 154.45 4.95 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.241 -1.763 . . . . 49.030000000000001 106.241 -173.514 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -78.51 162.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.869 0.867 . . . . 45.100000000000001 109.805 168.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -164.92 170.9 14.73 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.008 1.723 . . . . 41.909999999999997 106.526 170.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.2 p -150.74 111.94 4.37 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.122 -1.066 . . . . 36.159999999999997 108.122 -176.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.21 164.59 20.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.91 0.323 . . . . 32.100000000000001 110.182 173.017 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -128.38 166.1 19.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 28.579999999999998 108.524 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -101.19 -172.71 2.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.694 0.797 . . . . 24.039999999999999 109.842 177.503 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.81 113.33 2.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.478 1.111 . . . . 20.510000000000002 109.142 -178.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -129.96 136.6 49.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.257 -1.016 . . . . 16.899999999999999 108.257 169.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -156.55 166.86 32.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.705 2.402 . . . . 18.379999999999999 105.54 171.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 p -51.87 121.67 7.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.344 -0.984 . . . . 10.359999999999999 108.344 164.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 60.08 31.49 20.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 8.1099999999999994 112.994 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.26 122.7 16.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.293 -0.88 . . . . 14.4 108.809 171.38 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.9 -46.64 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.097 0.959 . . . . 15.5 111.553 -166.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -69.69 99.32 1.31 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.766 -0.584 . . . . 19.489999999999998 110.063 -171.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 71.1 -58.1 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.239 3.016 . . . . 16.120000000000001 111.923 170.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.5 m -33.64 -46.18 0.2 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.095 2.558 . . . . 12.17 112.92 173.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -34.42 -38.38 0.07 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.301 2.641 . . . . 11.380000000000001 114.845 -173.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -48.99 -63.99 0.94 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.449 1.1 . . . . 12.300000000000001 109.851 175.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 m -73.8 -31.2 63.15 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.783 -0.573 . . . . 9.5 112.531 170.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.71 -36.4 59.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.44 1.495 . . . . 6.8200000000000003 113.248 -174.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -9.56 58.79 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.78 1.4 . . . . 10.119999999999999 114.78 174.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 52.09 59.56 4.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.59 1.156 . . . . 9.4900000000000002 111.235 -171.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -33.83 -54.71 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.466 1.906 . . . . 13.859999999999999 112.775 175.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.21 -70.72 0.1 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.999 -0.741 . . . . 14.710000000000001 108.999 177.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 66.02 -37.57 0.27 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.058 2.143 . . . . 14.210000000000001 114.501 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -135.75 -45.24 0.66 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.703 1.601 . . . . 18.710000000000001 110.29 174.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.29 61.03 1.34 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.561 0.744 . . . . 18.629999999999999 109.834 -178.023 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.87 165.58 14.99 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.476 -1.676 . . . . 18.18 106.476 167.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -62.86 -37.43 86.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.001 0.364 . . . . 18.84 110.901 178.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.0 mt 60.12 -79.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.795 2.038 . . . . 13.619999999999999 109.847 -178.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.99 44.66 0.34 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.147 -1.581 . . . . 11.949999999999999 109.147 177.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.31 47.24 11.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.263 1.03 . . . . 12.82 109.745 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.8 143.18 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.128 -0.942 . . . . 9.2699999999999996 110.043 -172.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -153.76 -90.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.895 -1.52 . . . . 4.7199999999999998 106.895 166.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.24 -75.0 1.61 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 2.7799999999999998 109.975 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.9199999999999999 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.2599999999999998 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 2.8199999999999998 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.0099999999999998 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 3.9700000000000002 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.3999999999999999 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 3.3599999999999999 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 2.3999999999999999 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 1.9199999999999999 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.2199999999999998 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.0099999999999998 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 1.54 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.0599999999999996 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 1.4199999999999999 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 1.5800000000000001 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 3.0800000000000001 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 7.5800000000000001 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.68000000000000005 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 2.3700000000000001 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.1100000000000001 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 2.1899999999999999 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.89000000000000001 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 1.74 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.4900000000000002 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.2999999999999998 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 1.4199999999999999 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.0600000000000001 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 0.77000000000000002 113.559 -169.157 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 3.98 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 1.3100000000000001 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 2.4399999999999999 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 2.2000000000000002 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 1.1899999999999999 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 1.4199999999999999 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.3700000000000001 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 2.3700000000000001 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 1.6399999999999999 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 1.0800000000000001 115.032 169.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 6.5300000000000002 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.7200000000000002 111.602 -170.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 1.3200000000000001 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.0800000000000001 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 3.8999999999999999 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.689 HG23 ' HA3' ' A' ' 65' ' ' GLY . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 1.9099999999999999 107.983 -174.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.3799999999999999 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 4.1200000000000001 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 2.73 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 4.96 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 1.71 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 1.8999999999999999 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.3799999999999999 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 3.1499999999999999 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 1.4299999999999999 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.7999999999999998 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 1.71 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 1.1699999999999999 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 1.96 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 1.6200000000000001 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.5099999999999998 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 1.3500000000000001 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 9.2300000000000004 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 3.8999999999999999 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.5199999999999996 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.6499999999999999 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.0199999999999996 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 6.71 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 6.3899999999999997 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 3.7200000000000002 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 1.4299999999999999 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 2.6699999999999999 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 2.21 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.85999999999999999 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 1.8700000000000001 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 1.22 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 2.4100000000000001 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 5.71 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 3.52 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.5899999999999999 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 2.4100000000000001 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.582 ' CD ' HG21 ' A' ' 141' ' ' VAL . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 5.7800000000000002 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.29 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.1899999999999999 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 4.2199999999999998 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 2.3500000000000001 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -175.756 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.0600000000000001 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 2.79 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 4.2699999999999996 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 2.6299999999999999 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.8199999999999998 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 3.98 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.4299999999999999 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 2.5699999999999998 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.5699999999999998 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 154' ' ' ALA . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 1.28 106.77 164.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 0.90000000000000002 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.90000000000000002 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 1.5700000000000001 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 1.04 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.1799999999999997 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.869 HG22 ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 4.2999999999999998 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 3.8399999999999999 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 3.4199999999999999 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 1.9299999999999999 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.3399999999999999 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 141' ' ' VAL . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.5700000000000001 108.263 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 1.6100000000000001 107.84 174.171 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.5699999999999998 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 2.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 1.48 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 0.94999999999999996 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.605 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 1.47 107.056 178.044 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 1.3300000000000001 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 1.2 108.838 175.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 5.3300000000000001 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.1699999999999999 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.592 -1.633 . . . . 48.960000000000001 106.592 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -145.18 138.93 26.87 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.773 -1.195 . . . . 42.060000000000002 107.773 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -174.32 176.7 2.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.537 1.935 . . . . 38.520000000000003 106.616 169.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 170.67 148.55 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.753 2.021 . . . . 34.950000000000003 108.751 -176.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -165.93 173.4 10.54 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.719 -1.215 . . . . 31.16 107.719 169.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.93 155.11 3.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.248 1.819 . . . . 27.670000000000002 107.927 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.56 171.88 19.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.095 1.358 . . . . 25.920000000000002 109.64 -178.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 t -169.4 179.77 3.75 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.208 1.803 . . . . 21.579999999999998 107.059 173.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.92 20.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.389 0.885 . . . . 19.539999999999999 113.389 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.31 110.68 3.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.998 0.817 . . . . 15.65 109.514 176.621 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -124.46 16.67 8.93 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 18.059999999999999 111.631 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -167.89 174.69 7.29 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.407 -1.331 . . . . 10.779999999999999 107.407 177.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.57 54.27 1.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.879 0.871 . . . . 6.6500000000000004 111.42 -177.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.87 146.41 41.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.247 -1.39 . . . . 13.81 107.247 165.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm 50.16 50.41 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 122.313 1.054 . . . . 14.0 110.49 -168.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -171.49 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.702 -0.681 . . . . 15.59 109.676 162.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 66.33 -61.46 0.29 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.034 1.734 . . . . 15.15 111.225 -172.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.9 t -75.22 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.167 0.587 . . . . 12.970000000000001 112.108 164.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.03 -64.91 0.81 Allowed 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.313 -0.867 . . . . 11.51 111.306 -163.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.28 7.7 m-70 -70.0 0.86 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.034 1.733 . . . . 10.140000000000001 114.362 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -26.05 -39.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.434 2.694 . . . . 10.59 115.326 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -27.45 -46.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.976 1.75 . . . . 8.6600000000000001 112.23 167.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -27.49 -46.97 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.669 2.788 . . . . 10.1 113.693 174.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.4 mmt -152.95 60.6 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.692 0.758 . . . . 13.210000000000001 110.116 169.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -54.54 -69.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.819 -0.551 . . . . 16.27 110.823 170.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.83 -174.68 4.86 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 18.329999999999998 109.187 -169.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 54.23 29.8 11.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.521 1.128 . . . . 21.539999999999999 110.971 -172.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.58 -45.12 92.81 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.489 0.716 . . . . 21.23 111.439 -161.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -77.65 -22.0 51.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.636 0.774 . . . . 23.559999999999999 112.671 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.11 171.65 14.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.666 0.666 . . . . 23.260000000000002 110.271 -171.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -64.28 133.55 52.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.24 -1.022 . . . . 20.379999999999999 108.24 163.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.2 124.47 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 101.812 -3.403 . . . . 14.27 101.812 159.504 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.36 -44.96 9.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.736 -2.146 . . . . 11.550000000000001 107.736 170.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.0 170.53 0.43 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.691 2.397 . . . . 9.4700000000000006 110.624 172.098 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.1 mm 68.57 157.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.627 1.971 . . . . 7.4800000000000004 112.896 174.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 78.74 172.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.986 1.715 . . . . 3.8799999999999999 113.092 167.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.92 -54.59 0.05 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 2.7999999999999998 108.154 -177.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.6900000000000004 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.486 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.3099999999999996 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 3.1499999999999999 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 1.8899999999999999 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 3.6400000000000001 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.7999999999999998 109.837 -177.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 4.1100000000000003 110.913 -178.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 2.7999999999999998 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.0099999999999998 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.3099999999999996 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 2.75 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 1.6200000000000001 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 5.0700000000000003 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.699 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 2.5499999999999998 108.027 168.303 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.4300000000000002 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.1600000000000001 114.463 -172.429 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 4.4299999999999997 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.82999999999999996 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.25 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 0.96999999999999997 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 2.3900000000000001 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.96999999999999997 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.2400000000000002 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.5800000000000001 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.5599999999999996 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 1.3700000000000001 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.0700000000000001 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 0.88 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 3.52 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 1.0700000000000001 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 3.3399999999999999 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 2.9399999999999999 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 0.97999999999999998 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 1.22 106.284 175.657 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.9199999999999999 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 3.1899999999999999 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 1.3 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 1.1499999999999999 112.779 173.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 109' ' ' ILE . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 5.0499999999999998 115.087 178.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 109' ' ' ILE . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 1.3500000000000001 114.131 167.251 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.9900000000000002 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 0.93000000000000005 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 3.9300000000000002 111.432 -176.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 4.75 107.097 177.478 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.3399999999999999 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 4.2400000000000002 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 3.23 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.04 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 1.79 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 1.8999999999999999 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.1299999999999999 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 2.4399999999999999 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.4900000000000002 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 1.0900000000000001 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.9700000000000002 107.486 167.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 1.6899999999999999 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 1.1599999999999999 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 1.5 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1000000000000001 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 1.71 108.728 171.004 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 3.7799999999999998 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.6600000000000001 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.0299999999999998 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 5.3399999999999999 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 6.5800000000000001 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 5.5499999999999998 110.896 -172.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 2.6299999999999999 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 1.1599999999999999 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 76' ' ' LYS . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 2.48 107.223 158.35 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 1.8400000000000001 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.73999999999999999 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 1.45 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 0.89000000000000001 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 2.3300000000000001 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 7.2599999999999998 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.29 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 1.54 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.4500000000000002 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 3.5600000000000001 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.55000000000000004 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 0.79000000000000004 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 2.8700000000000001 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 1.8799999999999999 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 0.85999999999999999 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.0099999999999998 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 127' ' ' ILE . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 2.6699999999999999 109.517 157.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 4.6799999999999997 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 3.2799999999999998 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.8199999999999998 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 5.2800000000000002 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1000000000000001 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 2.5899999999999999 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.8200000000000003 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 154' ' ' ALA . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.0299999999999998 108.02 170.154 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 1.45 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.93000000000000005 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 1.6899999999999999 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 0.70999999999999996 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.4399999999999999 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 2.1499999999999999 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 3.4199999999999999 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 2.6200000000000001 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.1600000000000001 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.3999999999999999 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 0.96999999999999997 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 1.52 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.4300000000000002 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 2.5 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 1.3400000000000001 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 0.88 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.0900000000000001 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 0.93000000000000005 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 1.27 107.172 161.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 4.8799999999999999 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.6900000000000004 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 119.532 -0.271 . . . . 48.899999999999999 111.151 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -147.88 55.73 1.06 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 106.789 -1.559 . . . . 43.990000000000002 106.789 177.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -163.33 143.63 8.95 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.109 -1.441 . . . . 41.009999999999998 107.109 -173.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -165.62 156.57 13.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.647 -1.242 . . . . 36.119999999999997 107.647 177.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -163.23 162.59 25.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.726 -1.583 . . . . 32.200000000000003 106.726 166.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.81 54.81 0.2 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.816 0.846 . . . . 28.120000000000001 109.249 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.44 131.63 35.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.645 -0.872 . . . . 25.219999999999999 108.645 -178.281 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -159.83 179.01 9.18 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.282 -1.377 . . . . 21.780000000000001 107.282 170.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.28 178.55 2.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.116 1.366 . . . . 18.420000000000002 109.01 -175.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -159.95 -179.97 8.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.511 1.924 . . . . 14.880000000000001 106.418 173.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -153.88 156.9 38.43 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.794 0.725 . . . . 15.109999999999999 110.576 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 t 158.98 -154.35 0.0 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 131.282 3.833 . . . . 9.2100000000000009 103.957 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.68 28.33 0.13 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.279 1.832 . . . . 6.0 110.023 -170.633 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -130.01 114.98 16.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.364 -1.347 . . . . 11.76 107.364 177.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.314 40.7 pt 42.05 -137.53 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.518 1.927 . . . . 15.470000000000001 113.407 -172.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 8.08 83.19 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.091 2.957 . . . . 16.440000000000001 116.437 -170.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 66.46 -58.55 0.36 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.693 2.397 . . . . 12.1 112.357 -177.338 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -42.04 -32.41 0.45 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.237 2.215 . . . . 10.08 113.463 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -33.18 -57.82 0.39 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.515 1.926 . . . . 11.550000000000001 111.89 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.68 -68.01 0.42 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.463 1.105 . . . . 12.65 109.074 174.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -71.23 -56.95 5.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.81 1.244 . . . . 10.24 112.465 -159.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.9 -55.01 7.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.496 1.046 . . . . 7.2400000000000002 111.545 -176.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -9.03 57.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.696 1.199 . . . . 8.8300000000000001 112.173 -178.431 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 58.51 78.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.784 1.633 . . . . 13.529999999999999 111.325 173.381 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.75 92.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.463 -0.939 . . . . 14.710000000000001 108.463 165.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.62 175.15 0.29 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.419 1.488 . . . . 17.960000000000001 111.206 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.95 45.33 25.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.236 1.014 . . . . 22.440000000000001 111.692 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.0 71.75 1.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.208 -0.664 . . . . 20.390000000000001 109.208 172.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -143.16 55.02 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.935 1.694 . . . . 26.309999999999999 108.024 -177.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -141.73 -167.74 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.132 1.373 . . . . 21.690000000000001 108.243 -178.518 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -72.4 67.74 0.74 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.034 0.934 . . . . 22.75 110.638 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -77.5 72.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.186 -1.413 . . . . 17.68 107.186 174.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.8 55.81 0.32 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 107.655 -2.178 . . . . 14.130000000000001 107.655 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.12 -63.74 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.422 1.889 . . . . 11.539999999999999 107.311 -173.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.16 134.59 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.151 0.981 . . . . 9.2200000000000006 109.615 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.1 168.88 11.06 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.334 1.053 . . . . 4.3899999999999997 110.452 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.75 -68.62 2.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 2.71 111.942 168.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.6600000000000001 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 4.46 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.0499999999999998 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 3.6000000000000001 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 2.9100000000000001 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.6400000000000001 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 3.7799999999999998 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 4.3499999999999996 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 1.98 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.7999999999999998 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.1899999999999999 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 1.6200000000000001 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 6.3899999999999997 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 1.6200000000000001 111.084 168.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 1.74 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 135' ' ' VAL . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 4.2999999999999998 109.223 167.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 6.3499999999999996 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 0.95999999999999996 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.1400000000000001 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 0.93000000000000005 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 2.2599999999999998 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.0800000000000001 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.6600000000000001 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.9500000000000002 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.1399999999999999 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.1299999999999999 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 0.70999999999999996 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 3.8399999999999999 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 2.2400000000000002 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 2.1400000000000001 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.21 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 1.3799999999999999 108.533 177.035 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.6499999999999999 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 2.5800000000000001 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.26 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 1.28 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 5.4900000000000002 114.415 178.6 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.8300000000000001 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.29 111.165 -169.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.82999999999999996 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 3.3999999999999999 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.0699999999999998 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.9100000000000001 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 3.6400000000000001 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 1.47 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 3.2999999999999998 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.4299999999999999 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.49 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.2699999999999996 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.0 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 1.0700000000000001 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.0099999999999998 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 1.77 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 0.93000000000000005 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.1200000000000001 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.1399999999999999 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.1600000000000001 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 1.5800000000000001 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 8.2300000000000004 114.378 176.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 3.9100000000000001 112.989 -166.376 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.6100000000000003 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.27 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 4.9000000000000004 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 5.9299999999999997 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 5.7999999999999998 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 2.4300000000000002 110.996 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 1.3799999999999999 110.403 -177.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 78' ' ' GLY . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 2.1499999999999999 108.883 159.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 1.6799999999999999 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.84999999999999998 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.0600000000000001 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 141' ' ' VAL . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 0.81000000000000005 112.353 -160.026 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 2.4900000000000002 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.4500000000000002 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 3.6800000000000002 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.4399999999999999 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 1.52 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 3.9300000000000002 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.78000000000000003 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.03 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 2.3199999999999998 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 1.5700000000000001 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 1.26 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.0600000000000001 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 2.4900000000000002 108.35 175.719 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 7.0099999999999998 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 2.8500000000000001 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.5299999999999998 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.1000000000000001 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 1.6699999999999999 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 2.2999999999999998 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.7200000000000002 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 127' ' ' ILE . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 1.1200000000000001 107.81 167.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 0.83999999999999997 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 1.47 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.01 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 2.9500000000000002 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 113' ' ' VAL . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 2.5499999999999998 104.935 168.719 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 4.7699999999999996 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 2.77 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 2.52 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.3600000000000003 107.484 170.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.53 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 1.6399999999999999 108.73 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 2.7400000000000002 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 2.3500000000000001 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 1.4099999999999999 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.2 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.1299999999999999 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 1.4399999999999999 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 1.01 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.0899999999999999 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.3200000000000003 111.988 177.335 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 2.57 113.064 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.93 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 5.76 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 3.92 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.06 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 2.91 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 3.48 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HG3' ' A' ' 76' ' ' LYS . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 3.61 106.616 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.04 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.8 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.01 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 4.67 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 1.79 111.905 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 156' ' ' GLN . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 1.37 112.155 -161.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 3.58 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 4.62 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.76 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.01 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 0.89 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 2.83 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.78 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.65 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.99 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 1.27 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.13 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 0.76 112.735 -173.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 3.67 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 0.88 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 1.9 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 2.11 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 0.89 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 1.56 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.36 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 3.56 110.683 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 1.62 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.31 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 71' ' ' ILE . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 4.41 113.247 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.0 108.726 178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.66 112.638 -173.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.88 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 4.03 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.573 HG23 ' HA3' ' A' ' 65' ' ' GLY . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 1.82 107.072 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.53 ' H ' HD12 ' A' ' 85' ' ' LEU . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 3.79 112.691 -170.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 84' ' ' HIS . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 1.53 111.028 -174.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.3 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.32 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.43 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 1.99 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.58 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 115' ' ' TYR . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.07 106.721 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.9 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 2.99 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 1.12 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 1.27 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 1.13 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 1.65 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 7.2 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 5.41 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.41 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 3.41 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 6.83 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 7.32 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 9.17 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 4.48 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 1.95 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 2.54 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 1.84 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 1.43 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 0.96 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 2.07 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 92' ' ' VAL . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 6.55 107.453 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 3.71 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 2.61 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 1.51 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.24 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.26 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.85 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 0.85 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 5.34 108.629 172.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 2.53 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.3 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.15 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 2.97 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 5.15 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.26 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.76 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 4.63 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 1.83 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 3.82 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.41 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 1.42 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 1.03 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 0.97 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 1.98 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 123' ' ' TYR . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.1 110.032 158.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.41 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 2.56 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 4.39 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.09 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 2.77 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.19 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.32 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 1.89 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 2.7 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 2.26 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 1.48 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.52 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 1.42 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 1.71 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 1.24 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.17 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.27 105.071 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 2.34 112.325 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.64 111.315 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 4.94 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 2.49 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.19 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 3.63 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.41 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 3.62 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 2.96 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.11 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.86 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.16 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 1.54 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 5.61 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 1.49 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 1.99 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 4.38 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 6.95 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.71 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 2.44 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.15 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 2.51 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.15 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.24 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 1.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.34 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' HG23 ' A' ' 82' ' ' ILE . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.25 113.211 -175.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 6.57 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 0.94 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.17 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 2.59 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 1.16 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 2.0 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 3.16 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 2.06 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.535 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 1.23 109.915 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 3.69 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 2.4 107.156 172.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.27 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.15 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.94 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.05 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 82' ' ' ILE . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 2.41 106.571 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.66 104.568 157.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 5.84 104.986 31.14 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 1.69 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 4.49 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 1.7 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 1.79 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.78 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 2.1 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.82 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 1.08 109.572 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.76 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 2.14 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.16 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 1.73 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.13 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.01 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.45 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.02 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 4.83 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.55 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.9 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CB ' ' HZ3' ' A' ' 104' ' ' LYS . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 4.73 111.671 -158.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 7.93 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 5.62 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 2.4 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 1.28 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 2.22 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 1.67 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.76 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.19 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 1.09 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 3.12 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.639 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.15 107.562 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 2.96 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.16 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 1.61 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.61 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 3.89 111.123 140.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.51 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 0.98 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 2.28 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 2.21 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 152' ' ' LEU . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 0.86 108.426 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.38 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 2.79 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 6.83 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.81 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.73 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 4.25 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 1.79 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 3.63 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.56 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 1.8 107.301 163.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 1.09 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.09 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 1.79 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 0.94 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.44 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 2.19 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 3.8 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 2.11 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 2.16 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.22 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 1.57 109.69 -174.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 2.98 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 2.27 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 1.17 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 0.93 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 125' ' ' LEU . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 2.03 112.403 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 1.53 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 1.12 111.317 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 3.57 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 2.44 108.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.51 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 2.56 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 1.92 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 2.61 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.74 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 4.53 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7 115.112 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 4.1 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.05 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 5.43 111.365 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 1.23 112.692 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 1.38 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.665 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 2.98 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 4.95 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.08 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 2.85 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.06 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 2.64 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.36 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.95 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.12 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 1.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.91 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.18 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.24 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 80' ' ' GLY . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 1.73 105.686 169.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.52 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 2.35 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 1.4 109.011 168.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.721 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 1.55 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.38 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 3.17 113.126 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.16 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 1.46 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 5.3 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.75 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.721 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.19 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.01 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.0 110.273 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 3.97 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 1.97 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.3 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 3.52 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 1.83 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 4.96 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 1.81 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.54 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.05 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 2.1 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 0.9 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.14 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 1.67 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.18 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 1.6 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.04 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.44 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 1.51 108.152 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 8.33 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 3.86 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.08 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.84 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 4.7 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 6.82 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.24 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.443 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 3.79 105.792 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 1.48 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 2.41 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 1.89 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.74 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 2.12 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 0.77 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 2.04 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 4.57 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 2.75 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 2.33 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 1.47 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.11 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.08 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.5 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 0.94 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 3.72 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 1.9 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 126' ' ' GLY . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 0.97 112.359 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.467 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 2.13 106.222 154.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 5.77 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 3.58 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.37 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 3.59 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 1.43 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 3.34 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.64 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 125' ' ' LEU . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.4 107.391 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 1.3 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 1.7 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 0.7 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 2.05 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 3.56 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.34 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 2.98 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.9 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 0.97 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 2.32 108.319 -167.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 3.58 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 2.58 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 1.15 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 0.83 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.18 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 0.98 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 0.98 109.097 173.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 5.39 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.31 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 2.46 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.03 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 4.93 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 2.74 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.17 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 2.95 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.8 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 5.16 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 2.33 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 1.83 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.11 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 1.88 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.21 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 1.41 109.578 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 1.67 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 3.26 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 4.99 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.12 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 2.28 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.11 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 2.51 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.33 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 1.95 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.57 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.39 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 1.49 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.43 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.06 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 3.71 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 1.32 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.43 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 2.05 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.3 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.466 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 1.74 104.217 159.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.51 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 3.61 114.0 -171.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 1.41 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 1.32 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.11 110.591 164.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.65 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.2 112.343 -158.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.97 108.933 -171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.17 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.18 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 1.92 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.59 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 3.35 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 1.56 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 3.96 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 1.37 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.6 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.08 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 2.06 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.88 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 1.1 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 1.93 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 0.97 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 1.97 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 1.4 111.962 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.26 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.78 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.0 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 4.23 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.83 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 2.97 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 5.79 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 7.33 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 6.07 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 2.56 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 1.15 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 2.98 106.063 158.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 109' ' ' ILE . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 1.65 109.667 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.03 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.51 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 0.77 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 2.15 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.07 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.07 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.53 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 1.28 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.91 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 3.44 109.839 133.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.52 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 0.73 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.514 ' HE1' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 2.4 112.197 174.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 1.82 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 135' ' ' VAL . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 0.81 107.791 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.15 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 2.57 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 5.16 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 2.93 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 2.7 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 4.62 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 1.83 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 3.93 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.17 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.565 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 1.48 105.251 166.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 0.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 1.75 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 0.7 111.291 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.07 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 2.18 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.24 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 2.33 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 2.08 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.01 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.21 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 2.61 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.37 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 2.19 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 1.35 106.618 162.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.75 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 1.82 112.707 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 1.68 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 1.19 107.667 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 4.32 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.17 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 2.77 111.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.67 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 4.48 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.08 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 3.63 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 2.94 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 3.75 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 4.34 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 1.97 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.76 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.1 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 1.59 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 6.34 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 1.64 111.147 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 1.71 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 135' ' ' VAL . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 4.38 109.47 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 6.34 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 0.93 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.18 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 0.96 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 2.15 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.98 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.51 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.53 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.18 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.18 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 0.73 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 3.86 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 0.96 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 2.22 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 2.14 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.16 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 1.36 108.302 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.61 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 2.54 112.653 -172.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 1.31 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 1.34 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 5.51 114.062 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.88 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.54 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.34 110.656 -169.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.58 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 3.39 114.08 -164.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.08 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.14 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.407 ' H ' HD12 ' A' ' 85' ' ' LEU . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 3.58 112.334 153.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 84' ' ' HIS . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 1.49 111.202 -166.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 3.29 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.51 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.49 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.22 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.0 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.06 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.87 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 1.76 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 0.93 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.13 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.12 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.11 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 1.56 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 8.19 114.409 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 3.96 112.984 -166.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.63 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.26 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 4.91 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 5.93 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 5.81 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 2.41 110.733 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' ALA . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 1.43 111.007 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.54 HD11 ' H ' ' A' ' 78' ' ' GLY . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 2.17 108.928 162.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.02 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 0.84 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 2.6 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.3 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 3.88 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.44 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 1.36 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 3.29 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.65 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 0.82 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 2.31 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 1.5 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 1.2 112.635 -170.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.08 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 2.5 108.275 176.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 7.07 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 2.84 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.12 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 1.71 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 2.32 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.72 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 127' ' ' ILE . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 1.13 107.822 167.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.82 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.95 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 1.55 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 0.7 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 2.93 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 2.41 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 4.98 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 2.99 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 2.79 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.84 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.43 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 1.57 108.754 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.49 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 2.61 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 1.42 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.02 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.13 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 1.31 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 135' ' ' VAL . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 1.01 110.972 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.12 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.34 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . . . . . . 0 CA--C 1.517 0.189 0 N-CA-C 112.025 -0.43 . . . . 2.98 112.025 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.35 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 4.75 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 2.75 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 1.87 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.03 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 4.67 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 2.17 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 1.68 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.76 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.13 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 1.75 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 6.48 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 1.26 110.242 161.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 1.41 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 3.6 108.447 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 5.53 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 0.79 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 2.92 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.17 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 2.57 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.08 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.14 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.88 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.65 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.02 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.03 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 0.91 114.957 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 5.72 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 1.07 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 1.85 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 2.3 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 1.33 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 1.23 107.188 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.14 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 2.68 112.662 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 1.63 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 1.01 113.799 176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 6.6 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.434 HE22 ' HB3' ' A' ' 75' ' ' ALA . 3.9 mm-40 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.08 107.16 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.51 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 71' ' ' ILE . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.72 107.569 -164.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.79 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 4.14 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.11 107.041 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 4.79 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 90' ' ' LEU . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 1.78 110.089 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 3.7 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 2.24 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 2.76 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.05 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 2.43 113.367 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.08 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 2.48 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 2.96 109.613 -163.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.15 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.5 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 1.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.99 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 1.47 109.047 176.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 7.66 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 3.84 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.82 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 4.96 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 6.37 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 7.81 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.434 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 6.41 112.843 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 3.44 111.229 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 1.63 111.786 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 99' ' ' ILE . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 2.85 109.737 153.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 2.6 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.99 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 1.51 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 1.14 109.409 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 2.12 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 7.4 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.37 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 2.39 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 2.26 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.01 108.563 168.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 141' ' ' VAL . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.91 111.13 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.21 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 2.78 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 1.98 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 125' ' ' LEU . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 0.86 107.659 -176.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 3.01 109.771 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 4.86 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 2.71 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.86 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 3.38 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 1.39 112.92 171.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 2.49 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.11 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 154' ' ' ALA . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 1.54 105.993 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 1.09 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.16 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 1.76 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 1.33 108.738 160.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.37 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.668 HG13 ' HB1' ' A' ' 139' ' ' ALA . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 2.14 111.492 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 3.95 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 2.9 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.07 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.63 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.07 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 1.39 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 3.87 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 2.18 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 139' ' ' ALA . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 2.37 106.78 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.01 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 125' ' ' LEU . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 2.03 111.909 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 1.55 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 1.13 111.267 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 3.95 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.93 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 2.81 113.685 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.8 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CE1' ' H ' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 5.28 114.104 -174.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 106' ' ' HIS . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 3.01 109.775 167.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.64 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 3.76 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.45 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 3.9 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.0 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 3.32 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.53 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 2.88 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.08 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 5.55 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 1.39 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.29 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 3.58 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 5.79 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 2.57 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 0.97 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 2.27 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 0.96 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 3.32 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.67 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 1.14 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.09 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 0.85 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.01 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 1.24 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.19 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 2.35 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 1.18 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HA3' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 2.07 108.934 160.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.22 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 2.24 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 1.79 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 1.87 114.884 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 4.18 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.95 107.025 171.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA3' HG22 ' A' ' 71' ' ' ILE . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 2.56 110.661 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 5.34 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.1 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.16 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 3.39 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 90' ' ' LEU . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 2.24 110.654 -150.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 3.88 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 1.68 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.41 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.3 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 2.03 112.015 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 0.97 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.26 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 1.87 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 1.09 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 1.21 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 1.29 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.32 109.75 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 1.45 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 6.23 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 4.37 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.51 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.05 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 5.56 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.461 ' H ' ' CE1' ' A' ' 39' ' ' HIS . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 5.96 109.431 -162.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.62 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 8.75 108.804 -160.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 2.65 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 1.39 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.01 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.14 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.71 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 2.51 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 0.93 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 2.61 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 4.65 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 2.75 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 1.34 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.43 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.11 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.58 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 0.83 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 2.44 110.59 174.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 1.53 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 1.14 109.603 -170.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.511 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.67 111.498 -166.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 2.67 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 7.66 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 3.25 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.89 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 3.31 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 1.33 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 2.77 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.91 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 1.9 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.98 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.9 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 1.67 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.07 111.343 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.45 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 1.9 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 2.93 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 2.59 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 2.68 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.84 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.04 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 1.47 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 2.73 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.02 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 1.26 107.186 172.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.12 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.18 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 1.32 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 1.48 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.12 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.24 109.828 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 2.07 109.876 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.06 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 2.95 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 2.95 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 4.59 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.11 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 3.89 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 2.47 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 73' ' ' PHE . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 2.43 112.845 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.95 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 2.58 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 2.12 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 5.89 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 2.6 109.059 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 1.59 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' HD13 ' A' ' 127' ' ' ILE . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 3.19 109.598 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 4.15 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.25 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 2.66 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 0.99 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 2.48 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.06 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.16 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.53 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.23 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 1.47 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 0.96 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.28 112.173 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 6.26 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 152' ' ' LEU . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 1.15 109.425 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 1.94 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 2.27 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.05 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.553 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 1.4 107.027 167.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.17 106.944 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 71' ' ' ILE . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 2.3 113.849 -169.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.08 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 1.51 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 4.62 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.443 ' H ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 1.68 106.995 178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.51 114.826 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.74 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 0.98 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 3.49 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.704 HG23 ' HA3' ' A' ' 65' ' ' GLY . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 2.0 107.616 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.57 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 5.12 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 1.55 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 4.67 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 1.93 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 3.6 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.03 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 2.55 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 1.87 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 1.07 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.36 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 1.62 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 1.21 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 1.39 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.36 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.51 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.425 ' CG2' HG22 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 2.26 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 6.99 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 4.44 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.82 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.58 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 4.7 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 7.68 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 5.17 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 2.29 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.1 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 3.52 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 1.88 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.76 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 1.97 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG21 HG12 ' A' ' 141' ' ' VAL . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 0.85 109.227 170.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.03 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 5.86 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 5.89 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.25 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.15 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.63 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 0.76 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 139' ' ' ALA . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 2.86 108.888 -168.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 2.28 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.589 HD23 HD12 ' A' ' 152' ' ' LEU . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 0.74 110.636 -171.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.12 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 132' ' ' ALA . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 2.78 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 6.86 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 2.62 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.12 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 3.59 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HA ' HD11 ' A' ' 127' ' ' ILE . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 1.6 113.433 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 2.42 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 154' ' ' ALA 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.2 109.864 173.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 0.83 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.76 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 2.61 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 0.82 110.842 167.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 113' ' ' VAL . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 2.42 108.043 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 2.82 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 3.24 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 4.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.36 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.73 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 1.51 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.46 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 2.65 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 1.11 107.868 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.78 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.589 HD12 HD23 ' A' ' 125' ' ' LEU . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 1.15 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 0.98 111.751 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 4.61 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.44 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.926 0 N-CA-C 116.098 1.199 . . . . 3.02 116.098 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.49 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.25 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.11 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 1.89 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 3.3 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 4.11 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 2.29 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 1.92 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.47 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 1.79 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 1.55 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 5.68 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 1.44 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 1.64 109.81 -168.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 71' ' ' ILE . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 3.47 109.083 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 4.37 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.7 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.39 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.09 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 2.49 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.94 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.67 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.36 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.02 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.96 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 0.7 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 3.78 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 0.93 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 2.44 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 2.22 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.15 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 1.25 108.753 158.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.33 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 2.17 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 1.43 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 1.37 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 4.22 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.1 110.318 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.43 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.32 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 3.48 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 3.31 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.74 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 3.58 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 2.0 111.054 -164.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 5.39 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 1.89 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.51 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 2.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.03 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 115' ' ' TYR . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 1.02 109.008 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.65 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.06 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 1.27 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 1.47 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.29 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.92 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 1.67 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 8.23 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 5.17 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 4.66 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 5.49 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 7.5 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 6.51 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 3.87 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 2.14 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 2.98 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 2.37 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 0.71 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 2.34 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 0.74 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 2.69 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.449 ' HA ' HG22 ' A' ' 92' ' ' VAL . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 4.83 106.684 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.06 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.42 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 1.31 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 3.53 110.348 135.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.55 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 0.86 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 2.66 113.43 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.09 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 0.96 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.35 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 ' HE1' ' A' ' 53' ' ' TYR . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 2.9 107.855 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 5.3 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.01 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 2.87 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.05 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 1.52 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 2.51 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 1.12 106.5 154.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 0.95 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 0.82 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 1.98 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 0.95 111.425 166.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 1.86 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.07 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 2.27 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 3.29 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.41 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.22 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.05 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 2.74 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 2.72 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 1.27 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.97 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 1.35 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 1.07 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.76 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 0.89 111.526 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.12 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.715 ' HB3' HG23 ' A' ' 52' ' ' THR . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.85 111.613 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.061 0 N-CA-C 111.198 -0.761 . . . . 2.5 111.198 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.61 112.284 -174.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.31 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 3.15 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 2.68 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 2.91 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.11 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 4.34 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 2.58 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 1.87 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.01 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 1.78 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 1.8 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 4.96 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 1.33 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 1.5 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 3.48 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.22 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.76 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.13 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 0.87 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 2.11 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.14 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 1.76 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.95 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.44 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 1.68 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.04 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.75 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 3.67 107.352 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 0.9 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 1.96 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 2.48 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 1.1 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.599 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 1.95 105.287 152.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.38 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 2.67 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 1.56 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 1.18 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 4.35 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 1.68 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.4 112.098 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.68 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.87 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.1 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 2.26 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.66 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 3.75 116.805 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 1.9 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.05 113.378 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 2.2 110.096 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 1.84 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 2.81 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 2.17 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.32 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 2.73 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 1.1 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.1 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 0.98 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' HG13 ' A' ' 109' ' ' ILE . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 1.66 110.87 168.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 6.68 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 4.46 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.67 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 107' ' ' ALA . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 2.75 114.248 164.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 104' ' ' LYS . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 6.4 110.763 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 9.09 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 6.81 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 103' ' ' GLY . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 4.64 113.268 171.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 2.66 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 99' ' ' ILE . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 3.34 108.319 169.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 1.57 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 0.89 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 1.72 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 0.7 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 3.22 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 6.92 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.1 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.86 113.029 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 1.88 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.81 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 3.46 108.681 141.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.71 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 1.18 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 2.52 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 1.86 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.485 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 1.15 109.567 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.15 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 2.37 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 4.42 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 2.7 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.45 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 3.69 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 1.26 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 2.52 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.95 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.485 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 1.96 107.516 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.92 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 1.77 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 0.71 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.31 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 141' ' ' VAL . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 2.25 109.43 -174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.16 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 2.33 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.05 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.83 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.0 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.13 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 4.95 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 1.82 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 1.29 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.85 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 1.38 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 1.5 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 1.32 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 3.64 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.24 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 3.23 108.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.55 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 4.79 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 3.61 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 2.45 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 3.38 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.41 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 3.5 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HZ3' ' A' ' 76' ' ' LYS . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 2.86 106.312 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 1.83 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.48 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.22 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 1.96 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 5.94 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 2.43 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.18 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 5.11 115.083 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 6.39 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 0.87 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 2.74 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 0.96 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 2.03 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.0 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.26 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.97 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.76 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 1.34 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.9 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.18 113.206 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 6.37 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.26 108.127 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 3.69 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 2.14 112.02 -169.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.01 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 2.14 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.1 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.403 ' CE1' HD23 ' A' ' 45' ' ' LEU . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 2.77 114.826 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 1.77 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 1.91 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 4.2 110.204 167.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.66 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 1.54 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 4.75 111.622 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 65' ' ' GLY . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 2.09 107.708 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' GLU . 85.7 m-70 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 4.13 107.815 158.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 2.11 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 5.44 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 2.52 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.02 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.61 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 2.78 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 1.71 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 1.59 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 1.21 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 1.48 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 1.86 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' LYS 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 1.94 106.636 169.91 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 6.84 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 5.53 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.33 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.62 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 8.23 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 8.09 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 8.96 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 4.0 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 2.11 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 2.5 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.18 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.77 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 1.53 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 0.98 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 2.37 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 7.09 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.23 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 2.64 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 1.36 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.69 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.32 109.755 166.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 0.81 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 0.79 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 2.46 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 2.39 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 1.36 109.144 -170.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 2.97 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 4.46 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.78 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.36 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 4.48 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 2.44 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 4.2 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.07 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 1.29 107.488 167.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 1.34 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.17 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 1.69 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.26 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.17 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 2.32 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 3.88 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 3.22 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 2.02 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.3 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 1.84 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 1.78 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 3.88 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 3.53 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 1.26 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.77 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 1.11 107.61 -175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 1.22 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.879 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.53 109.271 167.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 3.28 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.63 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.044 0 CA-C-O 120.095 -0.281 . . . . 2.46 112.654 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.24 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 6.11 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 2.92 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 1.97 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 2.97 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.06 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 3.63 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 2.51 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 1.78 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.33 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.15 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 1.72 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 6.67 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 1.65 111.509 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 1.47 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 3.56 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 4.9 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.71 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 2.87 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 0.9 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 2.45 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.71 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.58 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.58 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 1.36 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 0.91 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 5.7 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 152' ' ' LEU . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 0.94 109.374 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 1.87 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 2.23 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 1.49 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 1.46 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.83 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 2.66 112.711 -164.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 1.35 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 1.33 112.71 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 4.58 113.159 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.755 HE22 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm-40 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.88 111.047 -172.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 1.54 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.86 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 7.07 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 3.14 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.82 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 5.41 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 1.48 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.29 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.38 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.46 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.24 111.667 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 4.02 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.34 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG13 ' HB ' ' A' ' 82' ' ' ILE . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 2.1 109.987 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.58 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 1.84 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 1.05 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.53 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.31 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.41 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 1.85 111.293 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 7.13 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 4.3 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.09 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.1 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 5.3 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 6.55 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.46 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.06 109.434 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.8 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 1.48 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 2.68 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 1.57 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.09 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 2.23 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 0.8 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 2.27 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 4.61 104.702 168.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 2.9 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 3.99 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 1.36 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.78 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 4.88 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.62 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.14 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 2.22 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 2.27 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 0.82 111.124 -171.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.35 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 2.26 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 4.7 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 2.93 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.68 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 3.72 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 1.38 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 2.34 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.81 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.754 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.24 107.605 157.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 1.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 1.83 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 1.13 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.14 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 2.47 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 3.5 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 2.1 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 2.61 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.64 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.0 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 1.93 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 4.92 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 2.9 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 1.39 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 0.83 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 125' ' ' LEU . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 1.12 106.907 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.03 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.754 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 0.83 113.224 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 5.75 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.92 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.43 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 3.98 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 2.89 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 1.8 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.0 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 4.57 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 127' ' ' ILE . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 2.35 108.193 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 1.88 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.83 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.05 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 1.72 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 4.58 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 1.48 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 1.87 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 5.41 112.335 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 5.83 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 0.93 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 2.79 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 150' ' ' ILE . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 0.92 105.549 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.423 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 2.56 110.28 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.08 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.82 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.06 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 1.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.18 110.449 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 0.97 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 4.45 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 1.15 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 3.35 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 2.33 112.252 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 1.08 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 76' ' ' LYS . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 1.65 105.923 166.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.42 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 2.36 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 1.24 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 1.35 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 71' ' ' ILE . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 4.31 114.494 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.63 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.596 ' CA ' HG22 ' A' ' 71' ' ' ILE . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.04 112.575 -137.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.41 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 0.87 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 4.59 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 2.69 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.93 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.549 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 5.41 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 85' ' ' LEU . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 2.26 110.876 -164.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 4.52 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.11 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.13 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.35 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 3.42 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 1.02 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 2.14 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.07 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.37 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.12 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.3 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 1.62 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 6.98 112.101 170.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.02 111.404 -169.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.99 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.63 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 5.8 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 6.48 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.1 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 4.45 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 1.91 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 2.71 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.29 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.68 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.45 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 0.73 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 2.0 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 5.58 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.07 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.28 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 1.44 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.91 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 3.38 109.961 131.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.68 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 0.84 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 2.76 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 2.96 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 0.86 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.06 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.673 HD12 HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.04 109.889 -162.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 5.94 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 2.88 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.16 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 3.72 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 2.85 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 3.96 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.85 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 1.27 106.744 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 1.03 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.75 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 2.26 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.06 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.11 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 1.98 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 3.57 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 2.12 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 2.57 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.52 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.0 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 2.25 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.15 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 2.78 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.42 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 3.96 108.7 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 0.87 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.08 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 1.23 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 1.57 109.656 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 3.48 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.92 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 109.25 -1.54 . . . . 2.71 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.6 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.37 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 2.3 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.41 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 3.49 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 5.39 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 2.29 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 1.81 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.67 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 2.69 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.49 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 5.96 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 1.33 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 1.65 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.455 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 5.31 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 4.93 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 0.92 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 2.47 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 1.07 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 4.34 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.1 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 1.64 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.82 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.66 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 1.22 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 0.96 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 0.98 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 3.41 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 0.98 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.12 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 2.04 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 1.43 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 2.23 105.123 167.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.35 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 2.79 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.03 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 1.54 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 5.11 113.121 174.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.12 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 1.65 110.73 171.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.57 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 0.79 109.553 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 5.36 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 2.67 110.087 -169.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 3.58 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 1.6 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 5.23 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 1.89 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.56 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.8 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 1.78 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 1.2 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.56 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 123' ' ' TYR . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 1.8 106.427 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.03 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 1.27 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 1.44 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.57 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 1.41 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 8.33 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 4.44 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.41 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.07 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 4.73 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 6.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 5.53 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 2.53 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.17 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 2.69 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 2.24 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.69 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 1.5 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 141' ' ' VAL . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 1.21 108.187 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 2.46 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 4.75 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.63 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.88 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 1.2 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 3.24 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 0.93 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 94' ' ' LEU . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 3.03 110.246 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 1.88 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.14 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 3.82 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 6.0 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 3.57 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.55 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 4.38 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.37 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 2.53 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.03 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 1.37 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 0.91 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.04 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 1.62 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.74 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 113' ' ' VAL . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 2.48 106.086 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 3.61 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.18 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 2.71 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.86 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.29 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.22 109.109 -173.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.13 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 2.47 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 1.45 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 152' ' ' LEU . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 2.12 112.235 -166.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 1.42 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 1.03 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.21 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.67 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 2.57 110.865 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 104' ' ' LYS . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 4.83 110.936 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 2.85 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 1.82 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 3.13 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.8 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 4.94 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 2.16 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.0 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.98 110.905 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 2.16 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 1.71 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 4.91 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 2.05 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 3.37 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 4.41 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.78 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 3.11 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.06 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 3.0 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 2.25 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.17 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.28 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 2.2 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.26 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.823 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 0.92 112.734 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 3.8 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 0.98 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 2.3 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 2.07 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 1.34 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 1.66 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 2.23 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 1.7 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' NE2' ' A' ' 77' ' ' GLN . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 1.14 112.749 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 109' ' ' ILE . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 5.49 111.72 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7 105.528 170.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.31 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 4.78 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.823 HG23 ' HA3' ' A' ' 65' ' ' GLY . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 1.83 106.895 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.37 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 4.28 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.99 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.04 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 1.76 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.7 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.59 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 2.19 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.51 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 0.92 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.66 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 1.81 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.1 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.01 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 1.45 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.56 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.05 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.27 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 5.13 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.23 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 4.38 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 4.59 110.92 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 5.65 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 6.18 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.28 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 1.43 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 3.03 107.58 150.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 1.58 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 0.81 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.48 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 0.76 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 2.23 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.21 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.05 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.66 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 1.39 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.32 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.06 107.77 167.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.6 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 0.9 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 3.73 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 1.6 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 0.98 112.933 -170.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.08 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 3.32 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 5.69 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 2.79 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.67 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 4.11 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.33 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 2.91 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2 107.076 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 154' ' ' ALA . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 1.79 108.899 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 1.25 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.86 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 1.65 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 0.83 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.56 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 2.24 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.35 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 2.85 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 2.4 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.68 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.34 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.07 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.45 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 2.65 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 1.56 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.03 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.03 108.597 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 1.05 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.02 109.635 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.17 113.774 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 CA-C-O 119.377 -0.679 . . . . 2.07 112.346 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.82 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 4.4 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 3.56 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.17 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 3.95 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.36 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 5.79 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 2.64 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 1.91 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.83 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 2.71 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 1.6 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 4.99 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 1.8 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 1.49 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.723 ' CZ ' HG13 ' A' ' 135' ' ' VAL . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 5.02 110.027 162.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 4.77 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 0.99 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 3.52 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 152' ' ' LEU . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 0.94 104.584 171.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 2.05 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.16 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.55 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.38 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.99 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.1 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 0.96 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 3.43 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 152' ' ' LEU . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 1.32 108.419 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 2.28 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 2.45 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.23 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.04 106.41 163.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 3.75 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 1.78 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' H ' HE22 ' A' ' 77' ' ' GLN . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 1.68 114.012 -170.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 5.59 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.524 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.02 107.785 168.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.6 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.88 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 6.14 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 82' ' ' ILE . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 1.88 109.18 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 3.57 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 1.8 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 3.87 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 1.41 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.57 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.12 111.039 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.04 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 1.14 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.95 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 80' ' ' GLY . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 2.42 106.433 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 1.53 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.73 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.09 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.84 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.04 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.02 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 3.39 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.65 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 3.17 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 5.91 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.566 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 6.3 108.24 -163.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 4.97 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 2.73 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 1.36 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 2.5 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 2.24 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.65 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.43 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 0.94 109.404 168.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 1.92 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 4.85 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 2.8 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.47 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 1.19 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.85 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 3.5 110.603 135.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.53 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 3.57 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.12 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 152' ' ' LEU . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 0.77 109.113 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.15 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 2.07 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 5.73 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 3.71 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.39 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 3.55 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 1.4 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 3.1 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 155' ' ' LYS . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.99 108.581 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 53' ' ' TYR . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 1.3 107.768 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 1.24 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 2.19 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 0.69 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.11 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 1.99 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 3.59 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 2.78 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 1.87 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.13 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 1.61 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 2.8 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 3.19 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 1.37 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.82 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.14 107.91 -171.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.02 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 0.94 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 134' ' ' GLU . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.25 107.628 160.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.76 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 1.96 113.928 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.52 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.35 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.03 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.09 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 4.46 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.87 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 4.48 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 2.47 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 1.83 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.69 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 2.73 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 4.88 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 1.3 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 1.95 110.288 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 71' ' ' ILE . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 3.21 109.109 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 4.9 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.66 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.22 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 0.94 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 2.32 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.09 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.19 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.78 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 1.26 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 0.95 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.727 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 0.89 112.555 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.22 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 152' ' ' LEU . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 0.88 107.321 165.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 2.35 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 2.32 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 1.07 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 1.67 109.501 171.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.66 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 2.35 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 1.49 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.26 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HG3' HD12 ' A' ' 71' ' ' ILE 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.01 115.444 167.044 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.55 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.17 112.074 -167.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 3.6 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.727 HG23 ' HA3' ' A' ' 65' ' ' GLY . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 1.84 107.952 -169.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.89 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 5.79 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 1.62 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 3.97 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 1.56 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 2.51 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.94 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 0.97 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.58 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 1.72 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 1.8 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.31 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 1.06 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.66 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 1.55 111.394 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 6.94 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 4.06 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.14 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.09 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 6.52 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.04 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 5.23 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 2.4 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 1.1 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 2.75 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 2.22 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.68 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 1.41 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 0.86 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 3.05 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 5.43 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.14 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.44 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 1.23 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 3.45 108.365 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.64 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.12 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 2.3 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.11 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 152' ' ' LEU . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 0.77 109.419 -171.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.16 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.592 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 2.22 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 4.56 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 2.79 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.33 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.26 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.26 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 3.3 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 155' ' ' LYS . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.01 108.07 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 125' ' ' LEU . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.19 109.21 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 0.9 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.72 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 2.61 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 1.4 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.14 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 2.54 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 3.9 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.31 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.01 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.78 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.08 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 2.32 108.143 -171.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 2.92 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 2.38 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 1.56 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.69 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.06 107.115 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 0.92 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.05 109.798 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 134' ' ' GLU . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.24 109.396 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.08 110.118 -157.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 2.5 108.099 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.11 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.48 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 2.55 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 1.93 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 2.65 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 4.47 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.83 115.001 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 4.01 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.78 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.09 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.437 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 5.44 111.604 -165.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 1.25 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 1.46 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 2.98 110.925 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 5.41 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.97 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 2.98 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 1.24 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 2.37 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.18 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.83 112.943 173.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.35 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 1.59 105.701 153.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.05 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.28 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 4.67 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.72 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.5 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 2.4 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.437 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 1.4 108.355 168.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.679 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 1.49 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.44 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 3.39 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 2.29 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 1.52 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 5.35 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.89 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.25 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.94 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 0.99 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 3.91 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 2.05 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.65 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 3.93 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 1.74 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 5.44 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 1.51 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.62 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 2.01 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.87 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 0.94 109.793 -169.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.24 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 1.61 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 1.29 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 1.67 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.08 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 1.51 108.764 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 8.35 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 3.87 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.05 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.82 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 4.65 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 6.8 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.23 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 3.79 105.771 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 1.48 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 2.42 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.02 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.79 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 1.97 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 0.74 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 2.09 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 4.5 106.622 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 2.79 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 2.49 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 1.36 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.13 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 3.29 108.669 163.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.7 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 0.87 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 3.55 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.16 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 0.98 112.892 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.49 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 2.14 106.044 155.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 5.82 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 3.54 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.33 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 3.44 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 1.47 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 3.48 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.62 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 125' ' ' LEU . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.57 107.694 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 1.65 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.04 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 1.79 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 0.85 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 1.92 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.01 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.39 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 3.09 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.16 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.12 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.476 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 2.35 109.364 -167.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 2.83 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 2.58 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 1.19 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 0.94 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 1.42 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 1.7 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.04 109.381 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.29 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.33 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 2.79 111.679 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.56 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 4.15 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 3.41 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 2.34 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 3.76 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.06 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 5.6 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 2.26 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 1.94 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.32 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 73' ' ' PHE . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 2.99 116.775 -160.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 1.73 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 7.79 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 2.35 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 1.62 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 4.45 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 5.54 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.0 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.46 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.06 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 2.31 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.31 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.19 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.47 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.72 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 1.6 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.2 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.03 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.21 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 1.52 109.629 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 1.85 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 2.63 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 0.92 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 1.74 106.833 158.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.24 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 3.04 113.437 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 1.4 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 1.59 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.532 ' H ' ' NE2' ' A' ' 77' ' ' GLN . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.19 114.268 169.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.89 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.14 111.704 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.86 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.32 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.09 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 3.89 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.72 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 4.68 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 1.82 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 4.3 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 1.98 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 2.29 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.15 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 1.0 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.08 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 2.21 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 2.4 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 1.4 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 1.24 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.13 112.887 -176.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.08 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 3.9 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 3.7 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 6.83 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 8.37 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 5.52 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 2.67 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 1.53 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 2.67 107.895 164.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 1.43 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 0.92 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 2.48 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 0.8 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 2.34 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 7.5 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.39 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.36 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 2.81 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.9 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 6.18 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.0 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.15 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 2.54 111.942 -171.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 1.58 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 152' ' ' LEU . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 1.54 110.184 -171.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 3.3 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 5.97 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 3.21 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.61 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 5.66 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 1.67 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 2.63 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.61 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 154' ' ' ALA . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 1.79 107.919 -173.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 1.54 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.01 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 1.77 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 0.8 110.513 163.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.03 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.1 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 4.84 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.01 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 3.19 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.65 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.57 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 1.68 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 2.62 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 2.44 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 1.23 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.77 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.464 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.12 107.946 -171.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 0.98 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 1.26 110.85 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 4.61 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.77 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 40' ' ' THR . . . . . . . . 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 2.73 111.185 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 10.76 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.495 HG22 ' CA ' ' A' ' 37' ' ' GLY . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 3.82 109.213 -165.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.14 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 5.21 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 4.13 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 2.78 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 3.21 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.8 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 2.76 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 1.99 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 5.55 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' H ' HG13 ' A' ' 71' ' ' ILE . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 1.49 108.759 158.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 1.56 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 2.92 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 5.76 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 0.86 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.16 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 0.9 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 2.09 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 1.87 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.24 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.92 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 1.06 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.06 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.1 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 3.58 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 1.04 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.52 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 1.99 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 1.12 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 1.66 109.122 174.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 71' ' ' ILE . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 2.88 115.943 -167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 1.74 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 1.2 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 4.47 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.412 ' N ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.32 106.668 177.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.27 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.61 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 94' ' ' LEU . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.79 106.587 161.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 5.86 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB ' ' A' ' 92' ' ' VAL 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 3.38 107.702 -177.093 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.69 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 3.84 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 90' ' ' LEU . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 1.92 109.859 -158.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 3.88 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.02 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 1.83 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.63 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 85' ' ' LEU . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 2.59 110.921 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' A' ' 82' ' ' ILE . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 0.95 109.08 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 80' ' ' GLY . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 1.63 109.134 -173.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 1.48 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 1.95 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 1.1 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.09 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 1.72 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 6.98 111.976 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.411 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.07 113.642 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.01 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 6.7 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 10.85 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 7.69 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 2.74 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 1.17 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 2.37 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 2.34 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 0.9 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.58 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 0.79 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 2.98 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 5.84 108.286 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.8 t30 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.66 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.26 109.201 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 1.47 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.06 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.6 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 0.82 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 2.33 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 2.52 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.1 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.08 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 3.0 108.547 176.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 4.51 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 2.49 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.85 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.27 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 1.31 113.241 172.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 2.91 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.08 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 154' ' ' ALA . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 1.86 108.42 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 2.23 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.27 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 2.28 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.01 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.03 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 1.97 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 3.76 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 2.44 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.07 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.93 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 0.95 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 1.42 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 3.7 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 2.3 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 1.34 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.08 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 1.17 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 1.03 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 0.88 108.835 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.15 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.03 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 2.83 113.483 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.39 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' NE2' HD11 ' A' ' 99' ' ' ILE . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.42 111.812 -170.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 2.7 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.16 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 3.51 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.48 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 6.69 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 2.33 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.1 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.65 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.0 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 8.71 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 1.83 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 1.9 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.546 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 4.91 112.524 157.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 5.96 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.07 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.31 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 0.95 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 2.14 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.66 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.38 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.4 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 1.36 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.47 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 0.89 113.671 -174.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 3.67 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 1.39 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 1.75 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 3.09 112.398 -172.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 1.35 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.591 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 1.6 111.16 173.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.47 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 2.3 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 1.57 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.12 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 5.27 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.36 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.18 110.932 -175.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.97 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.04 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 3.63 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 82' ' ' ILE . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 1.92 107.504 178.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.22 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 3.28 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 1.76 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 3.56 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 1.39 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.62 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.06 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 2.37 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.72 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 1.11 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.28 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 2.58 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.01 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 1.15 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 1.12 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.49 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.21 103.619 166.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 7.34 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 3.18 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.07 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.14 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 5.49 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 9.04 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.48 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.06 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 1.18 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 2.18 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 1.85 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.97 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.36 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 2.12 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 5.41 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.14 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.07 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 1.43 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 3.25 109.438 165.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.63 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 0.83 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 2.54 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 1.49 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 0.91 111.96 -163.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2 113.064 -168.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 2.29 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 4.95 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 4.16 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.68 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 3.49 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.04 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 3.44 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.63 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 1.87 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 0.85 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.11 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 2.25 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 1.18 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 2.09 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.24 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.3 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 2.28 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.58 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 0.99 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 1.52 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 2.82 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 2.2 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 1.22 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.12 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 1.29 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 1.18 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 1.59 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 3.39 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.86 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.208 -0.757 . . . . 2.93 111.208 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.83 113.128 -175.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 4.27 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' LYS . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 2.65 111.17 165.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.1 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 4.49 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.03 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 3.91 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 3.32 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.05 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.85 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 2.94 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 1.88 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.18 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 1.4 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 1.8 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' H ' ' HB3' ' A' ' 69' ' ' TYR 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 4.44 116.967 -177.832 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 4.93 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 0.95 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 3.62 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 1.24 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 2.34 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.94 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 1.83 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.19 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.38 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 1.06 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.04 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.19 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD13 HD21 ' A' ' 152' ' ' LEU . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 1.62 109.63 174.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.24 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 2.69 111.597 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 1.73 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 2.3 104.518 160.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.99 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 3.06 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.31 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 1.58 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HG2' HG21 ' A' ' 40' ' ' THR . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 7.66 113.969 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.7 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.14 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.86 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 6.65 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 1.98 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.34 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 4.38 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 2.95 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 4.1 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 2.44 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.53 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.35 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.06 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.84 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 1.1 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.32 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 1.78 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 1.08 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 1.57 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 1.13 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.89 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 1.94 108.543 170.001 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 7.76 110.138 163.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 6.39 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.68 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 4.4 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 7.6 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.436 ' CB ' HG23 ' A' ' 40' ' ' THR 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 6.19 112.013 -178.121 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 2.56 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 1.45 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 110' ' ' SER . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 2.96 108.242 157.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 109' ' ' ILE . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 1.9 110.937 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.77 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 1.36 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.89 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 2.34 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 6.35 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 3.63 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 2.07 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 1.84 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.04 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.63 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.05 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 2.55 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 1.56 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.672 HD23 HD12 ' A' ' 152' ' ' LEU . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 0.79 108.015 -174.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.11 111.402 -177.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 3.19 111.2 -174.261 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 7.06 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 3.24 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.36 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 5.85 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.406 ' H ' HD11 ' A' ' 127' ' ' ILE . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.47 107.117 -164.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 2.68 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.15 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 154' ' ' ALA . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 1.2 106.545 155.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 1.13 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.71 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 1.91 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 0.7 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.05 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 2.1 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.2 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 2.5 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.11 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.65 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.03 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 2.21 106.872 -171.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 2.86 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 2.28 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 1.48 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.13 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.672 HD12 HD23 ' A' ' 125' ' ' LEU . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.25 107.57 -175.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 1.12 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.18 109.879 174.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 4.52 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.37 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 2.96 111.052 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.07 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.32 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 2.27 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 1.7 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 3.45 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.02 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 5.65 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 3.02 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 1.95 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.59 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 1.82 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 1.83 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 5.45 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 1.77 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 156' ' ' GLN . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.22 109.202 176.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' CE1' HD13 ' A' ' 71' ' ' ILE . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 3.39 108.053 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 5.38 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.77 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 2.21 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.9 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 2.25 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.12 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.12 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.51 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.82 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.04 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 0.71 112.32 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 3.74 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 1.33 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 2.04 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 2.2 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.87 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 1.51 106.605 170.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.28 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 2.47 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 1.62 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 1.38 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.05 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 2.32 107.194 172.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.41 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.26 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 5.12 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.783 HG23 ' HA3' ' A' ' 65' ' ' GLY . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 1.83 106.56 172.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.49 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 3.73 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 1.81 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 3.65 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 1.87 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.12 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.53 110.277 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 2.13 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.24 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 115' ' ' TYR . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 1.05 108.465 -174.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.06 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 1.81 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 1.95 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.04 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.13 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 1.4 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 8.33 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 3.97 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.98 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 4.03 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 9.51 110.912 -174.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.04 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.0 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 3.82 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 1.47 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 2.65 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.38 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.69 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 1.43 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 141' ' ' VAL . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 1.09 113.656 178.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 2.11 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 4.78 104.711 174.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.44 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 1.21 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 7.83 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.09 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 0.78 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 2.73 109.695 -176.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 1.93 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 0.76 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.17 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 2.35 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 5.02 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 3.56 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.55 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 5.39 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 1.55 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 3.99 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 1.58 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 0.92 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.9 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 2.56 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 0.78 112.069 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.44 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 113' ' ' VAL . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 2.2 106.559 -166.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 3.37 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 2.72 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 1.8 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.58 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.05 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 1.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 2.59 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 3.38 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 1.31 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 0.84 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 1.39 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 1.05 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 1.27 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 3.58 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' A' ' 52' ' ' THR . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.33 110.752 -177.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 3.99 109.788 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.94 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 5.61 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 3.8 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 2.48 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 2.98 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.14 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 3.85 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 2.14 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 1.64 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.02 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.42 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 1.85 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 6.26 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 1.47 111.5 -178.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 52' ' ' THR . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.27 110.611 -165.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 3.62 110.031 -178.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 4.96 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.65 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 2.96 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.62 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 2.46 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.29 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.22 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.24 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.28 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.06 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.806 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 0.94 111.987 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.2 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 0.81 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 2.52 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 2.22 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 1.66 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.614 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 1.28 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.55 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 2.82 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 2.63 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' A' ' 98' ' ' ASP . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 1.92 114.021 -162.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 4.62 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.32 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.63 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.87 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 4.28 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.806 HG23 ' HA3' ' A' ' 65' ' ' GLY . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.1 106.647 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.35 104.082 153.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 5.01 107.493 37.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 1.89 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 4.5 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 2.12 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.11 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 2.72 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.94 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 1.07 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.19 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 1.93 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 1.97 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 1.25 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 1.02 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.443 ' OD1' ' HB1' ' A' ' 75' ' ' ALA . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.47 110.302 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.13 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.15 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 4.57 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.1 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.37 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 5.78 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 6.26 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 5.55 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 2.66 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 1.74 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 2.61 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 1.6 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.84 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 1.32 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 0.86 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 1.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 6.79 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.2 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.95 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 2.68 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 4.52 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.55 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 0.96 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 2.29 109.87 178.978 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 1.95 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 126' ' ' GLY . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 1.32 107.404 -176.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' HD13 ' A' ' 125' ' ' LEU . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 3.0 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 4.64 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 2.72 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.95 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 3.8 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 1.91 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 3.08 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 1.41 106.356 170.101 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 1.24 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.31 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.0 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 0.87 109.783 165.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.35 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 2.12 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 2.74 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.01 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.05 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.33 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 1.4 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 2.64 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 1.92 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 2.31 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.01 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 2.28 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 1.39 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 1.06 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 4.06 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 4.51 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 2.5 110.616 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.15 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 4.86 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 2.71 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.21 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 3.06 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.91 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 5.17 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 2.33 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 1.87 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.19 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.09 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 1.96 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.25 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 1.56 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 1.92 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 135' ' ' VAL . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 3.35 108.234 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.01 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 0.93 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 2.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.15 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 2.27 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 1.69 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.42 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 1.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.1 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 3.77 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 1.06 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.33 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 2.03 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.24 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 1.8 104.621 163.105 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 3.62 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 1.39 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 1.34 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.12 110.169 165.216 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.67 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.27 111.912 -162.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.92 109.13 -172.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.12 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 1.91 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.64 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 3.34 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 1.56 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 3.94 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 1.61 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.61 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.08 113.534 175.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 2.14 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.84 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 1.08 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 1.99 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 0.99 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 1.98 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 1.36 111.179 -167.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.58 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 6.87 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 4.34 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 2.93 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 5.79 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 7.39 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 6.02 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 2.58 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 1.15 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 3.1 104.921 155.672 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 109' ' ' ILE . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 2.28 109.713 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.08 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.46 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 0.77 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.14 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.12 106.415 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.01 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.39 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 1.27 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.99 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 3.46 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.53 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 0.8 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 2.48 113.022 177.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 1.92 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 152' ' ' LEU . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.02 108.209 -174.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.13 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 2.52 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 5.12 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 3.12 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 2.85 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 4.67 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.13 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 3.94 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.17 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 125' ' ' LEU . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 1.57 106.153 165.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 1.07 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.07 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 1.78 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 0.68 111.024 169.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 2.13 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.17 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 2.31 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 1.99 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.16 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 2.18 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.44 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 2.39 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 1.35 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 0.95 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.505 HD11 HD23 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 1.78 112.458 173.08 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 1.25 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HB3' ' H ' ' A' ' 135' ' ' VAL . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.09 107.27 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 3.98 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.39 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.958 0 CA-C-O 119.575 -0.57 . . . . 2.63 113.224 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.69 114.57 -178.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.5 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.537 HG23 HD12 ' A' ' 127' ' ' ILE . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 3.42 111.166 176.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.43 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 4.2 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 3.66 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 5.22 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 4.97 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 3.99 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.63 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.13 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.31 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 6.24 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 71' ' ' ILE . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 2.27 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 1.65 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.822 ' CE1' HG11 ' A' ' 135' ' ' VAL . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 2.86 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 4.82 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.71 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 3.13 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 1.24 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 3.22 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 2.59 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.09 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.47 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 2.15 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.81 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.5 113.426 -168.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.28 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 0.9 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 1.88 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 2.05 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 0.98 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 51' ' ' ALA . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 1.6 109.374 167.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.72 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 3.09 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 1.68 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 1.77 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 5.71 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.43 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 3.19 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.52 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.9 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 4.73 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.669 HG23 ' HA3' ' A' ' 65' ' ' GLY . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 2.37 107.923 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.43 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 4.8 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 2.17 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.24 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 1.89 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.5 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.35 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 3.98 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 1.7 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 1.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.43 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 1.93 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.2 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 1.4 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.23 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.95 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HH22 ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.0 107.896 -178.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 7.28 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 3.55 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.24 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 4.63 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.485 HH22 HD11 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 11.02 113.561 169.022 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 8.46 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 2.67 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 1.12 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 2.71 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 1.96 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.72 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 1.66 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 1.12 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 2.46 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 6.12 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 6.03 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 2.82 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.11 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.68 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 3.98 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 0.9 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 3.05 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.15 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.606 HD21 ' HB ' ' A' ' 135' ' ' VAL . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 1.03 109.551 -176.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.537 HD12 HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 3.25 108.416 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 7.32 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 2.52 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.59 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.07 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.03 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 2.66 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' CE1' ' A' ' 53' ' ' TYR . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 1.29 108.408 165.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 0.9 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.74 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 2.12 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 0.76 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.51 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 2.42 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 6.08 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 3.4 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 3.52 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.1 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.16 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 3.32 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 3.1 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 2.3 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 1.52 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.26 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 1.26 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 1.1 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 1.06 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 3.58 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 2.87 115.616 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.01 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.41 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 2.8 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.29 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 2.97 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.01 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 3.38 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 2.66 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 1.91 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.3 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.0 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 1.86 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 5.21 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 1.68 111.758 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 1.87 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 3.44 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 4.22 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.78 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.26 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 0.95 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 2.17 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.15 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.43 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.39 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.31 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 1.34 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 0.94 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.33 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 0.89 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 1.93 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 2.27 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.14 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 1.33 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 3.35 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 1.16 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 5.24 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.35 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.05 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 3.93 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 2.09 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 4.48 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 1.49 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 4.35 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 1.82 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.37 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.41 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 2.64 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.17 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.44 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 3.21 111.015 177.854 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 1.56 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.18 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 1.2 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.03 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 8.84 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 4.38 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.411 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.3 113.134 -176.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.07 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.411 ' NZ ' ' OD1' ' A' ' 102' ' ' ASP . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 4.67 109.254 -176.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 7.13 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 6.86 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 3.23 110.579 -176.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 1.36 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 2.19 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.24 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.62 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 0.92 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 1.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 7.54 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.19 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.5 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.27 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.61 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 4.17 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.86 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 0.96 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.429 ' OH ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 2.27 111.042 164.037 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 2.03 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 135' ' ' VAL . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 1.57 109.426 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 2.29 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 5.49 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 3.65 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.03 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 3.8 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 1.25 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 3.24 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.89 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 154' ' ' ALA . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 1.1 104.563 162.3 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 0.9 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.82 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 2.24 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 0.83 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.93 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 2.55 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 4.28 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 145' ' ' ASN . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 3.74 108.054 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 2.75 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.666 ' H ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.66 109.156 174.618 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 1.93 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 2.32 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 5.27 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 1.9 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 1.46 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.84 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 1.14 108.25 -173.325 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 0.99 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 0.85 111.847 175.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.2 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 2.78 109.975 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.92 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.26 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 2.82 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.01 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 3.97 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.4 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 3.36 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 2.4 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 1.92 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.22 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.01 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 1.54 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.06 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 1.42 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 1.58 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 3.08 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 7.58 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.68 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 2.37 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.11 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 2.19 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.89 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 1.74 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.49 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.3 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 1.42 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.06 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 0.77 113.559 -169.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 3.98 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 1.31 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 2.44 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 2.2 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 1.19 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 1.42 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 2.37 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 1.64 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.499 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 169.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 6.53 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.499 HE22 ' HB3' ' A' ' 75' ' ' ALA . 11.3 mm-40 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.72 111.602 -170.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 1.32 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.08 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 3.9 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.689 HG23 ' HA3' ' A' ' 65' ' ' GLY . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 1.91 107.983 -174.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.38 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 4.12 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 2.73 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 4.96 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 1.71 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 1.9 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.38 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 3.15 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 1.43 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.8 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 1.71 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 1.17 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 1.96 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 1.62 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.51 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 1.35 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 9.23 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 3.9 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.52 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.65 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.02 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 6.71 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 6.39 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 3.72 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 1.43 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 2.67 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 2.21 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.86 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 1.87 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 1.22 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 2.41 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 5.71 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 3.52 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.59 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 2.41 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.582 ' CD ' HG21 ' A' ' 141' ' ' VAL . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 5.78 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.29 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.19 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 4.22 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 2.35 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -175.756 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.06 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 2.79 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 4.27 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 2.63 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.82 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 3.98 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.43 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 2.57 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.57 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 154' ' ' ALA . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 1.28 106.77 164.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 0.9 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.9 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 1.57 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 1.04 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.18 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.869 HG22 ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 4.3 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 3.84 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 3.42 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 1.93 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.34 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 141' ' ' VAL . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.57 108.263 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 1.61 107.84 174.171 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.57 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 2.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 1.48 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 0.95 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.605 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 1.47 107.056 178.044 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 1.33 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 1.2 108.838 175.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 5.33 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.17 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 2.8 108.154 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.69 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.31 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 3.15 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 1.89 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 3.64 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.8 109.837 -177.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 4.11 110.913 -178.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 2.8 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.01 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.31 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 2.75 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 1.62 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 5.07 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.699 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 2.55 108.027 168.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.43 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.16 114.463 -172.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 4.43 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.83 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.25 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 0.97 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 2.39 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.97 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.24 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.58 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.56 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 1.37 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.07 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 0.88 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 3.52 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 1.07 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 3.34 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 2.94 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 0.98 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 1.22 106.284 175.657 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.92 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 3.19 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 1.3 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 1.15 112.779 173.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 109' ' ' ILE . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 5.05 115.087 178.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.465 HE22 ' HB3' ' A' ' 75' ' ' ALA . 10.2 mm-40 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 109' ' ' ILE . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 1.35 114.131 167.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.99 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 0.93 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 3.93 111.432 -176.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 4.75 107.097 177.478 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.34 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 4.24 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 3.23 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.04 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 1.79 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 1.9 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.13 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 2.44 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.49 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.97 107.486 167.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 1.69 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 1.16 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 1.5 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 1.71 108.728 171.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 3.78 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.66 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.03 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 5.34 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 6.58 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 5.55 110.896 -172.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 2.63 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 1.16 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 76' ' ' LYS . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 2.48 107.223 158.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 1.84 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.74 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 1.45 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 0.89 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 2.33 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 7.26 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.29 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 1.54 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.45 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 3.56 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.55 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 0.79 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 2.87 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 1.88 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 0.86 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.01 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 127' ' ' ILE . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 2.67 109.517 157.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 4.68 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 3.28 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.82 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 5.28 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 2.59 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.82 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 154' ' ' ALA . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.03 108.02 170.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 1.45 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.93 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 1.69 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 0.71 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.44 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 2.15 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 3.42 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 2.62 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.16 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.4 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 0.97 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 1.52 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.43 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 2.5 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 1.34 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 0.88 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.09 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 0.93 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 1.27 107.172 161.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 4.88 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.69 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 2.71 111.942 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.66 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 4.46 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.05 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 3.6 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 2.91 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.64 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 3.78 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 4.35 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 1.98 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.8 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.19 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 1.62 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 6.39 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 1.62 111.084 168.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 1.74 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 135' ' ' VAL . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 4.3 109.223 167.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 6.35 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 0.96 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.14 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 0.93 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 2.26 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.08 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.66 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.95 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.14 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.13 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 0.71 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 3.84 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 0.98 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 2.24 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 2.14 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.21 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 1.38 108.533 177.035 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.65 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 2.58 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.26 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 1.28 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 5.49 114.415 178.6 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.83 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.557 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.29 111.165 -169.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.83 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 3.4 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.07 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.91 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 3.64 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 1.47 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 3.3 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.43 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.49 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.27 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.0 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 1.07 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.01 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 1.77 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 0.93 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.12 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.14 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.16 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 1.58 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 8.23 114.378 176.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 3.91 112.989 -166.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.61 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.27 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 4.9 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 5.93 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 5.8 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 2.43 110.996 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 1.38 110.403 -177.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 78' ' ' GLY . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 2.15 108.883 159.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 1.68 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.85 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.06 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 141' ' ' VAL . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 0.81 112.353 -160.026 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 2.49 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.45 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 3.68 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.44 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 1.52 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 3.93 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.78 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.03 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 2.32 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 1.57 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 1.26 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.06 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 2.49 108.35 175.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 7.01 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 2.85 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.53 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.1 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 1.67 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 2.3 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.72 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 127' ' ' ILE . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 1.12 107.81 167.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 0.84 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 1.47 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.01 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 2.95 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 113' ' ' VAL . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 2.55 104.935 168.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 4.77 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 2.77 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 2.52 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.36 107.484 170.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.53 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 1.64 108.73 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 2.74 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 2.35 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 1.41 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.2 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.13 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 1.44 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 1.01 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.09 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.32 111.988 177.335 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 106.185 -1.783 . . . . 53.8 106.185 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -61.83 95.56 0.06 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.214 -1.773 . . . . 48.91 106.214 155.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 m -159.09 118.25 2.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.426 -0.953 . . . . 46.06 108.426 -166.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -163.63 156.02 17.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.329 -0.989 . . . . 40.98 108.329 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.1 m -173.07 153.63 2.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 127.745 2.418 . . . . 36.71 105.854 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.43 136.09 5.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.138 -1.06 . . . . 32.38 108.138 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 76.7 mt -148.93 153.15 37.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.394 -1.706 . . . . 28.41 106.394 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -168.43 166.61 12.22 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.48 -1.304 . . . . 24.5 107.48 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.41 148.65 1.25 Allowed 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 126.157 1.783 . . . . 20.67 107.612 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -169.56 156.75 6.78 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 107.533 -1.284 . . . . 16.6 107.533 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.17 159.74 15.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.27 1.428 . . . . 15.44 108.206 176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -176.18 173.61 2.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.214 1.806 . . . . 10.45 106.403 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.41 73.97 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.767 1.627 . . . . 7.78 111.359 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -166.62 -43.91 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 127.745 2.418 . . . . 14.57 107.093 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.7 mm -74.11 100.11 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.482 -0.562 . . . . 15.51 109.482 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -41.18 138.18 1.2 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.447 1.499 . . . . 17.01 111.783 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.7 t0 69.32 -53.92 0.59 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.265 2.226 . . . . 13.17 113.153 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -49.31 -36.52 21.3 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.611 -0.68 . . . . 11.92 109.943 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -34.2 -42.2 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.012 2.125 . . . . 9.9 113.837 167.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -58.93 -46.35 88.18 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.309 -0.869 . . . . 11.17 109.883 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.8 m -61.03 -52.2 65.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.023 -1.103 . . . . 10.53 108.023 169.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -40.98 -83.9 0.01 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.881 1.705 . . . . 7.64 114.596 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -72.11 -98.36 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.502 1.151 . . . . 8.78 112.806 -164.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 72.5 mtm -137.19 -87.89 0.28 Allowed 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 119.382 -2.074 . . . . 12.73 109.133 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t 69.27 -79.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 125.314 1.634 . . . . 14.23 110.496 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 179.21 108.5 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 125.045 1.338 . . . . 15.98 108.122 -174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -166.57 153.77 9.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.326 -1.361 . . . . 16.57 107.326 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -71.34 -63.2 1.16 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.487 -0.931 . . . . 24.24 108.487 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 52.97 -144.24 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.058 0.943 . . . . 19.19 110.586 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -153.34 -70.31 0.14 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.485 1.914 . . . . 21.44 108.59 -169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -170.61 22.03 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.477 1.111 . . . . 23.04 111.413 -173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.0 mt -125.25 112.3 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.951 -1.87 . . . . 14.28 105.951 -174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -146.82 174.27 26.72 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 106.815 -2.514 . . . . 10.99 106.815 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.09 -64.39 0.96 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.925 1.69 . . . . 8.58 112.027 -172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.7 mt 49.03 41.04 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 124.98 1.312 . . . . 10.52 111.614 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.57 -61.55 0.72 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.605 1.162 . . . . 3.92 109.978 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.52 -5.0 54.6 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.605 -1.108 . . . . 2.57 113.064 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -45.6 -76.66 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.957 1.379 . . . . 4.93 113.988 -167.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -71.77 -34.81 69.77 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.142 0.883 . . . . 5.76 109.921 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -71.59 -35.27 70.46 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 125.661 1.584 . . . . 3.92 113.344 -162.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -52.21 15.15 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.631 -0.668 . . . . 2.06 109.655 162.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -45.62 -34.29 3.34 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.287 1.835 . . . . 2.91 113.741 -176.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -31.2 -44.62 0.07 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.771 1.628 . . . . 5.04 112.094 168.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.4 mttt 136.33 57.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 131.038 3.735 . . . . 3.48 109.4 168.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 HD22 ' HG3' ' A' ' 76' ' ' LYS . 4.8 mp -123.59 116.95 27.83 Favored Pre-proline 0 N--CA 1.447 -0.616 0 C-N-CA 125.941 1.696 . . . . 3.61 106.616 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.49 -166.34 0.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.035 2.49 . . . . 2.04 110.905 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 -17.08 61.9 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.653 1.353 . . . . 5.8 114.653 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -167.96 20.58 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 115.842 1.097 . . . . 2.01 115.842 -160.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -95.38 -118.44 3.26 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.498 1.047 . . . . 2.98 112.779 -174.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.37 109.18 9.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.576 0.954 . . . . 4.67 113.576 -155.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -80.62 176.41 9.82 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.397 0.617 . . . . 1.79 111.905 168.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 156' ' ' GLN . 10.1 t -105.28 57.06 0.68 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.722 1.209 . . . . 1.37 112.155 -161.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 71' ' ' ILE . 3.1 m-85 -77.79 68.76 3.92 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.228 -1.545 . . . . 3.58 110.748 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.8 mmm-85 -79.45 117.94 20.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.267 1.027 . . . . 4.62 108.521 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 -169.92 23.72 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.22 -0.99 . . . . 0.76 112.7 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 m -146.11 140.71 26.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.498 1.119 . . . . 3.01 108.518 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.25 76.77 1.34 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.613 2.365 . . . . 0.89 107.138 -168.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -77.86 138.83 39.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.07 -0.715 . . . . 2.83 109.07 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.69 165.64 52.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.225 -1.15 . . . . 1.02 110.225 -171.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.2 t -57.33 -26.65 61.27 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.911 -0.758 . . . . 1.78 111.066 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.55 1.74 49.27 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.077 2.151 . . . . 2.65 111.452 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.457 25.9 t0 17.85 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 117.247 2.314 . . . . 2.99 117.247 -136.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.77 57.01 0.7 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.482 -1.673 . . . . 1.27 106.482 148.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.14 179.39 27.2 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 124.586 1.089 . . . . 1.13 111.94 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.573 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -115.7 177.84 17.32 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 125.815 1.674 . . . . 0.76 112.735 -173.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -97.56 142.29 29.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.533 -1.284 . . . . 3.67 107.533 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.0 tp -89.18 106.88 18.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.808 -1.553 . . . . 0.88 106.808 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.6 m -78.63 142.06 37.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.203 -0.666 . . . . 1.9 109.203 178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -79.03 115.04 18.46 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.828 -0.545 . . . . 2.11 110.551 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 83.7 m -153.98 87.32 1.2 Allowed 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.729 -0.841 . . . . 0.89 108.729 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.679 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -136.96 128.06 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 106.623 -1.621 . . . . 1.56 106.623 172.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.45 112.15 20.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.6 -0.889 . . . . 3.36 108.6 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 82.5 m-85 -44.5 -38.58 4.22 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.234 1.014 . . . . 3.56 110.683 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -27.36 -41.46 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.539 2.736 . . . . 1.62 114.611 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.31 -22.16 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 115.449 1.648 . . . . 2.31 115.449 172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 71' ' ' ILE . 1.8 ttmm 93.7 49.14 0.0 OUTLIER 'General case' 0 C--N 1.348 0.51 0 C-N-CA 128.533 2.733 . . . . 4.41 113.247 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -74.95 70.59 2.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.012 1.725 . . . . 2.0 108.726 178.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.439 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -66.78 84.52 0.11 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 126.634 2.064 . . . . 1.66 112.638 -173.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -134.99 153.6 52.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.419 -0.956 . . . . 2.88 108.419 -175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.68 121.31 1.06 Allowed Glycine 0 C--N 1.334 0.441 0 N-CA-C 109.669 -1.373 . . . . 0.89 109.669 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.48 147.28 33.98 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.481 0.641 . . . . 4.03 110.856 -174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.573 HG23 ' HA3' ' A' ' 65' ' ' GLY . 38.2 mt -108.48 116.43 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 127.511 2.324 . . . . 1.82 107.072 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -155.56 60.16 0.62 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.483 0.659 . . . . 2.7 109.911 -165.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.53 ' H ' HD12 ' A' ' 85' ' ' LEU . 52.0 t60 -158.83 45.72 0.29 Allowed 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.555 -0.716 . . . . 3.79 112.691 -170.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 84' ' ' HIS . 3.2 mp -128.11 156.37 42.94 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 118.535 0.607 . . . . 1.53 111.028 -174.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -20.49 59.48 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.8 1.24 . . . . 3.3 113.108 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -118.53 118.23 33.83 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 117.735 -1.126 . . . . 1.32 108.733 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.63 -36.62 89.98 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.322 2.015 . . . . 1.43 112.261 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.71 -33.92 36.49 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.053 0.941 . . . . 3.27 111.503 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.6 -12.61 60.81 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.182 0.593 . . . . 1.99 111.656 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.36 115.29 3.44 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.086 -1.079 . . . . 2.58 108.086 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.402 HG23 ' CE2' ' A' ' 115' ' ' TYR . 2.9 t -102.22 102.96 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 N-CA-C 106.721 -1.585 . . . . 1.07 106.721 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -85.76 145.64 27.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 118.632 -1.227 . . . . 1.9 108.27 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.32 131.37 55.11 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.352 1.861 . . . . 2.99 108.8 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.0 34.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.989 -0.745 . . . . 1.12 108.989 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.69 114.87 16.97 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.332 -1.359 . . . . 1.27 107.332 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.81 127.55 43.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.6 1.16 . . . . 1.13 108.207 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -93.13 173.06 7.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.337 1.055 . . . . 4.75 110.495 -172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.77 89.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.719 1.608 . . . . 1.65 109.624 -159.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.47 157.18 7.32 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.28 2.232 . . . . 7.2 112.633 169.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -70.03 81.43 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.163 2.576 . . . . 5.41 109.931 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.99 -122.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.159 1.383 . . . . 5.41 109.629 174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.86 78.89 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.783 -1.327 . . . . 3.41 109.783 161.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 56.72 -116.03 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.98 1.312 . . . . 6.83 109.065 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -56.21 -13.28 1.98 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.582 1.553 . . . . 7.32 114.086 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 59.22 76.72 0.34 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.428 1.091 . . . . 9.17 108.789 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.8 37.86 0.12 Allowed 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.315 -0.866 . . . . 4.48 113.081 -173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -162.64 149.98 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.166 2.186 . . . . 1.95 108.385 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.7 mt -128.73 119.4 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.546 1.938 . . . . 2.54 107.704 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.4 m -80.18 65.06 5.2 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.771 0.828 . . . . 1.84 110.909 -172.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -94.07 120.78 6.44 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.508 -0.637 . . . . 1.45 111.508 -172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.0 m -78.61 150.5 32.7 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.69 0.796 . . . . 1.43 109.328 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.4 160.34 37.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 C-N-CA 124.198 0.999 . . . . 0.96 108.562 -173.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.17 131.84 40.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.19 0.811 . . . . 2.07 113.19 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CE2' HG23 ' A' ' 92' ' ' VAL . 5.3 m-85 -78.97 85.61 4.9 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.453 -1.314 . . . . 6.55 107.453 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.5 t30 54.18 -67.57 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.895 2.478 . . . . 3.71 112.945 -170.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -107.5 -32.41 7.72 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.056 1.743 . . . . 2.61 112.341 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.27 99.26 12.27 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.443 -0.786 . . . . 1.51 111.217 -163.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -78.33 65.07 3.57 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.146 0.498 . . . . 3.24 110.034 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.63 61.47 0.93 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 123.166 1.46 . . . . 3.26 107.457 172.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.41 134.14 3.83 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.667 -1.606 . . . . 0.85 112.218 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.99 133.15 55.68 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.106 1.762 . . . . 0.85 107.753 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -107.64 164.09 12.52 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.338 1.055 . . . . 5.34 108.629 172.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.5 p -145.11 75.15 1.43 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.705 1.602 . . . . 2.53 106.849 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.76 135.83 34.4 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.3 107.487 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.78 16.24 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 125.544 1.545 . . . . 1.15 110.782 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.29 143.16 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 124.755 1.222 . . . . 2.97 110.097 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -158.43 156.4 30.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.674 -0.862 . . . . 5.15 108.674 161.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 104.49 7.95 38.78 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.885 1.231 . . . . 3.26 112.814 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.88 -69.94 2.98 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.69 -0.964 . . . . 3.76 110.69 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -67.31 -18.29 65.12 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.722 0.761 . . . . 4.63 111.456 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 99.52 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.221 3.008 . . . . 1.83 104.746 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -124.68 -70.11 0.77 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.321 -1.362 . . . . 3.82 107.321 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -91.84 77.39 5.51 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 104.992 -2.225 . . . . 5.41 104.992 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.7 m -77.77 68.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 107.08 -1.452 . . . . 1.42 107.08 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.51 142.69 40.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.603 -1.629 . . . . 1.03 106.603 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.31 179.24 33.22 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.665 -0.974 . . . . 0.97 110.665 -164.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.8 p -153.65 172.0 17.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.32 -1.733 . . . . 1.98 106.32 161.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 123' ' ' TYR . . . -136.87 171.73 14.07 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.395 0.678 . . . . 1.1 110.032 158.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.54 63.66 1.52 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 122.655 1.217 . . . . 3.41 109.873 167.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.4 m -68.04 115.84 6.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.942 -1.026 . . . . 2.56 109.476 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -123.38 102.55 7.97 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.424 -0.798 . . . . 4.39 111.43 -160.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.2 m -151.44 167.97 26.31 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.699 -1.593 . . . . 3.09 106.699 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.3 t -44.73 -28.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.936 0.894 . . . . 2.77 110.428 161.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.05 56.1 1.81 Allowed 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 108.302 -0.999 . . . . 5.19 108.302 171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.41 102.87 0.54 Allowed Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.776 -1.33 . . . . 1.32 109.776 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.73 59.0 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.746 0.818 . . . . 1.89 110.182 -168.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 -19.35 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.261 0 C-N-CA 126.697 1.999 . . . . 2.7 115.373 -166.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -66.26 78.72 0.1 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.736 0.814 . . . . 2.26 111.381 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.82 121.13 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 124.843 1.257 . . . . 1.48 108.866 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.73 100.79 1.86 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 108.542 -1.823 . . . . 1.52 108.542 169.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -94.67 106.99 19.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.538 1.135 . . . . 1.42 108.364 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -117.67 143.39 46.22 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 108.194 -1.039 . . . . 1.71 108.194 174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.92 154.99 32.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.818 0.735 . . . . 1.24 110.877 -174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -157.82 145.47 18.54 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.022 0.529 . . . . 4.17 109.785 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.406 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.7 pt20 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 105.071 -2.196 . . . . 4.27 105.071 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 107.272 -1.381 . . . . 60.17 107.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -65.2 98.61 0.33 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.871 -1.159 . . . . 55.7 107.871 171.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -156.2 126.86 6.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.892 -1.151 . . . . 49.49 107.892 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.47 170.19 22.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.526 1.53 . . . . 45.37 107.295 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -166.5 178.54 6.03 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.026 -1.472 . . . . 39.72 107.026 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.78 163.49 38.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.57 -1.27 . . . . 34.98 107.57 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.7 tp -147.41 137.99 23.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.264 -2.125 . . . . 30.17 105.264 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.6 t -85.24 140.61 30.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.651 -0.87 . . . . 25.82 108.651 173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.51 174.17 11.85 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.839 0.456 . . . . 21.72 110.53 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -170.73 161.58 7.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.607 -1.627 . . . . 19.33 106.607 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.3 176.66 0.23 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.613 0.765 . . . . 15.53 109.392 -169.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 p 56.59 -167.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.896 0.879 . . . . 11.59 109.945 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.33 70.57 0.41 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.793 1.637 . . . . 8.0 112.198 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -67.25 176.8 2.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.776 1.63 . . . . 13.6 111.295 172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.5 mt -130.6 153.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 107.474 -1.306 . . . . 14.12 107.474 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 75.0 100.08 0.07 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.822 1.649 . . . . 17.59 110.281 177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 62.77 -68.84 0.07 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.84 2.056 . . . . 15.4 111.703 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.8 m -42.74 -34.61 0.95 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.467 1.907 . . . . 12.74 111.876 172.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -30.18 -56.21 0.19 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.702 2.001 . . . . 9.53 111.39 167.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -55.74 -45.43 78.0 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.749 0.42 . . . . 11.52 110.988 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.5 m -64.98 -58.51 5.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.917 -0.771 . . . . 10.12 108.917 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.25 -54.0 36.99 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.304 0.954 . . . . 7.14 112.989 -172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 32.0 tttp -53.47 -40.86 65.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.287 1.435 . . . . 9.34 111.979 -170.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.2 ptp 169.97 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.502 1.921 . . . . 10.52 112.715 165.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.3 t 68.9 -52.09 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.923 1.689 . . . . 13.24 114.013 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.61 -174.5 4.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.222 0.919 . . . . 13.94 110.194 -175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -122.21 168.54 11.89 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.225 1.41 . . . . 15.68 107.367 168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 75.38 -60.92 0.49 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.49 1.916 . . . . 20.11 108.598 -167.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -118.88 158.29 25.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.006 -1.85 . . . . 19.54 106.006 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -161.88 171.14 18.21 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.406 -0.59 . . . . 17.74 109.406 -171.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.45 74.23 2.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.511 1.124 . . . . 14.88 110.671 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.78 155.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.238 -1.347 . . . . 13.19 113.229 168.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.2 56.97 10.87 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.829 1.204 . . . . 10.18 111.347 174.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -171.98 -175.05 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 105.937 -1.875 . . . . 8.12 105.937 -172.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mt 68.72 158.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.767 1.627 . . . . 7.35 110.365 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.19 -84.03 0.18 Allowed 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.929 -1.107 . . . . 4.37 110.226 171.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.47 49.31 3.67 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-O 118.578 -1.123 . . . . 2.34 112.325 -162.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -42.43 -75.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.114 0.957 . . . . 4.64 111.315 -174.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -71.13 -7.27 45.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 117.544 -1.217 . . . . 4.94 113.512 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 83.0 m -65.65 -79.04 0.05 OUTLIER 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.145 -1.428 . . . . 2.49 107.145 160.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 m -47.82 -53.71 14.64 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.899 0.88 . . . . 2.19 111.021 -172.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -60.44 -32.97 71.88 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.836 1.05 . . . . 3.63 113.836 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.25 -59.67 3.95 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.273 1.397 . . . . 3.41 109.427 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.56 53.46 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.643 2.377 . . . . 3.62 107.724 176.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.84 133.86 24.93 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 108.984 -0.747 . . . . 2.96 108.984 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.03 164.18 35.76 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.416 2.077 . . . . 2.11 110.34 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.59 48.42 0.67 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.381 1.086 . . . . 5.86 110.165 166.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.94 148.32 21.53 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.877 1.227 . . . . 2.16 111.188 -174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.21 -28.9 57.4 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.495 1.045 . . . . 1.54 113.206 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -147.72 146.81 29.38 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 118.11 0.955 . . . . 5.61 110.155 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 178.95 7.31 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.303 1.041 . . . . 1.49 109.174 160.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 t -128.86 110.18 11.91 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.528 -1.286 . . . . 1.99 107.528 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -155.42 164.64 38.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 115.212 1.56 . . . . 4.38 115.212 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -130.4 77.51 1.79 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.275 1.83 . . . . 6.95 106.408 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.34 152.46 24.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.754 -0.736 . . . . 0.71 111.939 -168.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -120.64 121.49 38.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.125 -1.435 . . . . 2.44 107.125 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.28 138.48 44.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.972 -1.121 . . . . 2.15 107.972 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -126.01 128.98 48.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.702 -0.851 . . . . 2.51 108.702 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.88 170.95 48.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.436 -1.066 . . . . 1.15 110.436 170.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -51.95 -42.85 63.18 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.079 -0.659 . . . . 2.5 110.951 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 38.6 t70 -76.22 0.44 19.11 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.724 1.21 . . . . 3.75 112.868 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.355 46.8 t0 21.61 75.38 0.02 OUTLIER 'General case' 0 C--N 1.34 0.184 0 CA-C-O 123.06 1.41 . . . . 3.24 113.338 -128.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.93 54.95 0.74 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.602 -1.635 . . . . 1.76 106.671 149.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -98.21 167.76 22.82 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 107.253 -2.339 . . . . 1.34 107.253 170.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' CA ' HG23 ' A' ' 82' ' ' ILE . . . -91.18 178.13 41.64 Favored Glycine 0 CA--C 1.523 0.575 0 O-C-N 121.572 -0.958 . . . . 1.25 113.211 -175.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.29 119.33 34.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.01 -1.288 . . . . 6.57 107.736 166.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 tp -86.82 112.29 21.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.411 1.085 . . . . 0.94 109.903 -158.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.4 p -78.77 136.24 37.32 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.3 1.44 . . . . 2.17 109.223 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -73.53 126.97 31.45 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.291 0.567 . . . . 2.59 109.618 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.5 m -156.4 92.21 1.3 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.36 -1.719 . . . . 1.16 106.36 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 117.53 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.668 0.387 . . . . 2.0 110.495 170.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.11 79.06 2.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 125.46 1.504 . . . . 4.54 109.191 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -35.57 -34.76 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 117.083 2.253 . . . . 3.16 117.083 -176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.58 56.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.289 1.035 . . . . 2.06 112.335 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.535 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -141.85 -41.45 0.36 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.659 1.183 . . . . 1.23 109.915 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm 83.84 63.64 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.162 1.785 . . . . 3.69 111.574 158.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -81.65 56.55 3.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.156 -1.424 . . . . 2.4 107.156 172.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.59 125.74 29.04 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.185 -1.166 . . . . 1.27 110.185 -166.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.81 161.94 41.3 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.715 -1.217 . . . . 3.15 107.715 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.12 137.48 5.53 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 105.339 -3.104 . . . . 0.94 105.339 170.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -78.2 140.95 38.94 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.091 -0.644 . . . . 4.05 110.145 -175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 82' ' ' ILE . 40.3 mt -82.2 66.47 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.571 -1.641 . . . . 2.41 106.571 174.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 13.7 tt0 -79.45 157.51 27.5 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 104.568 -2.382 . . . . 3.66 104.568 157.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -155.96 70.84 0.71 Allowed 'General case' 0 N--CA 1.452 -0.357 1 C-N-CA 131.767 4.027 . . . . 5.84 104.986 31.14 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.8 mp -91.99 168.9 11.08 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.312 -0.858 . . . . 1.69 111.689 -156.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -50.13 -20.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 126.661 1.984 . . . . 4.49 113.009 -174.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -145.08 140.54 16.22 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-O 118.966 -0.54 . . . . 1.7 110.572 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -55.41 -35.15 91.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.528 2.819 . . . . 1.79 111.878 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -54.08 -39.96 66.78 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.701 1.2 . . . . 3.78 110.664 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.6 -25.54 59.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 118.598 -0.715 . . . . 2.1 111.306 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.91 99.8 0.88 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.394 -1.336 . . . . 1.82 107.394 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.639 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.5 t -94.43 141.54 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 126.498 1.919 . . . . 1.08 109.572 -171.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.94 156.85 20.6 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.152 -1.425 . . . . 2.76 107.152 164.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.07 162.7 27.08 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.433 0.635 . . . . 2.14 112.236 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.39 129.76 34.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.978 -1.01 . . . . 1.16 109.795 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.05 83.84 3.56 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 1.73 107.877 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -98.59 158.56 15.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.634 1.574 . . . . 1.13 111.422 -171.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -79.39 171.64 14.89 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.822 0.82 . . . . 3.01 111.948 -172.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.46 -62.35 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 127.29 2.236 . . . . 3.45 108.025 168.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt 64.82 166.53 0.11 Allowed Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.361 1.065 . . . . 7.02 112.105 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.56 78.8 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.027 1.818 . . . . 4.83 112.993 -171.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.75 -46.58 15.25 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 4.55 108.435 144.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.9 -23.5 21.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.147 0.88 . . . . 3.9 113.111 170.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' CB ' ' HZ3' ' A' ' 104' ' ' LYS . 4.8 ttpm? -86.97 56.89 4.22 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 122.449 1.119 . . . . 4.73 111.671 -158.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 44.78 40.33 4.16 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.714 -1.13 . . . . 7.93 112.799 -159.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 68.02 112.59 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.2 2.2 . . . . 5.62 113.495 172.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.24 -78.82 0.46 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.715 -0.675 . . . . 2.4 111.48 -167.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.64 157.26 11.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 123.024 0.53 . . . . 1.28 112.35 -170.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.5 mt -86.96 158.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 126.693 1.997 . . . . 2.22 109.052 165.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.9 t -125.57 87.53 2.71 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.17 -1.048 . . . . 1.67 108.17 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -95.97 177.43 34.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.073 0.844 . . . . 0.76 111.581 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m -148.17 156.79 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.454 -1.313 . . . . 2.19 107.454 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -119.9 153.3 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.878 0.871 . . . . 1.09 112.135 -164.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.93 116.75 26.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.418 1.887 . . . . 3.12 108.428 174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.639 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.4 m-85 -79.6 70.68 6.13 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 126.631 1.973 . . . . 6.15 107.562 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 67.38 -57.0 0.44 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.264 1.825 . . . . 2.96 113.118 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.17 12.48 2.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.35 1.86 . . . . 3.16 112.168 177.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.71 123.31 19.76 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.069 0.948 . . . . 1.61 109.733 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -99.65 111.56 23.88 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 118.482 -0.771 . . . . 3.61 109.026 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.6 mmpt? -158.48 91.88 1.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.148 1.779 . . . . 3.89 111.123 140.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.57 149.54 20.42 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 110.839 -0.905 . . . . 0.51 110.839 159.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.92 150.14 25.13 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.997 1.719 . . . . 0.98 108.983 170.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.92 152.12 46.13 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.963 0.905 . . . . 2.28 109.723 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.3 t -146.97 138.8 24.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.435 -1.32 . . . . 2.21 107.435 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.506 HD23 HD11 ' A' ' 152' ' ' LEU . 1.7 tm? -144.98 137.7 26.29 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.426 -0.953 . . . . 0.86 108.426 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -132.06 141.63 12.98 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.29 -1.924 . . . . 1.38 108.29 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.4 134.72 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 N-CA-C 106.816 -1.55 . . . . 2.79 106.816 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -137.36 159.61 41.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.304 0.573 . . . . 6.83 111.157 -163.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.24 88.99 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 114.911 -1.04 . . . . 3.81 111.871 -170.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.37 -69.64 2.95 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.161 -1.176 . . . . 4.73 110.161 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -62.78 -8.78 7.47 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.901 -0.764 . . . . 4.25 112.96 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 89.76 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.907 2.883 . . . . 1.79 105.199 -174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -118.27 -50.48 2.45 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.879 -1.156 . . . . 3.63 107.879 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -134.57 156.09 49.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.54 -1.281 . . . . 2.56 107.54 165.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.729 HG22 ' HB3' ' A' ' 154' ' ' ALA . 1.0 OUTLIER -126.61 152.87 34.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 107.301 -1.37 . . . . 1.8 107.301 163.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.39 140.08 47.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.902 -1.518 . . . . 1.09 106.902 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.7 175.96 33.38 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.972 -0.851 . . . . 1.09 110.972 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 73.4 m -152.68 159.95 43.16 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.97 -1.122 . . . . 1.79 107.97 167.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.96 141.33 49.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.031 -0.729 . . . . 0.94 109.031 166.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -114.71 98.99 7.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.261 -1.385 . . . . 3.44 107.261 168.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.4 m -114.94 131.55 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 113.518 -1.674 . . . . 2.19 107.053 -173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -135.96 116.3 13.61 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.978 0.808 . . . . 3.8 110.384 -168.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.7 p -146.5 -174.28 4.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.535 -2.024 . . . . 2.11 105.535 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.9 t -45.8 -30.28 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.586 0.754 . . . . 2.16 110.744 163.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.24 56.98 1.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 172.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.42 125.43 5.91 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.667 -1.773 . . . . 1.22 108.667 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -91.19 101.0 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 124.957 1.303 . . . . 1.57 109.69 -174.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.21 -1.69 1.74 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.717 1.006 . . . . 2.98 113.717 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -128.07 96.32 4.44 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.655 1.182 . . . . 2.27 108.157 165.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 78.9 mt -103.19 126.78 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.204 -1.776 . . . . 1.17 106.204 153.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.61 152.51 17.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.399 -2.28 . . . . 0.93 107.399 166.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 125' ' ' LEU . 2.4 pp -149.3 158.65 44.35 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.434 1.617 . . . . 2.03 112.403 175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.18 34.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.456 -0.793 . . . . 1.53 108.94 171.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.79 167.26 28.0 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.207 0.527 . . . . 1.12 111.317 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -156.91 176.63 12.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.557 2.343 . . . . 3.57 106.476 163.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 156' ' ' GLN . 4.4 mp0 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.502 2.321 . . . . 4.79 110.918 -172.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.9 -0.407 . . . . 53.24 109.9 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.03 162.72 13.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.516 -1.661 . . . . 45.43 106.516 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -168.87 179.79 4.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.029 -1.471 . . . . 41.28 107.029 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.95 169.33 8.23 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 127.16 2.184 . . . . 37.34 107.281 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -165.17 170.41 14.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.456 -1.313 . . . . 33.25 107.456 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.35 162.34 33.4 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.248 -1.39 . . . . 29.37 107.248 176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 tp -157.17 146.58 20.29 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.764 -2.31 . . . . 25.42 104.764 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -159.73 170.76 20.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.947 -1.131 . . . . 21.96 107.947 172.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.86 154.57 1.53 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.953 1.701 . . . . 18.4 108.128 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -155.45 138.9 15.86 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.92 -1.141 . . . . 14.85 107.92 163.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -165.65 1.89 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.004 1.721 . . . . 13.07 108.405 -167.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.8 t -142.18 170.86 14.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.823 0.738 . . . . 9.92 109.934 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -173.97 48.71 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.494 1.518 . . . . 6.23 107.875 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -134.54 100.12 4.55 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.446 0.698 . . . . 11.7 111.108 -171.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.1 mm -94.86 -54.94 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.781 1.233 . . . . 15.73 109.411 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.82 -104.28 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.642 -1.244 . . . . 20.63 107.642 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -45.81 -42.69 12.54 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.546 1.138 . . . . 18.25 110.325 169.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.7 -29.15 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.942 2.097 . . . . 13.21 113.999 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -49.24 -45.79 45.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.413 1.085 . . . . 10.78 110.958 171.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -68.44 -76.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.78 -0.822 . . . . 15.01 108.78 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -68.35 -49.07 62.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.634 0.605 . . . . 13.99 112.634 -166.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.14 -60.03 6.81 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.86 -0.896 . . . . 8.38 110.86 -174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -70.41 -41.83 72.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 118.012 -0.994 . . . . 10.31 110.993 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.8 ptt? 38.31 66.41 0.5 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 125.053 1.341 . . . . 12.15 111.659 -177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t 68.01 -65.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 126.0 1.72 . . . . 12.29 109.581 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -160.16 96.21 1.19 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.349 0.66 . . . . 12.85 110.925 172.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 80.01 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.261 1.025 . . . . 18.41 109.212 168.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -59.09 107.55 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.871 1.269 . . . . 20.15 109.959 169.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -122.06 -76.12 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.237 -1.394 . . . . 20.82 107.237 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -140.9 -169.38 2.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 103.77 -2.678 . . . . 22.64 103.77 166.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.3 ttt180 -78.41 58.24 2.1 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.726 1.148 . . . . 17.66 109.876 167.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 21.7 mm -144.09 160.25 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 106.34 -1.726 . . . . 15.35 106.34 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 146.06 -127.95 2.93 Favored Glycine 0 N--CA 1.449 -0.452 1 N-CA-C 103.015 -4.034 . . . . 10.37 103.015 -173.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 76.46 -56.0 0.57 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.678 1.991 . . . . 7.91 111.825 156.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.2 mt -53.34 -67.54 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 126.161 1.785 . . . . 9.72 109.722 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 164.5 168.67 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.715 2.406 . . . . 4.53 106.201 -171.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.79 -54.65 0.49 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 108.499 -1.84 . . . . 2.44 108.499 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 38.71 -90.86 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.979 2.511 . . . . 5.04 113.71 162.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -64.94 -20.56 66.53 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.889 0.876 . . . . 4.51 111.077 -166.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.4 p -69.87 -80.18 0.05 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.75 -0.833 . . . . 2.56 108.75 165.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.1 t -40.16 -46.45 2.21 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 128.188 2.595 . . . . 1.92 112.421 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -29.61 -67.98 0.08 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 128.78 2.832 . . . . 2.61 113.586 168.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -74.26 0.1 Allowed 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 123.558 0.536 . . . . 3.74 110.044 -153.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt 178.8 45.13 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.235 1.414 . . . . 4.53 109.956 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.467 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -107.53 -39.39 0.15 Allowed Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 115.112 1.523 . . . . 4.7 115.112 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -82.99 77.7 3.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 CA-C-N 121.357 1.52 . . . . 4.1 112.165 -156.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -48.34 -22.44 0.69 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.339 1.456 . . . . 12.5 114.493 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 158.15 -90.37 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 120.12 1.327 . . . . 3.05 111.554 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -112.06 -109.34 3.03 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 109.896 -1.282 . . . . 3.04 109.896 -175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.9 ttm-85 -79.81 117.7 20.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.033 0.533 . . . . 5.43 111.365 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.585 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.38 155.56 29.95 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.956 0.884 . . . . 1.23 112.692 -175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -79.05 61.82 3.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.036 1.334 . . . . 1.38 111.177 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.665 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.4 72.95 4.96 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.446 -1.409 . . . . 2.98 111.737 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -79.87 86.93 5.35 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.998 -1.112 . . . . 4.95 107.998 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.17 176.03 31.4 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.551 0.528 . . . . 1.08 114.27 -177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -136.26 136.53 39.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.239 1.416 . . . . 2.85 109.162 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.64 74.94 1.9 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.006 -1.85 . . . . 1.06 106.006 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -81.7 136.87 35.46 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 123.227 0.611 . . . . 2.64 109.405 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 161.03 49.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 108.977 -1.649 . . . . 1.22 108.977 -178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.2 t -50.94 -38.37 50.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.201 1.001 . . . . 2.36 109.832 159.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.81 -7.99 55.79 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.553 1.141 . . . . 2.95 113.01 175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.266 34.9 t0 40.71 51.93 3.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.699 1.714 . . . . 3.12 112.461 -158.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.42 56.28 0.69 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.235 -1.765 . . . . 1.23 106.235 160.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 120.71 2.34 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.022 -1.231 . . . . 1.91 110.022 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.19 -178.58 51.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 126.3 1.905 . . . . 1.18 113.134 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -77.55 139.48 39.57 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.347 1.459 . . . . 4.24 107.717 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 80' ' ' GLY . 16.8 tp -78.77 78.26 5.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 105.686 -1.968 . . . . 1.73 105.686 169.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.3 128.23 34.46 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 118.808 -1.157 . . . . 2.52 109.396 -162.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -74.02 128.48 35.64 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 119.436 -0.906 . . . . 2.35 112.657 -137.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.2 m -156.5 102.57 2.08 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.417 1.087 . . . . 1.4 109.011 168.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.721 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -130.68 127.93 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 105.464 -2.05 . . . . 1.55 105.464 146.105 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.93 104.38 16.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.538 -1.653 . . . . 4.38 106.538 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.585 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 47.3 m-85 -53.43 -19.8 3.95 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.822 1.249 . . . . 3.17 113.126 -173.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.73 -44.7 3.29 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.791 0.837 . . . . 2.16 111.632 170.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.61 0.77 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.968 1.469 . . . . 1.46 114.968 170.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? 59.79 63.35 1.5 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.401 1.095 . . . . 5.3 113.259 171.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.36 79.69 8.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 104.954 -2.239 . . . . 1.75 104.954 172.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.721 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.25 67.81 1.46 Allowed Glycine 0 CA--C 1.528 0.868 0 CA-C-N 114.662 -1.154 . . . . 1.19 114.547 -164.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -138.04 89.96 2.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.658 0.729 . . . . 3.01 109.746 -156.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.71 123.85 6.06 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.286 1.422 . . . . 1.0 110.273 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -79.47 147.4 32.27 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 113.533 0.938 . . . . 3.97 113.533 -161.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.1 mt -101.51 64.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.239 2.216 . . . . 1.97 107.156 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -108.32 109.85 21.29 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.464 1.106 . . . . 3.3 108.45 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -160.8 -15.54 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 116.015 1.858 . . . . 3.52 116.015 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.74 159.94 14.61 Favored 'General case' 0 C--O 1.228 -0.07 0 CA-C-N 120.366 1.439 . . . . 1.83 113.949 -135.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.04 -30.21 24.51 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.914 2.085 . . . . 4.96 113.548 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.4 t -131.58 145.06 55.95 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.343 -1.354 . . . . 1.81 107.343 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.26 -55.38 1.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.784 2.322 . . . . 1.54 112.254 -167.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.49 -39.06 56.81 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 4.05 112.853 -177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.68 -26.88 36.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.785 1.234 . . . . 2.1 112.992 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -67.4 118.88 11.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.265 0.939 . . . . 1.76 109.456 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.22 134.4 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.64 -0.874 . . . . 0.9 108.64 -175.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -111.28 155.76 22.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.028 -1.101 . . . . 2.14 108.028 163.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.67 140.25 42.32 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.702 1.201 . . . . 1.67 108.988 -171.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.86 157.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.661 -0.866 . . . . 1.18 108.661 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.68 130.94 38.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.204 -1.036 . . . . 1.6 108.204 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.97 123.67 6.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.899 0.48 . . . . 1.04 109.775 -173.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -78.93 175.75 10.25 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.649 1.98 . . . . 3.44 109.673 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.0 OUTLIER -114.1 83.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.233 1.813 . . . . 1.51 108.152 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 148.39 11.11 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 126.045 1.738 . . . . 8.33 111.423 171.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.0 83.72 1.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.838 2.359 . . . . 3.86 112.973 -169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -64.05 -10.28 21.14 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.715 -0.615 . . . . 5.08 111.926 160.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 63.3 5.33 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.302 0.953 . . . . 2.84 111.528 171.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.72 61.43 0.8 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.547 0.689 . . . . 4.7 112.589 -171.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 56.76 16.31 2.61 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.372 1.069 . . . . 6.82 113.361 -174.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 p80 146.3 -153.77 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 130.604 3.562 . . . . 6.24 103.525 -159.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.443 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -173.57 -159.25 0.1 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.768 2.027 . . . . 3.79 105.792 -176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 m -127.78 156.22 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 119.921 1.237 . . . . 1.48 111.62 168.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.6 pt -82.88 159.08 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.381 -0.97 . . . . 2.41 108.381 157.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 31.6 t -135.26 68.7 1.45 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.84 1.256 . . . . 1.89 108.347 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.52 168.96 38.71 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 117.817 0.281 . . . . 0.74 112.61 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.5 p -101.42 162.95 12.53 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.727 1.211 . . . . 2.12 109.466 167.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.22 144.74 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.336 -0.616 . . . . 0.77 109.336 173.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.11 115.04 29.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.657 1.583 . . . . 2.04 107.917 170.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -79.27 72.04 5.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.88 -1.526 . . . . 4.57 106.88 170.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 62.46 -62.91 0.11 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.278 2.231 . . . . 2.75 113.205 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -100.74 -30.23 11.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.547 1.539 . . . . 2.33 111.703 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.93 109.62 15.31 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.367 0.53 . . . . 1.47 112.394 -150.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -82.81 59.48 4.83 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.815 -0.553 . . . . 3.11 111.423 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -111.54 64.7 0.62 Allowed 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 122.958 1.361 . . . . 3.08 108.679 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.45 142.82 8.91 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 113.115 -1.857 . . . . 0.5 111.907 168.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -122.17 158.77 28.63 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.642 1.577 . . . . 0.94 108.258 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -155.5 158.95 39.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.262 0.553 . . . . 3.72 112.123 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.8 p -121.71 134.78 54.95 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.288 1.835 . . . . 1.9 106.144 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 126' ' ' GLY . 2.1 tm? -151.33 135.29 16.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.657 0.741 . . . . 0.97 112.359 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -93.01 -175.17 40.99 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 130.472 3.891 . . . . 2.5 112.779 -174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.467 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -136.04 145.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 106.222 -1.77 . . . . 2.13 106.222 154.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -37.73 -46.93 0.94 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 115.938 1.829 . . . . 5.77 115.938 -173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.31 38.22 46.35 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.783 -0.527 . . . . 3.58 111.783 -171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.11 -65.89 0.03 OUTLIER Glycine 0 C--N 1.342 0.89 0 N-CA-C 108.865 -1.694 . . . . 2.37 108.865 166.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -160.49 48.42 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.751 0.786 . . . . 3.59 109.544 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.19 47.81 11.22 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.325 1.85 . . . . 1.43 111.0 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -78.94 -43.44 24.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.225 -0.287 . . . . 3.34 110.225 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -140.81 167.9 21.08 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.213 -1.402 . . . . 2.64 107.213 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 125' ' ' LEU . 23.3 m -135.71 106.9 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.391 -1.337 . . . . 1.4 107.391 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.42 134.66 36.56 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.002 -1.11 . . . . 1.3 108.002 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.59 176.86 33.81 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.435 -1.066 . . . . 1.02 110.435 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.4 m -151.39 118.17 5.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.626 -1.25 . . . . 1.7 107.626 168.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -98.72 146.29 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.728 1.211 . . . . 0.7 110.531 170.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -130.0 87.65 2.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.583 1.953 . . . . 3.54 109.064 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.5 t -101.0 110.94 29.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.663 1.185 . . . . 2.05 108.303 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.1 119.57 37.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.517 0.599 . . . . 3.56 109.992 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.4 p -137.85 -179.88 6.02 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.866 -1.161 . . . . 2.34 107.866 162.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.7 m -43.37 -28.46 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.987 1.315 . . . . 2.98 112.403 166.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.47 57.99 0.88 Allowed 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.844 -1.169 . . . . 2.9 107.844 169.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.58 124.23 5.5 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 106.163 -2.775 . . . . 0.97 106.163 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.5 mp -80.27 112.82 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.319 -0.993 . . . . 2.32 108.319 -167.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ttp85 -66.87 -57.27 7.32 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 119.023 -1.071 . . . . 3.58 109.434 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -75.84 86.24 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.284 -0.885 . . . . 2.58 110.175 -174.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 mt -103.98 122.99 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 125.009 1.324 . . . . 1.15 109.315 174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.13 107.48 2.54 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.671 -1.772 . . . . 0.83 108.671 170.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -85.48 106.21 16.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.183 -1.414 . . . . 1.18 107.183 170.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.78 43.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.029 -0.73 . . . . 0.98 109.029 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -149.27 157.79 43.64 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.097 -0.705 . . . . 0.98 109.097 173.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -156.2 123.11 5.26 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 124.777 1.298 . . . . 5.39 108.978 158.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.272 0 N-CA-C 104.724 -2.324 . . . . 4.31 104.724 166.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.444 -0.947 . . . . 67.4 108.444 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -172.02 -171.83 0.91 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.432 -1.692 . . . . 61.15 106.432 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 t -147.83 -173.64 4.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.182 -1.784 . . . . 57.06 106.182 159.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.06 164.79 2.84 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.073 1.749 . . . . 52.24 108.17 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -154.86 -170.84 3.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.577 -1.268 . . . . 47.24 107.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.9 146.05 39.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.887 1.275 . . . . 42.5 109.547 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.51 153.27 35.64 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.311 -0.626 . . . . 37.63 109.311 170.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.1 t -70.79 158.72 35.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.861 0.362 . . . . 34.21 110.097 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.49 166.55 22.41 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.515 -0.921 . . . . 29.12 108.515 160.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -134.23 174.19 10.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.055 1.342 . . . . 26.69 108.165 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -51.65 -60.69 2.87 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.64 0.776 . . . . 22.33 109.85 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m 69.2 158.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.009 1.324 . . . . 16.03 111.612 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -48.05 -56.93 6.55 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.843 2.057 . . . . 11.08 110.234 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -133.38 -179.01 5.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.5 -1.667 . . . . 14.11 106.5 165.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.7 mt -128.23 149.94 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.171 -1.789 . . . . 19.77 106.171 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.6 88.32 0.11 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.975 1.31 . . . . 21.68 110.87 172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.37 -62.61 0.36 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.495 1.918 . . . . 18.15 111.935 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.45 -41.07 1.34 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 126.318 1.847 . . . . 14.36 111.357 168.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -36.65 -56.29 0.83 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 125.232 1.413 . . . . 19.13 111.463 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -62.74 -43.92 97.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.493 0.717 . . . . 18.92 109.643 -175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.03 -44.6 94.52 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.227 0.211 . . . . 11.52 110.573 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.46 -66.05 2.32 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.258 -0.737 . . . . 9.04 111.258 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -70.65 -32.3 69.55 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.874 1.67 . . . . 16.35 112.924 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.371 0.0 OUTLIER 31.71 -124.48 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 126.339 1.855 . . . . 15.11 115.452 -170.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.5 t 54.08 57.76 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.223 0.92 . . . . 19.47 109.419 165.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -174.48 72.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 106.773 -1.566 . . . . 20.1 106.773 -175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.0 tttp 67.58 169.31 0.26 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.086 -1.416 . . . . 25.13 108.367 -155.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -145.58 143.7 30.05 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 104.083 -2.562 . . . . 20.01 104.083 163.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -166.71 -64.41 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.892 -0.781 . . . . 22.44 108.892 -171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -73.21 178.32 4.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.451 0.7 . . . . 20.15 110.31 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.69 64.47 1.23 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.01 0.924 . . . . 20.92 110.656 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -84.26 146.36 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.281 1.432 . . . . 13.21 107.827 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.13 -154.64 5.31 Favored Glycine 0 CA--C 1.529 0.915 0 O-C-N 121.767 -0.583 . . . . 11.73 111.744 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -89.41 -37.42 14.84 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 128.724 2.81 . . . . 12.01 110.135 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 mt -28.54 133.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.828 2.851 . . . . 9.02 114.137 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.35 -63.7 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 127.239 2.216 . . . . 4.25 107.095 161.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 62.12 3.76 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.511 -1.036 . . . . 2.46 110.511 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -46.56 -66.19 0.44 Allowed 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 113.43 0.9 . . . . 5.03 113.43 -162.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.29 -40.89 94.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.38 0.536 . . . . 4.93 109.764 -171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.5 t -66.08 -35.06 79.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 117.987 -1.006 . . . . 2.74 112.692 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -71.19 -62.19 1.49 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.173 0.897 . . . . 2.17 108.66 170.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -34.08 -46.13 0.23 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.006 2.122 . . . . 2.95 112.771 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -36.71 -53.96 0.9 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.304 1.442 . . . . 2.8 110.714 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.3 pttp 154.48 44.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 129.575 3.15 . . . . 5.16 109.474 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.62 149.24 72.93 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.456 1.103 . . . . 2.33 108.33 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.42 -168.79 0.66 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.997 3.132 . . . . 1.83 112.77 -165.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.01 -27.71 30.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.009 1.724 . . . . 5.21 111.654 166.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.5 123.21 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 128.6 3.0 . . . . 2.11 117.382 -168.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.75 27.76 1.09 Allowed Glycine 0 CA--C 1.539 1.562 0 O-C-N 121.306 -1.114 . . . . 1.88 115.162 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.91 155.78 28.33 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.181 1.792 . . . . 5.21 107.803 171.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -149.51 158.37 44.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.578 -0.527 . . . . 1.41 109.578 175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.3 t -83.67 99.71 10.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.414 0.686 . . . . 1.67 109.746 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -124.23 65.63 1.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.791 1.636 . . . . 3.26 107.573 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -79.76 67.65 5.6 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.173 -0.954 . . . . 4.99 108.9 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -99.68 151.47 19.28 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 121.245 0.358 . . . . 1.12 113.986 -167.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 p -119.68 105.09 10.83 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.361 1.464 . . . . 2.28 108.215 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.9 90.9 6.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.528 1.131 . . . . 1.11 109.329 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -96.68 124.16 40.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 2.51 109.823 -170.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.78 164.89 49.0 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.779 -0.929 . . . . 1.33 110.779 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.0 t -57.54 -23.06 48.29 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.14 0.793 . . . . 1.95 113.14 172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -94.2 -2.16 52.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.1 1.36 . . . . 3.57 111.211 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 50.66 22.36 1.08 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.988 1.315 . . . . 3.39 112.869 -158.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.88 58.85 3.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.701 -1.592 . . . . 1.49 106.701 160.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.49 177.21 23.69 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 109.517 -1.433 . . . . 1.43 109.517 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.32 175.97 21.65 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.167 -1.173 . . . . 1.06 110.167 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.12 128.87 40.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.13 -1.433 . . . . 3.71 107.13 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -75.43 87.03 2.58 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 104.008 -2.59 . . . . 1.32 104.008 174.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.7 m -78.34 131.77 37.15 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.58 -1.267 . . . . 2.43 107.58 -166.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -74.7 118.96 18.24 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.003 -0.679 . . . . 2.05 111.402 -148.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 m -156.29 117.18 3.76 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.031 0.932 . . . . 1.3 108.603 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.466 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -137.68 166.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 104.217 -2.512 . . . . 1.74 104.217 159.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -114.19 123.63 50.07 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 105.38 -2.082 . . . . 3.51 105.38 155.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 2.6 m-85 -61.62 -23.47 66.06 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 120.105 1.321 . . . . 3.61 114.0 -171.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.58 -44.92 89.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.624 1.102 . . . . 1.41 110.826 -170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.22 -10.26 10.84 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.3 1.04 . . . . 1.32 112.885 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.1 OUTLIER 65.16 50.23 1.85 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.52 1.629 . . . . 4.11 110.591 164.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.29 51.65 1.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.093 1.357 . . . . 1.65 110.688 -173.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.54 111.39 3.74 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-N 115.667 -0.697 . . . . 1.2 112.343 -158.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 51.2 m-80 -152.25 141.57 21.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.933 -0.766 . . . . 2.97 108.933 -171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -152.21 120.23 1.05 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.026 -1.23 . . . . 1.17 110.026 -171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -76.8 139.59 40.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.457 0.646 . . . . 4.18 112.012 -160.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.2 mt -86.2 58.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.11 -1.441 . . . . 1.92 107.11 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -98.67 106.08 18.3 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.179 -1.045 . . . . 2.59 108.179 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -157.79 -10.29 0.08 Allowed 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.517 1.302 . . . . 3.35 114.517 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.6 mt -114.3 156.95 23.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.676 1.732 . . . . 1.56 115.676 -133.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.87 -24.26 0.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.102 3.361 . . . . 3.96 113.758 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.6 m -148.68 145.62 20.36 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-O 118.641 -0.695 . . . . 1.37 110.565 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -51.42 -51.79 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.349 2.7 . . . . 1.6 110.698 -175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -35.94 -47.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.795 1.638 . . . . 4.08 113.611 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.14 -22.33 58.21 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.127 0.571 . . . . 2.06 111.677 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -71.73 76.63 0.85 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.102 0.864 . . . . 1.88 109.558 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -63.98 142.44 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 125.564 1.545 . . . . 1.1 110.646 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -119.31 159.03 24.89 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.456 168.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -121.27 138.2 54.34 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.176 2.59 . . . . 1.93 110.207 -170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.29 145.52 33.46 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.217 -0.66 . . . . 0.97 109.217 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.44 82.04 3.89 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.626 -0.879 . . . . 1.97 108.626 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -116.56 138.53 51.34 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.02 1.728 . . . . 1.4 111.962 -165.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.89 175.76 10.23 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.788 2.035 . . . . 3.26 113.326 -166.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.65 128.53 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 127.925 2.49 . . . . 1.78 104.75 159.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -71.67 178.69 1.18 Allowed Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 122.875 0.47 . . . . 7.0 109.736 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -61.53 72.7 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 121.465 1.443 . . . . 4.23 109.597 152.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -54.47 -55.99 23.31 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.037 1.335 . . . . 4.83 109.249 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 121.96 163.94 12.07 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.779 2.133 . . . . 2.97 108.856 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.0 tttp 64.65 56.39 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.466 0.706 . . . . 5.79 110.261 161.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.25 81.5 mtt-85 68.39 -46.31 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.174 1.39 . . . . 7.33 112.692 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 166.41 162.13 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.194 1.798 . . . . 6.07 108.964 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.92 -72.79 0.67 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.404 0.547 . . . . 2.56 110.176 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.4 m -151.86 146.77 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 113.228 0.825 . . . . 1.15 113.228 -167.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.601 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -80.71 145.08 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.063 -1.829 . . . . 2.98 106.063 158.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.459 ' N ' HD12 ' A' ' 109' ' ' ILE . 10.7 t -125.06 98.82 5.84 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.989 0.515 . . . . 1.65 109.667 -176.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.44 139.18 14.6 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 123.498 0.571 . . . . 1.03 113.225 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.0 m -78.56 146.96 33.95 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.258 -1.386 . . . . 1.51 107.258 163.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 m -128.85 155.65 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.014 -1.476 . . . . 0.77 107.014 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -124.37 145.75 49.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.021 0.439 . . . . 2.15 111.457 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -77.22 66.98 3.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 127.374 2.27 . . . . 5.07 106.139 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 60.59 -60.29 0.08 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.674 2.79 . . . . 3.07 113.285 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -98.85 -42.53 7.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.504 1.121 . . . . 2.53 111.814 170.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.57 125.23 50.75 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.793 -0.567 . . . . 1.28 112.5 -162.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -78.85 113.25 16.79 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.057 -1.027 . . . . 3.91 109.378 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.7 mmpt? -150.34 81.69 1.36 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.362 1.465 . . . . 3.44 109.839 133.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.29 155.03 26.0 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.148 -0.933 . . . . 0.52 111.07 161.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.8 p -141.76 144.35 33.94 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.719 1.608 . . . . 0.73 107.912 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.514 ' HE1' HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -135.96 163.18 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.304 0.574 . . . . 2.4 112.197 174.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.4 p -134.06 122.68 23.31 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.898 -2.26 . . . . 1.82 104.898 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.565 HD21 ' HB ' ' A' ' 135' ' ' VAL . 1.3 tm? -136.46 134.57 37.8 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.791 -1.188 . . . . 0.81 107.791 -174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.79 176.64 17.03 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.311 -1.515 . . . . 1.15 109.311 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.81 130.88 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.033 -1.099 . . . . 2.57 108.033 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -71.3 95.92 1.37 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.007 -1.108 . . . . 5.16 108.007 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.39 43.02 0.42 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.593 1.568 . . . . 2.93 115.196 -171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -89.53 -87.72 1.27 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 106.705 -2.558 . . . . 2.7 106.705 154.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -115.02 5.16 14.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.527 1.131 . . . . 4.62 112.561 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 85.69 43.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.139 1.776 . . . . 1.83 109.075 -169.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -62.79 -46.5 87.72 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 124.341 1.057 . . . . 3.93 109.549 -167.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -131.78 162.37 30.68 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.698 -1.964 . . . . 3.17 105.698 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.565 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.5 m -121.37 96.04 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.251 -2.129 . . . . 1.48 105.251 166.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.03 135.15 36.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.249 -1.019 . . . . 0.88 108.249 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.9 163.34 31.3 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-O 121.511 0.506 . . . . 1.01 112.901 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.5 m -139.78 135.52 33.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.076 -1.453 . . . . 1.75 107.076 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -116.52 145.34 43.4 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.332 0.653 . . . . 0.7 111.291 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -107.37 108.62 20.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.896 -1.89 . . . . 3.07 105.896 160.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.1 t -127.09 111.78 26.66 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 N-CA-C 107.918 -1.141 . . . . 2.18 107.918 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -132.56 120.88 22.44 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.652 0.66 . . . . 3.24 110.784 -163.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.2 p -150.44 -170.52 3.67 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 106.368 -1.716 . . . . 2.33 106.368 169.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.8 t -40.91 -36.15 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 124.569 1.148 . . . . 2.08 111.066 164.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.68 52.54 1.41 Allowed 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.782 -0.821 . . . . 3.01 108.782 167.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.4 120.83 6.64 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 104.97 -3.252 . . . . 1.21 104.97 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.13 59.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 122.688 0.395 . . . . 2.61 111.145 -161.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -6.34 -85.16 0.0 OUTLIER 'General case' 0 C--N 1.345 0.389 0 C-N-CA 127.703 2.401 . . . . 2.37 113.414 -160.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -70.14 106.49 3.3 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.366 1.041 . . . . 2.19 109.162 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.8 mt -105.05 113.92 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.618 -1.623 . . . . 1.35 106.618 162.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -89.12 145.58 18.63 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 107.671 -2.172 . . . . 0.75 107.671 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 125' ' ' LEU . 0.7 OUTLIER -146.89 146.97 30.34 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.831 1.315 . . . . 1.82 112.707 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.86 175.27 9.85 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.765 -1.939 . . . . 1.68 105.765 170.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -143.04 171.74 13.64 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.667 -1.234 . . . . 1.19 107.667 173.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -149.38 111.45 4.62 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.265 0.978 . . . . 4.32 110.863 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.161 0 C-N-CA 123.414 0.686 . . . . 4.17 110.436 172.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 119.537 -0.268 . . . . 48.91 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -147.36 56.09 1.1 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.69 -1.596 . . . . 43.99 106.69 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -163.47 143.19 8.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.079 -1.452 . . . . 41.02 107.079 -172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -165.57 156.54 13.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.61 -1.256 . . . . 36.12 107.61 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.4 p -163.01 162.71 26.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.746 -1.575 . . . . 32.19 106.746 166.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.3 53.94 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.83 0.852 . . . . 28.11 109.219 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 32.0 tp -79.52 130.6 35.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.575 -0.898 . . . . 25.26 108.575 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -159.5 178.37 9.96 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 107.249 -1.389 . . . . 21.78 107.249 170.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.41 178.79 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.083 1.353 . . . . 18.41 109.093 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -158.09 179.53 9.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.419 1.888 . . . . 14.87 106.395 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -153.61 155.73 36.64 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.725 0.693 . . . . 15.15 110.312 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 t 158.11 -152.06 0.0 OUTLIER 'General case' 0 C--O 1.232 0.178 0 C-N-CA 131.177 3.791 . . . . 9.22 104.166 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.21 24.05 0.07 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.571 1.948 . . . . 6.0 110.456 -170.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -116.65 104.28 11.22 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.185 -1.413 . . . . 11.91 107.185 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.305 40.5 pt 43.37 -136.5 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.522 1.929 . . . . 15.28 113.114 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 14.95 85.17 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.775 2.83 . . . . 16.5 116.19 -172.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t70 66.99 -59.28 0.39 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.608 2.363 . . . . 12.11 112.063 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.1 m -48.56 -27.7 2.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.98 1.712 . . . . 10.0 112.759 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -29.57 -57.33 0.16 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.141 2.176 . . . . 11.64 111.916 160.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -70.26 -67.92 0.46 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.476 1.11 . . . . 12.7 109.121 172.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -71.05 -57.91 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.917 1.287 . . . . 10.25 112.718 -158.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 -52.61 10.92 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 124.486 1.041 . . . . 7.26 111.473 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -8.89 56.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.184 1.393 . . . . 8.8 111.819 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 55.89 77.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.88 1.672 . . . . 13.57 111.529 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -59.29 93.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.489 -0.93 . . . . 14.74 108.489 163.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 70.6 175.41 0.29 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.176 1.39 . . . . 18.02 111.274 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.57 45.07 24.42 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.176 0.99 . . . . 22.49 111.84 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -74.09 71.79 1.64 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.245 -0.65 . . . . 20.47 109.245 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -143.35 54.91 1.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.916 1.686 . . . . 26.38 107.926 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -141.69 -167.83 2.53 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.174 1.39 . . . . 21.73 108.185 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -72.0 68.36 0.68 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.915 0.886 . . . . 22.67 110.643 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.4 mt -77.7 71.89 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 106.999 -1.482 . . . . 17.72 106.999 173.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.52 57.27 0.28 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 107.418 -2.273 . . . . 14.16 107.418 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -169.82 -64.72 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.718 2.007 . . . . 11.68 107.103 -172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.96 139.96 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.085 0.954 . . . . 9.24 109.396 171.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.04 170.87 7.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.553 1.141 . . . . 4.5 110.319 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.08 2.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.291 -0.727 . . . . 2.77 111.389 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 27.78 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 127.268 2.227 . . . . 5.67 113.713 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -61.72 -35.92 79.47 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.156 1.382 . . . . 4.48 110.596 -169.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.4 p -58.26 -70.45 0.14 Allowed 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.966 -0.753 . . . . 3.08 108.966 174.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.5 p -44.77 -51.74 9.11 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.633 -0.712 . . . . 3.63 110.991 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.58 -42.84 62.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.158 2.183 . . . . 2.94 113.319 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -60.24 -17.84 44.61 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.108 0.867 . . . . 3.6 112.343 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt 113.55 60.69 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 130.064 3.346 . . . . 3.75 109.781 169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.31 101.43 51.23 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.98 1.312 . . . . 4.34 108.636 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.83 -169.2 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.18 2.586 . . . . 1.97 111.412 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.55 41.55 0.26 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.401 1.081 . . . . 5.76 111.736 172.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.93 147.66 19.02 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.427 1.013 . . . . 2.1 111.627 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.09 -37.6 15.17 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.246 0.927 . . . . 1.59 114.793 -171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 115.6 7.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.563 . . . . 6.34 108.304 -177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.69 175.79 10.3 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 121.132 0.492 . . . . 1.64 111.147 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 t -109.93 129.78 55.61 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.853 1.661 . . . . 1.71 109.136 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CE1' HG13 ' A' ' 135' ' ' VAL . 76.1 m-85 -147.32 168.91 20.6 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.801 1.241 . . . . 4.38 109.47 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -138.87 134.45 33.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.474 -2.047 . . . . 6.34 105.474 157.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.98 177.42 42.76 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.798 -1.191 . . . . 0.93 114.075 -177.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.6 p -136.21 142.11 44.05 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.189 1.796 . . . . 2.18 108.581 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.26 70.26 0.78 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.825 2.05 . . . . 0.96 106.476 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -79.91 143.29 34.38 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.442 0.697 . . . . 2.15 109.481 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.4 155.11 43.26 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 108.716 -1.754 . . . . 0.98 108.716 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 24.9 t -56.67 -24.05 46.04 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.982 1.391 . . . . 2.51 110.959 163.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -96.78 7.84 45.68 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.532 1.533 . . . . 2.53 111.517 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.3 t0 10.17 71.96 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 118.098 2.629 . . . . 3.04 118.098 -144.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -108.19 53.82 0.68 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 113.659 -1.61 . . . . 1.18 106.916 150.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.47 -179.24 21.16 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.963 1.744 . . . . 1.18 109.603 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.94 179.73 16.9 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.827 1.203 . . . . 0.73 110.683 -172.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -77.99 169.55 18.09 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.437 0.695 . . . . 3.86 110.321 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.2 tp -120.31 105.2 10.7 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.759 -1.201 . . . . 0.96 107.759 157.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.6 m -78.54 148.83 33.23 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.123 -0.695 . . . . 2.22 109.123 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.651 -0.5 . . . . 2.14 109.651 -173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.1 m -155.3 85.56 1.07 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.375 -0.972 . . . . 1.16 108.375 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.72 122.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.302 -0.999 . . . . 1.36 108.302 176.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.19 114.32 21.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.656 -1.238 . . . . 3.61 107.656 170.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 86.4 m-85 -57.15 -32.33 66.27 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.788 1.235 . . . . 2.54 112.653 -172.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.1 -31.78 2.54 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.737 1.215 . . . . 1.31 113.259 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -154.49 10.59 0.37 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.908 1.447 . . . . 1.34 114.908 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.538 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 49.48 73.49 0.24 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.509 1.923 . . . . 5.51 114.062 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.1 65.01 6.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.668 -1.975 . . . . 1.88 105.668 170.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.54 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -78.55 85.74 1.15 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.27 -1.332 . . . . 1.34 110.656 -169.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -136.07 96.77 3.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.206 -1.035 . . . . 2.58 108.206 -164.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.25 134.07 11.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 126.17 1.843 . . . . 0.88 109.694 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -79.75 130.08 35.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 114.08 1.141 . . . . 3.39 114.08 -164.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.0 mt -83.3 69.14 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.458 1.503 . . . . 2.08 107.048 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -132.14 87.44 2.43 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.254 -0.885 . . . . 3.14 111.714 -154.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.407 ' H ' HD12 ' A' ' 85' ' ' LEU . 3.8 p80 -159.64 27.23 0.19 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.511 1.124 . . . . 3.58 112.334 153.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' H ' ' A' ' 84' ' ' HIS . 4.3 mp -92.27 140.46 29.58 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 121.141 -0.974 . . . . 1.49 111.202 -166.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -34.97 66.04 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.175 1.79 . . . . 3.29 112.085 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.7 m -89.4 116.6 66.76 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.499 -1.667 . . . . 1.51 106.499 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -52.44 -53.41 6.95 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.659 2.239 . . . . 1.49 111.304 -167.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -50.24 -35.71 27.96 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.72 1.208 . . . . 5.22 113.258 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -67.96 -13.68 62.37 Favored 'General case' 0 C--N 1.338 0.104 0 CA-C-O 118.556 -0.735 . . . . 2.0 111.678 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -72.59 74.56 1.07 Allowed 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.069 0.849 . . . . 1.8 108.886 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.26 121.53 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 124.159 0.984 . . . . 1.06 109.306 -173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -96.73 145.85 25.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.929 -1.508 . . . . 1.87 106.929 171.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.01 140.46 32.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.315 -0.624 . . . . 1.76 109.315 -176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.58 151.82 36.15 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.463 -0.94 . . . . 0.93 108.463 175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.11 122.45 25.0 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.464 -1.309 . . . . 1.13 107.464 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.45 131.8 17.56 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 117.883 0.311 . . . . 1.12 111.104 -170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.35 175.28 10.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.314 1.446 . . . . 3.11 111.697 -168.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.74 115.44 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 105.993 -1.855 . . . . 1.56 105.993 158.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 28.3 mttp -122.75 -42.62 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 114.409 1.263 . . . . 8.19 114.409 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 25.5 Cg_endo -93.75 22.02 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.794 1.663 . . . . 3.96 112.984 -166.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -74.47 91.67 2.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 120.765 -1.209 . . . . 5.63 109.561 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.36 51.89 1.79 Allowed Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.304 -0.873 . . . . 3.26 112.199 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt 171.31 147.65 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 128.642 2.777 . . . . 4.91 105.48 -170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtt85 -47.28 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.442 1.019 . . . . 5.93 113.308 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.5 t60 59.79 66.35 1.0 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.878 0.847 . . . . 5.81 111.693 157.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -59.56 -74.72 0.07 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.736 -1.12 . . . . 2.41 110.733 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' ALA . 2.7 m -167.11 163.87 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.592 0.757 . . . . 1.43 111.007 -175.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.54 HD11 ' H ' ' A' ' 78' ' ' GLY . 88.7 mt -76.94 164.59 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.783 1.233 . . . . 2.17 108.928 162.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -127.19 86.68 2.53 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.227 -1.027 . . . . 1.71 108.227 164.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 176.47 22.06 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.095 1.331 . . . . 0.88 112.743 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 52.0 m -146.64 157.82 43.78 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.853 1.261 . . . . 2.02 108.448 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.9 142.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.341 0.206 0 N-CA-C 111.698 0.258 . . . . 0.84 111.698 -152.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.36 119.23 26.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.306 1.442 . . . . 2.6 110.97 -153.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -80.71 57.17 2.88 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.904 1.681 . . . . 5.3 109.59 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 48.8 t30 64.04 -40.22 0.23 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.553 1.141 . . . . 3.88 113.37 -170.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -132.04 -26.57 1.92 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.847 1.659 . . . . 2.44 113.503 -169.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.76 131.61 37.76 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.886 0.875 . . . . 1.36 110.032 -168.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -101.33 70.78 1.33 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.487 0.715 . . . . 3.5 110.656 -173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -108.74 59.77 0.6 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 123.265 1.507 . . . . 3.29 106.958 175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.3 149.2 18.94 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 112.934 -1.939 . . . . 0.65 112.062 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.4 p -121.36 157.14 31.09 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 125.779 1.632 . . . . 0.82 108.342 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -154.37 150.84 28.36 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 119.331 0.969 . . . . 2.31 111.427 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.9 p -148.85 126.64 11.82 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.577 -0.898 . . . . 1.5 108.577 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.8 tm? -142.78 131.61 22.81 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.641 0.776 . . . . 1.2 112.635 -170.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -125.01 146.8 16.28 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 127.108 2.289 . . . . 1.08 110.069 -170.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.607 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.11 143.93 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.275 -1.009 . . . . 2.5 108.275 176.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -142.19 169.01 18.38 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.064 0.935 . . . . 7.07 111.835 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.96 -18.67 55.46 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 114.42 -1.264 . . . . 2.84 111.394 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.8 20.13 64.17 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 117.931 0.865 . . . . 2.52 112.437 164.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -162.59 45.66 0.14 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.558 1.543 . . . . 3.12 107.922 159.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 44.13 88.77 0.01 OUTLIER 'General case' 0 C--N 1.345 0.377 0 C-N-CA 126.207 1.803 . . . . 1.71 112.172 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.53 -59.08 1.97 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.582 -1.266 . . . . 2.32 107.582 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -121.48 149.31 43.24 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.044 1.738 . . . . 2.72 108.708 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.607 HG12 ' HA ' ' A' ' 127' ' ' ILE . 16.7 m -123.3 141.07 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 107.822 -1.177 . . . . 1.13 107.822 167.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.56 136.96 50.46 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.42 -1.326 . . . . 0.82 107.42 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.98 -179.14 32.65 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.529 -1.028 . . . . 0.95 110.529 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 40.3 m -139.92 142.85 36.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.699 -1.223 . . . . 1.55 107.699 157.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -106.62 140.28 39.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.375 -1.713 . . . . 0.7 106.375 160.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -101.86 108.32 19.77 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 106.271 -1.752 . . . . 2.93 106.271 150.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -93.23 116.25 33.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 104.402 -2.444 . . . . 2.41 104.402 157.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -127.78 98.1 5.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 107.693 -1.225 . . . . 4.98 107.693 -165.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 m -154.89 168.82 25.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.312 -1.736 . . . . 2.99 106.312 -169.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.0 t -45.25 -28.73 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.39 0.676 . . . . 2.79 110.324 163.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -131.25 57.17 1.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.48 1.112 . . . . 4.84 108.225 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.49 106.04 0.63 Allowed Glycine 0 C--N 1.337 0.594 0 CA-C-O 122.053 0.807 . . . . 1.43 111.167 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.94 77.74 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 C-N-CA 125.366 1.466 . . . . 1.57 108.754 178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -36.19 -52.0 0.78 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.308 1.043 . . . . 2.49 112.35 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -75.49 76.69 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.227 -0.657 . . . . 2.61 109.227 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 2.0 mt -89.18 130.48 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.914 -0.773 . . . . 1.42 108.914 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -84.74 103.85 2.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.552 -1.819 . . . . 1.02 108.552 166.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 102.84 14.09 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.631 -1.248 . . . . 1.13 107.631 171.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -127.31 117.36 22.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.092 0.957 . . . . 1.31 109.314 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.412 ' HB3' ' CG2' ' A' ' 135' ' ' VAL . . . -130.68 137.69 49.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.945 0.898 . . . . 1.01 110.972 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 ptpm? -157.71 132.02 8.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.967 -1.864 . . . . 4.12 105.967 166.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 115.975 -1.964 . . . . 4.34 111.946 178.072 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 106.31 -1.737 . . . . 67.55 106.31 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 59.19 175.37 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.577 1.173 . . . . 60.53 110.999 -170.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -170.07 158.94 7.29 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 127.147 2.179 . . . . 53.67 106.027 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.1 p-80 -162.91 153.33 16.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.094 -1.447 . . . . 49.27 107.094 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 p -174.68 103.51 0.09 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 107.695 -1.224 . . . . 42.5 107.695 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -155.28 163.52 40.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.343 -0.984 . . . . 37.51 108.343 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp -150.55 -175.84 5.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.397 1.879 . . . . 32.54 107.516 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -134.49 135.74 42.64 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.529 -1.656 . . . . 28.27 106.529 166.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.89 -175.46 0.31 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 126.405 1.882 . . . . 23.29 106.291 -174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -65.71 80.32 0.07 Allowed 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.726 -0.472 . . . . 18.55 109.726 167.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -72.43 65.02 0.62 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.662 0.785 . . . . 18.09 109.456 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -170.96 161.51 6.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.34 1.056 . . . . 11.3 109.362 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -62.23 89.26 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.765 2.426 . . . . 6.48 109.763 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -58.95 -82.56 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.991 -0.528 . . . . 12.45 109.671 173.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 54.0 mt 63.6 174.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 N-CA-C 108.368 -0.975 . . . . 13.16 108.368 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -116.29 -52.76 2.57 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 120.084 -1.635 . . . . 19.43 110.739 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.43 -54.66 2.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.691 -0.855 . . . . 17.31 108.691 -170.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.7 m -54.89 -8.34 0.25 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.101 1.76 . . . . 15.03 114.365 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -49.15 -47.61 45.52 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 120.38 1.445 . . . . 10.07 111.621 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -56.23 -41.66 76.05 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.049 1.34 . . . . 15.06 110.785 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -45.98 66.32 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.381 1.072 . . . . 13.04 109.558 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.52 -68.4 1.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 124.782 1.182 . . . . 8.79 111.914 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -72.41 -91.31 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.761 0.791 . . . . 8.62 111.034 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -168.37 153.69 6.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.192 0.997 . . . . 11.47 108.768 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -86.87 103.42 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.614 -1.63 . . . . 15.0 107.136 173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 65.91 -169.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.625 1.17 . . . . 14.77 111.519 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.55 78.11 1.46 Allowed 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.73 -0.606 . . . . 17.9 109.751 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -145.57 105.74 4.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.789 0.435 . . . . 22.79 110.061 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -151.9 151.0 30.69 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.316 -0.624 . . . . 17.6 109.316 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -146.55 -55.32 0.26 Allowed 'General case' 0 CA--C 1.527 0.086 0 C-N-CA 124.315 1.046 . . . . 20.66 110.952 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 139.83 -37.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 128.661 2.784 . . . . 23.47 109.912 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.8 mm -48.15 -43.88 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.509 1.124 . . . . 18.71 110.478 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -154.76 -158.06 8.51 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.657 -2.577 . . . . 12.53 106.657 172.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 64.41 41.45 5.74 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.31 1.444 . . . . 11.14 110.477 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 pt -143.07 154.91 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.021 1.329 . . . . 10.28 108.591 -175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 178.19 86.76 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.147 1.379 . . . . 3.69 110.641 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' HA2' HG23 ' A' ' 99' ' ' ILE . . . 78.79 -70.6 2.69 Favored Glycine 0 C--N 1.335 0.499 0 O-C-N 120.901 -1.125 . . . . 2.98 112.025 171.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 57.08 -84.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.124 1.37 . . . . 5.35 112.189 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -55.73 -44.34 77.45 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.689 1.595 . . . . 4.75 109.919 -168.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -52.97 -53.97 41.96 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.746 -1.115 . . . . 2.75 110.93 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.73 -50.86 69.44 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 109.31 -0.626 . . . . 1.87 109.31 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -46.69 -38.9 10.53 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.208 1.403 . . . . 3.03 112.222 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.64 -38.8 22.03 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 113.171 0.804 . . . . 2.71 113.171 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt 123.36 56.06 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 131.671 3.988 . . . . 4.67 107.457 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.1 mt -114.52 131.87 23.13 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.812 -1.181 . . . . 2.17 107.812 170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.52 -157.26 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.159 3.24 . . . . 1.68 110.952 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -122.61 27.75 7.67 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.031 2.132 . . . . 5.76 110.95 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.41 138.34 30.45 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.096 0.855 . . . . 2.13 112.6 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.41 0.4 9.11 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 116.611 1.404 . . . . 1.75 116.611 -169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.2 123.08 4.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.626 1.713 . . . . 6.48 109.679 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 73' ' ' PHE . . . -78.88 176.28 9.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.305 0.574 . . . . 1.26 110.242 161.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 t -105.64 58.6 0.67 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.316 1.446 . . . . 1.41 108.627 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.3 m-30 -79.68 60.16 3.27 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.829 -1.169 . . . . 3.6 108.447 173.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.45 107.35 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.026 1.331 . . . . 5.53 107.426 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.78 -168.92 20.14 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 119.763 -1.208 . . . . 0.79 114.292 -165.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -146.46 149.47 33.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.22 0.608 . . . . 2.92 109.67 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.6 134.77 54.43 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.794 2.037 . . . . 2.17 108.925 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -115.09 133.4 56.07 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.492 -0.929 . . . . 2.57 108.492 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.85 163.69 51.24 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.006 -1.237 . . . . 1.08 110.006 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 -37.88 67.17 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.851 -0.794 . . . . 3.14 110.512 171.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -100.06 23.36 10.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.486 1.514 . . . . 2.88 110.414 177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.428 29.6 t0 10.3 80.43 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 118.57 2.804 . . . . 2.65 118.57 -150.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -119.57 55.82 0.95 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.878 -1.51 . . . . 1.02 107.121 152.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.27 162.94 25.03 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.528 1.071 . . . . 1.03 111.381 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -80.16 176.95 54.53 Favored Glycine 0 N--CA 1.442 -0.933 0 O-C-N 121.146 -1.208 . . . . 0.91 114.957 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -121.64 119.92 33.25 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.172 -2.529 . . . . 5.72 104.172 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 tp -91.1 117.36 29.54 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.038 0.535 . . . . 1.07 109.79 -159.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -78.6 141.31 38.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.276 -0.638 . . . . 1.85 109.276 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -78.74 117.55 19.98 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.932 -0.766 . . . . 2.3 108.932 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 m -155.44 67.39 0.64 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.42 -0.8 . . . . 1.33 112.044 -173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.501 HG21 ' CD1' ' A' ' 53' ' ' TYR . 0.8 OUTLIER -132.5 112.36 19.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 107.188 -1.412 . . . . 1.23 107.188 -177.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -75.92 112.51 12.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.167 -1.42 . . . . 3.14 107.167 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 64.9 m-85 -62.57 -6.69 3.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 117.644 -1.169 . . . . 2.68 112.662 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.03 -36.64 63.25 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 121.852 2.114 . . . . 1.63 109.933 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -149.21 9.08 0.74 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.799 1.037 . . . . 1.01 113.799 176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.78 76.0 0.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.023 1.729 . . . . 6.6 112.744 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.434 HE22 ' HB3' ' A' ' 75' ' ' ALA . 3.9 mm-40 -78.52 66.4 4.04 Favored 'General case' 0 C--O 1.226 -0.132 0 N-CA-C 107.16 -1.422 . . . . 2.08 107.16 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.33 67.61 0.15 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.803 1.192 . . . . 1.51 114.878 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 71' ' ' ILE . 28.2 m120 -139.48 158.4 44.2 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.449 1.5 . . . . 2.72 107.569 -164.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.51 125.1 1.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 108.823 -1.711 . . . . 0.79 108.823 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -76.63 142.77 40.54 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.386 1.093 . . . . 4.14 108.951 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 13.8 mt -102.99 126.13 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 107.041 -1.466 . . . . 2.11 107.041 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -157.99 77.36 0.81 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 122.723 0.409 . . . . 2.52 111.556 -175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -160.81 60.91 0.31 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.378 -0.971 . . . . 4.79 108.378 153.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 90' ' ' LEU . 4.9 mt -127.45 137.99 52.85 Favored 'General case' 0 CA--C 1.521 -0.147 0 O-C-N 121.595 -0.691 . . . . 1.78 110.089 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -23.13 66.95 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.55 1.14 . . . . 3.7 112.547 -173.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.6 m -95.01 136.61 22.62 Favored Pre-proline 0 N--CA 1.453 -0.323 0 N-CA-C 106.027 -1.842 . . . . 2.24 106.027 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.91 -60.88 0.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.225 1.95 . . . . 2.76 110.615 -173.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -49.55 -37.7 28.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.094 1.358 . . . . 6.05 112.517 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.404 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -55.89 -25.25 41.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.404 1.081 . . . . 2.43 113.367 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -79.25 70.52 5.66 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.61 1.095 . . . . 2.08 108.113 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.81 113.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.25 -0.886 . . . . 2.48 111.293 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -86.47 155.48 20.52 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.509 -0.923 . . . . 2.2 108.509 169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.447 ' CD2' HG12 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -128.38 126.84 41.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.775 1.63 . . . . 2.96 109.613 -163.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.61 35.3 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.159 -0.682 . . . . 1.15 109.159 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.06 104.46 7.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.019 -1.104 . . . . 1.5 108.019 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.45 129.99 52.61 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.817 1.647 . . . . 1.0 107.2 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.83 176.11 9.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.864 0.84 . . . . 2.99 109.246 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -100.46 108.6 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 123.852 0.861 . . . . 1.47 109.047 176.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 143.78 91.77 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 119.134 -0.46 . . . . 7.66 110.032 168.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 59.1 Cg_endo -63.71 150.2 89.01 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.024 2.483 . . . . 3.84 109.122 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 101' ' ' PRO . 62.6 t0 117.67 -169.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 129.143 2.977 . . . . 5.82 107.854 -158.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.19 -61.14 4.63 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.099 -1.001 . . . . 4.96 110.964 175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.4 tttp 104.6 84.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.546 2.738 . . . . 6.37 108.855 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 57.27 62.27 2.25 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.059 0.944 . . . . 7.81 111.505 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' HA ' HD11 ' A' ' 99' ' ' ILE . 4.1 t-80 66.06 36.93 5.47 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.136 1.374 . . . . 6.41 112.843 174.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -58.6 -40.08 82.23 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 118.63 -0.7 . . . . 3.44 111.229 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.1 m -160.22 148.72 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.522 0.729 . . . . 1.63 111.786 175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 99' ' ' ILE . 8.1 pt -88.55 175.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 2.85 109.737 153.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.3 p -127.32 92.08 3.44 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.506 -1.294 . . . . 2.6 107.506 163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -110.61 176.14 18.6 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.255 0.931 . . . . 0.99 111.953 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.1 m -134.54 152.55 51.86 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.937 1.295 . . . . 1.51 109.396 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.447 HG12 ' CD2' ' A' ' 94' ' ' LEU . 0.9 OUTLIER -135.48 171.86 16.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 124.45 1.1 . . . . 1.14 109.409 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -138.76 133.57 32.35 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 121.362 0.601 . . . . 2.12 112.617 167.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -78.29 70.42 4.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.119 -1.437 . . . . 7.4 107.119 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 t30 55.11 -63.43 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 129.628 3.171 . . . . 3.37 113.571 -174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -89.57 -45.59 9.28 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.139 0.976 . . . . 2.39 109.839 167.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -88.41 92.86 9.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.053 -0.405 . . . . 2.26 111.413 -156.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -78.16 65.68 3.59 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.891 -0.781 . . . . 4.25 108.891 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.5 mmmt -132.13 67.76 1.52 Allowed 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 123.004 1.383 . . . . 3.01 108.563 168.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 141' ' ' VAL . . . -156.9 118.73 0.86 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 112.578 -2.101 . . . . 0.91 111.13 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.59 163.76 15.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.455 -1.313 . . . . 1.21 107.455 163.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -155.06 143.59 20.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 121.857 -0.527 . . . . 2.78 110.904 -173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -134.06 117.64 16.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.85 -1.537 . . . . 1.98 106.85 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.474 HD13 ' C ' ' A' ' 125' ' ' LEU . 0.9 OUTLIER -132.24 138.28 47.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.659 -1.238 . . . . 0.86 107.659 -176.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.57 154.95 21.97 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 125.043 1.306 . . . . 1.23 109.909 -174.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.3 OUTLIER -110.44 156.29 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 C-N-CA 124.141 0.977 . . . . 3.01 109.771 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -152.53 170.93 18.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 114.085 1.143 . . . . 4.86 114.085 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 108.56 -16.15 34.56 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 113.651 -1.613 . . . . 2.71 112.045 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 106.76 -87.49 0.51 Allowed Glycine 0 C--N 1.335 0.479 0 N-CA-C 107.701 -2.159 . . . . 2.86 107.701 -176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -77.53 53.63 1.09 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 117.789 0.795 . . . . 3.38 112.287 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 42.16 65.16 0.94 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.253 2.221 . . . . 1.39 112.92 171.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.48 -53.75 4.19 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.727 -0.215 . . . . 2.49 110.437 -169.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -129.6 131.32 46.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.058 -1.46 . . . . 3.11 107.058 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.537 HG22 ' CB ' ' A' ' 154' ' ' ALA . 1.1 m -100.76 154.42 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 105.993 -1.854 . . . . 1.54 105.993 172.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.14 139.71 47.23 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.15 -1.796 . . . . 1.09 106.15 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.02 172.27 33.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.651 -0.785 . . . . 1.16 112.341 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.5 m -151.39 149.22 29.05 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.001 -1.111 . . . . 1.76 108.001 162.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.668 ' HB1' HG13 ' A' ' 141' ' ' VAL . . . -89.18 174.58 7.78 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.738 -0.838 . . . . 1.33 108.738 160.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.65 59.25 1.7 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 122.921 1.344 . . . . 4.37 110.077 155.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.668 HG13 ' HB1' ' A' ' 139' ' ' ALA . 18.8 m -76.16 133.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.637 -1.165 . . . . 2.14 111.492 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.36 137.63 51.99 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.119 -0.696 . . . . 3.95 109.119 167.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.4 t -163.46 -167.4 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.714 -1.588 . . . . 2.9 106.714 163.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 42.0 t -45.3 -40.52 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 124.576 1.15 . . . . 2.07 109.571 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.74 54.46 1.91 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.003 -1.11 . . . . 2.63 108.003 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -105.19 112.96 4.16 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.692 -1.363 . . . . 1.07 109.692 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.68 97.18 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.306 0.643 . . . . 1.39 110.637 -174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -48.13 -61.53 1.93 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.323 0.649 . . . . 3.87 111.164 -176.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -81.87 59.72 4.42 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.032 -0.359 . . . . 2.18 110.032 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.668 ' CG2' ' HB3' ' A' ' 139' ' ' ALA . 10.5 tt -85.94 111.78 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.78 -1.563 . . . . 2.37 106.78 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -96.72 159.68 21.65 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 108.135 -1.986 . . . . 1.01 108.135 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 125' ' ' LEU . 2.0 pp -154.0 159.6 41.69 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.271 1.536 . . . . 2.03 111.909 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.98 162.46 40.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.297 0.639 . . . . 1.55 109.733 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -132.05 168.73 17.44 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 123.881 0.873 . . . . 1.13 111.267 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -148.63 126.96 12.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 124.794 1.238 . . . . 3.95 107.912 169.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--O 1.25 1.08 0 N-CA-C 107.7 -1.222 . . . . 5.93 107.7 159.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 106.178 -1.786 . . . . 48.32 106.178 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 59.91 -81.31 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.986 1.315 . . . . 42.24 108.325 -163.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -53.51 126.4 21.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.151 -0.685 . . . . 38.43 109.151 156.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -152.46 148.89 27.96 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.878 -1.527 . . . . 37.63 106.878 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.0 t 70.35 142.68 0.05 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.881 1.272 . . . . 32.12 110.21 -166.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -170.34 -69.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 107.035 -1.468 . . . . 27.9 107.035 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.7 mp -72.94 156.41 38.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.004 -1.48 . . . . 24.14 107.004 161.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.3 t -85.07 -168.41 2.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 23.82 110.633 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 62.78 -74.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.731 2.013 . . . . 22.53 113.489 172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.5 t80 51.23 61.85 3.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.504 1.121 . . . . 20.77 112.173 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.38 -79.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.026 -1.101 . . . . 20.08 108.026 168.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -173.19 179.12 2.28 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.585 1.154 . . . . 16.13 108.698 171.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.91 80.61 0.9 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.743 1.217 . . . . 10.73 107.825 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -170.86 -48.37 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.967 0.907 . . . . 16.9 110.699 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.6 mm -74.44 139.91 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 122.616 0.366 . . . . 18.26 110.064 -170.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -49.03 133.11 18.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.19 0.596 . . . . 20.13 110.545 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 65.55 -57.51 0.31 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 127.089 2.156 . . . . 15.35 112.74 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 t -57.93 -18.52 23.76 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.697 -0.627 . . . . 15.31 112.312 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -33.91 -58.51 0.44 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.457 1.103 . . . . 11.23 110.027 158.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -49.64 -56.28 10.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.5 1.52 . . . . 11.79 110.617 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 p -60.19 -45.73 92.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.418 -0.355 . . . . 13.38 110.463 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.2 -55.99 26.55 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.671 -0.972 . . . . 10.49 110.671 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -70.62 -44.07 67.95 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 113.102 0.779 . . . . 9.27 113.102 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.6 ptp -147.74 76.64 1.4 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.297 0.851 . . . . 10.61 113.297 -170.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -48.88 -48.74 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.53 -0.759 . . . . 15.16 109.124 157.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.91 106.61 2.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.043 -0.725 . . . . 15.7 109.043 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.6 72.85 0.06 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.385 1.474 . . . . 16.07 111.497 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.11 141.12 57.55 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.098 0.959 . . . . 18.31 110.542 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -39.16 126.67 1.68 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.756 2.022 . . . . 19.67 111.531 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -62.21 174.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.804 0.811 . . . . 17.12 112.737 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -162.12 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.401 -0.818 . . . . 17.96 109.375 -166.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 16.9 mm 62.89 64.76 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.671 1.188 . . . . 12.0 110.887 172.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.17 -62.6 0.05 OUTLIER Glycine 0 CA--C 1.523 0.592 0 N-CA-C 107.862 -2.095 . . . . 9.31 107.862 173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.51 68.43 0.24 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 127.414 2.285 . . . . 10.67 109.255 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.5 mt -106.15 -19.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.868 1.667 . . . . 7.47 110.588 -172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.27 172.34 12.6 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.001 0.52 . . . . 4.0 111.22 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.88 91.57 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.671 -0.516 . . . . 2.81 113.685 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -77.65 -58.23 3.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 118.224 1.012 . . . . 6.8 108.43 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.461 ' CE1' ' H ' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -58.86 -23.29 60.61 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 1.367 . . . . 5.28 114.104 -174.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 106' ' ' HIS . 3.8 p -71.1 -66.39 0.62 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.766 1.166 . . . . 3.01 109.775 167.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -48.45 -46.58 37.95 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.807 1.243 . . . . 2.64 110.993 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -28.89 -47.33 0.05 Allowed 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 129.944 3.298 . . . . 3.76 113.836 165.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' NZ ' ' A' ' 44' ' ' LYS . 23.0 t70 -54.84 -36.95 65.58 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-O 118.829 -0.605 . . . . 3.45 111.514 -164.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.416 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 8.8 ptpp? 152.19 40.2 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 129.584 3.154 . . . . 3.9 110.156 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.97 66.94 5.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 O-C-N 121.209 -0.932 . . . . 3.0 112.397 -166.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -79.62 -117.6 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.271 3.314 . . . . 3.32 107.76 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . 0.256 16.6 pt-20 51.25 45.8 27.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.406 1.482 . . . . 10.53 111.672 -172.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -39.34 108.39 0.09 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 126.354 1.931 . . . . 2.88 112.877 172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.34 -63.63 0.08 OUTLIER Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.103 -0.799 . . . . 2.08 111.103 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.45 113.46 2.06 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 123.741 0.816 . . . . 5.55 109.484 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.33 151.38 31.06 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.221 0.464 . . . . 1.39 109.99 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.0 t -81.11 55.55 2.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.044 0.537 . . . . 1.29 110.648 -172.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -80.71 71.36 7.6 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 120.94 -1.1 . . . . 3.58 111.738 -170.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 127.55 32.3 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.175 -1.417 . . . . 5.79 107.175 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.8 173.78 36.54 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.807 -0.711 . . . . 1.04 112.762 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.0 p -120.99 101.2 7.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.882 1.673 . . . . 2.57 108.533 -171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.34 68.04 10.34 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.542 -0.91 . . . . 0.97 108.542 173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -77.8 137.09 38.24 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.372 0.606 . . . . 2.27 109.706 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.66 166.48 53.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.83 -1.308 . . . . 0.96 109.83 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 m -52.77 -36.85 58.7 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.9 -0.765 . . . . 3.32 111.041 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -102.84 16.0 27.78 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.092 1.757 . . . . 2.67 110.891 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.42 29.8 t0 17.26 69.54 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.687 2.477 . . . . 3.27 117.687 -146.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.79 56.33 0.7 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.746 -1.575 . . . . 1.14 106.746 149.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.24 -179.25 21.89 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.594 1.569 . . . . 1.09 110.79 -173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -133.26 179.0 17.79 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 125.186 1.374 . . . . 0.85 110.794 -173.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -81.81 149.77 28.19 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.549 -0.971 . . . . 4.01 109.033 176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 tp -79.64 100.54 7.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.278 -2.119 . . . . 1.24 105.278 152.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m -81.48 134.85 35.59 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.463 -0.569 . . . . 2.19 109.463 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -78.34 116.99 19.15 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.87 -1.144 . . . . 2.35 113.985 -157.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.2 m -157.61 112.4 2.69 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.903 1.281 . . . . 1.18 110.798 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG22 ' HA3' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -146.6 168.96 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.911 1.285 . . . . 2.07 108.934 160.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -123.69 80.66 1.82 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.852 2.061 . . . . 4.22 111.509 178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -52.02 -11.1 0.15 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 117.536 2.421 . . . . 2.24 117.536 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.02 -32.03 65.74 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.832 0.742 . . . . 1.79 110.48 168.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -149.31 -19.56 0.28 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.884 1.439 . . . . 1.87 114.884 -176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.3 tptt 74.45 74.09 0.11 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.771 1.169 . . . . 4.18 112.913 164.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.472 HE22 ' HB3' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -134.93 74.01 1.5 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.025 -1.472 . . . . 2.95 107.025 171.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA3' HG22 ' A' ' 71' ' ' ILE . . . -116.11 171.43 13.74 Favored Glycine 0 N--CA 1.438 -1.2 0 CA-C-N 113.88 -1.509 . . . . 2.56 110.661 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.06 172.66 5.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.357 -1.72 . . . . 3.23 106.357 -165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.32 124.43 1.5 Allowed Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.505 -0.855 . . . . 0.93 111.648 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -76.63 126.93 31.84 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.544 -0.539 . . . . 5.34 109.544 -164.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -84.03 61.57 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.409 1.884 . . . . 2.1 106.16 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -107.14 107.29 18.2 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.758 1.623 . . . . 2.16 106.933 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -155.55 -10.39 0.11 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.976 1.102 . . . . 3.39 113.976 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 90' ' ' LEU . 8.8 mt -116.15 148.3 40.48 Favored 'General case' 0 CA--C 1.524 -0.058 0 CA-C-N 119.361 0.982 . . . . 2.24 110.654 -150.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 -21.25 65.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.01 0.924 . . . . 3.88 111.925 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.62 107.02 20.93 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.964 1.706 . . . . 1.68 106.398 -176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -53.62 -41.58 72.7 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.48 1.453 . . . . 1.41 110.591 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 pm0 -55.34 -34.91 64.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.61 1.164 . . . . 4.3 112.198 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' HB3' HD13 ' A' ' 85' ' ' LEU . 3.4 mm? -75.14 -20.62 59.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 118.589 -0.719 . . . . 2.03 112.015 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.18 98.04 0.29 Allowed 'General case' 0 C--N 1.34 0.19 0 CA-C-N 119.638 1.108 . . . . 1.99 108.027 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.55 122.64 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.2 -1.037 . . . . 0.97 108.2 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -96.04 159.7 14.83 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.23 -1.767 . . . . 2.26 106.23 163.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . 0.312 0.1 OUTLIER -139.82 153.91 47.2 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.635 1.346 . . . . 1.87 114.635 174.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.51 139.56 30.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.773 -1.103 . . . . 1.09 111.448 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.21 137.07 39.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.517 -0.92 . . . . 1.21 108.517 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.56 44.24 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.222 0.609 . . . . 1.29 110.871 -170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.17 155.17 28.77 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.734 1.614 . . . . 4.32 109.75 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 tt -136.62 99.06 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 129.513 3.125 . . . . 1.45 105.361 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.484 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -161.23 -45.13 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 117.522 -1.228 . . . . 6.23 112.436 -164.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.484 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 83.4 Cg_endo -81.78 63.0 8.38 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 N-CA-C 106.778 -2.047 . . . . 4.37 106.778 174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -151.63 153.52 34.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.764 1.225 . . . . 4.51 108.412 -161.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.05 112.19 0.52 Allowed Glycine 0 N--CA 1.449 -0.451 0 CA-C-O 119.732 -0.482 . . . . 3.05 112.275 -162.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt 126.37 70.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 129.467 3.107 . . . . 5.56 109.527 162.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.461 ' H ' ' CE1' ' A' ' 39' ' ' HIS . 91.6 mtt-85 69.04 26.08 5.71 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.312 1.845 . . . . 5.96 109.431 -162.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.62 ' HB2' HG23 ' A' ' 40' ' ' THR . 3.0 m-70 49.08 -163.31 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.288 1.035 . . . . 8.75 108.804 -160.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.56 -56.68 0.15 Allowed 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.991 -1.068 . . . . 2.65 110.244 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -149.61 142.96 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 114.987 1.477 . . . . 1.39 114.987 -168.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.88 151.22 4.77 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.555 -1.646 . . . . 3.01 106.555 150.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.9 m -127.29 105.7 8.72 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.209 -1.034 . . . . 2.14 108.209 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.01 162.18 12.84 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.339 0.495 . . . . 0.71 111.958 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.4 p -84.78 164.92 18.2 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.466 -1.02 . . . . 2.51 108.653 169.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.11 151.42 27.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 N-CA-C 109.406 -0.591 . . . . 0.93 109.406 169.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.07 119.81 37.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.519 1.152 . . . . 2.61 110.138 171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -78.7 70.87 5.12 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.605 -1.628 . . . . 4.65 106.605 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 67.16 -56.63 0.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 127.288 2.235 . . . . 2.75 111.949 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -114.61 -44.21 3.1 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.391 1.476 . . . . 2.73 111.112 168.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.49 114.83 27.09 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.763 -0.585 . . . . 1.34 111.717 -159.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -79.89 58.01 2.75 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.922 -0.486 . . . . 3.43 111.307 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -108.34 59.57 0.61 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 122.735 1.255 . . . . 3.11 108.506 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.26 155.97 27.06 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 113.831 -1.531 . . . . 0.58 113.121 164.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 p -133.05 135.28 45.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.419 1.888 . . . . 0.83 107.026 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -138.98 167.02 22.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.823 0.738 . . . . 2.44 110.59 174.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.6 p -144.69 144.46 31.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.742 -1.207 . . . . 1.53 107.742 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.511 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.7 tm? -144.58 135.18 24.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.405 -0.816 . . . . 1.14 109.603 -170.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.511 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -123.79 179.8 16.02 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 126.111 1.815 . . . . 1.67 111.498 -166.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.73 124.3 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.038 -1.097 . . . . 2.67 108.038 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -141.82 -178.72 5.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.968 0.89 . . . . 7.66 111.603 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.61 -43.91 3.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.722 -1.351 . . . . 3.25 109.722 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 101.63 37.44 3.48 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 111.505 -0.638 . . . . 2.89 111.505 166.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -156.88 35.16 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.05 0.94 . . . . 3.31 109.854 152.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 54.3 70.98 0.55 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.443 1.097 . . . . 1.33 109.984 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -125.15 -34.47 2.75 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.714 1.206 . . . . 2.77 111.548 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -132.5 108.54 9.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.797 -1.186 . . . . 2.91 107.797 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.27 77.88 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 C-N-CA 123.721 0.809 . . . . 1.9 109.514 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 149.85 36.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.98 108.689 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.74 31.25 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 109.092 -1.603 . . . . 0.9 109.092 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -148.44 153.11 38.07 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.229 -1.026 . . . . 1.67 108.229 163.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -124.52 156.72 36.83 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 122.493 0.317 . . . . 1.07 111.343 168.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -120.62 110.16 16.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.828 -1.545 . . . . 3.45 106.828 152.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.21 135.48 56.28 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 107.043 -1.465 . . . . 1.9 107.043 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -144.3 121.39 11.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 121.305 -0.872 . . . . 2.93 110.193 -172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.33 179.98 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.598 -2.001 . . . . 2.59 105.598 170.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.2 m -43.1 -28.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.701 1.2 . . . . 2.68 112.719 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.83 59.35 0.73 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.457 -1.312 . . . . 2.84 107.457 166.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.58 133.81 11.85 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 108.183 -1.967 . . . . 1.04 108.183 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.83 120.43 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.582 0.753 . . . . 1.47 111.051 -167.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -66.6 -79.91 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.047 -0.524 . . . . 2.73 111.231 -176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -73.4 81.82 1.42 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.011 -0.736 . . . . 2.02 109.011 -170.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 9.2 mt -79.45 117.97 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 107.186 -1.413 . . . . 1.26 107.186 172.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.18 81.67 1.3 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.972 -2.051 . . . . 1.12 107.972 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.29 74.74 3.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.636 -1.246 . . . . 1.18 107.636 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.63 156.81 18.82 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.717 1.207 . . . . 1.32 108.075 168.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -155.18 158.65 39.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.068 -0.395 . . . . 1.48 111.14 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -157.23 139.17 14.31 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.204 -1.406 . . . . 4.12 107.204 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 115.638 -2.125 . . . . 4.24 109.828 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 104.94 -2.244 . . . . 60.18 104.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -55.73 -47.6 76.63 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.92 1.236 . . . . 53.27 108.488 162.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.4 m 51.78 -142.68 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.997 0.919 . . . . 50.52 111.004 170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.32 170.54 17.43 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.815 -1.55 . . . . 45.72 106.815 177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.0 m -156.9 -52.79 0.08 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.436 0.695 . . . . 41.92 110.736 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.17 138.72 58.64 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.48 0.312 . . . . 37.58 110.809 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.11 153.3 45.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.795 1.638 . . . . 33.9 107.407 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.9 p -95.94 157.12 16.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.857 1.263 . . . . 29.29 110.867 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.09 166.16 33.92 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 106.983 -1.488 . . . . 25.14 106.983 170.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -150.85 147.56 27.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.238 0.615 . . . . 20.68 109.42 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -105.93 -140.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.984 1.714 . . . . 19.76 108.632 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p 71.69 177.68 0.26 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.008 1.723 . . . . 11.86 111.366 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -88.69 7.62 32.74 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.138 0.575 . . . . 10.02 110.458 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 60.84 -173.07 0.13 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.487 1.115 . . . . 16.01 111.049 -166.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.2 mt 70.62 92.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.421 1.488 . . . . 15.96 108.759 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.49 141.18 7.11 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.569 1.148 . . . . 19.61 111.178 -177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.0 t70 65.51 -50.6 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 127.301 2.24 . . . . 14.15 112.918 -170.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 m -54.25 -29.48 46.95 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.221 -0.925 . . . . 13.1 111.609 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -38.49 -47.04 1.23 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.507 1.123 . . . . 13.02 112.808 165.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -58.78 -42.26 88.57 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.713 1.205 . . . . 12.48 111.402 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -53.63 15.27 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.393 0.677 . . . . 9.6 109.801 174.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.67 -71.11 0.99 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 123.474 0.559 . . . . 6.34 112.483 -171.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -14.35 62.03 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.635 -0.921 . . . . 10.46 113.168 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.9 mmt 63.2 150.35 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 124.48 2.086 . . . . 10.82 115.304 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.7 t -145.19 -57.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 112.219 -2.264 . . . . 13.38 105.105 174.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -154.12 -151.33 0.36 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.558 1.143 . . . . 15.16 108.1 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? 77.76 -59.37 0.45 Allowed 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.514 1.926 . . . . 15.6 110.351 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 67.98 -7.61 0.61 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.369 1.468 . . . . 19.69 112.34 -156.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -70.81 115.44 9.96 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.541 -0.911 . . . . 17.99 108.541 162.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -88.11 -178.46 5.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.505 1.522 . . . . 16.68 106.922 162.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -79.12 44.69 0.58 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.78 -1.2 . . . . 15.85 110.724 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.0 mt 39.91 43.86 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.463 2.305 . . . . 14.81 114.302 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.02 47.37 0.02 OUTLIER Glycine 0 C--N 1.339 0.743 0 O-C-N 121.412 -0.805 . . . . 10.45 113.218 166.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -147.03 20.58 1.25 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.689 1.196 . . . . 9.23 110.638 -155.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.8 mm -75.66 78.92 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 108.633 -0.877 . . . . 9.34 108.633 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.96 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.028 0.931 . . . . 3.63 108.995 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.58 -97.53 2.31 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.876 -1.289 . . . . 2.07 109.876 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 47.49 -102.7 0.08 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.353 1.861 . . . . 4.7 111.704 170.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -9.1 14.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.008 0.822 . . . . 6.06 113.072 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -69.04 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.055 -0.72 . . . . 2.95 109.055 159.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.41 -42.58 22.39 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.84 0.856 . . . . 2.95 113.002 -172.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -44.09 -48.69 9.01 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.079 1.352 . . . . 4.59 113.438 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -51.23 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.345 0.383 0 O-C-N 123.448 0.468 . . . . 3.11 111.343 -161.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.78 58.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.48 1.912 . . . . 3.89 107.091 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 91.7 mt -142.27 152.08 60.03 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 114.306 -1.316 . . . . 2.47 110.203 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HG2' ' CD1' ' A' ' 73' ' ' PHE . 48.3 Cg_endo -77.1 -175.25 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.107 2.538 . . . . 2.43 112.845 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -55.49 -54.57 42.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.214 1.406 . . . . 5.95 112.592 173.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.6 -171.43 44.56 Favored Glycine 0 CA--C 1.522 0.486 0 O-C-N 121.116 -0.99 . . . . 2.58 111.881 -159.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.34 -71.36 0.4 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.128 1.347 . . . . 2.12 112.657 161.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -155.46 164.52 38.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.271 -1.381 . . . . 5.89 107.271 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -77.91 176.97 8.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.059 -0.719 . . . . 2.6 109.059 167.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -131.48 84.59 2.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.497 -1.668 . . . . 1.59 106.497 158.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' HD13 ' A' ' 127' ' ' ILE . 8.4 m-30 -120.62 166.02 14.24 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.339 1.456 . . . . 3.19 109.598 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.1 mtt85 -142.12 148.11 37.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.378 -2.453 . . . . 4.15 104.378 154.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -174.59 163.48 34.0 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 119.312 -1.423 . . . . 1.25 113.471 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -101.73 135.31 43.49 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.988 1.315 . . . . 2.66 108.19 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -108.69 69.85 0.73 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.263 -2.125 . . . . 0.99 105.263 168.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -84.46 137.15 33.52 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.49 0.716 . . . . 2.48 109.916 -166.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.08 163.88 51.02 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 109.968 -1.253 . . . . 1.06 109.968 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 p -51.07 -33.37 25.52 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.912 -0.758 . . . . 2.16 110.819 160.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -92.18 1.75 57.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.39 1.476 . . . . 2.53 112.05 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.292 0.5 OUTLIER 58.95 3.26 0.31 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.898 2.079 . . . . 4.23 116.061 -170.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.46 55.03 2.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.77 1.228 . . . . 1.47 109.47 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.59 176.51 17.77 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.022 -0.831 . . . . 0.96 111.022 -163.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.704 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.87 177.69 54.17 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 124.829 1.204 . . . . 1.28 112.173 177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.6 143.88 48.41 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.462 -1.311 . . . . 6.26 107.462 159.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD22 HD11 ' A' ' 152' ' ' LEU . 38.9 tp -88.83 131.29 35.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.25 0.62 . . . . 1.15 109.425 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.0 p -100.94 154.21 18.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.805 0.842 . . . . 1.94 110.803 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -82.88 102.26 11.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.259 0.623 . . . . 2.27 110.327 -171.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 m -153.67 92.49 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.302 -0.874 . . . . 1.05 110.841 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.553 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.97 156.51 20.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 107.027 -1.471 . . . . 1.4 107.027 167.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' N ' HD12 ' A' ' 71' ' ' ILE . 4.1 m-20 -119.56 115.04 23.19 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.944 -1.502 . . . . 3.17 106.944 169.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CD2' HD11 ' A' ' 71' ' ' ILE . 99.2 m-85 -46.61 -46.6 19.78 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.424 2.29 . . . . 2.3 113.849 -169.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -41.59 -48.07 3.95 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.235 1.414 . . . . 2.08 111.722 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.5 -18.43 5.28 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.825 0.676 . . . . 1.51 112.825 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 76.85 65.64 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 126.122 1.769 . . . . 4.62 111.326 165.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.443 ' H ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -80.89 71.43 7.83 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 106.995 -1.483 . . . . 1.68 106.995 178.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.553 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -65.19 66.29 0.09 OUTLIER Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.402 1.477 . . . . 1.51 114.826 -170.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -141.09 79.0 1.67 Allowed 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.714 1.257 . . . . 2.74 110.733 -155.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.08 147.42 24.71 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 109.688 -1.365 . . . . 0.98 109.688 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -79.5 138.18 37.45 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.061 -0.67 . . . . 3.49 109.266 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.704 HG23 ' HA3' ' A' ' 65' ' ' GLY . 20.0 mt -96.66 97.12 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 126.467 1.907 . . . . 2.0 107.616 172.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 84' ' ' HIS . 2.2 tt0 -91.25 175.54 6.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 104.899 -2.26 . . . . 4.57 104.899 155.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 83' ' ' GLU . 91.7 m-70 -156.53 45.41 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 1 C-N-CA 133.384 4.673 . . . . 5.12 106.467 41.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.05 163.73 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.911 -0.586 . . . . 1.55 110.932 -156.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -24.04 54.63 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 123.018 0.527 . . . . 4.67 111.945 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.1 m -108.85 104.09 53.73 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 104.703 -2.332 . . . . 1.93 104.703 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -49.68 -36.59 41.8 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 121.569 1.513 . . . . 3.6 111.545 172.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.19 -46.05 34.44 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 109.036 -0.727 . . . . 5.03 109.036 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -13.1 61.27 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.437 1.095 . . . . 2.55 112.938 -167.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.9 127.56 32.54 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.981 -1.118 . . . . 1.87 107.981 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.97 130.24 54.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 125.677 1.591 . . . . 1.07 108.326 -171.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.05 133.15 47.34 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.859 -1.534 . . . . 2.36 106.859 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 77.8 mt -78.91 141.35 37.69 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.619 -1.252 . . . . 1.62 107.619 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 151.57 34.74 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.16 -1.052 . . . . 1.21 108.16 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 127.12 32.32 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.326 -0.991 . . . . 1.39 108.326 -172.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.16 116.35 4.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.111 0.482 . . . . 1.36 110.762 -171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -95.86 175.13 6.62 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.153 2.181 . . . . 4.51 110.154 -173.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.425 ' CG2' HG22 ' A' ' 109' ' ' ILE 0.342 0.4 OUTLIER -116.63 124.66 73.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 123.181 1.467 . . . . 2.26 113.253 179.102 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -106.15 -43.36 0.14 Allowed Pre-proline 0 N--CA 1.437 -1.115 0 C-N-CA 131.3 3.84 . . . . 6.99 113.247 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -83.92 -169.39 0.68 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.532 1.488 . . . . 4.44 108.674 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 66.8 170.03 0.24 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.073 0.949 . . . . 4.82 111.229 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -177.74 40.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.244 -1.142 . . . . 4.58 110.244 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.29 60.52 1.22 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.448 1.124 . . . . 4.7 110.636 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? 53.61 48.73 20.98 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.182 0.993 . . . . 7.68 109.991 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 74.7 t60 71.25 124.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.836 1.655 . . . . 5.17 113.247 174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.42 -79.06 0.44 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.62 1.168 . . . . 2.29 111.295 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 m -158.28 159.79 2.26 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.929 0.892 . . . . 1.1 110.191 -171.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' CG2' ' A' ' 99' ' ' ILE . 1.0 OUTLIER -92.77 155.77 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 126.27 1.828 . . . . 3.52 107.217 157.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 t -130.43 104.83 7.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 105.902 -1.888 . . . . 1.88 105.902 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.54 153.47 16.66 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 111.939 -0.464 . . . . 0.76 111.939 -175.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.2 p -79.46 167.44 20.8 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.434 -0.95 . . . . 1.97 108.434 165.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG21 HG12 ' A' ' 141' ' ' VAL . 1.0 OUTLIER -128.06 154.01 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.227 -0.657 . . . . 0.85 109.227 170.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -78.45 117.04 19.28 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.081 -1.451 . . . . 2.03 107.081 170.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.77 65.85 2.58 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.714 -2.699 . . . . 5.86 103.714 159.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.8 m120 66.09 -67.77 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.03 2.132 . . . . 5.89 113.879 162.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -125.42 16.64 8.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.245 2.218 . . . . 3.27 110.166 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.24 177.7 11.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.676 2.39 . . . . 2.25 106.385 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -134.69 59.91 1.72 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.251 0.932 . . . . 3.48 110.469 -177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.61 66.26 0.74 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 124.239 1.971 . . . . 3.15 107.821 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.82 155.68 26.64 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 111.325 -2.67 . . . . 0.63 108.403 166.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.0 p -143.37 161.55 38.06 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.626 -0.879 . . . . 0.76 108.626 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 139' ' ' ALA . 12.8 t80 -155.42 146.12 22.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.888 -0.782 . . . . 2.86 108.888 -168.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.0 t -136.79 135.75 38.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.961 -1.126 . . . . 2.28 107.961 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.589 HD23 HD12 ' A' ' 152' ' ' LEU . 1.2 tm? -151.61 142.26 22.74 Favored 'General case' 0 C--O 1.221 -0.413 0 O-C-N 123.955 0.784 . . . . 0.74 110.636 -171.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.75 157.18 24.06 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.114 0.87 . . . . 1.12 112.852 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 132' ' ' ALA . 4.1 tp -102.48 130.68 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 126.814 2.046 . . . . 2.78 109.553 -173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -137.92 164.14 29.74 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.577 1.18 . . . . 6.86 113.213 -173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.41 -11.05 65.26 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 113.02 -1.9 . . . . 2.62 110.532 -169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.78 -69.64 3.28 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 108.02 -2.032 . . . . 3.12 108.02 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -77.06 46.89 0.5 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.512 -0.405 . . . . 3.59 111.342 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.49 ' HA ' HD11 ' A' ' 127' ' ' ILE . . . 37.39 93.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.271 0 C-N-CA 127.768 2.427 . . . . 1.6 113.433 178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -122.75 -48.89 2.01 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.529 0.604 . . . . 2.42 110.772 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.69 150.51 50.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.878 -0.786 . . . . 2.6 108.878 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 154' ' ' ALA 0.255 2.2 m -126.69 137.71 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 109.864 -0.421 . . . . 1.2 109.864 173.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.45 127.03 40.08 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.249 1.02 . . . . 0.83 108.411 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.75 178.74 33.92 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 112.302 -0.319 . . . . 0.76 112.302 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.4 t -139.87 145.45 38.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.399 -0.593 . . . . 2.61 109.399 160.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.656 ' HB3' ' HB ' ' A' ' 150' ' ' ILE . . . -109.79 151.09 27.42 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.586 1.155 . . . . 0.82 110.842 167.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.57 129.28 55.68 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.476 0.485 . . . . 3.21 109.903 150.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.425 HG12 HG21 ' A' ' 113' ' ' VAL . 3.9 m -133.5 95.24 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.043 -1.095 . . . . 2.42 108.043 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.58 58.71 4.02 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.536 -1.352 . . . . 2.82 109.264 -168.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -80.01 162.59 24.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.65 -0.82 . . . . 3.24 109.014 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.34 -17.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.83 0.678 . . . . 4.5 112.83 167.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.08 55.56 1.7 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.61 1.095 . . . . 3.36 108.524 163.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -138.11 147.92 19.55 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 111.015 -0.834 . . . . 1.73 111.015 -169.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.35 132.96 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.248 1.419 . . . . 1.51 109.825 -172.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -77.59 -14.57 59.61 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.451 -0.795 . . . . 3.46 111.038 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -126.23 98.74 5.58 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.925 -1.139 . . . . 2.65 107.925 177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.656 ' HB ' ' HB3' ' A' ' 139' ' ' ALA . 5.0 mt -104.76 121.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.868 -1.16 . . . . 1.11 107.868 168.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.84 121.8 5.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.901 -2.08 . . . . 0.78 107.901 165.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.589 HD12 HD23 ' A' ' 125' ' ' LEU . 2.1 tm? -105.33 108.91 20.68 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.223 -1.399 . . . . 1.05 107.223 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.23 118.94 24.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.978 0.911 . . . . 1.15 108.716 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -124.69 143.86 50.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.3 0.64 . . . . 0.98 111.751 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -155.65 129.7 8.72 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.863 -2.273 . . . . 4.61 104.863 169.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.103 -1.427 . . . . 4.44 113.135 172.199 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.756 -1.202 . . . . 65.9 107.756 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -74.66 90.07 2.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.035 0.934 . . . . 59.81 109.252 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.6 p -143.57 87.08 1.91 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.13 0.572 . . . . 55.4 110.334 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -160.21 150.03 18.0 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.115 0.966 . . . . 50.2 108.821 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.8 p -167.12 161.02 14.4 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.041 1.736 . . . . 44.8 106.499 165.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -168.8 51.34 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.65 0.78 . . . . 39.68 110.217 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 tp -90.3 124.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.775 -0.824 . . . . 35.22 108.775 -177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.8 t -164.01 166.99 20.97 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.273 -1.38 . . . . 30.26 107.273 172.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.73 20.47 0.17 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.682 0.793 . . . . 25.27 112.151 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -80.12 68.8 6.37 Favored 'General case' 0 CA--C 1.528 0.109 0 O-C-N 121.204 -0.935 . . . . 23.01 111.149 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -122.68 31.82 5.95 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.674 1.19 . . . . 20.53 110.306 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -148.46 152.85 37.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.12 -1.807 . . . . 13.57 106.12 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.77 -79.6 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.93 1.292 . . . . 8.61 110.803 -166.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -116.45 -19.2 10.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.135 0.974 . . . . 12.78 111.837 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.8 mt 73.26 158.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.045 1.738 . . . . 15.37 110.754 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 78.21 55.5 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.86 2.064 . . . . 18.79 109.722 168.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.1 t70 74.52 -42.54 0.5 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.585 1.554 . . . . 14.39 112.384 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 9.8 m -39.95 -40.64 1.05 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.385 1.474 . . . . 13.06 111.663 163.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -43.71 -38.55 3.2 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.3 1.44 . . . . 11.25 113.233 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -49.33 -44.54 44.51 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 119.656 1.116 . . . . 12.1 111.264 173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -68.24 -43.26 78.31 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.108 -0.33 . . . . 10.28 110.108 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.23 -75.97 0.51 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 123.587 0.613 . . . . 6.56 113.046 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -70.02 -35.76 74.58 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.808 -0.819 . . . . 12.09 111.674 -171.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.2 mmt 63.8 -67.13 0.1 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.365 1.466 . . . . 11.04 113.928 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 85.0 t 67.62 -74.83 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.054 1.341 . . . . 13.65 110.598 174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.14 123.31 1.14 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.47 1.508 . . . . 15.29 107.426 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -145.33 58.63 1.27 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.14 -1.43 . . . . 15.4 107.14 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 63.92 77.35 0.32 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.096 1.358 . . . . 22.78 108.383 -157.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 60.16 -162.06 0.27 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.472 1.109 . . . . 19.35 109.367 -170.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -86.3 -178.49 6.48 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.075 0.464 . . . . 17.07 109.923 174.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 -164.57 -52.16 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.963 -0.562 . . . . 16.5 110.189 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.6 mt 65.94 -72.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.368 1.467 . . . . 10.71 109.691 -173.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.53 -61.25 2.39 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.587 0.613 . . . . 9.92 111.573 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.21 172.07 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.342 1.457 . . . . 11.24 109.217 -175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.9 mt 67.15 -74.86 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 127.156 2.182 . . . . 11.12 110.729 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.29 -47.19 0.62 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.339 1.456 . . . . 4.54 113.767 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 21.78 -99.94 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.663 2.554 . . . . 3.02 116.098 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.298 41.5 mt-10 81.74 -136.37 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.915 2.486 . . . . 4.49 110.714 -161.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -62.73 -36.72 83.91 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 122.249 2.295 . . . . 4.25 110.237 -161.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 t -40.23 -47.05 2.38 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.22 1.008 . . . . 3.11 113.279 167.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.1 m -75.59 -62.45 1.57 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.543 1.537 . . . . 1.89 112.94 168.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -60.28 -25.86 66.05 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 127.705 2.402 . . . . 3.3 113.654 -164.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -52.98 -26.49 15.45 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.521 -0.737 . . . . 2.75 110.718 171.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 117.33 61.01 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.206 3.402 . . . . 4.11 106.96 164.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.35 145.3 40.14 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.869 -1.514 . . . . 2.29 107.641 176.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.16 -178.24 2.4 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.877 3.718 . . . . 1.92 112.927 -166.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -92.2 27.93 2.05 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.617 1.567 . . . . 5.47 110.34 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.73 170.87 45.65 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.426 -0.796 . . . . 1.79 113.432 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.46 -14.98 39.31 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.842 1.211 . . . . 1.55 113.87 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -153.77 117.48 4.69 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.327 -1.102 . . . . 5.68 109.967 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.97 170.31 16.88 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.87 -0.789 . . . . 1.44 108.87 156.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.715 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.5 t -97.88 61.44 1.55 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 124.561 1.144 . . . . 1.64 109.81 -168.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 71' ' ' ILE . 3.2 m-85 -76.29 73.04 3.09 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.179 -1.575 . . . . 3.47 109.083 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -98.3 110.54 23.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.848 1.259 . . . . 4.37 107.885 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.69 -161.85 18.19 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.216 -1.469 . . . . 0.7 113.989 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.7 p -126.6 139.81 52.9 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.237 1.815 . . . . 2.39 108.751 -175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -115.66 71.61 0.78 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 127.725 2.41 . . . . 1.09 104.949 164.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -83.78 139.34 32.76 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.701 0.8 . . . . 2.49 109.902 -171.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.62 163.76 51.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.021 -1.232 . . . . 0.94 110.021 -172.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -54.32 -31.7 54.83 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.768 -0.843 . . . . 1.67 110.492 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -91.05 -0.82 57.82 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.565 1.946 . . . . 2.36 111.909 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 25.2 t0 17.71 67.04 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 117.248 2.314 . . . . 3.25 117.248 -136.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.07 55.63 0.73 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.632 -1.622 . . . . 1.02 106.708 147.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.67 -179.53 19.97 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.675 1.607 . . . . 0.96 109.31 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.09 -178.89 15.61 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 125.678 1.609 . . . . 0.7 111.658 -169.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -78.84 170.76 16.17 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.745 0.818 . . . . 3.78 110.869 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 tp -116.95 120.98 40.11 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.748 -1.575 . . . . 0.93 106.748 164.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 p -97.37 139.49 33.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.277 1.831 . . . . 2.44 110.279 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -78.7 108.61 12.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.732 0.642 . . . . 2.22 112.732 -167.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 79.8 m -155.52 96.15 1.75 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.029 1.331 . . . . 1.15 110.287 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HG21 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -139.22 115.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.753 -0.832 . . . . 1.25 108.753 158.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.64 114.69 8.99 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.484 -1.673 . . . . 3.33 106.484 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -58.38 -42.37 86.92 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.734 0.814 . . . . 2.17 113.148 -170.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -43.36 -42.79 4.77 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.474 1.109 . . . . 1.43 111.754 -170.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -123.38 -15.98 6.99 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.163 0.985 . . . . 1.37 113.333 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.4 tptm 71.64 39.72 0.85 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.255 1.022 . . . . 4.22 112.248 161.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.476 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.1 OUTLIER -75.17 54.06 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.572 2.349 . . . . 2.1 110.318 177.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.77 132.74 11.32 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-O 119.036 -0.869 . . . . 1.43 113.343 -165.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.96 168.72 24.01 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.631 -1.248 . . . . 3.32 107.631 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.48 143.19 9.43 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.764 -1.02 . . . . 0.93 110.836 172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttp -96.26 143.58 27.22 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.728 1.381 . . . . 3.48 114.728 -168.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . 0.299 0.1 OUTLIER -87.98 59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 123.772 1.749 . . . . 3.31 108.145 -167.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -105.51 80.93 1.62 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 114.915 -1.039 . . . . 2.74 110.358 -161.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -158.11 13.82 0.2 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.439 1.274 . . . . 3.58 114.439 151.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.0 mp -75.6 142.84 42.6 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.623 1.556 . . . . 2.0 111.054 -164.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.0 -36.5 50.04 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.662 1.985 . . . . 5.39 113.329 -167.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -104.93 128.95 25.7 Favored Pre-proline 0 N--CA 1.452 -0.362 0 N-CA-C 106.58 -1.637 . . . . 1.89 106.58 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -51.37 -49.1 18.24 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.324 2.683 . . . . 1.51 112.131 -167.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.42 -20.46 59.82 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.041 1.336 . . . . 3.48 113.061 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.96 -18.31 60.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.502 0.592 . . . . 2.04 111.762 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -73.12 83.23 1.3 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.43 1.014 . . . . 2.03 108.952 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 115' ' ' TYR . 18.6 t -66.21 139.37 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.92 1.288 . . . . 1.02 109.008 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -104.4 155.79 18.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.888 -1.153 . . . . 2.65 107.888 161.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.44 116.03 21.89 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.209 2.204 . . . . 2.06 108.451 -164.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.44 132.77 36.47 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.933 -0.48 . . . . 1.27 111.715 -165.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.2 137.48 41.31 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.543 0.737 . . . . 1.47 109.028 -172.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.31 130.56 9.58 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.262 0.625 . . . . 1.29 109.864 -170.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.91 125.69 30.06 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.281 1.432 . . . . 3.92 111.141 -167.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -74.37 80.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.211 1.005 . . . . 1.67 109.893 171.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.5 mmtt -88.62 -31.98 0.39 Allowed Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.978 1.711 . . . . 8.23 114.39 156.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -69.21 77.56 0.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 CA-C-N 122.71 2.003 . . . . 5.17 108.4 162.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -65.59 76.07 0.07 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.445 1.098 . . . . 7.29 108.198 172.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.4 61.2 3.17 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.089 -0.839 . . . . 4.66 111.743 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt 78.01 116.38 0.06 Allowed 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.983 1.713 . . . . 5.49 109.193 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 65.92 -74.72 0.06 Allowed 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.807 1.243 . . . . 7.5 108.946 -170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 1.8 p80 171.92 53.35 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.729 2.011 . . . . 6.51 108.491 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.8 23.46 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.782 1.401 . . . . 3.87 114.782 -164.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.65 102.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.774 1.625 . . . . 2.14 114.242 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.8 mm -75.61 147.32 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.741 -1.948 . . . . 2.98 105.741 144.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.1 t -144.68 136.34 25.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.447 -1.316 . . . . 2.37 107.447 159.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.45 168.71 31.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.269 -0.732 . . . . 0.71 111.269 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.2 p -80.13 169.52 17.7 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.71 1.255 . . . . 2.34 110.303 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.98 141.14 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 108.208 -1.034 . . . . 0.74 108.208 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.2 116.4 32.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.57 1.548 . . . . 2.69 107.301 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.449 ' HA ' HG22 ' A' ' 92' ' ' VAL . 66.2 t80 -79.39 69.65 5.67 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.684 -1.599 . . . . 4.83 106.684 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 66.94 -52.01 0.46 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.377 2.271 . . . . 3.06 115.082 168.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.89 7.5 3.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.715 1.206 . . . . 2.42 112.916 172.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -147.65 136.1 21.67 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 119.746 1.157 . . . . 1.31 109.738 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.99 119.29 27.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.817 -1.179 . . . . 3.71 107.817 169.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.2 mmpt? -152.7 80.0 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.144 1.378 . . . . 3.53 110.348 135.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.96 164.48 32.78 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.032 -1.627 . . . . 0.55 109.032 155.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.9 p -147.52 142.06 26.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.707 1.203 . . . . 0.86 109.489 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -120.07 152.51 37.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 113.43 0.9 . . . . 2.66 113.43 177.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 p -127.04 106.47 9.3 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 105.129 -2.174 . . . . 2.09 105.129 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -128.28 130.53 48.0 Favored 'General case' 0 C--O 1.217 -0.641 0 O-C-N 123.873 0.733 . . . . 0.96 111.947 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.96 122.02 6.41 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 110.332 -1.107 . . . . 1.35 110.332 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.442 HD12 ' HE1' ' A' ' 53' ' ' TYR . 9.8 tt -79.1 132.44 32.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 107.855 -1.165 . . . . 2.9 107.855 171.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -161.66 -160.5 0.71 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-O 122.545 1.164 . . . . 5.3 113.038 -164.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.12 -55.35 1.13 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 126.515 2.007 . . . . 4.01 109.507 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -175.14 -47.22 0.05 OUTLIER Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.602 -0.809 . . . . 2.87 112.291 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -158.6 49.93 0.38 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.037 0.935 . . . . 4.05 109.94 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.14 64.69 0.36 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.819 1.648 . . . . 1.52 108.563 -174.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -121.08 -27.31 4.96 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.944 -1.025 . . . . 2.51 111.621 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -121.11 159.77 25.08 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.188 -1.412 . . . . 3.77 107.188 167.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.0 m -128.99 134.87 63.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 106.5 -1.667 . . . . 1.12 106.5 154.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.11 116.59 15.61 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.589 1.156 . . . . 0.95 109.361 -169.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.1 178.95 34.14 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-O 122.016 0.787 . . . . 0.82 112.133 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -143.68 154.5 43.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.808 -0.812 . . . . 1.98 108.808 158.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -112.41 152.16 28.98 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.417 1.087 . . . . 0.95 111.425 166.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -103.34 121.12 42.09 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.848 -1.538 . . . . 3.6 106.848 156.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.01 122.47 64.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.15 -1.426 . . . . 1.86 107.15 172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.4 101.5 5.37 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.941 0.791 . . . . 3.07 109.317 -169.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.3 p -146.66 -176.81 5.33 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.667 -1.605 . . . . 2.27 106.667 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -41.37 -30.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.003 0.921 . . . . 3.29 111.907 163.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -143.8 56.54 1.34 Allowed 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.118 0.872 . . . . 2.41 108.787 166.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.88 109.03 3.41 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 105.685 -2.966 . . . . 1.22 105.685 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.64 58.35 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 110.134 -0.321 . . . . 2.05 110.134 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 10.31 -97.65 0.0 OUTLIER 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.73 2.412 . . . . 2.74 114.343 -169.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.39 95.38 0.31 Allowed 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 124.043 0.839 . . . . 2.72 109.6 -174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.54 117.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.894 -1.521 . . . . 1.27 106.894 169.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.01 125.07 6.82 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.69 -1.764 . . . . 0.97 108.69 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.14 102.03 11.47 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.046 -1.464 . . . . 1.35 107.046 -174.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -134.58 117.9 16.65 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.48 0.712 . . . . 1.07 109.337 -173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.76 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -121.05 157.49 29.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 123.909 0.883 . . . . 0.89 111.526 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -134.07 110.33 9.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.198 -2.149 . . . . 4.12 105.198 166.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.715 ' HB3' HG23 ' A' ' 52' ' ' THR . 40.5 mt-30 . . . . . 0 C--O 1.252 1.194 0 O-C-N 124.085 0.866 . . . . 4.85 111.613 -170.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.311 -0.255 . . . . 50.42 110.311 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -162.52 150.03 13.79 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.505 -0.924 . . . . 44.82 108.505 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -61.2 163.68 6.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.304 1.042 . . . . 42.38 110.007 167.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -168.68 170.15 9.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.819 -1.549 . . . . 38.25 106.819 -173.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.7 p -166.01 172.41 11.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.331 -0.988 . . . . 34.02 108.331 -170.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.83 12.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.665 1.186 . . . . 30.07 108.216 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.27 -170.34 2.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.763 1.625 . . . . 25.95 108.916 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.1 t -154.53 -173.51 4.6 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.977 -1.12 . . . . 22.56 107.977 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.95 178.49 7.08 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.284 1.434 . . . . 18.67 108.565 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -117.55 171.13 8.21 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.126 1.37 . . . . 16.71 109.035 176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -129.84 39.84 3.64 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.311 1.044 . . . . 13.72 109.509 -166.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 t -115.7 175.85 5.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.869 1.268 . . . . 9.53 110.974 -165.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.98 -32.26 71.82 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.525 0.565 . . . . 8.54 112.525 -171.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -71.37 129.75 39.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.121 0.873 . . . . 14.32 111.151 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.1 mt 88.18 98.48 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 129.107 2.963 . . . . 17.29 110.402 168.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? 3.64 -72.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.383 3.073 . . . . 18.09 115.462 168.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.05 -50.76 71.75 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.696 -0.627 . . . . 16.65 110.137 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.2 m -66.22 -39.22 89.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.883 1.273 . . . . 12.6 110.869 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -45.41 -52.41 10.09 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 125.206 1.402 . . . . 11.95 110.492 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -46.7 -63.66 0.96 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.054 1.342 . . . . 13.61 111.797 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.93 -42.63 80.35 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 122.048 -0.407 . . . . 9.27 111.407 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.77 -63.14 5.23 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.132 -0.787 . . . . 6.43 111.132 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -60.59 -49.72 76.42 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 122.453 0.301 . . . . 11.89 110.427 -174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.3 ptt? 168.5 119.89 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.322 1.849 . . . . 13.83 108.905 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.97 -50.48 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.409 1.084 . . . . 13.41 109.508 172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 158.25 -60.52 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 128.349 2.66 . . . . 16.11 105.397 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -62.53 157.19 21.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.138 -0.937 . . . . 17.74 108.742 156.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.5 mtm105 -57.95 117.23 4.09 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.23 1.012 . . . . 22.1 110.226 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -74.5 161.16 30.04 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.534 -0.543 . . . . 16.74 109.534 167.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -62.34 -40.68 97.16 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 112.628 0.603 . . . . 19.05 112.628 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 38' ' ' GLU . 47.5 ttt180 69.23 22.97 6.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 20.49 111.173 -173.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.6 tt -64.42 -30.95 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 125.501 1.52 . . . . 15.7 112.786 -174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.6 -161.72 16.4 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 106.178 -2.769 . . . . 11.29 106.178 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 59.04 38.44 24.06 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.009 0.924 . . . . 9.13 110.828 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.1 mm -104.82 131.59 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.767 0.827 . . . . 9.04 110.453 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -166.9 153.8 8.8 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 126.843 2.057 . . . . 3.29 105.484 168.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.25 -83.14 0.64 Allowed Glycine 0 CA--C 1.531 1.061 0 CA-C-N 119.231 0.923 . . . . 2.5 111.198 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 31' ' ' ARG . 71.4 mt-10 52.98 -86.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.108 1.763 . . . . 4.61 112.284 -174.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.05 -46.46 67.82 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.58 -0.7 . . . . 4.31 109.245 -165.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 t -57.48 -38.99 75.44 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.994 -0.441 . . . . 3.15 111.985 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -59.64 2.74 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.003 1.721 . . . . 2.68 108.428 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -43.0 -44.01 4.47 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 127.255 2.222 . . . . 2.91 112.842 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -47.41 -30.17 3.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.939 0.896 . . . . 3.11 112.075 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? 126.23 60.07 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 129.882 3.273 . . . . 4.34 107.728 162.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.7 mt -112.44 144.92 31.85 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 114.285 -1.325 . . . . 2.58 109.234 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.14 175.96 9.16 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 124.787 3.658 . . . . 1.87 111.165 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.4 47.5 1.39 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.936 0.874 . . . . 6.01 109.99 157.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.51 -176.98 7.76 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.999 -0.84 . . . . 1.78 110.999 171.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -123.99 -1.86 8.7 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 115.645 1.018 . . . . 1.8 115.645 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.56 114.95 2.74 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.587 1.955 . . . . 4.96 108.023 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.67 159.43 15.05 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.246 -0.65 . . . . 1.33 109.246 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -81.79 56.03 2.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.332 0.653 . . . . 1.5 110.771 -172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -78.14 59.64 2.27 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.351 -1.468 . . . . 3.48 110.82 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.5 mtt180 -83.25 136.74 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.153 -0.967 . . . . 5.22 108.806 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -167.85 179.05 41.39 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.016 -1.088 . . . . 0.76 113.43 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 p -122.47 100.38 6.9 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.729 2.012 . . . . 2.13 106.808 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.76 74.05 5.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.724 -1.584 . . . . 0.87 106.724 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -79.79 136.52 36.75 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.193 1.397 . . . . 2.11 109.726 -173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.95 165.21 52.13 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.173 -1.171 . . . . 1.14 110.173 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.3 t -45.38 -42.52 10.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 117.368 0.584 . . . . 1.76 109.931 162.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.16 -0.14 54.99 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.485 1.514 . . . . 2.95 112.947 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.9 t0 41.1 47.54 2.79 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.606 1.562 . . . . 3.44 112.551 -160.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.75 57.64 0.63 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.67 -1.974 . . . . 1.68 105.67 165.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.05 178.53 17.54 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.185 0.897 . . . . 1.04 110.978 -167.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.42 175.65 16.34 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 123.986 0.803 . . . . 0.75 112.672 -172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -92.06 131.86 37.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.352 -1.351 . . . . 3.67 107.352 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -79.49 115.98 19.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.548 -1.279 . . . . 0.9 107.548 173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 m -78.47 141.14 38.46 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.892 -0.41 . . . . 1.96 109.892 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -81.84 90.25 6.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.675 0.62 . . . . 2.48 112.675 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.4 m -130.96 105.36 7.7 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.478 0.656 . . . . 1.1 111.536 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.599 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.6 pt -125.84 168.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 105.287 -2.116 . . . . 1.95 105.287 152.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.93 136.62 52.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 104.299 -2.482 . . . . 3.38 104.299 148.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -77.73 -18.71 56.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 120.353 1.433 . . . . 2.67 112.036 -173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.95 -37.07 42.19 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.898 0.772 . . . . 1.56 110.364 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.57 0.8 3.05 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.311 1.226 . . . . 1.18 114.311 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 66.4 43.68 2.6 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 124.172 1.939 . . . . 4.35 111.646 159.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.54 71.74 6.16 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 127.338 2.255 . . . . 1.68 109.039 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -48.62 115.61 2.66 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 113.743 -1.572 . . . . 1.4 112.098 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 155.58 33.46 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.252 1.026 . . . . 2.68 109.843 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.45 123.96 1.3 Allowed Glycine 0 C--N 1.333 0.375 0 N-CA-C 110.861 -0.896 . . . . 0.87 110.861 171.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -77.04 158.61 30.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.55 1.175 . . . . 4.1 109.036 174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 mt -104.77 141.48 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 107.121 -1.437 . . . . 2.26 107.121 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -155.61 103.82 2.31 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.931 0.872 . . . . 2.66 111.506 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -159.97 -12.46 0.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 116.805 2.15 . . . . 3.75 116.805 -178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.49 152.08 26.78 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.386 0.994 . . . . 1.9 111.127 -140.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -66.88 -8.68 30.86 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.357 1.063 . . . . 6.05 113.378 -176.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -117.91 126.42 27.3 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 123.523 0.729 . . . . 2.2 110.096 178.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -52.92 -37.25 77.53 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 CA-C-N 119.676 0.92 . . . . 1.84 109.925 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -78.22 40.84 0.36 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.027 1.731 . . . . 3.48 112.518 -176.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.02 -31.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.624 1.57 . . . . 2.81 113.135 -167.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -64.48 75.57 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 0.809 . . . . 1.78 109.401 166.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 134.34 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 125.872 1.669 . . . . 2.17 111.396 -168.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -104.32 162.61 13.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.262 -0.644 . . . . 2.32 109.262 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.23 133.62 53.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.013 2.125 . . . . 2.73 109.713 -166.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.07 132.29 35.94 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.236 0.614 . . . . 1.1 110.321 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.03 124.68 27.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.683 -0.858 . . . . 1.1 108.683 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.2 147.95 52.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.944 1.298 . . . . 0.98 107.971 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.67 175.52 10.54 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.391 1.476 . . . . 3.79 110.765 -175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' HG13 ' A' ' 109' ' ' ILE . 2.5 tt -119.7 78.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 123.795 1.76 . . . . 1.66 110.87 168.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.95 150.43 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.741 2.816 . . . . 6.68 111.402 156.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.31 64.96 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.615 2.877 . . . . 4.46 112.084 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.03 -41.85 75.62 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.071 0.948 . . . . 4.67 109.128 163.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 107' ' ' ALA . . . 65.01 21.53 67.92 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.213 1.387 . . . . 2.75 114.248 164.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 104' ' ' LYS . 2.9 ttmp? -85.27 47.93 1.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.116 -1.226 . . . . 6.4 110.763 -171.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 31.9 mtm-85 65.11 122.51 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.461 -1.311 . . . . 9.09 107.461 -146.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.7 p80 47.18 13.42 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 117.745 2.498 . . . . 6.81 117.745 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 103' ' ' GLY . . . 57.11 -163.83 0.17 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.369 1.068 . . . . 4.64 113.268 171.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.5 t -154.85 150.98 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.417 1.887 . . . . 2.66 110.152 -166.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' HB ' ' A' ' 99' ' ' ILE . 5.1 mp -113.84 148.83 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 128.817 2.847 . . . . 3.34 108.319 169.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.5 p -144.83 133.61 22.34 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.215 -0.661 . . . . 1.57 109.215 160.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.6 164.79 26.61 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.389 0.519 . . . . 0.89 112.381 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.9 m -78.01 162.71 26.53 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.632 0.773 . . . . 1.72 110.203 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.19 156.45 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.925 -0.769 . . . . 0.7 108.925 168.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.53 116.62 14.35 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.123 1.369 . . . . 3.22 108.695 -172.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -79.9 59.86 3.31 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.118 1.367 . . . . 6.92 107.589 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 68.45 -55.17 0.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.434 1.894 . . . . 3.1 113.166 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.67 7.01 5.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.365 1.066 . . . . 2.86 113.029 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -137.13 114.23 10.69 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 119.184 0.902 . . . . 1.88 110.296 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -90.51 119.88 31.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.511 -1.663 . . . . 3.81 106.511 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 2.5 mmpt? -161.98 68.88 0.28 Allowed 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 126.952 2.101 . . . . 3.46 108.681 141.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.4 157.0 27.38 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 112.519 -2.128 . . . . 0.71 108.381 168.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.4 p -152.78 165.81 34.21 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 125.555 1.542 . . . . 1.18 108.227 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 159.14 42.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 120.979 0.418 . . . . 2.52 111.686 176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.7 p -122.9 107.53 11.95 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 103.725 -2.694 . . . . 1.86 103.725 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.485 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.4 tm? -121.54 135.69 55.0 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 124.29 0.994 . . . . 1.15 109.567 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.03 152.68 17.31 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 108.075 -2.01 . . . . 1.15 108.075 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.8 tt -79.51 152.54 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.162 -1.421 . . . . 2.37 107.162 163.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -156.53 159.84 38.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.008 0.908 . . . . 4.42 110.864 166.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.03 -12.84 67.88 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-N 113.892 -1.504 . . . . 2.7 110.633 -163.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.62 -68.19 3.51 Favored Glycine 0 C--N 1.335 0.504 0 N-CA-C 108.409 -1.876 . . . . 3.45 108.409 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.01 50.41 0.73 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 122.232 -0.569 . . . . 3.69 110.918 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 34.27 81.34 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 128.265 2.626 . . . . 1.26 112.88 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -113.23 -40.29 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.397 0.544 . . . . 2.52 111.179 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -131.08 100.93 5.39 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.23 -1.396 . . . . 2.95 107.23 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.485 ' HB ' HD21 ' A' ' 125' ' ' LEU . 27.0 m -78.38 85.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 107.516 -1.29 . . . . 1.96 107.516 175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.59 123.97 26.9 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.068 -0.716 . . . . 1.29 109.068 -170.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 178.65 33.3 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.277 -0.729 . . . . 0.92 111.277 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 55.7 m -150.13 153.95 37.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.143 -1.058 . . . . 1.77 108.143 163.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -121.39 149.02 43.61 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.612 0.765 . . . . 0.71 111.598 173.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -112.27 131.38 55.54 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.896 -1.89 . . . . 4.31 105.896 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 141' ' ' VAL . 16.2 m -149.35 87.86 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 125.263 1.425 . . . . 2.25 109.43 -174.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -90.9 123.79 34.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.06 -1.025 . . . . 4.16 108.356 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.9 m -150.43 165.76 32.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.763 -1.94 . . . . 2.33 105.763 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.4 t -46.68 -33.45 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.404 0.682 . . . . 2.05 110.031 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -132.67 57.84 1.78 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 108.187 -1.042 . . . . 2.83 108.187 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.95 113.03 2.16 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 107.662 -2.175 . . . . 1.0 107.662 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.07 59.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.112 0.965 . . . . 2.13 109.885 -165.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.7 mtm105 1.64 -89.76 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 128.299 2.64 . . . . 4.95 116.259 -171.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -67.81 109.73 3.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.798 -0.815 . . . . 1.82 108.798 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.1 mt -110.12 123.96 66.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.199 -1.037 . . . . 1.29 108.199 170.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 111.36 3.25 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.636 -1.786 . . . . 0.85 108.636 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.7 67.21 5.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.718 -1.216 . . . . 1.38 107.718 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.35 37.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.309 -0.997 . . . . 1.5 108.309 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -149.21 155.56 40.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 122.381 0.272 . . . . 1.32 110.642 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -156.74 135.2 11.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.529 -0.915 . . . . 3.64 108.529 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 105.664 -1.976 . . . . 4.24 105.664 178.706 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 119.235 -0.412 . . . . 52.0 110.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -160.84 141.88 11.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.725 -1.584 . . . . 48.94 106.725 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.5 t -178.33 173.03 1.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.42 2.288 . . . . 44.24 105.953 169.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 168.22 133.99 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.541 1.936 . . . . 41.26 109.26 -177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.3 t -165.09 154.57 12.9 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 106.846 -1.539 . . . . 35.86 106.846 167.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.86 86.42 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.524 1.53 . . . . 31.84 108.571 -176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -135.16 145.78 48.1 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.135 0.974 . . . . 29.65 108.875 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.7 t -167.63 172.7 9.13 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.858 1.663 . . . . 24.59 106.838 169.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 178.22 83.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.588 1.555 . . . . 20.81 109.597 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -159.23 128.46 5.4 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.803 -0.561 . . . . 17.32 109.897 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -165.76 140.27 4.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.393 -2.077 . . . . 16.4 105.393 171.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -179.07 165.19 1.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.772 1.629 . . . . 10.8 106.925 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.12 69.05 1.97 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.897 0.879 . . . . 8.03 110.491 -166.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.67 -95.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.769 0.827 . . . . 11.95 111.81 -173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.45 143.78 17.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.604 0.761 . . . . 14.75 110.385 -175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 83.55 78.75 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.155 2.582 . . . . 16.98 110.197 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.3 t70 69.45 -56.67 0.55 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 128.332 2.653 . . . . 14.66 109.847 -172.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -28.8 -50.56 0.08 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.859 2.864 . . . . 11.22 111.77 167.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -32.56 -67.48 0.11 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.691 1.596 . . . . 11.39 113.697 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.95 -55.25 6.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.369 0.604 . . . . 14.14 110.675 168.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.4 m -70.56 -9.5 56.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.631 1.715 . . . . 13.41 115.631 -156.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.83 -85.68 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 CA-C-N 119.465 1.029 . . . . 10.66 111.921 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -31.4 65.04 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.094 -1.432 . . . . 11.85 111.577 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -120.64 58.35 0.94 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.898 1.226 . . . . 14.47 111.295 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.4 t -14.32 109.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 128.181 2.592 . . . . 17.25 114.158 170.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 48.04 75.86 0.13 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.634 1.574 . . . . 19.06 114.04 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -125.55 178.78 5.46 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.727 1.611 . . . . 23.04 107.581 170.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -85.95 147.93 26.01 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.572 -0.529 . . . . 27.12 109.572 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -65.48 161.71 19.47 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.035 0.445 . . . . 22.55 109.995 165.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.27 -71.01 0.52 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.873 -1.529 . . . . 25.92 106.873 165.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -164.74 55.0 0.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.039 -1.467 . . . . 25.01 107.039 164.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.8 mm -95.88 91.35 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 106.44 -1.689 . . . . 18.48 106.44 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.19 -145.36 1.65 Allowed Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.757 -0.937 . . . . 15.08 110.757 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -76.34 57.66 1.2 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.35 1.06 . . . . 11.99 110.819 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.3 mm -98.64 78.56 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.702 0.801 . . . . 11.1 110.088 -167.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.75 121.32 5.72 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.576 -1.268 . . . . 5.16 107.576 159.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.31 -49.39 0.89 Allowed Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.18 -1.968 . . . . 3.23 108.18 -154.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 50.08 -95.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.039 1.736 . . . . 4.55 112.457 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -54.03 -48.89 70.03 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.498 1.519 . . . . 4.79 110.275 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -44.31 -57.05 3.72 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.694 0.797 . . . . 3.61 110.945 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.1 t -71.36 -49.92 37.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.799 0.84 . . . . 2.45 111.717 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -45.45 -40.71 8.57 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.34 2.256 . . . . 3.38 113.568 -171.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.97 -20.22 2.25 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.644 0.979 . . . . 3.41 113.644 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 117.61 60.13 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 130.31 3.444 . . . . 3.5 109.07 165.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.558 HD13 ' HZ3' ' A' ' 76' ' ' LYS . 4.6 mp -125.43 118.6 24.82 Favored Pre-proline 0 N--CA 1.449 -0.516 0 N-CA-C 106.312 -1.736 . . . . 2.86 106.312 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.71 -174.41 2.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.239 2.626 . . . . 1.83 113.332 -164.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -67.17 44.95 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.139 1.776 . . . . 5.48 112.183 164.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.35 161.65 19.83 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.134 1.35 . . . . 2.22 110.654 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -117.5 21.89 10.43 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 123.986 0.803 . . . . 1.96 113.377 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.22 162.24 37.85 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.775 1.787 . . . . 5.94 107.585 170.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.94 -178.47 6.49 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.064 0.946 . . . . 2.43 111.32 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -138.63 85.86 2.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.552 -0.907 . . . . 4.18 108.552 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 22.3 p90 -156.48 176.32 12.86 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 115.083 1.512 . . . . 5.11 115.083 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.1 mtm-85 -145.24 109.95 5.05 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 127.377 2.271 . . . . 6.39 106.077 170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.77 15.97 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 118.756 0.707 . . . . 0.87 112.574 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.3 p -106.02 139.55 40.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.644 1.577 . . . . 2.74 106.825 170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.56 70.35 0.99 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 106.377 -1.712 . . . . 0.96 106.377 172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -78.99 139.86 38.11 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.375 0.607 . . . . 2.03 110.016 -167.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.31 157.78 48.47 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.927 -1.669 . . . . 1.0 108.927 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -32.32 29.55 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.091 0.945 . . . . 2.26 111.107 171.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -113.52 36.41 3.61 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.729 1.211 . . . . 3.97 110.028 176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.405 31.7 t0 -1.24 79.35 0.0 OUTLIER 'General case' 0 C--N 1.347 0.466 0 N-CA-C 118.643 2.831 . . . . 2.76 118.643 -153.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.14 52.18 0.88 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.709 -1.589 . . . . 1.34 106.709 154.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.31 177.81 19.76 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.66 -0.976 . . . . 0.9 110.66 -165.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -80.61 178.36 53.99 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 125.364 1.459 . . . . 1.18 113.206 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.31 149.73 51.87 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 104.743 -2.317 . . . . 6.37 104.743 160.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 6.3 tp -113.31 110.0 19.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.053 1.341 . . . . 1.26 108.127 -167.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 t -86.17 158.64 19.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.355 0.597 . . . . 3.69 110.284 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.443 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 52.9 p90 -75.32 106.97 7.12 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.584 0.754 . . . . 2.14 112.02 -169.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 94.9 m -150.98 88.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.845 -0.534 . . . . 1.01 110.817 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.5 117.86 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.665 -1.235 . . . . 2.14 107.665 169.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.51 84.24 3.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 121.579 -0.701 . . . . 4.1 109.277 -177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.403 ' CE1' HD23 ' A' ' 45' ' ' LEU . 22.7 m-85 -30.52 -38.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 128.273 2.629 . . . . 2.77 114.826 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.87 -23.36 4.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.934 1.293 . . . . 1.77 113.612 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.21 -44.99 0.33 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.319 1.047 . . . . 1.91 108.79 172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.558 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 11.3 ttpt 97.83 105.79 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.575 2.75 . . . . 4.2 110.204 167.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -87.87 -62.59 1.46 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.204 -0.907 . . . . 3.66 110.04 -172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 108.54 34.02 2.76 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.438 -1.201 . . . . 1.54 113.856 173.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -139.61 85.41 2.04 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.583 1.691 . . . . 2.75 112.533 -157.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -94.38 132.09 11.01 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' NZ ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.75 146.62 32.26 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.286 1.043 . . . . 4.75 111.622 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 65' ' ' GLY . 12.7 mt -102.36 117.78 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 126.272 1.829 . . . . 2.09 107.708 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 54.8 tt0 -147.27 107.44 4.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.754 -1.573 . . . . 3.29 106.754 175.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.459 ' CD2' ' O ' ' A' ' 83' ' ' GLU . 85.7 m-70 -157.41 39.47 0.29 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.815 -1.18 . . . . 4.13 107.815 158.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 mt -110.66 147.79 33.59 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.696 0.76 . . . . 2.11 110.841 -154.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -8.05 40.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.002 -0.999 . . . . 5.44 112.736 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.49 145.63 55.91 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 118.272 -0.87 . . . . 2.52 109.119 174.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -53.76 -47.63 26.18 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 N-CA-C 109.175 -1.125 . . . . 2.02 109.175 162.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -71.85 63.21 0.45 Allowed 'General case' 0 C--N 1.344 0.334 0 C-N-CA 126.637 1.975 . . . . 4.61 112.366 -173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.21 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.313 1.845 . . . . 2.78 110.707 -170.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -29.67 107.8 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.774 2.03 . . . . 2.6 112.321 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.8 t -94.81 89.71 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.383 -0.969 . . . . 1.71 108.383 -168.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.8 122.81 28.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.781 -1.562 . . . . 2.52 106.781 170.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.9 mt -78.76 135.43 37.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.193 -1.41 . . . . 1.59 107.193 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 152.12 35.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.28 -1.007 . . . . 1.21 108.28 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 118.16 17.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.177 -0.675 . . . . 1.48 109.177 -166.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -105.49 177.05 4.96 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.682 1.593 . . . . 1.86 108.413 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -127.73 128.97 46.29 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.12 -1.437 . . . . 3.71 107.12 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' LYS 0.271 0.0 OUTLIER -88.75 91.6 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 106.636 -1.616 . . . . 1.94 106.636 169.91 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 164.04 55.66 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 125.904 1.682 . . . . 6.84 109.61 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -67.84 130.01 20.92 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 121.773 1.648 . . . . 5.53 113.679 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -121.98 -97.25 0.46 Allowed 'General case' 0 C--N 1.341 0.201 0 N-CA-C 106.823 -1.547 . . . . 5.33 106.823 155.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.71 132.51 10.31 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 109.674 -1.37 . . . . 3.62 109.674 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.5 mttm 66.25 -62.44 0.27 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.388 2.275 . . . . 8.23 112.801 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -148.18 -1.25 0.56 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.818 2.447 . . . . 8.09 114.321 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 82.4 t60 58.19 84.31 0.1 Allowed 'General case' 0 C--N 1.347 0.473 0 CA-C-N 120.315 1.416 . . . . 8.96 108.304 -165.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.33 45.58 0.38 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.253 0.621 . . . . 4.0 112.063 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.68 159.38 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.12 2.168 . . . . 2.11 107.853 -173.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 mt -138.28 165.64 24.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 129.88 3.272 . . . . 2.5 104.182 169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.9 m -144.83 83.74 1.71 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 108.975 -0.75 . . . . 2.18 108.975 172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.72 147.97 19.03 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.744 -0.942 . . . . 0.77 110.744 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.2 m -83.02 157.03 23.09 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.365 -1.346 . . . . 1.53 107.365 159.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.84 132.09 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 119.262 0.937 . . . . 0.98 112.297 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.65 118.85 37.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.373 1.469 . . . . 2.37 108.493 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.48 84.64 5.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.971 -1.492 . . . . 7.09 106.971 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.2 t30 62.56 -59.1 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 128.018 2.527 . . . . 3.23 115.071 175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.08 9.27 2.11 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.645 1.578 . . . . 2.64 112.442 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.59 124.4 15.11 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.991 0.814 . . . . 1.36 108.909 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -111.67 103.95 12.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.194 0.997 . . . . 3.69 108.455 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HA ' ' CE ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -146.84 55.64 1.12 Allowed 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 122.479 1.133 . . . . 3.32 109.755 166.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.52 171.79 34.2 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.804 -1.318 . . . . 0.81 109.804 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 73.3 p -144.15 168.11 20.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 122.834 0.453 . . . . 0.79 110.855 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.6 131.94 22.09 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.16 1.384 . . . . 2.46 107.764 -177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -123.45 111.04 15.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.388 -1.708 . . . . 2.39 106.388 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.615 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -137.06 138.73 40.73 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 124.115 0.966 . . . . 1.36 109.144 -170.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -128.4 162.68 22.06 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 125.402 1.477 . . . . 1.55 110.747 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.0 tt -126.3 140.42 48.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 124.624 1.17 . . . . 2.97 111.662 -157.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -142.81 132.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.68 0.993 . . . . 4.46 113.68 -177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 15.41 7.75 Favored Glycine 0 C--N 1.34 0.787 0 C-N-CA 124.244 0.926 . . . . 3.78 113.685 156.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.47 -103.92 3.09 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 104.108 -3.597 . . . . 4.36 104.108 -174.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -74.82 51.55 0.49 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.734 0.814 . . . . 4.48 112.337 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 49.8 60.24 3.94 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 126.278 1.831 . . . . 2.44 110.109 170.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.77 -33.06 71.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.889 -0.596 . . . . 4.2 109.798 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -140.1 152.28 46.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.474 1.51 . . . . 3.07 108.375 168.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.0 m -134.68 141.07 44.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 107.488 -1.301 . . . . 1.29 107.488 167.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.19 128.11 27.43 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.897 0.879 . . . . 1.34 109.954 -172.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.66 178.76 34.74 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.097 0.38 . . . . 1.17 113.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.9 m -134.95 139.62 45.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.751 -1.203 . . . . 1.69 107.751 167.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.1 136.3 53.08 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 112.206 0.447 . . . . 1.26 112.206 167.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -114.48 68.0 0.69 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 125.153 2.406 . . . . 4.17 110.367 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.9 t -67.21 155.54 7.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 112.285 -2.234 . . . . 2.32 108.585 161.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.11 62.28 0.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 120.137 -1.602 . . . . 3.88 108.131 166.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 m -66.19 160.04 25.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.791 -1.559 . . . . 3.22 106.791 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.2 t -47.12 -30.5 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 123.062 0.545 . . . . 2.02 110.618 174.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -134.5 58.0 1.79 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.146 0.979 . . . . 3.3 108.793 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.25 134.15 6.87 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.609 -1.397 . . . . 1.84 109.609 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.25 146.35 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.547 1.139 . . . . 1.78 111.599 -171.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -103.18 0.11 31.27 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.03 1.332 . . . . 3.88 113.032 -174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -126.53 59.28 1.36 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.788 -1.56 . . . . 3.53 106.788 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 15.2 mt -82.71 110.45 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.238 -1.393 . . . . 1.26 107.238 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 117.82 4.66 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.327 -1.909 . . . . 0.77 108.327 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.615 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -102.72 115.27 30.26 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.61 -1.256 . . . . 1.11 107.61 -175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -141.75 116.34 9.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.082 0.553 . . . . 1.22 109.7 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.879 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -117.38 145.38 44.12 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.422 1.089 . . . . 1.53 109.271 167.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HB2' ' HZ3' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -158.1 127.86 5.96 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.216 -1.772 . . . . 3.28 106.216 169.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.407 ' O ' ' NZ ' ' A' ' 155' ' ' LYS . 4.6 mm-40 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 117.893 -1.523 . . . . 4.63 113.352 -161.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.363 -0.977 . . . . 57.46 108.363 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -160.88 134.4 6.71 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.056 -1.461 . . . . 54.3 107.056 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -179.57 156.19 0.7 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.548 -1.279 . . . . 48.7 107.548 -177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.89 156.65 3.43 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.641 1.576 . . . . 45.51 107.039 172.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.7 t -171.46 142.97 1.73 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 106.667 -1.605 . . . . 40.11 106.667 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -171.09 105.62 0.24 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.309 1.044 . . . . 36.1 108.632 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 tp -153.26 119.76 5.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.606 -1.627 . . . . 32.19 106.606 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.0 t -167.24 134.92 2.46 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.465 -1.309 . . . . 28.25 107.465 171.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -179.44 135.73 0.12 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.684 1.594 . . . . 24.43 107.759 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -168.42 135.41 2.01 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.743 0.817 . . . . 20.26 108.832 170.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -167.35 134.75 2.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.709 -0.478 . . . . 17.0 109.709 172.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.9 t -178.43 173.22 1.39 Allowed 'General case' 0 C--O 1.233 0.185 0 C-N-CA 128.42 2.688 . . . . 12.59 105.206 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.5 74.1 0.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.955 0.902 . . . . 7.72 111.99 -173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -129.55 175.63 8.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.886 2.074 . . . . 14.08 110.259 -176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.763 HG22 ' H ' ' A' ' 16' ' ' GLN 0.28 29.3 mm 56.7 -165.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.925 1.69 . . . . 15.09 110.58 173.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.763 ' H ' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -156.56 41.38 0.36 Allowed 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.752 -1.218 . . . . 14.52 109.051 169.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -74.89 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 105.953 -1.869 . . . . 15.13 105.953 -172.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.3 m -62.73 -90.08 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.099 2.16 . . . . 14.91 111.104 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.82 -8.33 1.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.591 1.33 . . . . 12.96 114.591 177.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -43.15 -41.56 3.76 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.478 1.036 . . . . 11.34 111.178 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 m -39.3 -56.93 1.46 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.653 1.581 . . . . 12.7 111.616 172.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.81 -49.85 27.12 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.342 -0.703 . . . . 9.81 111.342 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -47.24 -40.78 17.22 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.84 1.656 . . . . 9.86 114.359 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 33.5 tpp 60.01 59.57 2.37 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.002 -0.74 . . . . 11.84 109.002 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.8 t 67.29 -73.4 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 125.685 1.594 . . . . 12.4 111.298 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 53.54 86.34 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.01 1.724 . . . . 12.02 112.276 -177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -70.73 169.66 14.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.367 -0.833 . . . . 15.51 110.266 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -60.39 164.04 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.66 0.615 . . . . 22.5 112.66 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 67.6 -70.95 0.11 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.34 1.856 . . . . 21.6 110.9 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -158.75 -58.87 0.07 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.607 1.163 . . . . 20.75 109.618 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 56.15 74.45 0.39 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.003 -0.999 . . . . 17.93 109.441 -156.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 94.7 mt -49.5 130.76 7.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 107.878 -1.156 . . . . 16.46 107.878 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.14 -145.2 12.81 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 105.871 -2.891 . . . . 10.66 105.871 -169.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.57 41.75 0.2 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.543 1.937 . . . . 9.36 112.793 -170.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.7 pt -88.31 151.91 3.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 123.892 0.877 . . . . 8.34 109.27 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.74 -127.88 0.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.748 1.219 . . . . 4.06 109.065 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -50.93 60.52 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 118.773 0.715 . . . . 2.46 112.654 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 61.47 -96.66 0.06 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.825 0.85 . . . . 4.24 110.682 171.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -70.39 -34.95 73.14 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.852 1.661 . . . . 6.11 109.969 -168.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 t -70.2 -49.15 53.11 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.939 -0.763 . . . . 2.92 108.939 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.09 -62.6 1.76 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.738 0.815 . . . . 1.97 112.149 -176.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -59.59 -30.16 68.48 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 111.88 0.326 . . . . 2.97 111.88 -163.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.75 -42.61 71.83 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.52 0.728 . . . . 4.06 111.192 -171.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? 171.11 38.44 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.759 1.624 . . . . 3.63 111.159 176.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -132.1 137.36 29.92 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.372 0.987 . . . . 2.51 109.805 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.12 167.7 24.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.996 3.131 . . . . 1.78 111.526 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -84.11 45.08 1.06 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.318 0.58 . . . . 6.33 110.993 159.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.06 -180.0 12.85 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 121.205 -0.934 . . . . 2.15 112.313 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -109.65 -12.7 18.33 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 123.989 0.804 . . . . 1.72 114.937 -171.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -158.53 86.08 0.86 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.603 1.202 . . . . 6.67 112.624 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -78.5 153.79 31.04 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 121.652 -0.655 . . . . 1.65 111.509 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -79.7 58.77 2.87 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.263 1.425 . . . . 1.47 112.605 -168.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CE2' HG21 ' A' ' 71' ' ' ILE . 3.0 m-30 -78.48 70.72 4.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.129 -1.607 . . . . 3.56 109.088 177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -86.79 110.34 19.87 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.064 1.346 . . . . 4.9 109.451 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.47 -174.83 28.7 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 119.585 -1.293 . . . . 0.71 115.366 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -119.08 148.95 42.47 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.134 1.374 . . . . 2.87 108.945 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.55 78.55 1.32 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.705 -1.591 . . . . 0.9 106.705 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -83.24 131.76 35.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.299 0.64 . . . . 2.45 109.556 -169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.7 170.27 54.68 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.872 -0.891 . . . . 0.89 110.872 -173.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.1 t -55.45 -25.3 35.68 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.461 -0.435 . . . . 1.71 111.69 171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.54 8.64 23.02 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.114 2.166 . . . . 2.58 110.804 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.25 15.6 m-20 57.48 8.86 0.67 Allowed 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.887 1.675 . . . . 4.58 115.425 -168.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.58 58.22 2.66 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.907 1.283 . . . . 1.36 108.546 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.72 167.9 13.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 123.755 0.693 . . . . 1.0 111.813 -166.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 82' ' ' ILE . . . -95.87 178.79 35.11 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.186 1.374 . . . . 0.91 111.051 -173.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.18 137.23 52.03 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.7 -0.882 . . . . 5.7 110.289 173.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 152' ' ' LEU . 27.1 tp -82.35 114.02 20.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.465 0.706 . . . . 0.94 109.374 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.8 m -78.67 143.42 36.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.919 -0.771 . . . . 1.87 108.919 167.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -78.02 121.44 24.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.628 -0.878 . . . . 2.23 108.628 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -156.15 72.89 0.78 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.704 -0.622 . . . . 1.49 110.299 -171.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -134.99 115.68 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.046 0.927 . . . . 1.46 110.423 173.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.09 113.55 11.41 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.056 1.742 . . . . 3.83 106.497 165.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 51' ' ' ALA . 18.7 m-85 -66.27 -38.91 88.92 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 124.851 1.261 . . . . 2.66 112.711 -164.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -36.23 9.96 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 124.426 1.079 . . . . 1.35 110.966 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.755 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -122.35 -19.23 6.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.379 1.072 . . . . 1.33 112.71 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.472 ' HB2' ' CG2' ' A' ' 99' ' ' ILE . 15.4 mttm 62.08 85.27 0.13 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 126.909 2.084 . . . . 4.58 113.159 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.755 HE22 ' HB3' ' A' ' 75' ' ' ALA . 7.9 mm-40 -76.67 -48.28 19.45 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 115.564 -0.744 . . . . 2.88 111.047 -172.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.5 34.61 89.01 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 113.844 0.298 . . . . 1.54 113.844 164.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -137.51 103.16 4.97 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.498 -1.297 . . . . 3.86 107.498 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.15 159.79 45.58 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 123.414 1.563 . . . . 1.75 111.942 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.35 128.42 34.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.857 -1.905 . . . . 7.07 105.857 164.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' HB ' HG13 ' A' ' 92' ' ' VAL . 5.4 mt -125.45 117.99 51.17 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 118.838 0.744 . . . . 3.14 109.62 -171.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -112.51 173.0 6.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.167 -2.16 . . . . 4.82 105.167 168.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -159.24 53.76 0.39 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 129.563 3.145 . . . . 5.41 106.566 58.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.77 157.81 16.23 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 119.981 -0.688 . . . . 1.48 112.651 -145.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -17.46 38.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.79 1.236 . . . . 4.29 112.722 -171.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.0 m -130.83 136.51 29.03 Favored Pre-proline 0 C--O 1.234 0.249 0 N-CA-C 108.063 -1.088 . . . . 1.38 108.063 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -58.64 -28.05 84.96 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.672 2.248 . . . . 1.46 111.051 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 30.9 mt-10 -44.43 -39.29 4.61 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.857 1.263 . . . . 4.24 111.667 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.63 -1.1 57.92 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.613 -0.721 . . . . 4.02 112.626 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -76.06 94.93 3.52 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 104.928 -2.249 . . . . 2.34 104.928 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG13 ' HB ' ' A' ' 82' ' ' ILE . 14.7 p -105.14 119.01 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.594 1.158 . . . . 2.1 109.987 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.18 118.15 23.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.171 -1.789 . . . . 2.58 106.171 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -78.48 129.27 34.69 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 105.499 -2.037 . . . . 1.84 105.499 166.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.24 157.62 27.76 Favored 'General case' 0 C--O 1.226 -0.172 0 O-C-N 121.641 -0.662 . . . . 1.05 109.634 -169.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.5 157.95 31.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.589 -0.694 . . . . 1.53 110.141 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.37 179.01 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.424 1.89 . . . . 2.31 106.684 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.42 166.07 25.55 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 108.688 -0.856 . . . . 3.41 108.688 163.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 1.5 tt -126.17 80.46 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 C-N-CA 123.543 0.737 . . . . 1.85 111.293 175.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -83.12 -40.44 0.81 Allowed Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 114.498 -1.228 . . . . 7.13 114.136 150.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.88 -168.65 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.83 0 CA-C-N 122.396 1.891 . . . . 4.3 111.058 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.05 -63.91 0.31 Allowed 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.911 2.085 . . . . 5.09 110.941 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.94 -159.68 33.08 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 122.664 1.147 . . . . 4.1 111.3 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 69.93 -82.94 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.561 2.344 . . . . 5.3 108.233 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -164.15 47.09 0.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.05 1.34 . . . . 6.55 109.989 -172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.46 ' HA ' HD11 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 62.7 56.49 1.95 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.391 0.615 . . . . 6.06 109.434 177.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -63.06 1.27 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.943 -1.026 . . . . 2.8 109.593 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -143.48 148.58 18.96 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 CA-C-N 119.282 0.947 . . . . 1.48 112.907 159.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.86 143.56 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 106.838 -1.542 . . . . 2.68 106.838 154.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -105.08 119.62 39.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.644 -1.613 . . . . 1.57 106.644 168.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.2 179.29 17.14 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.689 1.138 . . . . 1.09 111.163 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.8 m -147.68 167.43 24.65 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 120.658 -1.495 . . . . 2.23 107.707 174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.57 149.87 31.88 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.083 0 CA-C-N 118.256 0.48 . . . . 0.8 111.983 -165.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.9 tp -104.81 109.2 21.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.256 1.423 . . . . 2.27 107.361 164.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 12.1 t80 -76.34 75.72 3.12 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 104.702 -2.332 . . . . 4.61 104.702 168.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.4 t30 65.12 -69.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.055 1.742 . . . . 2.9 112.723 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -130.31 13.07 5.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.32 1.448 . . . . 3.99 112.434 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.27 164.17 39.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.959 1.254 . . . . 1.36 107.683 173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.4 54.16 1.34 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 120.107 1.322 . . . . 5.78 112.955 -161.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.26 63.58 1.85 Allowed 'General case' 0 C--N 1.328 -0.356 0 O-C-N 119.613 -1.929 . . . . 4.88 107.584 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.24 120.76 0.99 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 112.731 -2.031 . . . . 0.62 114.081 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.34 166.72 16.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.44 1.096 . . . . 1.14 109.578 163.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -151.89 154.34 35.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.016 0.927 . . . . 2.22 109.35 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.2 t -152.13 141.5 21.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.795 -0.816 . . . . 2.27 108.795 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 152' ' ' LEU . 1.8 tm? -152.03 137.32 17.53 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 123.593 0.558 . . . . 0.82 111.124 -171.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -129.21 151.83 19.28 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.498 1.523 . . . . 1.35 110.468 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.11 159.02 2.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 C-N-CA 124.155 0.982 . . . . 2.26 109.781 177.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -154.1 168.47 26.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 122.606 1.193 . . . . 4.7 114.095 163.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.77 -9.07 61.91 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 113.067 -1.879 . . . . 2.93 110.589 -174.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.31 -68.51 3.51 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.19 -1.964 . . . . 2.68 108.19 174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -77.54 53.08 1.03 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 122.549 -0.383 . . . . 3.72 110.34 167.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 35.0 78.72 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.97 2.508 . . . . 1.38 113.101 168.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.45 -42.37 3.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 122.428 0.291 . . . . 2.34 111.654 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -113.94 150.9 33.07 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.917 -1.512 . . . . 3.81 106.917 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.754 HG22 ' CB ' ' A' ' 154' ' ' ALA . 2.9 m -133.7 141.02 45.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.605 -1.257 . . . . 1.24 107.605 157.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.05 127.44 26.56 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.209 1.404 . . . . 1.03 108.449 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.23 -179.5 33.15 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.351 -0.699 . . . . 0.91 111.351 -173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 51.1 m -142.21 153.13 43.75 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 122.286 -0.538 . . . . 1.83 110.014 155.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -96.23 142.4 28.44 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 1.13 107.817 154.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.49 66.86 0.8 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.486 1.115 . . . . 4.14 108.489 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.5 m -79.67 168.88 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.264 -0.88 . . . . 2.47 111.059 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -160.08 118.69 2.7 Favored 'General case' 0 C--N 1.335 -0.058 0 O-C-N 121.39 -0.819 . . . . 3.5 108.988 164.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 81.9 p -157.4 -178.09 7.09 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.327 -1.36 . . . . 2.1 107.327 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.4 t -44.64 -29.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 124.543 1.137 . . . . 2.61 110.86 167.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.0 56.68 1.56 Allowed 'General case' 0 C--N 1.343 0.301 0 N-CA-C 108.79 -0.819 . . . . 2.64 108.79 168.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.92 90.33 0.59 Allowed Glycine 0 C--N 1.333 0.368 0 N-CA-C 108.109 -1.996 . . . . 1.0 108.109 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.15 77.06 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.002 0.521 . . . . 1.93 109.719 -173.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.3 ttm180 -25.21 -65.14 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 127.406 2.283 . . . . 4.92 116.301 -163.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -72.22 70.66 0.84 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.804 0.729 . . . . 2.9 110.797 -174.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 8.0 mt -82.03 99.28 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.653 -1.24 . . . . 1.39 107.653 173.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.19 121.15 5.61 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.37 -1.892 . . . . 0.83 108.37 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 125' ' ' LEU . 1.9 tm? -101.41 114.32 28.22 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.907 -1.516 . . . . 1.12 106.907 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.44 127.74 30.2 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.432 0.693 . . . . 1.03 109.167 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.754 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -123.7 155.99 36.79 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 113.224 0.824 . . . . 0.83 113.224 -177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -155.07 108.6 2.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.633 -1.167 . . . . 5.75 108.055 164.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 C--O 1.251 1.173 0 N-CA-C 106.76 -1.57 . . . . 3.92 106.76 157.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 105.934 -1.876 . . . . 49.71 105.934 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.93 150.33 45.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.649 1.113 . . . . 43.99 108.481 170.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.1 m -151.03 149.05 29.1 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.517 -1.66 . . . . 40.25 106.517 167.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -160.93 166.08 28.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.893 -1.521 . . . . 36.34 106.893 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.6 m -164.02 153.46 14.18 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 107.02 -1.474 . . . . 32.35 107.02 173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.46 152.02 15.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.409 -1.7 . . . . 28.48 106.409 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 tp -158.62 137.56 11.3 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 105.502 -2.036 . . . . 24.69 105.502 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -161.82 155.55 21.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.541 -1.651 . . . . 21.47 106.541 168.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.24 153.52 5.44 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.28 -1.748 . . . . 18.05 106.28 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -162.05 158.23 24.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.219 -1.03 . . . . 14.73 108.219 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -174.83 160.43 2.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.824 1.65 . . . . 14.2 108.322 -175.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -168.04 179.31 4.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.237 -1.023 . . . . 9.39 108.237 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.5 tp10 -86.48 95.55 9.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.521 -1.288 . . . . 7.07 107.521 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 61.97 -68.0 0.06 Allowed 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 116.574 2.064 . . . . 14.02 116.574 167.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 mt -115.96 126.0 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 106.826 -1.546 . . . . 15.16 106.826 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.23 30.54 0.12 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.121 0.568 . . . . 14.29 112.481 -174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -148.87 -66.13 0.23 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.825 -1.546 . . . . 15.06 106.825 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -70.09 -86.59 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.616 1.167 . . . . 15.09 109.538 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -59.5 -33.87 71.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.204 1.002 . . . . 13.83 111.572 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -35.1 -62.74 0.36 Allowed 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 123.715 0.806 . . . . 11.32 111.021 161.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.1 m -70.44 -15.93 62.88 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 122.301 -0.249 . . . . 12.27 111.435 -172.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.5 -60.69 5.63 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.292 -1.123 . . . . 9.13 110.292 167.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -72.46 -64.51 0.94 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.229 1.411 . . . . 9.51 111.613 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 84.8 mtp -80.17 60.71 3.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.498 2.319 . . . . 11.59 109.652 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.8 t -47.1 -43.92 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.755 1.222 . . . . 15.09 109.646 164.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.72 167.8 21.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.07 1.348 . . . . 16.41 107.894 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.12 143.26 18.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.35 1.06 . . . . 19.04 112.232 -176.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -129.69 152.41 49.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 104.747 -2.316 . . . . 17.45 104.747 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -61.94 -58.95 5.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.441 0.564 . . . . 21.28 110.098 -177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -146.73 -64.91 0.29 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.688 1.195 . . . . 19.56 107.97 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.32 49.51 16.88 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.444 1.098 . . . . 17.67 111.086 172.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 85.5 mt -61.31 147.0 11.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.043 -0.981 . . . . 14.42 109.183 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.7 -177.71 17.15 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.963 -2.055 . . . . 10.77 107.963 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.45 37.96 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.433 1.093 . . . . 11.47 113.461 146.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.9 mt -84.95 148.9 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.708 -1.219 . . . . 7.52 107.708 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 86.84 52.74 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 127.621 2.368 . . . . 3.87 108.689 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.5 75.79 0.14 Allowed Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 107.714 -2.155 . . . . 3.5 107.714 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.98 -68.98 0.89 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.328 1.851 . . . . 5.43 108.42 -173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -66.12 -54.46 25.32 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.196 1.798 . . . . 3.98 107.252 -173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.6 t -51.23 -46.01 62.12 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.883 0.327 . . . . 2.89 111.883 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -65.07 -58.48 5.94 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.028 0.442 . . . . 1.8 110.105 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -44.01 -47.14 8.63 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.661 1.584 . . . . 3.0 112.431 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -65.7 -8.25 19.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.088 0.955 . . . . 3.54 113.048 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtpt 124.18 57.77 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 0 C-N-CA 129.07 2.948 . . . . 4.57 109.11 156.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.673 HD11 HD12 ' A' ' 127' ' ' ILE . 80.1 mt -131.14 144.06 51.95 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 125.154 1.381 . . . . 2.35 108.193 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.93 -172.19 1.06 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.536 3.49 . . . . 1.88 111.184 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -99.18 47.47 0.96 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.941 1.297 . . . . 6.83 108.173 165.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.31 149.36 17.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.862 1.696 . . . . 2.05 114.972 -169.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.4 -26.28 69.38 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 117.724 1.849 . . . . 1.72 117.724 -163.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -152.72 131.22 12.19 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.007 1.404 . . . . 4.58 108.762 -171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.64 177.86 8.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.036 0.534 . . . . 1.48 110.497 163.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.0 t -133.04 67.92 1.52 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.101 0.96 . . . . 1.87 110.127 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 69' ' ' TYR . 43.0 p90 -112.57 107.5 16.25 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.522 1.129 . . . . 5.41 112.335 172.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -85.32 138.65 32.16 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.665 -1.605 . . . . 5.83 106.665 164.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.74 -167.06 19.83 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 118.867 -1.635 . . . . 0.93 114.643 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.2 m -152.45 137.93 17.68 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.644 0.777 . . . . 2.79 108.905 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.42 ' HB1' HD11 ' A' ' 150' ' ' ILE . . . -109.77 95.34 5.54 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.8 2.04 . . . . 0.92 105.549 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.423 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 9.7 p90 -98.14 123.05 41.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.415 1.007 . . . . 2.56 110.28 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.12 162.97 48.75 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.0 t -55.77 -35.54 66.36 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.105 -0.644 . . . . 2.08 110.139 165.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 86' ' ' LYS . 24.4 t0 -73.55 -6.66 47.96 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.457 0.703 . . . . 3.82 112.24 174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.332 23.4 t0 22.61 58.56 0.03 OUTLIER 'General case' 0 C--N 1.347 0.479 0 CA-C-O 123.549 1.642 . . . . 3.06 112.788 -143.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.45 57.75 3.76 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.022 -2.214 . . . . 1.75 105.022 148.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 58' ' ' PHE . . . -91.2 176.23 40.25 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.449 -1.06 . . . . 1.18 110.449 -178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.52 175.6 24.16 Favored Glycine 0 N--CA 1.446 -0.692 0 O-C-N 122.084 -0.656 . . . . 0.97 112.03 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 10.1 mtmm -98.17 112.98 24.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.172 1.389 . . . . 4.45 108.73 -169.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 tp -79.55 143.55 34.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.007 -0.738 . . . . 1.15 109.007 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.0 t -126.54 150.32 48.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.37 1.068 . . . . 3.35 110.828 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 53' ' ' TYR . 51.6 p90 -76.84 106.18 8.35 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 125.018 1.327 . . . . 2.33 112.252 -175.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.9 m -155.48 86.78 1.08 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.781 0.832 . . . . 1.08 108.992 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 76' ' ' LYS . 2.1 pt -142.57 135.64 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 105.923 -1.88 . . . . 1.65 105.923 166.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -88.07 114.03 24.29 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.827 -1.175 . . . . 4.42 107.827 166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -57.33 -15.75 7.13 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.364 1.066 . . . . 2.36 112.672 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -42.11 -48.45 4.73 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.51 0.724 . . . . 1.24 111.099 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.8 14.24 0.48 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.123 1.157 . . . . 1.35 114.123 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 71' ' ' ILE . 14.2 ttpp 30.38 70.66 0.08 Allowed 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 127.113 2.165 . . . . 4.31 114.494 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -93.88 52.31 1.64 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.54 -2.022 . . . . 3.63 105.54 -175.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.596 ' CA ' HG22 ' A' ' 71' ' ' ILE . . . -94.2 146.31 18.09 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 113.716 -1.584 . . . . 2.04 112.575 -137.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.83 167.41 30.48 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.468 1.134 . . . . 3.41 112.934 -173.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.54 122.73 1.19 Allowed Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.485 -1.446 . . . . 0.87 109.485 169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.1 158.8 16.44 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.193 0.997 . . . . 4.59 109.647 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.2 pt -128.45 143.77 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.884 0.874 . . . . 2.69 110.594 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' H ' ' CD2' ' A' ' 84' ' ' HIS . 14.9 tt0 -156.84 59.01 0.53 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 122.167 0.984 . . . . 2.93 110.912 -166.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.549 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -157.0 11.75 0.23 Allowed 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.153 -1.592 . . . . 5.41 112.858 -170.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 85' ' ' LEU . 9.6 mp -90.32 164.25 14.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.086 0.47 . . . . 2.26 110.876 -164.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -67.45 -12.98 61.59 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.331 0.863 . . . . 4.52 113.331 -168.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 m -131.79 135.66 27.12 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.018 -0.734 . . . . 2.11 109.018 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.18 -31.14 92.73 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.203 2.602 . . . . 2.13 112.513 -170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -59.25 -28.27 66.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.413 1.085 . . . . 3.35 110.595 177.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mt -79.7 0.98 28.16 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.748 -0.644 . . . . 3.42 111.997 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -68.54 74.29 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.665 1.575 . . . . 2.27 108.608 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.7 t -70.58 126.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.717 2.007 . . . . 1.02 110.008 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -102.16 163.68 12.11 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.969 -1.123 . . . . 2.02 107.969 163.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.01 161.02 35.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.13 0.967 . . . . 2.14 113.039 172.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.25 146.2 24.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.718 1.207 . . . . 1.07 109.486 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.0 149.68 39.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.763 0.825 . . . . 1.37 108.812 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 144.32 20.75 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.478 -0.564 . . . . 1.12 109.478 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.8 173.66 12.38 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.999 1.719 . . . . 3.3 110.782 -168.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.4 tt -152.35 112.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 C-N-CA 124.719 1.208 . . . . 1.62 109.222 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.451 ' H ' ' HD2' ' A' ' 101' ' ' PRO . 6.2 tmtt? -165.94 -49.13 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.202 1.001 . . . . 6.98 112.101 170.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 100' ' ' LYS . 84.2 Cg_endo -80.69 69.8 7.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.004 1.751 . . . . 4.02 111.404 -169.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -166.69 -55.66 0.03 OUTLIER 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 126.686 1.994 . . . . 4.99 108.266 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 60.29 -108.62 1.87 Allowed Glycine 0 CA--C 1.523 0.58 0 CA-C-N 114.892 -1.049 . . . . 3.63 112.617 172.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.9 mttp 72.33 -55.07 0.68 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 128.215 2.606 . . . . 5.8 110.498 -175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -145.37 -51.27 0.26 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.21 1.404 . . . . 6.48 108.918 167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -129.68 -9.61 4.51 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 115.43 1.641 . . . . 6.1 115.43 -171.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 63.06 -171.33 0.17 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.438 1.095 . . . . 4.45 112.296 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.47 157.97 21.75 Favored 'Isoleucine or valine' 0 C--O 1.23 0.06 0 C-N-CA 125.653 1.581 . . . . 1.91 109.158 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.32 160.46 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.726 -0.842 . . . . 2.71 108.726 160.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.5 m -146.97 78.62 1.5 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.801 1.24 . . . . 2.29 109.14 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.63 170.99 27.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 121.595 0.553 . . . . 0.68 113.633 -173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -97.71 148.72 23.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.779 1.632 . . . . 1.45 108.594 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.6 152.38 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 119.09 0.859 . . . . 0.73 109.26 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.29 144.14 50.9 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 112.653 0.612 . . . . 2.0 112.653 176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -77.2 69.36 3.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.983 2.113 . . . . 5.58 106.139 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 55.86 -62.52 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 129.59 3.156 . . . . 3.07 113.6 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -94.25 -43.14 8.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.008 0.923 . . . . 2.28 111.523 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.38 123.92 48.8 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.982 -0.449 . . . . 1.44 112.081 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -78.57 115.76 18.49 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.059 -1.025 . . . . 3.91 108.703 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 4.2 mmpt? -149.5 80.86 1.4 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.811 1.245 . . . . 3.38 109.961 131.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.89 161.64 31.18 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.033 -1.227 . . . . 0.68 110.033 160.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 61.7 p -143.38 167.21 22.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.267 1.027 . . . . 0.84 108.67 175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -151.86 174.42 13.6 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.21 0.459 . . . . 2.76 110.943 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -150.39 145.31 26.01 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.607 -0.886 . . . . 2.96 108.607 169.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.98 140.96 25.96 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 124.312 1.007 . . . . 0.86 110.994 -167.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -135.75 157.72 23.45 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 127.662 2.553 . . . . 1.06 110.09 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.673 HD12 HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.99 140.25 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.405 1.082 . . . . 2.04 109.889 -162.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -73.24 116.98 14.43 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 122.833 0.453 . . . . 5.94 111.477 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.73 70.61 0.01 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.823 2.154 . . . . 2.88 114.733 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.22 -55.42 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.067 -1.213 . . . . 3.16 110.067 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -169.43 36.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.554 0.741 . . . . 3.72 109.924 -171.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 55.54 31.85 17.93 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.882 -1.136 . . . . 2.85 110.953 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -58.66 -41.23 85.61 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 126.022 1.729 . . . . 3.96 111.085 -165.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -152.35 81.68 1.24 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.674 -1.602 . . . . 2.85 106.674 -167.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 154' ' ' ALA . 5.1 m -75.47 145.69 10.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.744 -1.576 . . . . 1.27 106.744 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.6 128.24 47.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.635 -1.246 . . . . 1.03 107.635 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.21 176.68 33.56 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.022 -1.231 . . . . 0.75 110.022 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.9 t -141.32 148.0 39.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.206 -1.775 . . . . 2.26 106.206 162.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -102.12 166.67 10.48 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.18 0.925 . . . . 1.06 108.773 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -133.51 112.43 11.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.25 -1.759 . . . . 3.11 106.25 153.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.59 142.48 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.305 -1.739 . . . . 1.98 106.305 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -142.4 101.54 3.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.944 0.793 . . . . 3.57 109.12 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.8 p -134.45 -173.51 3.3 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.451 -1.315 . . . . 2.12 107.451 168.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -44.82 -26.99 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.856 0.862 . . . . 2.57 112.034 163.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.48 59.99 0.62 Allowed 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.009 -1.108 . . . . 2.52 108.009 172.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.97 126.52 6.84 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 107.305 -2.318 . . . . 1.0 107.305 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.92 110.92 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 122.301 1.048 . . . . 2.25 111.938 -167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -73.13 -60.7 2.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.612 -0.722 . . . . 3.15 110.245 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -85.69 108.01 17.83 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.154 -1.424 . . . . 2.78 107.154 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.42 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -141.35 136.91 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.616 1.167 . . . . 3.96 108.7 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.6 116.28 5.48 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.388 -1.485 . . . . 0.87 109.388 176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -95.51 117.69 30.87 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.353 1.461 . . . . 1.08 107.633 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.58 158.39 44.48 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.09 0.556 . . . . 1.23 109.513 171.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -150.09 139.47 21.39 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.82 -1.086 . . . . 1.57 109.656 172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -156.09 157.34 35.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 124.74 1.275 . . . . 3.48 111.304 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 C-N-CA 126.464 1.906 . . . . 3.92 109.388 -162.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttm . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.461 -1.681 . . . . 47.51 106.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -148.15 157.18 43.35 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.413 -1.699 . . . . 41.86 106.413 170.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -166.35 165.83 16.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 126.1 1.76 . . . . 38.32 106.554 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.49 141.05 49.52 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.671 -1.233 . . . . 34.39 107.671 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 t -75.03 168.79 19.29 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.06 0.457 . . . . 30.32 110.413 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.25 177.35 4.78 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.107 -1.442 . . . . 27.38 107.107 159.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -142.04 156.74 45.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.799 1.239 . . . . 23.68 107.783 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.7 t -79.35 -175.57 4.76 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.914 -1.143 . . . . 20.64 107.914 161.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -68.04 0.44 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.823 0.449 . . . . 17.78 109.789 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -151.23 67.68 0.91 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.702 0.801 . . . . 14.08 109.729 -173.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 52.4 -116.39 1.03 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.715 0.806 . . . . 14.5 110.155 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.0 t -161.36 176.21 11.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.527 -2.027 . . . . 10.72 105.527 164.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -66.95 152.63 45.36 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.576 0.171 . . . . 6.28 110.588 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 173.18 -43.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.334 1.854 . . . . 12.07 108.842 -169.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.1 mt -126.83 99.27 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.74 1.216 . . . . 12.02 108.527 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -48.48 164.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.382 1.473 . . . . 17.48 112.74 172.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.52 -67.5 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.868 1.667 . . . . 14.8 110.615 -162.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.9 t -61.16 -83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.05 1.34 . . . . 10.14 111.123 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -68.08 -15.82 63.76 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 120.66 -1.275 . . . . 8.69 111.677 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -53.75 -56.11 20.39 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.38 -0.825 . . . . 14.79 109.239 161.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 t -54.51 -45.26 73.26 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.584 -0.895 . . . . 11.73 108.584 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -35.2 -66.02 0.38 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.924 1.25 . . . . 9.39 113.935 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -7.99 52.49 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.563 1.319 . . . . 12.14 114.563 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 65.3 mmm -93.34 137.86 32.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.087 0.858 . . . . 13.75 109.869 -171.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 74.2 t -141.35 -65.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 106.881 -1.525 . . . . 18.58 106.881 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.3 106.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.275 -1.009 . . . . 20.38 108.275 170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -52.05 -33.81 40.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.835 0.854 . . . . 22.03 112.636 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 61.44 61.0 1.58 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.931 0.892 . . . . 24.38 109.711 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -71.22 64.88 0.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.221 1.408 . . . . 22.65 111.816 -174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -111.17 -89.16 0.5 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.866 1.266 . . . . 24.7 108.272 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -67.43 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.065 -1.458 . . . . 22.49 107.065 -169.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.9 mt -143.59 123.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.865 -1.902 . . . . 16.34 105.865 171.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.03 -139.74 5.3 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.134 -1.187 . . . . 12.54 110.134 176.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -70.8 71.74 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.091 1.756 . . . . 10.38 110.141 176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -48.03 -67.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.181 0 C-N-CA 123.895 0.878 . . . . 9.62 109.734 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.3 159.59 22.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 122.116 -0.365 . . . . 3.68 110.386 -175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.57 -46.25 4.07 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.629 1.585 . . . . 2.71 109.25 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 52.36 -87.69 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.564 1.546 . . . . 4.6 111.916 -172.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -69.23 -43.92 73.08 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.728 -0.842 . . . . 4.37 108.728 -164.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 t -53.92 -45.56 71.22 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.128 0.489 . . . . 2.3 111.685 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 m -72.65 -55.74 6.39 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.479 -0.763 . . . . 2.41 111.065 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -46.24 -35.32 5.11 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.034 2.134 . . . . 3.49 112.115 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -42.97 -42.66 3.84 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 117.821 -1.085 . . . . 2.46 111.599 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.9 mttp 130.67 60.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 131.582 3.953 . . . . 5.39 109.218 168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.63 121.47 27.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 105.294 -2.113 . . . . 2.29 105.294 166.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.02 -169.98 0.64 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 123.962 3.108 . . . . 1.81 115.152 -156.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -57.17 -32.79 66.78 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.728 1.211 . . . . 5.67 114.099 -173.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.23 154.68 21.97 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 118.994 0.815 . . . . 2.69 112.507 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 125.9 150.26 7.62 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.916 1.722 . . . . 3.49 112.366 173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 137.61 40.5 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.671 0.789 . . . . 5.96 109.16 -174.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.25 175.06 9.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.323 0.582 . . . . 1.33 110.194 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.99 118.35 32.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.876 1.67 . . . . 1.65 107.997 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.455 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 17.8 p90 -158.55 177.0 11.69 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.724 0.693 . . . . 5.31 112.636 163.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -136.17 134.89 38.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.854 -1.906 . . . . 4.93 105.854 161.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.14 166.04 26.12 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 120.471 1.487 . . . . 0.92 114.374 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.4 p -114.79 111.18 20.84 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.457 1.503 . . . . 2.47 107.743 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.0 68.66 0.77 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.785 1.234 . . . . 1.07 109.121 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 141.58 37.7 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.7 1.6 . . . . 4.34 108.945 173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.6 169.8 54.84 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.953 -1.659 . . . . 1.1 108.953 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.6 t -45.77 -39.88 8.82 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.682 0.793 . . . . 1.64 110.937 169.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.13 2.01 19.39 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.987 1.315 . . . . 2.82 113.203 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 43.4 t0 48.92 52.47 14.18 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 123.658 1.694 . . . . 3.66 110.186 -162.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.12 75.14 1.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.312 -2.107 . . . . 1.22 105.312 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.88 178.18 32.57 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 106.378 -2.689 . . . . 0.96 106.378 -178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -120.13 -178.77 16.33 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.948 1.737 . . . . 0.98 110.705 -165.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 133.19 34.6 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.936 -1.135 . . . . 3.41 107.936 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.7 tp -80.15 125.01 29.28 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.89 -0.781 . . . . 0.98 108.89 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 150.31 23.75 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.284 1.034 . . . . 2.12 111.584 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.8 p90 -75.98 99.25 4.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.053 1.741 . . . . 2.04 112.54 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -147.04 82.08 1.55 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.69 0.757 . . . . 1.43 110.43 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.571 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -133.61 102.08 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 105.123 -2.177 . . . . 2.23 105.123 167.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.31 121.78 25.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.616 -0.883 . . . . 3.35 108.616 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -48.92 -24.41 1.47 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.209 1.003 . . . . 2.79 113.482 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.86 -31.87 41.71 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.191 0.812 . . . . 2.03 113.191 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.45 2.61 0.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.191 1.552 . . . . 1.54 115.191 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HG3' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 56.53 67.2 1.03 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.656 1.182 . . . . 5.11 113.121 174.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.8 mp0 -71.92 -59.52 2.7 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.081 -1.012 . . . . 4.12 109.454 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . 76.56 51.88 6.31 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 110.73 -0.948 . . . . 1.65 110.73 171.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -137.95 89.22 2.38 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.96 -0.755 . . . . 2.57 108.96 -169.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -85.06 139.93 18.08 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.553 -1.419 . . . . 0.79 109.553 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -79.76 135.28 36.47 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.437 -1.32 . . . . 5.36 107.437 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.6 59.76 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 122.644 1.211 . . . . 2.67 110.087 -169.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -81.5 113.32 19.47 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.561 -0.745 . . . . 3.42 109.508 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -156.05 -16.11 0.1 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 116.445 2.017 . . . . 3.58 116.445 168.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.32 151.41 24.88 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.347 1.43 . . . . 1.6 112.68 -152.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -36.09 68.21 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.479 1.111 . . . . 5.23 111.166 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 m -86.31 111.86 41.89 Favored Pre-proline 0 N--CA 1.449 -0.512 0 N-CA-C 106.95 -1.5 . . . . 1.89 106.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -56.85 -38.54 95.61 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.335 2.023 . . . . 1.56 111.93 -168.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -30.17 68.55 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.632 -0.668 . . . . 3.8 111.694 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.35 -9.52 58.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.925 0.49 . . . . 1.78 110.613 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.433 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -75.29 69.24 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.36 -1.348 . . . . 1.78 107.36 173.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.33 149.8 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.633 1.173 . . . . 1.2 111.109 -168.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.21 154.61 24.16 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.463 -0.939 . . . . 2.56 108.463 162.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 123' ' ' TYR . 77.1 mt -116.12 127.97 55.27 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.945 2.098 . . . . 1.8 106.427 175.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.48 151.35 34.68 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.478 -0.764 . . . . 1.03 109.622 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.4 93.51 4.09 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.213 0.53 . . . . 1.27 109.848 -171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.59 176.4 9.05 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.646 1.978 . . . . 1.44 111.745 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.93 172.49 6.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.294 1.837 . . . . 4.57 109.597 169.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.4 tt -127.08 89.23 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.223 -1.028 . . . . 1.41 108.223 150.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -32.66 147.23 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.942 1.697 . . . . 8.33 111.901 157.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.09 84.25 1.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.458 2.106 . . . . 4.44 110.792 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.45 22.23 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.996 1.719 . . . . 4.41 114.674 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 47.65 47.3 23.99 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.963 1.268 . . . . 3.07 111.391 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.85 143.75 0.75 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 106.366 -1.716 . . . . 4.73 106.366 -172.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 38.6 mtm105 -57.53 75.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.323 1.849 . . . . 6.04 110.8 174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 60.78 84.15 0.13 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.254 1.422 . . . . 5.53 111.079 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.6 -86.87 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 118.593 -1.243 . . . . 2.53 108.032 159.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.81 144.5 20.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 N-CA-C 116.135 1.902 . . . . 1.17 116.135 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.4 mt -89.74 130.57 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.103 2.561 . . . . 2.69 106.487 168.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.2 p -116.3 103.79 10.84 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.966 1.306 . . . . 2.24 108.485 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.68 155.72 16.0 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 118.582 0.628 . . . . 0.69 113.74 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.6 m -79.86 167.09 21.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.732 0.813 . . . . 1.5 109.049 161.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG21 HG22 ' A' ' 141' ' ' VAL . 3.3 m -146.64 165.33 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.462 1.105 . . . . 1.21 108.187 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.87 121.66 14.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.018 0.927 . . . . 2.46 109.571 -167.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -83.55 57.33 4.0 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.793 2.037 . . . . 4.75 107.736 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.7 t30 58.31 -46.11 0.05 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.932 2.493 . . . . 3.63 115.08 -170.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -14.55 8.63 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.009 1.324 . . . . 2.88 114.289 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.27 123.26 26.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.885 1.22 . . . . 1.2 111.816 -169.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -87.99 87.94 7.49 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.768 -0.827 . . . . 3.27 108.768 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -136.64 77.24 1.64 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 123.221 1.486 . . . . 3.24 109.134 157.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.71 177.09 34.65 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 107.452 -2.259 . . . . 1.21 107.452 172.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 97.5 p -152.31 162.98 40.38 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.432 1.093 . . . . 0.93 108.163 174.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 94' ' ' LEU . 11.1 t80 -146.79 139.32 24.99 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.578 0.626 . . . . 3.03 110.246 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.0 t -124.55 114.36 19.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.655 -2.35 . . . . 1.88 104.655 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -125.24 139.53 53.64 Favored 'General case' 0 C--O 1.225 -0.223 0 O-C-N 123.458 0.474 . . . . 1.14 109.971 -176.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -133.46 147.11 18.9 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 108.509 -1.837 . . . . 1.27 108.509 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.77 144.36 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.589 0.756 . . . . 3.82 109.859 -173.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.89 90.84 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.861 -1.533 . . . . 6.0 106.861 161.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.96 77.97 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.981 1.753 . . . . 3.57 110.24 171.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -155.11 -56.99 0.01 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 107.742 -2.143 . . . . 2.55 107.742 175.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -153.05 30.66 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.235 0.828 . . . . 4.38 113.235 164.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.93 30.79 18.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.286 1.034 . . . . 2.37 110.319 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.77 -39.6 87.92 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 126.167 1.787 . . . . 2.53 111.158 -170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -129.26 155.77 45.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 105.49 -2.041 . . . . 3.03 105.49 164.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.78 153.33 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 104.124 -2.547 . . . . 1.37 104.124 162.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.75 129.76 49.01 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.015 -1.846 . . . . 0.91 106.015 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -144.68 162.86 28.01 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.76 -0.733 . . . . 1.04 112.575 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 63.7 m -147.44 114.32 6.11 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.329 -1.36 . . . . 1.62 107.329 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.38 10.81 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.162 0.506 . . . . 0.74 111.973 171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -134.7 147.58 50.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.367 1.067 . . . . 3.52 109.311 160.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 113' ' ' VAL . 38.4 t -142.42 71.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 106.086 -1.82 . . . . 2.48 106.086 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 119.76 24.01 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.732 -0.605 . . . . 3.61 109.684 -169.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.3 p -138.83 -173.83 3.67 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.738 -1.208 . . . . 2.18 107.738 166.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.11 -31.56 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.261 0.624 . . . . 2.71 110.251 167.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -140.14 56.27 1.62 Allowed 'General case' 0 C--N 1.343 0.304 0 N-CA-C 108.146 -1.057 . . . . 3.86 108.146 176.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.17 131.13 5.84 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 108.742 -1.743 . . . . 1.29 108.742 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.1 OUTLIER -77.5 135.81 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 124.997 1.319 . . . . 2.22 109.109 -173.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 mtp-105 -76.02 -114.41 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.22 -1.03 . . . . 3.13 108.22 163.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 36.7 m170 -45.59 99.22 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.511 0.93 . . . . 2.47 113.511 -164.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.0 mt -97.3 79.88 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 105.462 -2.051 . . . . 1.45 105.462 163.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.93 114.01 3.8 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.153 -2.379 . . . . 1.78 107.153 176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 152' ' ' LEU . 3.4 pp -127.16 161.62 28.06 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.657 0.729 . . . . 2.12 112.235 -166.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.66 155.59 43.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.603 1.161 . . . . 1.42 108.84 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -123.1 169.72 10.92 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.473 0.709 . . . . 1.03 112.343 170.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -145.08 139.59 27.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.468 1.907 . . . . 3.21 109.947 172.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 117.191 -1.385 . . . . 4.67 108.727 142.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.985 -0.746 . . . . 59.17 108.985 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -162.15 156.46 21.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.225 -1.028 . . . . 51.31 108.225 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p -86.8 -174.53 5.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.545 1.538 . . . . 47.09 110.504 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -154.68 -175.03 5.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.19 1.796 . . . . 43.23 106.307 170.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 t -158.86 -165.97 1.76 Allowed 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.954 -0.758 . . . . 37.76 108.954 177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.69 176.19 13.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.552 1.541 . . . . 33.36 109.117 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.85 157.47 31.05 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.15 1.38 . . . . 28.7 109.546 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 36.0 p -97.12 163.02 13.1 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.824 1.249 . . . . 25.21 111.31 -176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.5 171.49 11.04 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.731 0.812 . . . . 21.38 109.372 165.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.52 150.04 34.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.349 1.06 . . . . 16.95 109.736 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -94.35 -134.3 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.631 1.172 . . . . 16.42 108.844 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 p 70.63 -178.8 0.22 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.104 1.362 . . . . 9.82 110.495 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -71.69 73.59 0.8 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.346 0.594 . . . . 6.34 110.087 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -54.66 147.37 14.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.379 1.471 . . . . 12.77 109.979 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 mm 58.39 42.92 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 122.972 1.368 . . . . 12.79 110.01 -165.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.13 172.8 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.354 1.861 . . . . 13.07 111.529 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.42 -53.13 0.49 Allowed 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 127.245 2.218 . . . . 13.48 113.543 174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.8 t -74.5 -96.46 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 119.063 0.847 . . . . 12.6 110.927 163.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.54 -65.79 0.78 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.246 1.018 . . . . 11.96 112.866 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -70.93 -1.7 12.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.992 1.317 . . . . 11.93 113.608 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -28.28 -37.76 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 127.677 2.391 . . . . 11.41 115.735 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -28.52 -48.05 0.08 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.723 2.106 . . . . 9.7 115.247 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -55.28 -52.35 63.71 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.548 1.674 . . . . 11.1 112.482 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 97.4 mmm -146.0 70.88 1.24 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.902 1.281 . . . . 12.91 109.281 -166.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.86 -79.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.184 -1.413 . . . . 15.72 107.184 167.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.77 140.72 38.21 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.302 -0.999 . . . . 18.18 108.302 173.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -81.46 70.64 8.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.984 -1.117 . . . . 17.97 107.984 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 47' ' ' GLU . 36.8 mmt180 -36.67 -64.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.18 2.192 . . . . 22.21 113.391 -166.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -160.66 125.7 3.78 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.973 -0.751 . . . . 23.49 108.973 173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 59.92 -177.92 0.1 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.341 1.457 . . . . 22.48 111.631 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -78.02 56.25 1.58 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.425 -0.954 . . . . 16.19 108.425 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 54.9 mt -138.23 -88.82 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 107.787 -1.19 . . . . 14.86 107.787 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.06 -71.09 0.13 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-O 119.733 -0.482 . . . . 11.17 112.06 -168.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 1.6 p-10 -152.3 159.9 43.42 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.484 1.914 . . . . 8.87 107.733 -173.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.6 mm -69.09 -77.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.433 1.015 . . . . 9.99 110.557 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.14 -80.18 0.31 Allowed 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.26 0.482 . . . . 3.81 111.909 -165.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.16 -70.36 1.03 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.865 -0.894 . . . . 2.57 110.865 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 45.63 -80.98 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 128.539 2.736 . . . . 4.7 112.834 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 104' ' ' LYS . 25.8 m80 -52.04 -42.15 62.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.859 2.064 . . . . 4.83 110.936 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.3 t -55.28 -57.54 11.4 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.765 0.317 . . . . 2.85 110.877 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -57.95 -55.15 38.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.548 1.139 . . . . 1.82 109.064 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -49.72 -39.4 37.03 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.719 1.608 . . . . 3.13 112.589 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -55.64 -25.98 42.05 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.685 -0.674 . . . . 2.8 112.38 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.0 mttm 124.13 57.31 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 130.134 3.374 . . . . 4.94 108.399 166.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.3 mt -123.33 147.43 52.3 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 114.439 -1.255 . . . . 2.16 109.735 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.24 -179.5 2.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 125.079 3.853 . . . . 2.0 113.41 -174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 28' ' ' ARG . 19.6 tt0 -54.24 -54.94 33.23 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.846 0.858 . . . . 5.98 110.905 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -172.85 -172.84 38.87 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.152 -1.023 . . . . 2.16 112.127 -163.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.14 -108.54 3.46 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 125.151 1.358 . . . . 1.71 111.306 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.38 121.54 6.68 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.859 -0.789 . . . . 4.91 111.405 -164.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.53 159.71 24.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.93 -0.396 . . . . 1.71 109.93 161.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -79.01 64.46 3.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 122.549 1.166 . . . . 2.05 110.632 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.43 59.74 2.44 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.824 -1.173 . . . . 3.37 108.323 173.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -88.36 101.02 13.47 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.065 -1.458 . . . . 4.41 107.065 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.48 -159.82 9.57 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 118.456 -1.83 . . . . 0.78 114.88 -167.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t -146.0 149.6 34.44 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.49 1.116 . . . . 3.11 109.144 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -124.32 75.59 1.4 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.029 2.132 . . . . 1.06 105.896 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -84.86 122.96 29.91 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.737 -0.468 . . . . 3.0 109.737 -170.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.04 155.6 44.59 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 107.555 -2.218 . . . . 1.74 107.555 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.4 m -57.1 -25.04 58.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.163 0.982 . . . . 2.25 112.315 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.41 -11.54 59.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.535 0.734 . . . . 4.17 112.848 174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 45.16 42.39 6.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-O 124.006 1.86 . . . . 3.28 109.932 -156.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.2 66.85 8.63 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 103.482 -2.785 . . . . 2.2 103.482 143.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.67 152.8 17.74 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 109.174 -1.57 . . . . 1.26 109.174 -165.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.823 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -112.19 174.16 16.07 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 122.3 0.944 . . . . 0.92 112.734 -173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.6 mtmt -90.66 156.42 18.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.267 -1.753 . . . . 3.8 106.267 164.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.5 tp -107.3 119.17 38.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.566 -2.013 . . . . 0.98 105.566 164.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 p -86.48 141.59 28.98 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.083 1.353 . . . . 2.3 108.993 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -79.25 95.58 5.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 2.07 111.657 -168.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -151.25 98.12 2.51 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.15 -0.969 . . . . 1.34 112.105 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.84 116.64 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.638 1.575 . . . . 1.66 109.987 169.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -88.84 93.38 9.57 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.082 0.944 . . . . 3.23 108.511 169.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -29.02 -56.3 0.13 Allowed 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 129.046 2.938 . . . . 2.23 116.722 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -29.66 -50.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.016 2.126 . . . . 1.7 112.202 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB3' ' NE2' ' A' ' 77' ' ' GLN . . . -117.03 -22.41 8.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 114.449 -1.25 . . . . 1.14 112.749 174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 109' ' ' ILE . 1.6 tmtt? 69.88 66.58 0.23 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.192 1.797 . . . . 5.49 111.72 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.8 OUTLIER -81.3 64.39 6.01 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.528 -2.027 . . . . 2.7 105.528 170.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -83.45 96.34 1.93 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.662 -1.375 . . . . 1.31 109.662 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -142.9 165.94 26.01 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.221 -2.14 . . . . 3.0 105.221 -165.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.17 175.78 33.79 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.02 -1.232 . . . . 1.75 110.02 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -113.27 114.14 26.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 122.087 0.946 . . . . 4.78 112.841 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.823 HG23 ' HA3' ' A' ' 65' ' ' GLY . 77.3 mt -79.06 76.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 127.021 2.128 . . . . 1.83 106.895 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -123.6 91.92 3.58 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.045 0.938 . . . . 2.37 112.19 -172.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -158.35 -10.37 0.07 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 117.004 2.224 . . . . 4.28 117.004 157.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 mp -58.56 -113.12 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 115.143 1.534 . . . . 3.99 115.143 -123.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -31.56 6.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.004 1.322 . . . . 5.04 110.05 163.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.23 150.62 75.98 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.259 -1.015 . . . . 1.76 108.259 -175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -57.34 -50.52 10.77 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.156 2.571 . . . . 1.7 111.917 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -53.3 -34.65 58.22 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.033 1.733 . . . . 3.59 111.39 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -26.89 68.87 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 113.263 0.838 . . . . 2.19 113.263 -178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -71.58 133.99 46.12 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.252 0.933 . . . . 2.51 108.865 -168.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 t -116.33 141.17 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.844 0.858 . . . . 0.92 109.451 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -108.0 134.25 51.17 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 2.66 106.84 164.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.8 mt -90.51 126.23 35.85 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.183 -1.043 . . . . 1.81 108.183 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.65 164.72 23.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.27 0.557 . . . . 1.1 110.761 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.1 152.47 30.79 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.055 1.342 . . . . 2.01 112.903 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.46 129.91 8.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.197 1.399 . . . . 1.45 107.45 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.0 129.29 34.95 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.913 -1.884 . . . . 4.56 105.913 173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . 0.251 1.0 OUTLIER -79.69 154.42 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 119.725 1.148 . . . . 2.05 111.377 -174.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -168.23 -68.58 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.229 0 C-N-CA 126.887 2.075 . . . . 7.27 110.561 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -52.69 117.91 4.17 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.701 2.267 . . . . 5.13 112.128 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 t70 57.04 19.4 4.65 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.348 1.859 . . . . 6.23 114.407 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -48.83 -56.5 9.81 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.876 1.227 . . . . 4.38 112.131 -173.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' H ' ' CD2' ' A' ' 39' ' ' HIS . 3.4 ttmp? 73.98 -67.25 0.27 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.443 1.897 . . . . 4.59 110.92 163.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 35.1 mtm105 -145.72 81.21 1.6 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.093 -1.447 . . . . 5.65 107.093 155.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 55.24 53.79 9.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.36 0.664 . . . . 6.18 111.453 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.09 -62.88 1.41 Allowed 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 122.121 -0.362 . . . . 2.28 110.848 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.2 m -163.29 167.38 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.742 0.817 . . . . 1.43 110.617 -171.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -96.59 175.53 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.58 -1.267 . . . . 3.03 107.58 150.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.3 t -143.76 79.48 1.63 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.71 0.686 . . . . 1.58 109.245 166.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -97.39 168.91 24.46 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-O 121.519 0.51 . . . . 0.81 112.785 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -86.36 169.61 12.77 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.877 1.671 . . . . 1.48 109.577 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -145.53 163.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 119.4 1.0 . . . . 0.76 108.511 170.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -130.06 139.3 51.0 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 114.218 1.192 . . . . 2.23 114.218 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -78.36 79.35 4.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 126.694 1.997 . . . . 5.21 105.9 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.42 -62.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.708 2.403 . . . . 3.05 113.668 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -108.39 -39.42 5.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.567 1.947 . . . . 2.66 110.672 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -90.05 104.7 17.25 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.63 -0.669 . . . . 1.39 111.656 -165.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -78.24 72.79 4.79 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.013 -0.429 . . . . 3.32 109.945 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -128.78 67.68 1.4 Allowed 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 123.152 1.453 . . . . 3.06 107.77 167.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.43 162.24 32.25 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 112.913 -1.949 . . . . 0.6 110.461 165.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.7 p -154.06 165.36 36.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.221 1.008 . . . . 0.9 108.844 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -155.44 164.55 38.55 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.693 -0.403 . . . . 3.73 111.554 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.0 p -137.75 115.99 11.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.278 -1.749 . . . . 1.6 106.278 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.576 ' C ' HD13 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -146.42 133.6 20.5 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.802 0.811 . . . . 0.98 112.933 -170.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.6 161.48 23.31 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 125.875 1.702 . . . . 1.08 110.768 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.58 161.64 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 106.811 -1.551 . . . . 3.32 106.811 167.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.47 170.16 18.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.124 0.874 . . . . 5.69 111.44 155.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.8 10.8 48.79 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 115.178 -0.919 . . . . 2.79 112.827 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.78 -67.0 3.82 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.076 0.846 . . . . 2.67 111.168 160.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -71.06 -15.51 62.54 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.775 -0.25 . . . . 4.11 111.603 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 96.49 110.37 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 130.36 3.464 . . . . 2.33 105.361 -170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -120.9 -75.25 0.59 Allowed 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.709 -1.219 . . . . 2.91 107.709 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -134.19 135.97 43.4 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.076 -1.453 . . . . 3.2 107.076 -174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 154' ' ' ALA . 3.4 m -87.41 151.6 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.899 -0.778 . . . . 1.79 108.899 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -133.87 120.55 20.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.065 -1.458 . . . . 1.25 107.065 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.18 177.73 34.75 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.293 -0.723 . . . . 0.86 111.293 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.5 m -146.35 131.49 18.36 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.57 -1.27 . . . . 1.65 107.57 164.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.71 153.51 19.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.213 1.005 . . . . 0.83 109.302 164.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -133.0 131.39 40.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.503 0.502 . . . . 2.56 110.284 155.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.7 t -110.14 147.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.076 -1.824 . . . . 2.24 106.076 168.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -144.41 110.61 5.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.695 -1.224 . . . . 3.35 107.695 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.4 m -147.56 176.08 10.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.068 -2.197 . . . . 2.85 105.068 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.2 t -39.77 -29.12 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.073 1.349 . . . . 2.4 111.838 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -153.98 56.54 0.72 Allowed 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 107.337 -1.357 . . . . 2.68 107.337 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.72 124.18 7.28 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 108.347 -1.901 . . . . 1.34 108.347 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.75 116.39 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 124.28 1.032 . . . . 2.07 111.582 -170.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 -78.99 -59.47 2.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.158 0.504 . . . . 2.45 111.025 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 65.9 m170 -77.74 84.7 4.07 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.183 -0.673 . . . . 2.65 109.183 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 66.7 mt -102.93 120.51 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.938 1.695 . . . . 1.56 110.055 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.58 110.84 3.28 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.379 -1.488 . . . . 1.03 109.379 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 125' ' ' LEU . 1.2 tm? -99.67 122.06 42.14 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.894 1.278 . . . . 1.03 108.597 178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.34 161.04 41.79 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.051 0.54 . . . . 1.05 109.571 173.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.446 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -147.24 155.95 42.52 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.226 1.01 . . . . 1.02 109.635 175.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 tptt -155.65 59.87 0.61 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 124.504 1.128 . . . . 3.17 113.774 -173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 . . . . . 0 C--O 1.252 1.225 0 N-CA-C 117.157 2.28 . . . . 4.9 117.157 155.708 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.511 -1.663 . . . . 52.65 106.511 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -173.22 170.04 4.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.891 -1.522 . . . . 45.46 106.891 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -66.6 160.0 26.29 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.479 0.712 . . . . 41.65 109.811 169.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -148.81 171.4 16.32 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.738 -1.579 . . . . 38.73 106.738 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m 120.79 88.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 129.655 3.182 . . . . 33.25 109.66 178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.47 33.64 1.66 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.564 0.745 . . . . 29.69 110.636 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.87 142.26 33.79 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.019 0.528 . . . . 26.4 109.599 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -176.28 -162.86 0.09 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.109 1.764 . . . . 22.85 106.755 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 86.11 114.72 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 128.22 2.608 . . . . 19.57 111.82 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -163.18 167.51 22.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.842 -1.54 . . . . 16.16 106.842 172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.6 152.52 18.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.24 1.016 . . . . 13.85 109.511 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.44 -162.1 0.86 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.9 -1.518 . . . . 9.54 106.9 162.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -13.83 61.73 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.867 3.667 . . . . 6.87 118.282 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 71.0 146.8 0.07 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 127.677 2.391 . . . . 14.0 113.349 167.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.3 mt 73.8 162.81 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.032 1.733 . . . . 14.33 109.071 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -74.45 -105.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.026 -1.101 . . . . 17.02 108.026 169.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.87 -49.44 15.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.855 1.662 . . . . 16.95 112.582 -171.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 t -62.16 -13.55 28.37 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.128 -0.939 . . . . 14.12 113.36 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -53.24 -33.75 54.28 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 119.767 1.167 . . . . 9.78 110.831 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -66.49 -25.64 66.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.777 0.431 . . . . 14.0 111.415 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -72.5 -59.02 2.93 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.806 -1.183 . . . . 14.1 107.806 160.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -38.13 -60.98 1.25 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 126.624 2.059 . . . . 9.04 114.434 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -70.2 -6.6 35.61 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 114.769 1.396 . . . . 10.51 114.769 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 63.2 mtm 113.2 137.44 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 129.521 3.128 . . . . 11.61 106.659 -162.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 41.2 t -55.02 -39.52 50.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 125.801 1.64 . . . . 16.52 111.839 -170.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.69 172.31 5.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.868 0.842 . . . . 17.0 112.806 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -126.03 139.48 53.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.28 -1.748 . . . . 18.55 106.28 174.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 78.77 146.78 0.09 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.263 1.825 . . . . 22.94 109.343 -163.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -160.89 159.21 29.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.805 -1.554 . . . . 17.09 106.805 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -70.06 -57.11 5.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.569 0.348 . . . . 22.39 110.606 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -173.52 -56.98 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 125.028 1.331 . . . . 17.75 108.109 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.2 mt 62.75 -94.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.983 1.313 . . . . 14.29 109.396 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.36 -158.93 31.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.833 -2.107 . . . . 9.38 107.833 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -71.8 -23.57 61.59 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.242 1.417 . . . . 8.38 110.034 169.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.2 mt -62.69 76.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.533 1.533 . . . . 8.93 108.68 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.07 -11.01 56.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.228 1.011 . . . . 5.03 110.818 169.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.34 28.1 66.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.133 0.873 . . . . 2.07 112.346 -176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 6.46 -104.16 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.374 3.07 . . . . 4.82 115.732 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.23 -40.54 71.0 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.405 -0.809 . . . . 4.4 108.921 -166.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.3 m -60.88 -38.14 84.62 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.523 -0.308 . . . . 3.56 111.013 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -69.36 -53.87 17.32 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.688 -0.632 . . . . 2.17 110.975 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -42.46 -42.66 3.36 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.757 2.023 . . . . 3.95 110.802 177.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -39.12 -56.41 1.46 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 116.565 -1.684 . . . . 3.36 109.951 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 mttp 152.68 74.32 0.0 OUTLIER 'General case' 0 C--N 1.344 0.364 0 C-N-CA 129.072 2.949 . . . . 5.79 108.587 159.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -117.79 149.25 44.86 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-O 119.354 -0.355 . . . . 2.64 110.911 168.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.11 -166.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 126.56 4.84 . . . . 1.91 115.24 172.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -38.77 24.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.448 1.499 . . . . 5.83 111.623 -172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.67 167.27 39.06 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.464 -0.772 . . . . 2.71 112.284 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.86 -116.29 2.44 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 117.725 0.763 . . . . 1.6 112.117 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 113.97 3.29 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 120.501 -1.587 . . . . 4.99 109.17 -164.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.84 147.79 38.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.915 -1.142 . . . . 1.8 107.915 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 129.95 35.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.543 -0.54 . . . . 1.49 109.543 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.723 ' CZ ' HG13 ' A' ' 135' ' ' VAL . 74.6 m-85 -148.34 169.71 19.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.42 1.088 . . . . 5.02 110.027 162.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -136.48 151.51 49.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.591 -2.744 . . . . 4.77 103.591 141.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.11 -171.34 31.23 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 119.19 -1.481 . . . . 0.99 111.334 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -141.74 157.86 44.52 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.466 0.65 . . . . 3.52 109.784 174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 152' ' ' LEU . . . -119.26 82.86 1.94 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.584 -2.376 . . . . 0.94 104.584 171.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -79.19 139.99 37.82 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 108.537 -0.912 . . . . 2.05 108.537 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.39 163.0 52.68 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 109.716 -1.354 . . . . 1.16 109.716 -166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -53.05 -27.53 20.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.507 0.323 . . . . 2.55 111.227 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -120.92 26.44 9.06 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.193 1.797 . . . . 3.38 110.302 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.455 23.7 t0 13.27 71.68 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 118.689 2.848 . . . . 2.99 118.689 -150.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.51 56.01 0.65 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.769 -1.567 . . . . 1.1 106.769 146.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 -179.2 35.33 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.499 1.523 . . . . 1.22 109.85 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.54 177.31 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.931 -0.746 . . . . 0.96 111.762 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -78.34 166.55 22.53 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.476 0.71 . . . . 3.43 112.128 -166.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 152' ' ' LEU . 6.7 tp -116.7 111.64 20.09 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.716 1.206 . . . . 1.32 108.419 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.1 p -79.34 148.95 31.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.984 -0.747 . . . . 2.28 108.984 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -77.1 118.7 19.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.552 0.691 . . . . 2.45 109.491 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.2 m -154.48 95.61 1.82 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.689 -1.597 . . . . 1.23 106.689 174.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -140.93 113.25 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.41 -1.7 . . . . 2.04 106.41 163.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.73 133.72 35.38 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.691 -1.226 . . . . 3.25 107.691 169.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -58.75 -34.72 71.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.488 0.715 . . . . 3.75 112.521 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -39.46 -55.2 1.83 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.502 1.521 . . . . 1.78 112.31 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' H ' HE22 ' A' ' 77' ' ' GLN . . . -135.85 -1.98 2.41 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 114.012 1.115 . . . . 1.68 114.012 -170.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.18 50.97 12.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.944 1.354 . . . . 5.59 112.072 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.524 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 0.3 OUTLIER -71.51 66.07 0.48 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.319 2.248 . . . . 2.02 107.785 168.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 94.18 0.59 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 124.779 1.18 . . . . 1.6 110.433 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -135.4 153.82 51.68 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.964 -0.754 . . . . 2.88 108.964 -172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.527 ' O ' HD12 ' A' ' 94' ' ' LEU . . . -156.52 122.21 1.16 Allowed Glycine 0 C--O 1.221 -0.717 0 N-CA-C 111.197 -0.761 . . . . 1.45 111.197 172.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 131.62 37.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.404 1.081 . . . . 6.14 111.424 -165.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 82' ' ' ILE . 13.7 mt -84.04 56.42 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.82 1.648 . . . . 1.88 109.18 -171.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -90.8 94.65 9.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 120.463 -1.398 . . . . 2.54 108.658 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -143.29 -13.18 0.7 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 114.228 1.195 . . . . 3.57 114.228 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.3 mp -115.31 144.29 43.98 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.654 1.116 . . . . 1.8 111.926 -155.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.69 63.18 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.524 1.13 . . . . 3.87 113.476 -177.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.1 m -98.05 114.72 65.46 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 106.874 -1.528 . . . . 1.41 106.874 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.08 -35.88 95.48 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.548 2.166 . . . . 1.57 111.789 -170.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 89' ' ' GLU . 11.1 mp0 -46.92 -44.35 19.75 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 125.385 1.474 . . . . 4.12 111.039 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.02 -12.68 60.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 118.722 -0.656 . . . . 2.04 111.125 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -72.6 68.93 0.85 Allowed 'General case' 0 C--N 1.342 0.265 0 CA-C-N 119.618 1.099 . . . . 2.25 108.616 174.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.9 t -64.35 131.29 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 123.849 0.86 . . . . 1.14 108.887 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -86.92 147.34 25.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.746 -0.835 . . . . 2.95 108.746 161.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 80' ' ' GLY . 8.1 mt -109.6 110.67 21.8 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.589 1.956 . . . . 2.42 106.433 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 162.64 25.26 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.021 0.439 . . . . 1.53 111.028 -164.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.38 144.1 36.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.206 1.002 . . . . 1.73 111.385 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -156.13 132.11 9.85 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.144 0.977 . . . . 1.09 108.735 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.09 146.63 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.701 1.2 . . . . 3.84 109.738 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.97 102.49 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 124.106 0.962 . . . . 2.04 108.487 172.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -122.37 -18.35 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 115.173 1.546 . . . . 8.02 115.173 164.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 17.5 Cg_endo -90.2 36.93 0.34 Allowed 'Trans proline' 0 C--N 1.354 0.859 0 CA-C-N 123.288 2.21 . . . . 3.39 109.555 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.7 126.0 25.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 6.65 111.615 -174.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.0 76.85 1.19 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-O 119.176 -0.791 . . . . 3.17 112.443 -173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt 75.91 103.04 0.07 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 5.91 111.186 165.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.566 ' HB3' HH11 ' A' ' 105' ' ' ARG . 0.0 OUTLIER 62.3 -73.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.024 1.33 . . . . 6.3 108.24 -163.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 59.2 t60 -166.35 157.99 13.47 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 109.147 -0.686 . . . . 4.97 109.147 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.81 -78.2 0.47 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.565 -0.902 . . . . 2.73 108.565 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -158.48 144.56 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 123.159 0.584 . . . . 1.36 110.974 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mt -77.95 169.97 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 126.637 1.975 . . . . 2.5 107.13 163.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 m -146.69 64.29 1.19 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.961 -1.087 . . . . 2.24 111.93 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.96 175.43 46.69 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 121.642 0.579 . . . . 0.65 113.81 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 m -98.18 166.23 11.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.976 2.11 . . . . 1.43 109.427 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG12 HD23 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -127.91 152.18 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.652 0.66 . . . . 0.94 109.404 168.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.87 117.73 24.76 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 124.837 1.255 . . . . 1.92 109.313 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -77.7 73.71 4.27 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 126.249 1.82 . . . . 4.85 106.688 173.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 64.08 -62.7 0.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.491 2.317 . . . . 2.8 113.407 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -104.59 -27.67 11.72 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.374 1.47 . . . . 2.47 111.517 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -127.31 123.47 36.46 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.656 0.662 . . . . 1.19 112.448 -157.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.49 115.73 20.16 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.477 -0.935 . . . . 3.85 108.477 166.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 120' ' ' LYS . 3.5 mmpt? -149.08 75.73 1.3 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 122.876 1.322 . . . . 3.5 110.603 135.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.09 160.82 30.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.861 -1.295 . . . . 0.53 109.861 159.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 71.5 p -142.53 165.64 26.85 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.958 -1.127 . . . . 1.0 107.958 174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -151.24 160.28 43.91 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 118.774 0.715 . . . . 3.57 112.827 -175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.1 p -132.75 101.47 5.29 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 105.264 -2.124 . . . . 2.12 105.264 -172.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 152' ' ' LEU . 2.3 tm? -121.78 133.35 54.91 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.164 0.985 . . . . 0.77 109.113 -174.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -120.44 135.66 11.05 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 125.289 1.423 . . . . 1.15 110.094 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -91.83 135.26 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.889 1.676 . . . . 2.07 108.675 -179.061 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -69.18 95.78 0.78 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.964 -0.754 . . . . 5.73 108.964 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.71 70.54 0.27 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.229 1.395 . . . . 3.71 111.801 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.25 -66.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 107.033 -2.427 . . . . 2.39 107.033 170.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -158.65 51.87 0.4 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.75 0.785 . . . . 3.55 109.715 165.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 60.69 47.24 8.34 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.03 1.332 . . . . 1.4 110.764 166.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -76.27 -54.49 6.7 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.594 1.158 . . . . 3.1 109.925 -168.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 155' ' ' LYS . 33.3 mt-10 -146.9 104.69 3.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.38 1.072 . . . . 2.99 108.581 -170.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 53' ' ' TYR . 27.1 m -75.03 141.34 16.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 118.612 -1.235 . . . . 1.3 107.768 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.39 131.7 36.63 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 107.94 -1.133 . . . . 1.24 107.94 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.06 177.81 35.47 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-O 121.847 0.693 . . . . 0.87 113.51 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.0 p -132.49 128.17 36.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.875 -1.157 . . . . 2.19 107.875 167.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.06 139.35 34.84 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 118.368 0.531 . . . . 0.69 109.7 160.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -105.41 111.99 24.92 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 124.853 1.261 . . . . 4.11 108.193 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.3 t -126.7 111.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.755 1.285 . . . . 1.99 109.356 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.47 130.72 55.38 Favored 'General case' 0 C--O 1.228 -0.075 0 N-CA-C 109.399 -0.593 . . . . 3.59 109.399 -178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 t -170.86 -172.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.382 -1.71 . . . . 2.78 106.382 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t -48.23 -35.11 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.129 1.372 . . . . 1.87 110.217 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -137.98 55.18 1.78 Allowed 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.739 -1.208 . . . . 2.5 107.739 166.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.7 3.13 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 106.647 -2.581 . . . . 1.13 106.647 172.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.18 114.76 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.263 -1.384 . . . . 1.61 107.263 175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -51.91 -83.6 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.204 0.602 . . . . 2.8 111.607 -166.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -76.59 83.48 3.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.011 0.524 . . . . 3.19 110.188 -169.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.9 mt -79.67 113.87 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.706 -1.22 . . . . 1.37 107.706 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.76 117.65 4.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.627 -1.389 . . . . 0.82 109.627 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -101.71 119.51 38.89 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.151 1.38 . . . . 1.14 107.91 -171.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.8 137.73 22.73 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.912 0.778 . . . . 1.02 110.716 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.57 172.19 11.83 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 124.143 0.977 . . . . 0.94 113.154 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 134' ' ' GLU . 59.3 mttm -144.24 150.07 37.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 126.31 1.844 . . . . 3.25 107.628 160.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.952 -1.499 . . . . 5.76 110.251 155.328 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.33 -1.73 . . . . 51.84 106.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 178.9 178.53 0.44 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.916 1.687 . . . . 44.86 106.571 -177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.0 m -153.89 156.72 38.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.917 -1.512 . . . . 41.92 106.917 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.5 171.95 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.702 1.601 . . . . 37.39 106.98 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -166.2 164.69 17.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.336 -1.357 . . . . 33.37 107.336 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.21 159.83 44.14 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.767 -1.197 . . . . 29.51 107.767 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.4 mt -144.68 174.98 10.51 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.291 1.836 . . . . 26.24 106.911 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 t -152.51 170.42 20.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.743 -1.206 . . . . 22.39 107.743 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.86 -173.43 2.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.158 -1.423 . . . . 19.15 107.158 163.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -159.84 169.25 23.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 106.541 -1.652 . . . . 15.73 106.541 171.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 175.27 11.86 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.177 0.991 . . . . 16.19 108.882 -176.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.7 t -159.67 -179.13 7.61 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.423 -1.325 . . . . 9.69 107.423 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 21.49 71.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 128.009 2.523 . . . . 8.02 114.71 176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -96.66 -162.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.528 0.731 . . . . 13.17 109.685 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.34 169.03 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.815 1.246 . . . . 15.91 110.361 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 81.44 -54.29 0.28 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.828 2.451 . . . . 19.4 112.958 150.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -156.94 -47.66 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.323 1.449 . . . . 15.18 107.473 174.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 m -40.61 -38.35 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.66 1.184 . . . . 13.19 111.829 166.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -43.41 -42.95 4.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.649 0.981 . . . . 11.89 113.649 172.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -51.48 -48.29 62.89 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.769 0.828 . . . . 13.55 110.622 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -70.92 -43.1 68.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.931 0.492 . . . . 10.54 111.035 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.18 -71.93 0.94 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.582 1.087 . . . . 7.37 112.544 -169.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -71.76 -40.68 69.15 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 117.689 0.745 . . . . 10.69 110.299 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.8 ptp 49.51 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.341 0.211 0 C-N-CA 125.74 1.616 . . . . 10.26 113.091 -170.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.1 t -140.79 -94.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.346 -2.094 . . . . 14.53 105.346 177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.13 -179.39 0.57 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.39 1.876 . . . . 15.77 106.397 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt -64.3 -19.7 65.59 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.798 0.666 . . . . 19.07 112.798 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -134.38 161.93 33.62 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.969 -1.123 . . . . 25.94 107.969 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -77.92 67.23 3.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.968 0.907 . . . . 23.32 111.414 -169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -72.42 171.94 11.34 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.951 -0.389 . . . . 21.84 109.951 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -53.97 -64.22 0.9 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.58 0.752 . . . . 22.71 112.017 -176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mm 49.97 65.47 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 15.8 110.026 -174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -150.11 55.86 0.47 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.492 -1.843 . . . . 13.78 108.492 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -178.41 58.05 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.593 2.357 . . . . 13.96 110.118 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.2 mm -125.72 -57.48 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.799 0.84 . . . . 8.94 109.404 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.61 -82.34 0.13 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 118.903 -0.57 . . . . 3.32 110.781 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -128.41 -12.52 2.78 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.283 -1.287 . . . . 1.96 113.928 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 4.17 -94.91 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.429 2.691 . . . . 4.52 115.389 -172.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -72.23 -43.55 64.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.748 -0.595 . . . . 4.35 109.493 -171.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.8 m -53.44 -36.4 61.53 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.516 1.926 . . . . 3.03 112.703 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -73.8 -66.98 0.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.437 0.695 . . . . 2.09 110.145 163.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -53.24 -44.34 68.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.002 1.321 . . . . 4.46 114.124 -163.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -31.42 -58.56 0.25 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.066 1.746 . . . . 2.87 113.021 -160.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -174.23 62.93 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 127.131 2.172 . . . . 4.48 106.976 162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.9 mt -137.61 150.51 68.43 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 106.993 -1.484 . . . . 2.47 106.993 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.35 167.8 25.95 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.341 2.694 . . . . 1.83 111.423 -174.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -76.08 41.83 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 6.69 113.66 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.34 152.07 5.57 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.979 1.276 . . . . 2.73 112.013 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.06 170.27 13.26 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.677 1.031 . . . . 3.46 115.677 167.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -78.83 143.89 35.57 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.958 1.303 . . . . 4.88 110.766 -176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -105.28 176.71 5.07 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.256 1.422 . . . . 1.3 109.611 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 156' ' ' GLN . 1.7 t -101.34 59.75 0.89 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.001 1.32 . . . . 1.95 110.288 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 71' ' ' ILE . 4.6 m-30 -77.22 67.22 3.15 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.473 -1.392 . . . . 3.21 109.109 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt180 -87.12 116.82 25.45 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.138 -1.06 . . . . 4.9 108.138 174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.41 -171.31 28.4 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 119.273 -1.441 . . . . 0.66 115.074 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 p -125.59 125.73 43.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.819 2.048 . . . . 2.22 108.2 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.34 71.78 2.37 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.878 -1.897 . . . . 0.94 105.878 166.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -79.67 138.67 37.44 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.477 0.656 . . . . 2.32 109.956 -171.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.51 157.44 47.76 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.907 -1.677 . . . . 1.09 108.907 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.2 t -56.4 -28.15 58.48 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.312 -1.111 . . . . 2.19 109.851 161.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -86.17 0.4 53.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.547 1.139 . . . . 2.5 112.153 174.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.493 23.5 t0 10.02 70.45 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 117.757 2.503 . . . . 2.78 117.757 -137.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.6 54.5 0.67 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.045 -1.889 . . . . 1.26 106.512 152.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.84 178.3 32.16 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 124.613 1.101 . . . . 0.95 113.138 -173.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.727 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -99.85 176.51 28.47 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 125.59 1.567 . . . . 0.89 112.555 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 84' ' ' HIS . 19.5 mttm -92.88 172.36 8.38 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.928 -1.508 . . . . 4.22 106.928 165.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD22 HD11 ' A' ' 152' ' ' LEU . 26.4 tp -116.3 124.29 49.77 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.321 -1.363 . . . . 0.88 107.321 165.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.9 p -95.24 135.26 37.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.426 1.49 . . . . 2.35 109.386 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -79.47 108.59 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.0 0.429 . . . . 2.32 111.833 -169.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -155.24 97.86 1.94 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.339 0.656 . . . . 1.07 109.799 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG22 ' HA2' ' A' ' 78' ' ' GLY . 1.4 pt -135.85 176.9 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 1.67 109.501 171.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -115.26 171.75 7.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.836 -1.172 . . . . 4.66 107.836 158.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -119.43 17.55 12.96 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.331 -0.855 . . . . 2.35 112.203 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.67 -24.69 15.87 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.668 0.787 . . . . 1.49 111.077 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.43 -46.59 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.235 1.814 . . . . 1.26 109.107 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.567 ' HG3' HD12 ' A' ' 71' ' ' ILE 0.281 0.1 OUTLIER 98.36 79.76 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.046 2.138 . . . . 4.01 115.444 167.044 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -83.65 58.65 4.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.73 1.212 . . . . 2.55 108.218 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.617 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -73.02 89.08 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 CA-C-O 119.544 -0.587 . . . . 1.17 112.074 -167.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -145.79 146.57 31.23 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 2.71 106.996 -162.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.09 145.15 11.98 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 108.116 -1.994 . . . . 0.92 108.116 -177.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.07 142.85 28.51 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.525 1.13 . . . . 3.6 111.561 -167.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.727 HG23 ' HA3' ' A' ' 65' ' ' GLY . 43.9 mt -111.01 95.15 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.321 1.849 . . . . 1.84 107.952 -169.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 19.6 tt0 -147.59 56.1 1.09 Allowed 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.43 1.109 . . . . 2.89 110.947 -147.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.47 ' CG ' ' HE2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -158.45 36.79 0.23 Allowed 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.454 -0.779 . . . . 5.79 109.39 -170.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mt -111.36 167.73 10.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.871 0.868 . . . . 1.62 111.411 -165.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -10.5 59.87 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.607 1.163 . . . . 3.97 112.161 -170.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -138.88 143.03 35.71 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.44 -0.314 . . . . 1.56 110.889 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.54 -36.2 55.3 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.308 2.672 . . . . 1.75 111.922 -172.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -66.34 -20.76 66.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.522 -0.736 . . . . 3.2 111.019 178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.09 -5.64 54.54 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.538 -0.744 . . . . 2.51 111.918 173.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -65.46 84.69 0.06 Allowed 'General case' 0 C--N 1.341 0.208 0 N-CA-C 107.732 -1.21 . . . . 2.94 107.732 169.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.29 140.77 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 124.361 1.064 . . . . 0.97 108.723 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -124.06 164.04 20.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.775 -0.824 . . . . 2.58 108.775 166.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.77 134.89 30.89 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.368 1.067 . . . . 1.72 110.344 172.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.85 176.14 9.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.999 0.92 . . . . 1.8 111.595 -169.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.63 106.09 8.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.39 1.076 . . . . 1.31 109.278 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -102.33 125.2 48.96 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.62 0.768 . . . . 1.06 110.742 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -98.53 89.17 4.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.366 1.467 . . . . 3.66 111.416 -169.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.473 HD13 ' CE1' ' A' ' 106' ' ' HIS . 0.8 OUTLIER -61.99 92.93 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.902 1.681 . . . . 1.55 111.394 174.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -86.88 -51.55 0.44 Allowed Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 118.258 -0.877 . . . . 6.94 112.915 166.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.17 58.26 6.55 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.419 2.08 . . . . 4.06 113.205 -158.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 p30 -81.14 -93.96 0.05 OUTLIER 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.33 -0.856 . . . . 7.14 112.282 -172.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 40.42 61.38 1.82 Allowed Glycine 0 CA--C 1.522 0.47 0 C-N-CA 127.341 2.401 . . . . 3.09 112.92 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.64 64.44 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.469 3.108 . . . . 6.52 106.103 165.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.255 50.2 mtp180 61.09 -49.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.561 2.344 . . . . 7.04 114.155 -162.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.592 ' CD2' ' H ' ' A' ' 127' ' ' ILE . 64.2 t60 -168.03 -47.92 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.358 0.526 . . . . 5.23 112.069 -172.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 72.58 -109.28 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.673 -0.679 . . . . 2.4 111.597 -173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.72 135.55 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 CA-C-N 118.933 0.788 . . . . 1.1 111.478 -165.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.4 mt -80.0 126.43 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.117 2.167 . . . . 2.75 107.792 163.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 p -114.5 107.45 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.684 1.193 . . . . 2.22 108.058 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -123.7 159.46 18.33 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-N 118.638 0.654 . . . . 0.68 111.967 178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.2 m -79.37 159.27 27.19 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.108 -1.071 . . . . 1.41 108.108 166.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.79 154.8 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 107.538 -1.282 . . . . 0.86 107.538 165.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.45 134.67 37.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.333 0.587 . . . . 3.05 111.736 -176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -78.22 73.66 4.78 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.013 2.525 . . . . 5.43 106.148 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 66.52 -57.92 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.491 2.316 . . . . 3.14 112.065 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -106.46 -44.17 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.72 1.208 . . . . 2.44 111.27 162.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -87.88 107.75 18.84 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.439 -0.788 . . . . 1.23 112.93 -156.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -78.05 66.52 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.943 0.897 . . . . 3.27 110.589 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 30.3 mmmt -116.29 57.53 0.76 Allowed 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.754 1.264 . . . . 3.45 108.365 170.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -159.95 162.49 33.14 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 112.845 -1.98 . . . . 0.64 113.109 169.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.1 p -140.1 164.13 30.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.963 1.705 . . . . 1.12 109.452 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.52 131.74 16.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.119 -1.067 . . . . 2.3 108.119 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.7 m -121.89 107.05 11.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.931 -1.878 . . . . 2.11 105.931 178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.607 HD23 HD12 ' A' ' 152' ' ' LEU . 1.6 tm? -133.54 138.28 45.98 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 123.596 0.758 . . . . 0.77 109.419 -171.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.62 158.14 23.3 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.49 -0.644 . . . . 1.16 111.49 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.592 ' H ' ' CD2' ' A' ' 106' ' ' HIS . 3.3 tp -76.51 158.83 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.821 1.248 . . . . 2.22 108.841 177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -153.12 153.38 32.68 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.288 0.566 . . . . 4.56 110.249 161.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.8 -22.55 8.63 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.832 1.206 . . . . 2.79 111.82 171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.57 9.83 85.97 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 122.177 -0.602 . . . . 2.33 112.164 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 pttt -163.2 41.72 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.331 1.452 . . . . 3.26 108.116 165.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.1 68.41 0.86 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.39 1.476 . . . . 1.26 111.314 173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -98.44 -44.17 6.61 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 122.442 0.297 . . . . 3.3 110.577 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 155' ' ' LYS . 53.3 mt-10 -149.12 105.73 3.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.07 -1.085 . . . . 3.01 108.07 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 125' ' ' LEU . 22.4 m -77.1 145.43 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.441 1.019 . . . . 1.19 109.21 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -135.9 132.69 36.84 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.273 1.029 . . . . 0.9 108.808 -174.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.14 178.16 34.53 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.605 0.558 . . . . 0.72 113.114 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.6 p -125.25 122.09 35.94 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.57 -1.641 . . . . 2.61 106.57 164.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.79 150.61 20.02 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.509 -1.293 . . . . 1.4 107.509 164.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -146.37 135.8 22.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.217 0.821 . . . . 3.14 113.217 162.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.2 m -125.95 146.13 32.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 107.008 -1.479 . . . . 2.54 107.008 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.65 96.19 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.288 -1.375 . . . . 3.9 107.288 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.7 p -123.57 -171.04 2.23 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.333 -0.988 . . . . 2.31 108.333 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -49.7 -27.7 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 123.173 0.589 . . . . 2.01 110.644 165.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 57.85 0.52 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.719 0.771 . . . . 2.78 108.958 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.95 122.21 4.76 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 105.571 -3.012 . . . . 1.08 105.571 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.4 mp -79.57 127.66 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.143 -1.058 . . . . 2.32 108.143 -171.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -65.04 -76.32 0.07 Allowed 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.019 -0.672 . . . . 2.92 109.969 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -71.97 104.95 3.68 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.94 -1.1 . . . . 2.38 109.292 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -115.64 114.46 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.749 -1.204 . . . . 1.56 107.749 173.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.87 125.68 7.15 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 108.506 -1.838 . . . . 0.69 108.506 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.607 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -104.09 109.05 20.68 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.115 -1.439 . . . . 1.06 107.115 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.09 159.01 30.9 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 108.41 -0.959 . . . . 0.92 108.41 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.27 163.19 39.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.299 0.639 . . . . 1.05 109.798 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 134' ' ' GLU . 29.0 tttp -152.39 128.2 10.22 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.662 0.601 . . . . 3.24 109.396 173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.3 mt-30 . . . . . 0 C--O 1.253 1.254 0 CA-C-O 117.548 -1.215 . . . . 5.08 110.118 -157.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 110.022 -0.362 . . . . 53.14 110.022 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -168.68 164.02 12.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.499 -1.667 . . . . 45.27 106.499 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 t -168.81 -177.78 3.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.98 -1.489 . . . . 41.15 106.98 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.83 169.24 11.71 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.813 2.045 . . . . 37.22 107.436 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.9 p -164.6 169.29 17.19 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.205 -1.406 . . . . 33.13 107.205 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.57 160.68 32.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.276 -1.379 . . . . 29.25 107.276 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.5 tp -157.41 146.45 19.84 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.746 -2.316 . . . . 25.31 104.746 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.2 t -159.2 172.63 17.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.675 -1.232 . . . . 21.84 107.675 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.61 155.28 2.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.658 1.583 . . . . 18.28 108.199 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -153.28 139.15 18.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.407 -1.331 . . . . 14.73 107.407 162.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.61 -166.64 2.11 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.688 1.595 . . . . 13.02 108.53 -168.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 t -143.6 168.64 19.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 118.633 0.651 . . . . 9.85 110.326 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -171.84 54.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.896 -1.15 . . . . 6.2 107.896 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -139.59 110.72 6.93 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.612 0.765 . . . . 11.7 110.706 -170.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.3 mm -105.78 -56.62 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.254 1.421 . . . . 15.91 109.212 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -152.78 -106.09 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.34 -1.356 . . . . 20.88 107.34 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -45.65 -42.66 11.69 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 124.359 1.063 . . . . 18.49 110.316 169.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.02 -29.84 0.93 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.455 1.902 . . . . 13.53 113.926 176.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -48.04 -46.45 33.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.511 1.124 . . . . 10.78 110.928 171.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -63.84 -70.33 0.22 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.986 -0.746 . . . . 15.13 108.986 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.4 m -66.07 -55.51 16.17 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 112.486 0.55 . . . . 14.01 112.486 -168.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.16 -61.94 5.33 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 111.173 -0.771 . . . . 8.3 111.173 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -70.07 -44.39 69.21 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 117.794 -1.098 . . . . 10.33 110.57 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 21.2 ptt? 37.42 66.92 0.41 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.787 1.235 . . . . 12.13 111.67 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.8 t 68.35 -67.96 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.525 1.53 . . . . 12.26 109.588 -171.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.19 0.94 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.416 0.627 . . . . 12.76 111.915 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 79.39 0.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.059 1.344 . . . . 18.32 109.252 169.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -58.98 105.29 0.3 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.879 1.272 . . . . 19.98 109.73 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -114.48 -74.46 0.62 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 106.89 -1.522 . . . . 20.83 106.89 172.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.54 -167.93 2.22 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.686 -2.709 . . . . 22.64 103.686 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -78.49 57.89 2.07 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.102 . . . . 17.5 109.745 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.5 mm -144.46 164.14 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 105.766 -1.938 . . . . 15.37 105.766 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -127.17 3.88 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 103.266 -3.934 . . . . 10.4 103.266 -173.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 76.92 -57.57 0.53 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.637 1.975 . . . . 7.9 111.339 158.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 91.3 mt -53.31 -67.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 126.05 1.74 . . . . 9.68 109.799 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 169.32 168.47 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 127.281 2.232 . . . . 4.6 106.368 -172.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.28 -53.12 0.53 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 108.099 -2.0 . . . . 2.5 108.099 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 33.07 -89.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 129.031 2.932 . . . . 5.11 113.893 167.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.77 -18.61 65.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.915 0.886 . . . . 4.48 111.208 -165.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.8 p -70.35 -80.07 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.672 -0.862 . . . . 2.55 108.672 165.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.0 t -39.62 -46.67 1.84 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.348 2.659 . . . . 1.93 112.348 -175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -29.62 -66.86 0.09 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.492 2.717 . . . . 2.65 113.775 168.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -75.57 0.09 Allowed 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 123.609 0.568 . . . . 3.7 109.819 -152.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt 179.89 43.17 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.014 1.326 . . . . 4.47 109.984 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD22 HD12 ' A' ' 127' ' ' ILE . 1.7 mp -105.79 -39.46 0.17 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 115.001 1.482 . . . . 4.83 115.001 -176.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -82.58 79.85 2.91 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 121.197 1.463 . . . . 4.01 112.226 -155.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -48.19 -20.09 0.34 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.855 1.662 . . . . 12.78 114.673 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 155.58 -91.7 0.12 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 120.147 1.34 . . . . 3.09 110.359 173.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.28 -106.29 3.06 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 3.04 109.474 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.437 ' NH1' HG23 ' A' ' 70' ' ' THR . 11.8 ttm-85 -79.51 119.6 22.72 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.896 0.478 . . . . 5.44 111.604 -165.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.621 ' HB2' ' CE2' ' A' ' 73' ' ' PHE . . . -78.35 153.92 31.24 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.369 0.604 . . . . 1.25 112.496 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -79.38 64.34 4.24 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.91 0.884 . . . . 1.46 111.575 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 71' ' ' ILE . 3.5 m-30 -78.06 74.73 4.61 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.733 -1.229 . . . . 2.98 110.925 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -81.26 88.87 6.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.495 -1.298 . . . . 5.41 107.495 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.76 178.67 32.21 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.078 -0.582 . . . . 0.97 114.032 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.3 m -137.59 127.01 24.88 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.892 1.677 . . . . 2.98 107.862 -174.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.53 78.48 8.57 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.433 -2.062 . . . . 1.24 105.433 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -83.93 137.95 33.39 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.956 0.408 . . . . 2.37 110.313 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -85.81 159.88 33.46 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.235 -1.146 . . . . 1.3 110.235 -174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.7 t -51.46 -40.34 59.25 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 117.683 0.742 . . . . 2.18 111.377 163.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' OD1' ' HB2' ' A' ' 63' ' ' ALA . 29.9 t70 -66.4 -18.99 65.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.241 1.016 . . . . 3.83 112.943 173.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.253 35.8 t0 45.66 57.91 4.67 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 124.628 2.156 . . . . 3.35 111.204 -143.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.443 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . . . -114.85 58.99 0.7 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 105.701 -1.963 . . . . 1.59 105.701 153.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.77 114.98 1.34 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.2 -1.56 . . . . 2.05 109.2 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.03 -178.4 50.83 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-O 123.422 1.568 . . . . 1.28 112.604 -172.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -74.73 133.32 42.04 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.16 -1.422 . . . . 4.67 107.16 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.5 tp -79.15 75.52 5.68 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.762 -1.57 . . . . 1.72 106.762 176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -76.81 127.99 33.77 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 118.555 -1.258 . . . . 2.5 110.035 -159.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -73.76 128.38 35.36 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.346 -0.942 . . . . 2.4 112.595 -139.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.437 HG23 ' NH1' ' A' ' 50' ' ' ARG . 1.3 m -156.13 98.35 1.86 Allowed 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 124.801 1.24 . . . . 1.4 108.355 168.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.679 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -128.44 126.34 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 104.996 -2.224 . . . . 1.49 104.996 147.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.53 102.84 15.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.421 -1.696 . . . . 4.44 106.421 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 51' ' ' ALA . 41.5 m-85 -53.14 -18.04 1.97 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.208 1.403 . . . . 3.39 113.166 -175.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -40.91 -45.86 2.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.563 0.745 . . . . 2.29 111.383 167.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.4 10.82 0.77 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.965 1.469 . . . . 1.52 114.965 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? 58.38 63.02 1.82 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.472 1.13 . . . . 5.35 112.897 171.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.54 81.37 7.15 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.557 -2.386 . . . . 1.89 104.557 172.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -74.48 67.75 1.87 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 114.56 -1.2 . . . . 1.25 114.978 -161.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -137.87 85.4 2.1 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.114 0.957 . . . . 2.94 110.075 -155.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.52 131.71 10.77 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.267 -1.533 . . . . 0.99 109.267 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -87.99 148.58 24.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.329 1.065 . . . . 3.91 113.271 -163.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 53.7 mt -107.89 59.72 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 127.51 2.324 . . . . 2.05 106.617 -169.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -107.14 63.44 0.63 Allowed 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 123.853 0.861 . . . . 3.65 109.155 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -157.35 64.64 0.49 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.656 -0.702 . . . . 3.93 109.28 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.3 mt -129.99 153.57 48.27 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.482 0.549 . . . . 1.74 112.482 -178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -30.41 51.77 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.098 1.759 . . . . 5.44 113.131 -169.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.2 t -129.84 143.94 51.06 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.566 0.746 . . . . 1.51 109.593 -173.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.08 -56.87 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.921 2.414 . . . . 1.62 112.522 -165.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -40.15 35.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.387 0.675 . . . . 3.96 112.037 175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -55.35 -33.41 63.36 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.146 0.795 . . . . 2.01 113.146 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -63.99 117.75 7.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.735 1.152 . . . . 1.87 109.294 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 115' ' ' TYR . 2.6 t -107.29 142.96 18.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 124.455 1.102 . . . . 0.94 109.793 -169.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -118.53 157.35 27.47 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.149 -1.056 . . . . 2.24 108.149 162.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.7 mt -107.28 142.89 36.32 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.75 1.22 . . . . 1.61 109.003 -171.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.85 155.43 32.95 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.554 -0.906 . . . . 1.29 108.554 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 125.34 28.98 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.901 -1.148 . . . . 1.67 107.901 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.1 123.66 8.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.056 0.542 . . . . 1.08 109.643 -171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -79.26 175.25 10.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.553 1.941 . . . . 3.52 110.024 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.44 ' CG1' ' HB3' ' A' ' 107' ' ' ALA . 1.4 tt -114.11 84.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.883 1.673 . . . . 1.51 108.764 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 148.82 13.23 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.02 1.728 . . . . 8.35 111.441 171.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.92 83.86 1.35 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.883 2.389 . . . . 3.87 112.938 -170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -64.13 -10.51 23.12 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.673 -0.642 . . . . 5.05 111.859 160.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.78 63.81 4.87 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.356 0.979 . . . . 2.82 111.376 172.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.85 58.49 0.86 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.491 0.646 . . . . 4.65 112.289 -169.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 56.35 17.97 3.16 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.251 1.02 . . . . 6.8 113.178 -174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 28.5 p80 146.06 -154.45 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 130.685 3.594 . . . . 6.23 103.515 -160.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . . . -172.41 -158.99 0.12 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.783 2.033 . . . . 3.79 105.771 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.9 m -128.31 157.07 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 120.222 1.374 . . . . 1.48 111.681 168.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 pt -86.08 157.48 3.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.211 -1.033 . . . . 2.42 108.211 156.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.6 t -133.12 59.89 1.72 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.906 1.282 . . . . 2.02 109.021 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.84 163.73 46.01 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 122.339 -0.226 . . . . 0.79 113.442 -169.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.5 p -93.4 163.67 13.5 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.019 1.328 . . . . 1.97 109.446 166.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.58 146.2 34.54 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 C-N-CA 122.743 0.417 . . . . 0.74 110.063 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.68 115.69 31.08 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.032 1.733 . . . . 2.09 108.388 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.414 ' HA ' HG22 ' A' ' 92' ' ' VAL . 43.1 t80 -79.13 71.39 5.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.622 -1.622 . . . . 4.5 106.622 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 63.03 -63.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.343 2.257 . . . . 2.79 112.966 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.92 -31.58 11.75 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.246 1.418 . . . . 2.49 111.295 171.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -121.07 110.06 15.77 Favored 'General case' 0 C--N 1.34 0.179 0 N-CA-C 112.125 0.417 . . . . 1.36 112.125 -150.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -79.93 78.76 6.52 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.737 -0.602 . . . . 3.13 109.591 174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.0 mmmt -131.56 65.63 1.56 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 122.891 1.329 . . . . 3.29 108.669 163.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.92 157.76 28.51 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 113.123 -1.853 . . . . 0.7 109.83 165.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 p -155.09 156.4 35.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.611 1.164 . . . . 0.87 109.701 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -154.96 170.36 21.92 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.433 0.635 . . . . 3.55 111.656 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.4 p -126.11 134.87 51.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.879 2.072 . . . . 2.16 106.718 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 135' ' ' VAL . 2.5 tm? -152.49 122.13 6.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.362 0.983 . . . . 0.98 112.892 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.13 -173.55 46.07 Favored Glycine 0 CA--C 1.535 1.312 1 C-N-CA 131.203 4.239 . . . . 2.49 113.385 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.434 HD12 HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -135.96 146.55 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 106.044 -1.836 . . . . 2.14 106.044 155.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -35.78 -49.33 0.59 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 116.346 1.98 . . . . 5.82 116.346 -172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.0 37.31 33.27 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 111.812 -0.515 . . . . 3.54 111.812 -170.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.13 -67.17 0.03 OUTLIER Glycine 0 C--N 1.342 0.908 0 N-CA-C 109.238 -1.545 . . . . 2.33 109.238 166.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -159.48 48.2 0.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.894 0.854 . . . . 3.44 109.62 171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 59.08 48.47 10.62 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 126.639 1.976 . . . . 1.47 110.838 172.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -80.06 -42.43 23.74 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.296 -0.252 . . . . 3.48 110.323 -173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.27 170.61 15.38 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.49 -1.67 . . . . 2.62 106.49 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.48 ' HB ' HD21 ' A' ' 125' ' ' LEU . 33.4 m -136.86 106.29 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.694 -1.224 . . . . 1.57 107.694 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.83 124.13 27.92 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.48 -0.933 . . . . 1.65 108.48 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.0 177.02 34.09 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.558 -1.017 . . . . 1.04 110.558 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.5 m -154.09 130.91 10.84 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.043 -1.095 . . . . 1.79 108.043 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.3 148.48 37.45 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.93 1.292 . . . . 0.85 111.687 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.79 140.22 52.86 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.17 0.588 . . . . 2.71 110.045 162.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.46 112.03 15.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.051 -1.833 . . . . 1.92 106.051 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.6 88.38 2.9 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.251 -0.648 . . . . 3.01 109.251 -161.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 p -116.04 -176.68 2.99 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.784 -0.767 . . . . 2.39 109.852 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.7 m -45.9 -30.18 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 124.13 0.972 . . . . 3.09 111.752 163.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -156.65 74.26 0.81 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.639 -1.615 . . . . 3.16 106.639 170.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.97 145.95 17.89 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 106.308 -2.717 . . . . 1.12 106.308 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.476 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.1 mp -87.62 109.92 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 121.933 0.873 . . . . 2.35 109.364 -167.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 ttp85 -73.16 -7.87 53.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.107 0.78 . . . . 2.83 113.107 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -135.12 99.91 4.4 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.904 1.282 . . . . 2.58 108.527 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 10.3 mt -119.69 117.82 55.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.276 1.03 . . . . 1.19 108.963 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.38 113.54 3.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.193 -1.563 . . . . 0.94 109.193 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.69 88.18 5.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.057 -1.46 . . . . 1.42 107.057 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.36 145.79 26.35 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 109.443 -0.577 . . . . 1.7 109.443 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -152.8 151.84 30.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 109.381 -0.6 . . . . 1.04 109.381 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -155.84 128.12 7.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.54 1.15 . . . . 5.29 109.11 156.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 104.41 -2.441 . . . . 4.33 104.41 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 106.63 -1.618 . . . . 54.42 106.63 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -161.36 157.56 25.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.329 -1.73 . . . . 49.05 106.329 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -163.04 179.95 7.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.795 -1.557 . . . . 44.94 106.795 168.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -171.51 168.29 6.46 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.941 2.096 . . . . 40.52 107.459 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -166.74 -178.55 4.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.817 -1.549 . . . . 36.01 106.817 170.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -166.82 157.1 11.65 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.564 1.546 . . . . 31.64 107.802 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.3 mt -142.7 159.24 42.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.569 -1.641 . . . . 28.47 106.569 175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -163.58 166.94 21.94 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.837 -1.542 . . . . 23.8 106.837 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -165.24 175.84 8.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.331 -1.359 . . . . 19.83 107.331 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -159.38 -179.05 7.6 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.221 -1.4 . . . . 16.07 107.221 172.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -142.04 157.47 44.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.469 -1.678 . . . . 14.95 106.469 175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.7 t -159.17 140.17 12.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.605 0.717 . . . . 9.79 110.444 165.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -57.15 -43.02 82.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.975 2.91 . . . . 7.21 110.897 -177.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -135.73 177.51 7.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.393 1.477 . . . . 10.72 108.533 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -134.36 148.75 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.163 1.385 . . . . 13.32 109.631 -173.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 90.6 63.69 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.971 2.508 . . . . 19.31 110.147 166.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.73 -53.91 0.68 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 126.893 2.077 . . . . 17.25 111.681 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.7 m -32.89 -43.12 0.09 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.551 1.94 . . . . 14.07 112.117 159.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -38.22 -50.65 1.44 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.685 1.594 . . . . 11.03 112.443 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -52.1 -48.11 64.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.245 1.018 . . . . 14.92 110.539 -176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -70.02 -51.51 31.71 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.483 0.713 . . . . 13.22 110.383 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.85 -57.02 10.29 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.26 0.933 . . . . 8.53 112.224 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -71.0 -5.52 31.85 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.257 1.206 . . . . 11.92 114.257 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.1 mtt 56.39 59.31 3.7 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.314 1.445 . . . . 11.84 111.28 -176.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t 68.89 -69.66 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.779 1.632 . . . . 15.58 112.178 166.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.43 -95.45 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.665 -0.865 . . . . 15.05 108.665 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.4 166.56 0.61 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 127.359 2.264 . . . . 14.82 108.402 167.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.5 mtm105 -50.79 137.45 20.39 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.341 -0.614 . . . . 18.52 109.341 168.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 100.69 -35.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.784 2.834 . . . . 19.59 110.62 -171.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -99.6 116.54 31.95 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.475 -0.565 . . . . 17.43 109.475 -170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 69.81 -52.01 0.63 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.346 1.859 . . . . 18.66 111.082 -173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 7.2 mt 59.53 48.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.028 1.331 . . . . 14.1 108.641 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.48 99.69 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.213 -1.155 . . . . 10.63 110.213 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -154.53 168.8 25.53 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.499 1.52 . . . . 9.34 106.943 172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.1 mm -80.58 148.92 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 108.216 -1.031 . . . . 9.33 108.216 173.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.71 -79.64 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.992 0.517 . . . . 4.44 112.132 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.68 46.31 0.18 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.679 -0.568 . . . . 2.79 111.679 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.92 -73.2 0.05 OUTLIER 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 118.651 -0.69 . . . . 4.56 112.757 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -49.66 -58.42 5.3 Favored 'General case' 0 C--N 1.338 0.086 0 CA-C-N 119.066 0.848 . . . . 4.15 110.113 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -49.28 -58.19 5.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.093 -0.958 . . . . 3.41 113.069 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 t -74.52 -52.29 12.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.053 0.454 . . . . 2.34 111.864 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -22.36 65.07 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-O 117.733 -1.127 . . . . 3.76 113.14 -167.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -36.59 -56.96 0.8 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 124.844 1.258 . . . . 3.06 111.599 -163.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? 177.96 48.96 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 127.529 2.332 . . . . 5.6 106.997 171.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.7 mt -137.83 153.08 73.52 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 124.093 0.957 . . . . 2.26 109.981 -162.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.21 -177.74 2.24 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.006 3.137 . . . . 1.94 112.823 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -87.01 52.02 2.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.997 1.319 . . . . 5.32 109.136 162.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' H ' ' HB2' ' A' ' 73' ' ' PHE . . . -65.2 -18.41 64.95 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 116.775 1.47 . . . . 2.99 116.775 -160.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 -49.75 4.08 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 120.991 2.395 . . . . 1.73 112.686 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -140.79 161.32 38.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 7.79 109.263 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.76 -178.55 6.85 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.945 1.698 . . . . 2.35 112.122 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -136.16 95.77 3.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.942 -1.133 . . . . 1.62 107.942 164.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.14 176.58 12.55 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.369 0.877 . . . . 4.45 113.369 167.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -136.06 115.57 12.78 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 104.513 -2.402 . . . . 5.54 104.513 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.8 145.79 18.55 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-O 121.912 0.729 . . . . 1.0 113.91 -164.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.5 p -112.2 131.45 55.47 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.316 1.846 . . . . 2.46 107.179 173.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.88 76.38 1.06 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.877 -1.897 . . . . 1.06 105.877 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -78.65 138.17 38.18 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.239 0.615 . . . . 2.31 109.934 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.7 160.54 50.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.587 -1.005 . . . . 1.31 110.587 -169.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.5 t -46.49 -34.61 4.93 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.617 0.767 . . . . 2.19 110.912 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.58 29.43 7.75 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.123 1.769 . . . . 4.47 110.322 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.435 27.4 t0 9.49 78.83 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 119.106 3.002 . . . . 2.72 119.106 -152.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.73 54.42 0.9 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.698 -1.593 . . . . 1.6 106.698 150.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -88.05 -178.78 47.35 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.98 1.276 . . . . 1.2 112.086 -167.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.28 172.17 26.26 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.396 1.951 . . . . 1.03 113.248 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -110.79 105.22 14.0 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.192 1.797 . . . . 3.21 108.951 171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD22 HD11 ' A' ' 152' ' ' LEU . 7.8 tp -79.69 120.38 23.92 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.804 0.729 . . . . 1.52 109.629 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -79.85 155.94 27.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.696 0.76 . . . . 1.85 111.301 171.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -76.3 123.52 26.05 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.302 -0.629 . . . . 2.63 109.302 177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.3 m -158.14 95.61 1.39 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.293 -1.373 . . . . 0.92 107.293 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.428 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -134.08 141.35 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.833 -1.543 . . . . 1.74 106.833 158.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -92.13 108.48 19.97 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.48 -0.933 . . . . 4.24 108.48 160.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 48' ' ' GLY . 65.0 m-85 -50.32 -21.6 1.47 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.532 1.933 . . . . 3.04 113.437 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.65 23.77 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.332 0.969 . . . . 1.4 112.522 175.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.0 -35.02 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.429 0.9 . . . . 1.59 113.429 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.532 ' H ' ' NE2' ' A' ' 77' ' ' GLN . 9.7 tptt 100.96 52.02 0.0 OUTLIER 'General case' 0 C--N 1.346 0.435 0 C-N-CA 129.004 2.922 . . . . 4.19 114.268 169.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -73.81 67.14 1.17 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 126.948 2.099 . . . . 1.89 107.553 165.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -81.57 95.73 1.71 Allowed Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.013 -0.994 . . . . 1.14 111.704 -172.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -153.7 109.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.744 -1.206 . . . . 2.86 107.744 -166.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -138.53 144.56 15.7 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 107.071 -2.411 . . . . 1.32 107.071 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -78.87 164.24 24.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.914 0.709 . . . . 4.09 112.914 -168.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.8 pp -109.82 137.6 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 C-N-CA 123.426 0.691 . . . . 3.89 109.627 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -156.41 90.75 1.2 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.697 -0.683 . . . . 2.72 111.436 -162.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -164.4 -15.4 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.621 1.168 . . . . 4.68 113.439 156.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.2 mt -59.32 141.54 54.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.779 0.718 . . . . 1.82 111.942 -167.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -23.77 44.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.939 1.296 . . . . 4.3 112.026 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.24 110.78 54.1 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 104.357 -2.46 . . . . 1.98 104.357 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -49.88 -47.67 22.5 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.805 1.67 . . . . 1.6 109.739 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -55.95 -27.31 51.87 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.655 1.582 . . . . 3.2 112.708 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -82.15 -9.43 59.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 113.707 1.002 . . . . 2.29 113.707 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.32 72.39 2.37 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 119.476 1.035 . . . . 2.15 108.408 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.0 t -59.84 115.01 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 126.233 1.813 . . . . 1.0 109.862 -171.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -83.58 165.63 18.89 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.812 -1.181 . . . . 2.08 107.812 160.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.57 131.21 27.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.035 1.334 . . . . 2.21 109.798 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.36 176.13 9.62 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.911 0.884 . . . . 2.4 110.311 -173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.04 126.36 30.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.367 -0.605 . . . . 1.4 109.367 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.97 116.27 6.12 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.236 1.414 . . . . 1.24 108.093 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.98 176.31 7.71 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.306 1.042 . . . . 4.7 109.821 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -114.32 -20.86 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 125.454 1.502 . . . . 3.13 112.887 -176.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mppt? -2.57 -73.84 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 116.893 2.183 . . . . 8.08 116.893 -166.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -67.01 80.95 0.36 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.641 2.227 . . . . 3.9 110.633 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.24 -148.68 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.539 1.136 . . . . 5.04 111.088 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -156.97 41.31 0.55 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 117.871 -1.516 . . . . 3.7 113.006 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.1 tttm 126.4 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.601 2.76 . . . . 6.83 109.986 167.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 49.83 51.42 16.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.124 0.97 . . . . 8.37 111.097 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 71.29 81.42 0.15 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.682 1.193 . . . . 5.52 111.008 176.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.05 -71.75 0.16 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.301 -0.863 . . . . 2.67 109.321 169.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 163.05 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 123.465 0.706 . . . . 1.53 110.987 -176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.436 ' HA ' HG22 ' A' ' 99' ' ' ILE . 26.1 mt -78.01 162.92 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 125.247 1.419 . . . . 2.67 107.895 164.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.2 t -134.98 78.86 1.76 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.079 -1.452 . . . . 1.43 107.079 170.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.34 175.3 23.62 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.676 -0.569 . . . . 0.92 111.676 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.5 m -149.82 158.99 44.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.586 -0.949 . . . . 2.48 108.967 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.71 151.88 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.063 0.545 . . . . 0.8 111.694 -154.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.4 tp -78.2 100.49 6.66 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.767 1.27 . . . . 2.34 109.166 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.23 84.88 3.04 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.725 -2.324 . . . . 7.5 104.725 170.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.4 m120 68.73 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.243 1.417 . . . . 7.39 109.421 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -147.42 33.23 0.88 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.973 2.109 . . . . 2.36 108.241 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.06 177.12 11.68 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 127.697 2.399 . . . . 2.81 106.595 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.77 99.9 5.1 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.989 0.813 . . . . 3.9 110.835 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.62 66.02 1.12 Allowed 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.906 1.336 . . . . 6.18 108.237 155.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -134.57 142.52 13.99 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 106.662 -2.575 . . . . 1.0 106.662 144.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -132.36 127.86 36.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 126.072 1.749 . . . . 1.15 106.775 -175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -131.19 150.36 52.18 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 123.757 0.661 . . . . 2.54 111.942 -171.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.9 p -143.93 118.33 9.66 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.875 -1.157 . . . . 1.58 107.875 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 HD12 ' A' ' 152' ' ' LEU . 1.5 tm? -131.43 134.65 46.44 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 124.553 1.141 . . . . 1.54 110.184 -171.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.82 150.63 17.03 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 125.85 1.69 . . . . 1.8 109.914 -173.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.87 148.61 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.256 0.622 . . . . 3.3 110.728 -169.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.59 95.87 1.48 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.444 -1.317 . . . . 5.97 107.444 168.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.0 54.23 1.39 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.788 1.185 . . . . 3.21 112.817 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -92.58 -51.84 2.26 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 106.708 -2.557 . . . . 2.61 106.708 158.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.1 27.48 0.17 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.535 0.569 . . . . 5.66 112.535 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 65.57 92.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.433 1.093 . . . . 1.67 109.304 -169.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -125.94 -62.23 1.19 Allowed 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.122 -1.807 . . . . 2.63 106.122 -159.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -131.09 160.55 34.36 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.639 -1.986 . . . . 4.61 105.639 171.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 154' ' ' ALA . 11.0 m -142.76 151.98 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.919 -1.141 . . . . 1.79 107.919 -173.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -145.67 133.54 21.26 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.529 1.131 . . . . 1.54 108.623 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.89 177.9 35.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 123.633 0.635 . . . . 1.01 112.506 -172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.3 m -131.02 143.82 51.0 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.551 -0.907 . . . . 1.77 108.551 169.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.3 143.43 47.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.502 0.721 . . . . 0.8 110.513 163.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.82 127.85 44.05 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.784 -1.932 . . . . 3.03 105.784 156.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.88 116.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 CA-C-N 119.525 1.057 . . . . 2.1 108.836 170.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.9 132.08 52.43 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 107.899 -1.148 . . . . 4.84 107.899 167.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -136.29 177.11 8.1 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.528 -0.915 . . . . 3.01 108.528 164.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.8 t -45.58 -33.27 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.659 1.184 . . . . 3.19 111.015 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.4 58.51 1.33 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 109.698 -0.482 . . . . 3.65 109.698 168.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.02 130.39 7.36 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 110.015 -1.234 . . . . 1.57 110.015 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.97 124.33 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.201 1.401 . . . . 1.68 109.574 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -50.28 -72.08 0.06 Allowed 'General case' 0 C--O 1.226 -0.175 0 O-C-N 123.66 0.6 . . . . 2.62 110.581 -173.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -75.93 133.72 40.43 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.637 -1.246 . . . . 2.44 107.637 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.79 117.93 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.043 -1.466 . . . . 1.23 107.043 170.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.84 126.79 7.62 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 108.62 -1.792 . . . . 0.77 108.62 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.464 HD12 HD23 ' A' ' 125' ' ' LEU . 0.4 OUTLIER -108.66 124.39 50.45 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.946 -1.131 . . . . 1.12 107.946 -171.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.42 134.17 18.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 109.219 -0.66 . . . . 0.98 109.219 173.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.709 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.79 163.37 30.79 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 118.468 0.577 . . . . 1.26 110.85 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.96 155.25 33.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.445 -1.317 . . . . 4.61 107.445 163.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.369 0 N-CA-C 107.831 -1.174 . . . . 4.77 107.831 157.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 N-CA-C 107.098 -1.445 . . . . 59.3 107.098 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 61.52 0.09 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.751 1.22 . . . . 54.42 111.639 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -96.9 101.04 12.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.109 1.364 . . . . 49.58 109.209 -172.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -81.85 158.09 24.17 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.848 -0.797 . . . . 44.74 108.848 167.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.5 t -69.67 179.98 1.96 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.645 -0.502 . . . . 39.5 109.645 170.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.07 -135.1 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.785 -1.561 . . . . 35.01 106.785 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -90.84 167.29 12.56 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.968 -1.493 . . . . 30.44 106.968 154.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.0 t -53.72 150.83 6.81 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.217 -0.29 . . . . 26.03 110.217 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.08 -44.74 61.26 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.429 0.692 . . . . 22.42 110.488 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -164.79 -176.09 4.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.684 -1.228 . . . . 17.92 107.684 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -84.3 175.01 9.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.597 1.159 . . . . 18.81 108.079 162.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 13' ' ' GLU . 35.1 m 61.78 -170.21 0.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.581 -0.896 . . . . 10.86 108.581 -177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' H ' HG22 ' A' ' 12' ' ' THR . 11.2 mt-10 -62.32 -83.19 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 120.055 1.298 . . . . 9.37 110.729 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -154.72 171.1 20.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.939 1.296 . . . . 14.51 109.682 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.35 160.62 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 126.784 2.034 . . . . 17.76 110.965 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 70.97 -70.3 0.16 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.012 1.725 . . . . 17.69 108.588 -175.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 100' ' ' LYS . 1.2 m-20 -61.81 -10.26 8.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.857 1.263 . . . . 16.82 110.241 176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' OG ' ' A' ' 21' ' ' SER . 11.9 t -27.64 -26.6 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 131.29 3.836 . . . . 11.56 115.55 163.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.13 -88.18 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.612 1.165 . . . . 11.43 109.248 168.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -59.25 -18.61 38.64 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.316 1.046 . . . . 12.95 113.251 -175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 18' ' ' SER . 80.2 p -55.42 -9.24 0.44 Allowed 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.12 1.768 . . . . 9.0 113.678 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.46 -7.89 0.03 OUTLIER Glycine 0 CA--C 1.537 1.424 0 CA-C-O 119.03 -0.872 . . . . 7.75 114.166 160.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -26.04 -61.03 0.08 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 118.552 1.176 . . . . 9.84 111.651 150.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.3 ttt 61.71 -72.04 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.85 1.66 . . . . 13.58 112.733 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.62 -36.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.864 1.266 . . . . 16.02 112.044 -167.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.37 105.55 1.29 Allowed 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.491 -0.756 . . . . 17.86 109.437 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -143.33 -33.5 0.44 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.743 -1.122 . . . . 18.77 113.651 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 66.04 81.58 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.371 1.068 . . . . 25.81 112.94 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -126.22 167.87 14.85 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 107.706 -1.22 . . . . 20.78 107.706 164.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -58.41 -51.69 68.76 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.792 0.806 . . . . 26.22 109.46 166.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 154.84 117.14 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 130.156 3.382 . . . . 22.05 104.475 -167.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.9 mt -78.14 -71.01 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 107.568 -1.271 . . . . 17.31 107.568 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -132.83 -103.34 0.85 Allowed Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 106.015 -2.834 . . . . 14.82 106.015 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 35' ' ' ILE . 1.1 m-20 -59.19 158.75 8.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.474 1.51 . . . . 12.0 109.759 164.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 34' ' ' ASP . 15.6 pt -168.24 135.47 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 126.568 1.947 . . . . 11.66 106.74 -178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.67 26.72 1.39 Allowed 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 119.559 1.072 . . . . 4.3 113.834 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' CA ' HG22 ' A' ' 40' ' ' THR . . . -166.13 -55.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.185 -0.766 . . . . 2.73 111.185 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 44.07 -88.93 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 127.2 2.2 . . . . 6.75 112.173 -175.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.536 ' CB ' ' HA ' ' A' ' 106' ' ' HIS . 0.0 OUTLIER -54.72 -46.64 74.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.841 -1.162 . . . . 10.76 112.57 172.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.495 HG22 ' CA ' ' A' ' 37' ' ' GLY . 4.3 t -61.11 -37.15 81.75 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 118.992 -1.083 . . . . 3.82 109.213 -165.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.4 p -70.33 -66.78 0.56 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.606 -0.725 . . . . 3.14 109.741 167.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -49.56 -37.01 25.55 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.917 2.087 . . . . 5.21 115.686 -170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.76 -25.98 5.06 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.06 1.3 . . . . 4.7 109.946 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 100.4 55.38 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 130.453 3.501 . . . . 4.13 106.515 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.1 mt -107.72 155.77 39.2 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 113.24 -1.8 . . . . 2.78 109.17 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -59.28 178.63 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.938 3.092 . . . . 3.21 113.227 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -59.82 -47.51 85.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.51 0.724 . . . . 5.8 111.153 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.89 -175.51 34.86 Favored Glycine 0 CA--C 1.523 0.554 0 O-C-N 121.054 -1.029 . . . . 2.76 112.07 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 112.92 -84.06 0.35 Allowed Glycine 0 CA--C 1.531 1.071 0 C-N-CA 125.066 1.317 . . . . 1.99 114.223 166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -155.15 121.99 5.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 117.706 0.753 . . . . 5.55 111.525 -168.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' H ' HG13 ' A' ' 71' ' ' ILE . . . -78.95 175.14 10.83 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.759 -0.83 . . . . 1.49 108.759 158.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.8 t -119.45 57.22 0.91 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.267 0.627 . . . . 1.56 110.075 -165.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -80.79 93.7 6.28 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.94 -0.475 . . . . 2.92 110.319 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -84.69 106.89 16.58 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.364 -1.717 . . . . 5.76 106.364 155.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.16 169.73 34.29 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.27 -0.49 . . . . 0.86 112.456 -172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -121.77 142.84 49.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.5 1.52 . . . . 2.16 108.423 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.42 0.92 Allowed 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 104.87 -2.27 . . . . 0.9 104.87 163.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -79.84 142.76 34.97 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 123.133 0.573 . . . . 2.09 109.697 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.74 162.53 50.56 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.667 -0.973 . . . . 0.88 110.667 -168.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.9 t -54.21 -25.44 22.97 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.787 0.435 . . . . 1.87 111.206 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -122.34 24.37 9.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.285 1.834 . . . . 3.24 110.02 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.451 21.8 t0 15.01 72.84 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 118.803 2.89 . . . . 2.92 118.803 -151.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.99 54.67 0.67 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.12 -1.437 . . . . 1.06 107.12 146.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.96 -178.86 20.43 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.726 2.108 . . . . 1.06 108.007 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -151.2 -179.31 26.81 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.346 1.073 . . . . 1.1 112.693 -168.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -77.29 130.72 37.56 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.096 1.358 . . . . 3.58 111.153 -167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp -79.6 85.75 5.31 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.899 -0.778 . . . . 1.04 108.899 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 124.56 28.25 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.928 -0.482 . . . . 2.52 110.496 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -74.85 131.06 40.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.781 0.832 . . . . 1.99 112.239 -152.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.0 m -157.07 96.64 1.6 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.289 0.636 . . . . 1.12 110.202 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 73' ' ' PHE . 0.3 OUTLIER -144.82 137.29 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.223 0.92 . . . . 1.66 109.122 174.085 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.87 102.92 12.43 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.519 1.127 . . . . 3.52 109.932 175.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 71' ' ' ILE . 82.4 m-85 -34.68 -59.39 0.47 Allowed 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.198 2.199 . . . . 2.88 115.943 -167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -32.08 -56.94 0.31 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 126.524 1.93 . . . . 1.74 111.497 -172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.56 -18.01 13.95 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.039 -1.437 . . . . 1.2 111.08 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.274 18.5 tttm 50.3 86.44 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 127.289 2.236 . . . . 4.47 113.174 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.412 ' N ' HE21 ' A' ' 77' ' ' GLN . 0.0 OUTLIER -85.2 62.06 7.26 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.231 -2.259 . . . . 2.32 106.668 177.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.06 93.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 125.305 1.431 . . . . 1.27 111.276 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.47 169.68 17.36 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.99 -1.485 . . . . 2.61 106.99 -177.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' H ' HD12 ' A' ' 94' ' ' LEU . . . -156.36 136.94 5.24 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 106.587 -2.605 . . . . 0.79 106.587 161.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 128.83 33.95 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.225 -1.398 . . . . 5.86 107.225 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.461 HG23 ' HB ' ' A' ' 92' ' ' VAL 0.256 0.0 OUTLIER -100.52 98.28 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.702 -1.221 . . . . 3.38 107.702 -177.093 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -140.8 102.43 4.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 113.957 -1.474 . . . . 2.69 109.835 -159.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -162.35 -10.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.326 1.851 . . . . 3.84 114.95 157.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 90' ' ' LEU . 6.3 mp -74.89 140.33 43.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 120.508 -1.37 . . . . 1.92 109.859 -158.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -22.22 62.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.775 1.23 . . . . 3.88 113.283 -168.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 m -105.63 118.86 54.41 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 106.66 -1.607 . . . . 2.02 106.66 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -46.86 -48.78 13.55 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.885 2.39 . . . . 1.83 112.56 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.61 -35.95 22.66 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.338 1.455 . . . . 3.63 112.5 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' HD22 ' A' ' 85' ' ' LEU . 1.2 mm? -72.68 -16.86 61.68 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.415 0.686 . . . . 2.59 110.921 -173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -77.76 130.39 36.67 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.555 -1.646 . . . . 2.1 106.555 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.461 ' HB ' HG23 ' A' ' 82' ' ' ILE . 2.5 t -113.18 141.83 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 109.08 -0.711 . . . . 0.95 109.08 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -122.24 147.09 46.63 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 3.04 107.104 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 80' ' ' GLY . 9.7 mt -108.29 158.38 17.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.36 1.064 . . . . 1.63 109.134 -173.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.78 130.93 35.96 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.519 0.728 . . . . 1.48 110.563 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.01 64.12 2.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.363 1.865 . . . . 1.95 111.561 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.81 143.74 30.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.527 1.931 . . . . 1.1 109.341 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -96.59 175.86 6.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.406 1.482 . . . . 3.09 111.743 -171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.06 89.68 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.362 1.465 . . . . 1.72 109.264 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 8.5 tmtm? -115.81 -41.93 0.06 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 125.006 1.322 . . . . 6.98 111.976 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.411 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 38.7 Cg_exo -70.92 170.21 18.52 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 121.996 1.797 . . . . 4.07 113.642 177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.4 t70 69.15 -171.53 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.18 1.792 . . . . 5.25 112.68 164.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.97 74.63 0.02 OUTLIER Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.25 0.929 . . . . 3.01 110.994 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -123.7 -40.58 2.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.596 1.158 . . . . 6.7 112.187 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.86 93.87 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 126.632 1.973 . . . . 10.85 105.846 173.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 39' ' ' HIS 0.268 48.5 m-70 68.53 -47.54 0.55 Allowed 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.807 2.043 . . . . 7.69 114.239 -173.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 71.07 -177.02 0.2 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.741 1.217 . . . . 2.74 111.469 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.9 m -140.12 164.74 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 121.696 0.76 . . . . 1.17 112.833 -160.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.0 mt -99.6 174.36 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 127.712 2.405 . . . . 2.37 108.483 174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 p -151.91 63.23 0.85 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.648 1.179 . . . . 2.34 109.561 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.73 159.97 32.22 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 121.671 -0.643 . . . . 0.9 112.033 -177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.3 m -85.44 166.0 16.71 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.035 0.934 . . . . 1.58 109.403 166.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.15 159.74 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 119.077 0.853 . . . . 0.79 110.508 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.14 139.95 47.35 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 114.02 1.119 . . . . 2.98 114.02 -176.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.09 59.27 2.67 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.706 1.603 . . . . 5.84 108.286 175.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 34.8 t30 63.65 -29.42 0.09 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.531 1.932 . . . . 3.66 114.048 -172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.17 -57.7 0.96 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.13 2.172 . . . . 2.26 109.201 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -79.62 105.59 11.03 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.039 0.536 . . . . 1.47 111.116 -169.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -79.46 58.67 2.71 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.054 0.542 . . . . 3.48 111.325 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -111.44 61.15 0.61 Allowed 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 122.785 1.279 . . . . 3.06 108.965 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.8 155.57 26.62 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 113.385 -1.734 . . . . 0.6 112.968 168.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.37 162.09 18.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.463 1.905 . . . . 0.82 108.796 171.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -155.9 142.09 18.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.587 0.755 . . . . 2.33 109.187 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.1 t -133.71 131.5 39.52 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.225 -1.769 . . . . 2.52 106.225 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -145.96 137.3 24.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 123.778 0.673 . . . . 1.1 110.413 -171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -140.48 164.86 26.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 126.583 2.04 . . . . 1.08 108.651 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -106.1 165.96 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 108.547 -0.908 . . . . 3.0 108.547 176.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -141.79 151.28 42.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.269 0.84 . . . . 4.51 113.269 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.26 -9.68 20.27 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.549 -1.205 . . . . 2.49 114.77 151.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.5 36.67 7.9 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.045 1.422 . . . . 2.85 110.889 171.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? 163.96 44.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 131.352 3.861 . . . . 3.27 110.091 173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . 45.41 68.15 0.62 Allowed 'General case' 0 C--N 1.346 0.427 0 C-N-CA 125.191 1.396 . . . . 1.31 113.241 172.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -100.77 -48.9 4.33 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.194 0.452 . . . . 2.91 111.671 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -131.41 148.0 52.61 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.575 -1.268 . . . . 3.08 107.575 170.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 154' ' ' ALA . 19.2 m -92.31 144.79 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 108.42 -0.955 . . . . 1.86 108.42 170.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.85 117.36 29.52 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 105.734 -1.95 . . . . 2.23 105.734 172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.69 176.99 34.67 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.628 -0.989 . . . . 1.27 110.628 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 t -144.52 145.81 32.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.108 -1.812 . . . . 2.28 106.108 159.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.62 158.14 16.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.86 -1.533 . . . . 1.01 106.86 155.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -142.47 98.49 3.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.76 1.224 . . . . 4.03 108.397 163.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.91 151.48 12.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.164 1.385 . . . . 1.97 108.923 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -141.42 136.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.228 -0.656 . . . . 3.76 109.228 172.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.6 m -155.86 170.2 22.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 104.952 -2.24 . . . . 2.44 104.952 173.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.67 -33.54 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.933 0.893 . . . . 2.07 110.732 172.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -136.42 57.64 1.77 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.217 1.007 . . . . 2.93 108.714 168.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 123.66 5.6 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.321 -1.111 . . . . 0.95 110.321 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.16 127.25 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 124.632 1.173 . . . . 1.42 111.215 -174.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -75.75 -69.37 0.49 Allowed 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.567 -0.288 . . . . 3.7 110.935 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -74.89 73.2 2.12 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.292 0.568 . . . . 2.3 111.218 -163.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.45 126.45 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.751 1.22 . . . . 1.34 109.519 -176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.92 100.4 1.73 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 108.356 -1.897 . . . . 1.08 108.356 171.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.19 119.93 32.92 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.415 1.086 . . . . 1.17 108.169 175.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -148.07 152.59 37.64 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.569 0.622 . . . . 1.03 109.752 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -136.49 146.02 45.8 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.353 1.061 . . . . 0.88 108.835 171.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -140.96 118.63 11.64 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.614 -1.995 . . . . 4.15 105.614 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 119.828 -0.749 . . . . 4.03 113.003 -155.355 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ptp . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.02 -1.104 . . . . 54.35 108.02 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -161.82 169.99 20.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.113 -1.81 . . . . 46.85 106.113 176.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -151.39 164.04 37.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.452 -1.314 . . . . 44.05 107.452 171.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.4 171.65 16.68 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.472 1.909 . . . . 39.01 106.538 178.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.2 p -163.06 173.79 13.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.88 1.272 . . . . 34.96 107.597 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -160.11 172.83 16.75 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.795 -1.187 . . . . 30.74 107.795 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 pp -136.74 173.69 11.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.631 1.572 . . . . 26.96 109.109 177.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.4 p -144.78 159.4 42.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.659 1.184 . . . . 23.48 109.035 -175.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.92 168.64 24.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.869 1.267 . . . . 19.6 107.6 173.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -163.55 159.54 22.05 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.242 -1.392 . . . . 16.23 107.242 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -161.87 172.42 16.1 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.635 1.174 . . . . 14.04 109.173 177.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 t -135.09 -157.37 0.79 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.668 1.587 . . . . 10.55 109.083 178.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.65 133.32 13.61 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.169 -1.049 . . . . 7.21 108.169 172.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 162.45 -81.8 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 127.734 2.414 . . . . 13.09 110.494 -175.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -152.46 142.69 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.351 1.06 . . . . 14.99 108.47 -170.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 17' ' ' ASP . 38.1 tp60 76.91 -174.99 0.1 Allowed 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 126.819 2.048 . . . . 16.99 108.607 176.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 16' ' ' GLN . 2.3 m-20 -43.94 -36.77 2.57 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.081 -1.012 . . . . 14.67 113.318 -177.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.6 m -35.6 -43.97 0.29 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.94 1.696 . . . . 10.43 113.684 169.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -39.65 -76.05 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.075 1.75 . . . . 12.27 111.257 174.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -70.41 -49.31 50.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.978 -0.555 . . . . 13.06 110.339 179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -64.58 -25.71 68.09 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 112.19 0.441 . . . . 10.34 112.19 -166.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.99 -68.93 1.49 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.768 -1.333 . . . . 9.43 109.768 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -53.83 13.39 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 113.149 0.796 . . . . 11.92 113.149 -169.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.62 76.58 0.99 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.395 1.478 . . . . 11.69 108.865 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.2 t -41.83 139.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.522 1.929 . . . . 14.99 112.563 -179.056 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.08 98.89 0.05 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 126.898 2.079 . . . . 16.87 110.959 179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -68.76 124.08 22.67 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.984 -0.448 . . . . 17.27 111.58 -177.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -107.01 58.77 0.63 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.941 -1.133 . . . . 20.7 107.941 166.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 49.09 40.7 17.99 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.269 1.428 . . . . 21.64 112.908 173.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -57.07 -60.37 3.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.799 0.666 . . . . 19.25 112.799 -167.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -165.53 61.18 0.11 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 106.236 -1.765 . . . . 18.35 106.236 -176.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mm -75.45 76.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 123.774 0.829 . . . . 13.54 110.384 -163.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.54 85.53 0.08 OUTLIER Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.061 -1.216 . . . . 9.64 110.061 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.05 69.27 0.67 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.821 1.248 . . . . 8.76 110.791 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -69.86 -74.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.308 -1.738 . . . . 8.55 106.308 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 33.77 78.08 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.767 1.627 . . . . 4.8 111.768 -171.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.06 43.06 1.49 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-O 118.786 -1.008 . . . . 2.83 113.483 -161.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -101.22 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.56 2.744 . . . . 4.39 115.157 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' NE2' HD11 ' A' ' 99' ' ' ILE . 51.1 p-80 -55.98 -43.83 77.98 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.855 1.207 . . . . 7.42 111.812 -170.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 m -48.65 -57.66 5.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.599 1.56 . . . . 2.7 109.206 -174.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.57 -36.69 65.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.572 0.952 . . . . 2.16 113.572 175.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -39.41 -65.14 0.41 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.93 1.692 . . . . 3.51 114.165 -162.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -52.04 -51.09 59.78 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.649 0.737 . . . . 4.48 110.79 -166.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -157.14 -56.02 0.08 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.009 2.524 . . . . 6.69 108.131 -175.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -35.93 109.43 0.4 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.453 1.501 . . . . 2.33 113.379 -153.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -80.97 -138.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 124.491 3.461 . . . . 2.1 111.764 -174.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 -38.65 77.16 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.667 -1.271 . . . . 5.79 111.586 172.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.58 47.84 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 124.799 1.19 . . . . 2.65 113.203 -177.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.49 -39.18 0.8 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.48 -1.048 . . . . 2.0 110.48 -174.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.62 165.02 29.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.252 -1.018 . . . . 8.71 108.252 168.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.8 -179.38 3.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.686 1.595 . . . . 1.83 110.733 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.52 109.84 15.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.555 -1.276 . . . . 1.9 107.555 160.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.546 ' H ' ' HB3' ' A' ' 69' ' ' TYR . 31.5 p90 -157.56 117.8 3.44 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.331 1.053 . . . . 4.91 112.524 157.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -79.03 73.55 5.57 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.664 -1.272 . . . . 5.96 108.15 166.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.46 138.37 24.03 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-N 115.779 -0.646 . . . . 1.07 111.992 -175.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 p -117.71 109.94 17.24 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.188 1.395 . . . . 2.31 107.715 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 73.93 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.239 -1.393 . . . . 0.95 107.239 174.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -78.69 138.63 38.37 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.249 -0.649 . . . . 2.14 109.249 -176.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.42 165.11 52.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.964 -1.254 . . . . 1.04 109.964 -171.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -55.71 -30.26 60.85 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 122.112 -0.64 . . . . 1.66 110.672 172.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -107.77 16.35 23.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.222 1.809 . . . . 2.38 110.618 178.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.444 26.7 t0 16.44 70.85 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 117.944 2.572 . . . . 3.4 117.944 -146.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -107.92 55.45 0.64 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.846 -1.538 . . . . 1.36 106.846 149.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.32 -178.59 27.42 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.973 1.749 . . . . 1.27 110.75 -174.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.47 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -129.24 176.12 18.6 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 122.493 1.052 . . . . 0.89 113.671 -174.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -89.67 113.4 24.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.506 -1.294 . . . . 3.67 107.506 176.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 tp -79.12 92.43 5.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.826 -1.546 . . . . 1.39 106.826 174.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -77.72 145.52 36.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.72 0.772 . . . . 1.75 110.946 -173.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 35.0 p90 -75.84 117.41 17.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.008 0.923 . . . . 3.09 112.398 -172.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.2 m -156.7 88.7 1.06 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.706 -0.85 . . . . 1.35 108.706 175.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.591 HG22 ' HA2' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -129.82 145.72 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.291 0.95 . . . . 1.6 111.16 173.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -92.23 120.99 33.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.321 1.448 . . . . 4.47 107.201 168.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -66.9 -1.25 3.76 Favored 'General case' 0 C--N 1.322 -0.588 0 O-C-N 119.559 -1.963 . . . . 2.3 114.214 -177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.09 -42.68 56.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 119.317 0.962 . . . . 1.57 108.424 -178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.48 -14.89 0.33 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.822 1.045 . . . . 1.12 113.822 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? 84.56 74.42 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.866 0.867 . . . . 5.27 110.42 151.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -76.25 51.02 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.454 1.102 . . . . 2.36 109.986 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.591 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -57.76 106.63 0.82 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 124.299 0.952 . . . . 1.18 110.932 -175.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.22 160.15 43.24 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.843 -1.91 . . . . 2.97 105.843 -175.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.29 133.07 3.22 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 108.201 -1.96 . . . . 1.04 108.201 163.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -82.54 132.5 35.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.284 1.042 . . . . 3.63 112.001 -177.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 82' ' ' ILE . 44.0 mt -81.66 61.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.504 -1.295 . . . . 1.92 107.504 178.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -97.01 96.74 8.7 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.531 -1.285 . . . . 2.22 107.531 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -155.31 -10.75 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.82 1.045 . . . . 3.28 113.82 -172.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.5 mt -111.28 140.93 45.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 119.473 1.033 . . . . 1.76 111.578 -147.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -20.93 48.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.485 1.914 . . . . 3.56 113.464 -176.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 51.1 m -107.49 130.73 22.42 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 106.343 -1.725 . . . . 1.39 106.343 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -57.24 -54.95 2.93 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.414 2.076 . . . . 1.62 111.428 -168.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -20.28 66.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.635 1.174 . . . . 3.06 112.712 -176.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.27 -18.96 65.42 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 118.618 -0.706 . . . . 2.37 111.925 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -72.55 80.01 1.07 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.522 1.055 . . . . 1.72 108.667 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -61.91 135.95 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 125.249 1.42 . . . . 1.11 109.329 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -114.53 160.66 18.99 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.864 -0.791 . . . . 2.28 108.864 166.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.87 137.52 52.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.029 2.532 . . . . 2.58 109.422 -168.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.1 132.0 34.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.335 0.654 . . . . 1.01 110.446 176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.52 25.81 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.838 0.855 . . . . 1.15 109.074 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.96 146.16 30.01 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.381 1.073 . . . . 1.12 108.106 -178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.46 172.89 13.17 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.668 1.187 . . . . 4.49 110.434 -175.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -127.93 93.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 103.619 -2.734 . . . . 2.21 103.619 166.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.59 -63.63 0.05 OUTLIER Pre-proline 0 N--CA 1.439 -1.004 0 CA-C-O 118.008 -0.996 . . . . 7.34 110.291 -164.176 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -84.27 158.37 13.0 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 121.228 1.474 . . . . 3.18 110.742 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.31 -164.75 1.54 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.185 0.994 . . . . 6.07 108.444 156.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.76 55.21 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 106.626 -2.59 . . . . 4.14 106.626 160.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -164.01 36.79 0.08 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.081 0.467 . . . . 5.49 111.429 -164.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.55 -47.07 0.55 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.381 . . . . 9.04 111.558 -167.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.83 160.26 36.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.536 0.734 . . . . 7.48 111.715 173.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -116.33 -143.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.636 1.174 . . . . 3.06 110.58 170.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.28 167.33 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.343 1.857 . . . . 1.18 108.788 -176.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.4 mt -79.08 169.06 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.547 1.139 . . . . 2.18 107.965 163.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -147.64 82.58 1.52 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.46 -1.311 . . . . 1.85 107.46 165.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -104.04 146.77 16.39 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 109.973 -1.251 . . . . 0.97 109.973 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.8 m -79.29 157.91 27.64 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.934 -0.765 . . . . 1.36 108.934 174.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.13 155.88 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.555 -1.276 . . . . 0.81 107.555 175.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.36 144.25 51.16 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 112.196 0.443 . . . . 2.12 112.196 -178.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -77.4 66.69 3.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.62 -1.993 . . . . 5.41 105.62 174.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 59.46 -54.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 129.744 3.218 . . . . 3.14 114.076 -176.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -105.73 -42.83 5.06 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.865 1.266 . . . . 2.07 111.458 166.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.15 104.93 17.44 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.396 -0.815 . . . . 1.43 112.044 -165.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -79.22 77.62 5.73 Favored 'General case' 0 C--O 1.226 -0.142 0 O-C-N 121.776 -0.577 . . . . 3.29 111.152 -176.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 32.6 mmmt -130.57 69.33 1.46 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 122.778 1.275 . . . . 3.25 109.438 165.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.9 163.9 33.44 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 113.347 -1.751 . . . . 0.63 110.559 161.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 p -148.21 157.3 43.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.372 1.069 . . . . 0.83 109.572 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.18 142.06 26.89 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.014 -0.736 . . . . 2.54 109.014 -175.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 p -130.02 116.22 18.24 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.8 -1.185 . . . . 1.49 107.8 -179.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 126' ' ' GLY . 1.5 tm? -131.6 131.16 43.04 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.536 0.684 . . . . 0.91 111.96 -163.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.498 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -89.73 -178.68 45.0 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 128.069 2.747 . . . . 2.2 113.064 -168.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.85 131.43 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.045 -1.095 . . . . 2.29 108.045 161.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.67 83.8 1.59 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.129 -1.434 . . . . 4.95 107.129 168.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.26 70.88 0.34 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.22 1.391 . . . . 4.16 112.241 -173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.84 -44.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.841 -1.703 . . . . 2.68 108.841 169.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -149.77 21.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.155 0.582 . . . . 3.49 111.189 177.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.85 23.86 14.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.683 1.193 . . . . 2.04 112.967 171.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -64.71 -48.91 72.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 122.893 0.477 . . . . 3.44 110.138 -156.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -140.96 102.63 4.31 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.256 -1.387 . . . . 2.63 107.256 -169.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.6 84.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.033 -1.469 . . . . 1.87 107.033 171.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.93 36.93 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.118 -1.067 . . . . 0.85 108.118 177.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -156.33 177.93 33.09 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 110.839 -0.905 . . . . 1.11 110.839 -174.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 t -125.47 147.22 49.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.587 -1.634 . . . . 2.25 106.587 162.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.92 139.66 34.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.012 0.525 . . . . 1.18 110.026 173.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -122.96 133.76 54.37 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.63 1.172 . . . . 3.25 109.423 171.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.91 149.24 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 105.988 -1.856 . . . . 2.09 105.988 166.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 109.04 3.45 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.431 -0.581 . . . . 3.24 109.431 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.7 p -134.69 -161.79 1.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.976 -1.49 . . . . 2.3 106.976 167.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 92.4 t -49.12 -31.97 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.418 0.687 . . . . 2.28 110.604 163.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.66 57.73 0.62 Allowed 'General case' 0 C--N 1.34 0.163 0 CA-C-O 122.375 1.084 . . . . 2.58 108.459 174.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.27 122.83 7.2 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 105.162 -3.175 . . . . 0.99 105.162 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.52 124.58 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-O 121.401 0.62 . . . . 1.52 110.492 -167.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.4 mtp85 -64.42 -83.06 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 2.82 111.421 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -78.84 77.39 5.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.764 -0.585 . . . . 2.2 110.077 -164.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.9 mt -78.7 121.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.76 -1.2 . . . . 1.22 107.76 176.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -78.51 93.31 1.23 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 108.157 -1.977 . . . . 1.12 108.157 175.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -80.58 86.4 5.86 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.285 1.034 . . . . 1.29 108.973 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.78 153.45 19.8 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.798 0.839 . . . . 1.18 110.258 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -142.9 145.87 33.5 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.939 0.895 . . . . 1.59 110.347 178.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -145.18 163.57 33.98 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 106.82 -1.548 . . . . 3.39 106.82 160.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.438 -1.069 0 O-C-N 124.354 1.034 . . . . 3.86 109.446 163.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 106.629 -1.619 . . . . 58.61 106.629 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.42 144.24 56.09 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.986 0.812 . . . . 51.66 109.3 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -161.6 157.69 25.07 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.87 -1.529 . . . . 47.32 106.87 171.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -173.24 157.06 3.3 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.941 1.697 . . . . 43.04 106.862 179.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -163.43 171.99 15.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.844 -1.539 . . . . 38.56 106.844 165.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.31 153.78 5.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.658 1.583 . . . . 34.35 107.642 179.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 pp -151.15 162.8 40.2 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.291 1.436 . . . . 29.85 107.996 178.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.4 t -165.33 -134.02 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.256 0.622 . . . . 26.0 109.455 179.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 66.42 163.35 0.17 Allowed 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.009 2.524 . . . . 22.38 111.084 -174.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -143.86 159.86 41.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.563 1.145 . . . . 18.29 109.88 -174.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.74 157.07 0.13 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.951 2.101 . . . . 17.99 108.099 170.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 t -159.78 179.41 8.85 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 104.586 -2.376 . . . . 11.17 104.586 169.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.88 77.55 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.443 1.497 . . . . 8.16 111.331 -170.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -75.52 -164.85 0.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.547 1.939 . . . . 15.07 108.907 175.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -133.88 146.69 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 106.407 -1.701 . . . . 15.59 106.407 178.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 85.87 73.33 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 128.103 2.561 . . . . 22.54 109.783 178.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.04 -53.13 0.67 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 127.146 2.178 . . . . 23.8 111.287 172.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.4 m -48.82 -22.37 0.81 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.06 1.344 . . . . 17.89 112.938 169.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.01 -49.53 50.37 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.751 0.82 . . . . 17.23 112.293 169.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -71.33 -36.03 71.42 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.829 -0.544 . . . . 22.24 112.407 -169.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.3 p -70.52 -50.12 41.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.685 -0.857 . . . . 17.29 108.685 169.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -34.85 -50.18 0.78 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 127.453 2.454 . . . . 13.11 113.273 173.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -31.52 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.646 2.778 . . . . 16.87 115.047 170.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 58.3 mtt -73.86 75.34 1.63 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.864 0.84 . . . . 17.5 110.809 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.0 t -55.61 80.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 127.21 2.204 . . . . 16.81 108.279 165.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.43 -41.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.351 1.46 . . . . 18.88 109.429 -168.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -52.41 40.93 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.349 0.87 . . . . 20.17 113.349 -175.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -155.97 174.53 15.21 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.306 1.442 . . . . 22.37 108.185 -174.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -138.12 -52.32 0.61 Allowed 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 124.28 0.988 . . . . 17.38 108.688 157.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 61.84 -158.38 0.33 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.677 -0.86 . . . . 17.37 108.677 -168.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -69.43 -39.52 77.81 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.654 -0.653 . . . . 21.21 110.215 171.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.7 mt -141.86 135.25 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.601 -2.0 . . . . 16.99 105.601 175.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.78 49.12 0.04 OUTLIER Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.536 1.541 . . . . 12.0 109.713 178.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 p-10 -159.36 56.21 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.305 1.042 . . . . 12.06 109.558 -148.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.4 mm -71.54 164.43 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.17 -1.048 . . . . 9.82 108.17 171.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.64 64.5 1.29 Allowed 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.866 -0.521 . . . . 7.29 111.115 -174.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.73 60.32 7.92 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 121.303 -0.873 . . . . 2.93 111.208 175.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -35.26 -60.77 0.47 Allowed 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 126.489 1.916 . . . . 3.83 113.128 -175.487 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -67.46 -24.42 65.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.822 -0.608 . . . . 4.27 112.08 -170.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.52 HG21 ' HG2' ' A' ' 76' ' ' LYS . 2.8 m -73.97 -54.97 6.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.653 0.66 . . . . 2.65 111.17 165.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -35.74 20.15 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.816 0.446 . . . . 2.1 112.125 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -37.36 -48.63 0.94 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.807 2.043 . . . . 4.49 112.413 169.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.11 -5.97 20.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.31 1.044 . . . . 4.03 113.017 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER 88.79 60.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.384 2.673 . . . . 3.91 109.247 177.941 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.97 109.17 32.08 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.765 1.626 . . . . 3.32 107.668 172.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.96 -161.22 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.926 3.084 . . . . 2.05 116.22 -167.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.02 -37.02 78.53 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.679 1.991 . . . . 5.85 113.487 -177.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -163.6 156.19 27.89 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.173 -1.571 . . . . 2.94 109.173 -174.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 -139.06 5.94 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.078 0.939 . . . . 1.88 112.729 179.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.45 148.46 19.8 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 128.446 2.698 . . . . 5.18 104.701 169.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.69 176.89 7.27 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.994 -0.743 . . . . 1.4 108.994 177.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -130.39 55.1 1.83 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 122.242 -0.286 . . . . 1.8 110.27 -174.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' H ' ' HB3' ' A' ' 69' ' ' TYR 0.271 2.2 p90 -99.42 148.94 23.7 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 116.967 2.21 . . . . 4.44 116.967 -177.832 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -132.35 121.66 23.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 126.011 1.725 . . . . 4.93 107.325 -175.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -168.6 -172.47 35.5 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 118.383 0.538 . . . . 0.95 112.112 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -139.37 152.25 46.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.692 0.797 . . . . 3.62 110.251 176.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -107.52 76.24 1.06 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.68 -1.97 . . . . 1.24 105.68 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -82.81 136.56 34.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.863 0.865 . . . . 2.34 109.731 -169.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.79 161.61 49.73 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.886 -1.285 . . . . 0.94 109.886 -179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -53.08 -29.3 29.5 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.779 -0.836 . . . . 1.83 111.01 161.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -89.13 -1.4 58.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.622 1.569 . . . . 2.19 112.159 176.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.296 35.6 t0 33.4 50.96 0.3 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.205 1.802 . . . . 2.38 113.699 -155.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.16 57.05 0.66 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.05 -1.833 . . . . 1.06 106.05 160.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.14 117.2 1.59 Allowed Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 109.253 -1.539 . . . . 1.95 109.253 -171.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.38 179.47 52.98 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 123.396 1.553 . . . . 1.04 112.963 -172.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.29 148.13 33.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.31 1.444 . . . . 4.19 110.941 -167.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD13 HD21 ' A' ' 152' ' ' LEU . 15.8 tp -87.63 162.8 16.93 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 1.62 109.63 174.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.8 p -135.13 147.72 49.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.007 1.323 . . . . 2.24 108.964 173.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.48 ' HB3' ' H ' ' A' ' 53' ' ' TYR . 31.2 p90 -75.92 125.95 30.08 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.892 0.377 . . . . 2.69 111.597 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -156.98 99.38 1.82 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.133 -1.432 . . . . 1.73 107.133 164.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -143.9 110.27 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 104.518 -2.401 . . . . 2.3 104.518 160.3 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.7 128.25 51.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.941 0.877 . . . . 3.99 108.694 -167.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -74.42 5.84 4.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.276 1.584 . . . . 3.06 115.276 -150.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.63 -53.2 59.32 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.257 0.935 . . . . 2.31 109.238 168.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -135.53 3.78 3.07 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.74 0.816 . . . . 1.58 112.027 -176.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.52 ' HG2' HG21 ' A' ' 40' ' ' THR . 10.8 mptt 56.37 67.97 0.93 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.665 1.186 . . . . 7.66 113.969 177.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.3 61.04 5.31 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.01 0.924 . . . . 2.7 110.106 -171.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -44.71 117.9 2.34 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.543 1.068 . . . . 1.8 113.595 -173.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.21 158.47 16.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 122.022 -0.693 . . . . 3.14 109.67 -174.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.6 130.88 2.81 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.409 -1.476 . . . . 0.86 109.409 169.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.62 151.51 23.85 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 6.65 108.948 178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.1 mt -128.82 109.39 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.951 1.301 . . . . 1.98 109.322 -172.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -150.67 89.53 1.56 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.96 0.904 . . . . 3.34 109.65 175.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -159.61 76.14 0.66 Allowed 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 107.269 -1.382 . . . . 4.38 107.269 167.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -141.83 173.92 11.06 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.572 0.701 . . . . 2.95 111.957 -156.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -14.13 27.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.575 1.55 . . . . 4.1 111.139 -174.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.8 p -150.98 162.84 25.68 Favored Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 122.873 0.469 . . . . 2.44 110.617 -170.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.86 177.16 5.21 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.263 2.642 . . . . 3.53 109.826 163.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.321 9.3 pt-20 65.45 -44.78 0.37 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 130.266 3.426 . . . . 4.35 113.045 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.22 -26.29 1.88 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.596 1.558 . . . . 2.06 112.414 162.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.54 74.25 1.05 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 123.908 0.883 . . . . 2.84 108.841 -175.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.38 135.06 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.214 1.006 . . . . 1.1 110.805 -173.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -114.08 164.13 14.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.544 -1.651 . . . . 2.32 106.544 161.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.09 156.23 44.19 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.548 0.944 . . . . 1.78 113.548 168.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.53 131.67 36.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.057 0.943 . . . . 1.08 108.714 176.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.36 103.41 7.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.542 1.137 . . . . 1.57 108.662 -178.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -113.86 164.45 13.74 Favored 'General case' 0 CA--C 1.526 0.04 0 C-N-CA 125.322 1.449 . . . . 1.13 110.261 -172.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.27 175.19 10.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.629 0.772 . . . . 3.89 111.878 -173.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -121.44 140.86 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 124.456 1.102 . . . . 1.94 108.543 170.001 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 38' ' ' GLU . 4.5 tptp -178.28 55.91 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 130.333 3.453 . . . . 7.76 110.138 163.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.71 -44.7 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.268 1.312 . . . . 6.39 111.011 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -171.02 159.54 6.09 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 125.84 1.656 . . . . 6.0 106.912 -166.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.46 50.22 4.3 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.166 -0.774 . . . . 3.68 111.166 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -132.57 88.59 2.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.476 1.11 . . . . 4.4 109.515 -172.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.67 57.47 0.31 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.91 2.084 . . . . 7.6 113.091 165.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.436 ' CB ' HG23 ' A' ' 40' ' ' THR 0.25 3.9 t-160 40.48 57.34 2.56 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 123.066 1.412 . . . . 6.19 112.013 -178.121 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -44.5 -47.26 10.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.361 1.865 . . . . 2.56 111.991 174.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.4 m -157.96 166.48 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.493 1.117 . . . . 1.45 110.86 177.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 110' ' ' SER . 1.3 pp -112.02 177.2 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 127.599 2.36 . . . . 2.96 108.242 157.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 109' ' ' ILE . 40.9 t -137.18 86.42 2.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.066 0.848 . . . . 1.9 110.937 177.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -99.87 157.46 19.7 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 118.613 0.642 . . . . 0.77 112.06 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.6 m -97.48 147.02 24.66 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.692 1.197 . . . . 1.36 107.811 168.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.9 151.52 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 118.872 0.76 . . . . 0.89 109.973 -179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -132.78 142.51 49.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 113.212 0.819 . . . . 2.34 113.212 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.68 71.79 4.19 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.551 -1.648 . . . . 6.35 106.551 172.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.05 -53.79 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 130.191 3.397 . . . . 3.63 113.373 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -110.16 -34.56 6.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.136 1.775 . . . . 2.07 112.106 165.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.41 90.96 8.37 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.073 -1.017 . . . . 1.84 111.773 -165.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -79.59 75.3 6.24 Favored 'General case' 0 N--CA 1.46 0.047 0 C-N-CA 123.233 0.613 . . . . 3.48 111.023 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -128.13 63.48 1.41 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 123.002 1.382 . . . . 3.04 110.604 166.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -157.72 161.07 31.16 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.218 -1.81 . . . . 0.63 112.942 167.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 42.9 p -132.45 158.32 42.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.702 1.601 . . . . 1.05 109.058 173.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.74 131.92 20.56 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.986 -0.746 . . . . 2.55 108.986 -177.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.9 p -123.39 108.24 12.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.334 -1.728 . . . . 1.56 106.334 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.672 HD23 HD12 ' A' ' 152' ' ' LEU . 0.8 OUTLIER -130.1 142.6 50.58 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.436 1.494 . . . . 0.79 108.015 -174.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -147.13 168.74 28.25 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.402 -0.679 . . . . 1.11 111.402 -177.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 132' ' ' ALA . 0.0 OUTLIER -90.92 144.46 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.661 0.785 . . . . 3.19 111.2 -174.261 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -138.36 165.22 27.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.24 1.019 . . . . 7.06 112.766 171.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.06 -35.36 2.76 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 114.858 -1.065 . . . . 3.24 111.492 -177.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.75 29.96 19.55 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 117.94 0.87 . . . . 2.36 111.02 174.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -137.14 3.37 2.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.322 1.049 . . . . 5.85 111.036 165.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.406 ' H ' HD11 ' A' ' 127' ' ' ILE . . . 57.17 61.27 2.61 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 107.117 -1.438 . . . . 1.47 107.117 -164.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -113.91 -43.34 3.27 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.516 1.926 . . . . 2.68 108.286 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -114.69 144.87 42.75 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.796 -1.187 . . . . 3.15 107.796 158.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 154' ' ' ALA . 17.4 m -126.02 142.81 41.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 106.545 -1.65 . . . . 1.2 106.545 155.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -139.79 145.56 38.35 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.112 -0.699 . . . . 1.13 109.112 -173.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.08 178.19 34.46 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 121.454 0.474 . . . . 0.71 112.453 -173.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -128.59 140.77 51.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.463 -1.681 . . . . 1.91 106.463 166.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -120.22 134.32 55.28 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.351 0.407 . . . . 0.7 110.231 166.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -99.62 115.69 30.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.629 -1.619 . . . . 3.05 106.629 166.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.93 95.32 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 119.68 1.127 . . . . 2.1 110.53 178.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -100.17 129.51 46.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.627 -0.879 . . . . 3.2 108.627 -176.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.9 m -149.63 169.9 19.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.399 -1.704 . . . . 2.5 106.399 171.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 88.1 t -43.73 -32.61 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.745 1.218 . . . . 2.11 111.094 174.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -143.22 55.68 1.37 Allowed 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.742 -1.207 . . . . 2.65 107.742 166.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.65 124.43 6.28 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 107.453 -2.259 . . . . 1.03 107.453 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 147' ' ' ILE . 5.1 mp -78.45 101.27 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 106.872 -1.529 . . . . 2.21 106.872 -171.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -44.5 -66.87 0.34 Allowed 'General case' 0 C--O 1.226 -0.145 0 O-C-N 124.056 0.847 . . . . 2.86 110.393 -174.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -79.57 103.52 9.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.05 -0.722 . . . . 2.28 109.05 -177.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 12.0 mt -112.71 120.72 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 108.264 -1.013 . . . . 1.48 108.264 170.117 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.26 133.7 12.14 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.291 -1.923 . . . . 1.13 108.291 173.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.672 HD12 HD23 ' A' ' 125' ' ' LEU . 1.5 tm? -115.56 113.05 23.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.57 -1.27 . . . . 1.25 107.57 -175.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.74 128.26 28.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.327 -0.62 . . . . 1.12 109.327 -177.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.57 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -133.89 140.16 46.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 123.695 0.798 . . . . 1.18 109.879 174.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -157.13 147.91 21.52 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 124.217 0.948 . . . . 4.52 113.467 158.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.433 -1.32 0 C-N-CA 128.131 2.572 . . . . 4.37 110.908 -177.148 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mtp . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.156 -0.683 . . . . 64.82 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -166.87 154.25 9.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.087 -1.449 . . . . 56.08 107.087 -175.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -158.26 58.47 0.46 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.456 -0.942 . . . . 51.48 108.456 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -117.48 65.42 0.73 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.02 0.928 . . . . 48.46 108.658 -169.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.2 m -155.81 117.59 4.01 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.793 -0.818 . . . . 41.45 108.793 -177.153 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.37 62.87 1.22 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.183 0.993 . . . . 36.82 108.722 179.29 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' H ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.67 179.41 6.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.988 1.715 . . . . 32.41 108.762 179.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -150.99 161.43 42.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.744 -1.206 . . . . 27.62 107.744 169.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.18 113.89 0.56 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.074 -1.454 . . . . 23.36 107.074 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -74.18 71.61 1.68 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.618 -0.882 . . . . 19.5 108.618 177.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 68.0 -67.13 0.2 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.865 2.066 . . . . 17.0 109.741 -174.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m 56.45 22.09 6.17 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 125.811 1.645 . . . . 12.96 112.241 174.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 104' ' ' LYS . 20.7 mm-40 36.14 47.14 0.43 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 127.476 2.31 . . . . 9.68 113.164 -164.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 64.51 -173.0 0.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.058 1.343 . . . . 16.54 110.057 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 mm 66.53 -34.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.995 1.318 . . . . 15.34 114.446 -176.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 75.34 -48.13 0.61 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 128.165 2.586 . . . . 17.3 110.984 178.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -79.18 -104.92 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.015 -1.106 . . . . 13.73 108.015 167.331 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.7 t -28.88 -69.09 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.493 2.317 . . . . 11.92 113.876 -168.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -66.19 -4.93 8.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.765 1.765 . . . . 11.32 115.765 -169.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -46.61 -35.62 6.09 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.927 1.239 . . . . 10.17 110.258 159.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -49.65 -61.17 2.26 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 125.467 1.507 . . . . 8.78 111.461 168.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.72 -46.16 76.25 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.874 -0.89 . . . . 6.52 110.874 179.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -60.12 -45.68 92.17 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 116.967 -1.492 . . . . 12.66 112.048 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 146.51 -1.98 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.648 2.379 . . . . 9.75 115.418 172.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t 68.71 -68.25 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 120.312 1.415 . . . . 12.04 111.92 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.39 87.39 0.11 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 127.255 2.222 . . . . 14.06 111.32 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -167.35 -146.83 0.08 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 122.752 0.421 . . . . 16.43 110.388 -171.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -75.22 61.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.644 1.178 . . . . 21.2 110.94 -176.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -161.59 -66.66 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.772 -1.566 . . . . 16.11 106.772 169.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -140.68 175.67 9.42 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.198 0.999 . . . . 16.57 109.513 176.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -167.4 73.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.337 1.855 . . . . 17.87 106.167 -177.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.4 mt -130.4 128.75 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 107.503 -1.295 . . . . 12.06 107.503 -176.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.54 64.7 2.88 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.703 -1.359 . . . . 9.67 109.703 174.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -143.39 173.54 11.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.912 1.685 . . . . 9.31 107.68 -175.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.0 mt 68.36 -74.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.436 1.894 . . . . 7.59 110.762 173.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 28.93 61.81 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.097 2.159 . . . . 4.93 112.89 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -73.12 90.65 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.052 -0.819 . . . . 2.96 111.052 -170.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.66 -138.16 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.681 1.192 . . . . 9.07 111.662 169.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -34.49 13.44 Favored 'General case' 0 C--N 1.344 0.339 0 O-C-N 121.191 -0.943 . . . . 8.32 112.424 -174.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -35.95 -60.22 0.55 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.352 1.061 . . . . 2.27 110.134 168.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.29 -62.33 1.65 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.3 1.04 . . . . 1.7 111.894 169.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -53.21 -36.82 61.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.738 1.615 . . . . 3.45 114.183 -162.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -32.6 -64.7 0.17 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.025 1.33 . . . . 4.02 111.357 -175.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.23 48.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.839 2.056 . . . . 5.65 107.871 174.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 mt -124.61 149.35 61.78 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 122.664 0.386 . . . . 3.02 110.496 -163.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -80.31 -161.9 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.691 2.927 . . . . 1.95 110.656 -173.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -110.43 6.89 22.53 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.932 1.693 . . . . 5.59 111.92 172.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -50.18 142.91 12.91 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.552 1.549 . . . . 1.82 114.888 -174.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.56 1.19 45.71 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.329 0.966 . . . . 1.83 115.387 -172.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.28 98.95 2.18 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.87 1.835 . . . . 5.45 110.762 178.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 163.46 24.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.442 0.639 . . . . 1.77 112.111 175.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 156' ' ' GLN . 2.4 t -79.51 97.77 6.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.233 1.013 . . . . 2.22 109.202 176.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' CE1' HD13 ' A' ' 71' ' ' ILE . 3.4 m-85 -125.25 68.13 1.13 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.429 1.492 . . . . 3.39 108.053 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -99.53 131.16 45.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.189 -1.041 . . . . 5.38 108.189 177.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.75 -178.91 44.04 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.826 -0.702 . . . . 0.77 113.692 -178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -122.09 118.85 29.72 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.579 2.351 . . . . 2.21 108.049 -174.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.73 75.13 2.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.342 1.457 . . . . 0.9 107.797 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -78.24 138.64 38.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.248 -0.649 . . . . 2.25 109.248 -172.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.82 165.58 53.68 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.445 -1.062 . . . . 1.12 110.445 -168.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -59.49 -24.63 63.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.306 1.053 . . . . 2.12 110.858 169.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.67 1.87 46.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.381 2.272 . . . . 2.51 111.22 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.471 25.4 t0 17.08 70.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 117.651 2.463 . . . . 2.82 117.651 -137.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.46 56.28 0.62 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.569 -1.651 . . . . 1.04 106.632 149.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.48 179.39 34.6 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 122.059 0.811 . . . . 1.02 112.895 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.783 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.26 179.51 21.6 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 126.33 1.919 . . . . 0.71 112.32 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -101.56 174.94 5.74 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.028 -1.101 . . . . 3.74 108.028 169.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 tp -115.49 112.12 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.485 -1.302 . . . . 1.33 107.485 168.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -78.62 141.63 37.87 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.797 -1.186 . . . . 2.04 107.797 168.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -79.54 119.94 23.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.627 0.649 . . . . 2.2 112.031 -175.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 m -156.3 110.25 2.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.695 0.798 . . . . 1.87 109.716 169.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.461 HD13 ' CE1' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -155.27 141.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.605 -1.628 . . . . 1.51 106.605 170.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.81 102.46 14.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.302 -0.999 . . . . 3.28 108.302 169.151 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -42.52 -34.24 0.82 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.985 1.714 . . . . 2.47 113.374 -174.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -31.07 45.3 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 125.575 1.55 . . . . 1.62 112.268 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.4 -44.29 0.17 Allowed 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 123.93 0.892 . . . . 1.38 109.962 -172.166 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mttp 88.95 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.022 2.129 . . . . 5.05 113.247 166.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.12 61.68 1.27 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 112.145 -2.298 . . . . 2.32 107.194 172.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.34 111.39 4.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 125.77 1.652 . . . . 1.41 111.095 -175.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -149.9 148.17 28.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.476 -0.935 . . . . 3.26 108.476 -177.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.55 127.37 2.03 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.316 -1.514 . . . . 1.01 109.316 177.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -77.25 137.58 38.9 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.165 0.586 . . . . 5.12 111.198 -165.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.783 HG23 ' HA3' ' A' ' 65' ' ' GLY . 97.1 mt -86.88 75.03 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 106.56 -1.645 . . . . 1.83 106.56 172.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -128.3 74.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.337 1.455 . . . . 2.49 109.787 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -160.2 69.24 0.39 Allowed 'General case' 0 C--N 1.333 -0.113 0 O-C-N 121.392 -0.818 . . . . 3.73 108.903 172.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.0 mt -138.61 158.21 44.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.483 0.659 . . . . 1.81 110.667 -160.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -14.56 59.58 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.661 -1.154 . . . . 3.65 112.501 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 m -129.23 156.42 78.36 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.439 0.696 . . . . 1.87 111.238 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.48 -179.02 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.971 2.447 . . . . 4.12 108.501 155.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 42.8 mt-10 71.44 -59.39 0.55 Allowed 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 126.439 1.896 . . . . 4.53 110.277 -172.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -49.81 -28.2 6.04 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.51 1.924 . . . . 2.13 112.149 176.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.75 101.92 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.97 -1.122 . . . . 3.24 107.97 178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 115' ' ' TYR . 5.5 t -105.35 132.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 108.465 -0.939 . . . . 1.05 108.465 -174.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.72 140.3 53.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.487 -1.671 . . . . 3.06 106.487 170.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.17 170.47 8.66 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.003 0.43 . . . . 1.81 111.308 -175.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.67 132.55 36.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 174.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.66 70.7 4.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.399 1.079 . . . . 1.95 108.707 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.88 163.44 16.39 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.379 1.872 . . . . 1.04 111.161 -168.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.97 175.02 10.45 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.564 1.146 . . . . 4.13 110.493 -177.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 tt -124.36 77.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.286 1.434 . . . . 1.4 109.321 162.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.46 149.08 3.01 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.471 1.108 . . . . 8.33 110.092 161.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.05 71.82 4.17 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.874 2.383 . . . . 3.97 111.983 -175.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -62.94 -49.09 76.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.552 0.741 . . . . 5.98 110.857 178.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.67 -28.7 4.43 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.376 -0.829 . . . . 4.03 113.591 -151.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.2 OUTLIER 71.96 -53.85 0.69 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.713 1.605 . . . . 9.51 110.912 -174.519 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -61.88 -41.03 97.39 Favored 'General case' 0 N--CA 1.463 0.179 0 O-C-N 121.519 -0.738 . . . . 10.04 110.17 172.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.4 p80 176.16 97.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.87 2.068 . . . . 8.0 107.146 -178.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.99 179.65 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.083 0.953 . . . . 3.82 112.961 171.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 m -128.14 150.34 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 123.583 0.753 . . . . 1.47 112.101 179.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.7 mt -79.02 140.45 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 107.665 -1.235 . . . . 2.65 107.665 161.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.0 m -131.89 59.23 1.71 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.461 1.105 . . . . 2.38 109.469 -169.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.33 155.25 30.91 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 122.408 -0.183 . . . . 0.69 112.655 -172.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.0 m -79.0 163.01 25.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.971 0.908 . . . . 1.43 108.943 166.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 141' ' ' VAL . 0.9 OUTLIER -129.34 120.15 50.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 113.656 0.984 . . . . 1.09 113.656 178.878 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -87.23 131.43 34.21 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 125.16 1.384 . . . . 2.11 108.464 173.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 10.6 t80 -102.21 86.92 2.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 128.67 2.788 . . . . 4.78 104.711 174.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 58.56 -53.9 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 127.84 2.456 . . . . 3.44 115.528 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -26.67 3.95 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.91 2.484 . . . . 4.04 112.262 177.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 129.62 51.51 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.873 1.215 . . . . 1.21 112.193 -162.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.76 105.67 15.35 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.644 1.178 . . . . 3.75 111.103 176.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.468 ' HD3' ' N ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -147.51 30.0 0.93 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.66 1.184 . . . . 7.83 109.746 -174.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.33 169.0 33.23 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.244 1.402 . . . . 1.09 109.988 -175.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 p -143.22 157.77 44.2 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.067 1.347 . . . . 0.78 110.773 -166.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 38.6 t80 -128.05 147.51 50.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.878 1.671 . . . . 2.73 109.695 -176.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.0 m -135.91 106.53 6.52 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.317 -1.734 . . . . 1.93 106.317 175.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -125.66 133.1 52.3 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.074 0.55 . . . . 0.76 109.918 -173.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.94 174.62 16.14 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.153 1.359 . . . . 1.17 109.88 -177.27 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.6 tt -130.78 129.97 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.609 1.164 . . . . 2.35 108.041 -178.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.37 83.43 0.38 Allowed 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.833 -0.803 . . . . 5.02 108.833 171.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.05 107.49 0.48 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 108.18 -1.968 . . . . 3.56 108.18 164.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.69 -49.27 0.14 Allowed Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 106.205 -2.758 . . . . 3.55 106.205 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mttp -147.1 12.47 1.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 116.947 -1.502 . . . . 5.39 113.1 160.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 61.24 67.68 0.78 Allowed 'General case' 0 C--N 1.347 0.476 0 CA-C-N 121.107 1.776 . . . . 1.55 107.532 -161.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -99.16 -48.28 4.9 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.569 0.747 . . . . 3.99 111.039 -165.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -141.87 124.46 15.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.833 1.653 . . . . 2.48 106.819 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.95 91.22 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 108.974 -0.75 . . . . 1.58 108.974 168.013 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.8 131.3 35.87 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.248 -0.649 . . . . 0.92 109.248 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.38 178.61 33.65 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 118.518 0.599 . . . . 0.9 112.813 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.4 t -151.66 147.11 26.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.371 -0.974 . . . . 2.56 108.371 158.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -103.61 144.37 31.52 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.402 0.681 . . . . 0.78 112.069 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -102.42 102.4 12.71 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.541 2.336 . . . . 3.44 104.951 168.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 113' ' ' VAL . 42.4 t -126.59 91.19 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 106.559 -1.645 . . . . 2.2 106.559 -166.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -105.97 141.78 36.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.416 -1.698 . . . . 3.37 106.416 -174.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 t -176.03 -171.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 105.908 -1.886 . . . . 2.72 105.908 166.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.3 t -44.86 -39.63 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 125.683 1.593 . . . . 1.8 110.392 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -136.22 55.38 1.86 Allowed 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 108.087 -1.079 . . . . 2.58 108.087 167.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.51 110.73 3.92 Favored Glycine 0 CA--C 1.507 -0.423 0 N-CA-C 107.269 -2.333 . . . . 1.05 107.269 174.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.35 58.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 120.94 0.4 . . . . 1.99 110.397 -170.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 7.42 -94.67 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 129.511 3.125 . . . . 2.59 115.772 -171.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -77.95 80.62 4.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.828 0.851 . . . . 3.38 109.482 -166.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.59 110.29 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 106.459 -1.682 . . . . 1.31 106.459 175.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.7 124.4 6.5 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.937 -1.665 . . . . 0.84 108.937 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -105.18 98.14 7.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.376 -1.342 . . . . 1.39 107.376 -176.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.55 156.93 17.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 124.349 1.06 . . . . 1.05 108.198 174.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -152.07 164.66 36.78 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 112.79 0.663 . . . . 1.27 112.79 -166.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.75 100.93 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.301 -0.999 . . . . 3.58 108.301 171.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB3' HG23 ' A' ' 52' ' ' THR . 31.5 mt-30 . . . . . 0 C--O 1.252 1.23 0 CA-C-O 116.67 -1.633 . . . . 5.33 110.752 -177.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.332 -1.729 . . . . 51.83 106.332 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.88 175.63 9.57 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 106.948 -1.501 . . . . 45.79 106.948 174.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 p -155.08 169.63 23.66 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.155 -1.054 . . . . 42.07 108.155 -177.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -145.26 -179.76 6.85 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.198 1.399 . . . . 38.31 107.381 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -157.61 162.88 38.74 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.904 1.282 . . . . 34.24 107.549 175.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.44 171.11 7.63 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.636 1.175 . . . . 30.18 109.941 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.56 -179.07 3.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.336 1.454 . . . . 26.56 109.47 175.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -139.04 174.95 9.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.802 1.241 . . . . 23.37 107.99 175.062 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -148.51 169.37 20.42 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.911 1.284 . . . . 19.98 107.666 177.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -134.31 136.75 43.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.661 0.785 . . . . 19.49 110.85 -173.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -175.63 3.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.582 0.706 . . . . 15.48 109.625 158.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 t -164.24 -161.53 0.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.349 -2.093 . . . . 10.67 105.349 168.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -74.17 62.4 0.92 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.74 1.616 . . . . 7.2 109.338 175.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 62.23 165.85 0.11 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.654 1.982 . . . . 11.55 114.077 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 pt -172.14 97.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 127.042 2.137 . . . . 13.98 108.885 176.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -123.32 71.11 1.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.761 -1.2 . . . . 16.4 107.761 148.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.0 t70 64.13 -67.79 0.1 Allowed 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 126.543 1.937 . . . . 15.72 111.063 -176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 m -32.42 -68.8 0.09 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.828 2.051 . . . . 14.27 112.366 172.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -66.25 -9.89 36.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.205 0.602 . . . . 11.21 112.411 -173.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -57.22 -28.15 62.64 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.659 1.118 . . . . 13.24 110.567 171.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.7 p -69.4 -74.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.747 -0.835 . . . . 12.48 108.747 165.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -31.71 -50.88 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 127.711 2.577 . . . . 8.62 114.57 -177.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -18.58 61.64 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 114.934 1.457 . . . . 12.37 114.934 -174.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 19.8 mmt 40.1 53.96 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.348 0.976 . . . . 13.74 111.777 173.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.0 t 66.39 16.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 15.24 112.504 169.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.58 169.13 14.71 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.29 1.589 . . . . 14.19 115.29 -162.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -62.44 170.45 2.4 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.915 2.086 . . . . 20.87 112.744 -168.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.38 118.42 22.65 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.077 -1.453 . . . . 18.4 107.077 165.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -155.49 136.9 14.05 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.101 -1.074 . . . . 19.7 108.101 161.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -81.06 -71.13 0.48 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.499 0.32 . . . . 20.11 110.429 -170.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 50.17 31.73 5.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.429 1.091 . . . . 19.85 111.592 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.0 mp 59.72 104.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.147 1.379 . . . . 16.44 109.655 -163.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.34 74.12 0.2 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.642 1.115 . . . . 12.03 111.34 -179.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -155.29 -51.27 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.78 2.432 . . . . 8.87 108.197 -171.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.1 mt -75.51 68.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.065 0.946 . . . . 10.99 109.117 -178.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.8 118.38 6.11 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.371 0.669 . . . . 5.14 109.523 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.43 -56.81 2.74 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 109.788 -1.325 . . . . 3.99 109.788 -177.413 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 70.08 -137.25 0.06 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.068 1.347 . . . . 4.94 110.574 -173.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -22.12 66.73 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 113.87 1.063 . . . . 5.61 113.87 -164.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 p -54.19 -62.21 1.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.249 1.02 . . . . 3.8 109.823 170.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.26 -58.09 4.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.117 -1.402 . . . . 2.48 110.514 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -39.92 -54.04 2.24 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.227 1.411 . . . . 2.98 112.787 -165.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -40.99 -48.2 3.16 Favored 'General case' 0 C--N 1.344 0.34 0 O-C-N 123.998 0.811 . . . . 3.14 112.14 -165.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? 172.77 41.89 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.5 1.92 . . . . 3.85 109.853 170.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -127.0 130.74 23.72 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.827 0.851 . . . . 2.14 108.722 -171.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.78 -169.73 0.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.187 2.591 . . . . 1.64 110.357 -178.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.8 -44.82 54.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.459 0.704 . . . . 5.02 110.407 171.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 48.1 -140.23 9.89 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.424 1.011 . . . . 2.42 112.712 178.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.55 -35.18 0.05 OUTLIER Glycine 0 CA--C 1.534 1.273 0 C-N-CA 123.835 0.731 . . . . 1.85 113.689 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -149.66 86.92 1.47 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.845 0.823 . . . . 6.26 111.371 -176.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -77.75 157.17 30.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.255 1.026 . . . . 1.47 111.5 -178.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 52' ' ' THR . 8.0 t -78.47 58.07 2.09 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.958 2.503 . . . . 1.27 110.611 -165.526 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CD1' HG21 ' A' ' 71' ' ' ILE . 5.2 m-30 -91.63 67.29 5.45 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.272 -1.518 . . . . 3.62 110.031 -178.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mtm105 -79.61 110.42 14.92 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 118.001 -1.0 . . . . 4.96 110.205 175.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.97 175.24 25.57 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.067 -1.063 . . . . 0.65 115.716 -178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -128.29 135.47 49.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.784 1.633 . . . . 2.96 107.148 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.07 145.15 31.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.312 1.045 . . . . 2.62 108.264 171.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -131.72 131.85 43.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.188 1.395 . . . . 2.46 107.659 179.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -81.92 165.23 45.37 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.603 -1.399 . . . . 1.29 109.603 174.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.4 t -50.06 -37.19 32.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 117.528 0.664 . . . . 2.22 110.128 159.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.35 6.3 20.39 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.487 1.515 . . . . 2.24 112.574 176.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 45.08 35.19 1.52 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 126.385 1.874 . . . . 5.28 113.647 -169.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.69 55.62 0.75 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.284 -1.006 . . . . 1.47 108.284 178.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.76 166.97 19.56 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.654 -0.578 . . . . 1.06 111.654 -169.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.806 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -79.34 178.78 53.47 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 126.137 1.827 . . . . 0.94 111.987 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.45 158.14 24.03 Favored 'General case' 0 C--O 1.226 -0.179 0 O-C-N 121.555 -0.968 . . . . 6.2 110.5 158.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 tp -108.32 118.6 37.2 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.814 1.646 . . . . 0.81 108.191 -171.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 36.0 p -79.56 155.6 28.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.651 0.739 . . . . 2.52 110.745 176.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -78.53 104.58 9.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.161 -1.422 . . . . 2.22 107.161 176.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 m -155.82 64.59 0.59 Allowed 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.094 -1.004 . . . . 1.66 112.303 -163.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.614 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -145.55 139.0 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 119.38 0.991 . . . . 1.28 110.147 -177.699 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -84.3 136.22 34.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.867 -1.16 . . . . 4.55 107.867 167.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.49 -16.43 48.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 117.758 -1.115 . . . . 2.82 111.799 -167.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.73 -35.87 82.45 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.721 -1.214 . . . . 2.63 107.721 -176.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB1' ' OD1' ' A' ' 98' ' ' ASP . . . -146.34 -13.86 0.46 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 114.021 1.119 . . . . 1.92 114.021 -162.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 73.4 78.78 0.13 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.167 1.387 . . . . 4.62 113.332 171.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -80.91 62.24 4.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.64 -1.985 . . . . 2.27 105.64 170.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.45 ' HA2' ' CG2' ' A' ' 71' ' ' ILE . . . -78.35 69.06 2.83 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.719 -0.673 . . . . 1.32 112.205 -153.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -139.58 108.7 6.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.881 -0.785 . . . . 2.63 108.881 -159.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -118.29 136.13 12.07 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 107.756 -2.138 . . . . 0.87 107.756 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -77.96 132.47 37.88 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.566 0.683 . . . . 4.28 111.344 -167.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.806 HG23 ' HA3' ' A' ' 65' ' ' GLY . 52.8 mt -78.42 80.49 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.647 -1.612 . . . . 2.1 106.647 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 84' ' ' HIS . 18.0 tt0 -77.02 158.75 30.38 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 104.082 -2.562 . . . . 4.35 104.082 153.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 83' ' ' GLU . 3.2 m-70 -159.37 56.04 0.4 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 130.982 3.713 . . . . 5.01 107.493 37.135 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mp -81.68 169.01 17.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 114.824 1.416 . . . . 1.89 114.824 -148.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -19.24 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 128.988 2.915 . . . . 4.5 115.433 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m -145.66 135.87 11.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 106.814 -1.55 . . . . 2.12 106.814 164.267 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -49.53 -47.92 20.9 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.534 2.823 . . . . 3.11 112.299 -170.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -40.08 24.49 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.209 1.003 . . . . 4.79 110.095 -177.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 -16.88 64.39 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.232 1.013 . . . . 2.72 112.834 -171.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -37.23 124.4 0.96 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 119.693 1.133 . . . . 2.94 111.032 162.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.19 112.97 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.633 -1.617 . . . . 1.07 106.633 171.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -85.37 164.9 17.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.55 -1.278 . . . . 2.19 107.55 164.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.55 131.17 29.14 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.846 1.259 . . . . 1.93 109.332 171.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.02 174.59 10.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.042 0.537 . . . . 1.97 110.519 -171.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.87 113.98 15.14 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.223 -1.028 . . . . 1.25 108.223 -177.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.42 123.5 36.25 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.119 1.368 . . . . 1.02 108.114 -177.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.443 ' OD1' ' HB1' ' A' ' 75' ' ' ALA . 4.5 t70 -86.86 177.11 7.38 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.018 0.824 . . . . 4.47 110.302 -179.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -126.19 -14.79 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.692 1.197 . . . . 3.13 112.153 -159.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -21.32 -55.44 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 117.092 2.256 . . . . 8.15 117.092 -171.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.31 69.2 0.99 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 122.163 1.909 . . . . 4.57 112.458 172.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.2 -62.58 1.55 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 126.319 1.848 . . . . 5.1 108.081 168.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.87 30.22 52.51 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.024 -0.876 . . . . 3.37 112.976 176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -150.79 -84.5 0.09 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.918 1.359 . . . . 5.78 110.65 -173.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -159.06 37.67 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.248 1.419 . . . . 6.26 108.622 -177.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.0 t60 55.36 67.58 0.99 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.619 1.2 . . . . 5.55 110.017 -165.176 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.71 -49.43 73.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.821 1.249 . . . . 2.66 109.985 168.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.5 m -146.88 175.74 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 123.436 0.694 . . . . 1.74 111.774 -179.357 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.56 146.62 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 130.531 3.532 . . . . 2.61 104.042 157.154 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.0 t -117.15 108.35 15.59 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 106.535 -1.654 . . . . 1.6 106.535 168.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.61 169.31 14.11 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 123.219 0.438 . . . . 0.84 112.27 -178.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 71.0 m -103.02 161.1 14.04 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.991 -1.114 . . . . 1.32 107.991 168.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 148.59 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 109.338 -0.616 . . . . 0.86 109.338 169.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.13 113.49 17.3 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.295 -1.372 . . . . 1.98 107.295 167.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -75.35 76.09 2.44 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.377 -2.453 . . . . 6.79 104.377 162.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.8 m120 68.4 -68.61 0.17 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.506 1.922 . . . . 6.2 112.241 162.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -126.63 4.54 6.77 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.489 1.916 . . . . 3.95 111.275 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -151.88 176.25 11.64 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.511 1.524 . . . . 2.68 107.951 -175.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -118.13 94.92 4.68 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.985 0.914 . . . . 3.71 109.004 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -137.42 57.89 1.72 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.494 1.518 . . . . 4.52 108.52 170.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -158.62 147.08 14.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 113.153 -1.839 . . . . 0.55 111.783 161.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 p -108.62 156.73 19.21 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.249 1.419 . . . . 0.96 108.216 171.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -143.44 147.86 35.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.192 0.597 . . . . 2.29 109.87 178.978 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.6 m -140.56 115.15 9.46 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.553 -1.647 . . . . 1.95 106.553 -169.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.707 HD13 ' N ' ' A' ' 126' ' ' GLY . 1.8 tm? -126.33 150.5 48.48 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.404 -1.332 . . . . 1.32 107.404 -176.29 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.707 ' N ' HD13 ' A' ' 125' ' ' LEU . . . -148.75 134.21 4.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 119.662 1.119 . . . . 1.54 110.613 169.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.72 153.44 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 117.966 0.883 . . . . 3.0 108.942 175.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -141.91 158.3 43.94 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 122.099 0.952 . . . . 4.64 112.283 161.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.48 -0.05 37.27 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 114.219 -1.355 . . . . 2.72 111.989 177.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.56 -61.02 4.29 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.467 1.032 . . . . 2.95 111.075 167.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -71.88 -12.59 61.34 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.249 -0.559 . . . . 3.8 111.518 173.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 94.18 96.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 128.828 2.851 . . . . 1.91 107.639 -174.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -112.81 -59.48 2.01 Favored 'General case' 0 CA--C 1.521 -0.135 0 O-C-N 121.669 -0.644 . . . . 3.08 110.022 -176.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -135.07 139.78 45.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.836 -1.172 . . . . 3.7 107.836 170.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.433 HG11 ' CG ' ' A' ' 53' ' ' TYR . 0.6 OUTLIER -100.34 137.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 106.356 -1.72 . . . . 1.41 106.356 170.101 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.72 142.86 38.63 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.253 -1.758 . . . . 1.24 106.253 172.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.5 173.05 31.62 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.153 -1.022 . . . . 1.31 111.822 177.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.1 m -155.75 168.4 27.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.102 -1.444 . . . . 2.0 107.102 167.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 123' ' ' TYR . . . -137.36 166.76 23.04 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.783 -0.451 . . . . 0.87 109.783 165.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -113.7 108.68 17.45 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.651 -1.611 . . . . 3.35 106.651 154.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -118.28 122.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.095 -1.446 . . . . 2.12 107.095 173.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.92 68.01 0.79 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.603 -0.888 . . . . 2.74 108.603 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.62 165.53 24.93 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 106.719 -1.585 . . . . 3.01 106.719 172.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 60.4 t -51.08 -24.99 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 122.392 0.277 . . . . 2.05 110.696 172.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -139.16 56.95 1.67 Allowed 'General case' 0 C--N 1.34 0.185 0 N-CA-C 107.85 -1.167 . . . . 3.0 107.85 172.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.69 141.53 12.84 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.953 -1.259 . . . . 1.33 109.953 -173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.76 104.62 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 C-N-CA 123.687 0.795 . . . . 1.4 110.861 -165.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -48.38 -65.12 0.62 Allowed 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.929 -0.578 . . . . 2.64 109.912 173.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -75.71 84.22 2.7 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.571 -0.9 . . . . 1.92 108.571 178.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.19 122.49 69.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.876 1.27 . . . . 2.31 108.815 168.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.04 161.49 13.78 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.429 -1.869 . . . . 1.01 108.429 176.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -153.27 160.6 42.78 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.913 1.357 . . . . 2.28 112.219 175.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.38 152.31 35.55 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.331 0.653 . . . . 1.39 109.413 173.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -115.8 147.23 41.22 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.802 1.241 . . . . 1.06 111.184 174.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -139.6 98.32 3.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.916 1.286 . . . . 4.06 108.372 -176.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? . . . . . 0 N--CA 1.431 -1.41 0 CA-C-O 117.653 -1.165 . . . . 4.51 110.38 -166.56 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 108.464 -0.939 . . . . 67.42 108.464 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -173.29 -171.43 0.71 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.218 -1.771 . . . . 61.25 106.218 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.17 -172.58 4.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.116 -1.809 . . . . 57.11 106.116 159.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 166.78 3.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 126.266 1.826 . . . . 52.28 107.927 -176.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 t -152.94 -172.41 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.709 -1.219 . . . . 47.3 107.709 168.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.05 140.28 46.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.85 1.26 . . . . 42.56 109.4 -178.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.44 150.62 43.17 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.388 -0.597 . . . . 37.7 109.388 170.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -70.09 157.57 37.31 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.997 0.427 . . . . 34.25 110.001 174.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.23 165.74 23.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.552 -0.907 . . . . 29.13 108.552 160.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -133.56 175.6 9.29 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.923 1.289 . . . . 26.76 108.146 178.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -51.36 -60.33 3.25 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.683 0.793 . . . . 22.23 109.679 -176.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 m 68.58 158.85 0.16 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.043 1.337 . . . . 16.07 111.409 175.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -49.59 -55.51 13.3 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.321 1.849 . . . . 11.16 110.434 -173.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -131.83 -178.52 4.92 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.583 -1.636 . . . . 14.16 106.583 164.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.34 150.31 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 106.114 -1.81 . . . . 19.76 106.114 177.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.47 87.43 0.12 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.955 1.302 . . . . 21.69 110.87 173.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.6 t70 68.42 -62.41 0.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.546 1.938 . . . . 18.28 111.973 174.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.8 m -40.01 -41.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.403 1.881 . . . . 14.43 111.507 168.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -36.19 -56.12 0.77 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 125.45 1.5 . . . . 19.25 111.496 170.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -63.03 -43.81 97.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.589 0.756 . . . . 19.05 109.645 -175.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -60.52 -43.98 96.52 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 122.374 -0.204 . . . . 11.67 110.57 178.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.41 -65.41 2.52 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.093 -0.803 . . . . 9.17 111.093 -178.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -70.7 -32.15 69.27 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.577 1.551 . . . . 16.46 112.726 -172.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . 0.324 0.0 OUTLIER 30.81 -124.4 0.04 OUTLIER 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.274 1.83 . . . . 15.24 114.568 -171.606 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.1 t 48.27 61.01 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.708 0.803 . . . . 19.63 109.695 170.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -173.09 70.6 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.736 -1.579 . . . . 20.14 106.736 -174.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttp 68.06 169.87 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.784 -1.553 . . . . 25.32 108.225 -153.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.1 ttt85 -145.79 143.84 29.92 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.001 -2.592 . . . . 20.12 104.001 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -166.46 -64.65 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.085 0 N-CA-C 108.834 -0.802 . . . . 22.57 108.834 -171.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.22 178.14 4.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.351 0.66 . . . . 20.29 110.295 -178.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -74.67 64.58 1.24 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.971 0.909 . . . . 20.95 110.758 -177.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 88.9 mt -83.94 147.03 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.406 1.482 . . . . 13.27 107.783 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 -154.4 5.41 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.551 0.528 . . . . 11.71 111.884 -179.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -91.66 -37.32 13.12 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 128.952 2.901 . . . . 11.99 110.166 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.3 mt -28.14 132.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 128.816 2.846 . . . . 8.97 114.032 -177.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.51 -63.36 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.842 2.057 . . . . 4.33 107.364 161.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.54 61.98 3.88 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.616 -0.994 . . . . 2.5 110.616 176.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -47.26 -68.27 0.2 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 113.531 0.938 . . . . 5.15 113.531 -161.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -62.92 -40.64 98.22 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 118.589 0.632 . . . . 4.86 110.294 -172.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.8 t -65.82 -36.29 83.08 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 118.006 -0.997 . . . . 2.71 112.958 -176.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.2 p -70.83 -61.73 1.66 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.651 -0.87 . . . . 2.21 108.651 171.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -34.07 -46.37 0.24 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.013 2.125 . . . . 3.06 112.558 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -37.64 -53.72 1.21 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.122 1.369 . . . . 2.91 110.693 -176.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.3 pttp 152.79 46.05 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.553 3.141 . . . . 5.17 109.327 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.01 149.04 72.62 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.536 1.135 . . . . 2.33 108.148 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.41 -168.14 0.58 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.15 3.233 . . . . 1.87 113.007 -164.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.45 -27.99 27.13 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.389 1.876 . . . . 5.19 111.789 168.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -28.42 122.43 0.07 OUTLIER Glycine 0 CA--C 1.534 1.242 0 C-N-CA 128.509 2.957 . . . . 2.09 117.603 -168.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.84 25.35 1.19 Allowed Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.446 -1.032 . . . . 1.96 115.27 -178.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.9 156.38 29.43 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.499 1.92 . . . . 5.25 107.0 170.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.47 158.07 39.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 109.969 -0.382 . . . . 1.56 109.969 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.5 t -80.14 107.33 12.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.44 0.696 . . . . 1.92 109.801 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 135' ' ' VAL . 7.0 m-85 -135.19 59.15 1.74 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.375 1.87 . . . . 3.35 108.234 -177.191 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -79.81 79.53 6.3 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.279 -0.888 . . . . 5.01 109.734 -175.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -114.37 161.64 12.67 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 115.095 0.798 . . . . 0.93 115.095 -170.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.3 p -123.23 103.58 8.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.843 1.657 . . . . 2.02 108.05 179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.11 86.2 7.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.239 1.016 . . . . 1.15 108.28 175.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -94.34 134.94 36.3 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.924 0.889 . . . . 2.27 109.937 -169.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.3 160.19 45.7 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.637 -0.985 . . . . 1.05 110.637 -175.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.3 t -60.25 -21.92 62.44 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.436 -1.038 . . . . 1.69 112.028 164.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -89.4 -2.04 58.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.929 1.692 . . . . 3.21 110.996 172.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.259 2.5 m-20 52.83 10.43 0.15 Allowed 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.764 2.026 . . . . 3.42 114.436 -161.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 60.56 3.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.836 -1.165 . . . . 1.22 108.355 167.265 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.98 178.77 18.06 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 109.555 -1.418 . . . . 1.22 109.555 -179.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.18 176.8 21.1 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 124.303 0.954 . . . . 1.1 111.298 -173.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -86.16 127.25 34.68 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.049 -0.677 . . . . 3.77 109.403 -172.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.47 90.63 2.72 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.011 -2.588 . . . . 1.06 104.011 168.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.4 m -78.87 133.39 36.98 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.626 -1.25 . . . . 2.33 107.626 -172.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -75.5 116.87 16.67 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.163 -0.615 . . . . 2.03 110.947 -154.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.9 m -156.33 118.32 3.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.421 -0.955 . . . . 1.24 108.421 172.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.438 HD12 ' HG2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -141.01 164.74 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.621 -2.363 . . . . 1.8 104.621 163.105 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -114.16 122.92 48.28 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 105.585 -2.006 . . . . 3.5 105.585 155.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -62.07 -22.52 65.84 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.783 1.174 . . . . 3.62 113.832 -171.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.42 91.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.646 1.112 . . . . 1.39 110.819 -171.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -116.08 -9.5 11.68 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.207 1.003 . . . . 1.34 112.793 172.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 64.31 50.5 2.3 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 123.715 1.722 . . . . 4.12 110.169 165.216 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.85 53.6 2.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.163 -1.381 . . . . 1.67 110.453 -173.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 71' ' ' ILE . . . -70.53 113.16 4.68 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.37 -0.832 . . . . 1.27 111.912 -162.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 97' ' ' ALA . 59.4 m-80 -152.08 145.68 24.95 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.13 -0.692 . . . . 2.92 109.13 -172.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.43 118.65 0.87 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 110.328 -1.109 . . . . 1.2 110.328 -171.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -77.26 138.52 39.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.432 0.634 . . . . 4.12 112.128 -161.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.6 mt -85.52 58.54 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.377 -1.342 . . . . 1.91 107.377 -172.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -98.34 100.38 11.65 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.209 -1.034 . . . . 2.64 108.209 -176.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -156.65 -9.97 0.1 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.077 1.14 . . . . 3.34 114.077 -177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -111.77 152.56 27.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 114.863 1.431 . . . . 1.56 114.863 -138.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.88 -25.37 0.09 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 131.15 3.78 . . . . 3.94 114.951 -173.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -146.33 146.25 26.93 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-O 118.686 -0.673 . . . . 1.61 109.586 177.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -49.86 -52.14 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.7 2.933 . . . . 1.61 111.483 -170.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 115' ' ' TYR . 50.9 mt-10 -40.48 -43.14 1.77 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.657 1.583 . . . . 4.08 113.534 175.481 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.7 -19.38 61.42 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 119.26 -0.4 . . . . 2.14 111.955 -174.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -74.27 76.8 1.83 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.059 -0.719 . . . . 1.84 109.059 -177.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.5 t -64.68 141.21 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.502 1.521 . . . . 1.08 110.507 -178.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -116.78 158.97 23.03 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.381 -0.6 . . . . 1.95 109.381 168.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mt -120.57 137.05 54.61 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 128.173 2.589 . . . . 1.99 109.829 -171.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.47 146.32 32.79 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.234 -0.654 . . . . 0.99 109.234 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.35 80.04 3.86 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.678 -0.86 . . . . 1.98 108.678 -178.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 79' ' ' ASN . . . -110.73 133.72 53.09 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.207 1.803 . . . . 1.36 111.179 -167.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.08 176.04 9.56 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.915 2.086 . . . . 3.48 112.42 -168.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.8 tt -113.34 113.48 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 106.605 -1.628 . . . . 1.58 106.605 161.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -60.96 171.35 1.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.289 0.636 . . . . 6.87 109.46 171.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.73 78.64 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 121.667 1.578 . . . . 4.34 110.244 163.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -50.2 -52.24 37.31 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.196 1.398 . . . . 4.71 109.463 174.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 120.98 162.66 11.77 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.319 1.914 . . . . 2.93 108.543 -173.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.5 tttp 66.4 56.1 0.8 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.141 0.576 . . . . 5.79 110.062 160.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 68.6 -48.17 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.127 1.371 . . . . 7.39 112.445 -173.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 164.9 163.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.504 1.921 . . . . 6.02 108.987 170.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.58 -70.26 0.79 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.589 . . . . 2.58 110.324 167.24 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 m -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.754 0.706 . . . . 1.15 112.741 -167.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.605 HD12 ' C ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.96 145.77 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.921 -2.251 . . . . 3.1 104.921 155.672 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 109' ' ' ILE . 19.8 t -134.71 106.42 6.93 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-N 118.672 0.669 . . . . 2.28 109.713 176.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.09 152.49 17.29 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 124.021 0.819 . . . . 1.08 112.808 178.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.8 m -79.02 150.31 31.97 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.357 -1.349 . . . . 1.46 107.357 165.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.8 m -126.5 156.47 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 0.77 106.707 175.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -126.49 144.83 50.73 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.825 0.345 . . . . 2.14 111.204 172.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 89' ' ' GLU . 52.6 t80 -77.24 67.73 3.24 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.384 2.274 . . . . 5.12 106.415 176.066 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 60.31 -61.46 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.566 2.746 . . . . 3.01 112.975 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -97.97 -43.37 7.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.508 1.123 . . . . 2.39 111.811 170.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -104.87 126.46 51.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.544 0.572 . . . . 1.27 112.544 -161.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -78.95 110.4 14.14 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 120.887 -1.133 . . . . 3.99 109.712 174.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -150.67 82.68 1.35 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 122.214 1.007 . . . . 3.46 110.551 134.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -156.54 158.5 28.78 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.56 -1.016 . . . . 0.53 110.56 158.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.1 p -145.47 145.52 31.12 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.513 1.525 . . . . 0.8 107.947 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -135.28 170.52 15.8 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.022 0.749 . . . . 2.48 113.022 177.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.7 p -138.41 120.42 15.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.489 -2.041 . . . . 1.92 105.489 179.639 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 152' ' ' LEU . 1.6 tm? -132.69 120.02 21.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.209 -1.034 . . . . 1.02 108.209 -174.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.86 177.68 18.89 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 109.438 -1.465 . . . . 1.13 109.438 -178.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.19 130.58 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.024 -1.102 . . . . 2.52 108.024 -176.551 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -70.11 92.87 0.77 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.582 -0.896 . . . . 5.12 108.582 175.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.67 49.55 1.07 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.567 1.556 . . . . 3.12 114.054 -173.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.0 -79.67 0.96 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.735 -2.946 . . . . 2.85 105.735 151.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -118.54 -10.41 10.09 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.334 1.054 . . . . 4.67 112.552 174.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 93.78 87.67 0.01 OUTLIER 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.423 1.889 . . . . 2.13 107.308 -152.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -108.13 -44.73 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.602 0.761 . . . . 3.94 111.406 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -135.21 145.92 48.15 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.191 -2.151 . . . . 3.17 105.191 171.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 125' ' ' LEU . 21.9 m -106.02 89.69 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 106.153 -1.795 . . . . 1.57 106.153 165.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -78.71 137.64 37.88 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.502 -0.925 . . . . 1.07 108.502 -175.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.34 167.06 32.86 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-O 121.492 0.495 . . . . 1.07 112.494 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -142.28 136.39 29.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.236 -1.394 . . . . 1.78 107.236 175.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' TYR . . . -119.64 142.14 48.71 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.781 0.832 . . . . 0.68 111.024 169.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -101.18 112.69 25.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.954 -1.869 . . . . 3.02 105.954 161.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.32 113.5 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 N-CA-C 108.244 -1.021 . . . . 2.13 108.244 179.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -134.52 119.48 18.52 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.261 0.482 . . . . 3.17 110.649 -164.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 44.7 p -150.74 -170.32 3.62 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.497 -1.668 . . . . 2.31 106.497 169.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.0 t -42.71 -35.4 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.224 1.01 . . . . 1.99 110.627 163.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -139.97 71.83 1.38 Allowed 'General case' 0 C--N 1.342 0.281 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 164.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -113.0 115.97 3.84 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 105.257 -3.137 . . . . 1.16 105.257 168.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.48 60.65 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 123.685 0.794 . . . . 2.18 109.845 -167.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -5.36 -83.41 0.0 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 128.043 2.537 . . . . 2.44 113.502 -159.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -71.6 100.95 2.39 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.209 1.004 . . . . 2.39 108.956 -179.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.2 mt -98.86 111.91 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.749 -1.945 . . . . 1.35 105.749 162.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -85.25 151.16 25.42 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 107.551 -2.219 . . . . 0.95 107.551 174.379 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.505 HD11 HD23 ' A' ' 125' ' ' LEU . 0.6 OUTLIER -145.08 140.84 28.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.959 1.379 . . . . 1.78 112.458 173.08 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -135.96 171.65 14.16 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.167 -1.79 . . . . 1.25 106.167 172.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HB3' ' H ' ' A' ' 135' ' ' VAL . . . -154.87 168.7 26.06 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.27 -1.382 . . . . 1.09 107.27 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -140.24 132.07 27.53 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.109 0.881 . . . . 3.98 110.24 175.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.42 0.688 . . . . 4.39 110.011 -177.331 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 106.034 -1.839 . . . . 49.02 106.034 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.45 151.95 42.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.587 1.085 . . . . 42.12 109.926 177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 p -161.77 127.58 3.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.863 -1.162 . . . . 38.45 107.863 -178.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -133.15 165.28 25.13 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.64 1.176 . . . . 35.16 108.359 176.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.4 m -164.11 172.36 13.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.738 2.015 . . . . 31.04 106.37 177.535 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.64 174.19 15.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 124.087 0.955 . . . . 27.35 108.706 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.08 -174.34 3.9 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 126.33 1.852 . . . . 23.67 108.215 179.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.9 t -156.63 -175.08 5.23 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.345 -0.983 . . . . 20.49 108.345 175.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.12 176.3 11.46 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.859 1.664 . . . . 17.37 108.356 -178.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -163.72 174.83 11.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.575 -1.268 . . . . 14.46 107.575 -178.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -145.21 145.75 31.45 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.386 -0.968 . . . . 13.26 108.386 166.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -157.06 -158.08 0.74 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.091 1.756 . . . . 8.83 107.834 173.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 5.45 10.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.628 1.171 . . . . 5.8 113.001 -166.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.49 154.26 18.41 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.045 -1.034 . . . . 10.54 109.346 -175.839 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.9 mm 61.35 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 126.692 1.997 . . . . 14.19 111.067 -173.313 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 tp60 67.27 -56.31 0.45 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.985 1.714 . . . . 14.57 110.376 -167.479 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -71.82 25.58 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.578 1.151 . . . . 11.63 113.542 -177.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.1 t -67.26 -16.46 64.3 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.959 -1.088 . . . . 12.44 110.294 163.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -71.71 -57.64 4.18 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.206 0.603 . . . . 12.24 109.423 165.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -68.62 -20.38 64.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 113.365 0.876 . . . . 10.72 113.365 -174.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 p -50.56 -8.5 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 117.842 2.534 . . . . 10.74 117.842 -168.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.46 -9.06 72.8 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 121.108 -0.995 . . . . 9.67 113.604 166.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -53.22 -33.83 54.52 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.106 1.453 . . . . 11.03 111.777 177.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 14.0 ttt -53.89 84.14 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.066 0 C-N-CA 125.154 1.382 . . . . 13.01 112.019 172.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.6 t 74.58 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 127.942 2.497 . . . . 19.29 109.706 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 92.87 93.23 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.127 2.171 . . . . 17.89 108.85 -166.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -69.54 78.61 0.41 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.706 1.202 . . . . 22.39 110.143 -173.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.16 -69.24 0.61 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 119.21 -0.424 . . . . 21.62 110.692 -177.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -169.78 -171.22 1.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.196 1.398 . . . . 17.29 109.474 -169.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 71.63 -163.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.387 1.875 . . . . 15.72 110.702 -179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -55.46 133.14 49.82 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.423 -1.325 . . . . 16.23 107.423 163.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.4 mt -123.19 80.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 105.335 -2.098 . . . . 12.71 105.335 175.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 56.84 0.06 OUTLIER Glycine 0 CA--C 1.521 0.424 0 N-CA-C 107.487 -2.245 . . . . 9.68 107.487 -178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 170.17 65.22 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.171 1.788 . . . . 7.94 107.663 -158.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.72 -37.09 77.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.64 -0.709 . . . . 8.39 109.524 177.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.47 -159.33 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.573 1.149 . . . . 4.69 110.925 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.51 83.84 0.07 OUTLIER Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.672 -0.775 . . . . 2.63 113.224 -174.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . 0.276 0.0 OUTLIER -46.01 -81.88 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.57 1.322 . . . . 5.69 114.57 -178.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 105' ' ' ARG . 10.4 m80 -61.91 -34.46 76.1 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 120.676 1.58 . . . . 5.5 113.329 -166.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.537 HG23 HD12 ' A' ' 127' ' ' ILE . 22.7 m -71.07 -57.56 4.41 Favored 'General case' 0 C--O 1.228 -0.061 0 CA-C-N 119.26 0.936 . . . . 3.42 111.166 176.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 t -59.34 -28.7 67.07 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 120.639 -0.424 . . . . 2.43 111.051 -178.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -52.04 -17.57 1.09 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.696 1.598 . . . . 4.2 113.749 171.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -53.96 -24.27 15.98 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.791 1.632 . . . . 3.66 111.087 166.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt 76.07 64.58 0.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.456 2.702 . . . . 5.22 111.634 168.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pp -165.24 43.32 0.08 OUTLIER Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 114.573 -1.194 . . . . 4.97 113.56 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.77 88.34 0.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.973 1.782 . . . . 3.99 111.07 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -49.53 -35.86 21.53 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.907 0.883 . . . . 12.63 110.889 168.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.81 136.77 0.25 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.286 -1.125 . . . . 3.13 110.286 -173.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.49 -50.38 2.08 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 121.117 -1.225 . . . . 2.31 114.664 176.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.4 155.38 34.94 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.541 1.136 . . . . 6.24 110.615 -174.311 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' CG1' ' A' ' 71' ' ' ILE . . . -96.51 179.58 4.96 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.947 1.299 . . . . 2.27 109.215 168.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -119.08 53.04 1.03 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.221 0.325 . . . . 1.65 111.249 167.639 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.822 ' CE1' HG11 ' A' ' 135' ' ' VAL . 4.8 m-30 -88.2 124.47 33.87 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.324 -0.86 . . . . 2.86 111.886 -179.499 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -116.56 105.0 11.97 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 105.404 -2.073 . . . . 4.82 105.404 157.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -154.56 -179.6 29.94 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 118.404 0.547 . . . . 0.71 111.82 -173.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.4 m -154.77 139.3 16.89 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.829 0.852 . . . . 3.13 109.556 -177.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.0 85.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 126.052 1.741 . . . . 1.24 106.451 171.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -79.94 134.11 36.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.987 -0.745 . . . . 3.22 108.987 -177.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.14 161.93 52.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.225 -1.55 . . . . 1.79 109.225 -178.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.0 t -50.53 -36.29 33.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.708 -0.878 . . . . 2.59 109.623 158.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -88.16 10.12 20.49 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.795 1.638 . . . . 3.09 112.511 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 t0 34.95 53.79 0.68 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.687 1.995 . . . . 3.47 113.178 -164.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.59 55.13 1.6 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.794 -1.094 . . . . 2.15 108.759 178.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.06 166.59 15.42 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.076 -1.609 . . . . 1.81 109.076 171.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.669 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -81.1 175.23 54.76 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-O 122.44 1.022 . . . . 1.5 113.426 -168.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -84.39 168.15 15.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.377 0.671 . . . . 3.28 110.492 -176.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 tp -119.67 105.48 11.21 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.06 -0.718 . . . . 0.9 109.06 170.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -79.62 151.3 30.65 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.106 0.962 . . . . 1.88 110.628 170.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -79.47 110.45 14.79 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.071 -0.513 . . . . 2.05 111.228 -177.134 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.9 m -155.29 101.24 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.566 -0.731 . . . . 0.98 109.163 171.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.629 ' CG1' ' HB2' ' A' ' 51' ' ' ALA . 1.4 pp -147.32 136.05 15.64 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 118.681 0.673 . . . . 1.6 109.374 167.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -87.31 112.05 21.68 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.462 -0.57 . . . . 3.72 109.462 172.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -63.88 -5.86 5.05 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 117.784 -1.103 . . . . 3.09 113.293 174.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.2 -40.68 5.26 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.893 1.224 . . . . 1.68 110.996 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.84 -6.9 1.27 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.183 1.549 . . . . 1.77 115.183 166.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 tttp 56.49 115.19 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.643 1.577 . . . . 5.71 111.838 -155.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -112.12 0.22 Allowed 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 105.754 -1.943 . . . . 2.43 105.754 158.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.95 -173.47 18.14 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 124.733 1.159 . . . . 3.19 114.709 167.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.28 -165.45 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.165 1.386 . . . . 4.52 111.492 -169.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.73 6.27 Favored Glycine 0 C--N 1.343 0.92 0 N-CA-C 109.424 -1.47 . . . . 0.9 109.424 173.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.56 142.66 28.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.234 1.413 . . . . 4.73 112.87 -162.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.669 HG23 ' HA3' ' A' ' 65' ' ' GLY . 62.7 mt -84.28 63.45 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 107.923 -1.14 . . . . 2.37 107.923 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -107.72 85.9 2.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.859 -0.61 . . . . 2.43 110.809 -170.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -159.64 20.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.442 0.905 . . . . 4.8 113.442 154.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.81 141.03 28.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.048 -1.032 . . . . 2.17 110.58 -164.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -21.26 59.93 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.189 1.396 . . . . 3.24 112.564 -173.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.5 m -105.05 114.49 63.62 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 106.214 -1.773 . . . . 1.89 106.214 176.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -46.7 -50.43 10.61 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.645 2.23 . . . . 2.5 111.822 -174.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -39.86 42.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.447 1.099 . . . . 4.35 111.692 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.41 -4.21 35.18 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 118.429 -0.796 . . . . 3.98 112.494 -173.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -71.8 72.6 0.8 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.496 1.044 . . . . 1.7 109.292 175.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.3 t -55.24 130.09 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.414 1.486 . . . . 1.76 109.885 -173.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -86.69 146.49 26.27 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.056 -1.09 . . . . 2.43 108.056 167.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -109.17 119.81 40.64 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.936 2.094 . . . . 1.93 107.452 179.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.18 152.66 32.57 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.117 0.484 . . . . 1.2 110.329 -172.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.32 135.14 37.44 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.396 -0.964 . . . . 1.4 108.396 175.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.4 148.85 32.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.569 -1.271 . . . . 1.23 107.569 177.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -79.46 159.41 27.0 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.243 1.417 . . . . 3.95 110.242 -172.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.485 HD11 HH22 ' A' ' 105' ' ' ARG . 0.5 OUTLIER -98.98 112.55 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 125.787 1.635 . . . . 2.0 107.896 -178.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -79.23 155.28 77.05 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 122.8 0.44 . . . . 7.28 110.749 -164.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.99 75.8 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.318 2.012 . . . . 3.55 110.921 177.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -51.18 57.16 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.663 0.785 . . . . 5.24 112.393 178.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 117.66 28.98 2.16 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.784 1.183 . . . . 3.7 113.394 -177.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -152.5 -50.02 0.1 Allowed 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.894 0.847 . . . . 4.63 109.155 -175.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.485 HH22 HD11 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -145.73 5.4 1.03 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.561 0.949 . . . . 11.02 113.561 169.022 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 84.96 -18.46 0.39 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 128.275 2.63 . . . . 8.46 111.313 -150.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 54.76 -90.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 117.673 -1.156 . . . . 2.67 111.26 -173.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.05 166.74 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.569 1.548 . . . . 1.12 113.812 -164.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -82.65 176.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 124.584 1.153 . . . . 2.71 110.736 160.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -132.57 84.84 2.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 105.728 -1.953 . . . . 1.96 105.728 165.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.85 175.56 36.99 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.051 0.834 . . . . 0.72 111.552 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -152.31 172.61 16.18 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.714 1.205 . . . . 1.66 107.782 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.08 136.63 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 119.033 0.833 . . . . 1.12 110.562 -158.04 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.1 tp -83.89 107.4 16.26 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 120.954 -1.091 . . . . 2.46 109.597 177.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -77.85 85.53 4.12 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.659 -1.608 . . . . 6.12 106.659 169.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.32 -78.72 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.581 1.552 . . . . 6.03 109.641 174.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -148.22 30.74 0.85 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.382 2.273 . . . . 2.82 108.103 -177.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -155.28 177.79 10.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.58 2.352 . . . . 2.11 106.463 -175.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -144.73 113.22 6.62 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.459 0.572 . . . . 3.68 110.972 173.341 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.4 mmmt -128.47 88.08 2.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.829 0.824 . . . . 3.98 110.74 138.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.25 29.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.724 -2.151 . . . . 1.22 107.724 158.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 94.5 p -156.38 161.25 40.14 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.97 1.708 . . . . 0.9 106.953 174.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -153.33 142.6 21.53 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.244 0.929 . . . . 3.05 111.004 -172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -125.1 129.84 51.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.719 -1.956 . . . . 2.15 105.719 177.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.606 HD21 ' HB ' ' A' ' 135' ' ' VAL . 0.6 OUTLIER -152.64 134.56 14.77 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.53 0.732 . . . . 1.03 109.551 -176.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' H ' HD22 ' A' ' 125' ' ' LEU . . . -143.1 146.12 16.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 124.948 1.261 . . . . 1.2 110.233 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.537 HD12 HG23 ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.28 138.88 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 124.385 1.074 . . . . 3.25 108.416 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.04 146.18 40.5 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.892 -1.151 . . . . 7.32 107.892 178.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.53 -54.16 0.36 Allowed Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.942 -0.572 . . . . 2.52 111.927 -177.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.0 35.48 53.8 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 107.978 -2.049 . . . . 3.59 107.978 -162.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 pttt 154.57 32.7 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.16 1 C-N-CA 133.173 4.589 . . . . 4.07 111.476 -177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 47.63 88.67 0.02 OUTLIER 'General case' 0 C--N 1.347 0.462 0 C-N-CA 128.539 2.736 . . . . 2.03 111.923 175.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -118.68 -46.03 2.58 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.313 0.645 . . . . 2.66 110.162 -170.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -138.57 122.17 17.4 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.377 . . . . 2.72 107.283 -178.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.822 HG11 ' CE1' ' A' ' 53' ' ' TYR . 13.7 m -91.92 110.57 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.408 -0.96 . . . . 1.29 108.408 165.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -106.68 138.57 42.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.561 1.144 . . . . 0.9 108.463 -174.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.72 178.73 34.8 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 121.249 0.36 . . . . 0.74 112.585 -174.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 t -145.26 135.68 24.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.133 -1.062 . . . . 2.12 108.133 160.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.51 152.27 21.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.362 1.465 . . . . 0.76 110.48 170.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -118.79 139.41 51.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 123.812 0.695 . . . . 3.51 109.208 150.334 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 66.7 t -146.08 77.1 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.414 -1.699 . . . . 2.42 106.414 -173.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -71.64 109.87 5.84 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.081 -0.711 . . . . 6.08 109.081 -178.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -141.71 174.18 10.81 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.081 -1.081 . . . . 3.4 108.081 169.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 48.1 t -52.12 -36.43 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.198 0.599 . . . . 3.52 110.309 172.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -123.37 58.68 1.12 Allowed 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.304 -1.369 . . . . 4.1 107.304 172.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.7 113.0 0.56 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.543 -1.423 . . . . 2.16 109.543 -170.52 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 mp -80.62 144.85 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.918 1.687 . . . . 3.32 109.345 -178.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -84.18 -42.88 15.52 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 121.402 -0.811 . . . . 3.1 112.207 168.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -85.35 82.77 8.19 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.265 -1.522 . . . . 2.3 108.869 -177.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 13.6 mt -113.87 118.4 58.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.215 1.006 . . . . 1.52 109.195 177.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -87.88 147.15 20.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.264 -1.534 . . . . 1.26 109.264 175.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -113.73 109.8 19.15 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.094 0.947 . . . . 1.26 108.664 -176.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.44 149.17 24.34 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.032 0.933 . . . . 1.1 108.579 174.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -153.5 163.31 40.18 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.825 0.45 . . . . 1.06 111.245 175.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.97 131.47 30.85 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.322 1.449 . . . . 3.58 107.815 168.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.833 2.053 . . . . 5.04 107.308 161.735 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.807 0.337 . . . . 52.78 111.624 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -172.98 -50.91 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 105.997 -1.853 . . . . 48.87 105.997 -178.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.2 t -110.58 -167.6 1.21 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 106.543 -1.651 . . . . 46.0 106.543 139.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -113.37 137.77 51.03 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.398 1.879 . . . . 42.23 107.095 169.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.7 p -170.49 105.13 0.28 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.229 -1.026 . . . . 36.9 108.229 -171.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.31 58.4 2.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.35 0.523 . . . . 32.29 111.026 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.78 172.78 12.92 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 122.162 -0.336 . . . . 27.87 110.586 172.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -147.28 151.3 36.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.746 -1.205 . . . . 23.02 107.746 170.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.7 169.78 2.97 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 127.054 2.142 . . . . 18.84 106.203 -176.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -156.72 34.92 0.31 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.339 0.518 . . . . 17.08 110.859 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.22 -162.92 0.06 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.812 2.045 . . . . 12.45 107.13 -176.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.11 13.06 0.68 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 117.851 2.538 . . . . 11.97 117.851 -166.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -81.27 -73.75 0.36 Allowed 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 126.825 2.05 . . . . 6.95 108.223 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -178.4 161.53 1.39 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 104.732 -2.321 . . . . 12.56 104.732 -173.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.25 153.3 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.728 -1.212 . . . . 12.46 107.728 173.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 86.15 87.91 0.02 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.402 1.881 . . . . 16.67 110.039 169.382 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 28.9 t70 65.37 -65.19 0.17 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 127.624 2.37 . . . . 16.06 112.504 172.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 m -31.35 -45.33 0.08 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 128.673 2.789 . . . . 13.41 112.554 165.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -54.84 -30.37 57.36 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.713 1.205 . . . . 9.38 112.438 -177.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -53.96 -51.49 63.69 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 118.548 0.613 . . . . 15.39 110.299 172.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.9 m -70.12 -39.45 75.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.424 -0.172 . . . . 13.93 110.699 -178.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.16 -74.93 0.62 Allowed Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.625 -0.59 . . . . 9.45 111.625 179.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -73.56 -76.15 0.13 Allowed 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.216 2.207 . . . . 8.86 110.888 176.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.7 ptm 139.32 171.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 131.209 3.804 . . . . 11.75 105.783 -158.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t 124.81 171.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 1 C-N-CA 131.834 4.053 . . . . 13.56 107.188 -166.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 76.5 -69.48 0.16 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 126.242 1.817 . . . . 16.02 113.639 166.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -69.42 138.31 53.44 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.517 -0.473 . . . . 20.06 111.231 -171.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -76.34 61.38 1.67 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.979 0.912 . . . . 24.37 109.235 172.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -87.95 -171.4 3.39 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.564 1.146 . . . . 20.55 108.694 173.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.94 175.71 1.13 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.422 0.689 . . . . 23.68 111.376 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -73.74 62.69 0.82 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.814 0.846 . . . . 19.05 110.826 178.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.1 mt -77.56 143.46 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 105.956 -1.868 . . . . 15.23 105.956 166.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.69 29.13 0.26 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-O 119.06 -0.856 . . . . 9.95 113.508 -179.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -161.63 150.27 15.64 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.733 -1.21 . . . . 8.21 107.733 170.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.2 mm -144.76 123.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 126.77 2.028 . . . . 8.32 108.378 -176.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.84 -60.85 1.98 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.985 0.422 . . . . 5.19 110.525 174.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.55 47.48 3.01 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.911 -1.494 . . . . 2.87 115.616 -163.524 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -28.6 -69.92 0.05 Allowed 'General case' 0 C--N 1.345 0.384 0 C-N-CA 126.22 1.808 . . . . 4.01 112.343 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -70.9 -35.39 72.29 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.133 -0.94 . . . . 4.41 109.363 -162.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.1 p -61.69 -48.25 81.64 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.293 0.568 . . . . 2.8 110.418 176.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.0 m -65.23 -55.76 16.64 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 122.639 0.376 . . . . 2.29 110.384 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -39.15 -52.23 1.9 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.631 1.572 . . . . 2.97 111.869 170.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -43.44 -54.75 4.57 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 123.753 0.821 . . . . 3.01 110.859 -171.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 169.04 43.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.794 1.638 . . . . 3.38 110.407 177.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 95.2 mt -131.37 127.07 21.59 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 119.054 0.843 . . . . 2.66 110.442 -173.716 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.69 -164.95 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 124.586 3.524 . . . . 1.91 114.322 -163.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -81.54 15.81 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.582 1.953 . . . . 5.3 112.966 172.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.63 163.31 23.7 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.305 -0.872 . . . . 2.0 112.278 -172.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -93.78 -28.52 11.04 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 115.249 0.86 . . . . 1.86 115.249 -169.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -150.89 91.48 1.72 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.286 1.034 . . . . 5.21 111.386 -171.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 71' ' ' ILE . . . -79.39 162.84 25.28 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.437 0.637 . . . . 1.68 111.758 178.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -79.17 59.68 2.83 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.45 1.5 . . . . 1.87 112.969 -165.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HG12 ' A' ' 71' ' ' ILE . 3.4 m-30 -77.88 66.89 3.63 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.9 -1.125 . . . . 3.44 109.525 174.529 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -88.61 99.91 12.69 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 126.406 1.883 . . . . 4.22 109.363 -175.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -157.73 -158.57 9.03 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 117.824 -2.132 . . . . 0.78 117.211 -173.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.4 p -139.34 139.56 37.28 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.547 1.939 . . . . 2.26 108.133 -171.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.04 78.16 1.22 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.791 2.437 . . . . 0.95 105.605 172.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -91.32 139.87 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.805 0.842 . . . . 2.17 109.73 -169.383 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.22 156.12 43.03 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 109.491 -1.444 . . . . 1.15 109.491 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.8 t -52.24 -34.22 44.98 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.04 -0.726 . . . . 2.43 109.04 154.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.89 -8.22 58.65 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.095 0.958 . . . . 2.39 112.842 175.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 47.21 40.81 10.85 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.432 1.493 . . . . 4.31 112.073 -166.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.74 52.96 0.96 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.25 -1.341 . . . . 1.34 107.466 167.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.25 160.9 20.67 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.545 1.545 . . . . 1.54 109.324 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.42 179.7 16.99 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 124.925 1.25 . . . . 0.94 113.005 -162.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -79.19 133.26 36.71 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.239 1.415 . . . . 3.33 110.642 -170.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.6 111.67 16.11 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.809 -1.182 . . . . 0.89 107.809 170.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 m -78.84 150.59 32.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.141 -0.318 . . . . 1.93 110.141 174.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -91.62 114.23 26.7 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.668 -0.645 . . . . 2.27 111.079 -173.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.9 m -155.77 71.18 0.74 Allowed 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.322 -0.861 . . . . 1.14 112.274 -171.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -134.64 122.53 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 120.883 -1.136 . . . . 1.33 109.266 -179.582 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.14 123.13 23.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.165 -1.421 . . . . 3.77 107.165 167.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -70.12 -25.26 63.4 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.771 2.429 . . . . 3.35 112.466 -170.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.33 97.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.239 -1.023 . . . . 1.78 108.239 -173.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.71 -18.51 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.411 -1.268 . . . . 1.16 113.243 -171.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 mttp 77.37 75.69 0.07 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.184 2.193 . . . . 5.24 112.734 167.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.29 62.03 4.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.36 -1.718 . . . . 1.98 106.36 177.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.71 73.12 1.0 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-O 121.584 0.547 . . . . 1.35 112.511 -157.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -135.02 150.0 50.24 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.044 1.338 . . . . 3.0 107.972 -172.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.82 111.92 0.5 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.551 -1.02 . . . . 1.05 110.551 -172.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -78.14 162.53 26.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 119.054 -1.058 . . . . 3.93 112.611 -167.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.6 mt -128.6 87.32 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 124.681 1.238 . . . . 2.09 109.154 -162.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -127.5 110.12 12.41 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.983 1.313 . . . . 2.5 110.993 -172.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -161.9 -9.42 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.949 1.833 . . . . 4.48 115.949 153.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.84 162.38 25.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 120.414 -1.429 . . . . 1.49 109.871 -158.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -23.54 67.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.367 0.506 . . . . 4.35 112.367 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.52 110.63 53.82 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 123.407 0.683 . . . . 1.82 111.184 -166.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -56.12 -29.16 73.72 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 CA-C-N 120.094 1.069 . . . . 2.37 111.668 167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 5.98 4.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.776 1.171 . . . . 3.41 113.429 177.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -128.71 -53.86 1.24 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 117.982 -1.008 . . . . 2.64 111.87 -167.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -39.63 115.17 0.49 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.961 0.905 . . . . 2.17 110.856 -177.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.96 116.76 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.227 -0.657 . . . . 1.2 109.227 -163.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.72 132.31 48.95 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.297 -2.112 . . . . 3.44 105.297 168.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.491 HD22 ' H ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -119.03 160.7 21.54 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.91 -0.494 . . . . 3.21 111.015 177.854 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.96 175.31 10.74 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.911 -0.586 . . . . 1.56 110.798 -166.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.87 126.62 30.95 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.929 -1.508 . . . . 1.18 106.929 162.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.65 148.92 27.01 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.008 -1.478 . . . . 1.2 107.008 177.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.8 174.91 7.21 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.345 1.458 . . . . 4.03 112.262 -168.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.88 122.61 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.95 -1.87 . . . . 1.73 105.95 161.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -63.29 162.4 25.2 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.722 0.809 . . . . 8.84 110.586 -177.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.34 -55.54 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.773 1.649 . . . . 4.38 112.182 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.411 ' OD1' ' NZ ' ' A' ' 104' ' ' LYS . 15.5 t70 68.17 -56.02 0.5 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 127.09 2.156 . . . . 5.3 113.134 -176.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.31 50.58 2.56 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.632 -0.987 . . . . 4.07 110.632 -178.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.411 ' NZ ' ' OD1' ' A' ' 102' ' ' ASP . 2.6 ttmp? -156.52 60.42 0.55 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.254 -0.647 . . . . 4.67 109.254 -176.788 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 72.02 -53.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.871 1.669 . . . . 7.13 112.041 -178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -170.02 153.3 4.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.71 -1.589 . . . . 6.86 106.71 174.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 102' ' ' ASP . . . -103.73 -136.3 0.34 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.366 0.666 . . . . 3.23 110.579 -176.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -148.24 165.62 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.813 1.645 . . . . 1.36 109.152 -176.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 57.8 mt -102.52 165.16 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.898 2.079 . . . . 2.19 109.539 179.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.6 t -146.71 67.44 1.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.875 1.27 . . . . 2.24 107.913 170.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.2 135.81 13.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.143 -0.783 . . . . 1.2 111.143 -169.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -78.01 140.32 39.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.052 0.926 . . . . 1.62 109.502 178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.4 m -127.0 130.65 71.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 112.432 0.53 . . . . 0.92 112.432 -174.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.87 124.03 49.49 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.181 1.392 . . . . 1.97 109.183 -176.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.47 59.6 4.13 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.687 -1.227 . . . . 7.54 107.687 177.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 69.45 -49.19 0.61 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.589 1.956 . . . . 3.19 114.053 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -127.22 -18.96 4.41 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.949 1.299 . . . . 2.5 112.916 -170.485 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.51 151.49 50.94 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 108.374 -0.972 . . . . 1.27 108.374 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -131.24 109.48 10.43 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.272 -1.381 . . . . 3.61 107.272 175.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.47 40.36 1.58 Allowed 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 123.12 1.438 . . . . 4.17 110.704 169.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -154.87 166.03 32.31 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 114.652 -1.158 . . . . 0.86 111.699 -168.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.8 p -154.92 154.42 32.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.353 -1.424 . . . . 0.96 107.252 -170.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.429 ' OH ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -130.83 151.68 51.0 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 123.294 0.372 . . . . 2.27 111.042 164.037 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -117.26 128.36 54.99 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.933 -1.506 . . . . 2.03 106.933 175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.504 HD22 ' HB ' ' A' ' 135' ' ' VAL . 0.8 OUTLIER -121.81 152.06 39.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.518 1.527 . . . . 1.57 109.426 -178.688 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.25 150.39 19.15 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.579 -1.808 . . . . 1.25 108.579 165.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.1 tp -109.17 132.12 58.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 126.132 1.773 . . . . 2.29 108.029 -175.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.24 83.33 0.74 Allowed 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.554 -0.906 . . . . 5.49 108.554 173.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.08 65.32 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.332 1.444 . . . . 3.65 110.869 170.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.13 -48.68 0.43 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 106.22 -2.752 . . . . 3.03 106.22 163.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -162.13 42.34 0.13 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.614 0.766 . . . . 3.8 110.885 156.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.42 64.18 1.53 Allowed 'General case' 0 C--N 1.344 0.342 0 C-N-CA 124.295 1.038 . . . . 1.25 109.937 178.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -104.53 -32.91 8.74 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.987 1.315 . . . . 3.24 110.986 -166.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -145.23 156.63 43.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.324 -2.473 . . . . 2.89 104.324 175.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG22 ' HB3' ' A' ' 154' ' ' ALA . 35.0 m -121.73 140.21 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 104.563 -2.384 . . . . 1.1 104.563 162.3 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.57 129.11 38.58 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.799 -1.186 . . . . 0.9 107.799 -172.16 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -158.43 178.39 34.68 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 117.984 0.356 . . . . 0.82 112.424 -172.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.8 p -134.01 144.5 48.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.362 -0.977 . . . . 2.24 108.362 164.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -117.91 145.74 44.44 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.108 0.963 . . . . 0.83 109.772 173.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -120.82 102.91 8.69 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.239 1.019 . . . . 2.93 112.099 166.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.92 156.73 10.72 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 N-CA-C 107.953 -1.128 . . . . 2.55 107.953 169.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.51 60.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.14 -1.43 . . . . 4.28 107.14 -176.433 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.666 HG23 ' H ' ' A' ' 145' ' ' ASN . 1.9 t -81.43 -176.6 6.11 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 118.305 -1.358 . . . . 3.74 108.054 -179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 79.1 t -50.47 -24.2 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.116 0.966 . . . . 2.75 111.551 175.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.666 ' H ' HG23 ' A' ' 143' ' ' THR . 0.1 OUTLIER -152.0 59.33 0.85 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.243 1.417 . . . . 3.66 109.156 174.618 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.0 157.93 26.13 Favored Glycine 0 C--N 1.342 0.902 0 N-CA-C 110.648 -0.981 . . . . 1.93 110.648 -179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.36 126.57 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.622 0.769 . . . . 2.32 111.902 -154.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -68.46 -48.99 63.07 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 121.73 -0.606 . . . . 5.27 110.856 -179.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -83.22 80.91 8.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.393 -0.817 . . . . 1.9 108.969 -177.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 45.4 mt -104.31 123.55 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.39 0.676 . . . . 1.46 109.288 170.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.75 136.6 13.36 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.169 -1.573 . . . . 0.84 109.169 173.403 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.498 HD12 HD21 ' A' ' 125' ' ' LEU . 0.9 OUTLIER -116.32 120.55 39.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.25 -1.019 . . . . 1.14 108.25 -173.325 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.87 128.02 14.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.479 0.712 . . . . 0.99 110.569 -177.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -118.62 159.48 23.52 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.222 1.409 . . . . 0.85 111.847 175.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -143.43 123.11 13.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.31 1.444 . . . . 4.2 109.275 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 117.275 -1.345 . . . . 5.2 109.72 -153.543 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 107.527 -1.286 . . . . 56.78 107.527 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -170.19 154.45 4.95 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.241 -1.763 . . . . 49.03 106.241 -173.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -78.51 162.08 26.59 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.869 0.867 . . . . 45.1 109.805 168.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -164.92 170.9 14.73 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.008 1.723 . . . . 41.91 106.526 170.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.2 p -150.74 111.94 4.37 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.122 -1.066 . . . . 36.16 108.122 -176.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.21 164.59 20.18 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.91 0.323 . . . . 32.1 110.182 173.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 pp -128.38 166.1 19.34 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.525 1.53 . . . . 28.58 108.524 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.8 t -101.19 -172.71 2.22 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.694 0.797 . . . . 24.04 109.842 177.503 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.81 113.33 2.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.478 1.111 . . . . 20.51 109.142 -178.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -129.96 136.6 49.64 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.257 -1.016 . . . . 16.9 108.257 169.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -156.55 166.86 32.18 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.705 2.402 . . . . 18.38 105.54 171.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 p -51.87 121.67 7.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.344 -0.984 . . . . 10.36 108.344 164.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 60.08 31.49 20.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.497 1.119 . . . . 8.11 112.994 179.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.26 122.7 16.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.293 -0.88 . . . . 14.4 108.809 171.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 mt -67.9 -46.64 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.097 0.959 . . . . 15.5 111.553 -166.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -69.69 99.32 1.31 Allowed 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.766 -0.584 . . . . 19.49 110.063 -171.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 71.1 -58.1 0.58 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 129.239 3.016 . . . . 16.12 111.923 170.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 12.5 m -33.64 -46.18 0.2 Allowed 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.095 2.558 . . . . 12.17 112.92 173.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -34.42 -38.38 0.07 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 128.301 2.641 . . . . 11.38 114.845 -173.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -48.99 -63.99 0.94 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.449 1.1 . . . . 12.3 109.851 175.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.0 m -73.8 -31.2 63.15 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.783 -0.573 . . . . 9.5 112.531 170.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.71 -36.4 59.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 125.44 1.495 . . . . 6.82 113.248 -174.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.66 -9.56 58.79 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.78 1.4 . . . . 10.12 114.78 174.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 52.09 59.56 4.45 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.59 1.156 . . . . 9.49 111.235 -171.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.5 t -33.83 -54.71 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.466 1.906 . . . . 13.86 112.775 175.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -157.21 -70.72 0.1 Allowed 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.999 -0.741 . . . . 14.71 108.999 177.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 66.02 -37.57 0.27 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.058 2.143 . . . . 14.21 114.501 177.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -135.75 -45.24 0.66 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.703 1.601 . . . . 18.71 110.29 174.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.29 61.03 1.34 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.561 0.744 . . . . 18.63 109.834 -178.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.87 165.58 14.99 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 106.476 -1.676 . . . . 18.18 106.476 167.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -62.86 -37.43 86.84 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.001 0.364 . . . . 18.84 110.901 178.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 82.0 mt 60.12 -79.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.795 2.038 . . . . 13.62 109.847 -178.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -162.99 44.66 0.34 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.147 -1.581 . . . . 11.95 109.147 177.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 59.31 47.24 11.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.263 1.03 . . . . 12.82 109.745 173.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.4 mm -73.8 143.18 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.128 -0.942 . . . . 9.27 110.043 -172.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -153.76 -90.56 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.895 -1.52 . . . . 4.72 106.895 166.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.24 -75.0 1.61 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.975 -1.25 . . . . 2.78 109.975 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 41.42 -101.43 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.654 1.982 . . . . 4.92 111.677 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -39.08 -52.51 1.86 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.008 2.523 . . . . 4.26 109.488 174.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 m -56.67 -42.04 78.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.941 0.897 . . . . 2.82 112.489 -176.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -72.42 -53.34 12.48 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 122.004 -0.435 . . . . 2.01 110.0 174.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -46.06 -37.74 7.11 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.741 2.416 . . . . 3.97 113.003 177.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -55.3 -22.99 21.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.475 1.51 . . . . 3.4 111.565 177.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? 117.56 59.26 0.0 OUTLIER 'General case' 0 C--N 1.344 0.339 0 C-N-CA 130.943 3.697 . . . . 3.36 107.722 164.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.23 138.59 33.41 Favored Pre-proline 0 N--CA 1.446 -0.674 0 C-N-CA 125.893 1.677 . . . . 2.4 108.633 176.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.32 -160.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 124.62 3.546 . . . . 1.92 111.563 -173.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.06 21.85 14.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.486 2.314 . . . . 6.22 111.071 178.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.1 -170.6 5.64 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.369 0.985 . . . . 2.01 113.966 -179.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -108.53 -15.42 13.72 Favored Glycine 0 CA--C 1.535 1.335 0 N-CA-C 116.611 1.405 . . . . 1.54 116.611 -162.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.3 99.44 1.92 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 120.84 2.32 . . . . 5.06 112.235 -172.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.93 152.78 29.37 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.33 0.968 . . . . 1.42 111.432 171.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -79.15 59.54 2.77 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.567 1.547 . . . . 1.58 112.063 -169.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -78.95 67.86 4.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.549 -1.345 . . . . 3.08 110.016 178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -88.74 111.73 22.33 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.451 -1.315 . . . . 7.58 107.451 169.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.17 -169.79 27.12 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.593 -0.813 . . . . 0.68 112.941 -171.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m -133.63 143.05 48.36 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.839 1.656 . . . . 2.37 107.578 -178.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.11 70.69 0.76 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.667 1.987 . . . . 1.11 106.608 174.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -79.86 130.0 34.95 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.715 0.406 . . . . 2.19 110.484 -168.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.63 175.44 53.39 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.267 -0.733 . . . . 0.89 111.267 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 t -60.93 -34.75 75.19 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.97 -0.723 . . . . 1.74 111.278 174.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.4 -7.84 57.79 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.846 1.258 . . . . 3.49 111.641 173.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.314 25.5 t0 26.62 66.1 0.07 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.984 1.373 . . . . 3.3 113.003 -129.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.47 54.29 1.36 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 105.686 -1.968 . . . . 1.42 105.686 149.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.33 178.4 18.14 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 108.728 -1.749 . . . . 1.06 108.728 -174.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' HA3' HG23 ' A' ' 82' ' ' ILE . . . -108.43 175.08 19.39 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 124.457 1.027 . . . . 0.77 113.559 -169.157 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -95.66 151.91 18.92 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.903 -1.517 . . . . 3.98 106.903 160.144 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.0 tp -106.66 129.84 54.5 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.681 -0.859 . . . . 1.31 108.681 177.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.5 p -90.74 149.15 22.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.747 0.819 . . . . 2.44 109.778 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.4 101.82 8.35 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.21 -0.663 . . . . 2.2 109.21 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.8 m -154.87 77.43 1.03 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.274 0.559 . . . . 1.19 110.63 -163.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.64 120.64 3.14 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 N-CA-C 107.648 -1.241 . . . . 1.42 107.648 173.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.99 106.86 15.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.093 -1.077 . . . . 3.37 108.093 169.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -56.61 -15.78 5.03 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.419 1.088 . . . . 2.37 112.24 176.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -35.93 -43.42 0.32 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.809 0.731 . . . . 1.64 110.951 162.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.499 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -153.26 15.55 0.53 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.032 1.493 . . . . 1.08 115.032 169.093 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 mptt 55.15 75.59 0.3 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.182 2.593 . . . . 6.53 116.142 178.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.499 HE22 ' HB3' ' A' ' 75' ' ' ALA . 11.3 mm-40 -72.31 -54.65 8.89 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.22 0.533 . . . . 2.72 111.602 -170.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.57 56.57 2.62 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 123.939 0.781 . . . . 1.32 112.687 165.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -145.8 89.52 1.91 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 108.725 -0.843 . . . . 3.08 108.725 -163.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.27 175.4 44.45 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.492 -1.043 . . . . 1.97 110.492 173.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 151.4 23.38 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.127 0.417 . . . . 3.9 112.127 167.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.689 HG23 ' HA3' ' A' ' 65' ' ' GLY . 35.5 mt -115.14 106.24 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 127.459 2.304 . . . . 1.91 107.983 -174.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -152.73 81.86 1.22 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.704 0.764 . . . . 2.38 112.581 -164.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -158.88 23.1 0.21 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.713 1.205 . . . . 4.12 111.234 163.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.76 151.8 20.45 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.868 -0.52 . . . . 2.73 111.491 -157.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -30.16 68.71 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.262 -1.335 . . . . 4.96 112.407 -169.015 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.9 m -126.59 149.41 67.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.164 0.986 . . . . 1.71 109.891 -179.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.74 -45.96 33.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.491 2.128 . . . . 1.9 111.397 176.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.2 53.98 0.67 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.315 1.446 . . . . 3.38 111.365 177.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -167.49 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.375 3.07 . . . . 3.15 110.327 -179.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -62.58 120.85 11.94 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.871 -1.529 . . . . 1.98 106.871 168.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.74 145.97 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 125.309 1.444 . . . . 1.43 110.794 -164.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -112.0 130.79 55.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.855 -1.535 . . . . 2.8 106.855 161.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.0 mt -81.27 137.54 35.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.382 -1.34 . . . . 1.71 107.382 172.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.42 166.84 20.87 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.356 -0.979 . . . . 1.17 108.356 177.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.81 160.34 29.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 123.708 0.63 . . . . 1.96 109.821 -176.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.76 158.87 42.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.458 -0.571 . . . . 1.62 109.458 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -79.69 170.82 15.99 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.22 1.808 . . . . 4.51 108.731 162.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.7 tt -121.09 91.61 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.071 -1.085 . . . . 1.35 108.071 148.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -38.09 155.42 0.11 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.263 1.825 . . . . 9.23 112.407 157.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.22 63.84 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.292 2.662 . . . . 3.9 110.828 175.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.56 75.59 0.8 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.971 0.908 . . . . 5.52 108.711 175.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -28.75 113.48 0.04 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.414 1.959 . . . . 3.65 114.307 -172.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.64 -49.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.476 0.547 . . . . 6.02 112.476 162.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -175.04 -61.94 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 105.492 -2.04 . . . . 6.71 105.492 172.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -89.41 -146.05 0.16 Allowed 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 124.977 1.423 . . . . 6.39 107.321 145.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.7 -159.37 0.56 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.922 1.289 . . . . 3.72 108.247 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 m -136.11 152.63 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 119.292 0.951 . . . . 1.43 111.537 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.7 pt -83.11 177.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.934 0.894 . . . . 2.67 111.065 172.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.8 t -141.0 59.67 1.53 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.732 0.813 . . . . 2.21 110.903 173.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.07 177.77 54.02 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 121.671 0.595 . . . . 0.86 114.034 -176.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.1 m -142.25 167.86 21.11 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.736 1.614 . . . . 1.87 108.649 166.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.3 169.78 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.85 0.75 . . . . 1.22 112.312 -168.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pp -136.95 131.78 33.48 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.159 0.583 . . . . 2.41 109.732 169.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.88 66.85 1.92 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.489 1.516 . . . . 5.71 109.032 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 68.34 -56.16 0.51 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.081 1.353 . . . . 3.52 112.409 -166.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -89.41 -81.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.475 -0.565 . . . . 3.59 109.475 178.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -159.18 118.99 3.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.704 1.202 . . . . 2.41 109.246 -167.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.582 ' CD ' HG21 ' A' ' 141' ' ' VAL . 4.2 tp10 -134.01 80.19 1.85 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.873 -1.158 . . . . 11.32 107.873 -172.35 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -81.98 75.88 8.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.102 0.953 . . . . 5.78 109.88 -176.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -104.26 139.12 14.44 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 105.369 -3.093 . . . . 1.29 105.369 138.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.76 169.24 18.54 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.461 -0.941 . . . . 2.19 108.461 157.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -143.76 152.73 41.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.81 0.338 . . . . 4.22 110.65 175.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.2 t -128.92 120.96 27.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 104.631 -2.359 . . . . 2.35 104.631 -174.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD23 HD12 ' A' ' 152' ' ' LEU . 0.9 OUTLIER -137.84 142.27 40.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -175.756 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -134.61 142.92 14.45 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.728 1.632 . . . . 1.06 109.52 177.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.7 tt -78.87 158.83 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.203 -1.036 . . . . 2.79 108.203 176.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -148.52 150.77 33.96 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 115.272 1.582 . . . . 4.27 115.272 -175.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.24 -14.01 48.01 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.743 1.64 . . . . 2.63 112.657 169.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 107.02 -84.96 0.4 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.763 -2.135 . . . . 2.82 107.763 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 32.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.378 0.881 . . . . 3.98 113.378 -177.604 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 51.91 73.09 0.34 Allowed 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.601 1.091 . . . . 1.43 109.576 -176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -91.66 -53.46 4.29 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.164 -1.421 . . . . 2.57 107.164 -179.619 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -124.93 174.06 8.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.401 1.688 . . . . 2.57 108.802 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 154' ' ' ALA . 2.1 m -133.82 156.77 41.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 106.77 -1.567 . . . . 1.28 106.77 164.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.35 127.38 24.07 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 123.611 0.764 . . . . 0.9 109.033 177.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.76 177.24 34.62 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 121.718 0.621 . . . . 0.9 112.36 177.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 m -146.33 143.79 29.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.282 -0.54 . . . . 1.57 109.586 160.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.68 147.01 25.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.257 1.023 . . . . 1.04 108.579 163.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -130.07 78.37 1.84 Allowed 'General case' 0 C--N 1.341 0.2 0 N-CA-C 113.71 1.004 . . . . 4.18 113.71 178.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.869 HG22 ' H ' ' A' ' 142' ' ' LYS . 13.2 p -90.98 175.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.822 -0.626 . . . . 4.3 111.281 170.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.869 ' H ' HG22 ' A' ' 141' ' ' VAL . 16.8 pttp -177.65 58.88 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.725 -1.213 . . . . 3.84 107.725 -153.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 77.0 p -131.92 -177.07 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.394 -1.336 . . . . 3.42 107.394 -171.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.9 t -45.16 -32.38 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.146 0.979 . . . . 1.93 110.99 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -142.81 53.15 1.39 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.764 0.711 . . . . 2.34 109.36 169.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.429 ' CA ' HG13 ' A' ' 141' ' ' VAL . . . -115.1 105.69 1.51 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 108.263 -1.935 . . . . 1.57 108.263 179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.473 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -78.7 126.38 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.84 -1.17 . . . . 1.61 107.84 174.171 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -76.09 -45.02 36.09 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 120.863 0.363 . . . . 3.57 110.204 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -83.39 69.01 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.465 -0.772 . . . . 2.48 109.159 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 41.0 mt -83.09 108.13 15.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 N-CA-C 107.41 -1.33 . . . . 1.48 107.41 163.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.78 110.14 3.13 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.775 -1.73 . . . . 0.95 108.775 170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.605 HD12 HD23 ' A' ' 125' ' ' LEU . 1.3 tm? -95.52 113.08 24.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 107.056 -1.461 . . . . 1.47 107.056 178.044 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.07 142.55 38.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 109.154 -0.684 . . . . 1.33 109.154 177.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.497 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -135.48 155.13 51.02 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 124.384 1.074 . . . . 1.2 108.838 175.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.77 154.36 29.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 125.017 1.448 . . . . 5.33 108.955 162.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.231 0 N-CA-C 108.943 -0.762 . . . . 5.17 108.943 169.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.592 -1.633 . . . . 48.96 106.592 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -145.18 138.93 26.87 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.773 -1.195 . . . . 42.06 107.773 179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.3 t -174.32 176.7 2.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.537 1.935 . . . . 38.52 106.616 169.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 170.67 148.55 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.753 2.021 . . . . 34.95 108.751 -176.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.5 t -165.93 173.4 10.54 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.719 -1.215 . . . . 31.16 107.719 169.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -172.93 155.11 3.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.248 1.819 . . . . 27.67 107.927 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.56 171.88 19.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.095 1.358 . . . . 25.92 109.64 -178.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.5 t -169.4 179.77 3.75 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.208 1.803 . . . . 21.58 107.059 173.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.92 20.26 0.11 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.389 0.885 . . . . 19.54 113.389 -179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -66.31 110.68 3.15 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.998 0.817 . . . . 15.65 109.514 176.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -124.46 16.67 8.93 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.775 1.23 . . . . 18.06 111.631 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -167.89 174.69 7.29 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.407 -1.331 . . . . 10.78 107.407 177.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.57 54.27 1.45 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.879 0.871 . . . . 6.65 111.42 -177.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -74.87 146.41 41.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.247 -1.39 . . . . 13.81 107.247 165.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.0 mm 50.16 50.41 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 122.313 1.054 . . . . 14.0 110.49 -168.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -171.49 0.28 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.702 -0.681 . . . . 15.59 109.676 162.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 66.33 -61.46 0.29 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.034 1.734 . . . . 15.15 111.225 -172.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.9 t -75.22 -93.27 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.167 0.587 . . . . 12.97 112.108 164.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -71.03 -64.91 0.81 Allowed 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.313 -0.867 . . . . 11.51 111.306 -163.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.28 7.7 m-70 -70.0 0.86 5.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.034 1.733 . . . . 10.14 114.362 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -26.05 -39.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 128.434 2.694 . . . . 10.59 115.326 -179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -27.45 -46.52 0.04 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.976 1.75 . . . . 8.66 112.23 167.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -27.49 -46.97 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 128.669 2.788 . . . . 10.1 113.693 174.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.4 mmt -152.95 60.6 0.79 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.692 0.758 . . . . 13.21 110.116 169.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -54.54 -69.04 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.819 -0.551 . . . . 16.27 110.823 170.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -150.83 -174.68 4.86 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.318 1.047 . . . . 18.33 109.187 -169.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 54.23 29.8 11.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.521 1.128 . . . . 21.54 110.971 -172.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.58 -45.12 92.81 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.489 0.716 . . . . 21.23 111.439 -161.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -77.65 -22.0 51.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.636 0.774 . . . . 23.56 112.671 179.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.11 171.65 14.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.666 0.666 . . . . 23.26 110.271 -171.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -64.28 133.55 52.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.24 -1.022 . . . . 20.38 108.24 163.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.0 mt -133.2 124.47 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 101.812 -3.403 . . . . 14.27 101.812 159.504 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.36 -44.96 9.1 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 107.736 -2.146 . . . . 11.55 107.736 170.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.0 170.53 0.43 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.691 2.397 . . . . 9.47 110.624 172.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.1 mm 68.57 157.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.627 1.971 . . . . 7.48 112.896 174.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 78.74 172.44 0.17 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.986 1.715 . . . . 3.88 113.092 167.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.92 -54.59 0.05 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.154 -1.978 . . . . 2.8 108.154 -177.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -22.39 -55.47 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.552 2.341 . . . . 7.69 115.133 -175.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.486 ' CD2' ' H ' ' A' ' 39' ' ' HIS . 74.0 m-70 -29.79 -64.89 0.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.186 2.194 . . . . 6.31 109.942 174.134 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.6 t -78.64 -57.69 3.63 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.644 1.178 . . . . 3.15 113.222 163.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.2 m -68.84 -18.95 64.24 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 115.211 1.56 . . . . 1.89 115.211 -157.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -40.24 -51.53 2.7 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.24 1.816 . . . . 3.64 111.349 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -66.18 -60.96 2.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.168 0.508 . . . . 4.8 109.837 -177.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.19 -49.56 0.08 Allowed 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.01 0.924 . . . . 4.11 110.913 -178.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.4 mp -38.54 96.71 0.12 Allowed Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 128.23 2.612 . . . . 2.8 113.267 -161.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -93.81 -157.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.986 3.124 . . . . 2.01 112.577 -159.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.67 50.08 0.07 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.692 1.597 . . . . 5.31 111.885 162.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.2 -18.28 71.0 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.755 1.169 . . . . 2.75 115.597 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.21 -50.44 4.31 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 120.582 2.191 . . . . 1.62 112.873 172.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -136.73 162.16 33.95 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 117.966 0.883 . . . . 5.07 111.424 176.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.699 ' HB2' HG13 ' A' ' 71' ' ' ILE . . . -78.68 -179.5 6.51 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.743 1.617 . . . . 2.55 108.027 168.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 t -144.05 55.05 1.3 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.553 -0.859 . . . . 2.43 110.813 166.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' CD1' ' HB1' ' A' ' 51' ' ' ALA . 2.1 p90 -117.57 155.0 30.56 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 114.463 1.283 . . . . 5.16 114.463 -172.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.6 mtt85 -128.13 101.99 6.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.7 -1.963 . . . . 4.43 105.7 177.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -121.92 168.73 14.64 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-O 122.136 0.853 . . . . 0.83 112.597 -166.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -126.88 136.14 51.91 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.759 2.024 . . . . 2.25 106.956 -178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 73.31 0.86 Allowed 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.145 -1.798 . . . . 0.97 106.145 171.114 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -80.57 130.93 35.42 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.387 -0.597 . . . . 2.39 109.387 -170.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.4 165.74 51.92 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.946 -1.262 . . . . 0.97 109.946 -176.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 p -53.33 -37.13 62.04 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.068 -0.666 . . . . 2.24 110.602 167.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -87.85 -1.35 57.92 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.933 1.293 . . . . 2.58 112.246 177.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.255 10.3 m-20 57.68 13.32 1.92 Allowed 'General case' 0 C--N 1.344 0.359 0 C-N-CA 125.291 1.436 . . . . 4.56 114.593 -167.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.55 57.22 2.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.927 -1.138 . . . . 1.37 107.927 164.179 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.2 175.91 24.15 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.235 -0.746 . . . . 1.07 111.235 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.92 170.88 18.43 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.66 1.6 . . . . 0.88 110.012 178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -89.99 171.49 9.53 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.584 -0.895 . . . . 3.52 108.584 164.254 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 tp -136.92 136.97 39.08 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.28 -1.008 . . . . 1.07 108.28 171.381 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.8 t -123.12 162.94 21.51 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.894 0.878 . . . . 3.34 111.692 -174.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -75.08 99.5 3.94 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.412 1.485 . . . . 2.94 110.58 -166.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.5 m -151.91 80.89 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.068 -1.02 . . . . 0.98 110.996 177.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -146.64 133.87 14.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 106.284 -1.747 . . . . 1.22 106.284 175.657 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -95.56 112.65 24.33 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 120.26 1.391 . . . . 3.92 108.315 167.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -50.17 -21.88 1.49 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.37 1.468 . . . . 3.19 113.149 176.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.67 -43.39 12.54 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.123 0.874 . . . . 1.3 111.16 173.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' HB3' HE22 ' A' ' 77' ' ' GLN . . . -146.22 18.48 1.39 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.779 0.659 . . . . 1.15 112.779 173.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG2' HD11 ' A' ' 109' ' ' ILE . 6.4 tttm 42.36 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.368 2.667 . . . . 5.05 115.087 178.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.465 HE22 ' HB3' ' A' ' 75' ' ' ALA . 10.2 mm-40 -69.85 -52.91 20.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 119.923 -0.711 . . . . 2.98 110.421 -171.319 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA3' HD13 ' A' ' 109' ' ' ILE . . . 93.47 31.72 8.17 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-O 119.124 -0.82 . . . . 1.35 114.131 167.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -132.37 76.33 1.69 Allowed 'General case' 0 C--O 1.227 -0.087 0 CA-C-N 118.428 1.114 . . . . 2.99 109.878 -157.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.99 126.17 8.83 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.843 -1.703 . . . . 0.93 108.843 177.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.06 157.16 28.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.365 0.582 . . . . 3.93 111.432 -176.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.407 HD12 ' C ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.51 141.29 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 107.097 -1.446 . . . . 4.75 107.097 177.478 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -158.09 95.06 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.672 0.748 . . . . 2.34 112.734 -178.051 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.41 -12.85 0.05 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.799 1.239 . . . . 4.24 114.086 156.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -66.57 152.26 45.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 119.253 0.933 . . . . 3.23 112.326 -168.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -26.02 58.52 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 113.685 -1.598 . . . . 4.04 112.471 -166.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.9 m -94.13 130.92 32.75 Favored Pre-proline 0 N--CA 1.449 -0.524 0 N-CA-C 106.524 -1.658 . . . . 1.79 106.524 175.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -54.58 -42.17 70.68 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.013 1.809 . . . . 1.9 109.239 177.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -74.05 17.93 0.16 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.945 1.091 . . . . 6.13 113.945 178.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.53 0.03 9.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.769 0.827 . . . . 2.44 111.282 162.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.84 79.34 2.11 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.302 -1.37 . . . . 2.49 107.302 168.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.28 123.01 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.228 -0.442 . . . . 1.09 111.464 -174.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.42 136.26 46.49 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.486 -1.301 . . . . 2.97 107.486 167.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.39 142.23 30.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.032 -0.729 . . . . 1.69 109.032 -178.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.45 161.87 27.63 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.152 -1.055 . . . . 1.16 108.152 173.466 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.37 142.08 39.51 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 120.118 -0.633 . . . . 1.5 109.526 -176.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.55 175.44 9.16 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.273 1.029 . . . . 2.1 109.711 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -136.59 161.49 35.75 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.503 1.921 . . . . 3.54 107.185 -175.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.431 HD11 ' O ' ' A' ' 106' ' ' HIS . 0.1 OUTLIER -135.52 100.39 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.706 1.202 . . . . 1.71 108.728 171.004 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -108.77 -40.4 0.12 Allowed Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 126.082 1.753 . . . . 7.0 113.491 -179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.29 -55.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 CA-C-N 122.082 1.779 . . . . 3.78 113.396 -171.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.73 74.37 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.956 2.502 . . . . 4.66 116.886 -165.375 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.47 60.8 1.95 Allowed Glycine 0 CA--C 1.531 1.053 0 O-C-N 120.561 -1.337 . . . . 3.03 111.455 171.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -149.82 63.02 0.99 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.539 1.136 . . . . 5.34 108.425 -179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 59.84 7.09 1.02 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.571 1.548 . . . . 6.58 113.733 -175.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 3.4 t-80 119.69 -34.5 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 129.093 2.957 . . . . 5.55 110.896 -172.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 33.29 -96.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 120.398 1.454 . . . . 2.63 113.129 -161.567 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 m -138.91 152.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 CA-C-N 121.347 1.885 . . . . 1.16 116.016 -177.429 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' A' ' 76' ' ' LYS . 8.3 mt -88.04 153.73 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 126.603 1.961 . . . . 2.48 107.223 158.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.1 m -123.53 101.26 7.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.048 1.339 . . . . 1.84 108.977 173.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -102.91 175.2 23.96 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.309 0.957 . . . . 0.74 111.98 174.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 m -133.15 150.37 52.03 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.591 1.556 . . . . 1.45 107.157 175.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.56 132.04 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.299 0.481 . . . . 0.89 112.299 -158.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.8 tp -106.38 114.14 28.08 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 124.581 1.153 . . . . 2.33 110.372 -172.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -78.68 70.97 5.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.023 -1.473 . . . . 7.26 107.023 169.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 66.44 -65.41 0.2 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.341 1.856 . . . . 3.29 112.762 171.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -111.57 -14.78 13.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.815 1.646 . . . . 4.04 112.272 174.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -128.71 115.32 17.82 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.275 0.943 . . . . 1.54 110.787 -165.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -102.35 108.25 19.54 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 3.45 109.144 172.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.49 45.35 1.73 Allowed 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 120.936 -1.102 . . . . 3.56 111.606 161.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -139.58 148.93 20.44 Favored Glycine 0 CA--C 1.521 0.444 0 N-CA-C 110.669 -0.972 . . . . 0.55 110.669 179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.4 p -127.54 139.07 53.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.336 1.854 . . . . 0.79 107.344 -175.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -134.03 139.15 45.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 123.305 0.378 . . . . 2.87 110.705 -171.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.3 m -121.92 123.45 41.74 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.547 -2.02 . . . . 1.88 105.547 -174.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.13 134.3 24.29 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-N 118.685 0.675 . . . . 0.86 110.301 -170.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.52 -177.42 18.05 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.887 2.184 . . . . 2.01 111.365 -165.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.475 ' HA ' HD12 ' A' ' 127' ' ' ILE . 3.8 tp -137.38 143.58 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 O-C-N 121.569 -0.96 . . . . 2.67 109.517 157.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -161.02 179.05 8.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.522 0.677 . . . . 4.68 112.2 174.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.45 -48.16 1.71 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 126.067 1.794 . . . . 3.28 109.434 176.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 149.79 -84.91 0.16 Allowed Glycine 0 C--N 1.334 0.46 0 N-CA-C 107.75 -2.14 . . . . 2.82 107.75 174.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 pttt -76.84 49.79 0.66 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.569 0.581 . . . . 5.28 112.569 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 46.33 57.03 5.68 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.57 1.548 . . . . 2.1 112.252 173.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -99.62 -59.2 1.76 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.193 -1.821 . . . . 2.59 107.432 -178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.97 87.82 6.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.491 -0.559 . . . . 4.82 109.491 -179.088 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 154' ' ' ALA . 29.9 m -77.4 68.58 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.02 -1.104 . . . . 2.03 108.02 170.154 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.38 26.16 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.443 -1.411 . . . . 1.45 108.414 -167.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.83 176.33 34.92 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 112.124 -0.39 . . . . 0.93 112.124 -173.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.8 m -149.53 139.87 22.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.559 1.543 . . . . 1.69 107.454 170.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -103.45 149.12 25.12 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.01 -0.737 . . . . 0.71 109.01 163.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -110.4 127.01 54.89 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.98 -1.489 . . . . 3.44 106.98 148.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.13 147.02 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.796 -1.557 . . . . 2.15 106.796 165.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.01 121.98 10.69 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.462 -1.31 . . . . 3.42 107.462 177.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.0 t -149.96 -172.02 4.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.223 -2.14 . . . . 2.62 105.223 167.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 38.8 t -47.71 -33.35 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.575 1.15 . . . . 2.16 110.317 176.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -138.68 55.34 1.73 Allowed 'General case' 0 C--N 1.34 0.16 0 N-CA-C 108.61 -0.885 . . . . 3.4 108.61 168.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.73 119.83 5.73 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.064 -2.015 . . . . 0.97 108.064 174.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.97 121.66 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 124.135 0.974 . . . . 1.52 108.989 -172.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 mtp-105 -66.79 -70.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.099 0.407 . . . . 2.43 112.099 -171.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -75.21 76.37 2.35 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.266 -0.271 . . . . 2.5 110.805 -168.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 34.0 mt -79.99 119.88 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 123.583 0.753 . . . . 1.34 109.354 174.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.75 114.75 3.89 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.75 -1.74 . . . . 0.88 108.75 167.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -97.48 120.75 38.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.042 -1.095 . . . . 1.09 108.042 178.345 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.01 126.93 13.56 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 118.272 0.487 . . . . 0.93 110.65 177.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.604 ' HB3' HG22 ' A' ' 135' ' ' VAL . . . -129.76 159.67 35.8 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 107.172 -1.418 . . . . 1.27 107.172 161.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -160.45 114.12 2.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.216 1.406 . . . . 4.88 108.587 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.19 -1.041 . . . . 4.69 108.19 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 119.532 -0.271 . . . . 48.9 111.151 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -147.88 55.73 1.06 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 106.789 -1.559 . . . . 43.99 106.789 177.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -163.33 143.63 8.95 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.109 -1.441 . . . . 41.01 107.109 -173.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -165.62 156.57 13.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.647 -1.242 . . . . 36.12 107.647 177.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.9 p -163.23 162.59 25.41 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.726 -1.583 . . . . 32.2 106.726 166.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.81 54.81 0.2 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.816 0.846 . . . . 28.12 109.249 -179.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 33.2 tp -80.44 131.63 35.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.645 -0.872 . . . . 25.22 108.645 -178.281 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 t -159.83 179.01 9.18 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.282 -1.377 . . . . 21.78 107.282 170.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -172.28 178.55 2.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.116 1.366 . . . . 18.42 109.01 -175.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -159.95 -179.97 8.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.511 1.924 . . . . 14.88 106.418 173.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -153.88 156.9 38.43 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.794 0.725 . . . . 15.11 110.576 178.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 t 158.98 -154.35 0.0 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 131.282 3.833 . . . . 9.21 103.957 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.68 28.33 0.13 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.279 1.832 . . . . 6.0 110.023 -170.633 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -130.01 114.98 16.48 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 107.364 -1.347 . . . . 11.76 107.364 177.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . 0.314 40.7 pt 42.05 -137.53 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.518 1.927 . . . . 15.47 113.407 -172.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 8.08 83.19 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.091 2.957 . . . . 16.44 116.437 -170.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.7 t70 66.46 -58.55 0.36 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 127.693 2.397 . . . . 12.1 112.357 -177.338 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.9 m -42.04 -32.41 0.45 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.237 2.215 . . . . 10.08 113.463 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -33.18 -57.82 0.39 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.515 1.926 . . . . 11.55 111.89 164.013 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -67.68 -68.01 0.42 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.463 1.105 . . . . 12.65 109.074 174.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 m -71.23 -56.95 5.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.81 1.244 . . . . 10.24 112.465 -159.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.9 -55.01 7.58 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.496 1.046 . . . . 7.24 111.545 -176.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.21 -9.03 57.42 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.696 1.199 . . . . 8.83 112.173 -178.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER 58.51 78.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.784 1.633 . . . . 13.53 111.325 173.381 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.75 92.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.463 -0.939 . . . . 14.71 108.463 165.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.62 175.15 0.29 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.419 1.488 . . . . 17.96 111.206 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.95 45.33 25.22 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.236 1.014 . . . . 22.44 111.692 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 -74.0 71.75 1.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.208 -0.664 . . . . 20.39 109.208 172.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -143.16 55.02 1.37 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.935 1.694 . . . . 26.31 108.024 -177.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -141.73 -167.74 2.51 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.132 1.373 . . . . 21.69 108.243 -178.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -72.4 67.74 0.74 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.034 0.934 . . . . 22.75 110.638 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 60.9 mt -77.5 72.02 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.186 -1.413 . . . . 17.68 107.186 174.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -160.8 55.81 0.32 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 107.655 -2.178 . . . . 14.13 107.655 179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.12 -63.74 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.422 1.889 . . . . 11.54 107.311 -173.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.2 mm -54.16 134.59 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.151 0.981 . . . . 9.22 109.615 174.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.1 168.88 11.06 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.334 1.053 . . . . 4.39 110.452 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.75 -68.62 2.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 119.423 -0.654 . . . . 2.71 111.942 168.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 28.42 -92.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.205 2.202 . . . . 5.66 113.693 -176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -63.93 -34.49 78.09 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 124.486 1.115 . . . . 4.46 110.455 -168.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.1 p -58.39 -70.17 0.15 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.018 -0.734 . . . . 3.05 109.018 173.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.0 p -44.95 -51.22 10.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.607 -0.724 . . . . 3.6 110.955 -178.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -52.11 -41.91 62.85 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.037 2.135 . . . . 2.91 113.288 175.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.25 -18.21 47.3 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.104 0.865 . . . . 3.64 112.309 175.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.7 mtpt 113.74 60.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 130.158 3.383 . . . . 3.78 109.796 169.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -118.48 102.03 50.44 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 125.041 1.336 . . . . 4.35 108.6 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.86 -169.66 0.84 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.144 2.562 . . . . 1.98 111.354 -176.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.76 40.95 0.2 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.559 1.144 . . . . 5.8 111.948 173.286 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.67 151.61 20.99 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.532 1.063 . . . . 2.19 111.703 -175.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.07 -36.71 8.8 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.397 0.998 . . . . 1.62 114.955 -170.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 114.37 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 120.544 -1.562 . . . . 6.39 108.096 -178.257 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB3' HG13 ' A' ' 71' ' ' ILE . . . -79.6 175.58 10.49 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 121.173 0.511 . . . . 1.62 111.084 168.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.9 t -108.75 129.88 55.37 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.718 1.607 . . . . 1.74 109.089 -176.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 135' ' ' VAL . 78.8 m-85 -146.66 168.76 20.5 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 124.591 1.156 . . . . 4.3 109.223 167.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -138.04 135.47 35.91 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 105.393 -2.077 . . . . 6.35 105.393 157.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -169.38 175.43 43.66 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.855 -1.164 . . . . 0.96 113.933 -178.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.4 p -134.33 142.87 47.38 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 2.14 108.275 -169.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.0 69.05 0.8 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.781 2.032 . . . . 0.93 106.52 169.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -82.55 144.95 30.02 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 123.577 0.751 . . . . 2.26 109.759 -173.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.94 150.2 35.54 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.457 -1.457 . . . . 1.08 109.457 -178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.0 t -55.4 -24.21 28.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.802 1.301 . . . . 2.66 111.096 164.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -108.12 27.13 9.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.331 1.453 . . . . 3.04 110.388 174.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.393 28.0 t0 -3.45 79.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.371 0 N-CA-C 118.831 2.9 . . . . 2.95 118.831 -151.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.07 54.35 0.79 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.641 -1.614 . . . . 1.14 106.641 152.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.89 -179.98 22.6 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.546 1.546 . . . . 1.13 110.156 -175.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -126.89 179.9 16.11 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 124.986 1.279 . . . . 0.71 111.084 -172.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -77.28 168.92 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 122.194 -0.592 . . . . 3.84 109.483 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 tp -119.93 105.3 10.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.597 -1.26 . . . . 0.98 107.597 156.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.9 m -78.61 149.24 32.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.218 -0.66 . . . . 2.24 109.218 175.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -78.27 114.47 17.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.46 -0.57 . . . . 2.14 109.46 -173.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.9 m -155.42 84.4 1.05 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.51 -0.922 . . . . 1.21 108.51 -179.325 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -139.58 123.66 19.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 108.533 -0.914 . . . . 1.38 108.533 177.035 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.17 112.35 20.63 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.76 -1.2 . . . . 3.65 107.76 170.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -55.64 -34.6 65.09 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.108 1.363 . . . . 2.58 112.367 -172.177 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.33 -32.43 2.02 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.615 1.166 . . . . 1.26 113.094 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -152.53 12.78 0.54 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 115.001 1.482 . . . . 1.28 115.001 172.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.576 ' HG2' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER 46.12 73.63 0.17 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.876 2.07 . . . . 5.49 114.415 178.6 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.64 65.36 5.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.076 -1.824 . . . . 1.83 106.076 170.478 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.557 ' H ' HD11 ' A' ' 109' ' ' ILE . . . -80.54 88.68 1.31 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 114.272 -1.331 . . . . 1.29 111.165 -169.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -138.02 96.88 3.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.584 -0.895 . . . . 2.54 108.584 -165.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 138.54 14.46 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.259 1.409 . . . . 0.83 110.312 -174.558 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.84 124.93 29.08 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 113.603 0.964 . . . . 3.4 113.603 -168.019 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.19 73.73 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.569 1.548 . . . . 2.07 107.136 -178.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -135.67 91.66 2.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.96 -1.018 . . . . 2.91 111.666 -159.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -159.92 33.09 0.18 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 3.64 111.302 150.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.95 140.66 32.77 Favored 'General case' 0 C--N 1.334 -0.088 0 O-C-N 121.58 -0.7 . . . . 1.47 111.04 -164.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -36.95 75.69 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.779 1.631 . . . . 3.3 112.193 -173.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 m -87.8 115.99 64.75 Favored Pre-proline 0 N--CA 1.448 -0.572 0 N-CA-C 106.391 -1.707 . . . . 1.43 106.391 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -51.26 -51.91 10.19 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.798 2.332 . . . . 1.49 111.364 -167.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -52.03 -32.75 35.59 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.828 1.251 . . . . 5.27 113.774 -179.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -69.39 -16.18 63.46 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 118.787 -0.625 . . . . 2.0 111.307 -178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -70.83 89.45 0.76 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.713 -1.217 . . . . 1.77 107.713 177.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.77 120.1 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 124.4 1.08 . . . . 1.07 108.243 -168.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.87 148.92 25.16 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 106.749 -1.574 . . . . 2.01 106.749 166.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.8 mt -101.96 140.56 36.08 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.471 -1.307 . . . . 1.77 107.471 173.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.54 153.02 35.8 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.819 -0.808 . . . . 0.93 108.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.3 119.9 20.83 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 107.438 -1.319 . . . . 1.12 107.438 -177.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.55 131.82 19.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 123.091 0.245 . . . . 1.14 110.731 -168.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.64 173.58 12.28 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.071 1.348 . . . . 3.16 112.043 -167.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.2 tt -131.22 115.32 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.23 1.412 . . . . 1.58 107.228 157.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' H ' ' CD ' ' A' ' 101' ' ' PRO . 35.6 mttp -123.23 -42.24 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.848 1.259 . . . . 8.23 114.378 176.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' CD ' ' H ' ' A' ' 100' ' ' LYS . 26.9 Cg_endo -93.83 21.77 0.58 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 CA-C-N 121.664 1.63 . . . . 3.91 112.989 -166.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -74.48 92.78 2.38 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.888 -1.132 . . . . 5.61 109.402 179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 51.64 1.84 Allowed Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.384 -0.823 . . . . 3.27 112.18 173.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt 171.23 149.41 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 128.663 2.785 . . . . 4.9 105.501 -170.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 33.4 mtt85 -49.89 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.511 1.05 . . . . 5.93 113.126 -178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 2.3 t60 61.2 63.93 1.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.948 0.88 . . . . 5.8 111.567 155.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 108' ' ' VAL . . . -57.0 -72.98 0.07 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.624 -1.171 . . . . 2.43 110.996 178.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 107' ' ' ALA . 3.4 m -167.53 163.59 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 123.958 0.903 . . . . 1.38 110.403 -177.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.557 HD11 ' H ' ' A' ' 78' ' ' GLY . 91.7 mt -77.21 161.49 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 114.862 -1.063 . . . . 2.15 108.883 159.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.7 t -122.26 89.06 3.04 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.956 -1.127 . . . . 1.68 107.956 164.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -108.13 178.11 21.21 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.485 1.516 . . . . 0.85 112.438 -176.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.7 m -147.64 163.02 37.93 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.746 1.218 . . . . 2.06 108.546 175.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 141' ' ' VAL . 0.7 OUTLIER -128.21 137.43 57.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.059 0.544 . . . . 0.81 112.353 -160.026 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.66 114.94 27.11 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.148 2.179 . . . . 2.49 109.993 -173.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -79.11 58.89 2.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.642 2.377 . . . . 5.45 109.21 178.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 44.0 t30 66.19 -42.54 0.38 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.049 1.34 . . . . 3.68 113.388 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.47 -23.88 2.07 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.564 1.546 . . . . 2.44 113.525 -171.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -131.49 137.87 48.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.037 0.935 . . . . 1.52 108.512 -171.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -122.0 106.13 10.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.185 -1.413 . . . . 3.75 107.185 178.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.61 38.58 1.37 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.022 0.439 . . . . 3.93 111.102 172.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -143.8 151.65 23.53 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.775 1.655 . . . . 0.78 110.134 -176.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.25 162.72 16.21 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.37 1.868 . . . . 1.03 110.457 -166.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -156.01 153.71 29.92 Favored 'General case' 0 C--N 1.337 0.063 0 O-C-N 121.471 -0.768 . . . . 2.32 110.839 176.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 p -151.8 134.61 15.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.981 -0.748 . . . . 1.57 108.981 175.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -148.69 121.63 8.78 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.699 0.625 . . . . 1.26 112.613 -169.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.61 150.76 18.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.473 1.987 . . . . 1.06 110.642 -178.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.551 ' HA ' HG12 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -103.96 144.08 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.35 -0.981 . . . . 2.49 108.35 175.719 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -142.34 170.64 15.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 122.11 0.957 . . . . 7.01 111.859 178.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.3 -19.07 54.35 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 114.408 -1.269 . . . . 2.85 111.327 179.444 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.05 64.27 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 117.834 0.817 . . . . 2.53 112.498 165.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -163.5 46.47 0.12 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.696 1.598 . . . . 3.1 107.798 160.415 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 42.56 89.14 0.01 OUTLIER 'General case' 0 C--N 1.346 0.442 0 C-N-CA 126.408 1.883 . . . . 1.67 112.23 -178.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -117.23 -59.27 1.97 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.68 -1.23 . . . . 2.3 107.68 -178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -121.44 149.73 42.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.209 1.804 . . . . 2.72 108.642 -178.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 127' ' ' ILE . 15.8 m -122.3 140.47 46.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.81 -1.181 . . . . 1.12 107.81 167.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -124.22 132.64 53.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.017 -1.475 . . . . 0.84 107.017 -179.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -157.8 -179.22 32.54 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.595 -1.002 . . . . 0.87 110.595 -168.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.8 m -142.87 138.3 30.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.12 -1.437 . . . . 1.47 107.12 158.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.58 131.94 45.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.964 -1.495 . . . . 1.01 106.964 160.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -102.5 81.75 2.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.848 -1.538 . . . . 2.95 106.848 163.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 113' ' ' VAL . 3.4 m -81.56 113.08 20.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 104.935 -2.246 . . . . 2.55 104.935 168.719 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -130.27 113.78 14.84 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.172 -1.418 . . . . 4.77 107.172 -170.36 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 66.3 m -156.77 176.35 12.85 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.085 -2.191 . . . . 2.77 105.085 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.5 t -44.34 -30.47 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.392 0.677 . . . . 2.52 110.369 162.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -131.23 76.57 1.73 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.484 -1.302 . . . . 4.36 107.484 170.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.61 105.98 0.4 Allowed Glycine 0 C--N 1.333 0.367 0 N-CA-C 110.765 -0.934 . . . . 1.53 110.765 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 147' ' ' ILE . 0.0 OUTLIER -79.21 81.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 C-N-CA 123.956 0.902 . . . . 1.64 108.73 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -40.55 -47.73 2.74 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 123.24 0.616 . . . . 2.74 112.406 176.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -77.58 74.01 4.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.73 -0.841 . . . . 2.35 108.73 178.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 1.1 mt -89.06 129.84 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 108.943 -0.762 . . . . 1.41 108.943 166.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.9 100.46 1.86 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 108.421 -1.872 . . . . 1.2 108.421 167.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -82.95 100.69 10.58 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.466 -1.309 . . . . 1.13 107.466 170.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.06 115.34 21.02 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.111 0.965 . . . . 1.44 109.08 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -129.91 136.03 49.03 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 124.143 0.977 . . . . 1.01 110.858 177.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.1 ptpm? -158.34 132.09 7.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.806 -1.924 . . . . 4.09 105.806 165.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 116.017 -1.944 . . . . 4.32 111.988 177.335 . . . . . . . . 0 0 . 1 stop_ save_